data_2m2i_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m2i _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.56 ' HB2' ' HB2' ' A' ' 10' ' ' LYS . 62.8 pttt . . . . . 0 CA--C 1.558 1.253 0 CA-C-O 121.387 0.613 . . . . 0.0 112.227 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.464 HG21 ' HA ' ' A' ' 84' ' ' LEU . 44.7 mt -52.13 -34.7 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 125.714 1.605 . . . . 0.0 113.209 -174.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.423 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 67.8 m-85 -114.34 16.74 17.81 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.482 0.713 . . . . 0.0 110.914 -174.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.56 ' HB2' ' HB2' ' A' ' 7' ' ' LYS . 25.5 tptp -54.67 -43.82 72.77 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.275 1.03 . . . . 0.0 112.899 -169.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -102.98 7.2 39.16 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.362 0.665 . . . . 0.0 111.376 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.1 m -108.37 118.87 37.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.569 0.748 . . . . 0.0 111.24 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.502 HG13 HG22 ' A' ' 48' ' ' VAL . 69.9 t -89.78 125.36 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 164.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.517 ' HB ' HD11 ' A' ' 31' ' ' ILE . 4.1 mp -117.55 127.22 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.268 0.556 . . . . 0.0 111.125 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.459 ' HH ' ' HD1' ' A' ' 41' ' ' TYR . 19.3 t80 -103.48 150.87 23.47 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.739 1.216 . . . . 0.0 107.869 169.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.546 HG12 ' HB ' ' A' ' 52' ' ' VAL . 65.1 mt -123.03 130.91 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -128.46 141.7 51.31 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.612 1.165 . . . . 0.0 109.476 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.09 -168.37 48.7 Favored Glycine 0 N--CA 1.477 1.401 0 N-CA-C 112.263 -0.335 . . . . 0.0 112.263 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -101.22 108.49 20.15 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.418 HG21 HG12 ' A' ' 52' ' ' VAL . 69.4 p -110.08 139.73 44.9 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.06 0.944 . . . . 0.0 109.433 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -105.96 126.86 29.6 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 170.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD2' HD21 ' A' ' 27' ' ' LEU . 45.7 Cg_endo -78.81 175.23 47.42 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 124.449 -1.063 . . . . 0.0 111.977 -0.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.22 153.99 5.6 Favored Glycine 0 C--N 1.349 1.263 0 O-C-N 123.948 0.78 . . . . 0.0 114.671 -170.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -57.97 -34.76 70.29 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.665 0.786 . . . . 0.0 111.65 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 26' ' ' GLN . 2.7 pp -59.97 -45.9 91.18 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 123.589 0.556 . . . . 0.0 111.14 172.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.519 ' N ' HD11 ' A' ' 25' ' ' LEU . 6.0 tp-100 -67.11 -50.94 59.8 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.801 0.841 . . . . 0.0 111.012 -175.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.401 HD21 ' HD2' ' A' ' 22' ' ' PRO . 92.0 mt -55.93 -44.55 78.45 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.167 0.587 . . . . 0.0 111.208 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.496 ' HA ' HD12 ' A' ' 31' ' ' ILE . 30.2 m170 -62.61 -36.66 83.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.889 0.476 . . . . 0.0 111.299 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 46.2 mt-10 -66.16 -41.59 90.15 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.801 0.44 . . . . 0.0 110.713 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.533 ' HB3' HG23 ' A' ' 79' ' ' VAL . 5.6 mmt -60.52 -33.5 72.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.803 0.841 . . . . 0.0 110.721 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.517 HD11 ' HB ' ' A' ' 14' ' ' ILE . 60.0 mt -70.07 -49.77 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.977 0.911 . . . . 0.0 111.007 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 28' ' ' HIS . 80.0 t -61.45 -48.09 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.482 0.713 . . . . 0.0 112.113 -176.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.18 -23.39 66.58 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.222 0.609 . . . . 0.0 111.629 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.488 ' NE2' HG13 ' A' ' 79' ' ' VAL . 40.3 m-70 -95.87 27.03 3.73 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.892 0.877 . . . . 0.0 111.397 175.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.67 78.04 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.724 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.42 175.76 33.4 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 114.203 0.441 . . . . 0.0 114.203 -171.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -128.74 155.45 45.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.167 0.987 . . . . 0.0 108.75 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -138.51 168.72 19.17 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.177 0.513 . . . . 0.0 112.22 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.75 140.89 50.35 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -74.51 -46.36 39.83 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.762 0.825 . . . . 0.0 111.306 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.459 ' HD1' ' HH ' ' A' ' 15' ' ' TYR . 71.9 t80 . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 124.578 1.151 . . . . 0.0 109.688 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 120.894 0.378 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.6 m -120.07 24.25 10.57 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.497 0.719 . . . . 0.0 109.351 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.502 HG22 HG13 ' A' ' 13' ' ' VAL . 6.1 p -154.2 155.82 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.327 0.651 . . . . 0.0 109.608 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.8 t -114.63 -25.81 8.14 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.59 0.756 . . . . 0.0 111.466 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -133.03 138.78 46.91 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.616 0.766 . . . . 0.0 110.236 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.589 ' HB ' HG22 ' A' ' 69' ' ' VAL . 58.1 mt -123.64 143.33 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.562 1.145 . . . . 0.0 108.358 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.546 ' HB ' HG12 ' A' ' 16' ' ' ILE . 97.6 t -115.74 119.79 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.419 0.688 . . . . 0.0 110.287 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.26 157.85 38.73 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.37 0.668 . . . . 0.0 110.032 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.3 t -70.78 -49.36 47.45 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.405 ' HA ' HD12 ' A' ' 92' ' ' LEU . 41.1 t30 -147.02 147.43 30.67 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 168.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.526 ' HG ' HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -123.46 116.23 28.23 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -173.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.538 ' HG2' ' HB2' ' A' ' 60' ' ' LYS . 36.9 Cg_endo -64.68 156.35 61.85 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.132 2.555 . . . . 0.0 113.429 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.07 -47.34 86.78 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.569 1.148 . . . . 0.0 113.58 -167.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -67.16 -26.99 66.92 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 120.953 0.406 . . . . 0.0 110.429 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.538 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 4.6 mptp? -81.47 -23.15 37.61 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.34 -34.24 77.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.2 mt -72.83 -39.57 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.849 0.86 . . . . 0.0 110.228 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 3.1 tp10 -63.06 -34.52 77.76 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.131 0.972 . . . . 0.0 110.435 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -117.6 27.43 9.06 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.499 -175.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.02 67.56 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.294 0.568 . . . . 0.0 111.473 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -76.41 -23.03 53.99 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.404 1.082 . . . . 0.0 111.306 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -113.73 126.73 55.56 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.921 0.889 . . . . 0.0 109.272 -174.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.2 87.59 1.11 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.007 0.432 . . . . 0.0 110.315 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.589 HG22 ' HB ' ' A' ' 51' ' ' ILE . 16.5 t -76.08 134.45 29.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.211 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 87' ' ' TRP . 31.8 m -135.74 174.15 12.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.606 1.162 . . . . 0.0 109.531 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.5 t -86.09 152.37 55.79 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 171.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.26 -23.54 46.26 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 122.962 2.442 . . . . 0.0 113.15 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.12 -26.56 64.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.02 0.928 . . . . 0.0 112.26 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -61.02 -44.04 97.99 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.46 HD11 ' N ' ' A' ' 75' ' ' ILE . 2.7 mp -75.6 -52.46 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.726 0.81 . . . . 0.0 108.841 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.3 t -54.91 -53.73 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.491 1.116 . . . . 0.0 111.148 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.07 -39.08 66.16 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.546 -173.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 95.5 p -60.58 -41.56 94.92 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 120.905 0.383 . . . . 0.0 110.529 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.533 HG23 ' HB3' ' A' ' 30' ' ' MET . 70.8 t -64.51 -42.21 94.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 123.911 0.885 . . . . 0.0 111.066 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.444 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 10.0 mtmp? -67.61 -29.64 69.03 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.611 0.365 . . . . 0.0 111.441 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -89.78 -14.38 34.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.48 0.712 . . . . 0.0 110.925 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.97 27.38 16.23 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.168 1.387 . . . . 0.0 111.948 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -138.41 165.46 26.75 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.529 0.732 . . . . 0.0 111.02 -173.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.464 ' HA ' HG21 ' A' ' 8' ' ' ILE . 3.3 tm? -77.35 133.85 38.63 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 mt -114.18 154.92 46.18 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 123.586 0.754 . . . . 0.0 110.672 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.1 105.7 0.88 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.262 1.975 . . . . 0.0 110.81 171.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.48 ' HB2' HG12 ' A' ' 70' ' ' VAL . 36.3 p90 -66.52 -22.1 66.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.138 0.575 . . . . 0.0 111.588 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -62.44 -29.12 70.28 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.754 0.821 . . . . 0.0 111.476 174.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -67.91 -41.29 82.86 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.1 0.56 . . . . 0.0 109.904 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -93.43 4.8 53.38 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.056 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.9 t -62.14 121.27 12.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.919 0.888 . . . . 0.0 113.222 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 55' ' ' ASN . 84.4 mt -106.3 -0.07 24.67 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.83 0.852 . . . . 0.0 110.752 170.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.9 t -83.3 -15.66 49.24 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.889 0.476 . . . . 0.0 110.49 172.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.252 1.229 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.838 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.8 mt -59.32 -42.33 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.637 0.775 . . . . 0.0 111.409 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -113.85 17.05 18.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.552 0.741 . . . . 0.0 110.868 -176.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -54.55 -55.21 31.66 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 123.75 0.82 . . . . 0.0 112.171 -167.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -91.9 15.14 13.7 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.36 0.664 . . . . 0.0 111.271 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 54.0 t -117.11 120.38 38.16 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 123.986 0.914 . . . . 0.0 109.924 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.41 HG11 HD23 ' A' ' 39' ' ' LEU . 36.5 t -90.84 134.07 30.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 168.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.438 ' HB ' HD11 ' A' ' 31' ' ' ILE . 4.7 mp -123.45 123.29 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.046 0.538 . . . . 0.0 110.631 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -102.76 144.18 31.45 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.436 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 41.1 mt -121.68 137.68 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -147.19 136.13 22.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.688 0.795 . . . . 0.0 109.603 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.71 175.3 47.73 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 123.253 0.345 . . . . 0.0 113.156 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -73.93 111.93 9.56 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.107 0.479 . . . . 0.0 110.017 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.549 HG23 HG13 ' A' ' 52' ' ' VAL . 40.4 p -128.14 138.41 52.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.947 1.299 . . . . 0.0 108.226 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -105.33 130.22 23.45 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 118.257 0.48 . . . . 0.0 110.664 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.99 172.22 64.27 Favored 'Cis proline' 0 C--N 1.375 1.95 0 C-N-CA 124.232 -1.154 . . . . 0.0 111.485 -2.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.23 155.67 5.79 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.541 -0.589 . . . . 0.0 113.768 -174.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -55.36 -36.55 66.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.262 0.625 . . . . 0.0 111.809 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.448 HD13 ' N ' ' A' ' 26' ' ' GLN . 3.0 pp -59.3 -40.51 86.39 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.338 0.655 . . . . 0.0 111.738 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.448 ' N ' HD13 ' A' ' 25' ' ' LEU . 9.1 tp-100 -74.27 -43.86 55.16 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.87 0.868 . . . . 0.0 110.509 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.1 -39.75 83.22 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.87 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.439 ' HA ' HD12 ' A' ' 31' ' ' ILE . 15.9 m170 -60.8 -39.21 88.06 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.043 0.937 . . . . 0.0 110.304 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -67.88 -41.18 83.21 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.582 0.552 . . . . 0.0 110.932 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.528 ' SD ' HG13 ' A' ' 79' ' ' VAL . 25.0 mmt -60.17 -32.53 71.14 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.315 0.646 . . . . 0.0 111.748 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 28' ' ' HIS . 70.1 mt -71.07 -52.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.065 175.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.7 t -71.45 -44.84 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.362 0.665 . . . . 0.0 112.045 -170.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.2 -15.76 57.99 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.709 0.804 . . . . 0.0 111.705 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.441 ' NE2' HG11 ' A' ' 79' ' ' VAL . 68.5 m-70 -108.98 27.82 9.1 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.726 0.81 . . . . 0.0 111.154 175.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.85 9.97 86.3 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 114.798 -1.092 . . . . 0.0 114.656 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.13 177.74 34.03 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 114.453 0.541 . . . . 0.0 114.453 -170.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -123.85 150.08 45.0 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.471 0.708 . . . . 0.0 110.038 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -125.0 166.6 16.06 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.49 0.716 . . . . 0.0 110.417 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.41 HD23 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -131.35 141.65 49.93 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.04 -35.05 26.07 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.474 0.71 . . . . 0.0 112.862 -176.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.9 t80 . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 123.992 0.917 . . . . 0.0 109.51 -174.496 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.55 0.949 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.2 m -103.39 -8.94 19.83 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.847 0.859 . . . . 0.0 110.657 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.403 ' HA ' ' HB ' ' A' ' 13' ' ' VAL . 9.5 p -123.98 159.82 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.797 0.839 . . . . 0.0 109.867 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.625 HG21 ' HD1' ' A' ' 50' ' ' HIS . 5.1 t -114.15 -27.72 7.56 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.044 0.538 . . . . 0.0 111.202 175.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.625 ' HD1' HG21 ' A' ' 49' ' ' THR . 75.7 m80 -130.6 129.74 43.11 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.07 0.548 . . . . 0.0 110.591 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 22.5 mt -114.66 138.89 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.645 0.778 . . . . 0.0 109.045 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.549 HG13 HG23 ' A' ' 20' ' ' THR . 63.2 t -104.63 135.36 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 123.985 0.914 . . . . 0.0 109.526 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.03 163.33 39.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.019 0.928 . . . . 0.0 108.908 173.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.3 t -115.56 -49.12 2.75 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -120.06 111.59 18.07 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 tp -129.99 123.01 20.63 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.97 151.9 74.77 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.13 2.554 . . . . 0.0 112.406 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.41 HD22 ' HD2' ' A' ' 61' ' ' ARG . 94.8 mt -59.05 -32.58 69.89 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.531 0.733 . . . . 0.0 111.878 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -60.0 -43.44 95.2 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.335 0.654 . . . . 0.0 110.723 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -75.93 -28.78 58.11 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.724 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HD2' HD22 ' A' ' 58' ' ' LEU . 61.6 mtt180 -70.87 -29.32 65.4 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.865 0.466 . . . . 0.0 110.817 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.6 mt -80.13 -37.33 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.537 0.735 . . . . 0.0 110.638 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -61.66 -45.7 92.88 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.683 0.754 . . . . 0.0 110.03 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -99.75 19.47 15.91 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.703 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.67 -18.89 62.15 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.256 0.622 . . . . 0.0 110.415 169.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -70.64 -17.47 62.87 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.897 0.879 . . . . 0.0 110.407 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.17 171.4 7.57 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.602 1.161 . . . . 0.0 109.261 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -99.28 88.13 3.83 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.408 HG11 ' HB2' ' A' ' 92' ' ' LEU . 39.6 t -74.49 138.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.664 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.04 177.71 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.009 1.324 . . . . 0.0 109.723 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.3 m -87.45 160.07 48.79 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.101 0.96 . . . . 0.0 109.612 172.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.401 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.7 Cg_endo -59.75 -28.0 86.26 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 122.684 2.256 . . . . 0.0 112.223 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -65.88 -16.84 64.21 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.544 1.138 . . . . 0.0 111.969 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.3 t90 -62.69 -45.8 91.08 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 75' ' ' ILE . 3.2 mp -71.16 -50.41 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.706 -177.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.521 HG13 ' HE2' ' A' ' 80' ' ' LYS . 58.8 t -62.3 -50.74 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.878 -173.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -71.57 -33.63 69.25 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.808 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.7 m -61.19 -37.19 82.05 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 117.954 0.343 . . . . 0.0 110.718 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.528 HG13 ' SD ' ' A' ' 30' ' ' MET . 44.4 t -64.6 -47.41 89.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 C-N-CA 123.866 0.866 . . . . 0.0 111.03 173.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.521 ' HE2' HG13 ' A' ' 76' ' ' VAL . 54.3 mtmt -70.17 -26.46 63.92 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.266 0.627 . . . . 0.0 112.118 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -94.99 -15.98 23.1 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.834 0.453 . . . . 0.0 111.248 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.15 28.66 18.28 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.734 1.214 . . . . 0.0 111.84 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -144.96 149.15 34.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.418 1.087 . . . . 0.0 108.603 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.0 tp -72.73 112.07 8.45 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.9 mt -83.88 153.95 64.19 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 123.514 0.725 . . . . 0.0 110.82 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -57.59 122.15 11.26 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.992 2.461 . . . . 0.0 112.454 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -64.2 -32.34 73.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.992 0.517 . . . . 0.0 110.274 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -60.52 -31.62 70.68 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.065 0.946 . . . . 0.0 111.276 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -69.33 -25.08 64.03 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.651 0.781 . . . . 0.0 110.743 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -115.99 4.71 13.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.845 0.858 . . . . 0.0 111.423 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.9 t -66.46 126.7 29.67 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -167.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.408 ' HB2' HG11 ' A' ' 69' ' ' VAL . 49.9 mt -114.68 28.34 8.8 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.057 0.943 . . . . 0.0 110.292 173.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 39.7 p -65.78 -38.17 88.3 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.635 0.774 . . . . 0.0 111.027 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.254 1.294 0 C-N-CA 124.302 1.041 . . . . 0.0 109.001 -179.306 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.565 ' HA ' ' HB2' ' A' ' 10' ' ' LYS . 20.9 pttp . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 120.673 0.273 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 52.5 mt -66.08 -50.07 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.816 0.846 . . . . 0.0 110.584 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.406 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 50.4 m-85 -112.26 14.48 20.52 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.143 -176.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 7' ' ' LYS . 52.2 tptt -53.54 -55.63 23.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.064 0.946 . . . . 0.0 113.476 -165.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -100.15 17.52 21.0 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.371 0.605 . . . . 0.0 109.889 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.49 ' SG ' ' CD2' ' A' ' 50' ' ' HIS . 29.1 t -113.06 128.39 56.48 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.048 1.339 . . . . 0.0 110.901 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.86 130.34 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.242 1.017 . . . . 0.0 109.295 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.506 ' HB ' HD12 ' A' ' 31' ' ' ILE . 4.7 mp -124.42 129.37 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 CA-C-O 121.407 0.622 . . . . 0.0 111.852 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.484 ' HB2' ' HB3' ' A' ' 39' ' ' LEU . 55.2 t80 -104.02 152.39 22.09 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.43 1.892 . . . . 0.0 108.39 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -122.78 137.89 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.066 0.546 . . . . 0.0 109.987 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -143.74 141.63 30.55 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.39 1.076 . . . . 0.0 109.346 -174.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.27 -178.92 46.49 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 116.467 -0.333 . . . . 0.0 112.699 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -92.9 110.59 22.05 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.98 0.419 . . . . 0.0 109.955 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.584 HG22 HG13 ' A' ' 52' ' ' VAL . 65.0 p -122.59 142.59 50.47 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.715 1.206 . . . . 0.0 109.717 -174.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -96.82 130.76 29.4 Favored Pre-proline 0 N--CA 1.479 0.976 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 167.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.49 176.28 42.31 Favored 'Cis proline' 0 C--N 1.373 1.831 0 C-N-CA 124.758 -0.934 . . . . 0.0 111.666 -4.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.59 152.0 7.66 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.746 0.654 . . . . 0.0 114.07 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -54.01 -34.97 61.36 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.251 1.02 . . . . 0.0 112.263 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 pp -58.09 -48.28 80.63 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.898 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.49 ' HA ' HE21 ' A' ' 26' ' ' GLN . 0.0 OUTLIER -73.5 -41.77 62.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.355 0.662 . . . . 0.0 111.614 -175.235 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.485 HD12 HG11 ' A' ' 52' ' ' VAL . 29.1 mt -58.34 -44.58 88.78 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.033 0.533 . . . . 0.0 110.641 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.403 ' O ' HG22 ' A' ' 32' ' ' VAL . 16.8 m170 -65.79 -34.97 79.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.567 0.347 . . . . 0.0 111.498 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -62.85 -42.2 99.66 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 117.847 0.294 . . . . 0.0 110.443 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.617 ' HB3' HG22 ' A' ' 79' ' ' VAL . 22.9 mmt -62.26 -39.06 91.64 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.881 0.872 . . . . 0.0 110.677 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.506 HD12 ' HB ' ' A' ' 14' ' ' ILE . 71.1 mt -65.87 -51.55 59.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.044 0.938 . . . . 0.0 111.463 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 28' ' ' HIS . 99.9 t -68.56 -43.67 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 122.901 0.48 . . . . 0.0 111.599 -173.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.67 -17.8 63.32 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.271 0.629 . . . . 0.0 111.795 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.415 ' NE2' HG12 ' A' ' 79' ' ' VAL . 55.5 m-70 -108.91 26.51 10.51 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.675 0.79 . . . . 0.0 111.581 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.9 -0.33 72.87 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.615 -0.721 . . . . 0.0 114.821 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . -92.52 173.97 36.0 Favored Glycine 0 C--O 1.237 0.342 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 -166.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -117.4 159.33 22.94 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.605 1.162 . . . . 0.0 109.63 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -125.27 156.63 38.28 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.764 0.826 . . . . 0.0 110.987 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.589 ' HG ' ' HB ' ' A' ' 48' ' ' VAL . 2.4 tm? -134.65 129.38 34.76 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.412 ' HD2' ' H ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -79.74 -43.36 22.74 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.412 ' H ' ' HD2' ' A' ' 40' ' ' HIS . 71.9 t80 . . . . . 0 N--CA 1.474 0.76 0 C-N-CA 124.172 0.989 . . . . 0.0 109.727 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.8 p -83.44 -18.74 37.61 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.072 0.549 . . . . 0.0 111.111 -174.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.589 ' HB ' ' HG ' ' A' ' 39' ' ' LEU . 9.8 p -136.93 156.62 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.481 0.712 . . . . 0.0 109.858 176.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.514 HG23 ' HD2' ' A' ' 50' ' ' HIS . 4.6 t -114.51 -25.31 8.41 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.436 0.695 . . . . 0.0 111.127 175.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.514 ' HD2' HG23 ' A' ' 49' ' ' THR . 80.5 m-70 -132.55 130.47 40.39 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.939 0.495 . . . . 0.0 110.616 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.599 ' HB ' HG13 ' A' ' 69' ' ' VAL . 66.7 mt -114.98 135.21 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.584 HG13 HG22 ' A' ' 20' ' ' THR . 87.5 t -91.79 129.1 42.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.26 145.93 29.59 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.5 t -88.46 -39.15 14.44 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -143.96 139.73 29.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.476 1.11 . . . . 0.0 108.264 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.3 tp -128.07 128.38 23.76 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.97 150.29 73.56 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.066 2.51 . . . . 0.0 112.317 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.2 mt -57.22 -39.83 76.26 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.946 0.898 . . . . 0.0 111.339 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.28 -43.36 99.01 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.404 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -76.64 -20.79 56.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.603 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -66.43 -41.22 89.53 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 171.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.1 mt -65.41 -43.54 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 123.717 0.636 . . . . 0.0 110.797 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.63 -42.26 82.59 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.365 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -100.36 23.33 10.31 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.549 0.74 . . . . 0.0 110.674 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.63 -27.44 67.69 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.409 0.683 . . . . 0.0 111.386 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -71.3 -19.37 62.33 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.938 0.895 . . . . 0.0 111.239 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -108.9 143.89 37.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.882 0.873 . . . . 0.0 109.204 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.04 86.17 4.23 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.599 HG13 ' HB ' ' A' ' 51' ' ' ILE . 7.6 m -78.3 127.82 38.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.22 171.41 18.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.284 1.034 . . . . 0.0 109.667 -172.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.1 m -77.92 150.25 78.01 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.399 170.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.83 -25.86 78.17 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.332 2.021 . . . . 0.0 111.39 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.7 -29.38 52.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.387 1.475 . . . . 0.0 112.271 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -60.29 -54.37 46.5 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 79' ' ' VAL . 3.4 mp -64.15 -48.04 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 124.227 0.955 . . . . 0.0 109.165 -175.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.68 -52.24 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.835 1.254 . . . . 0.0 111.462 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.78 -33.29 66.2 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.74 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.46 ' HA ' HD13 ' A' ' 85' ' ' LEU . 61.9 m -62.34 -35.38 78.9 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.925 0.49 . . . . 0.0 111.361 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 30' ' ' MET . 71.4 t -69.5 -44.34 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.37 0.668 . . . . 0.0 110.863 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.5 -43.25 89.0 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.525 0.679 . . . . 0.0 110.843 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.579 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 64.7 mm-40 -82.65 -21.49 34.99 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.856 -176.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.66 24.93 12.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.241 1.017 . . . . 0.0 111.173 -173.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.579 ' HE ' ' HB3' ' A' ' 81' ' ' GLU . 9.2 ptp180 -134.81 166.02 23.95 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.457 0.703 . . . . 0.0 109.656 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -86.25 116.14 24.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.317 0.647 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 78' ' ' SER . 11.3 mp -90.17 155.19 47.07 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.745 0.818 . . . . 0.0 110.198 172.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.54 109.43 2.62 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.066 1.844 . . . . 0.0 110.755 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -62.38 -25.55 67.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.48 0.712 . . . . 0.0 111.725 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -57.92 -29.54 65.21 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.212 1.005 . . . . 0.0 111.64 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -75.6 -34.48 60.63 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.873 0.869 . . . . 0.0 111.046 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -96.34 -1.05 48.59 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.58 0.752 . . . . 0.0 111.253 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.2 t -72.67 115.59 12.12 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.45 0.7 . . . . 0.0 112.068 -170.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.6 mt -79.31 4.91 13.78 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.934 0.893 . . . . 0.0 111.898 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.2 p -62.4 -21.95 65.78 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.75 0.82 . . . . 0.0 111.463 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.255 1.377 0 C-N-CA 125.832 1.653 . . . . 0.0 111.189 176.253 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.2 mt -57.78 -46.87 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.033 1.333 . . . . 0.0 111.669 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.484 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 50.9 m-85 -112.53 17.01 19.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.607 0.763 . . . . 0.0 110.828 -174.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -57.16 -44.05 83.09 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.693 0.797 . . . . 0.0 112.47 -171.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -92.05 -5.81 52.2 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.475 0.31 . . . . 0.0 111.365 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.6 m -97.55 125.84 42.49 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.525 0.678 . . . . 0.0 111.242 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.496 HG11 HG22 ' A' ' 48' ' ' VAL . 36.9 t -103.52 130.6 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 169.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 3.2 mp -118.31 136.01 56.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 123.81 0.844 . . . . 0.0 111.147 -174.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -115.45 119.7 37.07 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 124.422 1.089 . . . . 0.0 108.465 169.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.9 mt -92.36 138.28 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.164 0.586 . . . . 0.0 109.508 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -147.16 136.94 23.05 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.049 0.94 . . . . 0.0 110.098 -166.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.36 -154.17 50.18 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.266 0.354 . . . . 0.0 113.465 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -78.1 128.63 34.11 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 172.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.2 p -146.68 126.86 13.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.672 1.189 . . . . 0.0 108.512 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -114.28 135.76 22.22 Favored Pre-proline 0 N--CA 1.481 1.102 0 CA-C-N 118.212 0.46 . . . . 0.0 111.141 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.11 175.12 38.98 Favored 'Cis proline' 0 C--N 1.379 2.161 0 C-N-CA 124.827 -0.905 . . . . 0.0 112.264 -1.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.58 141.09 9.87 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 124.126 0.891 . . . . 0.0 113.392 -175.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -50.29 -34.66 24.25 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.347 1.059 . . . . 0.0 112.904 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 pp -54.55 -45.7 73.51 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.803 0.441 . . . . 0.0 111.581 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -73.12 -45.41 57.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.976 0.91 . . . . 0.0 110.719 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.3 -44.84 76.1 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.724 0.64 . . . . 0.0 111.306 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -58.96 -40.54 85.04 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.768 0.827 . . . . 0.0 110.638 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.89 -39.87 87.58 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.336 0.397 . . . . 0.0 111.195 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.546 ' HB3' HG22 ' A' ' 79' ' ' VAL . 24.4 mmt -63.37 -33.1 74.79 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.981 0.513 . . . . 0.0 111.355 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.4 mt -72.48 -51.56 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.559 0.744 . . . . 0.0 111.003 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.03 -44.95 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.218 0.607 . . . . 0.0 111.681 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.8 -11.82 56.6 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.531 0.732 . . . . 0.0 111.805 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -113.3 27.23 9.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.71 0.804 . . . . 0.0 111.594 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.57 -6.16 83.86 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.283 -0.872 . . . . 0.0 114.764 167.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.13 156.88 42.34 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 113.944 0.338 . . . . 0.0 113.944 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -108.99 169.71 8.51 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 43.6 p90 -144.27 151.01 38.82 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.79 127.48 53.74 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.656 169.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -33.95 76.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.079 172.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.1 p90 . . . . . 0 C--O 1.241 0.643 0 C-N-CA 124.608 1.163 . . . . 0.0 109.01 173.539 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.19 0.519 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.3 m -108.1 -36.27 6.36 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.73 0.812 . . . . 0.0 110.496 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.496 HG22 HG11 ' A' ' 13' ' ' VAL . 6.9 p -93.29 157.77 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.086 0.554 . . . . 0.0 110.224 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 t -111.27 -32.63 6.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.969 0.508 . . . . 0.0 111.639 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -119.93 138.51 53.4 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.77 0.828 . . . . 0.0 109.088 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.657 ' HB ' HG12 ' A' ' 69' ' ' VAL . 52.7 mt -124.37 138.14 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.55 122.07 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.945 0.898 . . . . 0.0 110.378 -175.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.11 156.97 45.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.665 1.186 . . . . 0.0 108.075 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.1 t -76.23 -38.88 55.77 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -147.84 138.17 22.95 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.075 173.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.1 tp -116.49 124.57 29.31 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.61 156.59 36.25 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.564 2.842 . . . . 0.0 112.666 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.403 HD23 ' HD2' ' A' ' 61' ' ' ARG . 97.0 mt -60.01 -41.96 93.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.832 0.853 . . . . 0.0 112.039 -174.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -57.57 -41.76 81.72 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.671 0.789 . . . . 0.0 110.462 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.39 -23.45 46.78 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.823 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.403 ' HD2' HD23 ' A' ' 58' ' ' LEU . 99.6 mtt180 -70.73 -33.85 71.28 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.405 0.548 . . . . 0.0 110.656 173.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.7 -45.52 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.485 0.714 . . . . 0.0 109.997 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.68 -50.82 65.5 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.054 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.431 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 18.7 m-85 -92.67 26.35 2.73 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.442 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.63 -29.89 70.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.429 0.692 . . . . 0.0 111.38 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -77.52 -25.82 50.6 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.22 0.608 . . . . 0.0 111.062 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.431 ' CD1' ' HA ' ' A' ' 64' ' ' PHE . 10.3 m-85 -89.47 145.92 24.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.744 0.818 . . . . 0.0 109.638 -177.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -87.03 86.67 7.33 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.657 HG12 ' HB ' ' A' ' 51' ' ' ILE . 21.6 m -81.63 131.18 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.422 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.97 174.43 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.622 1.169 . . . . 0.0 110.112 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -82.78 157.21 67.12 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.795 0.838 . . . . 0.0 110.549 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.72 -23.28 75.84 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.672 2.248 . . . . 0.0 111.864 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.35 -27.42 65.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.331 1.452 . . . . 0.0 111.774 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -61.68 -48.71 79.55 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.506 0.504 . . . . 0.0 110.223 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.484 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.4 mp -67.47 -49.3 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.057 -175.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.2 -52.42 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.342 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.78 -36.19 70.26 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.113 -172.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.1 m -66.07 -40.34 90.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.014 0.525 . . . . 0.0 111.312 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 30' ' ' MET . 23.8 t -64.88 -44.0 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.533 0.733 . . . . 0.0 110.799 178.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -65.16 -36.67 84.94 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.676 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.53 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 48.0 mm-40 -86.24 -8.74 57.54 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.11 19.03 8.29 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.7 1.2 . . . . 0.0 112.763 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.53 ' HE ' ' HB3' ' A' ' 81' ' ' GLU . 13.5 ptp180 -134.21 161.85 33.77 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.509 0.724 . . . . 0.0 109.932 -172.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.8 tp -84.03 113.19 20.84 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 172.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.02 154.42 55.05 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 123.456 0.702 . . . . 0.0 109.968 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.1 117.12 3.96 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.232 1.954 . . . . 0.0 110.931 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -59.76 -27.88 66.91 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.561 0.744 . . . . 0.0 111.672 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -62.21 -25.78 67.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.481 1.113 . . . . 0.0 112.352 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -68.55 -26.99 65.69 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.588 0.755 . . . . 0.0 110.938 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -117.19 5.03 12.66 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.773 0.829 . . . . 0.0 111.114 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.6 t -72.7 125.26 27.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.136 0.574 . . . . 0.0 111.918 -171.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.4 mt -93.39 13.07 22.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.015 0.926 . . . . 0.0 111.862 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.5 p -61.7 -28.33 69.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.273 0.629 . . . . 0.0 110.654 174.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 125.075 1.35 . . . . 0.0 111.481 171.098 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.8 mttm . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.1 -46.98 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 124.154 0.982 . . . . 0.0 112.32 -168.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.443 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 55.5 m-85 -114.8 15.86 17.41 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.705 0.402 . . . . 0.0 111.292 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -64.85 -32.65 74.46 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 122.724 0.41 . . . . 0.0 111.928 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -96.96 6.75 48.07 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.839 0.456 . . . . 0.0 111.685 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 76.3 m -120.82 130.46 53.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.371 0.669 . . . . 0.0 111.477 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.459 HG11 HG23 ' A' ' 48' ' ' VAL . 39.1 t -96.95 131.8 42.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 167.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 mp -119.31 124.05 72.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.512 0.725 . . . . 0.0 110.648 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -105.97 109.74 21.79 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 166.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.5 mt -78.04 135.17 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -137.16 122.81 19.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.102 0.961 . . . . 0.0 109.257 -169.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.39 -179.13 29.8 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.406 0.441 . . . . 0.0 113.248 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -71.63 108.47 5.0 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.404 HG21 HG11 ' A' ' 52' ' ' VAL . 71.0 p -111.25 148.65 32.4 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 124.963 1.305 . . . . 0.0 108.897 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -107.35 122.05 42.52 Favored Pre-proline 0 N--CA 1.482 1.164 0 CA-C-N 118.229 0.468 . . . . 0.0 110.77 172.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -82.55 176.03 37.37 Favored 'Cis proline' 0 C--N 1.368 1.571 0 C-N-CA 123.939 -1.276 . . . . 0.0 111.78 0.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.17 154.04 6.89 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.704 0.628 . . . . 0.0 114.19 -173.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -55.38 -36.58 66.52 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.547 0.739 . . . . 0.0 111.858 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 26' ' ' GLN . 2.9 pp -61.12 -40.69 94.74 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 123.859 0.724 . . . . 0.0 111.826 176.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.452 ' N ' HD13 ' A' ' 25' ' ' LEU . 61.1 tp60 -73.33 -46.52 48.88 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.324 0.649 . . . . 0.0 110.145 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.3 mt -58.09 -39.24 78.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.68 0.792 . . . . 0.0 111.029 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -57.38 -42.72 82.71 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.752 0.821 . . . . 0.0 110.385 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -64.84 -43.39 93.23 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 79.1 mmm -62.81 -34.48 77.39 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.249 0.62 . . . . 0.0 111.212 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.6 mt -75.24 -54.94 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.486 0.714 . . . . 0.0 111.617 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.0 t -72.09 -40.18 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.224 0.61 . . . . 0.0 112.122 -166.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.48 -21.6 64.33 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.528 0.731 . . . . 0.0 111.677 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.459 ' NE2' HG11 ' A' ' 79' ' ' VAL . 60.2 m80 -105.12 26.97 8.66 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.305 1.042 . . . . 0.0 110.635 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.84 -3.74 83.11 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.853 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.49 151.79 47.03 Favored Glycine 0 C--O 1.239 0.421 0 N-CA-C 115.771 1.069 . . . . 0.0 115.771 -167.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -106.77 143.96 34.11 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -127.1 149.34 49.98 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.131 0.572 . . . . 0.0 109.724 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.25 123.47 49.32 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 175.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.55 -39.29 88.46 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.245 0.618 . . . . 0.0 112.109 -172.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.3 t80 . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 124.432 1.093 . . . . 0.0 108.716 -175.25 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.1 m -119.97 18.34 12.47 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-O 121.182 0.515 . . . . 0.0 110.71 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.459 HG23 HG11 ' A' ' 13' ' ' VAL . 9.9 p -144.31 147.98 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 122.016 -0.428 . . . . 0.0 110.451 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.5 t -103.79 -32.37 9.37 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.574 0.75 . . . . 0.0 111.725 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -126.06 128.76 47.9 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.5 0.72 . . . . 0.0 109.845 -175.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 41.4 mt -114.39 121.9 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.57 0.748 . . . . 0.0 109.275 175.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.404 HG11 HG21 ' A' ' 20' ' ' THR . 64.0 t -92.32 121.6 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.113 0.565 . . . . 0.0 110.022 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.0 154.07 49.36 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.207 0.603 . . . . 0.0 110.167 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.7 t -95.26 -34.61 12.14 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -140.87 120.85 13.64 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.51 ' HG ' HG13 ' A' ' 69' ' ' VAL . 2.2 tm? -127.43 108.96 21.07 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.04 155.11 70.07 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.846 2.364 . . . . 0.0 112.394 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 61' ' ' ARG . 70.6 mt -64.16 -29.74 70.84 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -172.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -59.36 -48.96 79.66 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.512 0.672 . . . . 0.0 110.298 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -76.01 -19.71 58.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.45 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 10.6 tpp85 -67.64 -40.39 84.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.41 0.684 . . . . 0.0 109.767 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.0 mt -77.06 -35.8 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.063 0.945 . . . . 0.0 110.488 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -69.16 -30.53 68.78 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.465 0.706 . . . . 0.0 111.032 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -115.55 28.64 8.53 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.205 1.002 . . . . 0.0 110.042 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.93 -33.47 75.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.509 0.724 . . . . 0.0 111.626 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -77.36 -26.72 52.24 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.004 0.522 . . . . 0.0 110.82 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -78.64 141.48 37.96 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -83.89 85.8 7.26 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.36 0.664 . . . . 0.0 109.353 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.51 HG13 ' HG ' ' A' ' 56' ' ' LEU . 57.3 t -78.21 127.59 38.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 174.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.05 173.78 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.139 0.975 . . . . 0.0 110.19 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.3 m -81.46 152.92 70.79 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.818 0.847 . . . . 0.0 110.402 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -59.62 -25.49 79.1 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.964 2.443 . . . . 0.0 112.698 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.67 -19.75 66.03 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.051 0.941 . . . . 0.0 112.047 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -59.37 -43.05 92.91 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.923 0.489 . . . . 0.0 109.83 173.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 75' ' ' ILE . 3.2 mp -75.55 -49.55 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.128 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.1 t -59.76 -51.73 69.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.321 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -71.22 -39.57 71.63 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.267 -175.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.8 p -63.62 -37.75 88.51 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 120.822 0.344 . . . . 0.0 111.699 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.459 HG11 ' NE2' ' A' ' 34' ' ' HIS . 33.4 t -62.38 -46.1 97.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 123.719 0.807 . . . . 0.0 110.696 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.1 -37.24 86.41 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.203 0.601 . . . . 0.0 111.542 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -83.96 -12.56 55.15 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.499 0.72 . . . . 0.0 111.594 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.52 26.06 15.86 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.136 1.374 . . . . 0.0 112.582 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -140.86 161.9 36.73 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.327 1.051 . . . . 0.0 109.32 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.6 tp -87.72 128.58 35.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 172.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 mp -93.56 153.39 41.28 Favored Pre-proline 0 C--O 1.241 0.646 0 C-N-CA 123.865 0.866 . . . . 0.0 108.953 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.6 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 30.0 Cg_endo -65.23 140.96 66.94 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.768 1.645 . . . . 0.0 111.865 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -57.76 -33.24 68.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.696 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.6 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 30.0 pt20 -57.7 -34.2 69.2 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.666 1.186 . . . . 0.0 113.046 -170.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.5 ' OD1' ' HG2' ' A' ' 86' ' ' PRO . 14.2 m120 -67.32 -36.02 80.61 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.576 0.35 . . . . 0.0 111.706 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -107.81 3.34 24.33 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.521 0.728 . . . . 0.0 111.31 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.9 t -67.82 118.7 11.4 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.627 0.771 . . . . 0.0 112.639 -170.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.5 mt -86.49 -35.36 19.65 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.055 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.8 t -57.41 -33.87 68.33 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 123.422 0.689 . . . . 0.0 111.614 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 p . . . . . 0 C--O 1.253 1.247 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.127 176.09 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.431 HD12 ' HD2' ' A' ' 34' ' ' HIS . 40.5 mt -66.94 -39.08 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.632 1.173 . . . . 0.0 112.734 -166.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.486 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 68.6 m-85 -113.21 16.9 19.0 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.195 0.598 . . . . 0.0 110.961 -176.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -60.14 -39.6 86.88 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -169.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -94.87 11.0 33.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.961 -0.462 . . . . 0.0 111.471 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 83.2 m -122.9 135.58 54.56 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.611 0.764 . . . . 0.0 112.095 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.485 HG11 HD23 ' A' ' 39' ' ' LEU . 50.0 t -104.21 134.25 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 167.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.509 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.6 mp -126.07 122.73 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 121.255 0.55 . . . . 0.0 111.107 -174.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -102.99 152.31 21.47 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.59 1.556 . . . . 0.0 107.98 174.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.1 mt -121.96 127.08 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -128.35 139.85 52.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.163 0.985 . . . . 0.0 109.565 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.65 -161.22 46.08 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.593 0.558 . . . . 0.0 112.443 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -102.19 113.12 26.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.633 0.773 . . . . 0.0 109.479 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.466 HG23 HG12 ' A' ' 52' ' ' VAL . 79.5 p -117.93 137.65 52.69 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.851 0.86 . . . . 0.0 109.829 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -106.02 125.83 32.14 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 165.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -76.72 165.16 85.81 Favored 'Cis proline' 0 C--N 1.374 1.903 0 C-N-CA 124.027 -1.239 . . . . 0.0 111.837 2.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.0 161.57 6.41 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 123.906 0.754 . . . . 0.0 114.656 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -55.8 -36.07 67.02 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.525 0.73 . . . . 0.0 111.179 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.518 HD11 ' N ' ' A' ' 26' ' ' GLN . 2.6 pp -61.95 -42.0 98.62 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 123.753 0.658 . . . . 0.0 111.678 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.518 ' N ' HD11 ' A' ' 25' ' ' LEU . 6.3 tp-100 -69.56 -52.24 28.06 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.328 0.651 . . . . 0.0 110.342 -175.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.52 HD11 HG13 ' A' ' 52' ' ' VAL . 71.2 mt -57.8 -44.28 86.22 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.53 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.477 ' HA ' HD11 ' A' ' 31' ' ' ILE . 13.7 m170 -61.79 -37.59 84.9 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.063 0.545 . . . . 0.0 111.321 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 52.0 mm-40 -63.28 -45.84 89.59 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.021 0.439 . . . . 0.0 110.014 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.415 ' HB3' HG23 ' A' ' 79' ' ' VAL . 25.6 mmt -60.77 -37.77 83.0 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.63 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.509 HD13 ' HB ' ' A' ' 14' ' ' ILE . 75.5 mt -62.8 -50.81 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.043 0.537 . . . . 0.0 110.981 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.65 -45.62 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.064 0.546 . . . . 0.0 111.62 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.69 -18.89 65.61 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.275 0.63 . . . . 0.0 111.848 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.431 ' HD2' HD12 ' A' ' 8' ' ' ILE . 21.0 m80 -103.76 27.1 7.82 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.423 0.689 . . . . 0.0 111.108 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.76 -3.25 87.39 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.836 166.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -91.82 171.24 34.27 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 -170.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.467 ' HB2' HG21 ' A' ' 13' ' ' VAL . 42.0 mmtm -110.24 158.07 18.78 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.457 0.703 . . . . 0.0 109.736 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -133.31 153.23 51.76 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.766 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.485 HD23 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -112.2 136.52 51.51 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -85.25 -35.03 21.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.507 0.723 . . . . 0.0 112.056 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.0 t80 . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 124.413 1.085 . . . . 0.0 108.983 -175.967 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.2 mttt . . . . . 0 CA--C 1.544 0.718 0 CA-C-O 121.612 0.72 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.8 m -84.66 5.15 29.24 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.349 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.04 150.72 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.856 0.862 . . . . 0.0 109.776 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.8 t -101.9 -38.18 7.92 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.058 0.543 . . . . 0.0 110.946 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.571 ' HD2' ' HB2' ' A' ' 68' ' ' LYS . 56.2 m170 -118.5 133.59 55.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.285 0.634 . . . . 0.0 109.442 -172.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.627 ' HB ' HG12 ' A' ' 69' ' ' VAL . 65.5 mt -123.63 134.14 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.52 HG13 HD11 ' A' ' 27' ' ' LEU . 52.1 t -92.69 128.96 43.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.03 143.86 28.7 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.4 t -92.78 -41.44 10.11 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 166.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -145.42 120.43 10.04 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.616 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.8 mt -92.21 148.82 37.43 Favored Pre-proline 0 C--O 1.24 0.583 0 C-N-CA 123.219 0.607 . . . . 0.0 109.678 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.72 157.42 37.67 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.808 2.339 . . . . 0.0 110.849 166.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.8 mt -53.3 -53.71 46.97 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.426 0.69 . . . . 0.0 112.105 -171.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.98 -46.19 90.35 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.38 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -72.67 -19.39 61.43 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.241 0.616 . . . . 0.0 112.251 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -72.84 -40.53 65.66 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 81.4 mt -66.88 -45.6 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.457 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.44 -40.3 73.85 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.074 0.55 . . . . 0.0 111.678 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.86 17.98 4.46 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.194 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.08 -26.51 61.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.697 0.399 . . . . 0.0 110.296 167.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -70.81 -27.27 63.76 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.301 0.641 . . . . 0.0 110.407 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -90.44 153.88 20.07 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.571 ' HB2' ' HD2' ' A' ' 50' ' ' HIS . 0.5 OUTLIER -84.86 85.31 7.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.109 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.627 HG12 ' HB ' ' A' ' 51' ' ' ILE . 31.6 m -85.08 129.85 37.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.835 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 m -134.98 171.56 17.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.502 1.121 . . . . 0.0 109.653 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.6 m -78.8 153.6 78.06 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.049 172.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.08 -24.95 52.02 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.743 2.296 . . . . 0.0 112.401 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.68 -27.1 48.32 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.878 1.271 . . . . 0.0 112.769 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -65.07 -45.16 86.45 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.227 0.537 . . . . 0.0 110.395 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.428 ' O ' HG21 ' A' ' 79' ' ' VAL . 3.2 mp -73.96 -45.5 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.74 -176.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 68.8 t -57.7 -49.8 79.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.908 0.883 . . . . 0.0 110.968 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 25.9 t70 -70.66 -35.18 72.73 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.85 0.46 . . . . 0.0 111.459 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.426 ' HB2' HG21 ' A' ' 8' ' ' ILE . 78.4 p -66.26 -37.33 85.23 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 120.428 0.156 . . . . 0.0 110.71 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 75' ' ' ILE . 72.6 t -64.08 -42.5 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.487 0.715 . . . . 0.0 110.771 173.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 77' ' ' ASP . 8.2 mtpm? -63.41 -45.64 90.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.661 0.784 . . . . 0.0 111.485 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -93.79 -9.54 37.17 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.972 0.509 . . . . 0.0 112.197 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.61 36.42 22.65 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.203 1.001 . . . . 0.0 111.729 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -150.74 167.21 28.09 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.764 0.826 . . . . 0.0 110.159 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.28 106.14 18.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.21 146.77 67.72 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.455 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 17.9 Cg_endo -58.88 113.86 1.75 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.33 2.02 . . . . 0.0 111.838 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -57.56 -24.53 56.7 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.498 1.119 . . . . 0.0 111.665 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.6 pt20 -58.37 -27.9 64.64 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 124.545 1.138 . . . . 0.0 112.507 -176.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -79.33 -18.83 51.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.178 0.591 . . . . 0.0 112.091 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -110.14 1.94 19.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.813 0.845 . . . . 0.0 111.232 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m -65.82 122.5 17.46 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.622 0.769 . . . . 0.0 112.377 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.0 mt -98.83 15.2 26.22 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.631 0.772 . . . . 0.0 110.286 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -64.4 -23.53 67.32 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.573 1.149 . . . . 0.0 111.661 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 C--O 1.25 1.1 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.09 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 121.101 0.477 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.9 mt -67.85 -49.65 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.35 1.06 . . . . 0.0 111.31 -172.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -110.28 12.02 23.34 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.432 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -58.72 -35.93 73.46 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.184 0.593 . . . . 0.0 111.651 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -108.1 16.94 22.88 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.662 0.785 . . . . 0.0 110.894 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 77.4 m -121.03 114.65 21.8 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 123.847 0.859 . . . . 0.0 110.485 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.428 HG12 HG21 ' A' ' 48' ' ' VAL . 48.6 t -97.81 125.12 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 168.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 50' ' ' HIS . 3.2 mp -115.7 129.67 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.23 1.012 . . . . 0.0 111.356 -175.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -111.74 118.58 35.99 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 167.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.1 mt -83.28 133.74 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -137.2 125.54 23.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.63 1.172 . . . . 0.0 108.374 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.19 -176.22 51.88 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 -174.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' A' ' 54' ' ' SER . 72.8 m-85 -88.01 112.34 22.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 122.813 0.445 . . . . 0.0 109.808 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.42 HG23 HG11 ' A' ' 52' ' ' VAL . 41.3 p -107.83 146.27 32.5 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.749 1.22 . . . . 0.0 109.652 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -110.87 124.54 32.72 Favored Pre-proline 0 N--CA 1.485 1.305 0 CA-C-N 117.665 0.211 . . . . 0.0 111.004 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.12 173.64 57.01 Favored 'Cis proline' 0 C--N 1.375 1.955 0 C-N-CA 124.196 -1.168 . . . . 0.0 112.043 3.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.69 149.66 10.32 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 123.749 0.656 . . . . 0.0 114.535 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -50.13 -38.49 39.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.61 1.164 . . . . 0.0 112.638 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.498 HD13 ' N ' ' A' ' 26' ' ' GLN . 1.4 pp -63.66 -39.45 94.36 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 122.968 0.507 . . . . 0.0 111.98 175.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.498 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.8 tp-100 -73.27 -48.61 33.32 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.093 0.957 . . . . 0.0 110.645 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 72' ' ' PRO . 88.7 mt -56.08 -45.61 79.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.522 0.729 . . . . 0.0 111.311 174.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -54.98 -39.01 68.55 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.678 0.611 . . . . 0.0 111.151 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -64.07 -46.92 82.18 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.778 0.323 . . . . 0.0 110.593 173.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.635 ' HB3' HG21 ' A' ' 79' ' ' VAL . 36.9 mmt -62.56 -35.01 78.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.534 0.734 . . . . 0.0 112.147 -175.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.9 mt -72.35 -53.68 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.566 0.746 . . . . 0.0 111.074 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.5 t -75.0 -37.22 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.878 -167.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.19 -13.84 62.64 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.751 0.82 . . . . 0.0 111.58 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.416 ' NE2' HG11 ' A' ' 79' ' ' VAL . 21.2 m-70 -106.63 26.12 10.35 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.967 0.907 . . . . 0.0 110.619 173.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.69 22.44 72.31 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.761 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.32 156.84 20.85 Favored Glycine 0 CA--C 1.503 -0.706 0 N-CA-C 113.443 0.137 . . . . 0.0 113.443 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.536 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -105.45 144.16 32.61 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.27 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -116.35 157.3 25.24 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.99 123.21 44.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 175.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -72.91 -32.93 65.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.078 0.951 . . . . 0.0 111.789 -174.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.9 t80 . . . . . 0 C--O 1.238 0.466 0 C-N-CA 124.428 1.091 . . . . 0.0 108.377 -172.57 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 121.082 0.467 . . . . 0.0 111.427 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.9 m -117.86 17.46 14.22 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.543 0.687 . . . . 0.0 110.754 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.428 HG21 HG12 ' A' ' 13' ' ' VAL . 9.9 p -137.95 150.31 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.9 -0.5 . . . . 0.0 109.998 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.6 p -106.74 -31.89 8.22 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.429 0.692 . . . . 0.0 111.083 -176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.45 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 80.4 m80 -135.28 129.67 33.91 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.353 1.061 . . . . 0.0 108.369 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.543 ' HB ' HG12 ' A' ' 69' ' ' VAL . 48.8 mt -113.72 118.98 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 174.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.42 HG11 HG23 ' A' ' 20' ' ' THR . 73.4 t -90.91 118.83 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 122.988 0.515 . . . . 0.0 109.725 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.53 144.21 34.18 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.291 0.636 . . . . 0.0 110.191 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.437 ' HB3' ' O ' ' A' ' 19' ' ' TYR . 29.8 t -115.43 -37.37 4.04 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 166.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -98.79 98.26 9.39 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.2 tp -139.91 109.96 7.18 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 122.575 0.35 . . . . 0.0 110.145 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.551 ' HD2' ' HB2' ' A' ' 60' ' ' LYS . 18.6 Cg_exo -68.1 158.79 55.9 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.473 2.782 . . . . 0.0 112.012 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.77 -40.77 93.79 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.66 0.784 . . . . 0.0 111.539 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -67.04 -28.64 68.38 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.602 0.761 . . . . 0.0 111.429 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.551 ' HB2' ' HD2' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -86.98 -14.4 41.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.211 0.604 . . . . 0.0 111.178 177.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.416 ' HD2' ' O ' ' A' ' 92' ' ' LEU . 32.2 mtm180 -73.87 -28.71 61.71 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 166.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.6 mt -77.98 -43.33 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.394 0.677 . . . . 0.0 110.298 173.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.538 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 38.8 tt0 -68.21 -32.63 72.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.653 0.781 . . . . 0.0 111.241 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -110.28 27.61 9.45 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.667 0.787 . . . . 0.0 110.649 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.21 98.4 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.616 0.766 . . . . 0.0 112.6 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -72.81 -25.31 61.1 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.07 0.548 . . . . 0.0 111.289 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -86.26 138.36 31.91 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.51 ' HB2' ' HZ2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -76.96 88.02 3.51 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -178.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.543 HG12 ' HB ' ' A' ' 51' ' ' ILE . 35.7 m -75.9 126.3 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 91' ' ' SER . 30.4 m -135.76 178.64 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.508 1.123 . . . . 0.0 109.601 -174.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.8 m -92.2 155.19 42.96 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.686 0.794 . . . . 0.0 110.523 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.488 ' HB3' HD11 ' A' ' 27' ' ' LEU . 17.9 Cg_endo -57.46 -24.52 61.62 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.383 2.722 . . . . 0.0 113.021 174.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.45 -23.24 62.54 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.056 1.342 . . . . 0.0 112.415 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -61.06 -47.8 84.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.632 0.773 . . . . 0.0 110.507 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 75' ' ' ILE . 3.2 mp -75.05 -40.03 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.588 -172.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.523 HG12 ' HZ3' ' A' ' 80' ' ' LYS . 69.2 t -53.82 -52.35 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.873 177.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -71.83 -44.42 63.91 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.336 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.506 ' HA ' HD22 ' A' ' 85' ' ' LEU . 61.2 m -60.34 -40.06 89.34 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.458 0.703 . . . . 0.0 112.695 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' A' ' 30' ' ' MET . 15.1 t -69.2 -47.95 71.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 123.454 0.702 . . . . 0.0 110.893 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.523 ' HZ3' HG12 ' A' ' 76' ' ' VAL . 54.5 mttp -64.53 -42.8 95.52 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.074 0.549 . . . . 0.0 112.065 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -85.9 -9.42 56.97 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.086 0.555 . . . . 0.0 111.624 -177.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.15 23.16 13.77 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.871 1.268 . . . . 0.0 112.3 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.463 ' HG3' HD23 ' A' ' 85' ' ' LEU . 16.5 ptm180 -129.25 171.39 12.51 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.37 1.068 . . . . 0.0 110.029 -177.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.36 111.93 23.72 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 78' ' ' SER . 4.5 mm? -82.22 154.84 69.66 Favored Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 123.225 0.61 . . . . 0.0 110.366 174.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.21 106.8 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.463 2.108 . . . . 0.0 111.502 172.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -56.8 -31.91 65.15 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.632 0.773 . . . . 0.0 111.081 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -63.43 -23.08 67.25 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.781 1.233 . . . . 0.0 112.561 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -68.37 -37.25 80.26 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.334 0.588 . . . . 0.0 110.2 174.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -99.77 -2.43 35.17 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.654 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 75.4 m -64.55 128.21 34.81 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -173.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.416 ' O ' ' HD2' ' A' ' 61' ' ' ARG . 46.4 mt -85.83 -0.09 54.4 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.686 173.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.7 p -57.5 -43.02 83.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.312 1.045 . . . . 0.0 110.609 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 CA--C 1.558 1.266 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.349 179.85 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.515 HG21 ' HA ' ' A' ' 84' ' ' LEU . 45.5 mt -54.03 -48.35 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.191 1.396 . . . . 0.0 112.49 -173.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.497 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 54.9 m-85 -111.02 13.02 22.04 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.017 -172.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.19 -53.48 57.64 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.345 0.658 . . . . 0.0 111.103 -169.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -87.31 -21.3 25.82 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.604 0.762 . . . . 0.0 110.509 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.8 m -72.26 131.8 43.2 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.354 0.597 . . . . 0.0 110.613 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.496 HG11 HG23 ' A' ' 48' ' ' VAL . 21.1 t -105.86 124.75 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.453 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.5 mp -121.52 123.55 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 118.227 0.467 . . . . 0.0 111.554 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 34.8 t80 -105.86 132.11 52.36 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.568 1.147 . . . . 0.0 108.011 170.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.8 mt -100.56 130.33 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -131.34 129.26 41.18 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.102 0.961 . . . . 0.0 109.21 -173.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.62 174.49 46.44 Favored Glycine 0 C--N 1.343 0.926 0 O-C-N 123.275 0.359 . . . . 0.0 112.918 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -82.06 112.28 18.98 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.959 0.504 . . . . 0.0 109.876 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.584 HG23 HG13 ' A' ' 52' ' ' VAL . 80.7 p -120.78 145.41 47.58 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.611 1.164 . . . . 0.0 110.053 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -99.75 129.09 29.48 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 122.7 0.4 . . . . 0.0 111.112 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.455 ' HD2' HD22 ' A' ' 27' ' ' LEU . 36.4 Cg_endo -81.42 177.13 36.16 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.855 -0.894 . . . . 0.0 111.662 -1.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.6 138.65 6.37 Favored Glycine 0 C--N 1.349 1.296 0 O-C-N 124.078 0.861 . . . . 0.0 113.997 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -54.25 -33.0 57.53 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.716 0.806 . . . . 0.0 112.497 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.444 HD11 ' N ' ' A' ' 26' ' ' GLN . 4.6 pp -55.26 -44.23 75.41 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 123.604 0.565 . . . . 0.0 111.045 175.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.444 ' N ' HD11 ' A' ' 25' ' ' LEU . 61.1 tt0 -73.75 -44.78 55.24 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.347 0.659 . . . . 0.0 110.856 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.455 HD22 ' HD2' ' A' ' 22' ' ' PRO . 81.3 mt -56.72 -39.24 73.55 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.907 0.483 . . . . 0.0 111.053 175.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.53 ' HA ' HD11 ' A' ' 31' ' ' ILE . 15.9 m170 -63.22 -42.64 99.29 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.451 0.7 . . . . 0.0 110.036 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.18 -36.12 82.56 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.984 0.514 . . . . 0.0 110.928 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.532 ' HB3' HG22 ' A' ' 79' ' ' VAL . 32.9 mmt -66.01 -31.59 72.58 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.676 0.79 . . . . 0.0 110.932 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.53 HD11 ' HA ' ' A' ' 28' ' ' HIS . 62.6 mt -70.82 -52.95 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.853 174.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 28' ' ' HIS . 20.9 t -68.04 -43.69 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 122.991 0.516 . . . . 0.0 111.941 -168.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.17 -19.61 61.76 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.383 0.673 . . . . 0.0 112.201 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -100.9 24.34 9.39 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.192 0.997 . . . . 0.0 110.84 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.8 18.28 70.22 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.106 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.08 160.3 30.77 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -166.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -106.32 142.51 35.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.402 0.681 . . . . 0.0 109.792 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -141.35 147.71 38.52 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.426 1.091 . . . . 0.0 108.635 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.4 mt -125.55 139.03 53.95 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.785 0.434 . . . . 0.0 111.09 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.41 -33.85 73.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.964 1.306 . . . . 0.0 112.374 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.8 t80 . . . . . 0 N--CA 1.469 0.51 0 C-N-CA 123.921 0.889 . . . . 0.0 109.564 -172.218 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.477 ' HA ' ' HE1' ' A' ' 67' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 122.449 1.119 . . . . 0.0 110.632 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.7 m -92.66 -11.22 34.72 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.923 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.496 HG23 HG11 ' A' ' 13' ' ' VAL . 3.9 p -108.37 151.57 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.258 0.623 . . . . 0.0 109.994 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -101.78 -40.18 7.07 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 121.193 0.52 . . . . 0.0 110.705 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -128.97 142.85 50.79 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.269 1.027 . . . . 0.0 109.188 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.566 ' HB ' HG13 ' A' ' 69' ' ' VAL . 61.1 mt -123.97 138.0 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.584 HG13 HG23 ' A' ' 20' ' ' THR . 60.4 t -91.91 138.44 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.518 0.727 . . . . 0.0 110.246 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.67 151.91 29.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.589 1.155 . . . . 0.0 107.953 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.6 m -79.76 -48.66 13.24 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -137.34 142.18 41.82 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.57 117.74 11.29 Favored Pre-proline 0 CA--C 1.558 1.25 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.92 160.66 36.91 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.599 2.866 . . . . 0.0 113.556 -174.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -51.98 -45.45 64.47 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.549 1.14 . . . . 0.0 112.684 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -57.53 -43.97 84.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.587 0.755 . . . . 0.0 110.995 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -79.24 -20.77 47.39 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 119.412 -0.328 . . . . 0.0 111.306 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -66.33 -29.76 70.03 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 117.931 0.332 . . . . 0.0 110.243 168.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.7 mt -75.11 -40.73 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 110.337 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -76.1 -25.11 55.14 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.971 0.508 . . . . 0.0 111.386 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.464 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 41.4 m-85 -114.07 30.5 7.23 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.61 1.164 . . . . 0.0 109.662 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.46 -37.93 58.14 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.128 0.971 . . . . 0.0 112.773 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -87.81 -26.87 22.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.602 0.761 . . . . 0.0 111.279 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.477 ' HE1' ' HA ' ' A' ' 46' ' ' LYS . 46.0 m-85 -91.92 120.92 33.03 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.448 0.699 . . . . 0.0 109.574 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -75.06 86.35 2.35 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' A' ' 51' ' ' ILE . 20.1 m -76.2 128.18 37.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.84 171.68 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.954 1.302 . . . . 0.0 109.368 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 53.7 m -78.08 153.88 79.96 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.244 0.618 . . . . 0.0 111.027 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.86 -24.98 77.81 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.661 2.241 . . . . 0.0 111.888 175.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.44 -23.62 65.97 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.899 1.28 . . . . 0.0 111.504 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -62.79 -48.09 80.65 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-O 120.933 0.397 . . . . 0.0 110.033 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.497 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.8 mp -67.46 -44.35 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.055 -175.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.2 t -63.32 -51.46 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.259 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.91 -35.56 69.72 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.666 -172.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.4 ' HB3' HG23 ' A' ' 8' ' ' ILE . 61.1 m -63.57 -44.53 93.83 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.117 0.261 . . . . 0.0 110.422 176.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 30' ' ' MET . 55.9 t -64.49 -34.26 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.454 0.702 . . . . 0.0 110.883 175.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -66.89 -32.68 74.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.303 0.641 . . . . 0.0 110.748 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -94.61 -10.98 30.3 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.61 0.764 . . . . 0.0 112.147 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.06 30.04 19.27 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.412 1.085 . . . . 0.0 112.055 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.8 ptt-85 -151.3 164.11 37.39 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.38 0.672 . . . . 0.0 110.498 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.515 ' HA ' HG21 ' A' ' 8' ' ' ILE . 3.2 tm? -79.49 106.74 11.74 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.2 mt -85.97 157.51 57.06 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.488 0.715 . . . . 0.0 109.94 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -65.49 120.8 8.06 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.079 1.853 . . . . 0.0 111.683 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -57.87 -31.52 66.79 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.542 1.137 . . . . 0.0 111.372 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -63.89 -21.69 66.58 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.702 1.201 . . . . 0.0 112.379 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -66.75 -30.8 71.11 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.139 0.576 . . . . 0.0 110.648 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.15 8.43 11.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.941 0.896 . . . . 0.0 111.946 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 p -67.74 111.52 4.31 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.997 0.519 . . . . 0.0 112.138 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.27 -11.85 58.39 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.452 0.701 . . . . 0.0 111.511 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.419 ' HB ' HG21 ' A' ' 69' ' ' VAL . 9.3 t -69.08 -27.05 65.26 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.493 0.717 . . . . 0.0 111.144 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.7 p . . . . . 0 C--O 1.251 1.16 0 C-N-CA 123.273 0.629 . . . . 0.0 109.867 175.693 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.464 HG23 ' HA ' ' A' ' 84' ' ' LEU . 67.6 mt -55.3 -48.59 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.193 0.997 . . . . 0.0 111.956 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -109.67 11.88 24.43 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.536 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -61.99 -41.65 98.28 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.948 0.499 . . . . 0.0 112.267 -170.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -76.62 -27.22 55.64 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.041 0.448 . . . . 0.0 110.214 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.2 m -88.1 144.18 26.64 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.284 1.04 . . . . 0.0 112.462 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.509 HG12 HG21 ' A' ' 48' ' ' VAL . 21.4 t -115.54 127.82 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.517 ' HB ' HD12 ' A' ' 31' ' ' ILE . 4.6 mp -123.19 128.19 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 122.764 0.426 . . . . 0.0 111.532 -171.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 24.6 t80 -108.36 151.37 26.1 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.377 1.471 . . . . 0.0 108.675 175.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.454 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 74.0 mt -118.32 123.18 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.373 0.669 . . . . 0.0 109.336 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -117.07 135.68 53.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.259 1.024 . . . . 0.0 109.388 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.89 -139.92 28.03 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.45 0.469 . . . . 0.0 112.767 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -112.6 120.25 40.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.304 0.642 . . . . 0.0 109.667 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.721 HG23 HG11 ' A' ' 52' ' ' VAL . 68.1 p -133.17 147.11 52.05 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.463 0.705 . . . . 0.0 109.559 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -108.91 135.61 20.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.366 0.667 . . . . 0.0 109.793 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.487 ' HD2' HD23 ' A' ' 27' ' ' LEU . 70.3 Cg_endo -74.81 177.24 39.72 Favored 'Cis proline' 0 C--N 1.369 1.631 0 C-N-CA 124.643 -0.982 . . . . 0.0 111.634 -5.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.18 146.98 3.68 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 124.019 0.824 . . . . 0.0 114.776 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -58.21 -36.38 73.05 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.077 0.951 . . . . 0.0 112.599 -172.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.01 -32.92 72.81 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.234 0.214 . . . . 0.0 110.65 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -69.19 -53.24 21.02 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.451 0.7 . . . . 0.0 110.425 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.487 HD23 ' HD2' ' A' ' 22' ' ' PRO . 87.8 mt -57.27 -40.55 77.96 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.458 0.703 . . . . 0.0 111.786 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.568 ' HA ' HD13 ' A' ' 31' ' ' ILE . 17.2 m170 -61.49 -38.96 89.23 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.9 0.48 . . . . 0.0 111.363 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.51 -35.05 68.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.628 0.371 . . . . 0.0 111.257 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.524 ' HB3' HG22 ' A' ' 79' ' ' VAL . 54.8 mtt -61.08 -31.97 71.63 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.971 0.509 . . . . 0.0 110.799 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 28' ' ' HIS . 66.1 mt -68.09 -51.03 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.299 0.64 . . . . 0.0 110.986 173.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 28' ' ' HIS . 92.0 t -60.99 -50.27 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.569 0.748 . . . . 0.0 112.747 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.1 -12.58 60.36 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.441 0.696 . . . . 0.0 112.326 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -108.77 26.29 10.73 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.092 0.957 . . . . 0.0 110.13 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.0 60.48 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-N 114.58 -1.191 . . . . 0.0 114.051 171.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.33 159.63 48.84 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 -164.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -103.49 152.55 21.54 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -137.23 159.04 43.07 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.043 0.449 . . . . 0.0 111.323 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.52 128.51 56.04 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 165.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.1 -33.39 70.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.405 172.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.422 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 35.1 t80 . . . . . 0 C--N 1.351 0.639 0 C-N-CA 124.414 1.086 . . . . 0.0 108.7 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.775 0 CA-C-O 121.357 0.598 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 m -90.45 -32.15 16.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.924 0.89 . . . . 0.0 110.223 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.509 HG21 HG12 ' A' ' 13' ' ' VAL . 6.5 p -92.98 155.26 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.196 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -109.18 -27.67 9.45 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 118.064 0.393 . . . . 0.0 111.42 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -118.77 140.47 49.9 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.224 0.61 . . . . 0.0 109.959 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.65 ' HB ' HG13 ' A' ' 69' ' ' VAL . 33.5 mt -125.08 140.07 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.721 HG11 HG23 ' A' ' 20' ' ' THR . 95.2 t -104.51 135.85 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.768 0.827 . . . . 0.0 109.666 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.02 150.18 27.99 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.41 0.684 . . . . 0.0 109.364 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -75.95 -42.68 47.87 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -139.73 133.52 30.6 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.132 -1.395 . . . . 0.0 108.034 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.566 ' HG ' HG21 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -116.14 110.37 43.58 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.88 156.42 66.0 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.964 2.442 . . . . 0.0 112.861 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.1 -47.88 81.88 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.333 1.053 . . . . 0.0 112.995 -169.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 1.1 mptm? -64.15 -31.19 72.29 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.913 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -83.55 -18.87 36.89 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.073 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -66.06 -32.5 74.01 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 168.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 64.9 mt -71.01 -49.62 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.498 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 38.6 mm-40 -66.34 -31.88 72.94 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.723 0.409 . . . . 0.0 111.76 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -106.47 25.91 10.55 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.559 0.744 . . . . 0.0 110.882 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.94 -32.88 74.57 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.054 0.454 . . . . 0.0 110.579 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -69.87 -26.47 64.21 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.101 0.961 . . . . 0.0 111.318 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -99.05 162.51 13.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.334 0.654 . . . . 0.0 110.582 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -101.58 88.21 3.37 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.65 HG13 ' HB ' ' A' ' 51' ' ' ILE . 26.8 m -75.89 134.6 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.731 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.538 HG12 ' HB2' ' A' ' 87' ' ' TRP . 34.6 m -137.62 175.45 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.808 1.243 . . . . 0.0 109.873 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.2 m -81.85 154.5 70.48 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.762 0.825 . . . . 0.0 110.113 172.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.42 -24.22 71.11 Favored 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.51 2.14 . . . . 0.0 111.426 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.98 -21.47 63.55 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.955 1.302 . . . . 0.0 111.27 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.73 -51.45 62.31 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 123.144 0.277 . . . . 0.0 110.266 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.1 mp -66.33 -43.94 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.79 -51.97 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.24 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -73.09 -33.15 65.43 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.197 0.599 . . . . 0.0 111.787 -171.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 71.9 m -66.97 -40.52 87.49 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.58 0.352 . . . . 0.0 110.281 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 30' ' ' MET . 55.0 t -70.68 -33.87 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.451 0.7 . . . . 0.0 110.786 173.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -64.58 -41.37 96.32 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.157 0.983 . . . . 0.0 110.523 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -95.41 -6.46 40.85 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.855 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.22 27.14 15.47 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.573 1.149 . . . . 0.0 112.33 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -142.49 159.33 42.44 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.774 0.83 . . . . 0.0 110.546 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.464 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.2 tm? -75.1 127.55 33.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.8 mt -114.7 152.12 46.0 Favored Pre-proline 0 C--O 1.24 0.596 0 C-N-CA 124.214 1.006 . . . . 0.0 109.714 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.403 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 35.3 Cg_endo -61.73 109.34 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.551 2.167 . . . . 0.0 111.877 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.538 ' HB2' HG12 ' A' ' 70' ' ' VAL . 29.9 p90 -62.14 -21.91 65.42 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.388 1.075 . . . . 0.0 112.206 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.403 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 12.7 pt20 -59.78 -25.11 64.65 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.127 0.971 . . . . 0.0 111.818 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -70.92 -31.66 68.35 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.788 0.835 . . . . 0.0 111.131 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.29 -0.79 25.97 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.905 0.882 . . . . 0.0 111.318 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -66.24 131.42 46.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.329 0.652 . . . . 0.0 112.0 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.8 mt -108.31 14.54 24.79 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.101 0.96 . . . . 0.0 110.951 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.0 p -65.56 -52.73 50.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.823 0.849 . . . . 0.0 111.321 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 C--O 1.252 1.185 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.166 -173.858 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.3 mt -49.08 -47.87 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.507 1.523 . . . . 0.0 112.352 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -109.58 15.32 22.98 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.862 0.465 . . . . 0.0 111.566 -174.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -57.82 -49.3 77.12 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.287 0.635 . . . . 0.0 111.448 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -76.41 -15.56 59.91 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.675 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.5 m -93.08 141.17 28.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.632 0.773 . . . . 0.0 111.421 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.56 124.84 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 171.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.412 ' HB ' HD11 ' A' ' 31' ' ' ILE . 4.2 mp -118.5 134.28 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 C-N-CA 123.155 0.582 . . . . 0.0 111.74 -170.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.437 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 33.3 t80 -113.0 149.49 33.24 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.414 1.486 . . . . 0.0 108.089 169.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 65.7 mt -114.54 110.01 30.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -103.83 122.44 45.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.277 1.431 . . . . 0.0 109.447 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.76 175.58 50.98 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.88 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -82.08 111.49 18.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.599 HG22 HG13 ' A' ' 52' ' ' VAL . 69.6 p -112.14 151.92 28.92 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.887 0.875 . . . . 0.0 110.037 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.52 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -102.99 122.91 43.88 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 163.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -81.66 172.08 54.41 Favored 'Cis proline' 0 C--N 1.37 1.698 0 C-N-CA 124.031 -1.237 . . . . 0.0 112.033 1.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.61 164.6 15.79 Favored Glycine 0 C--N 1.344 0.995 0 O-C-N 123.735 0.647 . . . . 0.0 114.357 -172.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -56.11 -36.53 68.3 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.362 0.665 . . . . 0.0 111.411 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.526 HD11 ' N ' ' A' ' 26' ' ' GLN . 2.9 pp -61.66 -43.12 99.46 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.454 0.701 . . . . 0.0 111.57 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.526 ' N ' HD11 ' A' ' 25' ' ' LEU . 6.2 tp-100 -71.29 -51.76 22.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.345 0.658 . . . . 0.0 110.22 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.68 -51.09 70.13 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.028 0.83 . . . . 0.0 111.402 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.431 ' O ' HG22 ' A' ' 32' ' ' VAL . 15.6 m170 -54.85 -47.55 74.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.727 0.642 . . . . 0.0 111.109 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.5 -38.94 91.19 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.27 0.356 . . . . 0.0 111.571 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.545 ' HB3' HG21 ' A' ' 79' ' ' VAL . 21.2 mmt -61.22 -40.0 92.39 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.991 0.516 . . . . 0.0 111.132 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.412 HD11 ' HB ' ' A' ' 14' ' ' ILE . 70.8 mt -65.19 -49.12 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.008 0.923 . . . . 0.0 111.348 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 28' ' ' HIS . 57.9 t -65.84 -41.55 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.979 0.512 . . . . 0.0 111.573 -176.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.39 -13.04 60.1 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.321 0.648 . . . . 0.0 111.844 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.597 ' HE1' HG11 ' A' ' 79' ' ' VAL . 38.6 m80 -108.92 26.85 10.11 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.699 0.799 . . . . 0.0 111.758 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.95 7.03 75.03 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.944 172.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.89 158.1 30.28 Favored Glycine 0 C--O 1.242 0.596 0 C-N-CA 123.026 0.346 . . . . 0.0 113.94 -173.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -102.83 158.67 16.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.502 0.721 . . . . 0.0 109.653 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.37 161.71 37.63 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.389 0.676 . . . . 0.0 110.473 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.1 149.42 42.23 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.789 0.836 . . . . 0.0 110.531 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -68.9 -47.87 64.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.612 1.165 . . . . 0.0 111.566 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.437 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 77.5 t80 . . . . . 0 N--CA 1.476 0.858 0 C-N-CA 124.674 1.19 . . . . 0.0 108.96 -170.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.49 ' HA ' ' HE1' ' A' ' 67' ' ' TYR . 54.1 mtpt . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -82.04 -24.32 35.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.748 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.84 151.53 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.12 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.6 p -114.57 -17.74 11.62 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -137.71 136.77 37.67 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.26 1.024 . . . . 0.0 109.096 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.595 ' HB ' HG12 ' A' ' 69' ' ' VAL . 67.4 mt -125.21 137.25 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.599 HG13 HG22 ' A' ' 20' ' ' THR . 54.5 t -105.84 133.72 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.41 1.084 . . . . 0.0 110.74 -173.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.45 146.01 20.79 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -77.14 -39.76 48.05 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -138.33 107.9 6.21 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.607 ' HB2' HD13 ' A' ' 92' ' ' LEU . 16.5 tp -100.53 119.61 58.29 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -64.32 159.55 43.19 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.623 2.882 . . . . 0.0 112.589 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.7 mt -58.99 -46.05 89.09 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.982 0.913 . . . . 0.0 112.38 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -57.56 -46.11 84.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.453 0.701 . . . . 0.0 110.713 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -66.26 -30.07 70.43 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.158 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -66.65 -38.24 86.47 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.159 0.584 . . . . 0.0 110.724 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.8 mt -70.39 -46.18 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 123.82 0.7 . . . . 0.0 110.384 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.71 -32.36 73.87 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.689 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.429 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 22.0 m-30 -103.08 15.05 30.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.451 0.701 . . . . 0.0 111.89 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.86 -18.81 62.69 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.323 0.583 . . . . 0.0 110.896 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -71.77 -19.91 61.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.268 1.027 . . . . 0.0 110.602 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.49 ' HE1' ' HA ' ' A' ' 46' ' ' LYS . 17.2 m-85 -113.47 169.83 8.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.382 1.073 . . . . 0.0 109.008 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.463 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -96.15 91.07 5.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.427 0.691 . . . . 0.0 109.413 175.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.595 HG12 ' HB ' ' A' ' 51' ' ' ILE . 20.3 m -82.88 129.95 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.288 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.476 HG13 ' HB2' ' A' ' 87' ' ' TRP . 31.6 m -139.79 167.56 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.754 1.221 . . . . 0.0 110.514 -175.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.6 m -75.76 155.91 84.89 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.847 172.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.06 -25.46 79.82 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.469 2.113 . . . . 0.0 111.495 172.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.5 -29.89 59.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.48 1.512 . . . . 0.0 112.651 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.425 ' CE3' HG23 ' A' ' 70' ' ' VAL . 27.6 t90 -62.18 -48.74 78.69 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.354 0.408 . . . . 0.0 110.197 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.77 -54.98 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.241 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.8 t -51.84 -52.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.841 1.257 . . . . 0.0 112.346 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -71.58 -42.1 68.17 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.732 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.433 ' HA ' HD13 ' A' ' 85' ' ' LEU . 72.5 m -61.63 -36.93 82.17 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.736 0.415 . . . . 0.0 111.448 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.597 HG11 ' HE1' ' A' ' 34' ' ' HIS . 21.8 t -63.57 -46.94 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.265 1.026 . . . . 0.0 111.057 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -65.97 -43.47 87.77 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.042 0.537 . . . . 0.0 111.102 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -76.5 -15.59 59.85 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.708 0.803 . . . . 0.0 112.04 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.41 40.92 23.69 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.091 0.956 . . . . 0.0 110.843 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -159.51 156.54 28.37 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.868 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -85.81 109.3 18.58 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 78' ' ' SER . 8.6 mp -79.64 155.28 76.04 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.126 0.57 . . . . 0.0 111.242 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.451 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 35.8 Cg_endo -61.12 114.83 2.36 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.426 2.084 . . . . 0.0 111.325 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.476 ' HB2' HG13 ' A' ' 70' ' ' VAL . 48.1 p90 -64.9 -20.09 66.26 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.649 0.78 . . . . 0.0 112.395 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.451 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.0 pt20 -58.19 -28.04 64.41 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.275 1.03 . . . . 0.0 112.023 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -70.6 -27.68 64.28 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.605 0.762 . . . . 0.0 110.814 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.78 5.95 14.27 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.047 0.939 . . . . 0.0 111.689 -175.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.427 ' HB2' HG23 ' A' ' 93' ' ' THR . 59.9 p -69.85 120.48 15.66 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.202 0.601 . . . . 0.0 112.287 -174.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' A' ' 56' ' ' LEU . 48.5 mt -73.62 -21.48 60.29 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.947 0.899 . . . . 0.0 111.666 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.427 HG23 ' HB2' ' A' ' 91' ' ' SER . 10.3 t -65.5 -17.53 64.63 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.694 0.798 . . . . 0.0 112.112 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.4 m . . . . . 0 C--O 1.26 1.613 0 C-N-CA 123.294 0.637 . . . . 0.0 109.993 175.568 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.545 HG21 ' OG ' ' A' ' 78' ' ' SER . 57.7 mt -64.73 -51.42 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.681 -167.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.623 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 61.7 m-85 -103.17 18.04 22.67 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.886 -175.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -51.16 -59.09 4.56 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.281 1.032 . . . . 0.0 112.877 -171.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -95.81 17.39 15.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.867 0.867 . . . . 0.0 111.01 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.448 ' SG ' ' HH2' ' A' ' 74' ' ' TRP . 41.1 t -116.9 123.26 46.58 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 124.484 1.114 . . . . 0.0 109.756 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.47 HG13 HD21 ' A' ' 39' ' ' LEU . 40.6 t -101.68 128.2 54.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.513 ' HB ' HD12 ' A' ' 31' ' ' ILE . 4.2 mp -122.36 123.28 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 122.833 0.453 . . . . 0.0 111.041 -175.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.43 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 28.4 t80 -104.35 150.74 24.22 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.341 1.456 . . . . 0.0 108.134 174.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.21 130.31 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -135.81 123.78 22.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.414 1.085 . . . . 0.0 109.771 -170.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.7 -161.57 42.45 Favored Glycine 0 C--N 1.343 0.958 0 O-C-N 123.496 0.498 . . . . 0.0 112.822 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -88.03 110.73 20.84 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.237 0.615 . . . . 0.0 109.558 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.513 HG22 HG12 ' A' ' 52' ' ' VAL . 61.5 p -133.94 134.4 42.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.044 0.937 . . . . 0.0 109.271 -177.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -117.47 139.17 25.83 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -69.94 170.69 58.03 Favored 'Cis proline' 0 C--N 1.389 2.707 0 C-N-CA 124.705 -0.956 . . . . 0.0 112.567 3.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.67 149.11 5.55 Favored Glycine 0 N--CA 1.475 1.257 0 O-C-N 124.01 0.819 . . . . 0.0 114.196 -169.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -52.23 -36.08 51.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.777 0.831 . . . . 0.0 112.197 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 26' ' ' GLN . 3.6 pp -62.46 -41.44 98.76 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.27 0.628 . . . . 0.0 111.63 174.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.508 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.5 tp-100 -72.19 -50.79 24.83 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.813 0.845 . . . . 0.0 110.945 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.1 mt -54.73 -44.96 74.01 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.215 0.606 . . . . 0.0 111.008 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.515 ' HA ' HD13 ' A' ' 31' ' ' ILE . 9.5 m170 -58.75 -43.5 90.31 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 123.572 0.545 . . . . 0.0 111.417 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -66.5 -38.89 88.23 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 123.168 0.292 . . . . 0.0 111.23 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.0 mmt -58.42 -39.36 79.57 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.338 0.655 . . . . 0.0 110.947 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.515 HD13 ' HA ' ' A' ' 28' ' ' HIS . 70.9 mt -62.69 -47.8 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.07 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 28' ' ' HIS . 39.1 t -64.19 -47.6 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.653 0.596 . . . . 0.0 111.117 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.01 -33.55 73.44 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.829 0.852 . . . . 0.0 111.47 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.472 ' HE1' HG11 ' A' ' 79' ' ' VAL . 54.9 m80 -86.44 27.47 0.94 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.255 0.622 . . . . 0.0 112.274 175.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.32 28.99 73.02 Favored Glycine 0 C--N 1.357 1.73 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.29 169.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.623 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -112.44 172.43 14.66 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 115.551 0.98 . . . . 0.0 115.551 -168.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -111.16 146.22 37.25 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.702 0.801 . . . . 0.0 109.444 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -128.83 166.25 19.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.562 0.745 . . . . 0.0 109.585 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.47 HD21 HG13 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -130.3 136.22 48.91 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.051 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -82.44 -36.79 26.27 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 123.867 0.729 . . . . 0.0 112.144 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.43 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 61.3 t80 . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 122.974 0.509 . . . . 0.0 110.539 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.548 0.896 0 CA-C-O 121.542 0.687 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.6 m -79.68 -27.86 40.74 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.435 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.4 p -86.64 151.71 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.984 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.439 HG22 ' ND1' ' A' ' 50' ' ' HIS . 5.1 t -114.79 -25.4 8.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.742 0.817 . . . . 0.0 110.683 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.439 ' ND1' HG22 ' A' ' 49' ' ' THR . 53.5 m80 -133.38 127.42 33.42 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.924 0.49 . . . . 0.0 110.419 -174.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.597 ' HB ' HG11 ' A' ' 69' ' ' VAL . 61.7 mt -119.04 129.41 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 20' ' ' THR . 70.8 t -90.76 123.27 42.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 123.63 0.772 . . . . 0.0 109.187 -173.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.93 140.69 31.23 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.834 0.853 . . . . 0.0 108.951 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -84.05 -49.95 8.43 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.61 132.99 56.54 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.518 -1.219 . . . . 0.0 107.719 170.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.98 101.55 10.41 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.09 160.16 48.68 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.092 2.528 . . . . 0.0 112.706 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.8 -31.97 67.1 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.052 0.941 . . . . 0.0 112.001 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 47.9 tptt -60.77 -53.42 57.61 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.269 0.628 . . . . 0.0 109.911 175.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -70.69 -19.25 62.79 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.821 0.448 . . . . 0.0 111.841 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -72.88 -27.69 62.05 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.735 0.814 . . . . 0.0 109.779 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.3 mt -79.11 -45.3 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.321 0.648 . . . . 0.0 110.043 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 24.4 mm-40 -63.52 -29.18 70.49 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.598 0.759 . . . . 0.0 112.215 -175.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -121.97 28.63 7.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.058 0.943 . . . . 0.0 110.293 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -30.68 69.26 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.447 0.699 . . . . 0.0 112.566 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -75.08 -23.63 58.03 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.119 0.568 . . . . 0.0 111.572 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -107.64 123.69 48.87 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.94 93.23 0.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.369 0.604 . . . . 0.0 109.755 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.597 HG11 ' HB ' ' A' ' 51' ' ' ILE . 27.4 m -73.89 128.83 36.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 87' ' ' TRP . 30.2 m -128.13 172.13 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.253 1.021 . . . . 0.0 109.862 -174.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -80.46 152.51 73.08 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.27 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -56.78 -25.09 59.15 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.693 2.262 . . . . 0.0 112.17 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.41 -26.5 53.55 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.884 1.273 . . . . 0.0 112.286 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.448 ' HH2' ' SG ' ' A' ' 12' ' ' CYS . 28.3 t90 -59.6 -48.45 81.62 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.825 0.284 . . . . 0.0 110.454 174.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.504 ' O ' HG21 ' A' ' 79' ' ' VAL . 3.3 mp -69.33 -42.71 81.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 O-C-N 124.042 0.839 . . . . 0.0 108.85 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.477 HG12 ' HE2' ' A' ' 80' ' ' LYS . 85.0 t -62.14 -50.52 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.006 0.922 . . . . 0.0 111.408 -177.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.23 -33.72 76.66 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.24 0.616 . . . . 0.0 110.849 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.545 ' OG ' HG21 ' A' ' 8' ' ' ILE . 38.5 t -62.54 -37.65 86.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.235 0.614 . . . . 0.0 111.449 177.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 75' ' ' ILE . 94.0 t -70.96 -47.13 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.502 0.721 . . . . 0.0 110.669 177.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.477 ' HE2' HG12 ' A' ' 76' ' ' VAL . 53.2 mtmt -64.74 -45.16 87.63 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.486 0.714 . . . . 0.0 111.744 -175.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -86.76 -15.51 39.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.342 0.657 . . . . 0.0 111.473 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.85 38.56 14.58 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.572 1.149 . . . . 0.0 111.869 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -149.75 164.49 35.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.395 0.678 . . . . 0.0 110.285 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.5 tp -84.05 95.26 8.52 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.8 142.94 96.15 Favored Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.441 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 16.8 Cg_endo -56.24 108.01 0.3 Allowed 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.302 2.001 . . . . 0.0 110.79 172.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.409 ' HB2' HG13 ' A' ' 70' ' ' VAL . 29.8 p90 -56.95 -22.69 39.9 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.547 1.139 . . . . 0.0 112.695 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.441 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 20.6 pt20 -57.47 -26.77 61.75 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.749 1.22 . . . . 0.0 112.105 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.401 HD22 ' HG2' ' A' ' 86' ' ' PRO . 61.4 m-20 -67.09 -38.46 85.75 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.196 0.598 . . . . 0.0 110.72 175.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -99.72 -5.62 28.46 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.07 0.948 . . . . 0.0 111.521 -172.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.0 m -66.23 121.74 15.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.111 0.564 . . . . 0.0 112.304 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.8 mt -81.86 -0.65 44.54 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.557 1.143 . . . . 0.0 111.062 172.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.8 p -66.96 -20.59 65.92 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.512 1.125 . . . . 0.0 111.665 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.558 1.254 0 C-N-CA 124.587 1.155 . . . . 0.0 111.876 -178.93 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 10' ' ' LYS . 15.3 ptpt . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.534 HG22 ' HA ' ' A' ' 84' ' ' LEU . 66.9 mt -49.49 -46.23 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.024 1.33 . . . . 0.0 112.167 -177.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.506 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 78.1 m-85 -104.8 15.86 27.06 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.976 -173.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 7' ' ' LYS . 28.5 ttpp -51.53 -48.26 63.07 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.902 0.881 . . . . 0.0 113.312 -173.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -98.78 2.04 46.53 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.036 0.534 . . . . 0.0 111.436 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.4 m -97.89 110.8 23.31 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.873 0.869 . . . . 0.0 110.919 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 41.0 t -93.31 127.84 45.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.465 ' HB ' HD12 ' A' ' 31' ' ' ILE . 2.6 mp -114.74 136.06 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.58 0.752 . . . . 0.0 110.941 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -118.05 110.84 18.14 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 170.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.7 mt -77.22 134.28 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -138.68 122.02 17.11 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -173.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.63 -173.91 52.95 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.681 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -79.97 110.76 15.66 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.213 0.605 . . . . 0.0 109.904 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.559 HG21 HG11 ' A' ' 52' ' ' VAL . 61.8 p -121.16 136.68 54.93 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.514 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 11.0 mmpt? -104.06 135.43 19.35 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 117.85 0.295 . . . . 0.0 110.685 176.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' HD23 ' A' ' 27' ' ' LEU . 94.1 Cg_endo -74.24 173.79 54.96 Favored 'Cis proline' 0 C--N 1.378 2.099 0 C-N-CA 124.613 -0.995 . . . . 0.0 112.107 -1.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.64 156.0 3.73 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 123.885 0.741 . . . . 0.0 114.745 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -54.46 -38.4 66.31 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.572 0.749 . . . . 0.0 111.519 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 26' ' ' GLN . 2.3 pp -60.62 -44.94 95.76 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 123.779 0.674 . . . . 0.0 111.338 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.519 ' N ' HD11 ' A' ' 25' ' ' LEU . 6.7 tp-100 -69.45 -50.31 46.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.344 0.658 . . . . 0.0 110.672 -175.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.417 HD23 ' HD2' ' A' ' 22' ' ' PRO . 81.6 mt -56.1 -50.45 71.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.975 0.51 . . . . 0.0 111.447 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.426 ' HA ' HD13 ' A' ' 31' ' ' ILE . 23.5 m170 -54.82 -41.92 71.25 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.698 0.799 . . . . 0.0 111.094 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -67.81 -44.49 77.18 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.156 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 34.2 mmt -63.16 -34.1 76.9 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.158 0.583 . . . . 0.0 111.629 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.465 HD12 ' HB ' ' A' ' 14' ' ' ILE . 66.1 mt -60.54 -50.73 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.386 173.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.3 t -66.64 -39.78 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.549 0.74 . . . . 0.0 112.367 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.3 -23.55 67.47 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.698 0.799 . . . . 0.0 111.388 178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -104.88 27.57 7.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.973 0.909 . . . . 0.0 111.044 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.49 14.16 80.52 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 114.893 -1.049 . . . . 0.0 114.114 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.86 174.88 22.85 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 114.524 0.57 . . . . 0.0 114.524 -170.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HZ1' ' HB2' ' A' ' 37' ' ' LYS . 2.7 ttmp? -128.54 151.19 49.73 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.157 0.583 . . . . 0.0 109.787 -177.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -121.18 161.4 21.93 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.532 0.733 . . . . 0.0 109.337 170.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.24 131.94 56.33 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -64.54 -40.01 94.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.094 0.958 . . . . 0.0 112.196 -165.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.1 t80 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -175.753 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 CA--C 1.543 0.711 0 CA-C-O 121.114 0.483 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.7 m -108.31 -28.06 9.64 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.304 0.642 . . . . 0.0 110.624 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.6 150.03 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.55 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.3 p -102.89 -26.86 12.96 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.299 0.639 . . . . 0.0 111.302 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -137.35 128.48 27.72 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.814 0.846 . . . . 0.0 109.653 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.467 ' HB ' HG21 ' A' ' 69' ' ' VAL . 43.7 mt -110.65 114.68 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 175.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 20' ' ' THR . 78.2 t -89.15 135.93 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.815 0.846 . . . . 0.0 109.919 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.37 170.59 19.71 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.598 0.759 . . . . 0.0 110.306 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.6 t -86.81 -52.23 5.62 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -145.07 103.17 3.84 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.488 ' HG ' HG13 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -89.1 114.71 61.28 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.85 143.49 91.03 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.362 2.708 . . . . 0.0 113.017 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.8 mt -55.93 -41.0 73.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.294 1.038 . . . . 0.0 112.428 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -56.61 -50.16 72.8 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.661 0.784 . . . . 0.0 110.524 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -76.1 -17.85 59.43 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.487 -175.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -68.99 -32.05 71.32 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.983 0.356 . . . . 0.0 110.162 170.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.5 mt -65.58 -42.92 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.03 -40.18 94.44 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 120.931 0.396 . . . . 0.0 111.122 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.407 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 21.0 m-85 -95.58 25.14 4.7 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.939 0.496 . . . . 0.0 111.124 -176.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.02 -16.77 62.06 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.269 0.627 . . . . 0.0 111.406 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -79.05 -14.94 58.86 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.729 0.412 . . . . 0.0 110.853 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.407 ' HD2' ' HA ' ' A' ' 64' ' ' PHE . 32.4 m-85 -115.71 152.77 32.58 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 109.408 -175.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -90.28 88.81 7.36 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.513 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 73.2 t -74.88 124.68 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' A' ' 87' ' ' TRP . 32.7 m -133.03 176.64 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.941 0.896 . . . . 0.0 110.966 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.3 m -87.63 158.93 50.53 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 124.278 1.031 . . . . 0.0 109.957 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.62 -21.24 70.24 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.418 2.079 . . . . 0.0 111.794 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.23 -26.14 66.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.129 1.372 . . . . 0.0 111.637 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -62.3 -44.88 95.48 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.759 0.314 . . . . 0.0 110.381 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.506 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.6 mp -71.43 -50.98 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.985 -176.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.9 t -57.89 -52.5 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.557 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.81 -37.75 73.25 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.071 -172.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 98.2 p -65.73 -39.25 90.94 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.29 0.236 . . . . 0.0 111.139 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.06 -41.55 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.67 0.788 . . . . 0.0 110.793 176.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.57 -38.06 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.559 0.744 . . . . 0.0 111.252 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -82.28 -18.51 42.13 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.649 0.78 . . . . 0.0 111.39 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.59 32.94 22.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.716 1.206 . . . . 0.0 111.539 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -139.12 162.03 35.94 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.801 0.84 . . . . 0.0 109.922 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.534 ' HA ' HG22 ' A' ' 8' ' ' ILE . 3.0 tm? -79.21 125.37 29.37 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.97 148.64 35.1 Favored Pre-proline 0 C--O 1.243 0.713 0 C-N-CA 123.66 0.784 . . . . 0.0 109.975 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.05 115.11 2.75 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.131 1.887 . . . . 0.0 110.335 166.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.498 ' HB2' HG12 ' A' ' 70' ' ' VAL . 12.7 p90 -62.96 -25.2 68.25 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.65 0.78 . . . . 0.0 111.862 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -60.03 -22.91 63.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.388 1.075 . . . . 0.0 112.13 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -63.45 -45.45 90.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.884 0.874 . . . . 0.0 110.105 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -102.42 6.43 40.18 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.57 0.748 . . . . 0.0 111.604 -173.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 36.7 m -65.84 114.54 5.15 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.038 0.535 . . . . 0.0 112.362 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.7 -26.33 63.37 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.79 0.836 . . . . 0.0 110.201 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.513 ' HB ' ' HB ' ' A' ' 69' ' ' VAL . 8.8 t -69.95 -11.05 60.59 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.934 0.894 . . . . 0.0 112.261 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.258 1.53 0 C-N-CA 123.213 0.605 . . . . 0.0 110.091 174.563 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.3 mttm . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.4 mt -53.37 -45.67 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.845 0.858 . . . . 0.0 112.253 -172.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.468 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 70.4 m-85 -111.63 15.54 21.02 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 119.275 -0.393 . . . . 0.0 111.127 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -56.37 -41.51 76.32 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.539 0.736 . . . . 0.0 112.811 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -96.92 -3.6 41.52 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.099 0.559 . . . . 0.0 111.391 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.452 ' SG ' ' ND1' ' A' ' 50' ' ' HIS . 51.8 t -99.0 127.05 44.84 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 123.974 0.91 . . . . 0.0 110.676 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.456 HG12 HD23 ' A' ' 39' ' ' LEU . 32.4 t -106.41 134.42 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.484 ' HB ' HD12 ' A' ' 31' ' ' ILE . 4.9 mp -125.64 128.47 72.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 123.391 0.677 . . . . 0.0 111.359 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -114.69 120.32 39.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.97 1.308 . . . . 0.0 108.174 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.6 mt -93.29 109.55 21.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -98.33 123.73 42.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.672 1.189 . . . . 0.0 109.599 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.88 -159.77 52.31 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 123.416 0.447 . . . . 0.0 113.892 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.74 122.48 32.19 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.782 0.833 . . . . 0.0 110.54 -177.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.596 HG22 HG13 ' A' ' 52' ' ' VAL . 72.3 p -132.88 146.24 51.64 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.015 1.326 . . . . 0.0 108.944 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -112.49 130.51 23.32 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.02 171.75 65.21 Favored 'Cis proline' 0 C--N 1.382 2.291 0 C-N-CA 124.146 -1.189 . . . . 0.0 111.381 -0.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.28 147.71 5.91 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.833 0.708 . . . . 0.0 114.493 -173.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -52.78 -36.48 58.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.713 0.805 . . . . 0.0 112.41 -175.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 pp -59.23 -43.01 92.38 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.319 0.648 . . . . 0.0 111.615 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -67.39 -50.15 60.86 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.858 0.863 . . . . 0.0 110.327 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 31' ' ' ILE . 92.9 mt -55.81 -41.24 73.89 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.474 0.709 . . . . 0.0 111.732 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.609 ' HA ' HD13 ' A' ' 31' ' ' ILE . 13.0 m80 -62.46 -37.52 86.25 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.68 0.792 . . . . 0.0 110.877 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -68.36 -40.92 81.31 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.225 0.61 . . . . 0.0 110.569 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.575 ' HB3' HG23 ' A' ' 79' ' ' VAL . 64.5 mtt -59.69 -33.49 71.65 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.436 0.695 . . . . 0.0 111.142 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.609 HD13 ' HA ' ' A' ' 28' ' ' HIS . 74.4 mt -70.3 -54.1 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.321 0.648 . . . . 0.0 110.982 177.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.58 -45.52 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.428 0.691 . . . . 0.0 112.185 -170.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.82 -21.03 66.71 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.479 0.712 . . . . 0.0 112.241 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -104.27 26.91 8.28 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.564 0.746 . . . . 0.0 110.726 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.36 -1.35 87.63 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.882 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . -75.51 160.37 52.0 Favored Glycine 0 CA--C 1.5 -0.859 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -170.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.433 ' HB3' HG22 ' A' ' 13' ' ' VAL . 2.9 tppp? -112.98 145.82 40.15 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -127.75 149.77 50.09 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.459 0.703 . . . . 0.0 109.329 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.456 HD23 HG12 ' A' ' 13' ' ' VAL . 1.3 mm? -116.65 128.74 55.65 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.54 -42.19 95.88 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.603 1.161 . . . . 0.0 111.594 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.6 p90 . . . . . 0 N--CA 1.476 0.847 0 C-N-CA 123.609 0.763 . . . . 0.0 109.515 171.663 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.636 ' HB3' ' HZ2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 122.619 1.199 . . . . 0.0 109.635 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 m -87.12 -8.84 56.59 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.968 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.448 HG23 HG11 ' A' ' 13' ' ' VAL . 9.9 p -112.7 155.84 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.8 0.84 . . . . 0.0 110.001 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 74.1 p -111.79 -30.74 7.2 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.14 0.576 . . . . 0.0 111.231 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.452 ' ND1' ' SG ' ' A' ' 12' ' ' CYS . 80.7 m80 -128.42 134.02 48.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.872 0.869 . . . . 0.0 110.016 -175.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 36.6 mt -121.75 114.19 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 121.443 0.639 . . . . 0.0 109.798 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.596 HG13 HG22 ' A' ' 20' ' ' THR . 74.7 t -90.53 119.19 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.145 0.978 . . . . 0.0 110.413 -175.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.0 137.9 18.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.744 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.1 t -86.05 -35.23 20.43 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 171.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -127.6 99.42 5.58 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 124.213 1.005 . . . . 0.0 108.519 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -107.28 107.89 61.06 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -61.41 152.63 71.56 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.155 2.57 . . . . 0.0 113.173 -173.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.33 -35.95 74.77 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.32 1.048 . . . . 0.0 112.566 -171.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -62.82 -45.26 93.46 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.567 0.699 . . . . 0.0 109.966 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -77.89 -18.34 56.27 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.001 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.42 ' NH1' ' HA ' ' A' ' 93' ' ' THR . 1.2 mmp_? -65.59 -35.23 80.21 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.18 0.592 . . . . 0.0 111.038 171.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.7 mt -69.17 -47.06 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 123.572 0.545 . . . . 0.0 109.806 172.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -58.02 -40.39 80.71 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.779 0.832 . . . . 0.0 111.655 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.405 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 18.3 m-85 -110.17 27.12 9.93 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.215 1.006 . . . . 0.0 110.741 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.42 -44.69 93.9 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.165 0.586 . . . . 0.0 111.301 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.407 ' N ' HD21 ' A' ' 66' ' ' ASN . 0.8 OUTLIER -77.62 -26.0 50.21 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.457 0.703 . . . . 0.0 110.722 179.195 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.405 ' CD1' ' HA ' ' A' ' 64' ' ' PHE . 16.3 m-85 -75.52 135.69 40.62 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.585 ' HA ' HG23 ' A' ' 93' ' ' THR . 43.7 mmtm -80.71 86.1 5.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.355 0.598 . . . . 0.0 109.784 -177.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 93.3 t -73.76 125.25 32.59 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.0 m -131.08 173.59 14.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 C-N-CA 123.392 0.677 . . . . 0.0 110.161 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.4 m -79.64 149.4 71.26 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.044 173.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.83 -28.45 87.15 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.395 2.064 . . . . 0.0 111.338 168.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.44 -23.89 64.78 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.321 1.449 . . . . 0.0 111.695 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -63.42 -48.6 77.11 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.957 0.503 . . . . 0.0 110.43 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.441 ' N ' HD11 ' A' ' 75' ' ' ILE . 2.4 mp -69.06 -45.14 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.325 -173.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -58.04 -49.73 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.24 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.85 -36.73 70.24 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.812 0.695 . . . . 0.0 110.993 -172.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.1 m -65.79 -41.25 92.18 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.611 0.365 . . . . 0.0 110.81 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 30' ' ' MET . 54.7 t -71.03 -33.03 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.748 0.819 . . . . 0.0 110.841 175.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -65.39 -42.9 92.14 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.441 1.096 . . . . 0.0 110.522 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -92.91 -6.15 49.24 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.048 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.07 36.59 24.27 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.431 1.092 . . . . 0.0 111.812 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -156.45 151.91 26.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.007 0.923 . . . . 0.0 109.768 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.83 121.62 19.3 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -105.95 160.82 24.8 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 124.054 0.942 . . . . 0.0 110.342 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -54.3 108.7 0.31 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.991 2.461 . . . . 0.0 112.756 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -62.03 -34.08 75.57 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.736 174.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -58.15 -26.88 63.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.833 1.253 . . . . 0.0 112.087 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -74.54 -37.76 62.94 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.446 0.699 . . . . 0.0 110.362 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.49 -0.7 29.52 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.398 0.679 . . . . 0.0 112.33 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.0 p -75.42 110.7 10.0 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.055 0.455 . . . . 0.0 111.039 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.6 mt -73.26 -17.38 61.34 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.332 1.053 . . . . 0.0 111.041 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.585 HG23 ' HA ' ' A' ' 68' ' ' LYS . 13.7 t -74.67 -26.48 59.88 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.608 0.763 . . . . 0.0 111.837 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.343 -0.837 . . . . 0.0 109.694 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt . . . . . 0 CA--C 1.545 0.752 0 CA-C-O 120.675 0.274 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.414 HG21 ' HA ' ' A' ' 84' ' ' LEU . 64.6 mt -67.71 -50.3 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.209 0.604 . . . . 0.0 110.223 -177.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.85 16.2 17.32 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.01 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -62.44 -36.56 82.78 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 120.913 0.387 . . . . 0.0 111.569 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -98.77 8.36 45.04 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.688 0.795 . . . . 0.0 111.161 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 71.9 m -117.24 114.1 23.15 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.605 0.762 . . . . 0.0 111.134 -174.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.35 126.77 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.89 131.47 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.142 0.577 . . . . 0.0 111.425 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 16.7 t80 -114.34 114.27 25.68 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.639 1.175 . . . . 0.0 108.635 169.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.7 mt -88.48 137.83 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -142.74 143.05 32.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.887 0.875 . . . . 0.0 109.646 -166.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.96 -137.84 32.37 Favored Glycine 0 C--N 1.346 1.117 0 O-C-N 123.519 0.512 . . . . 0.0 111.975 -174.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.1 145.38 37.24 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 171.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.498 HG21 HG12 ' A' ' 52' ' ' VAL . 37.1 p -142.21 140.67 32.39 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.741 1.216 . . . . 0.0 108.619 178.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -109.76 126.34 29.31 Favored Pre-proline 0 N--CA 1.485 1.277 0 CA-C-N 118.288 0.495 . . . . 0.0 110.264 171.582 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HD2' HD21 ' A' ' 27' ' ' LEU . 43.9 Cg_endo -76.15 174.3 53.63 Favored 'Cis proline' 0 C--N 1.374 1.905 0 C-N-CA 124.362 -1.099 . . . . 0.0 112.076 2.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.04 144.23 4.96 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.938 0.774 . . . . 0.0 114.094 -174.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.422 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 10.0 ptp180 -55.4 -36.3 66.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.191 0.596 . . . . 0.0 112.151 -172.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.93 -32.13 72.37 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.992 0.517 . . . . 0.0 111.857 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.401 ' O ' ' HG2' ' A' ' 30' ' ' MET . 8.5 tt0 -68.45 -51.84 39.16 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.459 HD21 ' HD2' ' A' ' 22' ' ' PRO . 91.9 mt -55.29 -39.58 70.05 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.606 0.763 . . . . 0.0 111.006 176.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -59.67 -47.61 84.93 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.628 1.171 . . . . 0.0 109.514 -178.105 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -65.96 -39.65 90.59 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.029 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.543 ' HB3' HG21 ' A' ' 79' ' ' VAL . 26.4 mmt -60.79 -33.27 72.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.876 0.47 . . . . 0.0 110.986 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -72.29 -51.92 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.398 0.679 . . . . 0.0 111.004 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.0 -47.42 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.573 0.749 . . . . 0.0 111.817 -174.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.82 -16.61 58.98 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.031 0.932 . . . . 0.0 111.713 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -109.76 28.33 8.68 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.903 0.881 . . . . 0.0 111.235 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.24 5.9 88.46 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.4 -0.818 . . . . 0.0 114.227 170.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.69 160.57 32.81 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 115.105 0.802 . . . . 0.0 115.105 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -105.38 162.0 13.83 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.557 -0.821 . . . . 0.0 109.44 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -136.09 164.88 27.0 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.502 174.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.77 130.38 31.86 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -66.34 -46.69 75.95 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 124.131 0.894 . . . . 0.0 113.263 -164.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.46 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 74.7 t80 . . . . . 0 N--CA 1.479 1.014 0 C-N-CA 123.641 0.776 . . . . 0.0 109.471 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.0 m -126.96 -10.43 6.0 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.039 0.536 . . . . 0.0 110.615 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.8 p -113.54 143.28 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.066 0.546 . . . . 0.0 110.734 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 t -108.41 -13.82 14.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.923 0.489 . . . . 0.0 111.55 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -138.94 128.23 24.17 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.383 0.673 . . . . 0.0 109.953 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.612 ' HB ' HG22 ' A' ' 69' ' ' VAL . 66.4 mt -114.18 136.43 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.498 HG12 HG21 ' A' ' 20' ' ' THR . 86.8 t -113.19 119.33 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.86 173.3 11.85 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.595 0.758 . . . . 0.0 109.613 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -89.77 -44.17 10.17 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 174.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -130.34 145.84 51.84 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.041 -1.436 . . . . 0.0 108.473 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.508 ' HG ' HG11 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -136.13 117.34 11.57 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.181 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.409 ' O ' ' HG3' ' A' ' 61' ' ' ARG . 95.2 Cg_endo -77.31 155.38 32.64 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.861 2.374 . . . . 0.0 113.201 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.0 mt -51.32 -49.72 60.79 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.062 1.345 . . . . 0.0 114.266 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.56 -31.38 69.54 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.467 -177.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -72.11 -27.77 62.85 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 118.183 0.447 . . . . 0.0 111.131 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 85.3 mtt180 -60.1 -38.58 83.39 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 172.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.7 mt -64.88 -43.59 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.61 0.764 . . . . 0.0 110.782 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 6.2 mm-40 -72.99 -21.76 60.79 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.374 0.67 . . . . 0.0 111.396 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -113.19 27.11 9.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.275 1.03 . . . . 0.0 110.119 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.36 -28.17 69.58 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.186 0.595 . . . . 0.0 112.303 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -88.67 -29.38 19.94 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.936 0.495 . . . . 0.0 111.017 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -88.87 117.36 27.82 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -71.11 87.17 0.76 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.963 0.505 . . . . 0.0 109.677 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.612 HG22 ' HB ' ' A' ' 51' ' ' ILE . 22.9 t -81.09 128.41 38.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.34 172.31 16.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 124.874 1.27 . . . . 0.0 110.034 -175.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 60.9 p -85.28 159.47 56.33 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.81 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.32 -24.32 67.37 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.714 2.276 . . . . 0.0 112.718 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.82 -26.52 68.17 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.498 1.119 . . . . 0.0 112.084 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 37.1 t90 -61.63 -40.56 95.29 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.173 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 75' ' ' ILE . 2.8 mp -76.69 -49.65 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.025 0.93 . . . . 0.0 108.961 -177.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.98 -51.36 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.079 0.952 . . . . 0.0 111.343 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.43 -39.4 71.06 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.622 -173.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.5 p -64.49 -44.97 89.31 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 120.949 0.404 . . . . 0.0 111.309 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 30' ' ' MET . 41.7 t -65.5 -33.74 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.356 1.062 . . . . 0.0 111.298 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -72.83 -38.66 67.06 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 120.8 0.334 . . . . 0.0 110.889 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -89.0 -7.66 55.56 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.816 0.846 . . . . 0.0 112.048 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.89 27.85 16.97 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.669 1.188 . . . . 0.0 112.474 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -138.23 165.36 26.89 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.804 0.841 . . . . 0.0 110.365 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.414 ' HA ' HG21 ' A' ' 8' ' ' ILE . 51.2 tp -82.53 142.91 31.45 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 169.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.5 mt -110.61 155.06 42.8 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 123.777 0.831 . . . . 0.0 110.407 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.05 111.55 1.79 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.145 1.897 . . . . 0.0 110.309 166.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -59.64 -27.54 66.45 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.627 0.771 . . . . 0.0 111.961 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -58.37 -28.35 65.05 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.219 1.008 . . . . 0.0 111.974 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -71.9 -35.79 69.82 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.26 0.624 . . . . 0.0 110.674 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -105.91 7.48 32.17 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.649 0.78 . . . . 0.0 111.561 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.2 t -65.28 116.5 6.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.961 0.904 . . . . 0.0 112.456 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.5 -24.77 56.88 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.431 0.692 . . . . 0.0 111.443 175.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.52 HG23 ' HB ' ' A' ' 69' ' ' VAL . 22.7 p -69.56 -21.67 63.6 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.174 0.59 . . . . 0.0 112.315 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 C--O 1.249 1.069 0 CA-C-O 119.045 -0.502 . . . . 0.0 109.655 177.277 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.569 1.701 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.24 -46.84 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 124.029 0.932 . . . . 0.0 111.694 176.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -107.13 10.22 30.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.196 0.599 . . . . 0.0 111.55 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -57.46 -43.84 84.32 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.378 0.671 . . . . 0.0 111.301 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -78.69 -18.8 53.78 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.262 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.85 127.19 44.71 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.728 0.811 . . . . 0.0 112.306 -172.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.8 t -96.81 130.66 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 162.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.438 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.4 mp -121.56 122.86 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 36.8 t80 -105.1 125.52 51.07 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 167.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.432 HG12 ' HB ' ' A' ' 52' ' ' VAL . 47.4 mt -98.85 139.8 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -136.07 141.52 44.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.334 1.053 . . . . 0.0 109.893 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.47 -149.13 49.45 Favored Glycine 0 C--N 1.348 1.206 0 O-C-N 123.804 0.69 . . . . 0.0 113.439 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -95.54 116.3 28.63 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.64 0.776 . . . . 0.0 109.893 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.422 HG22 HG13 ' A' ' 52' ' ' VAL . 72.9 p -129.15 134.85 48.22 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.17 0.988 . . . . 0.0 108.673 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -111.16 131.37 22.23 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-N 117.993 0.36 . . . . 0.0 110.727 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.84 173.87 53.98 Favored 'Cis proline' 0 C--N 1.38 2.188 0 C-N-CA 124.416 -1.077 . . . . 0.0 111.992 0.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.81 146.86 9.03 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.053 0.846 . . . . 0.0 114.248 -173.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -52.39 -34.82 49.7 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.667 1.187 . . . . 0.0 112.763 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.4 pp -63.26 -43.63 97.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.452 0.301 . . . . 0.0 110.959 177.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -72.18 -41.71 66.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.083 0.553 . . . . 0.0 110.486 -176.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.6 mt -56.02 -43.96 78.24 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.344 0.658 . . . . 0.0 111.18 170.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.525 ' HA ' HD11 ' A' ' 31' ' ' ILE . 10.8 m170 -65.41 -34.94 79.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.097 0.559 . . . . 0.0 111.042 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 22.7 mm-40 -65.39 -41.17 93.99 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.584 0.354 . . . . 0.0 110.268 174.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.63 ' HB3' HG22 ' A' ' 79' ' ' VAL . 68.5 mtt -58.52 -35.72 72.73 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.364 0.665 . . . . 0.0 111.243 176.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.525 HD11 ' HA ' ' A' ' 28' ' ' HIS . 64.6 mt -72.76 -51.8 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.757 0.823 . . . . 0.0 111.609 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.5 t -70.38 -41.83 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.286 0.634 . . . . 0.0 111.648 -172.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -65.92 -12.72 56.81 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.652 0.781 . . . . 0.0 111.983 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -107.84 24.99 12.09 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.349 1.06 . . . . 0.0 111.227 174.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.71 15.5 68.86 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.878 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.03 161.15 25.4 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 122.918 0.294 . . . . 0.0 113.335 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -106.53 148.63 27.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.673 0.789 . . . . 0.0 109.854 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -131.5 151.12 51.84 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.069 0.547 . . . . 0.0 110.746 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.6 tp -115.27 137.44 52.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.639 1.176 . . . . 0.0 108.975 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.57 -35.75 33.89 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.155 0.982 . . . . 0.0 112.997 -173.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.3 t80 . . . . . 0 N--CA 1.475 0.807 0 C-N-CA 124.568 1.147 . . . . 0.0 108.4 -169.268 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 121.925 0.869 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.7 m -84.84 -37.57 20.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.572 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.07 150.54 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.654 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t -115.17 -22.7 9.33 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.524 0.729 . . . . 0.0 111.081 175.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 27.8 m170 -133.77 126.19 30.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.491 0.717 . . . . 0.0 109.824 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.617 ' HB ' HG22 ' A' ' 69' ' ' VAL . 68.5 mt -109.39 139.84 30.66 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.432 ' HB ' HG12 ' A' ' 16' ' ' ILE . 61.2 t -110.74 122.0 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.156 0.582 . . . . 0.0 109.704 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.69 170.65 18.2 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.454 0.701 . . . . 0.0 109.568 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.2 t -108.87 -48.24 3.32 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 168.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -106.83 91.41 3.66 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.06 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.465 ' HG ' HG13 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -112.18 106.99 55.99 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.34 147.78 44.76 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.77 2.98 . . . . 0.0 113.84 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.41 -38.34 71.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.758 0.823 . . . . 0.0 110.667 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.457 ' HB3' ' HZ1' ' A' ' 59' ' ' LYS . 3.2 mmmp? -51.56 -55.23 20.31 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.241 1.016 . . . . 0.0 110.899 172.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 63' ' ' GLU . 43.0 mtmt -80.79 -10.18 59.75 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.98 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -72.4 -30.97 65.14 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.474 0.579 . . . . 0.0 109.885 170.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.8 mt -80.54 -40.84 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 123.448 0.467 . . . . 0.0 109.922 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.491 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 42.3 mt-10 -67.34 -37.24 82.96 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.333 0.653 . . . . 0.0 111.147 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -104.68 26.59 8.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.865 0.866 . . . . 0.0 110.44 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.24 -23.79 64.84 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.828 0.451 . . . . 0.0 111.249 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.423 ' N ' HD21 ' A' ' 66' ' ' ASN . 0.8 OUTLIER -70.52 -28.33 64.86 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.253 0.621 . . . . 0.0 110.031 175.556 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -95.45 174.77 6.85 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 170.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -126.55 97.02 4.86 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.617 HG22 ' HB ' ' A' ' 51' ' ' ILE . 17.6 t -76.32 129.78 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.634 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.95 176.95 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.059 1.344 . . . . 0.0 109.298 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.9 m -85.95 156.51 57.92 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.464 0.706 . . . . 0.0 110.255 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.403 ' O ' HG21 ' A' ' 76' ' ' VAL . 19.8 Cg_endo -56.6 -27.57 70.35 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 123.116 2.544 . . . . 0.0 112.401 174.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -61.51 -24.11 66.38 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.884 1.274 . . . . 0.0 111.959 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -62.21 -48.09 81.53 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 172.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.437 ' N ' HD13 ' A' ' 75' ' ' ILE . 2.6 mp -69.66 -47.08 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.0 -174.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 72' ' ' PRO . 95.9 t -59.83 -54.75 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.068 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 16.7 t70 -72.38 -36.41 68.71 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.741 -171.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.2 m -60.9 -40.32 92.68 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 120.694 0.283 . . . . 0.0 111.087 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.63 HG22 ' HB3' ' A' ' 30' ' ' MET . 45.2 t -70.0 -40.27 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.293 0.637 . . . . 0.0 111.476 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -63.57 -46.14 87.27 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.837 0.455 . . . . 0.0 110.794 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 17.5 mm-40 -80.16 -15.44 57.07 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.484 0.714 . . . . 0.0 111.066 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.86 28.8 14.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.015 1.326 . . . . 0.0 112.114 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -141.99 158.57 43.61 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.962 0.905 . . . . 0.0 109.755 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.4 tp -79.14 121.63 25.25 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.9 mt -101.68 158.57 31.53 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 124.104 0.962 . . . . 0.0 110.055 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.88 108.76 0.96 Allowed 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.153 1.902 . . . . 0.0 111.64 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -57.87 -33.15 68.39 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.726 0.81 . . . . 0.0 110.948 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -59.65 -31.16 69.28 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.533 1.133 . . . . 0.0 111.729 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -70.73 -39.44 73.35 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.548 0.739 . . . . 0.0 110.844 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -93.56 0.27 56.56 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.427 0.691 . . . . 0.0 111.661 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.6 t -72.2 124.91 26.02 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.612 0.365 . . . . 0.0 111.702 -171.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.5 mt -73.07 -43.89 61.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.99 168.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p -75.63 84.12 2.65 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.292 0.568 . . . . 0.0 109.805 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.248 1.026 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -178.642 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.3 pttp . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.479 0.181 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.4 -49.5 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.062 0.545 . . . . 0.0 111.623 -172.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.542 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 57.2 m-85 -108.4 17.48 22.07 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.778 -176.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -62.34 -43.88 97.79 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.508 0.723 . . . . 0.0 111.112 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -84.82 6.17 25.68 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.499 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.9 m -120.94 131.66 54.48 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.958 0.903 . . . . 0.0 111.261 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.47 HG21 ' HD3' ' A' ' 37' ' ' LYS . 15.1 t -103.18 127.27 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 166.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.417 ' H ' ' HA ' ' A' ' 38' ' ' PHE . 4.1 mp -118.1 120.17 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.14 0.576 . . . . 0.0 112.196 -176.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 13.0 t80 -106.54 126.26 52.04 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 166.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -97.95 110.85 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -104.25 128.13 51.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.943 0.897 . . . . 0.0 109.598 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.17 -171.45 50.32 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.383 0.427 . . . . 0.0 113.224 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.07 135.91 33.11 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.638 0.775 . . . . 0.0 110.09 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.5 HG21 HG13 ' A' ' 52' ' ' VAL . 41.5 p -138.06 148.4 45.02 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.417 1.087 . . . . 0.0 109.214 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 11.9 mmpt? -105.54 120.63 48.78 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 165.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.462 ' HD2' HD21 ' A' ' 27' ' ' LEU . 31.3 Cg_endo -84.2 174.62 37.64 Favored 'Cis proline' 0 CA--C 1.553 1.474 0 C-N-CA 123.896 -1.293 . . . . 0.0 111.295 -1.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.98 155.38 8.84 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -171.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -48.35 -37.1 15.81 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.022 1.329 . . . . 0.0 112.743 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.4 pp -63.05 -44.68 95.17 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.943 0.897 . . . . 0.0 111.439 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.494 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.5 tp-100 -71.83 -45.85 60.07 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.648 0.779 . . . . 0.0 110.542 -176.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.462 HD21 ' HD2' ' A' ' 22' ' ' PRO . 93.1 mt -57.86 -46.43 84.83 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.058 176.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.427 ' HA ' HD13 ' A' ' 31' ' ' ILE . 15.5 m170 -60.6 -36.46 78.62 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.019 0.528 . . . . 0.0 111.573 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -63.97 -46.41 84.77 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.74 0.416 . . . . 0.0 110.347 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.62 ' HB3' HG23 ' A' ' 79' ' ' VAL . 26.2 mmt -60.15 -34.0 72.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.71 0.804 . . . . 0.0 111.926 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 28' ' ' HIS . 78.6 mt -68.63 -51.26 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.526 0.73 . . . . 0.0 111.551 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.7 t -73.05 -40.4 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.034 0.534 . . . . 0.0 111.775 -172.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.04 -15.95 64.05 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.387 0.675 . . . . 0.0 111.754 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -109.57 26.59 10.47 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.768 0.827 . . . . 0.0 110.398 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.51 39.24 79.65 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-N 114.582 -1.19 . . . . 0.0 114.013 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.542 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -115.74 161.41 12.89 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 -173.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.47 ' HD3' HG21 ' A' ' 13' ' ' VAL . 88.3 tttt -105.86 150.13 25.9 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 122.925 0.49 . . . . 0.0 110.22 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.417 ' HA ' ' H ' ' A' ' 14' ' ' ILE . 27.0 p90 -141.85 164.73 29.39 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.374 0.67 . . . . 0.0 110.637 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.532 HD13 ' HB ' ' A' ' 48' ' ' VAL . 55.8 mt -124.8 146.88 49.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.723 0.809 . . . . 0.0 109.647 168.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.448 ' HD2' ' H ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -73.87 -35.3 64.72 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.661 175.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.448 ' H ' ' HD2' ' A' ' 40' ' ' HIS . 53.9 p90 . . . . . 0 N--CA 1.48 1.048 0 C-N-CA 125.517 1.527 . . . . 0.0 109.02 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.2 p -125.06 -37.96 2.38 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.3 0.64 . . . . 0.0 112.477 -171.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.532 ' HB ' HD13 ' A' ' 39' ' ' LEU . 6.6 p -82.52 152.76 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 122.262 -0.274 . . . . 0.0 110.345 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 t -114.55 -24.0 9.01 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.804 0.441 . . . . 0.0 111.508 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -129.0 130.28 46.45 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.763 0.425 . . . . 0.0 110.399 -177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 23.1 mt -116.93 134.97 58.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.5 HG13 HG21 ' A' ' 20' ' ' THR . 91.0 t -108.67 120.99 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.176 0.59 . . . . 0.0 110.954 -176.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.81 150.88 48.59 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.485 1.114 . . . . 0.0 108.625 172.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.1 t -76.71 -33.12 58.21 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -161.17 111.41 1.69 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.341 1.056 . . . . 0.0 108.348 170.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.59 HD21 HG12 ' A' ' 69' ' ' VAL . 16.4 tp -85.37 135.11 39.2 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 118.65 -0.69 . . . . 0.0 109.596 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.62 153.65 47.7 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.147 2.565 . . . . 0.0 112.56 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.59 -45.61 93.33 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.23 0.612 . . . . 0.0 112.125 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.0 mmmm -65.99 -36.81 84.32 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.642 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -66.96 -28.27 68.14 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.486 0.314 . . . . 0.0 111.649 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.17 -31.94 72.7 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.453 0.301 . . . . 0.0 110.319 173.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.9 mt -74.43 -37.76 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.07 0.548 . . . . 0.0 110.56 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 27.4 mm-40 -66.34 -42.01 88.73 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.424 0.631 . . . . 0.0 110.637 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -104.65 27.58 7.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.256 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.68 -22.83 64.35 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.495 0.718 . . . . 0.0 112.222 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.29 -6.94 59.46 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.849 0.46 . . . . 0.0 111.312 174.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -110.68 141.75 43.51 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.585 0.754 . . . . 0.0 109.411 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -79.33 86.03 5.1 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.59 HG12 HD21 ' A' ' 56' ' ' LEU . 55.7 t -75.47 130.04 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.474 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' A' ' 87' ' ' TRP . 35.2 m -134.65 177.18 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.003 1.321 . . . . 0.0 109.831 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -89.32 160.48 42.41 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.136 0.975 . . . . 0.0 110.541 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HB3' HD13 ' A' ' 27' ' ' LEU . 23.3 Cg_endo -59.56 -23.38 70.79 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.802 2.335 . . . . 0.0 111.995 172.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.65 -27.31 66.25 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 124.708 1.203 . . . . 0.0 111.863 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -61.43 -43.68 98.45 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.108 0.413 . . . . 0.0 110.45 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.435 ' N ' HD13 ' A' ' 75' ' ' ILE . 2.9 mp -72.05 -46.16 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -176.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.93 -47.8 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.371 1.068 . . . . 0.0 111.625 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.26 -42.27 75.8 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.761 0.824 . . . . 0.0 111.574 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.6 m -65.85 -36.85 84.59 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 120.72 0.295 . . . . 0.0 111.191 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' A' ' 30' ' ' MET . 24.9 t -70.41 -33.86 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.771 0.828 . . . . 0.0 110.655 173.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -67.24 -34.51 77.61 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.549 0.74 . . . . 0.0 110.977 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -96.38 -13.6 23.1 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.189 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.64 39.06 24.99 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.284 1.033 . . . . 0.0 111.245 -175.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -156.18 156.53 34.35 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.884 0.874 . . . . 0.0 109.886 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.6 tp -75.51 107.77 7.87 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.245 0.618 . . . . 0.0 110.432 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.7 mt -88.72 156.09 50.22 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.556 0.742 . . . . 0.0 111.081 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.34 108.66 1.22 Allowed 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.524 2.149 . . . . 0.0 111.809 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.57 ' HB2' HG12 ' A' ' 70' ' ' VAL . 24.0 p90 -62.8 -20.91 65.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.112 0.965 . . . . 0.0 112.538 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -57.14 -35.45 69.52 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.176 0.99 . . . . 0.0 111.545 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.39 -27.23 68.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.798 0.839 . . . . 0.0 110.986 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.1 -6.15 18.87 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.696 0.798 . . . . 0.0 111.067 -175.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 75.5 m -64.19 130.17 42.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -172.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.3 mt -106.94 22.05 16.59 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.475 1.11 . . . . 0.0 110.498 173.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.7 p -64.22 -50.78 66.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.615 0.766 . . . . 0.0 110.717 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 C--O 1.251 1.163 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.659 176.49 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.5 mttp . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.407 HG21 ' HA ' ' A' ' 84' ' ' LEU . 55.9 mt -57.52 -45.72 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 123.568 0.747 . . . . 0.0 111.462 -176.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.714 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 50.8 m-85 -112.03 18.98 18.28 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.988 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -60.22 -40.21 89.36 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 118.312 0.505 . . . . 0.0 111.933 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -87.16 -7.64 57.76 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.687 0.795 . . . . 0.0 111.031 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 74.1 m -112.45 108.51 17.68 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 122.189 0.995 . . . . 0.0 111.818 -171.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 48' ' ' VAL . 38.7 t -89.14 125.76 42.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 164.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.436 ' HB ' HD12 ' A' ' 31' ' ' ILE . 2.7 mp -110.54 128.63 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.774 0.83 . . . . 0.0 110.624 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -111.6 116.53 30.96 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 166.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.0 mt -84.62 137.13 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.421 0.688 . . . . 0.0 109.388 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -146.55 134.91 21.87 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.311 1.044 . . . . 0.0 109.696 -168.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.02 -160.2 54.02 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.638 0.586 . . . . 0.0 112.915 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.22 131.36 41.88 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -148.64 136.91 21.11 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.775 1.23 . . . . 0.0 108.843 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -116.65 134.07 22.95 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 122.974 0.51 . . . . 0.0 110.72 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.75 174.98 44.24 Favored 'Cis proline' 0 C--N 1.371 1.739 0 C-N-CA 124.408 -1.08 . . . . 0.0 110.996 -7.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.16 157.88 9.34 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -171.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -53.53 -35.44 60.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.546 1.138 . . . . 0.0 113.004 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 pp -60.62 -44.65 96.08 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.327 0.392 . . . . 0.0 110.559 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' A' ' 30' ' ' MET . 6.9 tp-100 -70.48 -51.89 25.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.811 0.845 . . . . 0.0 110.045 -176.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -54.79 -41.33 70.43 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.525 0.73 . . . . 0.0 111.505 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.419 ' O ' HG21 ' A' ' 32' ' ' VAL . 23.3 m170 -55.13 -48.2 74.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.314 0.645 . . . . 0.0 110.47 176.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.05 -38.95 92.5 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.731 0.645 . . . . 0.0 111.25 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.575 ' HB3' HG22 ' A' ' 79' ' ' VAL . 55.8 mmm -58.22 -36.54 73.3 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.505 0.722 . . . . 0.0 110.407 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.436 HD12 ' HB ' ' A' ' 14' ' ' ILE . 46.1 mt -72.23 -50.46 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.897 0.879 . . . . 0.0 111.654 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 28' ' ' HIS . 57.9 t -67.44 -42.26 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.233 -172.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.06 -12.6 61.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.967 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.45 ' NE2' HG13 ' A' ' 79' ' ' VAL . 34.1 m-70 -110.09 26.38 10.73 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.391 0.676 . . . . 0.0 111.163 173.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.83 37.93 75.67 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 114.867 -1.061 . . . . 0.0 113.615 171.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.714 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -118.61 -179.68 16.94 Favored Glycine 0 CA--C 1.503 -0.691 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 -175.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -123.74 144.52 49.63 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 121.201 0.524 . . . . 0.0 110.459 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -122.03 159.81 26.25 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.292 1.037 . . . . 0.0 108.484 173.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.7 tp -120.08 138.43 53.55 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.64 -46.76 74.73 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 124.049 0.843 . . . . 0.0 111.98 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.8 t80 . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 123.788 0.835 . . . . 0.0 109.525 -170.0 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt . . . . . 0 CA--C 1.546 0.798 0 CA-C-O 121.138 0.494 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.4 m -108.75 12.3 25.78 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.42 1.088 . . . . 0.0 109.936 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.451 HG21 HG11 ' A' ' 13' ' ' VAL . 9.9 p -149.14 152.02 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.268 0.627 . . . . 0.0 109.655 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 t -107.33 -27.99 10.15 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.086 0.555 . . . . 0.0 111.595 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -124.62 135.8 53.4 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.308 0.643 . . . . 0.0 109.952 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.639 ' HB ' HG12 ' A' ' 69' ' ' VAL . 67.9 mt -121.85 116.09 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.7 t -91.5 120.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 123.951 0.901 . . . . 0.0 110.245 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.08 167.73 20.96 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.318 1.047 . . . . 0.0 108.786 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.1 t -115.45 -49.39 2.75 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -119.62 124.05 45.36 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.8 tp -150.02 128.35 5.93 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.07 155.91 17.58 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.594 2.863 . . . . 0.0 113.812 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.515 HD21 ' NH2' ' A' ' 61' ' ' ARG . 85.7 mt -55.48 -60.82 2.89 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.916 0.886 . . . . 0.0 111.022 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -59.8 -29.64 68.36 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.329 1.052 . . . . 0.0 111.851 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.461 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -68.69 -46.25 69.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.008 178.17 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.515 ' NH2' HD21 ' A' ' 58' ' ' LEU . 53.4 mtm180 -69.18 -27.49 65.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.917 0.887 . . . . 0.0 112.234 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 98.0 mt -72.37 -35.71 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.194 0.598 . . . . 0.0 109.843 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.4 -36.96 68.78 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.458 0.647 . . . . 0.0 109.504 172.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -87.98 17.49 4.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.03 0.932 . . . . 0.0 111.141 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.69 -23.81 65.34 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.035 0.534 . . . . 0.0 109.687 166.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -73.61 -6.89 49.48 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.084 0.954 . . . . 0.0 111.03 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -122.91 157.99 31.35 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.352 1.061 . . . . 0.0 109.46 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.67 85.06 5.56 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.639 HG12 ' HB ' ' A' ' 51' ' ' ILE . 22.1 m -83.06 131.38 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.187 -177.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 87' ' ' TRP . 24.6 m -134.67 171.17 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.612 0.765 . . . . 0.0 109.859 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.423 ' HB3' HD23 ' A' ' 92' ' ' LEU . 47.5 p -86.85 156.95 55.21 Favored Pre-proline 0 C--O 1.245 0.828 0 C-N-CA 123.85 0.86 . . . . 0.0 109.469 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -60.4 -21.58 68.15 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 122.55 2.167 . . . . 0.0 112.707 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.23 -29.71 67.72 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.652 1.181 . . . . 0.0 111.818 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -59.58 -47.26 86.28 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.564 0.54 . . . . 0.0 110.084 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 75' ' ' ILE . 2.7 mp -70.8 -51.95 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.754 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.7 t -53.95 -52.66 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.224 1.01 . . . . 0.0 111.447 -176.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.66 -43.59 65.78 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.855 0.722 . . . . 0.0 111.158 -173.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.3 p -60.33 -36.96 79.16 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.018 0.437 . . . . 0.0 111.302 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' A' ' 30' ' ' MET . 46.9 t -67.89 -41.34 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.087 0.955 . . . . 0.0 111.512 176.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -67.38 -37.39 83.07 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.084 0.554 . . . . 0.0 111.285 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.19 -14.7 40.42 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.25 1.02 . . . . 0.0 111.479 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.27 26.71 15.58 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.146 1.378 . . . . 0.0 112.408 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -137.47 164.38 28.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.126 0.57 . . . . 0.0 110.32 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.407 ' HA ' HG21 ' A' ' 8' ' ' ILE . 60.7 tp -78.31 131.48 37.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.363 0.665 . . . . 0.0 110.606 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -108.33 150.66 40.84 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.744 1.218 . . . . 0.0 109.458 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.49 113.87 3.84 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.363 2.042 . . . . 0.0 110.47 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.498 ' HB2' HG13 ' A' ' 70' ' ' VAL . 64.6 p-90 -61.76 -27.8 68.99 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.629 0.771 . . . . 0.0 111.922 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -62.46 -27.82 69.39 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.134 0.974 . . . . 0.0 112.097 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -71.59 -21.07 61.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.799 0.84 . . . . 0.0 111.071 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -114.7 1.11 14.09 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.335 1.054 . . . . 0.0 110.731 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 27.0 t -69.27 131.36 44.75 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.196 0.598 . . . . 0.0 111.783 -171.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' A' ' 71' ' ' SER . 38.6 mt -96.72 8.66 43.75 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.29 0.636 . . . . 0.0 112.111 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.5 t -72.43 -14.56 61.72 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.526 0.603 . . . . 0.0 111.075 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.5 t . . . . . 0 C--O 1.251 1.167 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 169.854 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.405 HD13 ' CD2' ' A' ' 34' ' ' HIS . 67.1 mt -55.0 -48.1 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.763 1.225 . . . . 0.0 111.867 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.584 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 73.1 m-85 -105.05 7.34 33.9 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.463 -175.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.404 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 47.3 tptt -57.1 -49.31 76.29 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.053 0.541 . . . . 0.0 110.721 -174.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -84.11 -4.95 59.13 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.937 -1.028 . . . . 0.0 111.927 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.1 m -106.37 128.21 53.86 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.28 0.632 . . . . 0.0 111.488 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.422 HG12 HG22 ' A' ' 48' ' ' VAL . 21.9 t -95.12 126.94 47.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 168.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.38 122.73 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-O 121.241 0.543 . . . . 0.0 111.491 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -104.63 143.36 33.18 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.132 1.373 . . . . 0.0 107.693 167.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.8 mt -114.36 113.46 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -102.73 123.57 46.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.29 1.036 . . . . 0.0 110.417 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.66 -169.3 50.58 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.826 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -85.54 110.32 19.13 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.554 0.742 . . . . 0.0 109.487 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.65 HG21 HG13 ' A' ' 52' ' ' VAL . 74.0 p -122.55 148.54 45.08 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.556 1.143 . . . . 0.0 108.963 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -99.9 131.66 24.12 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-N 118.155 0.434 . . . . 0.0 111.962 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.474 ' HD2' HD22 ' A' ' 27' ' ' LEU . 80.9 Cg_endo -76.57 175.92 46.14 Favored 'Cis proline' 0 C--N 1.374 1.883 0 C-N-CA 124.65 -0.979 . . . . 0.0 110.933 -7.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.5 148.43 7.22 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 114.631 0.612 . . . . 0.0 114.631 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -52.26 -35.79 50.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.082 0.953 . . . . 0.0 112.927 -174.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 26' ' ' GLN . 4.1 pp -63.51 -41.24 98.53 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.502 0.321 . . . . 0.0 111.08 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.432 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.4 tp-100 -69.88 -48.43 58.75 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.675 0.79 . . . . 0.0 110.509 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.474 HD22 ' HD2' ' A' ' 22' ' ' PRO . 69.4 mt -56.48 -46.26 80.55 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.259 0.623 . . . . 0.0 111.242 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.437 ' O ' HG23 ' A' ' 32' ' ' VAL . 9.9 m80 -56.57 -43.82 80.37 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.455 0.702 . . . . 0.0 110.677 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.57 -36.74 83.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.81 0.444 . . . . 0.0 111.3 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.557 ' HB3' HG23 ' A' ' 79' ' ' VAL . 23.8 mmt -63.79 -35.2 79.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.188 0.595 . . . . 0.0 110.895 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.8 mt -70.61 -51.17 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.724 0.81 . . . . 0.0 111.244 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 28' ' ' HIS . 64.1 t -66.89 -40.33 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.111 0.564 . . . . 0.0 111.731 -173.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.09 -11.67 61.0 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.098 0.559 . . . . 0.0 111.845 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.405 ' CD2' HD13 ' A' ' 8' ' ' ILE . 22.9 m80 -100.33 20.49 14.67 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.208 1.003 . . . . 0.0 111.107 170.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.404 ' O ' ' HD2' ' A' ' 10' ' ' LYS . . . 72.11 9.44 71.79 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.815 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.86 159.66 46.0 Favored Glycine 0 C--O 1.24 0.518 0 N-CA-C 114.124 0.41 . . . . 0.0 114.124 -170.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -101.89 153.63 19.67 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -144.01 145.81 32.46 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.938 0.495 . . . . 0.0 110.967 -174.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.62 ' HG ' HG21 ' A' ' 47' ' ' THR . 1.5 mm? -130.43 145.88 51.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.039 0.936 . . . . 0.0 109.961 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -109.45 -34.08 6.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.749 0.82 . . . . 0.0 109.069 170.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.9 p90 . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -169.838 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.62 HG21 ' HG ' ' A' ' 39' ' ' LEU . 3.0 m -84.61 -28.18 26.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.486 -176.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 13' ' ' VAL . 11.5 p -150.09 162.95 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.956 0.903 . . . . 0.0 109.193 -172.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 t -115.86 -18.19 10.82 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.504 0.593 . . . . 0.0 112.237 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -134.04 131.71 39.18 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.418 0.687 . . . . 0.0 110.662 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.596 ' HB ' HG12 ' A' ' 69' ' ' VAL . 54.0 mt -114.73 129.58 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.65 HG13 HG21 ' A' ' 20' ' ' THR . 62.7 t -92.03 129.01 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.89 0.876 . . . . 0.0 109.461 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.99 147.0 30.26 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.114 0.566 . . . . 0.0 110.492 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.0 t -90.07 -34.49 15.9 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -145.65 142.36 28.97 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.191 173.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.73 107.57 4.03 Favored Pre-proline 0 CA--C 1.561 1.37 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.31 159.32 53.78 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.216 2.61 . . . . 0.0 113.061 -175.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.425 ' O ' HG13 ' A' ' 62' ' ' ILE . 65.7 mt -50.99 -49.7 59.87 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.375 1.07 . . . . 0.0 112.432 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -59.56 -45.71 91.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.039 0.536 . . . . 0.0 111.209 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -69.29 -26.03 64.53 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.634 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -73.88 -26.68 60.68 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.721 0.409 . . . . 0.0 111.015 176.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 58' ' ' LEU . 60.8 mt -76.44 -39.27 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.85 -42.01 97.68 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.864 0.866 . . . . 0.0 110.955 174.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -104.01 26.81 8.27 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.081 0.952 . . . . 0.0 110.411 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.12 -19.48 64.04 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 122.842 0.457 . . . . 0.0 111.274 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -75.49 -26.12 57.88 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.839 0.856 . . . . 0.0 110.647 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -111.7 145.42 39.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.999 0.92 . . . . 0.0 109.418 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -85.74 90.6 8.07 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -177.294 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.596 HG12 ' HB ' ' A' ' 51' ' ' ILE . 27.1 m -74.0 127.13 35.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.83 172.59 15.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.827 1.251 . . . . 0.0 109.112 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.7 m -79.44 151.5 74.86 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.99 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.416 ' O ' HG22 ' A' ' 76' ' ' VAL . 26.5 Cg_endo -60.11 -25.35 79.61 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.78 2.32 . . . . 0.0 111.643 170.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -59.12 -23.16 61.89 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.173 1.389 . . . . 0.0 112.149 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -61.3 -46.62 89.56 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.021 0.439 . . . . 0.0 109.921 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.584 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.7 mp -71.86 -47.24 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.113 -177.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 72' ' ' PRO . 61.0 t -54.92 -50.72 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.999 0.92 . . . . 0.0 111.01 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -70.58 -47.52 59.85 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.205 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.446 ' HA ' HD21 ' A' ' 85' ' ' LEU . 79.5 p -63.09 -44.31 96.08 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.281 0.363 . . . . 0.0 111.445 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.557 HG23 ' HB3' ' A' ' 30' ' ' MET . 55.5 t -59.3 -42.8 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.054 0.942 . . . . 0.0 110.738 174.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -68.97 -33.06 73.08 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.033 0.933 . . . . 0.0 111.897 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.38 -11.35 38.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.583 0.753 . . . . 0.0 111.625 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.78 22.43 12.43 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.572 1.149 . . . . 0.0 112.323 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -142.49 156.5 45.16 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.512 0.725 . . . . 0.0 109.552 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.09 117.97 18.35 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.446 HD21 ' HA ' ' A' ' 78' ' ' SER . 4.0 mm? -92.6 144.83 29.33 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 167.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.606 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 38.2 Cg_endo -62.49 124.04 13.5 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.081 1.854 . . . . 0.0 111.587 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -64.15 -19.85 65.58 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.079 0.952 . . . . 0.0 112.469 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.606 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.8 pt20 -59.3 -25.84 64.46 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.928 0.891 . . . . 0.0 111.629 174.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -71.22 -27.07 63.22 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.779 0.832 . . . . 0.0 110.115 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -116.26 2.02 13.2 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.911 0.884 . . . . 0.0 111.975 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.4 p -66.57 110.87 3.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.473 0.709 . . . . 0.0 111.537 -173.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.3 mt -74.87 -16.34 60.68 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.834 173.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 p -47.81 -51.97 20.65 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.724 1.209 . . . . 0.0 111.601 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 CA--C 1.553 1.094 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.129 176.829 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.527 ' HB3' ' HZ2' ' A' ' 7' ' ' LYS . 0.3 OUTLIER . . . . . 0 CA--C 1.558 1.252 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.549 HG21 ' HA ' ' A' ' 84' ' ' LEU . 43.1 mt -54.83 -48.13 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.609 1.164 . . . . 0.0 111.109 176.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -113.87 10.11 17.66 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.882 -173.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -50.56 -65.75 0.51 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.848 0.859 . . . . 0.0 112.813 -167.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -85.8 -8.56 58.04 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.075 0.464 . . . . 0.0 110.338 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.3 m -79.9 118.02 21.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.698 0.799 . . . . 0.0 110.036 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -90.09 124.78 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 170.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.409 ' HB ' HD11 ' A' ' 31' ' ' ILE . 3.5 mp -116.0 126.32 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.023 0.529 . . . . 0.0 111.727 -178.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -104.96 148.82 26.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.977 1.311 . . . . 0.0 108.421 172.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -120.47 137.78 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -135.24 128.01 31.1 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.512 1.125 . . . . 0.0 108.876 -167.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.46 -159.75 48.7 Favored Glycine 0 C--N 1.343 0.924 0 O-C-N 123.404 0.44 . . . . 0.0 112.073 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -103.21 111.37 23.73 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.283 0.633 . . . . 0.0 109.624 176.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.0 p -119.49 134.64 55.12 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.743 1.217 . . . . 0.0 108.657 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -102.62 133.34 20.53 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 117.896 0.316 . . . . 0.0 110.629 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.02 164.86 85.74 Favored 'Cis proline' 0 C--N 1.384 2.405 0 C-N-CA 124.469 -1.055 . . . . 0.0 112.272 1.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.71 157.99 3.89 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 124.169 0.918 . . . . 0.0 114.556 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -54.65 -37.17 65.37 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.931 0.892 . . . . 0.0 112.478 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 26' ' ' GLN . 3.3 pp -62.96 -43.99 97.29 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.162 0.585 . . . . 0.0 110.804 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.583 ' HG3' ' HE2' ' A' ' 30' ' ' MET . 56.2 tp60 -67.79 -49.8 60.39 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.878 0.871 . . . . 0.0 110.618 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.1 mt -55.15 -51.47 66.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.877 0.871 . . . . 0.0 111.649 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.447 ' HA ' HD12 ' A' ' 31' ' ' ILE . 23.0 m170 -61.35 -35.26 76.93 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.873 0.469 . . . . 0.0 111.649 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.44 ' O ' HD11 ' A' ' 33' ' ' LEU . 43.3 mt-10 -64.23 -46.48 83.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 0.0 110.191 173.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.652 ' HB3' HG22 ' A' ' 79' ' ' VAL . 67.3 mtt -56.68 -37.3 70.66 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.465 0.65 . . . . 0.0 110.499 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.447 HD12 ' HA ' ' A' ' 28' ' ' HIS . 77.2 mt -66.17 -50.65 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.556 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 28' ' ' HIS . 59.3 t -71.06 -29.35 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.144 0.578 . . . . 0.0 111.173 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.44 HD11 ' O ' ' A' ' 29' ' ' GLU . 6.8 mp -64.34 -22.73 67.05 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.515 1.126 . . . . 0.0 110.744 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.403 ' HE1' HG13 ' A' ' 79' ' ' VAL . 60.6 m80 -105.5 26.93 8.88 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.398 1.079 . . . . 0.0 110.678 173.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.35 18.14 76.62 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.471 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.2 164.41 29.62 Favored Glycine 0 C--O 1.241 0.556 0 N-CA-C 114.179 0.431 . . . . 0.0 114.179 -171.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -113.42 161.79 16.88 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.824 0.849 . . . . 0.0 109.635 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -145.78 154.29 41.86 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 122.715 0.406 . . . . 0.0 111.406 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -121.16 137.64 54.58 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.23 -49.92 9.57 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.619 0.768 . . . . 0.0 112.724 -173.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 N--CA 1.493 1.72 0 C-N-CA 125.6 1.56 . . . . 0.0 108.691 -176.297 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.542 0.687 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.6 m -91.51 -22.95 20.11 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 121.792 -0.567 . . . . 0.0 111.439 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 p -92.86 152.23 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 122.23 -0.294 . . . . 0.0 111.665 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.447 HG22 ' HD2' ' A' ' 50' ' ' HIS . 10.1 t -114.18 -25.34 8.53 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.348 0.659 . . . . 0.0 111.297 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.447 ' HD2' HG22 ' A' ' 49' ' ' THR . 58.5 m-70 -128.56 125.72 38.86 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.314 0.646 . . . . 0.0 109.742 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.438 ' HB ' HG22 ' A' ' 69' ' ' VAL . 40.4 mt -106.1 138.38 31.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.9 t -117.57 120.21 64.07 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 C-N-CA 123.905 0.882 . . . . 0.0 108.811 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -139.44 159.66 41.65 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.348 0.659 . . . . 0.0 109.612 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.0 t -84.64 -46.42 11.52 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 168.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -140.01 124.34 17.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.809 1.243 . . . . 0.0 108.933 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.4 HD23 HG11 ' A' ' 69' ' ' VAL . 38.7 tp -107.49 128.39 26.02 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.13 153.6 38.27 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.347 2.698 . . . . 0.0 112.832 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.4 mt -59.26 -44.88 92.38 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.707 0.803 . . . . 0.0 111.234 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -61.5 -46.65 89.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.24 1.016 . . . . 0.0 110.191 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -70.91 -24.66 62.5 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.993 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -73.71 -30.81 63.08 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.07 0.548 . . . . 0.0 110.132 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -70.99 -43.38 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.783 0.833 . . . . 0.0 109.957 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.32 -38.34 87.46 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.812 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.404 ' HA ' ' HD1' ' A' ' 67' ' ' TYR . 23.2 m-85 -100.22 26.26 6.7 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.976 0.911 . . . . 0.0 110.744 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 -24.95 66.59 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.291 0.637 . . . . 0.0 112.103 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -80.33 -27.45 38.34 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.072 0.549 . . . . 0.0 110.761 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.404 ' HD1' ' HA ' ' A' ' 64' ' ' PHE . 62.4 m-85 -88.72 141.63 28.35 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.78 0.832 . . . . 0.0 109.641 -177.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -82.97 85.86 7.08 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 51' ' ' ILE . 41.4 t -77.9 128.68 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.266 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.499 HG13 ' HB2' ' A' ' 87' ' ' TRP . 27.7 m -139.96 174.53 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.093 1.357 . . . . 0.0 109.466 -175.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.0 m -87.83 159.88 48.05 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.306 0.642 . . . . 0.0 110.382 171.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -58.66 -23.16 64.38 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.935 2.423 . . . . 0.0 112.485 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.21 -24.34 64.74 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.004 1.322 . . . . 0.0 112.151 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -62.15 -50.78 70.5 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.94 -52.15 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.87 -176.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.19 -54.34 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.245 1.018 . . . . 0.0 111.537 -175.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -72.71 -37.31 67.85 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 123.335 0.397 . . . . 0.0 111.289 -172.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.5 m -63.95 -37.61 88.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.64 0.376 . . . . 0.0 111.234 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.652 HG22 ' HB3' ' A' ' 30' ' ' MET . 40.2 t -72.32 -36.8 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.896 0.878 . . . . 0.0 111.575 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -65.85 -41.09 92.12 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.763 0.425 . . . . 0.0 110.618 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -89.6 -10.33 46.42 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.78 0.832 . . . . 0.0 111.901 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 55.32 37.71 29.29 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.828 1.251 . . . . 0.0 112.226 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -146.76 155.5 42.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.815 0.846 . . . . 0.0 110.048 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.549 ' HA ' HG21 ' A' ' 8' ' ' ILE . 60.9 tp -78.11 94.76 4.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.403 0.681 . . . . 0.0 109.571 -178.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.22 151.74 66.78 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.771 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.66 110.55 0.84 Allowed 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.77 2.313 . . . . 0.0 112.685 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.499 ' HB2' HG13 ' A' ' 70' ' ' VAL . 61.7 p-90 -63.82 -22.23 66.82 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.917 0.887 . . . . 0.0 111.246 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -63.44 -24.16 67.71 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.284 1.034 . . . . 0.0 111.433 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.28 -5.99 58.4 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.232 0.613 . . . . 0.0 111.527 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -126.93 1.42 6.61 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.536 0.734 . . . . 0.0 110.895 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.9 p -68.49 113.46 6.05 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.456 0.702 . . . . 0.0 112.368 -170.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.9 mt -89.78 20.4 4.13 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.008 0.923 . . . . 0.0 111.283 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.5 p -68.4 -27.74 66.48 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.179 0.991 . . . . 0.0 111.553 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.937 176.861 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.636 ' HZ3' ' HB2' ' A' ' 7' ' ' LYS . 9.5 mtmp? . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.8 mt -50.49 -45.65 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 125.503 1.521 . . . . 0.0 112.243 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 75' ' ' ILE . 63.8 m-85 -108.98 16.49 22.59 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.412 0.685 . . . . 0.0 111.371 -174.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 7' ' ' LYS . 13.6 tptp -50.23 -51.91 40.36 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.035 0.934 . . . . 0.0 113.288 -168.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -99.5 -2.79 35.03 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.407 0.683 . . . . 0.0 111.069 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.6 m -82.2 128.47 34.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.141 0.577 . . . . 0.0 109.904 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.573 HG12 HG22 ' A' ' 48' ' ' VAL . 38.8 t -104.27 119.58 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.416 ' HB ' HD12 ' A' ' 31' ' ' ILE . 4.8 mp -119.62 131.95 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.294 0.638 . . . . 0.0 111.174 -173.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -113.67 150.95 32.49 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.935 1.694 . . . . 0.0 108.165 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.28 132.2 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -139.65 135.6 33.43 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.163 1.385 . . . . 0.0 108.562 -170.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.25 -172.76 54.35 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -92.65 110.41 21.84 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.505 HG22 HG11 ' A' ' 52' ' ' VAL . 65.4 p -113.74 141.57 47.1 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.05 0.94 . . . . 0.0 109.871 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.487 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -104.97 127.25 29.12 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 167.172 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.38 173.84 54.5 Favored 'Cis proline' 0 C--N 1.372 1.769 0 C-N-CA 124.184 -1.173 . . . . 0.0 112.276 -0.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.05 157.2 9.72 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.679 0.612 . . . . 0.0 113.939 -174.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -51.47 -35.45 39.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.127 0.971 . . . . 0.0 111.901 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 26' ' ' GLN . 2.1 pp -56.76 -48.95 76.69 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.049 0.939 . . . . 0.0 112.001 177.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.521 ' N ' HD11 ' A' ' 25' ' ' LEU . 6.8 tp-100 -72.37 -43.55 63.83 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.749 0.819 . . . . 0.0 110.334 -174.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.54 -44.79 96.4 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.854 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.56 ' HA ' HD13 ' A' ' 31' ' ' ILE . 16.5 m170 -61.26 -36.8 81.01 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.102 0.561 . . . . 0.0 111.0 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.19 -45.05 86.38 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.745 0.418 . . . . 0.0 110.632 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.535 ' SD ' HG13 ' A' ' 79' ' ' VAL . 23.9 mmt -59.29 -31.99 69.63 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.349 0.66 . . . . 0.0 111.475 176.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.56 HD13 ' HA ' ' A' ' 28' ' ' HIS . 84.0 mt -69.39 -52.33 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.05 175.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 28' ' ' HIS . 59.9 t -72.29 -38.84 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 122.986 0.514 . . . . 0.0 112.164 -169.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.34 -19.14 64.37 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.199 0.6 . . . . 0.0 111.661 176.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -104.43 25.89 9.63 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.624 0.77 . . . . 0.0 111.4 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.65 14.75 70.24 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.654 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.82 161.17 36.23 Favored Glycine 0 C--O 1.242 0.618 0 N-CA-C 113.954 0.342 . . . . 0.0 113.954 -171.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -103.17 144.61 31.09 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.278 1.031 . . . . 0.0 108.614 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -134.29 145.37 49.01 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 122.961 0.505 . . . . 0.0 110.627 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.41 142.86 50.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.293 1.037 . . . . 0.0 109.277 173.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -109.05 -43.71 4.13 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.919 170.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 p90 . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.559 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 122.575 1.179 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -89.01 -1.07 57.93 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.713 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.573 HG22 HG12 ' A' ' 13' ' ' VAL . 9.1 p -162.97 160.11 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.921 0.888 . . . . 0.0 109.436 -172.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.3 t -114.29 -21.27 10.51 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -126.5 139.17 53.43 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.04 0.536 . . . . 0.0 110.225 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.705 ' HB ' HG12 ' A' ' 69' ' ' VAL . 58.1 mt -124.42 129.72 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.505 HG11 HG22 ' A' ' 20' ' ' THR . 51.6 t -104.93 119.05 53.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 C-N-CA 123.741 0.816 . . . . 0.0 110.355 -172.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.07 146.44 35.45 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.6 p -85.38 -10.29 56.47 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.792 0.437 . . . . 0.0 110.613 173.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -156.76 89.05 1.07 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.48 1.112 . . . . 0.0 108.009 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.67 110.18 47.77 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.42 ' O ' ' HG3' ' A' ' 61' ' ' ARG . 54.3 Cg_exo -55.41 151.15 38.51 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.84 3.027 . . . . 0.0 114.001 -176.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 61' ' ' ARG . 95.4 mt -57.2 -46.01 83.25 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 0.0 111.528 -177.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -63.88 -39.81 95.06 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.7 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.57 -34.95 77.99 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 119.431 -0.319 . . . . 0.0 111.657 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 80.0 mtt180 -60.36 -36.04 77.09 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 122.94 0.496 . . . . 0.0 110.69 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.9 mt -71.5 -42.13 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.009 0.923 . . . . 0.0 110.761 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.58 -26.94 61.05 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.204 0.602 . . . . 0.0 111.045 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -110.28 28.72 8.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.488 1.115 . . . . 0.0 109.76 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.54 -22.84 65.51 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -91.99 -26.93 18.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.16 0.584 . . . . 0.0 110.393 176.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -85.86 135.13 33.82 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -83.96 86.48 7.18 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.705 HG12 ' HB ' ' A' ' 51' ' ' ILE . 21.4 m -77.18 127.69 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.117 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 87' ' ' TRP . 35.9 m -136.8 172.3 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.339 1.056 . . . . 0.0 109.735 -175.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.1 m -80.69 154.91 73.62 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.301 172.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.25 -22.04 63.07 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.512 2.141 . . . . 0.0 111.869 171.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.9 -29.61 60.29 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.368 1.467 . . . . 0.0 112.292 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -63.57 -49.06 74.89 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 120.8 0.333 . . . . 0.0 110.34 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . 2.8 mp -68.38 -49.43 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.979 -175.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.1 t -58.48 -53.79 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.791 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 21.1 t0 -72.65 -31.73 65.33 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.081 0.238 . . . . 0.0 111.488 -172.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.563 ' HA ' HD12 ' A' ' 85' ' ' LEU . 58.0 m -63.68 -37.86 88.95 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 120.643 0.258 . . . . 0.0 110.932 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.535 HG13 ' SD ' ' A' ' 30' ' ' MET . 86.3 t -70.87 -36.45 64.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 122.97 0.508 . . . . 0.0 110.787 175.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.471 ' HB3' ' HZ1' ' A' ' 80' ' ' LYS . 9.8 mtpm? -62.49 -45.59 92.3 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.769 0.428 . . . . 0.0 111.06 178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 10.7 mm-40 -85.37 -11.88 53.5 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.252 0.621 . . . . 0.0 111.159 -176.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.26 34.98 10.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.758 1.223 . . . . 0.0 111.691 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -153.67 168.97 24.45 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.448 0.699 . . . . 0.0 110.647 -177.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -86.37 108.39 18.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.293 0.637 . . . . 0.0 109.879 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 78' ' ' SER . 10.8 mp -83.89 152.56 62.8 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.553 0.741 . . . . 0.0 110.654 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.548 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 49.0 Cg_endo -67.1 120.85 7.95 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.459 2.106 . . . . 0.0 111.295 171.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.521 ' HB2' HG11 ' A' ' 70' ' ' VAL . 69.0 p-90 -63.66 -21.67 66.5 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.695 0.798 . . . . 0.0 111.922 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.548 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 21.0 pt20 -59.08 -29.16 67.13 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.061 0.944 . . . . 0.0 111.945 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.62 -21.33 63.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.586 0.754 . . . . 0.0 111.504 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -121.49 9.64 10.31 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.823 0.849 . . . . 0.0 110.852 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.488 ' OG ' HG22 ' A' ' 93' ' ' THR . 41.2 t -72.91 114.33 10.93 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.614 0.766 . . . . 0.0 111.446 -172.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.7 mt -91.46 2.21 56.59 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.723 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.488 HG22 ' OG ' ' A' ' 91' ' ' SER . 6.7 t -74.23 -18.28 60.77 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.602 0.637 . . . . 0.0 111.179 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.7 t . . . . . 0 C--O 1.255 1.355 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.661 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 43.1 mm . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 p -133.15 120.46 21.23 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.415 0.686 . . . . 0.0 109.592 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 m -62.11 -55.39 29.34 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.858 0.863 . . . . 0.0 111.201 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 57.29 29.43 16.79 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.308 1.043 . . . . 0.0 111.051 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.4 m -106.52 145.29 32.02 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.054 0.942 . . . . 0.0 110.146 -174.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.9 m 58.48 38.66 25.53 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.044 0.937 . . . . 0.0 110.629 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.56 ' HB2' ' HB2' ' A' ' 10' ' ' LYS . 62.8 pttt -83.51 38.05 0.6 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.441 1.496 . . . . 0.0 112.227 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.464 HG21 ' HA ' ' A' ' 84' ' ' LEU . 44.7 mt -52.13 -34.7 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 125.714 1.605 . . . . 0.0 113.209 -174.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.423 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 67.8 m-85 -114.34 16.74 17.81 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.482 0.713 . . . . 0.0 110.914 -174.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.56 ' HB2' ' HB2' ' A' ' 7' ' ' LYS . 25.5 tptp -54.67 -43.82 72.77 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.275 1.03 . . . . 0.0 112.899 -169.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -102.98 7.2 39.16 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.362 0.665 . . . . 0.0 111.376 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.1 m -108.37 118.87 37.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.569 0.748 . . . . 0.0 111.24 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.502 HG13 HG22 ' A' ' 48' ' ' VAL . 69.9 t -89.78 125.36 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 164.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.517 ' HB ' HD11 ' A' ' 31' ' ' ILE . 4.1 mp -117.55 127.22 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.268 0.556 . . . . 0.0 111.125 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.459 ' HH ' ' HD1' ' A' ' 41' ' ' TYR . 19.3 t80 -103.48 150.87 23.47 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.739 1.216 . . . . 0.0 107.869 169.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.546 HG12 ' HB ' ' A' ' 52' ' ' VAL . 65.1 mt -123.03 130.91 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -128.46 141.7 51.31 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.612 1.165 . . . . 0.0 109.476 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.09 -168.37 48.7 Favored Glycine 0 N--CA 1.477 1.401 0 N-CA-C 112.263 -0.335 . . . . 0.0 112.263 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -101.22 108.49 20.15 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.418 HG21 HG12 ' A' ' 52' ' ' VAL . 69.4 p -110.08 139.73 44.9 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.06 0.944 . . . . 0.0 109.433 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -105.96 126.86 29.6 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 170.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD2' HD21 ' A' ' 27' ' ' LEU . 45.7 Cg_endo -78.81 175.23 47.42 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 124.449 -1.063 . . . . 0.0 111.977 -0.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.22 153.99 5.6 Favored Glycine 0 C--N 1.349 1.263 0 O-C-N 123.948 0.78 . . . . 0.0 114.671 -170.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -57.97 -34.76 70.29 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.665 0.786 . . . . 0.0 111.65 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 26' ' ' GLN . 2.7 pp -59.97 -45.9 91.18 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 123.589 0.556 . . . . 0.0 111.14 172.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.519 ' N ' HD11 ' A' ' 25' ' ' LEU . 6.0 tp-100 -67.11 -50.94 59.8 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.801 0.841 . . . . 0.0 111.012 -175.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.401 HD21 ' HD2' ' A' ' 22' ' ' PRO . 92.0 mt -55.93 -44.55 78.45 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.167 0.587 . . . . 0.0 111.208 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.496 ' HA ' HD12 ' A' ' 31' ' ' ILE . 30.2 m170 -62.61 -36.66 83.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.889 0.476 . . . . 0.0 111.299 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 46.2 mt-10 -66.16 -41.59 90.15 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.801 0.44 . . . . 0.0 110.713 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.533 ' HB3' HG23 ' A' ' 79' ' ' VAL . 5.6 mmt -60.52 -33.5 72.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.803 0.841 . . . . 0.0 110.721 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.517 HD11 ' HB ' ' A' ' 14' ' ' ILE . 60.0 mt -70.07 -49.77 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.977 0.911 . . . . 0.0 111.007 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 28' ' ' HIS . 80.0 t -61.45 -48.09 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.482 0.713 . . . . 0.0 112.113 -176.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.18 -23.39 66.58 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.222 0.609 . . . . 0.0 111.629 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.488 ' NE2' HG13 ' A' ' 79' ' ' VAL . 40.3 m-70 -95.87 27.03 3.73 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.892 0.877 . . . . 0.0 111.397 175.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.67 78.04 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.724 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.42 175.76 33.4 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 114.203 0.441 . . . . 0.0 114.203 -171.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -128.74 155.45 45.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.167 0.987 . . . . 0.0 108.75 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -138.51 168.72 19.17 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.177 0.513 . . . . 0.0 112.22 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.75 140.89 50.35 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -74.51 -46.36 39.83 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.762 0.825 . . . . 0.0 111.306 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.459 ' HD1' ' HH ' ' A' ' 15' ' ' TYR . 71.9 t80 -174.18 138.65 0.59 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.578 1.151 . . . . 0.0 109.688 -171.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -106.86 150.27 26.56 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.487 0.715 . . . . 0.0 110.513 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.5 t -128.67 70.46 1.39 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.318 1.047 . . . . 0.0 108.585 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.8 t 75.4 -40.83 0.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.861 1.665 . . . . 0.0 113.671 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -70.39 148.37 48.47 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.46 0.704 . . . . 0.0 112.097 -173.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -80.73 82.56 6.7 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.331 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.6 m -120.07 24.25 10.57 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.497 0.719 . . . . 0.0 109.351 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.502 HG22 HG13 ' A' ' 13' ' ' VAL . 6.1 p -154.2 155.82 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.327 0.651 . . . . 0.0 109.608 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.8 t -114.63 -25.81 8.14 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.59 0.756 . . . . 0.0 111.466 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -133.03 138.78 46.91 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.616 0.766 . . . . 0.0 110.236 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.589 ' HB ' HG22 ' A' ' 69' ' ' VAL . 58.1 mt -123.64 143.33 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.562 1.145 . . . . 0.0 108.358 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.546 ' HB ' HG12 ' A' ' 16' ' ' ILE . 97.6 t -115.74 119.79 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.419 0.688 . . . . 0.0 110.287 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.26 157.85 38.73 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.37 0.668 . . . . 0.0 110.032 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.3 t -70.78 -49.36 47.45 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.405 ' HA ' HD12 ' A' ' 92' ' ' LEU . 41.1 t30 -147.02 147.43 30.67 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 168.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.526 ' HG ' HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -123.46 116.23 28.23 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -173.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.538 ' HG2' ' HB2' ' A' ' 60' ' ' LYS . 36.9 Cg_endo -64.68 156.35 61.85 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.132 2.555 . . . . 0.0 113.429 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.07 -47.34 86.78 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.569 1.148 . . . . 0.0 113.58 -167.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -67.16 -26.99 66.92 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 120.953 0.406 . . . . 0.0 110.429 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.538 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 4.6 mptp? -81.47 -23.15 37.61 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.34 -34.24 77.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.2 mt -72.83 -39.57 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.849 0.86 . . . . 0.0 110.228 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 3.1 tp10 -63.06 -34.52 77.76 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.131 0.972 . . . . 0.0 110.435 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -117.6 27.43 9.06 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.499 -175.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.02 67.56 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.294 0.568 . . . . 0.0 111.473 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -76.41 -23.03 53.99 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.404 1.082 . . . . 0.0 111.306 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -113.73 126.73 55.56 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.921 0.889 . . . . 0.0 109.272 -174.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.2 87.59 1.11 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.007 0.432 . . . . 0.0 110.315 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.589 HG22 ' HB ' ' A' ' 51' ' ' ILE . 16.5 t -76.08 134.45 29.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.211 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 87' ' ' TRP . 31.8 m -135.74 174.15 12.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.606 1.162 . . . . 0.0 109.531 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.5 t -86.09 152.37 55.79 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 171.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.26 -23.54 46.26 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 122.962 2.442 . . . . 0.0 113.15 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.12 -26.56 64.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.02 0.928 . . . . 0.0 112.26 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -61.02 -44.04 97.99 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.46 HD11 ' N ' ' A' ' 75' ' ' ILE . 2.7 mp -75.6 -52.46 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.726 0.81 . . . . 0.0 108.841 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.3 t -54.91 -53.73 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.491 1.116 . . . . 0.0 111.148 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.07 -39.08 66.16 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.546 -173.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 95.5 p -60.58 -41.56 94.92 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 120.905 0.383 . . . . 0.0 110.529 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.533 HG23 ' HB3' ' A' ' 30' ' ' MET . 70.8 t -64.51 -42.21 94.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 123.911 0.885 . . . . 0.0 111.066 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.444 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 10.0 mtmp? -67.61 -29.64 69.03 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.611 0.365 . . . . 0.0 111.441 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -89.78 -14.38 34.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.48 0.712 . . . . 0.0 110.925 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.97 27.38 16.23 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.168 1.387 . . . . 0.0 111.948 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -138.41 165.46 26.75 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.529 0.732 . . . . 0.0 111.02 -173.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.464 ' HA ' HG21 ' A' ' 8' ' ' ILE . 3.3 tm? -77.35 133.85 38.63 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 mt -114.18 154.92 46.18 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 123.586 0.754 . . . . 0.0 110.672 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.1 105.7 0.88 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.262 1.975 . . . . 0.0 110.81 171.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.48 ' HB2' HG12 ' A' ' 70' ' ' VAL . 36.3 p90 -66.52 -22.1 66.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.138 0.575 . . . . 0.0 111.588 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -62.44 -29.12 70.28 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.754 0.821 . . . . 0.0 111.476 174.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -67.91 -41.29 82.86 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.1 0.56 . . . . 0.0 109.904 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -93.43 4.8 53.38 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.056 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.9 t -62.14 121.27 12.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.919 0.888 . . . . 0.0 113.222 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 55' ' ' ASN . 84.4 mt -106.3 -0.07 24.67 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.83 0.852 . . . . 0.0 110.752 170.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.9 t -83.3 -15.66 49.24 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.889 0.476 . . . . 0.0 110.49 172.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.252 1.229 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.838 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 32.3 mt . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.2 m -68.33 89.0 0.33 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.844 0.858 . . . . 0.0 111.38 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.5 t -99.0 142.97 29.81 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.646 1.179 . . . . 0.0 110.531 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -84.97 69.49 10.81 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.651 0.739 . . . . 0.0 109.209 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 64.0 p -139.44 174.38 10.57 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.655 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.1 m -77.54 176.44 8.92 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-O 120.761 0.315 . . . . 0.0 110.229 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -129.81 29.87 4.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.75 0.82 . . . . 0.0 109.929 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.8 mt -59.32 -42.33 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.637 0.775 . . . . 0.0 111.409 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -113.85 17.05 18.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.552 0.741 . . . . 0.0 110.868 -176.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -54.55 -55.21 31.66 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 123.75 0.82 . . . . 0.0 112.171 -167.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -91.9 15.14 13.7 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.36 0.664 . . . . 0.0 111.271 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 54.0 t -117.11 120.38 38.16 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 123.986 0.914 . . . . 0.0 109.924 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.41 HG11 HD23 ' A' ' 39' ' ' LEU . 36.5 t -90.84 134.07 30.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 168.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.438 ' HB ' HD11 ' A' ' 31' ' ' ILE . 4.7 mp -123.45 123.29 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.046 0.538 . . . . 0.0 110.631 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -102.76 144.18 31.45 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.436 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 41.1 mt -121.68 137.68 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -147.19 136.13 22.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.688 0.795 . . . . 0.0 109.603 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.71 175.3 47.73 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 123.253 0.345 . . . . 0.0 113.156 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -73.93 111.93 9.56 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.107 0.479 . . . . 0.0 110.017 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.549 HG23 HG13 ' A' ' 52' ' ' VAL . 40.4 p -128.14 138.41 52.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.947 1.299 . . . . 0.0 108.226 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -105.33 130.22 23.45 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 118.257 0.48 . . . . 0.0 110.664 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.99 172.22 64.27 Favored 'Cis proline' 0 C--N 1.375 1.95 0 C-N-CA 124.232 -1.154 . . . . 0.0 111.485 -2.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.23 155.67 5.79 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.541 -0.589 . . . . 0.0 113.768 -174.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -55.36 -36.55 66.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.262 0.625 . . . . 0.0 111.809 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.448 HD13 ' N ' ' A' ' 26' ' ' GLN . 3.0 pp -59.3 -40.51 86.39 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.338 0.655 . . . . 0.0 111.738 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.448 ' N ' HD13 ' A' ' 25' ' ' LEU . 9.1 tp-100 -74.27 -43.86 55.16 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.87 0.868 . . . . 0.0 110.509 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.1 -39.75 83.22 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.87 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.439 ' HA ' HD12 ' A' ' 31' ' ' ILE . 15.9 m170 -60.8 -39.21 88.06 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.043 0.937 . . . . 0.0 110.304 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -67.88 -41.18 83.21 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.582 0.552 . . . . 0.0 110.932 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.528 ' SD ' HG13 ' A' ' 79' ' ' VAL . 25.0 mmt -60.17 -32.53 71.14 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.315 0.646 . . . . 0.0 111.748 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 28' ' ' HIS . 70.1 mt -71.07 -52.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.065 175.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.7 t -71.45 -44.84 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.362 0.665 . . . . 0.0 112.045 -170.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.2 -15.76 57.99 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.709 0.804 . . . . 0.0 111.705 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.441 ' NE2' HG11 ' A' ' 79' ' ' VAL . 68.5 m-70 -108.98 27.82 9.1 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.726 0.81 . . . . 0.0 111.154 175.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.85 9.97 86.3 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 114.798 -1.092 . . . . 0.0 114.656 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.13 177.74 34.03 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 114.453 0.541 . . . . 0.0 114.453 -170.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -123.85 150.08 45.0 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.471 0.708 . . . . 0.0 110.038 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -125.0 166.6 16.06 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.49 0.716 . . . . 0.0 110.417 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.41 HD23 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -131.35 141.65 49.93 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.04 -35.05 26.07 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.474 0.71 . . . . 0.0 112.862 -176.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.9 t80 179.62 141.14 0.13 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.992 0.917 . . . . 0.0 109.51 -174.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -93.88 116.46 28.91 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.277 0.631 . . . . 0.0 109.892 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.3 m -92.71 61.77 3.68 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.368 1.067 . . . . 0.0 109.68 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.8 m 61.39 26.28 16.09 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.402 1.081 . . . . 0.0 111.967 -175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -132.17 140.62 48.8 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.099 0.56 . . . . 0.0 110.748 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.69 78.31 6.27 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.2 m -103.39 -8.94 19.83 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.847 0.859 . . . . 0.0 110.657 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.403 ' HA ' ' HB ' ' A' ' 13' ' ' VAL . 9.5 p -123.98 159.82 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.797 0.839 . . . . 0.0 109.867 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.625 HG21 ' HD1' ' A' ' 50' ' ' HIS . 5.1 t -114.15 -27.72 7.56 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.044 0.538 . . . . 0.0 111.202 175.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.625 ' HD1' HG21 ' A' ' 49' ' ' THR . 75.7 m80 -130.6 129.74 43.11 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.07 0.548 . . . . 0.0 110.591 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 22.5 mt -114.66 138.89 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.645 0.778 . . . . 0.0 109.045 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.549 HG13 HG23 ' A' ' 20' ' ' THR . 63.2 t -104.63 135.36 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 123.985 0.914 . . . . 0.0 109.526 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.03 163.33 39.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.019 0.928 . . . . 0.0 108.908 173.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.3 t -115.56 -49.12 2.75 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -120.06 111.59 18.07 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 tp -129.99 123.01 20.63 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.97 151.9 74.77 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.13 2.554 . . . . 0.0 112.406 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.41 HD22 ' HD2' ' A' ' 61' ' ' ARG . 94.8 mt -59.05 -32.58 69.89 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.531 0.733 . . . . 0.0 111.878 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -60.0 -43.44 95.2 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.335 0.654 . . . . 0.0 110.723 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -75.93 -28.78 58.11 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.724 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HD2' HD22 ' A' ' 58' ' ' LEU . 61.6 mtt180 -70.87 -29.32 65.4 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.865 0.466 . . . . 0.0 110.817 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.6 mt -80.13 -37.33 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.537 0.735 . . . . 0.0 110.638 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -61.66 -45.7 92.88 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.683 0.754 . . . . 0.0 110.03 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -99.75 19.47 15.91 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.703 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.67 -18.89 62.15 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.256 0.622 . . . . 0.0 110.415 169.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -70.64 -17.47 62.87 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.897 0.879 . . . . 0.0 110.407 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.17 171.4 7.57 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.602 1.161 . . . . 0.0 109.261 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -99.28 88.13 3.83 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.408 HG11 ' HB2' ' A' ' 92' ' ' LEU . 39.6 t -74.49 138.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.664 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.04 177.71 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.009 1.324 . . . . 0.0 109.723 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.3 m -87.45 160.07 48.79 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.101 0.96 . . . . 0.0 109.612 172.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.401 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.7 Cg_endo -59.75 -28.0 86.26 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 122.684 2.256 . . . . 0.0 112.223 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -65.88 -16.84 64.21 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.544 1.138 . . . . 0.0 111.969 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.3 t90 -62.69 -45.8 91.08 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 75' ' ' ILE . 3.2 mp -71.16 -50.41 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.706 -177.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.521 HG13 ' HE2' ' A' ' 80' ' ' LYS . 58.8 t -62.3 -50.74 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.878 -173.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -71.57 -33.63 69.25 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.808 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.7 m -61.19 -37.19 82.05 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 117.954 0.343 . . . . 0.0 110.718 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.528 HG13 ' SD ' ' A' ' 30' ' ' MET . 44.4 t -64.6 -47.41 89.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 C-N-CA 123.866 0.866 . . . . 0.0 111.03 173.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.521 ' HE2' HG13 ' A' ' 76' ' ' VAL . 54.3 mtmt -70.17 -26.46 63.92 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.266 0.627 . . . . 0.0 112.118 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -94.99 -15.98 23.1 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.834 0.453 . . . . 0.0 111.248 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.15 28.66 18.28 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.734 1.214 . . . . 0.0 111.84 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -144.96 149.15 34.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.418 1.087 . . . . 0.0 108.603 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.0 tp -72.73 112.07 8.45 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.9 mt -83.88 153.95 64.19 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 123.514 0.725 . . . . 0.0 110.82 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -57.59 122.15 11.26 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.992 2.461 . . . . 0.0 112.454 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -64.2 -32.34 73.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.992 0.517 . . . . 0.0 110.274 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -60.52 -31.62 70.68 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.065 0.946 . . . . 0.0 111.276 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -69.33 -25.08 64.03 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.651 0.781 . . . . 0.0 110.743 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -115.99 4.71 13.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.845 0.858 . . . . 0.0 111.423 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.9 t -66.46 126.7 29.67 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -167.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.408 ' HB2' HG11 ' A' ' 69' ' ' VAL . 49.9 mt -114.68 28.34 8.8 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.057 0.943 . . . . 0.0 110.292 173.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 39.7 p -65.78 -38.17 88.3 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.635 0.774 . . . . 0.0 111.027 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.254 1.294 0 C-N-CA 124.302 1.041 . . . . 0.0 109.001 -179.306 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 t -115.76 143.58 45.19 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.255 1.022 . . . . 0.0 108.867 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.2 t -164.93 169.06 16.94 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.32 0.648 . . . . 0.0 109.979 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -126.71 94.0 3.93 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.3 p -57.77 -40.36 79.61 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.916 0.865 . . . . 0.0 109.211 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 m -142.52 145.51 33.73 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.059 164.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.565 ' HA ' ' HB2' ' A' ' 10' ' ' LYS . 20.9 pttp -111.02 21.22 16.66 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.237 0.615 . . . . 0.0 110.35 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 52.5 mt -66.08 -50.07 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.816 0.846 . . . . 0.0 110.584 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.406 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 50.4 m-85 -112.26 14.48 20.52 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.143 -176.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 7' ' ' LYS . 52.2 tptt -53.54 -55.63 23.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.064 0.946 . . . . 0.0 113.476 -165.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -100.15 17.52 21.0 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.371 0.605 . . . . 0.0 109.889 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.49 ' SG ' ' CD2' ' A' ' 50' ' ' HIS . 29.1 t -113.06 128.39 56.48 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.048 1.339 . . . . 0.0 110.901 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.86 130.34 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.242 1.017 . . . . 0.0 109.295 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.506 ' HB ' HD12 ' A' ' 31' ' ' ILE . 4.7 mp -124.42 129.37 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 CA-C-O 121.407 0.622 . . . . 0.0 111.852 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.484 ' HB2' ' HB3' ' A' ' 39' ' ' LEU . 55.2 t80 -104.02 152.39 22.09 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.43 1.892 . . . . 0.0 108.39 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -122.78 137.89 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.066 0.546 . . . . 0.0 109.987 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -143.74 141.63 30.55 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.39 1.076 . . . . 0.0 109.346 -174.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.27 -178.92 46.49 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 116.467 -0.333 . . . . 0.0 112.699 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -92.9 110.59 22.05 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.98 0.419 . . . . 0.0 109.955 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.584 HG22 HG13 ' A' ' 52' ' ' VAL . 65.0 p -122.59 142.59 50.47 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.715 1.206 . . . . 0.0 109.717 -174.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -96.82 130.76 29.4 Favored Pre-proline 0 N--CA 1.479 0.976 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 167.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.49 176.28 42.31 Favored 'Cis proline' 0 C--N 1.373 1.831 0 C-N-CA 124.758 -0.934 . . . . 0.0 111.666 -4.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.59 152.0 7.66 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.746 0.654 . . . . 0.0 114.07 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -54.01 -34.97 61.36 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.251 1.02 . . . . 0.0 112.263 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 pp -58.09 -48.28 80.63 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.898 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.49 ' HA ' HE21 ' A' ' 26' ' ' GLN . 0.0 OUTLIER -73.5 -41.77 62.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.355 0.662 . . . . 0.0 111.614 -175.235 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.485 HD12 HG11 ' A' ' 52' ' ' VAL . 29.1 mt -58.34 -44.58 88.78 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.033 0.533 . . . . 0.0 110.641 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.403 ' O ' HG22 ' A' ' 32' ' ' VAL . 16.8 m170 -65.79 -34.97 79.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.567 0.347 . . . . 0.0 111.498 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -62.85 -42.2 99.66 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 117.847 0.294 . . . . 0.0 110.443 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.617 ' HB3' HG22 ' A' ' 79' ' ' VAL . 22.9 mmt -62.26 -39.06 91.64 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.881 0.872 . . . . 0.0 110.677 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.506 HD12 ' HB ' ' A' ' 14' ' ' ILE . 71.1 mt -65.87 -51.55 59.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.044 0.938 . . . . 0.0 111.463 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 28' ' ' HIS . 99.9 t -68.56 -43.67 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 122.901 0.48 . . . . 0.0 111.599 -173.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.67 -17.8 63.32 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.271 0.629 . . . . 0.0 111.795 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.415 ' NE2' HG12 ' A' ' 79' ' ' VAL . 55.5 m-70 -108.91 26.51 10.51 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.675 0.79 . . . . 0.0 111.581 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.9 -0.33 72.87 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.615 -0.721 . . . . 0.0 114.821 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . -92.52 173.97 36.0 Favored Glycine 0 C--O 1.237 0.342 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 -166.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -117.4 159.33 22.94 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.605 1.162 . . . . 0.0 109.63 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -125.27 156.63 38.28 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.764 0.826 . . . . 0.0 110.987 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.589 ' HG ' ' HB ' ' A' ' 48' ' ' VAL . 2.4 tm? -134.65 129.38 34.76 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.412 ' HD2' ' H ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -79.74 -43.36 22.74 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.412 ' H ' ' HD2' ' A' ' 40' ' ' HIS . 71.9 t80 -175.33 146.21 0.8 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.172 0.989 . . . . 0.0 109.727 -170.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -88.46 97.67 11.2 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.364 0.666 . . . . 0.0 110.244 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.2 t -91.53 -24.13 19.72 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 164.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.7 m -141.4 163.74 32.13 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.916 0.886 . . . . 0.0 110.819 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -84.51 166.51 17.18 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.331 0.652 . . . . 0.0 111.416 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? 68.22 3.9 3.9 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.858 1.263 . . . . 0.0 112.847 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.8 p -83.44 -18.74 37.61 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.072 0.549 . . . . 0.0 111.111 -174.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.589 ' HB ' ' HG ' ' A' ' 39' ' ' LEU . 9.8 p -136.93 156.62 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.481 0.712 . . . . 0.0 109.858 176.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.514 HG23 ' HD2' ' A' ' 50' ' ' HIS . 4.6 t -114.51 -25.31 8.41 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.436 0.695 . . . . 0.0 111.127 175.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.514 ' HD2' HG23 ' A' ' 49' ' ' THR . 80.5 m-70 -132.55 130.47 40.39 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.939 0.495 . . . . 0.0 110.616 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.599 ' HB ' HG13 ' A' ' 69' ' ' VAL . 66.7 mt -114.98 135.21 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.584 HG13 HG22 ' A' ' 20' ' ' THR . 87.5 t -91.79 129.1 42.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.26 145.93 29.59 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.5 t -88.46 -39.15 14.44 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -143.96 139.73 29.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.476 1.11 . . . . 0.0 108.264 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.3 tp -128.07 128.38 23.76 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.97 150.29 73.56 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.066 2.51 . . . . 0.0 112.317 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.2 mt -57.22 -39.83 76.26 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.946 0.898 . . . . 0.0 111.339 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.28 -43.36 99.01 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.404 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -76.64 -20.79 56.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.603 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -66.43 -41.22 89.53 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 171.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.1 mt -65.41 -43.54 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 123.717 0.636 . . . . 0.0 110.797 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.63 -42.26 82.59 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.365 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -100.36 23.33 10.31 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.549 0.74 . . . . 0.0 110.674 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.63 -27.44 67.69 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.409 0.683 . . . . 0.0 111.386 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -71.3 -19.37 62.33 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.938 0.895 . . . . 0.0 111.239 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -108.9 143.89 37.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.882 0.873 . . . . 0.0 109.204 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.04 86.17 4.23 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.599 HG13 ' HB ' ' A' ' 51' ' ' ILE . 7.6 m -78.3 127.82 38.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.22 171.41 18.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.284 1.034 . . . . 0.0 109.667 -172.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.1 m -77.92 150.25 78.01 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.399 170.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.83 -25.86 78.17 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.332 2.021 . . . . 0.0 111.39 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.7 -29.38 52.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.387 1.475 . . . . 0.0 112.271 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -60.29 -54.37 46.5 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 79' ' ' VAL . 3.4 mp -64.15 -48.04 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 124.227 0.955 . . . . 0.0 109.165 -175.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.68 -52.24 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.835 1.254 . . . . 0.0 111.462 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.78 -33.29 66.2 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.74 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.46 ' HA ' HD13 ' A' ' 85' ' ' LEU . 61.9 m -62.34 -35.38 78.9 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.925 0.49 . . . . 0.0 111.361 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 30' ' ' MET . 71.4 t -69.5 -44.34 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.37 0.668 . . . . 0.0 110.863 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.5 -43.25 89.0 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.525 0.679 . . . . 0.0 110.843 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.579 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 64.7 mm-40 -82.65 -21.49 34.99 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.856 -176.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.66 24.93 12.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.241 1.017 . . . . 0.0 111.173 -173.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.579 ' HE ' ' HB3' ' A' ' 81' ' ' GLU . 9.2 ptp180 -134.81 166.02 23.95 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.457 0.703 . . . . 0.0 109.656 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -86.25 116.14 24.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.317 0.647 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 78' ' ' SER . 11.3 mp -90.17 155.19 47.07 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.745 0.818 . . . . 0.0 110.198 172.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.54 109.43 2.62 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.066 1.844 . . . . 0.0 110.755 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -62.38 -25.55 67.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.48 0.712 . . . . 0.0 111.725 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -57.92 -29.54 65.21 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.212 1.005 . . . . 0.0 111.64 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -75.6 -34.48 60.63 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.873 0.869 . . . . 0.0 111.046 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -96.34 -1.05 48.59 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.58 0.752 . . . . 0.0 111.253 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.2 t -72.67 115.59 12.12 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.45 0.7 . . . . 0.0 112.068 -170.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.6 mt -79.31 4.91 13.78 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.934 0.893 . . . . 0.0 111.898 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.2 p -62.4 -21.95 65.78 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.75 0.82 . . . . 0.0 111.463 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.255 1.377 0 C-N-CA 125.832 1.653 . . . . 0.0 111.189 176.253 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 10.0 pt . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.713 0.292 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 m -63.5 113.34 3.23 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 169.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.4 m -74.05 78.85 1.71 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.626 0.726 . . . . 0.0 111.171 -171.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -87.47 -18.64 29.42 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.592 1.157 . . . . 0.0 109.043 171.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 50.7 m -74.14 107.99 6.67 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.632 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.7 m -62.89 128.75 37.35 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 167.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -79.47 32.09 0.24 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -165.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.2 mt -57.78 -46.87 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.033 1.333 . . . . 0.0 111.669 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.484 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 50.9 m-85 -112.53 17.01 19.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.607 0.763 . . . . 0.0 110.828 -174.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -57.16 -44.05 83.09 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.693 0.797 . . . . 0.0 112.47 -171.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -92.05 -5.81 52.2 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.475 0.31 . . . . 0.0 111.365 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.6 m -97.55 125.84 42.49 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.525 0.678 . . . . 0.0 111.242 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.496 HG11 HG22 ' A' ' 48' ' ' VAL . 36.9 t -103.52 130.6 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 169.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 3.2 mp -118.31 136.01 56.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 123.81 0.844 . . . . 0.0 111.147 -174.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -115.45 119.7 37.07 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 124.422 1.089 . . . . 0.0 108.465 169.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.9 mt -92.36 138.28 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.164 0.586 . . . . 0.0 109.508 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -147.16 136.94 23.05 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.049 0.94 . . . . 0.0 110.098 -166.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.36 -154.17 50.18 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.266 0.354 . . . . 0.0 113.465 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -78.1 128.63 34.11 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 172.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.2 p -146.68 126.86 13.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.672 1.189 . . . . 0.0 108.512 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -114.28 135.76 22.22 Favored Pre-proline 0 N--CA 1.481 1.102 0 CA-C-N 118.212 0.46 . . . . 0.0 111.141 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.11 175.12 38.98 Favored 'Cis proline' 0 C--N 1.379 2.161 0 C-N-CA 124.827 -0.905 . . . . 0.0 112.264 -1.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.58 141.09 9.87 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 124.126 0.891 . . . . 0.0 113.392 -175.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -50.29 -34.66 24.25 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.347 1.059 . . . . 0.0 112.904 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 pp -54.55 -45.7 73.51 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.803 0.441 . . . . 0.0 111.581 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -73.12 -45.41 57.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.976 0.91 . . . . 0.0 110.719 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.3 -44.84 76.1 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.724 0.64 . . . . 0.0 111.306 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -58.96 -40.54 85.04 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.768 0.827 . . . . 0.0 110.638 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.89 -39.87 87.58 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.336 0.397 . . . . 0.0 111.195 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.546 ' HB3' HG22 ' A' ' 79' ' ' VAL . 24.4 mmt -63.37 -33.1 74.79 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.981 0.513 . . . . 0.0 111.355 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.4 mt -72.48 -51.56 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.559 0.744 . . . . 0.0 111.003 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.03 -44.95 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.218 0.607 . . . . 0.0 111.681 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 5' ' ' SER . 4.6 mm? -66.8 -11.82 56.6 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.531 0.732 . . . . 0.0 111.805 177.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -113.3 27.23 9.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.71 0.804 . . . . 0.0 111.594 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.57 -6.16 83.86 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.283 -0.872 . . . . 0.0 114.764 167.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.13 156.88 42.34 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 113.944 0.338 . . . . 0.0 113.944 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -108.99 169.71 8.51 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 43.6 p90 -144.27 151.01 38.82 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.79 127.48 53.74 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.656 169.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -33.95 76.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.079 172.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -172.81 151.32 2.24 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.608 1.163 . . . . 0.0 109.01 173.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.3 -47.43 5.18 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.7 t 56.15 56.79 5.54 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 124.615 1.197 . . . . 0.0 109.081 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.7 m 61.76 82.47 0.17 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.521 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -164.37 127.78 2.5 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -89.26 75.11 7.82 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.459 0.572 . . . . 0.0 110.394 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.3 m -108.1 -36.27 6.36 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.73 0.812 . . . . 0.0 110.496 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.496 HG22 HG11 ' A' ' 13' ' ' VAL . 6.9 p -93.29 157.77 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.086 0.554 . . . . 0.0 110.224 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 t -111.27 -32.63 6.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.969 0.508 . . . . 0.0 111.639 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -119.93 138.51 53.4 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.77 0.828 . . . . 0.0 109.088 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.657 ' HB ' HG12 ' A' ' 69' ' ' VAL . 52.7 mt -124.37 138.14 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.55 122.07 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.945 0.898 . . . . 0.0 110.378 -175.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.11 156.97 45.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.665 1.186 . . . . 0.0 108.075 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.1 t -76.23 -38.88 55.77 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -147.84 138.17 22.95 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.075 173.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.1 tp -116.49 124.57 29.31 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.61 156.59 36.25 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.564 2.842 . . . . 0.0 112.666 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.403 HD23 ' HD2' ' A' ' 61' ' ' ARG . 97.0 mt -60.01 -41.96 93.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.832 0.853 . . . . 0.0 112.039 -174.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -57.57 -41.76 81.72 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.671 0.789 . . . . 0.0 110.462 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.39 -23.45 46.78 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.823 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.403 ' HD2' HD23 ' A' ' 58' ' ' LEU . 99.6 mtt180 -70.73 -33.85 71.28 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.405 0.548 . . . . 0.0 110.656 173.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.7 -45.52 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.485 0.714 . . . . 0.0 109.997 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.68 -50.82 65.5 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.054 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.431 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 18.7 m-85 -92.67 26.35 2.73 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.442 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.63 -29.89 70.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.429 0.692 . . . . 0.0 111.38 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -77.52 -25.82 50.6 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.22 0.608 . . . . 0.0 111.062 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.431 ' CD1' ' HA ' ' A' ' 64' ' ' PHE . 10.3 m-85 -89.47 145.92 24.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.744 0.818 . . . . 0.0 109.638 -177.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -87.03 86.67 7.33 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.657 HG12 ' HB ' ' A' ' 51' ' ' ILE . 21.6 m -81.63 131.18 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.422 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.97 174.43 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.622 1.169 . . . . 0.0 110.112 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -82.78 157.21 67.12 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.795 0.838 . . . . 0.0 110.549 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.72 -23.28 75.84 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.672 2.248 . . . . 0.0 111.864 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.35 -27.42 65.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.331 1.452 . . . . 0.0 111.774 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -61.68 -48.71 79.55 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.506 0.504 . . . . 0.0 110.223 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.484 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.4 mp -67.47 -49.3 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.057 -175.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.2 -52.42 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.342 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.78 -36.19 70.26 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.113 -172.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.1 m -66.07 -40.34 90.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.014 0.525 . . . . 0.0 111.312 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 30' ' ' MET . 23.8 t -64.88 -44.0 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.533 0.733 . . . . 0.0 110.799 178.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -65.16 -36.67 84.94 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.676 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.53 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 48.0 mm-40 -86.24 -8.74 57.54 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.11 19.03 8.29 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.7 1.2 . . . . 0.0 112.763 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.53 ' HE ' ' HB3' ' A' ' 81' ' ' GLU . 13.5 ptp180 -134.21 161.85 33.77 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.509 0.724 . . . . 0.0 109.932 -172.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.8 tp -84.03 113.19 20.84 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 172.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.02 154.42 55.05 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 123.456 0.702 . . . . 0.0 109.968 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.1 117.12 3.96 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.232 1.954 . . . . 0.0 110.931 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -59.76 -27.88 66.91 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.561 0.744 . . . . 0.0 111.672 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -62.21 -25.78 67.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.481 1.113 . . . . 0.0 112.352 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -68.55 -26.99 65.69 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.588 0.755 . . . . 0.0 110.938 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -117.19 5.03 12.66 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.773 0.829 . . . . 0.0 111.114 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.6 t -72.7 125.26 27.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.136 0.574 . . . . 0.0 111.918 -171.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.4 mt -93.39 13.07 22.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.015 0.926 . . . . 0.0 111.862 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.5 p -61.7 -28.33 69.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.273 0.629 . . . . 0.0 110.654 174.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 125.075 1.35 . . . . 0.0 111.481 171.098 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 12.8 tt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.9 m -138.65 147.96 43.49 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.98 0.912 . . . . 0.0 108.958 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.4 p -156.53 145.03 19.89 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.841 0.857 . . . . 0.0 110.04 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -71.22 107.8 4.4 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.249 0.62 . . . . 0.0 110.826 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -164.31 154.69 14.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.018 0.927 . . . . 0.0 109.186 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.566 ' HB3' HG13 ' A' ' 8' ' ' ILE . 15.9 m -85.71 158.47 20.03 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.23 0.612 . . . . 0.0 111.534 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -112.06 15.12 20.73 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.947 0.899 . . . . 0.0 110.185 176.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.566 HG13 ' HB3' ' A' ' 6' ' ' SER . 76.3 mt -57.1 -46.98 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 124.154 0.982 . . . . 0.0 112.32 -168.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.443 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 55.5 m-85 -114.8 15.86 17.41 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.705 0.402 . . . . 0.0 111.292 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -64.85 -32.65 74.46 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 122.724 0.41 . . . . 0.0 111.928 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -96.96 6.75 48.07 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.839 0.456 . . . . 0.0 111.685 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 76.3 m -120.82 130.46 53.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.371 0.669 . . . . 0.0 111.477 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.459 HG11 HG23 ' A' ' 48' ' ' VAL . 39.1 t -96.95 131.8 42.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 167.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 mp -119.31 124.05 72.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.512 0.725 . . . . 0.0 110.648 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -105.97 109.74 21.79 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 166.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.5 mt -78.04 135.17 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -137.16 122.81 19.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.102 0.961 . . . . 0.0 109.257 -169.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.39 -179.13 29.8 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.406 0.441 . . . . 0.0 113.248 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -71.63 108.47 5.0 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.404 HG21 HG11 ' A' ' 52' ' ' VAL . 71.0 p -111.25 148.65 32.4 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 124.963 1.305 . . . . 0.0 108.897 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -107.35 122.05 42.52 Favored Pre-proline 0 N--CA 1.482 1.164 0 CA-C-N 118.229 0.468 . . . . 0.0 110.77 172.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -82.55 176.03 37.37 Favored 'Cis proline' 0 C--N 1.368 1.571 0 C-N-CA 123.939 -1.276 . . . . 0.0 111.78 0.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.17 154.04 6.89 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.704 0.628 . . . . 0.0 114.19 -173.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -55.38 -36.58 66.52 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.547 0.739 . . . . 0.0 111.858 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 26' ' ' GLN . 2.9 pp -61.12 -40.69 94.74 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 123.859 0.724 . . . . 0.0 111.826 176.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.452 ' N ' HD13 ' A' ' 25' ' ' LEU . 61.1 tp60 -73.33 -46.52 48.88 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.324 0.649 . . . . 0.0 110.145 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.3 mt -58.09 -39.24 78.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.68 0.792 . . . . 0.0 111.029 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -57.38 -42.72 82.71 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.752 0.821 . . . . 0.0 110.385 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -64.84 -43.39 93.23 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 79.1 mmm -62.81 -34.48 77.39 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.249 0.62 . . . . 0.0 111.212 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.6 mt -75.24 -54.94 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.486 0.714 . . . . 0.0 111.617 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.0 t -72.09 -40.18 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.224 0.61 . . . . 0.0 112.122 -166.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.48 -21.6 64.33 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.528 0.731 . . . . 0.0 111.677 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.459 ' NE2' HG11 ' A' ' 79' ' ' VAL . 60.2 m80 -105.12 26.97 8.66 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.305 1.042 . . . . 0.0 110.635 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.84 -3.74 83.11 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.853 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.49 151.79 47.03 Favored Glycine 0 C--O 1.239 0.421 0 N-CA-C 115.771 1.069 . . . . 0.0 115.771 -167.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -106.77 143.96 34.11 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -127.1 149.34 49.98 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.131 0.572 . . . . 0.0 109.724 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.25 123.47 49.32 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 175.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.55 -39.29 88.46 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.245 0.618 . . . . 0.0 112.109 -172.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -175.53 132.34 0.28 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.432 1.093 . . . . 0.0 108.716 -175.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.71 171.91 9.64 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.805 0.812 . . . . 0.0 112.482 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.7 p -135.04 -156.58 0.73 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.807 -177.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.7 t -67.06 -17.93 65.12 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.219 0.608 . . . . 0.0 111.271 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.612 ' HZ2' ' HB2' ' A' ' 45' ' ' LYS . 5.1 ttmp? -91.29 128.96 37.32 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.893 0.877 . . . . 0.0 110.715 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.04 98.34 2.52 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.1 m -119.97 18.34 12.47 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-O 121.182 0.515 . . . . 0.0 110.71 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.459 HG23 HG11 ' A' ' 13' ' ' VAL . 9.9 p -144.31 147.98 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 122.016 -0.428 . . . . 0.0 110.451 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.5 t -103.79 -32.37 9.37 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.574 0.75 . . . . 0.0 111.725 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -126.06 128.76 47.9 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.5 0.72 . . . . 0.0 109.845 -175.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 41.4 mt -114.39 121.9 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.57 0.748 . . . . 0.0 109.275 175.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.404 HG11 HG21 ' A' ' 20' ' ' THR . 64.0 t -92.32 121.6 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.113 0.565 . . . . 0.0 110.022 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.0 154.07 49.36 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.207 0.603 . . . . 0.0 110.167 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.7 t -95.26 -34.61 12.14 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -140.87 120.85 13.64 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.51 ' HG ' HG13 ' A' ' 69' ' ' VAL . 2.2 tm? -127.43 108.96 21.07 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.04 155.11 70.07 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.846 2.364 . . . . 0.0 112.394 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 61' ' ' ARG . 70.6 mt -64.16 -29.74 70.84 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -172.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -59.36 -48.96 79.66 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.512 0.672 . . . . 0.0 110.298 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -76.01 -19.71 58.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.45 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 10.6 tpp85 -67.64 -40.39 84.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.41 0.684 . . . . 0.0 109.767 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.0 mt -77.06 -35.8 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.063 0.945 . . . . 0.0 110.488 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -69.16 -30.53 68.78 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.465 0.706 . . . . 0.0 111.032 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -115.55 28.64 8.53 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.205 1.002 . . . . 0.0 110.042 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.93 -33.47 75.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.509 0.724 . . . . 0.0 111.626 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -77.36 -26.72 52.24 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.004 0.522 . . . . 0.0 110.82 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -78.64 141.48 37.96 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -83.89 85.8 7.26 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.36 0.664 . . . . 0.0 109.353 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.51 HG13 ' HG ' ' A' ' 56' ' ' LEU . 57.3 t -78.21 127.59 38.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 174.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.05 173.78 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.139 0.975 . . . . 0.0 110.19 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.3 m -81.46 152.92 70.79 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.818 0.847 . . . . 0.0 110.402 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -59.62 -25.49 79.1 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.964 2.443 . . . . 0.0 112.698 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.67 -19.75 66.03 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.051 0.941 . . . . 0.0 112.047 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -59.37 -43.05 92.91 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.923 0.489 . . . . 0.0 109.83 173.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 75' ' ' ILE . 3.2 mp -75.55 -49.55 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.128 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.1 t -59.76 -51.73 69.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.321 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -71.22 -39.57 71.63 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.267 -175.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.8 p -63.62 -37.75 88.51 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 120.822 0.344 . . . . 0.0 111.699 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.459 HG11 ' NE2' ' A' ' 34' ' ' HIS . 33.4 t -62.38 -46.1 97.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 123.719 0.807 . . . . 0.0 110.696 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.1 -37.24 86.41 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.203 0.601 . . . . 0.0 111.542 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -83.96 -12.56 55.15 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.499 0.72 . . . . 0.0 111.594 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.52 26.06 15.86 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.136 1.374 . . . . 0.0 112.582 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -140.86 161.9 36.73 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.327 1.051 . . . . 0.0 109.32 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.6 tp -87.72 128.58 35.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 172.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 mp -93.56 153.39 41.28 Favored Pre-proline 0 C--O 1.241 0.646 0 C-N-CA 123.865 0.866 . . . . 0.0 108.953 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.6 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 30.0 Cg_endo -65.23 140.96 66.94 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.768 1.645 . . . . 0.0 111.865 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -57.76 -33.24 68.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.696 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.6 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 30.0 pt20 -57.7 -34.2 69.2 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.666 1.186 . . . . 0.0 113.046 -170.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.5 ' OD1' ' HG2' ' A' ' 86' ' ' PRO . 14.2 m120 -67.32 -36.02 80.61 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.576 0.35 . . . . 0.0 111.706 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -107.81 3.34 24.33 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.521 0.728 . . . . 0.0 111.31 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.9 t -67.82 118.7 11.4 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.627 0.771 . . . . 0.0 112.639 -170.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.5 mt -86.49 -35.36 19.65 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.055 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.8 t -57.41 -33.87 68.33 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 123.422 0.689 . . . . 0.0 111.614 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 p . . . . . 0 C--O 1.253 1.247 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.127 176.09 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.582 HD11 ' H1 ' ' A' ' 1' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.375 0.131 . . . . 0.0 111.233 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -81.39 104.37 11.78 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.233 0.613 . . . . 0.0 110.387 -177.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.1 m -152.79 111.81 3.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.169 0.987 . . . . 0.0 108.971 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -89.51 139.43 30.54 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.137 0.575 . . . . 0.0 110.132 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 p -63.16 -39.16 93.86 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.402 0.681 . . . . 0.0 111.748 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.455 ' HB2' ' HA ' ' A' ' 34' ' ' HIS . 43.3 m -83.19 130.4 35.09 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -120.48 31.61 6.38 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.92 0.888 . . . . 0.0 108.961 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.431 HD12 ' HD2' ' A' ' 34' ' ' HIS . 40.5 mt -66.94 -39.08 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.632 1.173 . . . . 0.0 112.734 -166.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.486 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 68.6 m-85 -113.21 16.9 19.0 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.195 0.598 . . . . 0.0 110.961 -176.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -60.14 -39.6 86.88 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -169.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -94.87 11.0 33.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.961 -0.462 . . . . 0.0 111.471 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 83.2 m -122.9 135.58 54.56 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.611 0.764 . . . . 0.0 112.095 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.485 HG11 HD23 ' A' ' 39' ' ' LEU . 50.0 t -104.21 134.25 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 167.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.509 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.6 mp -126.07 122.73 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 121.255 0.55 . . . . 0.0 111.107 -174.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -102.99 152.31 21.47 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.59 1.556 . . . . 0.0 107.98 174.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.1 mt -121.96 127.08 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -128.35 139.85 52.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.163 0.985 . . . . 0.0 109.565 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.65 -161.22 46.08 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.593 0.558 . . . . 0.0 112.443 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -102.19 113.12 26.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.633 0.773 . . . . 0.0 109.479 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.466 HG23 HG12 ' A' ' 52' ' ' VAL . 79.5 p -117.93 137.65 52.69 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.851 0.86 . . . . 0.0 109.829 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -106.02 125.83 32.14 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 165.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -76.72 165.16 85.81 Favored 'Cis proline' 0 C--N 1.374 1.903 0 C-N-CA 124.027 -1.239 . . . . 0.0 111.837 2.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.0 161.57 6.41 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 123.906 0.754 . . . . 0.0 114.656 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -55.8 -36.07 67.02 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.525 0.73 . . . . 0.0 111.179 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.518 HD11 ' N ' ' A' ' 26' ' ' GLN . 2.6 pp -61.95 -42.0 98.62 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 123.753 0.658 . . . . 0.0 111.678 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.518 ' N ' HD11 ' A' ' 25' ' ' LEU . 6.3 tp-100 -69.56 -52.24 28.06 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.328 0.651 . . . . 0.0 110.342 -175.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.52 HD11 HG13 ' A' ' 52' ' ' VAL . 71.2 mt -57.8 -44.28 86.22 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.53 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.477 ' HA ' HD11 ' A' ' 31' ' ' ILE . 13.7 m170 -61.79 -37.59 84.9 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.063 0.545 . . . . 0.0 111.321 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 52.0 mm-40 -63.28 -45.84 89.59 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.021 0.439 . . . . 0.0 110.014 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.415 ' HB3' HG23 ' A' ' 79' ' ' VAL . 25.6 mmt -60.77 -37.77 83.0 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.63 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.509 HD13 ' HB ' ' A' ' 14' ' ' ILE . 75.5 mt -62.8 -50.81 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.043 0.537 . . . . 0.0 110.981 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.65 -45.62 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.064 0.546 . . . . 0.0 111.62 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.69 -18.89 65.61 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.275 0.63 . . . . 0.0 111.848 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 6' ' ' SER . 21.0 m80 -103.76 27.1 7.82 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.423 0.689 . . . . 0.0 111.108 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.76 -3.25 87.39 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.836 166.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -91.82 171.24 34.27 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 -170.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.467 ' HB2' HG21 ' A' ' 13' ' ' VAL . 42.0 mmtm -110.24 158.07 18.78 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.457 0.703 . . . . 0.0 109.736 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -133.31 153.23 51.76 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.766 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.485 HD23 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -112.2 136.52 51.51 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -85.25 -35.03 21.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.507 0.723 . . . . 0.0 112.056 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -176.99 139.69 0.29 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.413 1.085 . . . . 0.0 108.983 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.33 141.2 29.19 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.139 0.576 . . . . 0.0 110.369 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.7 m -85.27 45.88 1.23 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.309 1.044 . . . . 0.0 109.09 170.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.8 m 63.39 12.25 6.14 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.355 1.462 . . . . 0.0 112.315 -171.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -101.83 166.5 10.62 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.364 0.666 . . . . 0.0 111.542 -173.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -96.58 52.63 1.23 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.996 0.918 . . . . 0.0 109.816 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.8 m -84.66 5.15 29.24 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.349 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.04 150.72 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.856 0.862 . . . . 0.0 109.776 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.8 t -101.9 -38.18 7.92 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.058 0.543 . . . . 0.0 110.946 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.571 ' HD2' ' HB2' ' A' ' 68' ' ' LYS . 56.2 m170 -118.5 133.59 55.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.285 0.634 . . . . 0.0 109.442 -172.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.627 ' HB ' HG12 ' A' ' 69' ' ' VAL . 65.5 mt -123.63 134.14 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.52 HG13 HD11 ' A' ' 27' ' ' LEU . 52.1 t -92.69 128.96 43.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.03 143.86 28.7 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.4 t -92.78 -41.44 10.11 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 166.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -145.42 120.43 10.04 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.616 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.8 mt -92.21 148.82 37.43 Favored Pre-proline 0 C--O 1.24 0.583 0 C-N-CA 123.219 0.607 . . . . 0.0 109.678 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.72 157.42 37.67 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.808 2.339 . . . . 0.0 110.849 166.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.8 mt -53.3 -53.71 46.97 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.426 0.69 . . . . 0.0 112.105 -171.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.98 -46.19 90.35 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.38 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -72.67 -19.39 61.43 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.241 0.616 . . . . 0.0 112.251 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -72.84 -40.53 65.66 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 81.4 mt -66.88 -45.6 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.457 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.44 -40.3 73.85 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.074 0.55 . . . . 0.0 111.678 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.86 17.98 4.46 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.194 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.08 -26.51 61.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.697 0.399 . . . . 0.0 110.296 167.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -70.81 -27.27 63.76 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.301 0.641 . . . . 0.0 110.407 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -90.44 153.88 20.07 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.571 ' HB2' ' HD2' ' A' ' 50' ' ' HIS . 0.5 OUTLIER -84.86 85.31 7.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.109 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.627 HG12 ' HB ' ' A' ' 51' ' ' ILE . 31.6 m -85.08 129.85 37.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.835 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 m -134.98 171.56 17.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.502 1.121 . . . . 0.0 109.653 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.6 m -78.8 153.6 78.06 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.049 172.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.08 -24.95 52.02 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.743 2.296 . . . . 0.0 112.401 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.68 -27.1 48.32 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.878 1.271 . . . . 0.0 112.769 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -65.07 -45.16 86.45 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.227 0.537 . . . . 0.0 110.395 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.428 ' O ' HG21 ' A' ' 79' ' ' VAL . 3.2 mp -73.96 -45.5 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.74 -176.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 68.8 t -57.7 -49.8 79.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.908 0.883 . . . . 0.0 110.968 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 25.9 t70 -70.66 -35.18 72.73 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.85 0.46 . . . . 0.0 111.459 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.426 ' HB2' HG21 ' A' ' 8' ' ' ILE . 78.4 p -66.26 -37.33 85.23 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 120.428 0.156 . . . . 0.0 110.71 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 75' ' ' ILE . 72.6 t -64.08 -42.5 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.487 0.715 . . . . 0.0 110.771 173.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 77' ' ' ASP . 8.2 mtpm? -63.41 -45.64 90.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.661 0.784 . . . . 0.0 111.485 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -93.79 -9.54 37.17 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.972 0.509 . . . . 0.0 112.197 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.61 36.42 22.65 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.203 1.001 . . . . 0.0 111.729 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -150.74 167.21 28.09 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.764 0.826 . . . . 0.0 110.159 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.28 106.14 18.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.21 146.77 67.72 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.455 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 17.9 Cg_endo -58.88 113.86 1.75 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.33 2.02 . . . . 0.0 111.838 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -57.56 -24.53 56.7 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.498 1.119 . . . . 0.0 111.665 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.6 pt20 -58.37 -27.9 64.64 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 124.545 1.138 . . . . 0.0 112.507 -176.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -79.33 -18.83 51.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.178 0.591 . . . . 0.0 112.091 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -110.14 1.94 19.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.813 0.845 . . . . 0.0 111.232 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m -65.82 122.5 17.46 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.622 0.769 . . . . 0.0 112.377 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.0 mt -98.83 15.2 26.22 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.631 0.772 . . . . 0.0 110.286 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -64.4 -23.53 67.32 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.573 1.149 . . . . 0.0 111.661 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 C--O 1.25 1.1 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.09 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.6 tt . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 t 62.56 73.47 0.46 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.976 1.311 . . . . 0.0 111.293 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.3 t -136.1 147.13 47.66 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.275 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -139.47 9.74 2.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.394 1.077 . . . . 0.0 109.63 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.8 m -59.9 -28.31 67.47 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.575 1.15 . . . . 0.0 112.135 -172.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.4 m -136.78 120.71 17.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.299 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -98.29 20.49 12.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.841 0.857 . . . . 0.0 110.565 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.9 mt -67.85 -49.65 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.35 1.06 . . . . 0.0 111.31 -172.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -110.28 12.02 23.34 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.432 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -58.72 -35.93 73.46 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.184 0.593 . . . . 0.0 111.651 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -108.1 16.94 22.88 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.662 0.785 . . . . 0.0 110.894 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 77.4 m -121.03 114.65 21.8 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 123.847 0.859 . . . . 0.0 110.485 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.428 HG12 HG21 ' A' ' 48' ' ' VAL . 48.6 t -97.81 125.12 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 168.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 50' ' ' HIS . 3.2 mp -115.7 129.67 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.23 1.012 . . . . 0.0 111.356 -175.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -111.74 118.58 35.99 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 167.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.1 mt -83.28 133.74 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -137.2 125.54 23.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.63 1.172 . . . . 0.0 108.374 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.19 -176.22 51.88 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 -174.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' A' ' 54' ' ' SER . 72.8 m-85 -88.01 112.34 22.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 122.813 0.445 . . . . 0.0 109.808 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.42 HG23 HG11 ' A' ' 52' ' ' VAL . 41.3 p -107.83 146.27 32.5 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.749 1.22 . . . . 0.0 109.652 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -110.87 124.54 32.72 Favored Pre-proline 0 N--CA 1.485 1.305 0 CA-C-N 117.665 0.211 . . . . 0.0 111.004 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.12 173.64 57.01 Favored 'Cis proline' 0 C--N 1.375 1.955 0 C-N-CA 124.196 -1.168 . . . . 0.0 112.043 3.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.69 149.66 10.32 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 123.749 0.656 . . . . 0.0 114.535 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -50.13 -38.49 39.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.61 1.164 . . . . 0.0 112.638 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.498 HD13 ' N ' ' A' ' 26' ' ' GLN . 1.4 pp -63.66 -39.45 94.36 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 122.968 0.507 . . . . 0.0 111.98 175.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.498 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.8 tp-100 -73.27 -48.61 33.32 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.093 0.957 . . . . 0.0 110.645 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 72' ' ' PRO . 88.7 mt -56.08 -45.61 79.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.522 0.729 . . . . 0.0 111.311 174.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -54.98 -39.01 68.55 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.678 0.611 . . . . 0.0 111.151 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -64.07 -46.92 82.18 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.778 0.323 . . . . 0.0 110.593 173.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.635 ' HB3' HG21 ' A' ' 79' ' ' VAL . 36.9 mmt -62.56 -35.01 78.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.534 0.734 . . . . 0.0 112.147 -175.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.9 mt -72.35 -53.68 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.566 0.746 . . . . 0.0 111.074 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.5 t -75.0 -37.22 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.878 -167.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.19 -13.84 62.64 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.751 0.82 . . . . 0.0 111.58 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.416 ' NE2' HG11 ' A' ' 79' ' ' VAL . 21.2 m-70 -106.63 26.12 10.35 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.967 0.907 . . . . 0.0 110.619 173.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.69 22.44 72.31 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.761 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.32 156.84 20.85 Favored Glycine 0 CA--C 1.503 -0.706 0 N-CA-C 113.443 0.137 . . . . 0.0 113.443 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.536 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -105.45 144.16 32.61 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.27 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -116.35 157.3 25.24 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.99 123.21 44.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 175.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -72.91 -32.93 65.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.078 0.951 . . . . 0.0 111.789 -174.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -176.13 126.07 0.2 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.428 1.091 . . . . 0.0 108.377 -172.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.69 139.15 31.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.056 0.543 . . . . 0.0 110.393 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.8 t -84.44 -157.42 0.28 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.077 0.951 . . . . 0.0 108.465 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 m -83.76 47.17 1.25 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.192 0.597 . . . . 0.0 111.85 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -159.56 172.12 18.41 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.169 0.509 . . . . 0.0 111.482 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.62 91.49 7.57 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.294 1.038 . . . . 0.0 111.427 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.9 m -117.86 17.46 14.22 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.543 0.687 . . . . 0.0 110.754 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.428 HG21 HG12 ' A' ' 13' ' ' VAL . 9.9 p -137.95 150.31 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.9 -0.5 . . . . 0.0 109.998 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.6 p -106.74 -31.89 8.22 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.429 0.692 . . . . 0.0 111.083 -176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.45 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 80.4 m80 -135.28 129.67 33.91 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.353 1.061 . . . . 0.0 108.369 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.543 ' HB ' HG12 ' A' ' 69' ' ' VAL . 48.8 mt -113.72 118.98 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 174.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.42 HG11 HG23 ' A' ' 20' ' ' THR . 73.4 t -90.91 118.83 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 122.988 0.515 . . . . 0.0 109.725 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.53 144.21 34.18 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.291 0.636 . . . . 0.0 110.191 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.437 ' HB3' ' O ' ' A' ' 19' ' ' TYR . 29.8 t -115.43 -37.37 4.04 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 166.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -98.79 98.26 9.39 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.2 tp -139.91 109.96 7.18 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 122.575 0.35 . . . . 0.0 110.145 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.551 ' HD2' ' HB2' ' A' ' 60' ' ' LYS . 18.6 Cg_exo -68.1 158.79 55.9 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.473 2.782 . . . . 0.0 112.012 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.77 -40.77 93.79 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.66 0.784 . . . . 0.0 111.539 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -67.04 -28.64 68.38 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.602 0.761 . . . . 0.0 111.429 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.551 ' HB2' ' HD2' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -86.98 -14.4 41.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.211 0.604 . . . . 0.0 111.178 177.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.416 ' HD2' ' O ' ' A' ' 92' ' ' LEU . 32.2 mtm180 -73.87 -28.71 61.71 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 166.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.6 mt -77.98 -43.33 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.394 0.677 . . . . 0.0 110.298 173.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.538 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 38.8 tt0 -68.21 -32.63 72.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.653 0.781 . . . . 0.0 111.241 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -110.28 27.61 9.45 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.667 0.787 . . . . 0.0 110.649 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.21 98.4 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.616 0.766 . . . . 0.0 112.6 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -72.81 -25.31 61.1 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.07 0.548 . . . . 0.0 111.289 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -86.26 138.36 31.91 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.51 ' HB2' ' HZ2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -76.96 88.02 3.51 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -178.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.543 HG12 ' HB ' ' A' ' 51' ' ' ILE . 35.7 m -75.9 126.3 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 91' ' ' SER . 30.4 m -135.76 178.64 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.508 1.123 . . . . 0.0 109.601 -174.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.8 m -92.2 155.19 42.96 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.686 0.794 . . . . 0.0 110.523 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.488 ' HB3' HD11 ' A' ' 27' ' ' LEU . 17.9 Cg_endo -57.46 -24.52 61.62 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.383 2.722 . . . . 0.0 113.021 174.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.45 -23.24 62.54 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.056 1.342 . . . . 0.0 112.415 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -61.06 -47.8 84.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.632 0.773 . . . . 0.0 110.507 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 75' ' ' ILE . 3.2 mp -75.05 -40.03 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.588 -172.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.523 HG12 ' HZ3' ' A' ' 80' ' ' LYS . 69.2 t -53.82 -52.35 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.873 177.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -71.83 -44.42 63.91 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.336 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.506 ' HA ' HD22 ' A' ' 85' ' ' LEU . 61.2 m -60.34 -40.06 89.34 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.458 0.703 . . . . 0.0 112.695 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' A' ' 30' ' ' MET . 15.1 t -69.2 -47.95 71.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 123.454 0.702 . . . . 0.0 110.893 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.523 ' HZ3' HG12 ' A' ' 76' ' ' VAL . 54.5 mttp -64.53 -42.8 95.52 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.074 0.549 . . . . 0.0 112.065 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -85.9 -9.42 56.97 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.086 0.555 . . . . 0.0 111.624 -177.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.15 23.16 13.77 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.871 1.268 . . . . 0.0 112.3 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.463 ' HG3' HD23 ' A' ' 85' ' ' LEU . 16.5 ptm180 -129.25 171.39 12.51 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.37 1.068 . . . . 0.0 110.029 -177.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.36 111.93 23.72 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 78' ' ' SER . 4.5 mm? -82.22 154.84 69.66 Favored Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 123.225 0.61 . . . . 0.0 110.366 174.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.21 106.8 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.463 2.108 . . . . 0.0 111.502 172.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -56.8 -31.91 65.15 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.632 0.773 . . . . 0.0 111.081 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -63.43 -23.08 67.25 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.781 1.233 . . . . 0.0 112.561 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -68.37 -37.25 80.26 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.334 0.588 . . . . 0.0 110.2 174.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -99.77 -2.43 35.17 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.654 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 75.4 m -64.55 128.21 34.81 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -173.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.416 ' O ' ' HD2' ' A' ' 61' ' ' ARG . 46.4 mt -85.83 -0.09 54.4 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.686 173.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.7 p -57.5 -43.02 83.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.312 1.045 . . . . 0.0 110.609 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 CA--C 1.558 1.266 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.349 179.85 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 47.2 mm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -90.55 58.4 3.94 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.714 0.768 . . . . 0.0 109.05 173.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.8 p -126.96 86.34 2.49 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.529 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -105.3 154.09 20.73 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.902 0.881 . . . . 0.0 109.769 178.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.6 t -168.61 178.15 4.86 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.041 0.936 . . . . 0.0 109.21 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -68.11 105.37 2.04 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -81.54 33.74 0.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.607 1.163 . . . . 0.0 113.033 -168.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.515 HG21 ' HA ' ' A' ' 84' ' ' LEU . 45.5 mt -54.03 -48.35 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.191 1.396 . . . . 0.0 112.49 -173.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.497 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 54.9 m-85 -111.02 13.02 22.04 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.017 -172.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.19 -53.48 57.64 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.345 0.658 . . . . 0.0 111.103 -169.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -87.31 -21.3 25.82 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.604 0.762 . . . . 0.0 110.509 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.8 m -72.26 131.8 43.2 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.354 0.597 . . . . 0.0 110.613 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.496 HG11 HG23 ' A' ' 48' ' ' VAL . 21.1 t -105.86 124.75 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.453 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.5 mp -121.52 123.55 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 118.227 0.467 . . . . 0.0 111.554 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 34.8 t80 -105.86 132.11 52.36 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.568 1.147 . . . . 0.0 108.011 170.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.8 mt -100.56 130.33 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -131.34 129.26 41.18 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.102 0.961 . . . . 0.0 109.21 -173.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.62 174.49 46.44 Favored Glycine 0 C--N 1.343 0.926 0 O-C-N 123.275 0.359 . . . . 0.0 112.918 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -82.06 112.28 18.98 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.959 0.504 . . . . 0.0 109.876 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.584 HG23 HG13 ' A' ' 52' ' ' VAL . 80.7 p -120.78 145.41 47.58 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.611 1.164 . . . . 0.0 110.053 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -99.75 129.09 29.48 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 122.7 0.4 . . . . 0.0 111.112 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.455 ' HD2' HD22 ' A' ' 27' ' ' LEU . 36.4 Cg_endo -81.42 177.13 36.16 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.855 -0.894 . . . . 0.0 111.662 -1.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.6 138.65 6.37 Favored Glycine 0 C--N 1.349 1.296 0 O-C-N 124.078 0.861 . . . . 0.0 113.997 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -54.25 -33.0 57.53 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.716 0.806 . . . . 0.0 112.497 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.444 HD11 ' N ' ' A' ' 26' ' ' GLN . 4.6 pp -55.26 -44.23 75.41 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 123.604 0.565 . . . . 0.0 111.045 175.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.444 ' N ' HD11 ' A' ' 25' ' ' LEU . 61.1 tt0 -73.75 -44.78 55.24 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.347 0.659 . . . . 0.0 110.856 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.455 HD22 ' HD2' ' A' ' 22' ' ' PRO . 81.3 mt -56.72 -39.24 73.55 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.907 0.483 . . . . 0.0 111.053 175.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.53 ' HA ' HD11 ' A' ' 31' ' ' ILE . 15.9 m170 -63.22 -42.64 99.29 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.451 0.7 . . . . 0.0 110.036 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.18 -36.12 82.56 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.984 0.514 . . . . 0.0 110.928 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.532 ' HB3' HG22 ' A' ' 79' ' ' VAL . 32.9 mmt -66.01 -31.59 72.58 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.676 0.79 . . . . 0.0 110.932 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.53 HD11 ' HA ' ' A' ' 28' ' ' HIS . 62.6 mt -70.82 -52.95 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.853 174.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 28' ' ' HIS . 20.9 t -68.04 -43.69 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 122.991 0.516 . . . . 0.0 111.941 -168.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.17 -19.61 61.76 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.383 0.673 . . . . 0.0 112.201 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -100.9 24.34 9.39 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.192 0.997 . . . . 0.0 110.84 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.8 18.28 70.22 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.106 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.08 160.3 30.77 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -166.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -106.32 142.51 35.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.402 0.681 . . . . 0.0 109.792 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -141.35 147.71 38.52 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.426 1.091 . . . . 0.0 108.635 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.4 mt -125.55 139.03 53.95 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.785 0.434 . . . . 0.0 111.09 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.41 -33.85 73.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.964 1.306 . . . . 0.0 112.374 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -171.69 143.06 1.65 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.921 0.889 . . . . 0.0 109.564 -172.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -116.49 109.64 17.55 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -82.57 74.66 9.52 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.2 m 66.94 -6.25 0.58 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.431 1.492 . . . . 0.0 114.015 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -93.85 153.17 18.41 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.157 0.583 . . . . 0.0 111.504 -168.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.477 ' HA ' ' HE1' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -100.27 59.25 1.0 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.449 1.119 . . . . 0.0 110.632 -176.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.7 m -92.66 -11.22 34.72 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.923 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.496 HG23 HG11 ' A' ' 13' ' ' VAL . 3.9 p -108.37 151.57 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.258 0.623 . . . . 0.0 109.994 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -101.78 -40.18 7.07 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 121.193 0.52 . . . . 0.0 110.705 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -128.97 142.85 50.79 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.269 1.027 . . . . 0.0 109.188 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.566 ' HB ' HG13 ' A' ' 69' ' ' VAL . 61.1 mt -123.97 138.0 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.584 HG13 HG23 ' A' ' 20' ' ' THR . 60.4 t -91.91 138.44 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.518 0.727 . . . . 0.0 110.246 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.67 151.91 29.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.589 1.155 . . . . 0.0 107.953 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.6 m -79.76 -48.66 13.24 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -137.34 142.18 41.82 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.57 117.74 11.29 Favored Pre-proline 0 CA--C 1.558 1.25 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.92 160.66 36.91 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.599 2.866 . . . . 0.0 113.556 -174.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -51.98 -45.45 64.47 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.549 1.14 . . . . 0.0 112.684 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -57.53 -43.97 84.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.587 0.755 . . . . 0.0 110.995 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -79.24 -20.77 47.39 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 119.412 -0.328 . . . . 0.0 111.306 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -66.33 -29.76 70.03 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 117.931 0.332 . . . . 0.0 110.243 168.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.7 mt -75.11 -40.73 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 110.337 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -76.1 -25.11 55.14 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.971 0.508 . . . . 0.0 111.386 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.464 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 41.4 m-85 -114.07 30.5 7.23 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.61 1.164 . . . . 0.0 109.662 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.46 -37.93 58.14 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.128 0.971 . . . . 0.0 112.773 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -87.81 -26.87 22.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.602 0.761 . . . . 0.0 111.279 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.477 ' HE1' ' HA ' ' A' ' 46' ' ' LYS . 46.0 m-85 -91.92 120.92 33.03 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.448 0.699 . . . . 0.0 109.574 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -75.06 86.35 2.35 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' A' ' 51' ' ' ILE . 20.1 m -76.2 128.18 37.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.84 171.68 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.954 1.302 . . . . 0.0 109.368 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 53.7 m -78.08 153.88 79.96 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.244 0.618 . . . . 0.0 111.027 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.86 -24.98 77.81 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.661 2.241 . . . . 0.0 111.888 175.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.44 -23.62 65.97 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.899 1.28 . . . . 0.0 111.504 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -62.79 -48.09 80.65 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-O 120.933 0.397 . . . . 0.0 110.033 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.497 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.8 mp -67.46 -44.35 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.055 -175.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.2 t -63.32 -51.46 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.259 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.91 -35.56 69.72 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.666 -172.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.4 ' HB3' HG23 ' A' ' 8' ' ' ILE . 61.1 m -63.57 -44.53 93.83 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.117 0.261 . . . . 0.0 110.422 176.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 30' ' ' MET . 55.9 t -64.49 -34.26 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.454 0.702 . . . . 0.0 110.883 175.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -66.89 -32.68 74.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.303 0.641 . . . . 0.0 110.748 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -94.61 -10.98 30.3 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.61 0.764 . . . . 0.0 112.147 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.06 30.04 19.27 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.412 1.085 . . . . 0.0 112.055 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.8 ptt-85 -151.3 164.11 37.39 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.38 0.672 . . . . 0.0 110.498 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.515 ' HA ' HG21 ' A' ' 8' ' ' ILE . 3.2 tm? -79.49 106.74 11.74 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.2 mt -85.97 157.51 57.06 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.488 0.715 . . . . 0.0 109.94 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -65.49 120.8 8.06 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.079 1.853 . . . . 0.0 111.683 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -57.87 -31.52 66.79 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.542 1.137 . . . . 0.0 111.372 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -63.89 -21.69 66.58 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.702 1.201 . . . . 0.0 112.379 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -66.75 -30.8 71.11 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.139 0.576 . . . . 0.0 110.648 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.15 8.43 11.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.941 0.896 . . . . 0.0 111.946 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 p -67.74 111.52 4.31 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.997 0.519 . . . . 0.0 112.138 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.27 -11.85 58.39 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.452 0.701 . . . . 0.0 111.511 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.419 ' HB ' HG21 ' A' ' 69' ' ' VAL . 9.3 t -69.08 -27.05 65.26 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.493 0.717 . . . . 0.0 111.144 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.7 p . . . . . 0 C--O 1.251 1.16 0 C-N-CA 123.273 0.629 . . . . 0.0 109.867 175.693 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -90.04 75.69 7.08 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.619 0.768 . . . . 0.0 109.379 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.5 p -71.81 -57.15 4.59 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.471 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 54.02 30.33 11.64 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.653 1.181 . . . . 0.0 111.138 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.6 t -74.81 -18.93 60.38 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.054 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.536 ' HB2' HG13 ' A' ' 8' ' ' ILE . 25.6 p -155.56 140.14 16.94 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.89 32.2 6.02 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.035 0.934 . . . . 0.0 109.458 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.536 HG13 ' HB2' ' A' ' 6' ' ' SER . 67.6 mt -55.3 -48.59 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.193 0.997 . . . . 0.0 111.956 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -109.67 11.88 24.43 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.536 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -61.99 -41.65 98.28 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.948 0.499 . . . . 0.0 112.267 -170.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -76.62 -27.22 55.64 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.041 0.448 . . . . 0.0 110.214 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.2 m -88.1 144.18 26.64 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.284 1.04 . . . . 0.0 112.462 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.509 HG12 HG21 ' A' ' 48' ' ' VAL . 21.4 t -115.54 127.82 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.517 ' HB ' HD12 ' A' ' 31' ' ' ILE . 4.6 mp -123.19 128.19 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 122.764 0.426 . . . . 0.0 111.532 -171.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 24.6 t80 -108.36 151.37 26.1 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.377 1.471 . . . . 0.0 108.675 175.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.454 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 74.0 mt -118.32 123.18 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.373 0.669 . . . . 0.0 109.336 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -117.07 135.68 53.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.259 1.024 . . . . 0.0 109.388 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.89 -139.92 28.03 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.45 0.469 . . . . 0.0 112.767 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -112.6 120.25 40.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.304 0.642 . . . . 0.0 109.667 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.721 HG23 HG11 ' A' ' 52' ' ' VAL . 68.1 p -133.17 147.11 52.05 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.463 0.705 . . . . 0.0 109.559 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -108.91 135.61 20.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.366 0.667 . . . . 0.0 109.793 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.487 ' HD2' HD23 ' A' ' 27' ' ' LEU . 70.3 Cg_endo -74.81 177.24 39.72 Favored 'Cis proline' 0 C--N 1.369 1.631 0 C-N-CA 124.643 -0.982 . . . . 0.0 111.634 -5.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.18 146.98 3.68 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 124.019 0.824 . . . . 0.0 114.776 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -58.21 -36.38 73.05 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.077 0.951 . . . . 0.0 112.599 -172.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.01 -32.92 72.81 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.234 0.214 . . . . 0.0 110.65 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -69.19 -53.24 21.02 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.451 0.7 . . . . 0.0 110.425 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.487 HD23 ' HD2' ' A' ' 22' ' ' PRO . 87.8 mt -57.27 -40.55 77.96 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.458 0.703 . . . . 0.0 111.786 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.568 ' HA ' HD13 ' A' ' 31' ' ' ILE . 17.2 m170 -61.49 -38.96 89.23 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.9 0.48 . . . . 0.0 111.363 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.51 -35.05 68.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.628 0.371 . . . . 0.0 111.257 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.524 ' HB3' HG22 ' A' ' 79' ' ' VAL . 54.8 mtt -61.08 -31.97 71.63 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.971 0.509 . . . . 0.0 110.799 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 28' ' ' HIS . 66.1 mt -68.09 -51.03 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.299 0.64 . . . . 0.0 110.986 173.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 28' ' ' HIS . 92.0 t -60.99 -50.27 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.569 0.748 . . . . 0.0 112.747 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.1 -12.58 60.36 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.441 0.696 . . . . 0.0 112.326 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -108.77 26.29 10.73 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.092 0.957 . . . . 0.0 110.13 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.0 60.48 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-N 114.58 -1.191 . . . . 0.0 114.051 171.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.33 159.63 48.84 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 -164.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -103.49 152.55 21.54 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -137.23 159.04 43.07 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.043 0.449 . . . . 0.0 111.323 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.52 128.51 56.04 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 165.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.1 -33.39 70.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.405 172.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.422 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 35.1 t80 -171.33 149.77 2.81 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 124.414 1.086 . . . . 0.0 108.7 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.11 139.67 38.33 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.538 0.735 . . . . 0.0 110.069 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.0 m -83.73 45.82 1.11 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.819 0.848 . . . . 0.0 109.391 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.9 m 58.87 23.18 11.07 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 125.384 1.473 . . . . 0.0 112.111 -172.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -107.88 145.72 33.32 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.823 0.849 . . . . 0.0 110.183 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.37 64.51 8.26 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.897 0.879 . . . . 0.0 109.777 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 m -90.45 -32.15 16.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.924 0.89 . . . . 0.0 110.223 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.509 HG21 HG12 ' A' ' 13' ' ' VAL . 6.5 p -92.98 155.26 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.196 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -109.18 -27.67 9.45 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 118.064 0.393 . . . . 0.0 111.42 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -118.77 140.47 49.9 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.224 0.61 . . . . 0.0 109.959 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.65 ' HB ' HG13 ' A' ' 69' ' ' VAL . 33.5 mt -125.08 140.07 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.721 HG11 HG23 ' A' ' 20' ' ' THR . 95.2 t -104.51 135.85 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.768 0.827 . . . . 0.0 109.666 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.02 150.18 27.99 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.41 0.684 . . . . 0.0 109.364 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -75.95 -42.68 47.87 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -139.73 133.52 30.6 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.132 -1.395 . . . . 0.0 108.034 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.566 ' HG ' HG21 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -116.14 110.37 43.58 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.88 156.42 66.0 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.964 2.442 . . . . 0.0 112.861 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.1 -47.88 81.88 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.333 1.053 . . . . 0.0 112.995 -169.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 1.1 mptm? -64.15 -31.19 72.29 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.913 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -83.55 -18.87 36.89 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.073 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -66.06 -32.5 74.01 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 168.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 64.9 mt -71.01 -49.62 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.498 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 38.6 mm-40 -66.34 -31.88 72.94 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.723 0.409 . . . . 0.0 111.76 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -106.47 25.91 10.55 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.559 0.744 . . . . 0.0 110.882 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.94 -32.88 74.57 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.054 0.454 . . . . 0.0 110.579 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -69.87 -26.47 64.21 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.101 0.961 . . . . 0.0 111.318 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -99.05 162.51 13.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.334 0.654 . . . . 0.0 110.582 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -101.58 88.21 3.37 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.65 HG13 ' HB ' ' A' ' 51' ' ' ILE . 26.8 m -75.89 134.6 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.731 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.538 HG12 ' HB2' ' A' ' 87' ' ' TRP . 34.6 m -137.62 175.45 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.808 1.243 . . . . 0.0 109.873 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.2 m -81.85 154.5 70.48 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.762 0.825 . . . . 0.0 110.113 172.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.42 -24.22 71.11 Favored 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.51 2.14 . . . . 0.0 111.426 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.98 -21.47 63.55 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.955 1.302 . . . . 0.0 111.27 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.73 -51.45 62.31 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 123.144 0.277 . . . . 0.0 110.266 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.1 mp -66.33 -43.94 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.79 -51.97 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.24 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -73.09 -33.15 65.43 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.197 0.599 . . . . 0.0 111.787 -171.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 71.9 m -66.97 -40.52 87.49 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.58 0.352 . . . . 0.0 110.281 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 30' ' ' MET . 55.0 t -70.68 -33.87 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.451 0.7 . . . . 0.0 110.786 173.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -64.58 -41.37 96.32 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.157 0.983 . . . . 0.0 110.523 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -95.41 -6.46 40.85 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.855 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.22 27.14 15.47 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.573 1.149 . . . . 0.0 112.33 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -142.49 159.33 42.44 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.774 0.83 . . . . 0.0 110.546 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.464 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.2 tm? -75.1 127.55 33.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.8 mt -114.7 152.12 46.0 Favored Pre-proline 0 C--O 1.24 0.596 0 C-N-CA 124.214 1.006 . . . . 0.0 109.714 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.403 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 35.3 Cg_endo -61.73 109.34 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.551 2.167 . . . . 0.0 111.877 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.538 ' HB2' HG12 ' A' ' 70' ' ' VAL . 29.9 p90 -62.14 -21.91 65.42 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.388 1.075 . . . . 0.0 112.206 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.403 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 12.7 pt20 -59.78 -25.11 64.65 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.127 0.971 . . . . 0.0 111.818 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -70.92 -31.66 68.35 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.788 0.835 . . . . 0.0 111.131 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.29 -0.79 25.97 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.905 0.882 . . . . 0.0 111.318 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -66.24 131.42 46.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.329 0.652 . . . . 0.0 112.0 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.8 mt -108.31 14.54 24.79 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.101 0.96 . . . . 0.0 110.951 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.0 p -65.56 -52.73 50.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.823 0.849 . . . . 0.0 111.321 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 C--O 1.252 1.185 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.166 -173.858 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 21.8 pt . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 p -73.51 85.19 1.54 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.034 0.534 . . . . 0.0 110.103 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.5 m -76.26 82.69 3.04 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.315 0.646 . . . . 0.0 109.602 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -123.59 69.54 1.04 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.261 -176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.3 m -147.68 132.84 18.34 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.935 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.574 ' HB2' ' HD2' ' A' ' 34' ' ' HIS . 24.8 m -67.17 106.44 2.01 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -81.01 36.0 0.39 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.739 1.216 . . . . 0.0 113.73 -165.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.3 mt -49.08 -47.87 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.507 1.523 . . . . 0.0 112.352 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -109.58 15.32 22.98 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.862 0.465 . . . . 0.0 111.566 -174.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -57.82 -49.3 77.12 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.287 0.635 . . . . 0.0 111.448 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -76.41 -15.56 59.91 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.675 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.5 m -93.08 141.17 28.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.632 0.773 . . . . 0.0 111.421 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.56 124.84 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 171.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.412 ' HB ' HD11 ' A' ' 31' ' ' ILE . 4.2 mp -118.5 134.28 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 C-N-CA 123.155 0.582 . . . . 0.0 111.74 -170.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.437 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 33.3 t80 -113.0 149.49 33.24 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.414 1.486 . . . . 0.0 108.089 169.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 65.7 mt -114.54 110.01 30.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -103.83 122.44 45.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.277 1.431 . . . . 0.0 109.447 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.76 175.58 50.98 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.88 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -82.08 111.49 18.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.599 HG22 HG13 ' A' ' 52' ' ' VAL . 69.6 p -112.14 151.92 28.92 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.887 0.875 . . . . 0.0 110.037 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.52 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -102.99 122.91 43.88 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 163.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -81.66 172.08 54.41 Favored 'Cis proline' 0 C--N 1.37 1.698 0 C-N-CA 124.031 -1.237 . . . . 0.0 112.033 1.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.61 164.6 15.79 Favored Glycine 0 C--N 1.344 0.995 0 O-C-N 123.735 0.647 . . . . 0.0 114.357 -172.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -56.11 -36.53 68.3 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.362 0.665 . . . . 0.0 111.411 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.526 HD11 ' N ' ' A' ' 26' ' ' GLN . 2.9 pp -61.66 -43.12 99.46 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.454 0.701 . . . . 0.0 111.57 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.526 ' N ' HD11 ' A' ' 25' ' ' LEU . 6.2 tp-100 -71.29 -51.76 22.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.345 0.658 . . . . 0.0 110.22 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.68 -51.09 70.13 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.028 0.83 . . . . 0.0 111.402 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.431 ' O ' HG22 ' A' ' 32' ' ' VAL . 15.6 m170 -54.85 -47.55 74.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.727 0.642 . . . . 0.0 111.109 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.5 -38.94 91.19 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.27 0.356 . . . . 0.0 111.571 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.545 ' HB3' HG21 ' A' ' 79' ' ' VAL . 21.2 mmt -61.22 -40.0 92.39 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.991 0.516 . . . . 0.0 111.132 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.412 HD11 ' HB ' ' A' ' 14' ' ' ILE . 70.8 mt -65.19 -49.12 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.008 0.923 . . . . 0.0 111.348 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 28' ' ' HIS . 57.9 t -65.84 -41.55 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.979 0.512 . . . . 0.0 111.573 -176.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.39 -13.04 60.1 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.321 0.648 . . . . 0.0 111.844 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.597 ' HE1' HG11 ' A' ' 79' ' ' VAL . 38.6 m80 -108.92 26.85 10.11 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.699 0.799 . . . . 0.0 111.758 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.95 7.03 75.03 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.944 172.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.89 158.1 30.28 Favored Glycine 0 C--O 1.242 0.596 0 C-N-CA 123.026 0.346 . . . . 0.0 113.94 -173.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -102.83 158.67 16.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.502 0.721 . . . . 0.0 109.653 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.37 161.71 37.63 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.389 0.676 . . . . 0.0 110.473 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.1 149.42 42.23 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.789 0.836 . . . . 0.0 110.531 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -68.9 -47.87 64.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.612 1.165 . . . . 0.0 111.566 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.437 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 77.5 t80 -178.73 139.16 0.17 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.674 1.19 . . . . 0.0 108.96 -170.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mp -141.15 162.6 35.11 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.412 0.685 . . . . 0.0 109.441 171.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.0 m -142.96 -39.77 0.33 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.378 1.071 . . . . 0.0 109.226 172.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 t -146.59 79.96 1.54 Allowed 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.205 0.602 . . . . 0.0 109.428 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.586 ' HB2' ' HZ3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -169.16 136.62 1.84 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.163 175.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.49 ' HA ' ' HE1' ' A' ' 67' ' ' TYR . 54.1 mtpt -105.3 47.24 0.88 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.376 0.67 . . . . 0.0 110.631 -175.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -82.04 -24.32 35.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.748 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.84 151.53 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.12 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.6 p -114.57 -17.74 11.62 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -137.71 136.77 37.67 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.26 1.024 . . . . 0.0 109.096 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.595 ' HB ' HG12 ' A' ' 69' ' ' VAL . 67.4 mt -125.21 137.25 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.599 HG13 HG22 ' A' ' 20' ' ' THR . 54.5 t -105.84 133.72 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.41 1.084 . . . . 0.0 110.74 -173.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.45 146.01 20.79 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -77.14 -39.76 48.05 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -138.33 107.9 6.21 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.607 ' HB2' HD13 ' A' ' 92' ' ' LEU . 16.5 tp -100.53 119.61 58.29 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -64.32 159.55 43.19 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.623 2.882 . . . . 0.0 112.589 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.7 mt -58.99 -46.05 89.09 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.982 0.913 . . . . 0.0 112.38 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -57.56 -46.11 84.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.453 0.701 . . . . 0.0 110.713 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -66.26 -30.07 70.43 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.158 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -66.65 -38.24 86.47 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.159 0.584 . . . . 0.0 110.724 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.8 mt -70.39 -46.18 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 123.82 0.7 . . . . 0.0 110.384 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.71 -32.36 73.87 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.689 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.429 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 22.0 m-30 -103.08 15.05 30.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.451 0.701 . . . . 0.0 111.89 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.86 -18.81 62.69 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.323 0.583 . . . . 0.0 110.896 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -71.77 -19.91 61.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.268 1.027 . . . . 0.0 110.602 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.49 ' HE1' ' HA ' ' A' ' 46' ' ' LYS . 17.2 m-85 -113.47 169.83 8.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.382 1.073 . . . . 0.0 109.008 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -96.15 91.07 5.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.427 0.691 . . . . 0.0 109.413 175.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.595 HG12 ' HB ' ' A' ' 51' ' ' ILE . 20.3 m -82.88 129.95 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.288 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.476 HG13 ' HB2' ' A' ' 87' ' ' TRP . 31.6 m -139.79 167.56 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.754 1.221 . . . . 0.0 110.514 -175.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.6 m -75.76 155.91 84.89 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.847 172.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.06 -25.46 79.82 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.469 2.113 . . . . 0.0 111.495 172.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.5 -29.89 59.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.48 1.512 . . . . 0.0 112.651 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.425 ' CE3' HG23 ' A' ' 70' ' ' VAL . 27.6 t90 -62.18 -48.74 78.69 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.354 0.408 . . . . 0.0 110.197 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.77 -54.98 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.241 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.8 t -51.84 -52.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.841 1.257 . . . . 0.0 112.346 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -71.58 -42.1 68.17 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.732 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.433 ' HA ' HD13 ' A' ' 85' ' ' LEU . 72.5 m -61.63 -36.93 82.17 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.736 0.415 . . . . 0.0 111.448 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.597 HG11 ' HE1' ' A' ' 34' ' ' HIS . 21.8 t -63.57 -46.94 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.265 1.026 . . . . 0.0 111.057 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -65.97 -43.47 87.77 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.042 0.537 . . . . 0.0 111.102 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -76.5 -15.59 59.85 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.708 0.803 . . . . 0.0 112.04 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.41 40.92 23.69 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.091 0.956 . . . . 0.0 110.843 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -159.51 156.54 28.37 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.868 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -85.81 109.3 18.58 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 78' ' ' SER . 8.6 mp -79.64 155.28 76.04 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.126 0.57 . . . . 0.0 111.242 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.451 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 35.8 Cg_endo -61.12 114.83 2.36 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.426 2.084 . . . . 0.0 111.325 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.476 ' HB2' HG13 ' A' ' 70' ' ' VAL . 48.1 p90 -64.9 -20.09 66.26 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.649 0.78 . . . . 0.0 112.395 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.451 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.0 pt20 -58.19 -28.04 64.41 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.275 1.03 . . . . 0.0 112.023 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -70.6 -27.68 64.28 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.605 0.762 . . . . 0.0 110.814 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.78 5.95 14.27 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.047 0.939 . . . . 0.0 111.689 -175.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.427 ' HB2' HG23 ' A' ' 93' ' ' THR . 59.9 p -69.85 120.48 15.66 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.202 0.601 . . . . 0.0 112.287 -174.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' A' ' 56' ' ' LEU . 48.5 mt -73.62 -21.48 60.29 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.947 0.899 . . . . 0.0 111.666 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.427 HG23 ' HB2' ' A' ' 91' ' ' SER . 10.3 t -65.5 -17.53 64.63 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.694 0.798 . . . . 0.0 112.112 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.4 m . . . . . 0 C--O 1.26 1.613 0 C-N-CA 123.294 0.637 . . . . 0.0 109.993 175.568 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 19.8 pt . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -72.33 86.43 1.11 Allowed 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.69 0.796 . . . . 0.0 111.054 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.1 m -72.71 91.78 1.49 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.382 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -98.7 134.03 42.2 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.444 1.098 . . . . 0.0 109.482 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.2 t -69.84 -25.86 63.94 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.9 0.48 . . . . 0.0 109.894 172.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.728 ' HB2' ' HA ' ' A' ' 34' ' ' HIS . 61.2 p -74.47 88.4 2.11 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.062 177.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -120.92 28.1 8.11 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.25 1.42 . . . . 0.0 108.59 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.545 HG21 ' OG ' ' A' ' 78' ' ' SER . 57.7 mt -64.73 -51.42 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.681 -167.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.623 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 61.7 m-85 -103.17 18.04 22.67 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.886 -175.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -51.16 -59.09 4.56 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.281 1.032 . . . . 0.0 112.877 -171.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -95.81 17.39 15.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.867 0.867 . . . . 0.0 111.01 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.448 ' SG ' ' HH2' ' A' ' 74' ' ' TRP . 41.1 t -116.9 123.26 46.58 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 124.484 1.114 . . . . 0.0 109.756 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.47 HG13 HD21 ' A' ' 39' ' ' LEU . 40.6 t -101.68 128.2 54.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.513 ' HB ' HD12 ' A' ' 31' ' ' ILE . 4.2 mp -122.36 123.28 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 122.833 0.453 . . . . 0.0 111.041 -175.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.43 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 28.4 t80 -104.35 150.74 24.22 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.341 1.456 . . . . 0.0 108.134 174.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.21 130.31 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -135.81 123.78 22.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.414 1.085 . . . . 0.0 109.771 -170.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.7 -161.57 42.45 Favored Glycine 0 C--N 1.343 0.958 0 O-C-N 123.496 0.498 . . . . 0.0 112.822 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -88.03 110.73 20.84 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.237 0.615 . . . . 0.0 109.558 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.513 HG22 HG12 ' A' ' 52' ' ' VAL . 61.5 p -133.94 134.4 42.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.044 0.937 . . . . 0.0 109.271 -177.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -117.47 139.17 25.83 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -69.94 170.69 58.03 Favored 'Cis proline' 0 C--N 1.389 2.707 0 C-N-CA 124.705 -0.956 . . . . 0.0 112.567 3.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.67 149.11 5.55 Favored Glycine 0 N--CA 1.475 1.257 0 O-C-N 124.01 0.819 . . . . 0.0 114.196 -169.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -52.23 -36.08 51.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.777 0.831 . . . . 0.0 112.197 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 26' ' ' GLN . 3.6 pp -62.46 -41.44 98.76 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.27 0.628 . . . . 0.0 111.63 174.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.508 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.5 tp-100 -72.19 -50.79 24.83 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.813 0.845 . . . . 0.0 110.945 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.1 mt -54.73 -44.96 74.01 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.215 0.606 . . . . 0.0 111.008 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.515 ' HA ' HD13 ' A' ' 31' ' ' ILE . 9.5 m170 -58.75 -43.5 90.31 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 123.572 0.545 . . . . 0.0 111.417 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -66.5 -38.89 88.23 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 123.168 0.292 . . . . 0.0 111.23 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.0 mmt -58.42 -39.36 79.57 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.338 0.655 . . . . 0.0 110.947 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.515 HD13 ' HA ' ' A' ' 28' ' ' HIS . 70.9 mt -62.69 -47.8 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.07 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 28' ' ' HIS . 39.1 t -64.19 -47.6 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.653 0.596 . . . . 0.0 111.117 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.01 -33.55 73.44 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.829 0.852 . . . . 0.0 111.47 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.728 ' HA ' ' HB2' ' A' ' 6' ' ' SER . 54.9 m80 -86.44 27.47 0.94 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.255 0.622 . . . . 0.0 112.274 175.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.32 28.99 73.02 Favored Glycine 0 C--N 1.357 1.73 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.29 169.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.623 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -112.44 172.43 14.66 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 115.551 0.98 . . . . 0.0 115.551 -168.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -111.16 146.22 37.25 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.702 0.801 . . . . 0.0 109.444 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -128.83 166.25 19.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.562 0.745 . . . . 0.0 109.585 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.47 HD21 HG13 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -130.3 136.22 48.91 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.051 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -82.44 -36.79 26.27 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 123.867 0.729 . . . . 0.0 112.144 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.43 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 61.3 t80 -171.83 135.24 0.83 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.974 0.509 . . . . 0.0 110.539 -175.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.42 142.05 44.19 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.0 t -139.33 -51.36 0.53 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.323 1.049 . . . . 0.0 108.419 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -147.94 59.7 1.12 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.254 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -160.38 156.99 27.06 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.625 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.46 46.53 2.36 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.394 1.078 . . . . 0.0 110.907 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.6 m -79.68 -27.86 40.74 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.435 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.4 p -86.64 151.71 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.984 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.439 HG22 ' ND1' ' A' ' 50' ' ' HIS . 5.1 t -114.79 -25.4 8.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.742 0.817 . . . . 0.0 110.683 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.439 ' ND1' HG22 ' A' ' 49' ' ' THR . 53.5 m80 -133.38 127.42 33.42 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.924 0.49 . . . . 0.0 110.419 -174.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.597 ' HB ' HG11 ' A' ' 69' ' ' VAL . 61.7 mt -119.04 129.41 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 20' ' ' THR . 70.8 t -90.76 123.27 42.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 123.63 0.772 . . . . 0.0 109.187 -173.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.93 140.69 31.23 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.834 0.853 . . . . 0.0 108.951 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -84.05 -49.95 8.43 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.61 132.99 56.54 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.518 -1.219 . . . . 0.0 107.719 170.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.98 101.55 10.41 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.09 160.16 48.68 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.092 2.528 . . . . 0.0 112.706 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.8 -31.97 67.1 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.052 0.941 . . . . 0.0 112.001 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 47.9 tptt -60.77 -53.42 57.61 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.269 0.628 . . . . 0.0 109.911 175.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -70.69 -19.25 62.79 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.821 0.448 . . . . 0.0 111.841 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -72.88 -27.69 62.05 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.735 0.814 . . . . 0.0 109.779 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.3 mt -79.11 -45.3 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.321 0.648 . . . . 0.0 110.043 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 24.4 mm-40 -63.52 -29.18 70.49 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.598 0.759 . . . . 0.0 112.215 -175.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -121.97 28.63 7.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.058 0.943 . . . . 0.0 110.293 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -30.68 69.26 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.447 0.699 . . . . 0.0 112.566 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -75.08 -23.63 58.03 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.119 0.568 . . . . 0.0 111.572 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -107.64 123.69 48.87 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.94 93.23 0.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.369 0.604 . . . . 0.0 109.755 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.597 HG11 ' HB ' ' A' ' 51' ' ' ILE . 27.4 m -73.89 128.83 36.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 87' ' ' TRP . 30.2 m -128.13 172.13 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.253 1.021 . . . . 0.0 109.862 -174.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -80.46 152.51 73.08 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.27 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -56.78 -25.09 59.15 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.693 2.262 . . . . 0.0 112.17 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.41 -26.5 53.55 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.884 1.273 . . . . 0.0 112.286 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.448 ' HH2' ' SG ' ' A' ' 12' ' ' CYS . 28.3 t90 -59.6 -48.45 81.62 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.825 0.284 . . . . 0.0 110.454 174.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.504 ' O ' HG21 ' A' ' 79' ' ' VAL . 3.3 mp -69.33 -42.71 81.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 O-C-N 124.042 0.839 . . . . 0.0 108.85 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.477 HG12 ' HE2' ' A' ' 80' ' ' LYS . 85.0 t -62.14 -50.52 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.006 0.922 . . . . 0.0 111.408 -177.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.23 -33.72 76.66 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.24 0.616 . . . . 0.0 110.849 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.545 ' OG ' HG21 ' A' ' 8' ' ' ILE . 38.5 t -62.54 -37.65 86.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.235 0.614 . . . . 0.0 111.449 177.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 75' ' ' ILE . 94.0 t -70.96 -47.13 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.502 0.721 . . . . 0.0 110.669 177.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.477 ' HE2' HG12 ' A' ' 76' ' ' VAL . 53.2 mtmt -64.74 -45.16 87.63 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.486 0.714 . . . . 0.0 111.744 -175.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -86.76 -15.51 39.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.342 0.657 . . . . 0.0 111.473 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.85 38.56 14.58 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.572 1.149 . . . . 0.0 111.869 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -149.75 164.49 35.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.395 0.678 . . . . 0.0 110.285 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.5 tp -84.05 95.26 8.52 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.8 142.94 96.15 Favored Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.441 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 16.8 Cg_endo -56.24 108.01 0.3 Allowed 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.302 2.001 . . . . 0.0 110.79 172.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.409 ' HB2' HG13 ' A' ' 70' ' ' VAL . 29.8 p90 -56.95 -22.69 39.9 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.547 1.139 . . . . 0.0 112.695 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.441 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 20.6 pt20 -57.47 -26.77 61.75 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.749 1.22 . . . . 0.0 112.105 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.401 HD22 ' HG2' ' A' ' 86' ' ' PRO . 61.4 m-20 -67.09 -38.46 85.75 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.196 0.598 . . . . 0.0 110.72 175.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -99.72 -5.62 28.46 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.07 0.948 . . . . 0.0 111.521 -172.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.0 m -66.23 121.74 15.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.111 0.564 . . . . 0.0 112.304 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.8 mt -81.86 -0.65 44.54 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.557 1.143 . . . . 0.0 111.062 172.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.8 p -66.96 -20.59 65.92 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.512 1.125 . . . . 0.0 111.665 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.558 1.254 0 C-N-CA 124.587 1.155 . . . . 0.0 111.876 -178.93 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 49.6 mm . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.1 t -153.38 89.02 1.32 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.203 1.001 . . . . 0.0 108.498 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.3 t -78.3 116.9 19.06 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.372 0.669 . . . . 0.0 110.458 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -80.97 87.02 6.01 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.3 m -147.5 164.81 32.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.901 0.881 . . . . 0.0 110.627 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.2 m -72.67 81.9 1.13 Allowed 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 170.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 10' ' ' LYS . 15.3 ptpt -83.81 36.33 0.55 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.675 1.59 . . . . 0.0 112.999 -167.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.534 HG22 ' HA ' ' A' ' 84' ' ' LEU . 66.9 mt -49.49 -46.23 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.024 1.33 . . . . 0.0 112.167 -177.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.506 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 78.1 m-85 -104.8 15.86 27.06 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.976 -173.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 7' ' ' LYS . 28.5 ttpp -51.53 -48.26 63.07 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.902 0.881 . . . . 0.0 113.312 -173.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -98.78 2.04 46.53 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.036 0.534 . . . . 0.0 111.436 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.4 m -97.89 110.8 23.31 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.873 0.869 . . . . 0.0 110.919 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 41.0 t -93.31 127.84 45.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.465 ' HB ' HD12 ' A' ' 31' ' ' ILE . 2.6 mp -114.74 136.06 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.58 0.752 . . . . 0.0 110.941 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -118.05 110.84 18.14 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 170.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.7 mt -77.22 134.28 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -138.68 122.02 17.11 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -173.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.63 -173.91 52.95 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.681 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -79.97 110.76 15.66 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.213 0.605 . . . . 0.0 109.904 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.559 HG21 HG11 ' A' ' 52' ' ' VAL . 61.8 p -121.16 136.68 54.93 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.514 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 11.0 mmpt? -104.06 135.43 19.35 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 117.85 0.295 . . . . 0.0 110.685 176.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' HD23 ' A' ' 27' ' ' LEU . 94.1 Cg_endo -74.24 173.79 54.96 Favored 'Cis proline' 0 C--N 1.378 2.099 0 C-N-CA 124.613 -0.995 . . . . 0.0 112.107 -1.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.64 156.0 3.73 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 123.885 0.741 . . . . 0.0 114.745 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -54.46 -38.4 66.31 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.572 0.749 . . . . 0.0 111.519 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 26' ' ' GLN . 2.3 pp -60.62 -44.94 95.76 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 123.779 0.674 . . . . 0.0 111.338 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.519 ' N ' HD11 ' A' ' 25' ' ' LEU . 6.7 tp-100 -69.45 -50.31 46.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.344 0.658 . . . . 0.0 110.672 -175.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.417 HD23 ' HD2' ' A' ' 22' ' ' PRO . 81.6 mt -56.1 -50.45 71.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.975 0.51 . . . . 0.0 111.447 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.426 ' HA ' HD13 ' A' ' 31' ' ' ILE . 23.5 m170 -54.82 -41.92 71.25 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.698 0.799 . . . . 0.0 111.094 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -67.81 -44.49 77.18 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.156 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 34.2 mmt -63.16 -34.1 76.9 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.158 0.583 . . . . 0.0 111.629 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.465 HD12 ' HB ' ' A' ' 14' ' ' ILE . 66.1 mt -60.54 -50.73 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.386 173.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.3 t -66.64 -39.78 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.549 0.74 . . . . 0.0 112.367 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.3 -23.55 67.47 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.698 0.799 . . . . 0.0 111.388 178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -104.88 27.57 7.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.973 0.909 . . . . 0.0 111.044 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.49 14.16 80.52 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 114.893 -1.049 . . . . 0.0 114.114 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.86 174.88 22.85 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 114.524 0.57 . . . . 0.0 114.524 -170.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HZ1' ' HB2' ' A' ' 37' ' ' LYS . 2.7 ttmp? -128.54 151.19 49.73 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.157 0.583 . . . . 0.0 109.787 -177.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -121.18 161.4 21.93 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.532 0.733 . . . . 0.0 109.337 170.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.607 ' HB3' HD11 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -118.24 131.94 56.33 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -64.54 -40.01 94.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.094 0.958 . . . . 0.0 112.196 -165.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -177.53 139.72 0.25 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.607 HD11 ' HB3' ' A' ' 39' ' ' LEU . 2.7 mp -137.66 170.59 15.8 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.886 0.475 . . . . 0.0 110.347 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.7 t -160.04 -60.94 0.06 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.155 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.1 m -123.03 10.94 9.49 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.194 0.598 . . . . 0.0 112.526 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -120.1 131.58 55.12 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -97.09 82.92 3.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.441 0.696 . . . . 0.0 109.757 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.7 m -108.31 -28.06 9.64 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.304 0.642 . . . . 0.0 110.624 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.6 150.03 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.55 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.3 p -102.89 -26.86 12.96 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.299 0.639 . . . . 0.0 111.302 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -137.35 128.48 27.72 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.814 0.846 . . . . 0.0 109.653 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.467 ' HB ' HG21 ' A' ' 69' ' ' VAL . 43.7 mt -110.65 114.68 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 175.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 20' ' ' THR . 78.2 t -89.15 135.93 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.815 0.846 . . . . 0.0 109.919 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.37 170.59 19.71 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.598 0.759 . . . . 0.0 110.306 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.6 t -86.81 -52.23 5.62 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -145.07 103.17 3.84 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.488 ' HG ' HG13 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -89.1 114.71 61.28 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.85 143.49 91.03 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.362 2.708 . . . . 0.0 113.017 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.8 mt -55.93 -41.0 73.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.294 1.038 . . . . 0.0 112.428 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -56.61 -50.16 72.8 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.661 0.784 . . . . 0.0 110.524 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -76.1 -17.85 59.43 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.487 -175.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -68.99 -32.05 71.32 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.983 0.356 . . . . 0.0 110.162 170.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.5 mt -65.58 -42.92 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.03 -40.18 94.44 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 120.931 0.396 . . . . 0.0 111.122 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.407 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 21.0 m-85 -95.58 25.14 4.7 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.939 0.496 . . . . 0.0 111.124 -176.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.02 -16.77 62.06 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.269 0.627 . . . . 0.0 111.406 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -79.05 -14.94 58.86 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.729 0.412 . . . . 0.0 110.853 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.407 ' HD2' ' HA ' ' A' ' 64' ' ' PHE . 32.4 m-85 -115.71 152.77 32.58 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 109.408 -175.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -90.28 88.81 7.36 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.513 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 73.2 t -74.88 124.68 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' A' ' 87' ' ' TRP . 32.7 m -133.03 176.64 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.941 0.896 . . . . 0.0 110.966 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.3 m -87.63 158.93 50.53 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 124.278 1.031 . . . . 0.0 109.957 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.62 -21.24 70.24 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.418 2.079 . . . . 0.0 111.794 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.23 -26.14 66.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.129 1.372 . . . . 0.0 111.637 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -62.3 -44.88 95.48 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.759 0.314 . . . . 0.0 110.381 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.506 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.6 mp -71.43 -50.98 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.985 -176.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.9 t -57.89 -52.5 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.557 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.81 -37.75 73.25 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.071 -172.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 98.2 p -65.73 -39.25 90.94 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.29 0.236 . . . . 0.0 111.139 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.06 -41.55 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.67 0.788 . . . . 0.0 110.793 176.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.57 -38.06 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.559 0.744 . . . . 0.0 111.252 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -82.28 -18.51 42.13 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.649 0.78 . . . . 0.0 111.39 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.59 32.94 22.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.716 1.206 . . . . 0.0 111.539 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -139.12 162.03 35.94 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.801 0.84 . . . . 0.0 109.922 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.534 ' HA ' HG22 ' A' ' 8' ' ' ILE . 3.0 tm? -79.21 125.37 29.37 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.97 148.64 35.1 Favored Pre-proline 0 C--O 1.243 0.713 0 C-N-CA 123.66 0.784 . . . . 0.0 109.975 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.05 115.11 2.75 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.131 1.887 . . . . 0.0 110.335 166.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.498 ' HB2' HG12 ' A' ' 70' ' ' VAL . 12.7 p90 -62.96 -25.2 68.25 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.65 0.78 . . . . 0.0 111.862 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -60.03 -22.91 63.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.388 1.075 . . . . 0.0 112.13 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -63.45 -45.45 90.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.884 0.874 . . . . 0.0 110.105 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -102.42 6.43 40.18 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.57 0.748 . . . . 0.0 111.604 -173.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 36.7 m -65.84 114.54 5.15 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.038 0.535 . . . . 0.0 112.362 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.7 -26.33 63.37 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.79 0.836 . . . . 0.0 110.201 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.513 ' HB ' ' HB ' ' A' ' 69' ' ' VAL . 8.8 t -69.95 -11.05 60.59 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.934 0.894 . . . . 0.0 112.261 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.258 1.53 0 C-N-CA 123.213 0.605 . . . . 0.0 110.091 174.563 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m -76.27 82.48 3.05 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.1 m -109.88 72.41 0.8 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.97 -174.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -89.78 134.35 34.22 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.161 172.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -67.34 -47.36 70.72 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.322 0.649 . . . . 0.0 109.814 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.5 m -76.42 112.98 13.51 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 168.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -109.31 29.58 7.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.218 0.607 . . . . 0.0 110.373 -175.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.4 mt -53.37 -45.67 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.845 0.858 . . . . 0.0 112.253 -172.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.468 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 70.4 m-85 -111.63 15.54 21.02 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 119.275 -0.393 . . . . 0.0 111.127 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -56.37 -41.51 76.32 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.539 0.736 . . . . 0.0 112.811 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -96.92 -3.6 41.52 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.099 0.559 . . . . 0.0 111.391 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.452 ' SG ' ' ND1' ' A' ' 50' ' ' HIS . 51.8 t -99.0 127.05 44.84 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 123.974 0.91 . . . . 0.0 110.676 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.456 HG12 HD23 ' A' ' 39' ' ' LEU . 32.4 t -106.41 134.42 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.484 ' HB ' HD12 ' A' ' 31' ' ' ILE . 4.9 mp -125.64 128.47 72.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 123.391 0.677 . . . . 0.0 111.359 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -114.69 120.32 39.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.97 1.308 . . . . 0.0 108.174 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.6 mt -93.29 109.55 21.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -98.33 123.73 42.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.672 1.189 . . . . 0.0 109.599 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.88 -159.77 52.31 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 123.416 0.447 . . . . 0.0 113.892 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.74 122.48 32.19 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.782 0.833 . . . . 0.0 110.54 -177.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.596 HG22 HG13 ' A' ' 52' ' ' VAL . 72.3 p -132.88 146.24 51.64 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.015 1.326 . . . . 0.0 108.944 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -112.49 130.51 23.32 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.02 171.75 65.21 Favored 'Cis proline' 0 C--N 1.382 2.291 0 C-N-CA 124.146 -1.189 . . . . 0.0 111.381 -0.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.28 147.71 5.91 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.833 0.708 . . . . 0.0 114.493 -173.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -52.78 -36.48 58.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.713 0.805 . . . . 0.0 112.41 -175.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 pp -59.23 -43.01 92.38 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.319 0.648 . . . . 0.0 111.615 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -67.39 -50.15 60.86 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.858 0.863 . . . . 0.0 110.327 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 31' ' ' ILE . 92.9 mt -55.81 -41.24 73.89 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.474 0.709 . . . . 0.0 111.732 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.609 ' HA ' HD13 ' A' ' 31' ' ' ILE . 13.0 m80 -62.46 -37.52 86.25 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.68 0.792 . . . . 0.0 110.877 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -68.36 -40.92 81.31 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.225 0.61 . . . . 0.0 110.569 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.575 ' HB3' HG23 ' A' ' 79' ' ' VAL . 64.5 mtt -59.69 -33.49 71.65 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.436 0.695 . . . . 0.0 111.142 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.609 HD13 ' HA ' ' A' ' 28' ' ' HIS . 74.4 mt -70.3 -54.1 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.321 0.648 . . . . 0.0 110.982 177.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.58 -45.52 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.428 0.691 . . . . 0.0 112.185 -170.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.82 -21.03 66.71 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.479 0.712 . . . . 0.0 112.241 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -104.27 26.91 8.28 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.564 0.746 . . . . 0.0 110.726 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.36 -1.35 87.63 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.882 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . -75.51 160.37 52.0 Favored Glycine 0 CA--C 1.5 -0.859 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -170.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.433 ' HB3' HG22 ' A' ' 13' ' ' VAL . 2.9 tppp? -112.98 145.82 40.15 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -127.75 149.77 50.09 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.459 0.703 . . . . 0.0 109.329 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.456 HD23 HG12 ' A' ' 13' ' ' VAL . 1.3 mm? -116.65 128.74 55.65 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.54 -42.19 95.88 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.603 1.161 . . . . 0.0 111.594 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -165.29 160.81 18.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.609 0.763 . . . . 0.0 109.515 171.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -124.34 119.76 30.18 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.615 0.766 . . . . 0.0 109.884 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 t -90.18 68.09 7.0 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.7 m 71.87 -22.8 0.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.835 1.654 . . . . 0.0 114.021 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -63.52 130.96 46.57 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.846 0.858 . . . . 0.0 110.876 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.636 ' HB3' ' HZ2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -92.71 62.63 3.82 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 122.619 1.199 . . . . 0.0 109.635 -178.459 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 m -87.12 -8.84 56.59 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.968 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.448 HG23 HG11 ' A' ' 13' ' ' VAL . 9.9 p -112.7 155.84 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.8 0.84 . . . . 0.0 110.001 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 74.1 p -111.79 -30.74 7.2 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.14 0.576 . . . . 0.0 111.231 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.452 ' ND1' ' SG ' ' A' ' 12' ' ' CYS . 80.7 m80 -128.42 134.02 48.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.872 0.869 . . . . 0.0 110.016 -175.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 36.6 mt -121.75 114.19 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 121.443 0.639 . . . . 0.0 109.798 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.596 HG13 HG22 ' A' ' 20' ' ' THR . 74.7 t -90.53 119.19 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.145 0.978 . . . . 0.0 110.413 -175.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.0 137.9 18.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.744 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.1 t -86.05 -35.23 20.43 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 171.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -127.6 99.42 5.58 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 124.213 1.005 . . . . 0.0 108.519 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -107.28 107.89 61.06 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -61.41 152.63 71.56 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.155 2.57 . . . . 0.0 113.173 -173.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.33 -35.95 74.77 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.32 1.048 . . . . 0.0 112.566 -171.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -62.82 -45.26 93.46 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.567 0.699 . . . . 0.0 109.966 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -77.89 -18.34 56.27 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.001 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.42 ' NH1' ' HA ' ' A' ' 93' ' ' THR . 1.2 mmp_? -65.59 -35.23 80.21 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.18 0.592 . . . . 0.0 111.038 171.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.7 mt -69.17 -47.06 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 123.572 0.545 . . . . 0.0 109.806 172.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -58.02 -40.39 80.71 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.779 0.832 . . . . 0.0 111.655 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.405 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 18.3 m-85 -110.17 27.12 9.93 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.215 1.006 . . . . 0.0 110.741 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.42 -44.69 93.9 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.165 0.586 . . . . 0.0 111.301 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.407 ' N ' HD21 ' A' ' 66' ' ' ASN . 0.8 OUTLIER -77.62 -26.0 50.21 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.457 0.703 . . . . 0.0 110.722 179.195 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.405 ' CD1' ' HA ' ' A' ' 64' ' ' PHE . 16.3 m-85 -75.52 135.69 40.62 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.585 ' HA ' HG23 ' A' ' 93' ' ' THR . 43.7 mmtm -80.71 86.1 5.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.355 0.598 . . . . 0.0 109.784 -177.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 93.3 t -73.76 125.25 32.59 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.0 m -131.08 173.59 14.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 C-N-CA 123.392 0.677 . . . . 0.0 110.161 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.4 m -79.64 149.4 71.26 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.044 173.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.83 -28.45 87.15 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.395 2.064 . . . . 0.0 111.338 168.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.44 -23.89 64.78 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.321 1.449 . . . . 0.0 111.695 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -63.42 -48.6 77.11 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.957 0.503 . . . . 0.0 110.43 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.441 ' N ' HD11 ' A' ' 75' ' ' ILE . 2.4 mp -69.06 -45.14 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.325 -173.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -58.04 -49.73 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.24 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.85 -36.73 70.24 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.812 0.695 . . . . 0.0 110.993 -172.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.1 m -65.79 -41.25 92.18 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.611 0.365 . . . . 0.0 110.81 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 30' ' ' MET . 54.7 t -71.03 -33.03 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.748 0.819 . . . . 0.0 110.841 175.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -65.39 -42.9 92.14 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.441 1.096 . . . . 0.0 110.522 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -92.91 -6.15 49.24 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.048 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.07 36.59 24.27 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.431 1.092 . . . . 0.0 111.812 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -156.45 151.91 26.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.007 0.923 . . . . 0.0 109.768 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.83 121.62 19.3 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -105.95 160.82 24.8 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 124.054 0.942 . . . . 0.0 110.342 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -54.3 108.7 0.31 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.991 2.461 . . . . 0.0 112.756 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -62.03 -34.08 75.57 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.736 174.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -58.15 -26.88 63.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.833 1.253 . . . . 0.0 112.087 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -74.54 -37.76 62.94 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.446 0.699 . . . . 0.0 110.362 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.49 -0.7 29.52 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.398 0.679 . . . . 0.0 112.33 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.0 p -75.42 110.7 10.0 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.055 0.455 . . . . 0.0 111.039 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.6 mt -73.26 -17.38 61.34 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.332 1.053 . . . . 0.0 111.041 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.585 HG23 ' HA ' ' A' ' 68' ' ' LYS . 13.7 t -74.67 -26.48 59.88 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.608 0.763 . . . . 0.0 111.837 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.343 -0.837 . . . . 0.0 109.694 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 48.5 mm . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -85.0 81.68 8.79 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.796 0.839 . . . . 0.0 109.571 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.3 p -121.48 106.92 11.86 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.086 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -88.56 137.1 32.62 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.579 0.751 . . . . 0.0 109.489 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.4 t -144.02 156.51 44.41 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.258 0.623 . . . . 0.0 110.156 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.4 m -65.96 149.25 50.52 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 123.537 0.523 . . . . 0.0 110.538 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -107.76 21.94 16.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.883 0.873 . . . . 0.0 110.267 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.414 HG21 ' HA ' ' A' ' 84' ' ' LEU . 64.6 mt -67.71 -50.3 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.209 0.604 . . . . 0.0 110.223 -177.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.85 16.2 17.32 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.01 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -62.44 -36.56 82.78 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 120.913 0.387 . . . . 0.0 111.569 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -98.77 8.36 45.04 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.688 0.795 . . . . 0.0 111.161 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 71.9 m -117.24 114.1 23.15 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.605 0.762 . . . . 0.0 111.134 -174.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.35 126.77 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.89 131.47 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.142 0.577 . . . . 0.0 111.425 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 16.7 t80 -114.34 114.27 25.68 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.639 1.175 . . . . 0.0 108.635 169.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.7 mt -88.48 137.83 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -142.74 143.05 32.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.887 0.875 . . . . 0.0 109.646 -166.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.96 -137.84 32.37 Favored Glycine 0 C--N 1.346 1.117 0 O-C-N 123.519 0.512 . . . . 0.0 111.975 -174.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.1 145.38 37.24 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 171.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.498 HG21 HG12 ' A' ' 52' ' ' VAL . 37.1 p -142.21 140.67 32.39 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.741 1.216 . . . . 0.0 108.619 178.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -109.76 126.34 29.31 Favored Pre-proline 0 N--CA 1.485 1.277 0 CA-C-N 118.288 0.495 . . . . 0.0 110.264 171.582 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HD2' HD21 ' A' ' 27' ' ' LEU . 43.9 Cg_endo -76.15 174.3 53.63 Favored 'Cis proline' 0 C--N 1.374 1.905 0 C-N-CA 124.362 -1.099 . . . . 0.0 112.076 2.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.04 144.23 4.96 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.938 0.774 . . . . 0.0 114.094 -174.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.422 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 10.0 ptp180 -55.4 -36.3 66.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.191 0.596 . . . . 0.0 112.151 -172.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.93 -32.13 72.37 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.992 0.517 . . . . 0.0 111.857 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.401 ' O ' ' HG2' ' A' ' 30' ' ' MET . 8.5 tt0 -68.45 -51.84 39.16 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.459 HD21 ' HD2' ' A' ' 22' ' ' PRO . 91.9 mt -55.29 -39.58 70.05 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.606 0.763 . . . . 0.0 111.006 176.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -59.67 -47.61 84.93 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.628 1.171 . . . . 0.0 109.514 -178.105 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -65.96 -39.65 90.59 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.029 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.543 ' HB3' HG21 ' A' ' 79' ' ' VAL . 26.4 mmt -60.79 -33.27 72.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.876 0.47 . . . . 0.0 110.986 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -72.29 -51.92 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.398 0.679 . . . . 0.0 111.004 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.0 -47.42 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.573 0.749 . . . . 0.0 111.817 -174.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.82 -16.61 58.98 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.031 0.932 . . . . 0.0 111.713 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -109.76 28.33 8.68 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.903 0.881 . . . . 0.0 111.235 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.24 5.9 88.46 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.4 -0.818 . . . . 0.0 114.227 170.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.69 160.57 32.81 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 115.105 0.802 . . . . 0.0 115.105 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -105.38 162.0 13.83 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.557 -0.821 . . . . 0.0 109.44 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -136.09 164.88 27.0 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.502 174.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.755 ' HB3' HD12 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -136.77 130.38 31.86 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -66.34 -46.69 75.95 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 124.131 0.894 . . . . 0.0 113.263 -164.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.46 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 74.7 t80 -164.49 132.74 3.43 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.641 0.776 . . . . 0.0 109.471 -175.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.755 HD12 ' HB3' ' A' ' 39' ' ' LEU . 4.5 mp -137.2 112.26 9.04 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.956 0.502 . . . . 0.0 110.856 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.3 t -90.77 84.5 5.85 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.4 m 66.79 9.54 6.83 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.717 1.207 . . . . 0.0 112.742 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 57.9 tptt -73.62 137.39 44.19 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.356 1.063 . . . . 0.0 110.247 -176.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -98.63 72.08 2.0 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.839 0.456 . . . . 0.0 109.771 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.0 m -126.96 -10.43 6.0 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.039 0.536 . . . . 0.0 110.615 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.8 p -113.54 143.28 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.066 0.546 . . . . 0.0 110.734 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 t -108.41 -13.82 14.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.923 0.489 . . . . 0.0 111.55 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -138.94 128.23 24.17 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.383 0.673 . . . . 0.0 109.953 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.612 ' HB ' HG22 ' A' ' 69' ' ' VAL . 66.4 mt -114.18 136.43 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.498 HG12 HG21 ' A' ' 20' ' ' THR . 86.8 t -113.19 119.33 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.86 173.3 11.85 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.595 0.758 . . . . 0.0 109.613 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -89.77 -44.17 10.17 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 174.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -130.34 145.84 51.84 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.041 -1.436 . . . . 0.0 108.473 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.508 ' HG ' HG11 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -136.13 117.34 11.57 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.181 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.409 ' O ' ' HG3' ' A' ' 61' ' ' ARG . 95.2 Cg_endo -77.31 155.38 32.64 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.861 2.374 . . . . 0.0 113.201 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.0 mt -51.32 -49.72 60.79 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.062 1.345 . . . . 0.0 114.266 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.56 -31.38 69.54 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.467 -177.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -72.11 -27.77 62.85 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 118.183 0.447 . . . . 0.0 111.131 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 85.3 mtt180 -60.1 -38.58 83.39 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 172.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.7 mt -64.88 -43.59 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.61 0.764 . . . . 0.0 110.782 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 6.2 mm-40 -72.99 -21.76 60.79 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.374 0.67 . . . . 0.0 111.396 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -113.19 27.11 9.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.275 1.03 . . . . 0.0 110.119 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.36 -28.17 69.58 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.186 0.595 . . . . 0.0 112.303 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -88.67 -29.38 19.94 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.936 0.495 . . . . 0.0 111.017 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -88.87 117.36 27.82 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -71.11 87.17 0.76 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.963 0.505 . . . . 0.0 109.677 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.612 HG22 ' HB ' ' A' ' 51' ' ' ILE . 22.9 t -81.09 128.41 38.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.34 172.31 16.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 124.874 1.27 . . . . 0.0 110.034 -175.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 60.9 p -85.28 159.47 56.33 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.81 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.32 -24.32 67.37 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.714 2.276 . . . . 0.0 112.718 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.82 -26.52 68.17 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.498 1.119 . . . . 0.0 112.084 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 37.1 t90 -61.63 -40.56 95.29 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.173 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 75' ' ' ILE . 2.8 mp -76.69 -49.65 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.025 0.93 . . . . 0.0 108.961 -177.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.98 -51.36 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.079 0.952 . . . . 0.0 111.343 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.43 -39.4 71.06 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.622 -173.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.5 p -64.49 -44.97 89.31 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 120.949 0.404 . . . . 0.0 111.309 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 30' ' ' MET . 41.7 t -65.5 -33.74 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.356 1.062 . . . . 0.0 111.298 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -72.83 -38.66 67.06 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 120.8 0.334 . . . . 0.0 110.889 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -89.0 -7.66 55.56 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.816 0.846 . . . . 0.0 112.048 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.89 27.85 16.97 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.669 1.188 . . . . 0.0 112.474 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -138.23 165.36 26.89 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.804 0.841 . . . . 0.0 110.365 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.414 ' HA ' HG21 ' A' ' 8' ' ' ILE . 51.2 tp -82.53 142.91 31.45 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 169.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.5 mt -110.61 155.06 42.8 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 123.777 0.831 . . . . 0.0 110.407 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.05 111.55 1.79 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.145 1.897 . . . . 0.0 110.309 166.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -59.64 -27.54 66.45 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.627 0.771 . . . . 0.0 111.961 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -58.37 -28.35 65.05 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.219 1.008 . . . . 0.0 111.974 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -71.9 -35.79 69.82 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.26 0.624 . . . . 0.0 110.674 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -105.91 7.48 32.17 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.649 0.78 . . . . 0.0 111.561 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.2 t -65.28 116.5 6.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.961 0.904 . . . . 0.0 112.456 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.5 -24.77 56.88 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.431 0.692 . . . . 0.0 111.443 175.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.52 HG23 ' HB ' ' A' ' 69' ' ' VAL . 22.7 p -69.56 -21.67 63.6 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.174 0.59 . . . . 0.0 112.315 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 C--O 1.249 1.069 0 CA-C-O 119.045 -0.502 . . . . 0.0 109.655 177.277 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 11.8 tt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.8 t -148.6 117.57 6.74 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.4 t -155.01 163.24 40.58 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.316 0.646 . . . . 0.0 110.397 -176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -78.91 76.69 5.4 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 166.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 p -103.85 101.24 11.04 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.848 -166.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.4 m -69.22 122.27 18.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.737 0.815 . . . . 0.0 109.484 173.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.92 30.12 0.08 Allowed 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -166.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.24 -46.84 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 124.029 0.932 . . . . 0.0 111.694 176.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -107.13 10.22 30.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.196 0.599 . . . . 0.0 111.55 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -57.46 -43.84 84.32 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.378 0.671 . . . . 0.0 111.301 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -78.69 -18.8 53.78 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.262 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.85 127.19 44.71 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.728 0.811 . . . . 0.0 112.306 -172.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.8 t -96.81 130.66 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 162.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.438 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.4 mp -121.56 122.86 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 36.8 t80 -105.1 125.52 51.07 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 167.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.432 HG12 ' HB ' ' A' ' 52' ' ' VAL . 47.4 mt -98.85 139.8 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -136.07 141.52 44.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.334 1.053 . . . . 0.0 109.893 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.47 -149.13 49.45 Favored Glycine 0 C--N 1.348 1.206 0 O-C-N 123.804 0.69 . . . . 0.0 113.439 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -95.54 116.3 28.63 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.64 0.776 . . . . 0.0 109.893 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.422 HG22 HG13 ' A' ' 52' ' ' VAL . 72.9 p -129.15 134.85 48.22 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.17 0.988 . . . . 0.0 108.673 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -111.16 131.37 22.23 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-N 117.993 0.36 . . . . 0.0 110.727 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.84 173.87 53.98 Favored 'Cis proline' 0 C--N 1.38 2.188 0 C-N-CA 124.416 -1.077 . . . . 0.0 111.992 0.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.81 146.86 9.03 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.053 0.846 . . . . 0.0 114.248 -173.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -52.39 -34.82 49.7 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.667 1.187 . . . . 0.0 112.763 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.4 pp -63.26 -43.63 97.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.452 0.301 . . . . 0.0 110.959 177.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -72.18 -41.71 66.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.083 0.553 . . . . 0.0 110.486 -176.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.6 mt -56.02 -43.96 78.24 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.344 0.658 . . . . 0.0 111.18 170.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.525 ' HA ' HD11 ' A' ' 31' ' ' ILE . 10.8 m170 -65.41 -34.94 79.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.097 0.559 . . . . 0.0 111.042 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 22.7 mm-40 -65.39 -41.17 93.99 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.584 0.354 . . . . 0.0 110.268 174.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.63 ' HB3' HG22 ' A' ' 79' ' ' VAL . 68.5 mtt -58.52 -35.72 72.73 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.364 0.665 . . . . 0.0 111.243 176.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.525 HD11 ' HA ' ' A' ' 28' ' ' HIS . 64.6 mt -72.76 -51.8 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.757 0.823 . . . . 0.0 111.609 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.5 t -70.38 -41.83 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.286 0.634 . . . . 0.0 111.648 -172.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -65.92 -12.72 56.81 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.652 0.781 . . . . 0.0 111.983 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -107.84 24.99 12.09 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.349 1.06 . . . . 0.0 111.227 174.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.71 15.5 68.86 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.878 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.03 161.15 25.4 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 122.918 0.294 . . . . 0.0 113.335 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -106.53 148.63 27.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.673 0.789 . . . . 0.0 109.854 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -131.5 151.12 51.84 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.069 0.547 . . . . 0.0 110.746 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.6 tp -115.27 137.44 52.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.639 1.176 . . . . 0.0 108.975 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.57 -35.75 33.89 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.155 0.982 . . . . 0.0 112.997 -173.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -171.17 163.68 7.23 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.568 1.147 . . . . 0.0 108.4 -169.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.6 76.14 1.8 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.775 0.798 . . . . 0.0 110.472 176.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.8 t -107.26 -13.22 15.19 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.873 165.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.7 m -90.06 -170.82 2.91 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.57 1.148 . . . . 0.0 110.715 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -83.16 -153.82 0.13 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.721 0.808 . . . . 0.0 108.845 173.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -77.33 73.3 3.91 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.925 0.869 . . . . 0.0 109.644 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.7 m -84.84 -37.57 20.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.572 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.07 150.54 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.654 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t -115.17 -22.7 9.33 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.524 0.729 . . . . 0.0 111.081 175.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 27.8 m170 -133.77 126.19 30.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.491 0.717 . . . . 0.0 109.824 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.617 ' HB ' HG22 ' A' ' 69' ' ' VAL . 68.5 mt -109.39 139.84 30.66 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.432 ' HB ' HG12 ' A' ' 16' ' ' ILE . 61.2 t -110.74 122.0 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.156 0.582 . . . . 0.0 109.704 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.69 170.65 18.2 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.454 0.701 . . . . 0.0 109.568 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.2 t -108.87 -48.24 3.32 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 168.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -106.83 91.41 3.66 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.06 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.465 ' HG ' HG13 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -112.18 106.99 55.99 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.34 147.78 44.76 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.77 2.98 . . . . 0.0 113.84 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.41 -38.34 71.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.758 0.823 . . . . 0.0 110.667 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.457 ' HB3' ' HZ1' ' A' ' 59' ' ' LYS . 3.2 mmmp? -51.56 -55.23 20.31 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.241 1.016 . . . . 0.0 110.899 172.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 63' ' ' GLU . 43.0 mtmt -80.79 -10.18 59.75 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.98 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -72.4 -30.97 65.14 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.474 0.579 . . . . 0.0 109.885 170.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.8 mt -80.54 -40.84 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 123.448 0.467 . . . . 0.0 109.922 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.491 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 42.3 mt-10 -67.34 -37.24 82.96 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.333 0.653 . . . . 0.0 111.147 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -104.68 26.59 8.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.865 0.866 . . . . 0.0 110.44 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.24 -23.79 64.84 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.828 0.451 . . . . 0.0 111.249 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.423 ' N ' HD21 ' A' ' 66' ' ' ASN . 0.8 OUTLIER -70.52 -28.33 64.86 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.253 0.621 . . . . 0.0 110.031 175.556 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -95.45 174.77 6.85 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 170.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -126.55 97.02 4.86 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.617 HG22 ' HB ' ' A' ' 51' ' ' ILE . 17.6 t -76.32 129.78 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.634 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.95 176.95 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.059 1.344 . . . . 0.0 109.298 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.9 m -85.95 156.51 57.92 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.464 0.706 . . . . 0.0 110.255 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.403 ' O ' HG21 ' A' ' 76' ' ' VAL . 19.8 Cg_endo -56.6 -27.57 70.35 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 123.116 2.544 . . . . 0.0 112.401 174.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -61.51 -24.11 66.38 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.884 1.274 . . . . 0.0 111.959 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -62.21 -48.09 81.53 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 172.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.437 ' N ' HD13 ' A' ' 75' ' ' ILE . 2.6 mp -69.66 -47.08 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.0 -174.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 72' ' ' PRO . 95.9 t -59.83 -54.75 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.068 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 16.7 t70 -72.38 -36.41 68.71 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.741 -171.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.2 m -60.9 -40.32 92.68 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 120.694 0.283 . . . . 0.0 111.087 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.63 HG22 ' HB3' ' A' ' 30' ' ' MET . 45.2 t -70.0 -40.27 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.293 0.637 . . . . 0.0 111.476 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -63.57 -46.14 87.27 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.837 0.455 . . . . 0.0 110.794 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 17.5 mm-40 -80.16 -15.44 57.07 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.484 0.714 . . . . 0.0 111.066 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.86 28.8 14.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.015 1.326 . . . . 0.0 112.114 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -141.99 158.57 43.61 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.962 0.905 . . . . 0.0 109.755 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.4 tp -79.14 121.63 25.25 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.9 mt -101.68 158.57 31.53 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 124.104 0.962 . . . . 0.0 110.055 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.88 108.76 0.96 Allowed 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.153 1.902 . . . . 0.0 111.64 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -57.87 -33.15 68.39 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.726 0.81 . . . . 0.0 110.948 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -59.65 -31.16 69.28 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.533 1.133 . . . . 0.0 111.729 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -70.73 -39.44 73.35 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.548 0.739 . . . . 0.0 110.844 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -93.56 0.27 56.56 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.427 0.691 . . . . 0.0 111.661 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.6 t -72.2 124.91 26.02 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.612 0.365 . . . . 0.0 111.702 -171.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.5 mt -73.07 -43.89 61.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.99 168.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p -75.63 84.12 2.65 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.292 0.568 . . . . 0.0 109.805 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.248 1.026 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -178.642 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 38.7 pt . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.9 m -145.42 -48.79 0.23 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.419 0.687 . . . . 0.0 110.152 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.2 t -135.1 132.62 38.35 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.171 0.589 . . . . 0.0 110.505 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.509 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 51.1 mt-30 -113.77 30.15 7.47 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.477 1.111 . . . . 0.0 109.925 177.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.5 p -77.25 -58.09 3.47 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -90.11 82.16 6.11 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.811 0.844 . . . . 0.0 108.868 174.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.509 ' HD3' ' HB3' ' A' ' 4' ' ' GLN . 20.3 pttp -131.1 30.09 4.6 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.338 0.655 . . . . 0.0 110.662 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.4 -49.5 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.062 0.545 . . . . 0.0 111.623 -172.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.542 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 57.2 m-85 -108.4 17.48 22.07 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.778 -176.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -62.34 -43.88 97.79 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.508 0.723 . . . . 0.0 111.112 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -84.82 6.17 25.68 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.499 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.9 m -120.94 131.66 54.48 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.958 0.903 . . . . 0.0 111.261 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.47 HG21 ' HD3' ' A' ' 37' ' ' LYS . 15.1 t -103.18 127.27 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 166.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.417 ' H ' ' HA ' ' A' ' 38' ' ' PHE . 4.1 mp -118.1 120.17 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.14 0.576 . . . . 0.0 112.196 -176.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 13.0 t80 -106.54 126.26 52.04 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 166.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -97.95 110.85 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -104.25 128.13 51.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.943 0.897 . . . . 0.0 109.598 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.17 -171.45 50.32 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.383 0.427 . . . . 0.0 113.224 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.07 135.91 33.11 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.638 0.775 . . . . 0.0 110.09 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.5 HG21 HG13 ' A' ' 52' ' ' VAL . 41.5 p -138.06 148.4 45.02 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.417 1.087 . . . . 0.0 109.214 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 21' ' ' LYS . 11.9 mmpt? -105.54 120.63 48.78 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 165.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.462 ' HD2' HD21 ' A' ' 27' ' ' LEU . 31.3 Cg_endo -84.2 174.62 37.64 Favored 'Cis proline' 0 CA--C 1.553 1.474 0 C-N-CA 123.896 -1.293 . . . . 0.0 111.295 -1.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.98 155.38 8.84 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -171.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -48.35 -37.1 15.81 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.022 1.329 . . . . 0.0 112.743 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.4 pp -63.05 -44.68 95.17 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.943 0.897 . . . . 0.0 111.439 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.494 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.5 tp-100 -71.83 -45.85 60.07 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.648 0.779 . . . . 0.0 110.542 -176.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.462 HD21 ' HD2' ' A' ' 22' ' ' PRO . 93.1 mt -57.86 -46.43 84.83 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.058 176.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.427 ' HA ' HD13 ' A' ' 31' ' ' ILE . 15.5 m170 -60.6 -36.46 78.62 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.019 0.528 . . . . 0.0 111.573 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -63.97 -46.41 84.77 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.74 0.416 . . . . 0.0 110.347 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.62 ' HB3' HG23 ' A' ' 79' ' ' VAL . 26.2 mmt -60.15 -34.0 72.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.71 0.804 . . . . 0.0 111.926 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 28' ' ' HIS . 78.6 mt -68.63 -51.26 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.526 0.73 . . . . 0.0 111.551 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.7 t -73.05 -40.4 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.034 0.534 . . . . 0.0 111.775 -172.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.04 -15.95 64.05 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.387 0.675 . . . . 0.0 111.754 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -109.57 26.59 10.47 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.768 0.827 . . . . 0.0 110.398 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.51 39.24 79.65 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-N 114.582 -1.19 . . . . 0.0 114.013 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.542 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -115.74 161.41 12.89 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 -173.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.47 ' HD3' HG21 ' A' ' 13' ' ' VAL . 88.3 tttt -105.86 150.13 25.9 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 122.925 0.49 . . . . 0.0 110.22 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.417 ' HA ' ' H ' ' A' ' 14' ' ' ILE . 27.0 p90 -141.85 164.73 29.39 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.374 0.67 . . . . 0.0 110.637 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.532 HD13 ' HB ' ' A' ' 48' ' ' VAL . 55.8 mt -124.8 146.88 49.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.723 0.809 . . . . 0.0 109.647 168.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.448 ' HD2' ' H ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -73.87 -35.3 64.72 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.661 175.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.448 ' H ' ' HD2' ' A' ' 40' ' ' HIS . 53.9 p90 -175.59 175.32 2.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.517 1.527 . . . . 0.0 109.02 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -105.74 117.51 34.2 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.9 t -71.91 -42.39 66.77 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.778 0.831 . . . . 0.0 110.527 178.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.3 t -171.98 -49.7 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.681 0.792 . . . . 0.0 110.513 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -77.94 144.4 36.86 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.727 0.811 . . . . 0.0 111.919 -169.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -73.09 97.65 2.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.156 0.982 . . . . 0.0 109.147 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.2 p -125.06 -37.96 2.38 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.3 0.64 . . . . 0.0 112.477 -171.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.532 ' HB ' HD13 ' A' ' 39' ' ' LEU . 6.6 p -82.52 152.76 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 122.262 -0.274 . . . . 0.0 110.345 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 t -114.55 -24.0 9.01 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.804 0.441 . . . . 0.0 111.508 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -129.0 130.28 46.45 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.763 0.425 . . . . 0.0 110.399 -177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 23.1 mt -116.93 134.97 58.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.5 HG13 HG21 ' A' ' 20' ' ' THR . 91.0 t -108.67 120.99 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.176 0.59 . . . . 0.0 110.954 -176.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.81 150.88 48.59 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.485 1.114 . . . . 0.0 108.625 172.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.1 t -76.71 -33.12 58.21 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -161.17 111.41 1.69 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.341 1.056 . . . . 0.0 108.348 170.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.59 HD21 HG12 ' A' ' 69' ' ' VAL . 16.4 tp -85.37 135.11 39.2 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 118.65 -0.69 . . . . 0.0 109.596 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.62 153.65 47.7 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.147 2.565 . . . . 0.0 112.56 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.59 -45.61 93.33 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.23 0.612 . . . . 0.0 112.125 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.0 mmmm -65.99 -36.81 84.32 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.642 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -66.96 -28.27 68.14 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.486 0.314 . . . . 0.0 111.649 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.17 -31.94 72.7 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.453 0.301 . . . . 0.0 110.319 173.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.9 mt -74.43 -37.76 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.07 0.548 . . . . 0.0 110.56 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 27.4 mm-40 -66.34 -42.01 88.73 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.424 0.631 . . . . 0.0 110.637 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -104.65 27.58 7.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.256 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.68 -22.83 64.35 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.495 0.718 . . . . 0.0 112.222 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.29 -6.94 59.46 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.849 0.46 . . . . 0.0 111.312 174.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -110.68 141.75 43.51 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.585 0.754 . . . . 0.0 109.411 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -79.33 86.03 5.1 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.59 HG12 HD21 ' A' ' 56' ' ' LEU . 55.7 t -75.47 130.04 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.474 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' A' ' 87' ' ' TRP . 35.2 m -134.65 177.18 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.003 1.321 . . . . 0.0 109.831 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -89.32 160.48 42.41 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.136 0.975 . . . . 0.0 110.541 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HB3' HD13 ' A' ' 27' ' ' LEU . 23.3 Cg_endo -59.56 -23.38 70.79 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.802 2.335 . . . . 0.0 111.995 172.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.65 -27.31 66.25 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 124.708 1.203 . . . . 0.0 111.863 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -61.43 -43.68 98.45 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.108 0.413 . . . . 0.0 110.45 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.435 HD13 ' N ' ' A' ' 75' ' ' ILE . 2.9 mp -72.05 -46.16 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -176.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.93 -47.8 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.371 1.068 . . . . 0.0 111.625 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.26 -42.27 75.8 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.761 0.824 . . . . 0.0 111.574 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.6 m -65.85 -36.85 84.59 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 120.72 0.295 . . . . 0.0 111.191 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' A' ' 30' ' ' MET . 24.9 t -70.41 -33.86 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.771 0.828 . . . . 0.0 110.655 173.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -67.24 -34.51 77.61 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.549 0.74 . . . . 0.0 110.977 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -96.38 -13.6 23.1 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.189 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.64 39.06 24.99 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.284 1.033 . . . . 0.0 111.245 -175.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -156.18 156.53 34.35 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.884 0.874 . . . . 0.0 109.886 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.6 tp -75.51 107.77 7.87 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.245 0.618 . . . . 0.0 110.432 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.7 mt -88.72 156.09 50.22 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.556 0.742 . . . . 0.0 111.081 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.34 108.66 1.22 Allowed 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.524 2.149 . . . . 0.0 111.809 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.57 ' HB2' HG12 ' A' ' 70' ' ' VAL . 24.0 p90 -62.8 -20.91 65.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.112 0.965 . . . . 0.0 112.538 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -57.14 -35.45 69.52 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.176 0.99 . . . . 0.0 111.545 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.39 -27.23 68.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.798 0.839 . . . . 0.0 110.986 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.1 -6.15 18.87 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.696 0.798 . . . . 0.0 111.067 -175.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 75.5 m -64.19 130.17 42.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -172.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.3 mt -106.94 22.05 16.59 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.475 1.11 . . . . 0.0 110.498 173.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.7 p -64.22 -50.78 66.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.615 0.766 . . . . 0.0 110.717 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 C--O 1.251 1.163 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.659 176.49 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.575 ' H3 ' HD12 ' A' ' 1' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 119.895 -0.097 . . . . 0.0 110.948 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.4 p -71.46 85.2 0.83 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.536 0.734 . . . . 0.0 110.984 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.574 ' HB2' ' HB2' ' A' ' 6' ' ' SER . 22.8 p -173.9 122.61 0.33 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.48 1.112 . . . . 0.0 109.03 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -106.41 -49.76 3.28 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.071 0.548 . . . . 0.0 110.12 177.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -84.35 -26.3 28.55 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.421 0.689 . . . . 0.0 111.114 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.574 ' HB2' ' HB2' ' A' ' 3' ' ' SER . 20.3 m -84.11 27.82 0.65 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.772 0.829 . . . . 0.0 112.795 -171.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -125.26 32.01 5.46 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.183 0.993 . . . . 0.0 110.337 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.407 HG21 ' HA ' ' A' ' 84' ' ' LEU . 55.9 mt -57.52 -45.72 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 123.568 0.747 . . . . 0.0 111.462 -176.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.714 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 50.8 m-85 -112.03 18.98 18.28 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.988 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -60.22 -40.21 89.36 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 118.312 0.505 . . . . 0.0 111.933 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -87.16 -7.64 57.76 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.687 0.795 . . . . 0.0 111.031 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 74.1 m -112.45 108.51 17.68 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 122.189 0.995 . . . . 0.0 111.818 -171.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 48' ' ' VAL . 38.7 t -89.14 125.76 42.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 164.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.436 ' HB ' HD12 ' A' ' 31' ' ' ILE . 2.7 mp -110.54 128.63 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.774 0.83 . . . . 0.0 110.624 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -111.6 116.53 30.96 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 166.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.0 mt -84.62 137.13 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.421 0.688 . . . . 0.0 109.388 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -146.55 134.91 21.87 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.311 1.044 . . . . 0.0 109.696 -168.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.02 -160.2 54.02 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.638 0.586 . . . . 0.0 112.915 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.22 131.36 41.88 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -148.64 136.91 21.11 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.775 1.23 . . . . 0.0 108.843 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -116.65 134.07 22.95 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 122.974 0.51 . . . . 0.0 110.72 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.75 174.98 44.24 Favored 'Cis proline' 0 C--N 1.371 1.739 0 C-N-CA 124.408 -1.08 . . . . 0.0 110.996 -7.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.16 157.88 9.34 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -171.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -53.53 -35.44 60.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.546 1.138 . . . . 0.0 113.004 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 pp -60.62 -44.65 96.08 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.327 0.392 . . . . 0.0 110.559 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' A' ' 30' ' ' MET . 6.9 tp-100 -70.48 -51.89 25.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.811 0.845 . . . . 0.0 110.045 -176.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -54.79 -41.33 70.43 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.525 0.73 . . . . 0.0 111.505 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.419 ' O ' HG21 ' A' ' 32' ' ' VAL . 23.3 m170 -55.13 -48.2 74.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.314 0.645 . . . . 0.0 110.47 176.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.05 -38.95 92.5 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.731 0.645 . . . . 0.0 111.25 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.575 ' HB3' HG22 ' A' ' 79' ' ' VAL . 55.8 mmm -58.22 -36.54 73.3 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.505 0.722 . . . . 0.0 110.407 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.436 HD12 ' HB ' ' A' ' 14' ' ' ILE . 46.1 mt -72.23 -50.46 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.897 0.879 . . . . 0.0 111.654 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 28' ' ' HIS . 57.9 t -67.44 -42.26 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.233 -172.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.06 -12.6 61.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.967 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.45 ' NE2' HG13 ' A' ' 79' ' ' VAL . 34.1 m-70 -110.09 26.38 10.73 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.391 0.676 . . . . 0.0 111.163 173.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.83 37.93 75.67 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 114.867 -1.061 . . . . 0.0 113.615 171.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.714 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -118.61 -179.68 16.94 Favored Glycine 0 CA--C 1.503 -0.691 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 -175.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -123.74 144.52 49.63 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 121.201 0.524 . . . . 0.0 110.459 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -122.03 159.81 26.25 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.292 1.037 . . . . 0.0 108.484 173.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.7 tp -120.08 138.43 53.55 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.64 -46.76 74.73 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 124.049 0.843 . . . . 0.0 111.98 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -179.74 146.28 0.25 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.788 0.835 . . . . 0.0 109.525 -170.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.56 130.74 35.01 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.152 0.581 . . . . 0.0 109.943 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.7 t -81.24 -62.89 1.53 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.4 m -155.9 -58.2 0.1 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.58 0.752 . . . . 0.0 110.156 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -66.27 153.53 42.31 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.946 0.898 . . . . 0.0 111.175 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -59.55 96.37 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.661 0.784 . . . . 0.0 110.071 171.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.4 m -108.75 12.3 25.78 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.42 1.088 . . . . 0.0 109.936 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.451 HG21 HG11 ' A' ' 13' ' ' VAL . 9.9 p -149.14 152.02 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.268 0.627 . . . . 0.0 109.655 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 t -107.33 -27.99 10.15 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.086 0.555 . . . . 0.0 111.595 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -124.62 135.8 53.4 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.308 0.643 . . . . 0.0 109.952 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.639 ' HB ' HG12 ' A' ' 69' ' ' VAL . 67.9 mt -121.85 116.09 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.7 t -91.5 120.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 123.951 0.901 . . . . 0.0 110.245 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.08 167.73 20.96 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.318 1.047 . . . . 0.0 108.786 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.1 t -115.45 -49.39 2.75 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -119.62 124.05 45.36 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.8 tp -150.02 128.35 5.93 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.07 155.91 17.58 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.594 2.863 . . . . 0.0 113.812 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.515 HD21 ' NH2' ' A' ' 61' ' ' ARG . 85.7 mt -55.48 -60.82 2.89 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.916 0.886 . . . . 0.0 111.022 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -59.8 -29.64 68.36 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.329 1.052 . . . . 0.0 111.851 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.461 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -68.69 -46.25 69.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.008 178.17 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.515 ' NH2' HD21 ' A' ' 58' ' ' LEU . 53.4 mtm180 -69.18 -27.49 65.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.917 0.887 . . . . 0.0 112.234 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 98.0 mt -72.37 -35.71 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.194 0.598 . . . . 0.0 109.843 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.4 -36.96 68.78 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.458 0.647 . . . . 0.0 109.504 172.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -87.98 17.49 4.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.03 0.932 . . . . 0.0 111.141 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.69 -23.81 65.34 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.035 0.534 . . . . 0.0 109.687 166.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -73.61 -6.89 49.48 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.084 0.954 . . . . 0.0 111.03 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -122.91 157.99 31.35 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.352 1.061 . . . . 0.0 109.46 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.67 85.06 5.56 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.639 HG12 ' HB ' ' A' ' 51' ' ' ILE . 22.1 m -83.06 131.38 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.187 -177.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 87' ' ' TRP . 24.6 m -134.67 171.17 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.612 0.765 . . . . 0.0 109.859 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.423 ' HB3' HD23 ' A' ' 92' ' ' LEU . 47.5 p -86.85 156.95 55.21 Favored Pre-proline 0 C--O 1.245 0.828 0 C-N-CA 123.85 0.86 . . . . 0.0 109.469 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -60.4 -21.58 68.15 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 122.55 2.167 . . . . 0.0 112.707 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.23 -29.71 67.72 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.652 1.181 . . . . 0.0 111.818 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -59.58 -47.26 86.28 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.564 0.54 . . . . 0.0 110.084 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 75' ' ' ILE . 2.7 mp -70.8 -51.95 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.754 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.7 t -53.95 -52.66 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.224 1.01 . . . . 0.0 111.447 -176.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.66 -43.59 65.78 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.855 0.722 . . . . 0.0 111.158 -173.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.3 p -60.33 -36.96 79.16 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.018 0.437 . . . . 0.0 111.302 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' A' ' 30' ' ' MET . 46.9 t -67.89 -41.34 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.087 0.955 . . . . 0.0 111.512 176.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -67.38 -37.39 83.07 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.084 0.554 . . . . 0.0 111.285 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.19 -14.7 40.42 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.25 1.02 . . . . 0.0 111.479 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.27 26.71 15.58 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.146 1.378 . . . . 0.0 112.408 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -137.47 164.38 28.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.126 0.57 . . . . 0.0 110.32 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.407 ' HA ' HG21 ' A' ' 8' ' ' ILE . 60.7 tp -78.31 131.48 37.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.363 0.665 . . . . 0.0 110.606 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -108.33 150.66 40.84 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.744 1.218 . . . . 0.0 109.458 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.49 113.87 3.84 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.363 2.042 . . . . 0.0 110.47 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.498 ' HB2' HG13 ' A' ' 70' ' ' VAL . 64.6 p-90 -61.76 -27.8 68.99 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.629 0.771 . . . . 0.0 111.922 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -62.46 -27.82 69.39 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.134 0.974 . . . . 0.0 112.097 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -71.59 -21.07 61.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.799 0.84 . . . . 0.0 111.071 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -114.7 1.11 14.09 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.335 1.054 . . . . 0.0 110.731 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 27.0 t -69.27 131.36 44.75 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.196 0.598 . . . . 0.0 111.783 -171.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' A' ' 71' ' ' SER . 38.6 mt -96.72 8.66 43.75 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.29 0.636 . . . . 0.0 112.111 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.5 t -72.43 -14.56 61.72 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.526 0.603 . . . . 0.0 111.075 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.5 t . . . . . 0 C--O 1.251 1.167 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 169.854 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.3 p -92.94 51.85 1.75 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -72.47 -50.12 28.41 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.833 -170.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 56.94 29.18 15.86 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.265 1.031 . . . . 0.0 110.575 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.2 m -75.88 101.39 5.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.494 1.118 . . . . 0.0 111.846 -172.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.9 p -63.6 125.08 23.09 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 167.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -82.87 33.57 0.44 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.367 1.067 . . . . 0.0 113.445 -161.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.405 HD13 ' CD2' ' A' ' 34' ' ' HIS . 67.1 mt -55.0 -48.1 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.763 1.225 . . . . 0.0 111.867 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.584 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 73.1 m-85 -105.05 7.34 33.9 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.463 -175.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.404 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 47.3 tptt -57.1 -49.31 76.29 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.053 0.541 . . . . 0.0 110.721 -174.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -84.11 -4.95 59.13 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.937 -1.028 . . . . 0.0 111.927 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.1 m -106.37 128.21 53.86 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.28 0.632 . . . . 0.0 111.488 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.422 HG12 HG22 ' A' ' 48' ' ' VAL . 21.9 t -95.12 126.94 47.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 168.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.38 122.73 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-O 121.241 0.543 . . . . 0.0 111.491 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -104.63 143.36 33.18 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.132 1.373 . . . . 0.0 107.693 167.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.8 mt -114.36 113.46 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -102.73 123.57 46.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.29 1.036 . . . . 0.0 110.417 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.66 -169.3 50.58 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.826 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -85.54 110.32 19.13 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.554 0.742 . . . . 0.0 109.487 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.65 HG21 HG13 ' A' ' 52' ' ' VAL . 74.0 p -122.55 148.54 45.08 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.556 1.143 . . . . 0.0 108.963 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -99.9 131.66 24.12 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-N 118.155 0.434 . . . . 0.0 111.962 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.474 ' HD2' HD22 ' A' ' 27' ' ' LEU . 80.9 Cg_endo -76.57 175.92 46.14 Favored 'Cis proline' 0 C--N 1.374 1.883 0 C-N-CA 124.65 -0.979 . . . . 0.0 110.933 -7.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.5 148.43 7.22 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 114.631 0.612 . . . . 0.0 114.631 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -52.26 -35.79 50.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.082 0.953 . . . . 0.0 112.927 -174.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 26' ' ' GLN . 4.1 pp -63.51 -41.24 98.53 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.502 0.321 . . . . 0.0 111.08 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.432 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.4 tp-100 -69.88 -48.43 58.75 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.675 0.79 . . . . 0.0 110.509 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.474 HD22 ' HD2' ' A' ' 22' ' ' PRO . 69.4 mt -56.48 -46.26 80.55 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.259 0.623 . . . . 0.0 111.242 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.437 ' O ' HG23 ' A' ' 32' ' ' VAL . 9.9 m80 -56.57 -43.82 80.37 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.455 0.702 . . . . 0.0 110.677 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.57 -36.74 83.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.81 0.444 . . . . 0.0 111.3 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.557 ' HB3' HG23 ' A' ' 79' ' ' VAL . 23.8 mmt -63.79 -35.2 79.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.188 0.595 . . . . 0.0 110.895 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.8 mt -70.61 -51.17 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.724 0.81 . . . . 0.0 111.244 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 28' ' ' HIS . 64.1 t -66.89 -40.33 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.111 0.564 . . . . 0.0 111.731 -173.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.09 -11.67 61.0 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.098 0.559 . . . . 0.0 111.845 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.405 ' CD2' HD13 ' A' ' 8' ' ' ILE . 22.9 m80 -100.33 20.49 14.67 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.208 1.003 . . . . 0.0 111.107 170.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.404 ' O ' ' HD2' ' A' ' 10' ' ' LYS . . . 72.11 9.44 71.79 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.815 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.86 159.66 46.0 Favored Glycine 0 C--O 1.24 0.518 0 N-CA-C 114.124 0.41 . . . . 0.0 114.124 -170.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -101.89 153.63 19.67 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -144.01 145.81 32.46 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.938 0.495 . . . . 0.0 110.967 -174.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.62 ' HG ' HG21 ' A' ' 47' ' ' THR . 1.5 mm? -130.43 145.88 51.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.039 0.936 . . . . 0.0 109.961 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -109.45 -34.08 6.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.749 0.82 . . . . 0.0 109.069 170.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -117.64 138.47 51.95 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -169.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.481 ' HA ' HG22 ' A' ' 47' ' ' THR . 0.8 OUTLIER -106.32 168.34 9.22 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.346 0.593 . . . . 0.0 110.838 -170.222 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.8 t -135.49 174.35 10.71 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.866 1.266 . . . . 0.0 108.337 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -69.81 -24.63 63.51 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.277 0.56 . . . . 0.0 110.211 172.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -82.13 177.71 8.66 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.353 1.061 . . . . 0.0 111.332 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.29 88.27 0.45 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.62 HG21 ' HG ' ' A' ' 39' ' ' LEU . 3.0 m -84.61 -28.18 26.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.486 -176.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 13' ' ' VAL . 11.5 p -150.09 162.95 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.956 0.903 . . . . 0.0 109.193 -172.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 t -115.86 -18.19 10.82 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.504 0.593 . . . . 0.0 112.237 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -134.04 131.71 39.18 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.418 0.687 . . . . 0.0 110.662 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.596 ' HB ' HG12 ' A' ' 69' ' ' VAL . 54.0 mt -114.73 129.58 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.65 HG13 HG21 ' A' ' 20' ' ' THR . 62.7 t -92.03 129.01 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.89 0.876 . . . . 0.0 109.461 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.99 147.0 30.26 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.114 0.566 . . . . 0.0 110.492 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.0 t -90.07 -34.49 15.9 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -145.65 142.36 28.97 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.191 173.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.73 107.57 4.03 Favored Pre-proline 0 CA--C 1.561 1.37 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.31 159.32 53.78 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.216 2.61 . . . . 0.0 113.061 -175.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.425 ' O ' HG13 ' A' ' 62' ' ' ILE . 65.7 mt -50.99 -49.7 59.87 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.375 1.07 . . . . 0.0 112.432 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -59.56 -45.71 91.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.039 0.536 . . . . 0.0 111.209 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -69.29 -26.03 64.53 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.634 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -73.88 -26.68 60.68 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.721 0.409 . . . . 0.0 111.015 176.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 58' ' ' LEU . 60.8 mt -76.44 -39.27 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.85 -42.01 97.68 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.864 0.866 . . . . 0.0 110.955 174.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -104.01 26.81 8.27 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.081 0.952 . . . . 0.0 110.411 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.12 -19.48 64.04 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 122.842 0.457 . . . . 0.0 111.274 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -75.49 -26.12 57.88 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.839 0.856 . . . . 0.0 110.647 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -111.7 145.42 39.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.999 0.92 . . . . 0.0 109.418 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -85.74 90.6 8.07 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -177.294 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.596 HG12 ' HB ' ' A' ' 51' ' ' ILE . 27.1 m -74.0 127.13 35.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.83 172.59 15.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.827 1.251 . . . . 0.0 109.112 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.7 m -79.44 151.5 74.86 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.99 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.416 ' O ' HG22 ' A' ' 76' ' ' VAL . 26.5 Cg_endo -60.11 -25.35 79.61 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.78 2.32 . . . . 0.0 111.643 170.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -59.12 -23.16 61.89 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.173 1.389 . . . . 0.0 112.149 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -61.3 -46.62 89.56 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.021 0.439 . . . . 0.0 109.921 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.584 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.7 mp -71.86 -47.24 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.113 -177.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 72' ' ' PRO . 61.0 t -54.92 -50.72 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.999 0.92 . . . . 0.0 111.01 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -70.58 -47.52 59.85 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.205 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.446 ' HA ' HD21 ' A' ' 85' ' ' LEU . 79.5 p -63.09 -44.31 96.08 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.281 0.363 . . . . 0.0 111.445 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.557 HG23 ' HB3' ' A' ' 30' ' ' MET . 55.5 t -59.3 -42.8 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.054 0.942 . . . . 0.0 110.738 174.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -68.97 -33.06 73.08 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.033 0.933 . . . . 0.0 111.897 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.38 -11.35 38.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.583 0.753 . . . . 0.0 111.625 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.78 22.43 12.43 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.572 1.149 . . . . 0.0 112.323 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -142.49 156.5 45.16 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.512 0.725 . . . . 0.0 109.552 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.09 117.97 18.35 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.446 HD21 ' HA ' ' A' ' 78' ' ' SER . 4.0 mm? -92.6 144.83 29.33 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 167.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.606 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 38.2 Cg_endo -62.49 124.04 13.5 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.081 1.854 . . . . 0.0 111.587 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -64.15 -19.85 65.58 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.079 0.952 . . . . 0.0 112.469 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.606 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.8 pt20 -59.3 -25.84 64.46 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.928 0.891 . . . . 0.0 111.629 174.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -71.22 -27.07 63.22 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.779 0.832 . . . . 0.0 110.115 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -116.26 2.02 13.2 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.911 0.884 . . . . 0.0 111.975 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.4 p -66.57 110.87 3.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.473 0.709 . . . . 0.0 111.537 -173.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.3 mt -74.87 -16.34 60.68 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.834 173.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 p -47.81 -51.97 20.65 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.724 1.209 . . . . 0.0 111.601 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 CA--C 1.553 1.094 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.129 176.829 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.9 t -83.67 66.7 9.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.396 0.679 . . . . 0.0 109.661 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.7 p -72.41 100.28 2.65 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.028 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -113.92 93.8 4.54 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.879 0.871 . . . . 0.0 108.841 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 m -137.83 131.97 31.9 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.426 1.09 . . . . 0.0 109.581 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.501 ' HB2' ' HD2' ' A' ' 34' ' ' HIS . 17.7 m -62.22 126.04 25.98 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.098 0.559 . . . . 0.0 109.939 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.527 ' HB3' ' HZ2' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -78.35 32.32 0.19 Allowed 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -170.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.549 HG21 ' HA ' ' A' ' 84' ' ' LEU . 43.1 mt -54.83 -48.13 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.609 1.164 . . . . 0.0 111.109 176.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -113.87 10.11 17.66 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.882 -173.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -50.56 -65.75 0.51 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.848 0.859 . . . . 0.0 112.813 -167.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -85.8 -8.56 58.04 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.075 0.464 . . . . 0.0 110.338 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.3 m -79.9 118.02 21.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.698 0.799 . . . . 0.0 110.036 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -90.09 124.78 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 170.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.409 ' HB ' HD11 ' A' ' 31' ' ' ILE . 3.5 mp -116.0 126.32 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.023 0.529 . . . . 0.0 111.727 -178.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -104.96 148.82 26.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.977 1.311 . . . . 0.0 108.421 172.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -120.47 137.78 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -135.24 128.01 31.1 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.512 1.125 . . . . 0.0 108.876 -167.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.46 -159.75 48.7 Favored Glycine 0 C--N 1.343 0.924 0 O-C-N 123.404 0.44 . . . . 0.0 112.073 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -103.21 111.37 23.73 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.283 0.633 . . . . 0.0 109.624 176.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.0 p -119.49 134.64 55.12 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.743 1.217 . . . . 0.0 108.657 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -102.62 133.34 20.53 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 117.896 0.316 . . . . 0.0 110.629 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.02 164.86 85.74 Favored 'Cis proline' 0 C--N 1.384 2.405 0 C-N-CA 124.469 -1.055 . . . . 0.0 112.272 1.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.71 157.99 3.89 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 124.169 0.918 . . . . 0.0 114.556 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -54.65 -37.17 65.37 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.931 0.892 . . . . 0.0 112.478 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 26' ' ' GLN . 3.3 pp -62.96 -43.99 97.29 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.162 0.585 . . . . 0.0 110.804 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.583 ' HG3' ' HE2' ' A' ' 30' ' ' MET . 56.2 tp60 -67.79 -49.8 60.39 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.878 0.871 . . . . 0.0 110.618 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.1 mt -55.15 -51.47 66.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.877 0.871 . . . . 0.0 111.649 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.447 ' HA ' HD12 ' A' ' 31' ' ' ILE . 23.0 m170 -61.35 -35.26 76.93 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.873 0.469 . . . . 0.0 111.649 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.44 ' O ' HD11 ' A' ' 33' ' ' LEU . 43.3 mt-10 -64.23 -46.48 83.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 0.0 110.191 173.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.652 ' HB3' HG22 ' A' ' 79' ' ' VAL . 67.3 mtt -56.68 -37.3 70.66 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.465 0.65 . . . . 0.0 110.499 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.447 HD12 ' HA ' ' A' ' 28' ' ' HIS . 77.2 mt -66.17 -50.65 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.556 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 28' ' ' HIS . 59.3 t -71.06 -29.35 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.144 0.578 . . . . 0.0 111.173 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.44 HD11 ' O ' ' A' ' 29' ' ' GLU . 6.8 mp -64.34 -22.73 67.05 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.515 1.126 . . . . 0.0 110.744 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.501 ' HD2' ' HB2' ' A' ' 6' ' ' SER . 60.6 m80 -105.5 26.93 8.88 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.398 1.079 . . . . 0.0 110.678 173.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.35 18.14 76.62 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.471 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.2 164.41 29.62 Favored Glycine 0 C--O 1.241 0.556 0 N-CA-C 114.179 0.431 . . . . 0.0 114.179 -171.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -113.42 161.79 16.88 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.824 0.849 . . . . 0.0 109.635 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -145.78 154.29 41.86 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 122.715 0.406 . . . . 0.0 111.406 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -121.16 137.64 54.58 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.23 -49.92 9.57 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.619 0.768 . . . . 0.0 112.724 -173.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -166.97 134.48 2.5 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.6 1.56 . . . . 0.0 108.691 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.51 100.76 10.28 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.465 0.706 . . . . 0.0 110.272 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.2 p -92.64 65.49 4.33 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.322 0.649 . . . . 0.0 109.809 175.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.8 t 64.4 12.94 7.71 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.845 1.258 . . . . 0.0 112.527 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -123.62 119.62 30.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.373 0.669 . . . . 0.0 110.624 -174.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 69.3 7.99 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.367 1.067 . . . . 0.0 112.514 -173.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.6 m -91.51 -22.95 20.11 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 121.792 -0.567 . . . . 0.0 111.439 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 p -92.86 152.23 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 122.23 -0.294 . . . . 0.0 111.665 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.447 HG22 ' HD2' ' A' ' 50' ' ' HIS . 10.1 t -114.18 -25.34 8.53 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.348 0.659 . . . . 0.0 111.297 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.447 ' HD2' HG22 ' A' ' 49' ' ' THR . 58.5 m-70 -128.56 125.72 38.86 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.314 0.646 . . . . 0.0 109.742 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.438 ' HB ' HG22 ' A' ' 69' ' ' VAL . 40.4 mt -106.1 138.38 31.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.9 t -117.57 120.21 64.07 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 C-N-CA 123.905 0.882 . . . . 0.0 108.811 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -139.44 159.66 41.65 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.348 0.659 . . . . 0.0 109.612 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.0 t -84.64 -46.42 11.52 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 168.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -140.01 124.34 17.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.809 1.243 . . . . 0.0 108.933 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.4 HD23 HG11 ' A' ' 69' ' ' VAL . 38.7 tp -107.49 128.39 26.02 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.13 153.6 38.27 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.347 2.698 . . . . 0.0 112.832 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.4 mt -59.26 -44.88 92.38 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.707 0.803 . . . . 0.0 111.234 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -61.5 -46.65 89.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.24 1.016 . . . . 0.0 110.191 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -70.91 -24.66 62.5 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.993 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -73.71 -30.81 63.08 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.07 0.548 . . . . 0.0 110.132 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -70.99 -43.38 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.783 0.833 . . . . 0.0 109.957 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.32 -38.34 87.46 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.812 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.404 ' HA ' ' HD1' ' A' ' 67' ' ' TYR . 23.2 m-85 -100.22 26.26 6.7 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.976 0.911 . . . . 0.0 110.744 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 -24.95 66.59 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.291 0.637 . . . . 0.0 112.103 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -80.33 -27.45 38.34 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.072 0.549 . . . . 0.0 110.761 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.404 ' HD1' ' HA ' ' A' ' 64' ' ' PHE . 62.4 m-85 -88.72 141.63 28.35 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.78 0.832 . . . . 0.0 109.641 -177.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -82.97 85.86 7.08 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 51' ' ' ILE . 41.4 t -77.9 128.68 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.266 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.499 HG13 ' HB2' ' A' ' 87' ' ' TRP . 27.7 m -139.96 174.53 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.093 1.357 . . . . 0.0 109.466 -175.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.0 m -87.83 159.88 48.05 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.306 0.642 . . . . 0.0 110.382 171.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -58.66 -23.16 64.38 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.935 2.423 . . . . 0.0 112.485 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.21 -24.34 64.74 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.004 1.322 . . . . 0.0 112.151 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -62.15 -50.78 70.5 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.94 -52.15 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.87 -176.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.19 -54.34 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.245 1.018 . . . . 0.0 111.537 -175.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -72.71 -37.31 67.85 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 123.335 0.397 . . . . 0.0 111.289 -172.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.5 m -63.95 -37.61 88.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.64 0.376 . . . . 0.0 111.234 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.652 HG22 ' HB3' ' A' ' 30' ' ' MET . 40.2 t -72.32 -36.8 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.896 0.878 . . . . 0.0 111.575 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -65.85 -41.09 92.12 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.763 0.425 . . . . 0.0 110.618 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -89.6 -10.33 46.42 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.78 0.832 . . . . 0.0 111.901 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 55.32 37.71 29.29 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.828 1.251 . . . . 0.0 112.226 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -146.76 155.5 42.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.815 0.846 . . . . 0.0 110.048 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.549 ' HA ' HG21 ' A' ' 8' ' ' ILE . 60.9 tp -78.11 94.76 4.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.403 0.681 . . . . 0.0 109.571 -178.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.22 151.74 66.78 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.771 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.66 110.55 0.84 Allowed 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.77 2.313 . . . . 0.0 112.685 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.499 ' HB2' HG13 ' A' ' 70' ' ' VAL . 61.7 p-90 -63.82 -22.23 66.82 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.917 0.887 . . . . 0.0 111.246 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -63.44 -24.16 67.71 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.284 1.034 . . . . 0.0 111.433 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.28 -5.99 58.4 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.232 0.613 . . . . 0.0 111.527 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -126.93 1.42 6.61 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.536 0.734 . . . . 0.0 110.895 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.9 p -68.49 113.46 6.05 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.456 0.702 . . . . 0.0 112.368 -170.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.9 mt -89.78 20.4 4.13 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.008 0.923 . . . . 0.0 111.283 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.5 p -68.4 -27.74 66.48 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.179 0.991 . . . . 0.0 111.553 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.937 176.861 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 58.3 mt . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -87.03 53.6 2.88 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.866 0.866 . . . . 0.0 110.526 -175.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.1 t -146.11 110.7 5.14 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.47 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -73.24 141.14 47.27 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.808 0.843 . . . . 0.0 110.131 178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.1 m 57.97 32.71 22.32 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.549 1.14 . . . . 0.0 112.37 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.5 p -86.68 15.77 5.36 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.008 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.636 ' HZ3' ' HB2' ' A' ' 7' ' ' LYS . 9.5 mtmp? -82.08 35.26 0.43 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.648 1.179 . . . . 0.0 112.103 -174.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.8 mt -50.49 -45.65 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 125.503 1.521 . . . . 0.0 112.243 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 75' ' ' ILE . 63.8 m-85 -108.98 16.49 22.59 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.412 0.685 . . . . 0.0 111.371 -174.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 7' ' ' LYS . 13.6 tptp -50.23 -51.91 40.36 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.035 0.934 . . . . 0.0 113.288 -168.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -99.5 -2.79 35.03 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.407 0.683 . . . . 0.0 111.069 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.6 m -82.2 128.47 34.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.141 0.577 . . . . 0.0 109.904 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.573 HG12 HG22 ' A' ' 48' ' ' VAL . 38.8 t -104.27 119.58 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.416 ' HB ' HD12 ' A' ' 31' ' ' ILE . 4.8 mp -119.62 131.95 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.294 0.638 . . . . 0.0 111.174 -173.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -113.67 150.95 32.49 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.935 1.694 . . . . 0.0 108.165 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.28 132.2 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -139.65 135.6 33.43 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.163 1.385 . . . . 0.0 108.562 -170.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.25 -172.76 54.35 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -92.65 110.41 21.84 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.505 HG22 HG11 ' A' ' 52' ' ' VAL . 65.4 p -113.74 141.57 47.1 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.05 0.94 . . . . 0.0 109.871 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.487 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -104.97 127.25 29.12 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 167.172 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.38 173.84 54.5 Favored 'Cis proline' 0 C--N 1.372 1.769 0 C-N-CA 124.184 -1.173 . . . . 0.0 112.276 -0.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.05 157.2 9.72 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.679 0.612 . . . . 0.0 113.939 -174.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -51.47 -35.45 39.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.127 0.971 . . . . 0.0 111.901 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 26' ' ' GLN . 2.1 pp -56.76 -48.95 76.69 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.049 0.939 . . . . 0.0 112.001 177.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.521 ' N ' HD11 ' A' ' 25' ' ' LEU . 6.8 tp-100 -72.37 -43.55 63.83 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.749 0.819 . . . . 0.0 110.334 -174.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.54 -44.79 96.4 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.854 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.56 ' HA ' HD13 ' A' ' 31' ' ' ILE . 16.5 m170 -61.26 -36.8 81.01 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.102 0.561 . . . . 0.0 111.0 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.19 -45.05 86.38 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.745 0.418 . . . . 0.0 110.632 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.535 ' SD ' HG13 ' A' ' 79' ' ' VAL . 23.9 mmt -59.29 -31.99 69.63 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.349 0.66 . . . . 0.0 111.475 176.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.56 HD13 ' HA ' ' A' ' 28' ' ' HIS . 84.0 mt -69.39 -52.33 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.05 175.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 28' ' ' HIS . 59.9 t -72.29 -38.84 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 122.986 0.514 . . . . 0.0 112.164 -169.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.34 -19.14 64.37 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.199 0.6 . . . . 0.0 111.661 176.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -104.43 25.89 9.63 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.624 0.77 . . . . 0.0 111.4 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.65 14.75 70.24 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.654 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.82 161.17 36.23 Favored Glycine 0 C--O 1.242 0.618 0 N-CA-C 113.954 0.342 . . . . 0.0 113.954 -171.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -103.17 144.61 31.09 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.278 1.031 . . . . 0.0 108.614 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -134.29 145.37 49.01 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 122.961 0.505 . . . . 0.0 110.627 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.41 142.86 50.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.293 1.037 . . . . 0.0 109.277 173.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -109.05 -43.71 4.13 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.919 170.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -120.78 135.67 55.09 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.97 157.65 16.19 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.239 -171.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.4 t -92.77 12.73 22.49 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.532 0.733 . . . . 0.0 110.759 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.4 t 64.25 16.18 9.9 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.763 1.225 . . . . 0.0 110.906 -171.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -122.59 -170.73 2.14 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.069 1.347 . . . . 0.0 108.576 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -75.86 67.76 2.3 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.575 1.179 . . . . 0.0 110.186 174.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -89.01 -1.07 57.93 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.713 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.573 HG22 HG12 ' A' ' 13' ' ' VAL . 9.1 p -162.97 160.11 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.921 0.888 . . . . 0.0 109.436 -172.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.3 t -114.29 -21.27 10.51 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -126.5 139.17 53.43 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.04 0.536 . . . . 0.0 110.225 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.705 ' HB ' HG12 ' A' ' 69' ' ' VAL . 58.1 mt -124.42 129.72 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.505 HG11 HG22 ' A' ' 20' ' ' THR . 51.6 t -104.93 119.05 53.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 C-N-CA 123.741 0.816 . . . . 0.0 110.355 -172.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.07 146.44 35.45 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.6 p -85.38 -10.29 56.47 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.792 0.437 . . . . 0.0 110.613 173.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -156.76 89.05 1.07 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.48 1.112 . . . . 0.0 108.009 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.67 110.18 47.77 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.42 ' O ' ' HG3' ' A' ' 61' ' ' ARG . 54.3 Cg_exo -55.41 151.15 38.51 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.84 3.027 . . . . 0.0 114.001 -176.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 61' ' ' ARG . 95.4 mt -57.2 -46.01 83.25 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 0.0 111.528 -177.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -63.88 -39.81 95.06 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.7 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.57 -34.95 77.99 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 119.431 -0.319 . . . . 0.0 111.657 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 80.0 mtt180 -60.36 -36.04 77.09 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 122.94 0.496 . . . . 0.0 110.69 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.9 mt -71.5 -42.13 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.009 0.923 . . . . 0.0 110.761 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.58 -26.94 61.05 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.204 0.602 . . . . 0.0 111.045 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -110.28 28.72 8.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.488 1.115 . . . . 0.0 109.76 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.54 -22.84 65.51 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -91.99 -26.93 18.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.16 0.584 . . . . 0.0 110.393 176.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -85.86 135.13 33.82 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -83.96 86.48 7.18 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.705 HG12 ' HB ' ' A' ' 51' ' ' ILE . 21.4 m -77.18 127.69 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.117 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 87' ' ' TRP . 35.9 m -136.8 172.3 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.339 1.056 . . . . 0.0 109.735 -175.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.1 m -80.69 154.91 73.62 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.301 172.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.25 -22.04 63.07 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.512 2.141 . . . . 0.0 111.869 171.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.9 -29.61 60.29 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.368 1.467 . . . . 0.0 112.292 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -63.57 -49.06 74.89 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 120.8 0.333 . . . . 0.0 110.34 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . 2.8 mp -68.38 -49.43 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.979 -175.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.1 t -58.48 -53.79 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.791 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 21.1 t0 -72.65 -31.73 65.33 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.081 0.238 . . . . 0.0 111.488 -172.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.563 ' HA ' HD12 ' A' ' 85' ' ' LEU . 58.0 m -63.68 -37.86 88.95 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 120.643 0.258 . . . . 0.0 110.932 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.535 HG13 ' SD ' ' A' ' 30' ' ' MET . 86.3 t -70.87 -36.45 64.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 122.97 0.508 . . . . 0.0 110.787 175.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.471 ' HB3' ' HZ1' ' A' ' 80' ' ' LYS . 9.8 mtpm? -62.49 -45.59 92.3 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.769 0.428 . . . . 0.0 111.06 178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 10.7 mm-40 -85.37 -11.88 53.5 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.252 0.621 . . . . 0.0 111.159 -176.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.26 34.98 10.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.758 1.223 . . . . 0.0 111.691 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -153.67 168.97 24.45 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.448 0.699 . . . . 0.0 110.647 -177.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -86.37 108.39 18.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.293 0.637 . . . . 0.0 109.879 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 78' ' ' SER . 10.8 mp -83.89 152.56 62.8 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.553 0.741 . . . . 0.0 110.654 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.548 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 49.0 Cg_endo -67.1 120.85 7.95 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.459 2.106 . . . . 0.0 111.295 171.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.521 ' HB2' HG11 ' A' ' 70' ' ' VAL . 69.0 p-90 -63.66 -21.67 66.5 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.695 0.798 . . . . 0.0 111.922 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.548 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 21.0 pt20 -59.08 -29.16 67.13 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.061 0.944 . . . . 0.0 111.945 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.62 -21.33 63.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.586 0.754 . . . . 0.0 111.504 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -121.49 9.64 10.31 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.823 0.849 . . . . 0.0 110.852 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.488 ' OG ' HG22 ' A' ' 93' ' ' THR . 41.2 t -72.91 114.33 10.93 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.614 0.766 . . . . 0.0 111.446 -172.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.7 mt -91.46 2.21 56.59 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.723 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.488 HG22 ' OG ' ' A' ' 91' ' ' SER . 6.7 t -74.23 -18.28 60.77 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.602 0.637 . . . . 0.0 111.179 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.7 t . . . . . 0 C--O 1.255 1.355 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.661 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 10' ' ' LYS . 62.8 pttt . . . . . 0 CA--C 1.558 1.253 0 CA-C-O 121.387 0.613 . . . . 0.0 112.227 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.467 HG23 ' HA ' ' A' ' 84' ' ' LEU . 44.7 mt -52.13 -34.7 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 125.714 1.605 . . . . 0.0 113.209 -174.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.419 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 67.8 m-85 -114.34 16.74 17.81 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.482 0.713 . . . . 0.0 110.914 -174.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 7' ' ' LYS . 25.5 tptp -54.67 -43.82 72.77 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.275 1.03 . . . . 0.0 112.899 -169.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -102.98 7.2 39.16 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.362 0.665 . . . . 0.0 111.376 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.1 m -108.37 118.87 37.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.569 0.748 . . . . 0.0 111.24 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.537 HG12 HG23 ' A' ' 48' ' ' VAL . 69.9 t -89.78 125.36 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 164.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.558 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.1 mp -117.55 127.22 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.268 0.556 . . . . 0.0 111.125 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.437 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 19.3 t80 -103.48 150.87 23.47 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.739 1.216 . . . . 0.0 107.869 169.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.552 HG12 ' HB ' ' A' ' 52' ' ' VAL . 65.1 mt -123.03 130.91 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -128.46 141.7 51.31 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.612 1.165 . . . . 0.0 109.476 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.09 -168.37 48.7 Favored Glycine 0 N--CA 1.477 1.401 0 N-CA-C 112.263 -0.335 . . . . 0.0 112.263 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -101.22 108.49 20.15 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.438 HG21 HG12 ' A' ' 52' ' ' VAL . 69.4 p -110.08 139.73 44.9 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.06 0.944 . . . . 0.0 109.433 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -105.96 126.86 29.6 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 170.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -78.81 175.23 47.42 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 124.449 -1.063 . . . . 0.0 111.977 -0.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.22 153.99 5.6 Favored Glycine 0 C--N 1.349 1.263 0 O-C-N 123.948 0.78 . . . . 0.0 114.671 -170.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -57.97 -34.76 70.29 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.665 0.786 . . . . 0.0 111.65 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.7 pp -59.97 -45.9 91.18 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 123.589 0.556 . . . . 0.0 111.14 172.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.532 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.0 tp-100 -67.11 -50.94 59.8 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.801 0.841 . . . . 0.0 111.012 -175.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.0 mt -55.93 -44.55 78.45 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.167 0.587 . . . . 0.0 111.208 177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.558 ' HA ' HD12 ' A' ' 31' ' ' ILE . 30.2 m170 -62.61 -36.66 83.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.889 0.476 . . . . 0.0 111.299 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 46.2 mt-10 -66.16 -41.59 90.15 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.801 0.44 . . . . 0.0 110.713 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.552 ' HB3' HG21 ' A' ' 79' ' ' VAL . 5.6 mmt -60.52 -33.5 72.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.803 0.841 . . . . 0.0 110.721 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.558 HD13 ' HB ' ' A' ' 14' ' ' ILE . 60.0 mt -70.07 -49.77 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.977 0.911 . . . . 0.0 111.007 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 28' ' ' HIS . 80.0 t -61.45 -48.09 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.482 0.713 . . . . 0.0 112.113 -176.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.18 -23.39 66.58 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.222 0.609 . . . . 0.0 111.629 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.5 ' NE2' HG13 ' A' ' 79' ' ' VAL . 40.3 m-70 -95.87 27.03 3.73 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.892 0.877 . . . . 0.0 111.397 175.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.67 78.04 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.724 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.42 175.76 33.4 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 114.203 0.441 . . . . 0.0 114.203 -171.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -128.74 155.45 45.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.167 0.987 . . . . 0.0 108.75 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -138.51 168.72 19.17 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.177 0.513 . . . . 0.0 112.22 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.75 140.89 50.35 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -74.51 -46.36 39.83 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.762 0.825 . . . . 0.0 111.306 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.437 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 71.9 t80 . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 124.578 1.151 . . . . 0.0 109.688 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HA ' ' HE1' ' A' ' 67' ' ' TYR . 95.4 mttt . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 120.894 0.378 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.6 m -120.07 24.25 10.57 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.497 0.719 . . . . 0.0 109.351 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.537 HG23 HG12 ' A' ' 13' ' ' VAL . 6.1 p -154.2 155.82 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.327 0.651 . . . . 0.0 109.608 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.8 t -114.63 -25.81 8.14 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.59 0.756 . . . . 0.0 111.466 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -133.03 138.78 46.91 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.616 0.766 . . . . 0.0 110.236 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.613 ' HB ' HG22 ' A' ' 69' ' ' VAL . 58.1 mt -123.64 143.33 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.562 1.145 . . . . 0.0 108.358 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.552 ' HB ' HG12 ' A' ' 16' ' ' ILE . 97.6 t -115.74 119.79 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.419 0.688 . . . . 0.0 110.287 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.26 157.85 38.73 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.37 0.668 . . . . 0.0 110.032 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.3 t -70.78 -49.36 47.45 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -147.02 147.43 30.67 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 168.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.558 ' HG ' HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -123.46 116.23 28.23 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -173.795 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.532 ' HG2' ' HB2' ' A' ' 60' ' ' LYS . 36.9 Cg_endo -64.68 156.35 61.85 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.132 2.555 . . . . 0.0 113.429 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.07 -47.34 86.78 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.569 1.148 . . . . 0.0 113.58 -167.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -67.16 -26.99 66.92 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 120.953 0.406 . . . . 0.0 110.429 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.532 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 4.6 mptp? -81.47 -23.15 37.61 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.34 -34.24 77.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.2 mt -72.83 -39.57 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.849 0.86 . . . . 0.0 110.228 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 3.1 tp10 -63.06 -34.52 77.76 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.131 0.972 . . . . 0.0 110.435 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -117.6 27.43 9.06 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.499 -175.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.02 67.56 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.294 0.568 . . . . 0.0 111.473 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -76.41 -23.03 53.99 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.404 1.082 . . . . 0.0 111.306 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.401 ' HE1' ' HA ' ' A' ' 46' ' ' LYS . 15.9 m-85 -113.73 126.73 55.56 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.921 0.889 . . . . 0.0 109.272 -174.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.2 87.59 1.11 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.007 0.432 . . . . 0.0 110.315 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.613 HG22 ' HB ' ' A' ' 51' ' ' ILE . 16.5 t -76.08 134.45 29.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.211 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 87' ' ' TRP . 31.8 m -135.74 174.15 12.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.606 1.162 . . . . 0.0 109.531 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.5 t -86.09 152.37 55.79 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 171.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.26 -23.54 46.26 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 122.962 2.442 . . . . 0.0 113.15 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.12 -26.56 64.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.02 0.928 . . . . 0.0 112.26 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -61.02 -44.04 97.99 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.7 mp -75.6 -52.46 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.726 0.81 . . . . 0.0 108.841 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.3 t -54.91 -53.73 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.491 1.116 . . . . 0.0 111.148 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.07 -39.08 66.16 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.546 -173.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 95.5 p -60.58 -41.56 94.92 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 120.905 0.383 . . . . 0.0 110.529 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 30' ' ' MET . 70.8 t -64.51 -42.21 94.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 123.911 0.885 . . . . 0.0 111.066 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -67.61 -29.64 69.03 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.611 0.365 . . . . 0.0 111.441 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -89.78 -14.38 34.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.48 0.712 . . . . 0.0 110.925 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.97 27.38 16.23 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.168 1.387 . . . . 0.0 111.948 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -138.41 165.46 26.75 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.529 0.732 . . . . 0.0 111.02 -173.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.467 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.3 tm? -77.35 133.85 38.63 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 mt -114.18 154.92 46.18 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 123.586 0.754 . . . . 0.0 110.672 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.1 105.7 0.88 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.262 1.975 . . . . 0.0 110.81 171.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.488 ' HB2' HG11 ' A' ' 70' ' ' VAL . 36.3 p90 -66.52 -22.1 66.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.138 0.575 . . . . 0.0 111.588 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -62.44 -29.12 70.28 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.754 0.821 . . . . 0.0 111.476 174.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -67.91 -41.29 82.86 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.1 0.56 . . . . 0.0 109.904 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -93.43 4.8 53.38 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.056 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.9 t -62.14 121.27 12.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.919 0.888 . . . . 0.0 113.222 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -106.3 -0.07 24.67 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.83 0.852 . . . . 0.0 110.752 170.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.425 ' HB ' ' H ' ' A' ' 69' ' ' VAL . 11.9 t -83.3 -15.66 49.24 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.889 0.476 . . . . 0.0 110.49 172.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.252 1.229 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.838 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.419 HD12 ' ND1' ' A' ' 34' ' ' HIS . 66.8 mt -59.32 -42.33 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.637 0.775 . . . . 0.0 111.409 -177.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.423 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 63.7 m-85 -113.85 17.05 18.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.552 0.741 . . . . 0.0 110.868 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -54.55 -55.21 31.66 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 123.75 0.82 . . . . 0.0 112.171 -167.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -91.9 15.14 13.7 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.36 0.664 . . . . 0.0 111.271 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 54.0 t -117.11 120.38 38.16 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 123.986 0.914 . . . . 0.0 109.924 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.424 HG11 HD23 ' A' ' 39' ' ' LEU . 36.5 t -90.84 134.07 30.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 168.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.438 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.7 mp -123.45 123.29 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.046 0.538 . . . . 0.0 110.631 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -102.76 144.18 31.45 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.445 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 41.1 mt -121.68 137.68 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -147.19 136.13 22.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.688 0.795 . . . . 0.0 109.603 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.71 175.3 47.73 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 123.253 0.345 . . . . 0.0 113.156 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -73.93 111.93 9.56 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.107 0.479 . . . . 0.0 110.017 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.573 HG21 HG12 ' A' ' 52' ' ' VAL . 40.4 p -128.14 138.41 52.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.947 1.299 . . . . 0.0 108.226 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -105.33 130.22 23.45 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 118.257 0.48 . . . . 0.0 110.664 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.99 172.22 64.27 Favored 'Cis proline' 0 C--N 1.375 1.95 0 C-N-CA 124.232 -1.154 . . . . 0.0 111.485 -2.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.23 155.67 5.79 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.541 -0.589 . . . . 0.0 113.768 -174.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -55.36 -36.55 66.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.262 0.625 . . . . 0.0 111.809 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 26' ' ' GLN . 3.0 pp -59.3 -40.51 86.39 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.338 0.655 . . . . 0.0 111.738 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.454 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.1 tp-100 -74.27 -43.86 55.16 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.87 0.868 . . . . 0.0 110.509 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.1 -39.75 83.22 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.87 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.439 ' HA ' HD12 ' A' ' 31' ' ' ILE . 15.9 m170 -60.8 -39.21 88.06 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.043 0.937 . . . . 0.0 110.304 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -67.88 -41.18 83.21 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.582 0.552 . . . . 0.0 110.932 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.535 ' SD ' HG11 ' A' ' 79' ' ' VAL . 25.0 mmt -60.17 -32.53 71.14 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.315 0.646 . . . . 0.0 111.748 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 28' ' ' HIS . 70.1 mt -71.07 -52.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.065 175.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.7 t -71.45 -44.84 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.362 0.665 . . . . 0.0 112.045 -170.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.2 -15.76 57.99 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.709 0.804 . . . . 0.0 111.705 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.45 ' NE2' HG13 ' A' ' 79' ' ' VAL . 68.5 m-70 -108.98 27.82 9.1 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.726 0.81 . . . . 0.0 111.154 175.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.85 9.97 86.3 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 114.798 -1.092 . . . . 0.0 114.656 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.423 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -96.13 177.74 34.03 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 114.453 0.541 . . . . 0.0 114.453 -170.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -123.85 150.08 45.0 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.471 0.708 . . . . 0.0 110.038 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -125.0 166.6 16.06 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.49 0.716 . . . . 0.0 110.417 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.424 HD23 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -131.35 141.65 49.93 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.04 -35.05 26.07 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.474 0.71 . . . . 0.0 112.862 -176.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.9 t80 . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 123.992 0.917 . . . . 0.0 109.51 -174.496 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.55 0.949 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.2 m -103.39 -8.94 19.83 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.847 0.859 . . . . 0.0 110.657 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.403 ' HA ' ' HB ' ' A' ' 13' ' ' VAL . 9.5 p -123.98 159.82 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.797 0.839 . . . . 0.0 109.867 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -114.15 -27.72 7.56 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.044 0.538 . . . . 0.0 111.202 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -130.6 129.74 43.11 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.07 0.548 . . . . 0.0 110.591 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 22.5 mt -114.66 138.89 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.645 0.778 . . . . 0.0 109.045 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.573 HG12 HG21 ' A' ' 20' ' ' THR . 63.2 t -104.63 135.36 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 123.985 0.914 . . . . 0.0 109.526 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.03 163.33 39.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.019 0.928 . . . . 0.0 108.908 173.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.3 t -115.56 -49.12 2.75 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -120.06 111.59 18.07 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 tp -129.99 123.01 20.63 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.97 151.9 74.77 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.13 2.554 . . . . 0.0 112.406 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.428 HD23 ' HD2' ' A' ' 61' ' ' ARG . 94.8 mt -59.05 -32.58 69.89 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.531 0.733 . . . . 0.0 111.878 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -60.0 -43.44 95.2 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.335 0.654 . . . . 0.0 110.723 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -75.93 -28.78 58.11 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.724 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.428 ' HD2' HD23 ' A' ' 58' ' ' LEU . 61.6 mtt180 -70.87 -29.32 65.4 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.865 0.466 . . . . 0.0 110.817 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.6 mt -80.13 -37.33 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.537 0.735 . . . . 0.0 110.638 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -61.66 -45.7 92.88 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.683 0.754 . . . . 0.0 110.03 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -99.75 19.47 15.91 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.703 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.67 -18.89 62.15 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.256 0.622 . . . . 0.0 110.415 169.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -70.64 -17.47 62.87 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.897 0.879 . . . . 0.0 110.407 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.17 171.4 7.57 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.602 1.161 . . . . 0.0 109.261 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -99.28 88.13 3.83 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' A' ' 92' ' ' LEU . 39.6 t -74.49 138.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.664 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.04 177.71 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.009 1.324 . . . . 0.0 109.723 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.3 m -87.45 160.07 48.79 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.101 0.96 . . . . 0.0 109.612 172.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.422 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.7 Cg_endo -59.75 -28.0 86.26 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 122.684 2.256 . . . . 0.0 112.223 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -65.88 -16.84 64.21 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.544 1.138 . . . . 0.0 111.969 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.3 t90 -62.69 -45.8 91.08 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 75' ' ' ILE . 3.2 mp -71.16 -50.41 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.706 -177.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.53 HG12 ' HE2' ' A' ' 80' ' ' LYS . 58.8 t -62.3 -50.74 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.878 -173.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -71.57 -33.63 69.25 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.808 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.7 m -61.19 -37.19 82.05 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 117.954 0.343 . . . . 0.0 110.718 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.535 HG11 ' SD ' ' A' ' 30' ' ' MET . 44.4 t -64.6 -47.41 89.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 C-N-CA 123.866 0.866 . . . . 0.0 111.03 173.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.53 ' HE2' HG12 ' A' ' 76' ' ' VAL . 54.3 mtmt -70.17 -26.46 63.92 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.266 0.627 . . . . 0.0 112.118 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -94.99 -15.98 23.1 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.834 0.453 . . . . 0.0 111.248 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.15 28.66 18.28 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.734 1.214 . . . . 0.0 111.84 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -144.96 149.15 34.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.418 1.087 . . . . 0.0 108.603 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.0 tp -72.73 112.07 8.45 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.9 mt -83.88 153.95 64.19 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 123.514 0.725 . . . . 0.0 110.82 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -57.59 122.15 11.26 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.992 2.461 . . . . 0.0 112.454 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -64.2 -32.34 73.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.992 0.517 . . . . 0.0 110.274 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -60.52 -31.62 70.68 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.065 0.946 . . . . 0.0 111.276 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -69.33 -25.08 64.03 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.651 0.781 . . . . 0.0 110.743 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -115.99 4.71 13.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.845 0.858 . . . . 0.0 111.423 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.9 t -66.46 126.7 29.67 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -167.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.425 ' HB2' HG12 ' A' ' 69' ' ' VAL . 49.9 mt -114.68 28.34 8.8 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.057 0.943 . . . . 0.0 110.292 173.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 69' ' ' VAL . 39.7 p -65.78 -38.17 88.3 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.635 0.774 . . . . 0.0 111.027 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.254 1.294 0 C-N-CA 124.302 1.041 . . . . 0.0 109.001 -179.306 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 10' ' ' LYS . 20.9 pttp . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 120.673 0.273 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 52.5 mt -66.08 -50.07 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.816 0.846 . . . . 0.0 110.584 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.41 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 50.4 m-85 -112.26 14.48 20.52 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.143 -176.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.588 ' HB2' ' HA ' ' A' ' 7' ' ' LYS . 52.2 tptt -53.54 -55.63 23.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.064 0.946 . . . . 0.0 113.476 -165.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -100.15 17.52 21.0 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.371 0.605 . . . . 0.0 109.889 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.1 t -113.06 128.39 56.48 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.048 1.339 . . . . 0.0 110.901 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.86 130.34 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.242 1.017 . . . . 0.0 109.295 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.525 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.7 mp -124.42 129.37 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 CA-C-O 121.407 0.622 . . . . 0.0 111.852 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.496 ' HB2' ' HB3' ' A' ' 39' ' ' LEU . 55.2 t80 -104.02 152.39 22.09 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.43 1.892 . . . . 0.0 108.39 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -122.78 137.89 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.066 0.546 . . . . 0.0 109.987 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 15' ' ' TYR . 58.5 t30 -143.74 141.63 30.55 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.39 1.076 . . . . 0.0 109.346 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.27 -178.92 46.49 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 116.467 -0.333 . . . . 0.0 112.699 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -92.9 110.59 22.05 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.98 0.419 . . . . 0.0 109.955 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.612 HG21 HG12 ' A' ' 52' ' ' VAL . 65.0 p -122.59 142.59 50.47 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.715 1.206 . . . . 0.0 109.717 -174.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -96.82 130.76 29.4 Favored Pre-proline 0 N--CA 1.479 0.976 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 167.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.49 176.28 42.31 Favored 'Cis proline' 0 C--N 1.373 1.831 0 C-N-CA 124.758 -0.934 . . . . 0.0 111.666 -4.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.59 152.0 7.66 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.746 0.654 . . . . 0.0 114.07 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -54.01 -34.97 61.36 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.251 1.02 . . . . 0.0 112.263 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 pp -58.09 -48.28 80.63 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.898 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -73.5 -41.77 62.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.355 0.662 . . . . 0.0 111.614 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.493 HD13 HG11 ' A' ' 52' ' ' VAL . 29.1 mt -58.34 -44.58 88.78 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.033 0.533 . . . . 0.0 110.641 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.436 ' O ' HG23 ' A' ' 32' ' ' VAL . 16.8 m170 -65.79 -34.97 79.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.567 0.347 . . . . 0.0 111.498 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -62.85 -42.2 99.66 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 117.847 0.294 . . . . 0.0 110.443 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.638 ' HB3' HG21 ' A' ' 79' ' ' VAL . 22.9 mmt -62.26 -39.06 91.64 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.881 0.872 . . . . 0.0 110.677 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.525 HD13 ' HB ' ' A' ' 14' ' ' ILE . 71.1 mt -65.87 -51.55 59.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.044 0.938 . . . . 0.0 111.463 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 28' ' ' HIS . 99.9 t -68.56 -43.67 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 122.901 0.48 . . . . 0.0 111.599 -173.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.67 -17.8 63.32 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.271 0.629 . . . . 0.0 111.795 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.424 ' NE2' HG13 ' A' ' 79' ' ' VAL . 55.5 m-70 -108.91 26.51 10.51 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.675 0.79 . . . . 0.0 111.581 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.9 -0.33 72.87 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.615 -0.721 . . . . 0.0 114.821 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . -92.52 173.97 36.0 Favored Glycine 0 C--O 1.237 0.342 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 -166.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -117.4 159.33 22.94 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.605 1.162 . . . . 0.0 109.63 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -125.27 156.63 38.28 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.764 0.826 . . . . 0.0 110.987 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.617 ' HG ' ' HB ' ' A' ' 48' ' ' VAL . 2.4 tm? -134.65 129.38 34.76 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.74 -43.36 22.74 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.9 t80 . . . . . 0 N--CA 1.474 0.76 0 C-N-CA 124.172 0.989 . . . . 0.0 109.727 -170.327 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.8 p -83.44 -18.74 37.61 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.072 0.549 . . . . 0.0 111.111 -174.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.617 ' HB ' ' HG ' ' A' ' 39' ' ' LEU . 9.8 p -136.93 156.62 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.481 0.712 . . . . 0.0 109.858 176.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.6 t -114.51 -25.31 8.41 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.436 0.695 . . . . 0.0 111.127 175.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.408 ' HB2' HG13 ' A' ' 14' ' ' ILE . 76.5 m80 -132.55 130.47 40.39 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.939 0.495 . . . . 0.0 110.616 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.64 ' HB ' HG12 ' A' ' 69' ' ' VAL . 66.7 mt -114.98 135.21 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.612 HG12 HG21 ' A' ' 20' ' ' THR . 87.5 t -91.79 129.1 42.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.26 145.93 29.59 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.5 t -88.46 -39.15 14.44 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -143.96 139.73 29.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.476 1.11 . . . . 0.0 108.264 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.3 tp -128.07 128.38 23.76 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.97 150.29 73.56 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.066 2.51 . . . . 0.0 112.317 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.2 mt -57.22 -39.83 76.26 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.946 0.898 . . . . 0.0 111.339 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.28 -43.36 99.01 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.404 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -76.64 -20.79 56.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.603 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -66.43 -41.22 89.53 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 171.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.1 mt -65.41 -43.54 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 123.717 0.636 . . . . 0.0 110.797 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.63 -42.26 82.59 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.365 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -100.36 23.33 10.31 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.549 0.74 . . . . 0.0 110.674 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.63 -27.44 67.69 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.409 0.683 . . . . 0.0 111.386 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -71.3 -19.37 62.33 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.938 0.895 . . . . 0.0 111.239 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -108.9 143.89 37.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.882 0.873 . . . . 0.0 109.204 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.04 86.17 4.23 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.64 HG12 ' HB ' ' A' ' 51' ' ' ILE . 7.6 m -78.3 127.82 38.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.22 171.41 18.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.284 1.034 . . . . 0.0 109.667 -172.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.1 m -77.92 150.25 78.01 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.399 170.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.83 -25.86 78.17 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.332 2.021 . . . . 0.0 111.39 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.7 -29.38 52.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.387 1.475 . . . . 0.0 112.271 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -60.29 -54.37 46.5 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.487 ' H ' HD12 ' A' ' 75' ' ' ILE . 3.4 mp -64.15 -48.04 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 124.227 0.955 . . . . 0.0 109.165 -175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.68 -52.24 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.835 1.254 . . . . 0.0 111.462 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.78 -33.29 66.2 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.74 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.467 ' HA ' HD13 ' A' ' 85' ' ' LEU . 61.9 m -62.34 -35.38 78.9 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.925 0.49 . . . . 0.0 111.361 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 30' ' ' MET . 71.4 t -69.5 -44.34 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.37 0.668 . . . . 0.0 110.863 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.5 -43.25 89.0 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.525 0.679 . . . . 0.0 110.843 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.626 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 64.7 mm-40 -82.65 -21.49 34.99 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.856 -176.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.66 24.93 12.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.241 1.017 . . . . 0.0 111.173 -173.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.626 ' HE ' ' HB3' ' A' ' 81' ' ' GLU . 9.2 ptp180 -134.81 166.02 23.95 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.457 0.703 . . . . 0.0 109.656 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -86.25 116.14 24.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.317 0.647 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 78' ' ' SER . 11.3 mp -90.17 155.19 47.07 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.745 0.818 . . . . 0.0 110.198 172.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.54 109.43 2.62 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.066 1.844 . . . . 0.0 110.755 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -62.38 -25.55 67.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.48 0.712 . . . . 0.0 111.725 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -57.92 -29.54 65.21 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.212 1.005 . . . . 0.0 111.64 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -75.6 -34.48 60.63 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.873 0.869 . . . . 0.0 111.046 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -96.34 -1.05 48.59 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.58 0.752 . . . . 0.0 111.253 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.2 t -72.67 115.59 12.12 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.45 0.7 . . . . 0.0 112.068 -170.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.6 mt -79.31 4.91 13.78 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.934 0.893 . . . . 0.0 111.898 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.2 p -62.4 -21.95 65.78 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.75 0.82 . . . . 0.0 111.463 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.255 1.377 0 C-N-CA 125.832 1.653 . . . . 0.0 111.189 176.253 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.2 mt -57.78 -46.87 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.033 1.333 . . . . 0.0 111.669 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 50.9 m-85 -112.53 17.01 19.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.607 0.763 . . . . 0.0 110.828 -174.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -57.16 -44.05 83.09 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.693 0.797 . . . . 0.0 112.47 -171.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -92.05 -5.81 52.2 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.475 0.31 . . . . 0.0 111.365 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.6 m -97.55 125.84 42.49 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.525 0.678 . . . . 0.0 111.242 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.531 HG12 HG23 ' A' ' 48' ' ' VAL . 36.9 t -103.52 130.6 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 169.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 3.2 mp -118.31 136.01 56.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 123.81 0.844 . . . . 0.0 111.147 -174.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -115.45 119.7 37.07 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 124.422 1.089 . . . . 0.0 108.465 169.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.9 mt -92.36 138.28 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.164 0.586 . . . . 0.0 109.508 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -147.16 136.94 23.05 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.049 0.94 . . . . 0.0 110.098 -166.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.36 -154.17 50.18 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.266 0.354 . . . . 0.0 113.465 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -78.1 128.63 34.11 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 172.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.2 p -146.68 126.86 13.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.672 1.189 . . . . 0.0 108.512 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -114.28 135.76 22.22 Favored Pre-proline 0 N--CA 1.481 1.102 0 CA-C-N 118.212 0.46 . . . . 0.0 111.141 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.11 175.12 38.98 Favored 'Cis proline' 0 C--N 1.379 2.161 0 C-N-CA 124.827 -0.905 . . . . 0.0 112.264 -1.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.58 141.09 9.87 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 124.126 0.891 . . . . 0.0 113.392 -175.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -50.29 -34.66 24.25 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.347 1.059 . . . . 0.0 112.904 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 pp -54.55 -45.7 73.51 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.803 0.441 . . . . 0.0 111.581 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -73.12 -45.41 57.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.976 0.91 . . . . 0.0 110.719 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.3 -44.84 76.1 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.724 0.64 . . . . 0.0 111.306 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -58.96 -40.54 85.04 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.768 0.827 . . . . 0.0 110.638 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.89 -39.87 87.58 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.336 0.397 . . . . 0.0 111.195 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.547 ' HB3' HG21 ' A' ' 79' ' ' VAL . 24.4 mmt -63.37 -33.1 74.79 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.981 0.513 . . . . 0.0 111.355 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.4 mt -72.48 -51.56 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.559 0.744 . . . . 0.0 111.003 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.03 -44.95 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.218 0.607 . . . . 0.0 111.681 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.8 -11.82 56.6 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.531 0.732 . . . . 0.0 111.805 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -113.3 27.23 9.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.71 0.804 . . . . 0.0 111.594 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.57 -6.16 83.86 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.283 -0.872 . . . . 0.0 114.764 167.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.13 156.88 42.34 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 113.944 0.338 . . . . 0.0 113.944 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -108.99 169.71 8.51 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 43.6 p90 -144.27 151.01 38.82 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.79 127.48 53.74 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.656 169.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -33.95 76.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.079 172.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.1 p90 . . . . . 0 C--O 1.241 0.643 0 C-N-CA 124.608 1.163 . . . . 0.0 109.01 173.539 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.19 0.519 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.3 m -108.1 -36.27 6.36 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.73 0.812 . . . . 0.0 110.496 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.531 HG23 HG12 ' A' ' 13' ' ' VAL . 6.9 p -93.29 157.77 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.086 0.554 . . . . 0.0 110.224 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 t -111.27 -32.63 6.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.969 0.508 . . . . 0.0 111.639 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -119.93 138.51 53.4 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.77 0.828 . . . . 0.0 109.088 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.685 ' HB ' HG12 ' A' ' 69' ' ' VAL . 52.7 mt -124.37 138.14 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.55 122.07 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.945 0.898 . . . . 0.0 110.378 -175.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.11 156.97 45.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.665 1.186 . . . . 0.0 108.075 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.1 t -76.23 -38.88 55.77 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -147.84 138.17 22.95 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.075 173.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.1 tp -116.49 124.57 29.31 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.61 156.59 36.25 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.564 2.842 . . . . 0.0 112.666 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.406 HD23 ' HD2' ' A' ' 61' ' ' ARG . 97.0 mt -60.01 -41.96 93.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.832 0.853 . . . . 0.0 112.039 -174.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -57.57 -41.76 81.72 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.671 0.789 . . . . 0.0 110.462 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.39 -23.45 46.78 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.823 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HD2' HD23 ' A' ' 58' ' ' LEU . 99.6 mtt180 -70.73 -33.85 71.28 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.405 0.548 . . . . 0.0 110.656 173.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.7 -45.52 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.485 0.714 . . . . 0.0 109.997 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.68 -50.82 65.5 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.054 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.436 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 18.7 m-85 -92.67 26.35 2.73 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.442 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.63 -29.89 70.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.429 0.692 . . . . 0.0 111.38 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -77.52 -25.82 50.6 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.22 0.608 . . . . 0.0 111.062 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.436 ' CD1' ' HA ' ' A' ' 64' ' ' PHE . 10.3 m-85 -89.47 145.92 24.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.744 0.818 . . . . 0.0 109.638 -177.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 68' ' ' LYS . 11.3 mptt -87.03 86.67 7.33 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.685 HG12 ' HB ' ' A' ' 51' ' ' ILE . 21.6 m -81.63 131.18 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.422 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.97 174.43 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.622 1.169 . . . . 0.0 110.112 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -82.78 157.21 67.12 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.795 0.838 . . . . 0.0 110.549 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.72 -23.28 75.84 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.672 2.248 . . . . 0.0 111.864 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.35 -27.42 65.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.331 1.452 . . . . 0.0 111.774 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -61.68 -48.71 79.55 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.506 0.504 . . . . 0.0 110.223 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.4 mp -67.47 -49.3 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.057 -175.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.2 -52.42 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.342 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.78 -36.19 70.26 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.113 -172.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.1 m -66.07 -40.34 90.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.014 0.525 . . . . 0.0 111.312 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.547 HG21 ' HB3' ' A' ' 30' ' ' MET . 23.8 t -64.88 -44.0 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.533 0.733 . . . . 0.0 110.799 178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -65.16 -36.67 84.94 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.676 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.534 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 48.0 mm-40 -86.24 -8.74 57.54 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.11 19.03 8.29 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.7 1.2 . . . . 0.0 112.763 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.534 ' HE ' ' HB3' ' A' ' 81' ' ' GLU . 13.5 ptp180 -134.21 161.85 33.77 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.509 0.724 . . . . 0.0 109.932 -172.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.8 tp -84.03 113.19 20.84 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 172.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.02 154.42 55.05 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 123.456 0.702 . . . . 0.0 109.968 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.1 117.12 3.96 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.232 1.954 . . . . 0.0 110.931 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -59.76 -27.88 66.91 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.561 0.744 . . . . 0.0 111.672 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -62.21 -25.78 67.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.481 1.113 . . . . 0.0 112.352 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -68.55 -26.99 65.69 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.588 0.755 . . . . 0.0 110.938 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -117.19 5.03 12.66 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.773 0.829 . . . . 0.0 111.114 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.6 t -72.7 125.26 27.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.136 0.574 . . . . 0.0 111.918 -171.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.4 mt -93.39 13.07 22.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.015 0.926 . . . . 0.0 111.862 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.5 p -61.7 -28.33 69.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.273 0.629 . . . . 0.0 110.654 174.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 125.075 1.35 . . . . 0.0 111.481 171.098 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.8 mttm . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.1 -46.98 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 124.154 0.982 . . . . 0.0 112.32 -168.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.439 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 55.5 m-85 -114.8 15.86 17.41 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.705 0.402 . . . . 0.0 111.292 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -64.85 -32.65 74.46 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 122.724 0.41 . . . . 0.0 111.928 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -96.96 6.75 48.07 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.839 0.456 . . . . 0.0 111.685 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 76.3 m -120.82 130.46 53.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.371 0.669 . . . . 0.0 111.477 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.494 HG12 HG23 ' A' ' 48' ' ' VAL . 39.1 t -96.95 131.8 42.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 167.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.411 HG23 HG23 ' A' ' 52' ' ' VAL . 3.6 mp -119.31 124.05 72.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.512 0.725 . . . . 0.0 110.648 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -105.97 109.74 21.79 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 166.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.5 mt -78.04 135.17 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -137.16 122.81 19.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.102 0.961 . . . . 0.0 109.257 -169.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.39 -179.13 29.8 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.406 0.441 . . . . 0.0 113.248 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -71.63 108.47 5.0 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.416 HG21 HG12 ' A' ' 52' ' ' VAL . 71.0 p -111.25 148.65 32.4 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 124.963 1.305 . . . . 0.0 108.897 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 11.2 mmpt? -107.35 122.05 42.52 Favored Pre-proline 0 N--CA 1.482 1.164 0 CA-C-N 118.229 0.468 . . . . 0.0 110.77 172.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -82.55 176.03 37.37 Favored 'Cis proline' 0 C--N 1.368 1.571 0 C-N-CA 123.939 -1.276 . . . . 0.0 111.78 0.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.17 154.04 6.89 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.704 0.628 . . . . 0.0 114.19 -173.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -55.38 -36.58 66.52 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.547 0.739 . . . . 0.0 111.858 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.9 pp -61.12 -40.69 94.74 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 123.859 0.724 . . . . 0.0 111.826 176.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.456 ' N ' HD12 ' A' ' 25' ' ' LEU . 61.1 tp60 -73.33 -46.52 48.88 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.324 0.649 . . . . 0.0 110.145 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 72' ' ' PRO . 66.3 mt -58.09 -39.24 78.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.68 0.792 . . . . 0.0 111.029 174.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -57.38 -42.72 82.71 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.752 0.821 . . . . 0.0 110.385 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -64.84 -43.39 93.23 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 79.1 mmm -62.81 -34.48 77.39 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.249 0.62 . . . . 0.0 111.212 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.6 mt -75.24 -54.94 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.486 0.714 . . . . 0.0 111.617 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.0 t -72.09 -40.18 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.224 0.61 . . . . 0.0 112.122 -166.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.48 -21.6 64.33 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.528 0.731 . . . . 0.0 111.677 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.475 ' NE2' HG13 ' A' ' 79' ' ' VAL . 60.2 m80 -105.12 26.97 8.66 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.305 1.042 . . . . 0.0 110.635 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.84 -3.74 83.11 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.853 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.49 151.79 47.03 Favored Glycine 0 C--O 1.239 0.421 0 N-CA-C 115.771 1.069 . . . . 0.0 115.771 -167.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -106.77 143.96 34.11 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -127.1 149.34 49.98 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.131 0.572 . . . . 0.0 109.724 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.25 123.47 49.32 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 175.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.55 -39.29 88.46 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.245 0.618 . . . . 0.0 112.109 -172.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.3 t80 . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 124.432 1.093 . . . . 0.0 108.716 -175.25 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.1 m -119.97 18.34 12.47 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-O 121.182 0.515 . . . . 0.0 110.71 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.494 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -144.31 147.98 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 122.016 -0.428 . . . . 0.0 110.451 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.5 t -103.79 -32.37 9.37 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.574 0.75 . . . . 0.0 111.725 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -126.06 128.76 47.9 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.5 0.72 . . . . 0.0 109.845 -175.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 41.4 mt -114.39 121.9 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.57 0.748 . . . . 0.0 109.275 175.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.416 HG12 HG21 ' A' ' 20' ' ' THR . 64.0 t -92.32 121.6 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.113 0.565 . . . . 0.0 110.022 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.0 154.07 49.36 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.207 0.603 . . . . 0.0 110.167 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.7 t -95.26 -34.61 12.14 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -140.87 120.85 13.64 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.589 ' HG ' HG11 ' A' ' 69' ' ' VAL . 2.2 tm? -127.43 108.96 21.07 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.04 155.11 70.07 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.846 2.364 . . . . 0.0 112.394 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 61' ' ' ARG . 70.6 mt -64.16 -29.74 70.84 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -172.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -59.36 -48.96 79.66 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.512 0.672 . . . . 0.0 110.298 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -76.01 -19.71 58.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.45 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 10.6 tpp85 -67.64 -40.39 84.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.41 0.684 . . . . 0.0 109.767 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.0 mt -77.06 -35.8 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.063 0.945 . . . . 0.0 110.488 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -69.16 -30.53 68.78 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.465 0.706 . . . . 0.0 111.032 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -115.55 28.64 8.53 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.205 1.002 . . . . 0.0 110.042 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.93 -33.47 75.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.509 0.724 . . . . 0.0 111.626 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -77.36 -26.72 52.24 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.004 0.522 . . . . 0.0 110.82 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -78.64 141.48 37.96 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -83.89 85.8 7.26 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.36 0.664 . . . . 0.0 109.353 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' A' ' 56' ' ' LEU . 57.3 t -78.21 127.59 38.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 174.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.05 173.78 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.139 0.975 . . . . 0.0 110.19 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.3 m -81.46 152.92 70.79 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.818 0.847 . . . . 0.0 110.402 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HB3' HD11 ' A' ' 27' ' ' LEU . 21.6 Cg_endo -59.62 -25.49 79.1 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.964 2.443 . . . . 0.0 112.698 173.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.67 -19.75 66.03 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.051 0.941 . . . . 0.0 112.047 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -59.37 -43.05 92.91 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.923 0.489 . . . . 0.0 109.83 173.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 75' ' ' ILE . 3.2 mp -75.55 -49.55 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.128 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.1 t -59.76 -51.73 69.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.321 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -71.22 -39.57 71.63 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.267 -175.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.8 p -63.62 -37.75 88.51 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 120.822 0.344 . . . . 0.0 111.699 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.475 HG13 ' NE2' ' A' ' 34' ' ' HIS . 33.4 t -62.38 -46.1 97.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 123.719 0.807 . . . . 0.0 110.696 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.1 -37.24 86.41 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.203 0.601 . . . . 0.0 111.542 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -83.96 -12.56 55.15 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.499 0.72 . . . . 0.0 111.594 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.52 26.06 15.86 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.136 1.374 . . . . 0.0 112.582 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -140.86 161.9 36.73 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.327 1.051 . . . . 0.0 109.32 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.6 tp -87.72 128.58 35.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 172.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 mp -93.56 153.39 41.28 Favored Pre-proline 0 C--O 1.241 0.646 0 C-N-CA 123.865 0.866 . . . . 0.0 108.953 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.616 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 30.0 Cg_endo -65.23 140.96 66.94 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.768 1.645 . . . . 0.0 111.865 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -57.76 -33.24 68.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.696 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.616 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 30.0 pt20 -57.7 -34.2 69.2 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.666 1.186 . . . . 0.0 113.046 -170.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.51 ' OD1' ' HG2' ' A' ' 86' ' ' PRO . 14.2 m120 -67.32 -36.02 80.61 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.576 0.35 . . . . 0.0 111.706 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -107.81 3.34 24.33 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.521 0.728 . . . . 0.0 111.31 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.9 t -67.82 118.7 11.4 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.627 0.771 . . . . 0.0 112.639 -170.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.5 mt -86.49 -35.36 19.65 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.055 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.8 t -57.41 -33.87 68.33 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 123.422 0.689 . . . . 0.0 111.614 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 p . . . . . 0 C--O 1.253 1.247 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.127 176.09 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.523 HD12 ' HD2' ' A' ' 34' ' ' HIS . 40.5 mt -66.94 -39.08 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.632 1.173 . . . . 0.0 112.734 -166.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.505 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 68.6 m-85 -113.21 16.9 19.0 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.195 0.598 . . . . 0.0 110.961 -176.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -60.14 -39.6 86.88 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -169.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -94.87 11.0 33.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.961 -0.462 . . . . 0.0 111.471 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 83.2 m -122.9 135.58 54.56 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.611 0.764 . . . . 0.0 112.095 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 37' ' ' LYS . 50.0 t -104.21 134.25 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 167.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.497 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.6 mp -126.07 122.73 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 121.255 0.55 . . . . 0.0 111.107 -174.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -102.99 152.31 21.47 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.59 1.556 . . . . 0.0 107.98 174.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.1 mt -121.96 127.08 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -128.35 139.85 52.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.163 0.985 . . . . 0.0 109.565 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.65 -161.22 46.08 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.593 0.558 . . . . 0.0 112.443 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -102.19 113.12 26.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.633 0.773 . . . . 0.0 109.479 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.492 HG21 HG12 ' A' ' 52' ' ' VAL . 79.5 p -117.93 137.65 52.69 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.851 0.86 . . . . 0.0 109.829 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -106.02 125.83 32.14 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 165.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -76.72 165.16 85.81 Favored 'Cis proline' 0 C--N 1.374 1.903 0 C-N-CA 124.027 -1.239 . . . . 0.0 111.837 2.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.0 161.57 6.41 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 123.906 0.754 . . . . 0.0 114.656 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -55.8 -36.07 67.02 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.525 0.73 . . . . 0.0 111.179 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.535 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.6 pp -61.95 -42.0 98.62 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 123.753 0.658 . . . . 0.0 111.678 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.535 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.3 tp-100 -69.56 -52.24 28.06 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.328 0.651 . . . . 0.0 110.342 -175.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.528 HD13 HG11 ' A' ' 52' ' ' VAL . 71.2 mt -57.8 -44.28 86.22 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.53 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.483 ' HA ' HD12 ' A' ' 31' ' ' ILE . 13.7 m170 -61.79 -37.59 84.9 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.063 0.545 . . . . 0.0 111.321 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 52.0 mm-40 -63.28 -45.84 89.59 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.021 0.439 . . . . 0.0 110.014 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.424 ' HB3' HG21 ' A' ' 79' ' ' VAL . 25.6 mmt -60.77 -37.77 83.0 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.63 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.497 HD13 ' HB ' ' A' ' 14' ' ' ILE . 75.5 mt -62.8 -50.81 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.043 0.537 . . . . 0.0 110.981 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.65 -45.62 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.064 0.546 . . . . 0.0 111.62 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.69 -18.89 65.61 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.275 0.63 . . . . 0.0 111.848 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.523 ' HD2' HD12 ' A' ' 8' ' ' ILE . 21.0 m80 -103.76 27.1 7.82 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.423 0.689 . . . . 0.0 111.108 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.76 -3.25 87.39 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.836 166.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -91.82 171.24 34.27 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 -170.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HB2' HG22 ' A' ' 13' ' ' VAL . 42.0 mmtm -110.24 158.07 18.78 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.457 0.703 . . . . 0.0 109.736 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -133.31 153.23 51.76 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.766 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.483 HD23 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -112.2 136.52 51.51 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.25 -35.03 21.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.507 0.723 . . . . 0.0 112.056 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.0 t80 . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 124.413 1.085 . . . . 0.0 108.983 -175.967 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.2 mttt . . . . . 0 CA--C 1.544 0.718 0 CA-C-O 121.612 0.72 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.8 m -84.66 5.15 29.24 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.349 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.404 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -137.04 150.72 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.856 0.862 . . . . 0.0 109.776 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.8 t -101.9 -38.18 7.92 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.058 0.543 . . . . 0.0 110.946 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.49 ' HB2' HG13 ' A' ' 14' ' ' ILE . 6.7 m-70 -118.5 133.59 55.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.285 0.634 . . . . 0.0 109.442 -172.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.659 ' HB ' HG12 ' A' ' 69' ' ' VAL . 65.5 mt -123.63 134.14 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.528 HG11 HD13 ' A' ' 27' ' ' LEU . 52.1 t -92.69 128.96 43.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.03 143.86 28.7 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.4 t -92.78 -41.44 10.11 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 166.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -145.42 120.43 10.04 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.616 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.8 mt -92.21 148.82 37.43 Favored Pre-proline 0 C--O 1.24 0.583 0 C-N-CA 123.219 0.607 . . . . 0.0 109.678 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.72 157.42 37.67 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.808 2.339 . . . . 0.0 110.849 166.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.8 mt -53.3 -53.71 46.97 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.426 0.69 . . . . 0.0 112.105 -171.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.98 -46.19 90.35 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.38 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -72.67 -19.39 61.43 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.241 0.616 . . . . 0.0 112.251 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -72.84 -40.53 65.66 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 81.4 mt -66.88 -45.6 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.457 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.44 -40.3 73.85 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.074 0.55 . . . . 0.0 111.678 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.86 17.98 4.46 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.194 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.08 -26.51 61.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.697 0.399 . . . . 0.0 110.296 167.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -70.81 -27.27 63.76 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.301 0.641 . . . . 0.0 110.407 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -90.44 153.88 20.07 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.424 ' HE2' ' H ' ' A' ' 68' ' ' LYS . 0.5 OUTLIER -84.86 85.31 7.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.109 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.659 HG12 ' HB ' ' A' ' 51' ' ' ILE . 31.6 m -85.08 129.85 37.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.835 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 m -134.98 171.56 17.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.502 1.121 . . . . 0.0 109.653 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.6 m -78.8 153.6 78.06 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.049 172.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.08 -24.95 52.02 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.743 2.296 . . . . 0.0 112.401 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.68 -27.1 48.32 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.878 1.271 . . . . 0.0 112.769 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -65.07 -45.16 86.45 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.227 0.537 . . . . 0.0 110.395 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 79' ' ' VAL . 3.2 mp -73.96 -45.5 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.74 -176.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 68.8 t -57.7 -49.8 79.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.908 0.883 . . . . 0.0 110.968 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.488 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 25.9 t70 -70.66 -35.18 72.73 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.85 0.46 . . . . 0.0 111.459 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB2' HG21 ' A' ' 8' ' ' ILE . 78.4 p -66.26 -37.33 85.23 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 120.428 0.156 . . . . 0.0 110.71 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 75' ' ' ILE . 72.6 t -64.08 -42.5 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.487 0.715 . . . . 0.0 110.771 173.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' A' ' 77' ' ' ASP . 8.2 mtpm? -63.41 -45.64 90.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.661 0.784 . . . . 0.0 111.485 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -93.79 -9.54 37.17 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.972 0.509 . . . . 0.0 112.197 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.61 36.42 22.65 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.203 1.001 . . . . 0.0 111.729 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -150.74 167.21 28.09 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.764 0.826 . . . . 0.0 110.159 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.28 106.14 18.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.21 146.77 67.72 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.466 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 17.9 Cg_endo -58.88 113.86 1.75 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.33 2.02 . . . . 0.0 111.838 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -57.56 -24.53 56.7 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.498 1.119 . . . . 0.0 111.665 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.466 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.6 pt20 -58.37 -27.9 64.64 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 124.545 1.138 . . . . 0.0 112.507 -176.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -79.33 -18.83 51.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.178 0.591 . . . . 0.0 112.091 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -110.14 1.94 19.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.813 0.845 . . . . 0.0 111.232 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m -65.82 122.5 17.46 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.622 0.769 . . . . 0.0 112.377 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.0 mt -98.83 15.2 26.22 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.631 0.772 . . . . 0.0 110.286 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -64.4 -23.53 67.32 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.573 1.149 . . . . 0.0 111.661 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 C--O 1.25 1.1 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.09 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 121.101 0.477 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.9 mt -67.85 -49.65 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.35 1.06 . . . . 0.0 111.31 -172.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -110.28 12.02 23.34 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.432 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -58.72 -35.93 73.46 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.184 0.593 . . . . 0.0 111.651 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -108.1 16.94 22.88 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.662 0.785 . . . . 0.0 110.894 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 77.4 m -121.03 114.65 21.8 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 123.847 0.859 . . . . 0.0 110.485 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.442 HG12 HG23 ' A' ' 48' ' ' VAL . 48.6 t -97.81 125.12 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 168.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.439 HG23 HG23 ' A' ' 52' ' ' VAL . 3.2 mp -115.7 129.67 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.23 1.012 . . . . 0.0 111.356 -175.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -111.74 118.58 35.99 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 167.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.1 mt -83.28 133.74 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -137.2 125.54 23.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.63 1.172 . . . . 0.0 108.374 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.19 -176.22 51.88 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 -174.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' O ' ' HB3' ' A' ' 54' ' ' SER . 72.8 m-85 -88.01 112.34 22.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 122.813 0.445 . . . . 0.0 109.808 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.422 HG21 HG12 ' A' ' 52' ' ' VAL . 41.3 p -107.83 146.27 32.5 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.749 1.22 . . . . 0.0 109.652 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -110.87 124.54 32.72 Favored Pre-proline 0 N--CA 1.485 1.305 0 CA-C-N 117.665 0.211 . . . . 0.0 111.004 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.12 173.64 57.01 Favored 'Cis proline' 0 C--N 1.375 1.955 0 C-N-CA 124.196 -1.168 . . . . 0.0 112.043 3.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.69 149.66 10.32 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 123.749 0.656 . . . . 0.0 114.535 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -50.13 -38.49 39.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.61 1.164 . . . . 0.0 112.638 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 26' ' ' GLN . 1.4 pp -63.66 -39.45 94.36 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 122.968 0.507 . . . . 0.0 111.98 175.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.499 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.8 tp-100 -73.27 -48.61 33.32 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.093 0.957 . . . . 0.0 110.645 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 72' ' ' PRO . 88.7 mt -56.08 -45.61 79.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.522 0.729 . . . . 0.0 111.311 174.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -54.98 -39.01 68.55 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.678 0.611 . . . . 0.0 111.151 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -64.07 -46.92 82.18 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.778 0.323 . . . . 0.0 110.593 173.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.667 ' HB3' HG21 ' A' ' 79' ' ' VAL . 36.9 mmt -62.56 -35.01 78.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.534 0.734 . . . . 0.0 112.147 -175.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.9 mt -72.35 -53.68 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.566 0.746 . . . . 0.0 111.074 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.5 t -75.0 -37.22 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.878 -167.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.19 -13.84 62.64 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.751 0.82 . . . . 0.0 111.58 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.423 ' NE2' HG13 ' A' ' 79' ' ' VAL . 21.2 m-70 -106.63 26.12 10.35 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.967 0.907 . . . . 0.0 110.619 173.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.69 22.44 72.31 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.761 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.32 156.84 20.85 Favored Glycine 0 CA--C 1.503 -0.706 0 N-CA-C 113.443 0.137 . . . . 0.0 113.443 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.557 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -105.45 144.16 32.61 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.27 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -116.35 157.3 25.24 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.99 123.21 44.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 175.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -72.91 -32.93 65.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.078 0.951 . . . . 0.0 111.789 -174.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.9 t80 . . . . . 0 C--O 1.238 0.466 0 C-N-CA 124.428 1.091 . . . . 0.0 108.377 -172.57 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 121.082 0.467 . . . . 0.0 111.427 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.9 m -117.86 17.46 14.22 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.543 0.687 . . . . 0.0 110.754 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -137.95 150.31 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.9 -0.5 . . . . 0.0 109.998 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.6 p -106.74 -31.89 8.22 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.429 0.692 . . . . 0.0 111.083 -176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 80.4 m80 -135.28 129.67 33.91 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.353 1.061 . . . . 0.0 108.369 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.559 ' HB ' HG12 ' A' ' 69' ' ' VAL . 48.8 mt -113.72 118.98 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 174.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.439 HG23 HG23 ' A' ' 14' ' ' ILE . 73.4 t -90.91 118.83 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 122.988 0.515 . . . . 0.0 109.725 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.53 144.21 34.18 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.291 0.636 . . . . 0.0 110.191 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 19' ' ' TYR . 29.8 t -115.43 -37.37 4.04 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 166.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -98.79 98.26 9.39 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.2 tp -139.91 109.96 7.18 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 122.575 0.35 . . . . 0.0 110.145 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 60' ' ' LYS . 18.6 Cg_exo -68.1 158.79 55.9 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.473 2.782 . . . . 0.0 112.012 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.77 -40.77 93.79 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.66 0.784 . . . . 0.0 111.539 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -67.04 -28.64 68.38 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.602 0.761 . . . . 0.0 111.429 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.543 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -86.98 -14.4 41.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.211 0.604 . . . . 0.0 111.178 177.693 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 92' ' ' LEU . 32.2 mtm180 -73.87 -28.71 61.71 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 166.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.6 mt -77.98 -43.33 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.394 0.677 . . . . 0.0 110.298 173.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.543 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 38.8 tt0 -68.21 -32.63 72.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.653 0.781 . . . . 0.0 111.241 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -110.28 27.61 9.45 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.667 0.787 . . . . 0.0 110.649 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.21 98.4 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.616 0.766 . . . . 0.0 112.6 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -72.81 -25.31 61.1 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.07 0.548 . . . . 0.0 111.289 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -86.26 138.36 31.91 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.96 88.02 3.51 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.559 HG12 ' HB ' ' A' ' 51' ' ' ILE . 35.7 m -75.9 126.3 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 91' ' ' SER . 30.4 m -135.76 178.64 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.508 1.123 . . . . 0.0 109.601 -174.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.8 m -92.2 155.19 42.96 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.686 0.794 . . . . 0.0 110.523 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.561 ' HB3' HD11 ' A' ' 27' ' ' LEU . 17.9 Cg_endo -57.46 -24.52 61.62 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.383 2.722 . . . . 0.0 113.021 174.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.45 -23.24 62.54 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.056 1.342 . . . . 0.0 112.415 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -61.06 -47.8 84.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.632 0.773 . . . . 0.0 110.507 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 75' ' ' ILE . 3.2 mp -75.05 -40.03 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.588 -172.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.2 t -53.82 -52.35 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.873 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -71.83 -44.42 63.91 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.336 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.498 ' HA ' HD23 ' A' ' 85' ' ' LEU . 61.2 m -60.34 -40.06 89.34 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.458 0.703 . . . . 0.0 112.695 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.667 HG21 ' HB3' ' A' ' 30' ' ' MET . 15.1 t -69.2 -47.95 71.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 123.454 0.702 . . . . 0.0 110.893 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -64.53 -42.8 95.52 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.074 0.549 . . . . 0.0 112.065 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -85.9 -9.42 56.97 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.086 0.555 . . . . 0.0 111.624 -177.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.15 23.16 13.77 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.871 1.268 . . . . 0.0 112.3 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.444 ' HG3' HD22 ' A' ' 85' ' ' LEU . 16.5 ptm180 -129.25 171.39 12.51 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.37 1.068 . . . . 0.0 110.029 -177.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.36 111.93 23.72 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 78' ' ' SER . 4.5 mm? -82.22 154.84 69.66 Favored Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 123.225 0.61 . . . . 0.0 110.366 174.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.21 106.8 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.463 2.108 . . . . 0.0 111.502 172.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.405 ' HB2' HG11 ' A' ' 70' ' ' VAL . 2.9 p90 -56.8 -31.91 65.15 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.632 0.773 . . . . 0.0 111.081 173.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -63.43 -23.08 67.25 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.781 1.233 . . . . 0.0 112.561 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -68.37 -37.25 80.26 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.334 0.588 . . . . 0.0 110.2 174.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -99.77 -2.43 35.17 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.654 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 75.4 m -64.55 128.21 34.81 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -173.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.422 ' O ' ' HD2' ' A' ' 61' ' ' ARG . 46.4 mt -85.83 -0.09 54.4 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.686 173.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.7 p -57.5 -43.02 83.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.312 1.045 . . . . 0.0 110.609 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 CA--C 1.558 1.266 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.349 179.85 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.495 HG23 ' HA ' ' A' ' 84' ' ' LEU . 45.5 mt -54.03 -48.35 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.191 1.396 . . . . 0.0 112.49 -173.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.49 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 54.9 m-85 -111.02 13.02 22.04 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.017 -172.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.19 -53.48 57.64 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.345 0.658 . . . . 0.0 111.103 -169.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -87.31 -21.3 25.82 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.604 0.762 . . . . 0.0 110.509 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.8 m -72.26 131.8 43.2 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.354 0.597 . . . . 0.0 110.613 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.532 HG12 HG23 ' A' ' 48' ' ' VAL . 21.1 t -105.86 124.75 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.44 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.5 mp -121.52 123.55 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 118.227 0.467 . . . . 0.0 111.554 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 34.8 t80 -105.86 132.11 52.36 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.568 1.147 . . . . 0.0 108.011 170.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.8 mt -100.56 130.33 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -131.34 129.26 41.18 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.102 0.961 . . . . 0.0 109.21 -173.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.62 174.49 46.44 Favored Glycine 0 C--N 1.343 0.926 0 O-C-N 123.275 0.359 . . . . 0.0 112.918 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -82.06 112.28 18.98 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.959 0.504 . . . . 0.0 109.876 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.609 HG21 HG12 ' A' ' 52' ' ' VAL . 80.7 p -120.78 145.41 47.58 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.611 1.164 . . . . 0.0 110.053 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -99.75 129.09 29.48 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 122.7 0.4 . . . . 0.0 111.112 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.472 ' HD2' HD21 ' A' ' 27' ' ' LEU . 36.4 Cg_endo -81.42 177.13 36.16 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.855 -0.894 . . . . 0.0 111.662 -1.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.6 138.65 6.37 Favored Glycine 0 C--N 1.349 1.296 0 O-C-N 124.078 0.861 . . . . 0.0 113.997 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -54.25 -33.0 57.53 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.716 0.806 . . . . 0.0 112.497 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 26' ' ' GLN . 4.6 pp -55.26 -44.23 75.41 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 123.604 0.565 . . . . 0.0 111.045 175.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.455 ' N ' HD12 ' A' ' 25' ' ' LEU . 61.1 tt0 -73.75 -44.78 55.24 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.347 0.659 . . . . 0.0 110.856 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.472 HD21 ' HD2' ' A' ' 22' ' ' PRO . 81.3 mt -56.72 -39.24 73.55 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.907 0.483 . . . . 0.0 111.053 175.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 32' ' ' VAL . 15.9 m170 -63.22 -42.64 99.29 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.451 0.7 . . . . 0.0 110.036 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.18 -36.12 82.56 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.984 0.514 . . . . 0.0 110.928 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.532 ' HB3' HG21 ' A' ' 79' ' ' VAL . 32.9 mmt -66.01 -31.59 72.58 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.676 0.79 . . . . 0.0 110.932 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 28' ' ' HIS . 62.6 mt -70.82 -52.95 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.853 174.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 28' ' ' HIS . 20.9 t -68.04 -43.69 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 122.991 0.516 . . . . 0.0 111.941 -168.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.17 -19.61 61.76 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.383 0.673 . . . . 0.0 112.201 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -100.9 24.34 9.39 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.192 0.997 . . . . 0.0 110.84 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.8 18.28 70.22 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.106 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.08 160.3 30.77 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -166.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HG3' HG13 ' A' ' 13' ' ' VAL . 17.9 tppt? -106.32 142.51 35.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.402 0.681 . . . . 0.0 109.792 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -141.35 147.71 38.52 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.426 1.091 . . . . 0.0 108.635 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.4 mt -125.55 139.03 53.95 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.785 0.434 . . . . 0.0 111.09 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.41 -33.85 73.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.964 1.306 . . . . 0.0 112.374 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.8 t80 . . . . . 0 N--CA 1.469 0.51 0 C-N-CA 123.921 0.889 . . . . 0.0 109.564 -172.218 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HA ' ' HE1' ' A' ' 67' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 122.449 1.119 . . . . 0.0 110.632 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.7 m -92.66 -11.22 34.72 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.923 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.532 HG23 HG12 ' A' ' 13' ' ' VAL . 3.9 p -108.37 151.57 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.258 0.623 . . . . 0.0 109.994 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -101.78 -40.18 7.07 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 121.193 0.52 . . . . 0.0 110.705 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -128.97 142.85 50.79 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.269 1.027 . . . . 0.0 109.188 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.638 ' HB ' HG12 ' A' ' 69' ' ' VAL . 61.1 mt -123.97 138.0 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.609 HG12 HG21 ' A' ' 20' ' ' THR . 60.4 t -91.91 138.44 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.518 0.727 . . . . 0.0 110.246 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.67 151.91 29.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.589 1.155 . . . . 0.0 107.953 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.6 m -79.76 -48.66 13.24 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -137.34 142.18 41.82 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.57 117.74 11.29 Favored Pre-proline 0 CA--C 1.558 1.25 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.92 160.66 36.91 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.599 2.866 . . . . 0.0 113.556 -174.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -51.98 -45.45 64.47 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.549 1.14 . . . . 0.0 112.684 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -57.53 -43.97 84.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.587 0.755 . . . . 0.0 110.995 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -79.24 -20.77 47.39 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 119.412 -0.328 . . . . 0.0 111.306 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -66.33 -29.76 70.03 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 117.931 0.332 . . . . 0.0 110.243 168.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.7 mt -75.11 -40.73 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 110.337 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -76.1 -25.11 55.14 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.971 0.508 . . . . 0.0 111.386 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.475 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 41.4 m-85 -114.07 30.5 7.23 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.61 1.164 . . . . 0.0 109.662 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.46 -37.93 58.14 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.128 0.971 . . . . 0.0 112.773 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -87.81 -26.87 22.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.602 0.761 . . . . 0.0 111.279 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.491 ' HE1' ' HA ' ' A' ' 46' ' ' LYS . 46.0 m-85 -91.92 120.92 33.03 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.448 0.699 . . . . 0.0 109.574 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -75.06 86.35 2.35 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.638 HG12 ' HB ' ' A' ' 51' ' ' ILE . 20.1 m -76.2 128.18 37.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.84 171.68 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.954 1.302 . . . . 0.0 109.368 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 53.7 m -78.08 153.88 79.96 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.244 0.618 . . . . 0.0 111.027 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.86 -24.98 77.81 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.661 2.241 . . . . 0.0 111.888 175.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.44 -23.62 65.97 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.899 1.28 . . . . 0.0 111.504 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -62.79 -48.09 80.65 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-O 120.933 0.397 . . . . 0.0 110.033 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.49 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.8 mp -67.46 -44.35 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.055 -175.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.2 t -63.32 -51.46 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.259 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.91 -35.56 69.72 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.666 -172.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB3' HG21 ' A' ' 8' ' ' ILE . 61.1 m -63.57 -44.53 93.83 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.117 0.261 . . . . 0.0 110.422 176.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.532 HG21 ' HB3' ' A' ' 30' ' ' MET . 55.9 t -64.49 -34.26 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.454 0.702 . . . . 0.0 110.883 175.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -66.89 -32.68 74.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.303 0.641 . . . . 0.0 110.748 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -94.61 -10.98 30.3 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.61 0.764 . . . . 0.0 112.147 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.06 30.04 19.27 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.412 1.085 . . . . 0.0 112.055 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.8 ptt-85 -151.3 164.11 37.39 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.38 0.672 . . . . 0.0 110.498 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.495 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.2 tm? -79.49 106.74 11.74 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.2 mt -85.97 157.51 57.06 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.488 0.715 . . . . 0.0 109.94 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -65.49 120.8 8.06 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.079 1.853 . . . . 0.0 111.683 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -57.87 -31.52 66.79 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.542 1.137 . . . . 0.0 111.372 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -63.89 -21.69 66.58 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.702 1.201 . . . . 0.0 112.379 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -66.75 -30.8 71.11 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.139 0.576 . . . . 0.0 110.648 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.15 8.43 11.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.941 0.896 . . . . 0.0 111.946 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 p -67.74 111.52 4.31 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.997 0.519 . . . . 0.0 112.138 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.27 -11.85 58.39 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.452 0.701 . . . . 0.0 111.511 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.442 ' HB ' HG22 ' A' ' 69' ' ' VAL . 9.3 t -69.08 -27.05 65.26 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.493 0.717 . . . . 0.0 111.144 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.7 p . . . . . 0 C--O 1.251 1.16 0 C-N-CA 123.273 0.629 . . . . 0.0 109.867 175.693 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.467 HG23 ' HA ' ' A' ' 84' ' ' LEU . 67.6 mt -55.3 -48.59 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.193 0.997 . . . . 0.0 111.956 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -109.67 11.88 24.43 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.536 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -61.99 -41.65 98.28 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.948 0.499 . . . . 0.0 112.267 -170.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -76.62 -27.22 55.64 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.041 0.448 . . . . 0.0 110.214 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.2 m -88.1 144.18 26.64 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.284 1.04 . . . . 0.0 112.462 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.538 HG12 HG23 ' A' ' 48' ' ' VAL . 21.4 t -115.54 127.82 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.543 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.6 mp -123.19 128.19 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 122.764 0.426 . . . . 0.0 111.532 -171.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 24.6 t80 -108.36 151.37 26.1 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.377 1.471 . . . . 0.0 108.675 175.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.458 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 74.0 mt -118.32 123.18 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.373 0.669 . . . . 0.0 109.336 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -117.07 135.68 53.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.259 1.024 . . . . 0.0 109.388 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.89 -139.92 28.03 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.45 0.469 . . . . 0.0 112.767 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -112.6 120.25 40.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.304 0.642 . . . . 0.0 109.667 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.737 HG21 HG12 ' A' ' 52' ' ' VAL . 68.1 p -133.17 147.11 52.05 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.463 0.705 . . . . 0.0 109.559 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -108.91 135.61 20.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.366 0.667 . . . . 0.0 109.793 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.482 ' HD2' HD21 ' A' ' 27' ' ' LEU . 70.3 Cg_endo -74.81 177.24 39.72 Favored 'Cis proline' 0 C--N 1.369 1.631 0 C-N-CA 124.643 -0.982 . . . . 0.0 111.634 -5.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.18 146.98 3.68 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 124.019 0.824 . . . . 0.0 114.776 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -58.21 -36.38 73.05 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.077 0.951 . . . . 0.0 112.599 -172.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.01 -32.92 72.81 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.234 0.214 . . . . 0.0 110.65 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -69.19 -53.24 21.02 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.451 0.7 . . . . 0.0 110.425 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.482 HD21 ' HD2' ' A' ' 22' ' ' PRO . 87.8 mt -57.27 -40.55 77.96 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.458 0.703 . . . . 0.0 111.786 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.584 ' HA ' HD12 ' A' ' 31' ' ' ILE . 17.2 m170 -61.49 -38.96 89.23 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.9 0.48 . . . . 0.0 111.363 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.51 -35.05 68.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.628 0.371 . . . . 0.0 111.257 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.534 ' HB3' HG21 ' A' ' 79' ' ' VAL . 54.8 mtt -61.08 -31.97 71.63 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.971 0.509 . . . . 0.0 110.799 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.584 HD12 ' HA ' ' A' ' 28' ' ' HIS . 66.1 mt -68.09 -51.03 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.299 0.64 . . . . 0.0 110.986 173.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 28' ' ' HIS . 92.0 t -60.99 -50.27 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.569 0.748 . . . . 0.0 112.747 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.1 -12.58 60.36 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.441 0.696 . . . . 0.0 112.326 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -108.77 26.29 10.73 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.092 0.957 . . . . 0.0 110.13 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.0 60.48 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-N 114.58 -1.191 . . . . 0.0 114.051 171.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.33 159.63 48.84 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 -164.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.405 ' HB3' HG22 ' A' ' 13' ' ' VAL . 21.7 ttmm -103.49 152.55 21.54 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -137.23 159.04 43.07 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.043 0.449 . . . . 0.0 111.323 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.52 128.51 56.04 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 165.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -33.39 70.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.405 172.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.413 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 35.1 t80 . . . . . 0 C--N 1.351 0.639 0 C-N-CA 124.414 1.086 . . . . 0.0 108.7 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.775 0 CA-C-O 121.357 0.598 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 m -90.45 -32.15 16.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.924 0.89 . . . . 0.0 110.223 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.538 HG23 HG12 ' A' ' 13' ' ' VAL . 6.5 p -92.98 155.26 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.196 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -109.18 -27.67 9.45 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 118.064 0.393 . . . . 0.0 111.42 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -118.77 140.47 49.9 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.224 0.61 . . . . 0.0 109.959 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.693 ' HB ' HG12 ' A' ' 69' ' ' VAL . 33.5 mt -125.08 140.07 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.737 HG12 HG21 ' A' ' 20' ' ' THR . 95.2 t -104.51 135.85 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.768 0.827 . . . . 0.0 109.666 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.02 150.18 27.99 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.41 0.684 . . . . 0.0 109.364 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -75.95 -42.68 47.87 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -139.73 133.52 30.6 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.132 -1.395 . . . . 0.0 108.034 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.579 ' HG ' HG21 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -116.14 110.37 43.58 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.803 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.88 156.42 66.0 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.964 2.442 . . . . 0.0 112.861 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.1 -47.88 81.88 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.333 1.053 . . . . 0.0 112.995 -169.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 1.1 mptm? -64.15 -31.19 72.29 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.913 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -83.55 -18.87 36.89 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.073 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -66.06 -32.5 74.01 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 168.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 64.9 mt -71.01 -49.62 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.498 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 38.6 mm-40 -66.34 -31.88 72.94 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.723 0.409 . . . . 0.0 111.76 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -106.47 25.91 10.55 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.559 0.744 . . . . 0.0 110.882 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.94 -32.88 74.57 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.054 0.454 . . . . 0.0 110.579 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -69.87 -26.47 64.21 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.101 0.961 . . . . 0.0 111.318 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -99.05 162.51 13.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.334 0.654 . . . . 0.0 110.582 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -101.58 88.21 3.37 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.693 HG12 ' HB ' ' A' ' 51' ' ' ILE . 26.8 m -75.89 134.6 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.731 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 87' ' ' TRP . 34.6 m -137.62 175.45 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.808 1.243 . . . . 0.0 109.873 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.2 m -81.85 154.5 70.48 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.762 0.825 . . . . 0.0 110.113 172.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.42 -24.22 71.11 Favored 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.51 2.14 . . . . 0.0 111.426 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.98 -21.47 63.55 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.955 1.302 . . . . 0.0 111.27 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.73 -51.45 62.31 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 123.144 0.277 . . . . 0.0 110.266 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 75' ' ' ILE . 3.1 mp -66.33 -43.94 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.79 -51.97 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.24 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -73.09 -33.15 65.43 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.197 0.599 . . . . 0.0 111.787 -171.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 71.9 m -66.97 -40.52 87.49 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.58 0.352 . . . . 0.0 110.281 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 30' ' ' MET . 55.0 t -70.68 -33.87 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.451 0.7 . . . . 0.0 110.786 173.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -64.58 -41.37 96.32 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.157 0.983 . . . . 0.0 110.523 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -95.41 -6.46 40.85 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.855 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.22 27.14 15.47 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.573 1.149 . . . . 0.0 112.33 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -142.49 159.33 42.44 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.774 0.83 . . . . 0.0 110.546 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.467 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.2 tm? -75.1 127.55 33.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.8 mt -114.7 152.12 46.0 Favored Pre-proline 0 C--O 1.24 0.596 0 C-N-CA 124.214 1.006 . . . . 0.0 109.714 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.414 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 35.3 Cg_endo -61.73 109.34 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.551 2.167 . . . . 0.0 111.877 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.549 ' HB2' HG11 ' A' ' 70' ' ' VAL . 29.9 p90 -62.14 -21.91 65.42 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.388 1.075 . . . . 0.0 112.206 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.414 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 12.7 pt20 -59.78 -25.11 64.65 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.127 0.971 . . . . 0.0 111.818 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -70.92 -31.66 68.35 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.788 0.835 . . . . 0.0 111.131 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.29 -0.79 25.97 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.905 0.882 . . . . 0.0 111.318 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -66.24 131.42 46.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.329 0.652 . . . . 0.0 112.0 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.8 mt -108.31 14.54 24.79 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.101 0.96 . . . . 0.0 110.951 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.0 p -65.56 -52.73 50.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.823 0.849 . . . . 0.0 111.321 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 C--O 1.252 1.185 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.166 -173.858 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 82' ' ' ALA . 64.3 mt -49.08 -47.87 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.507 1.523 . . . . 0.0 112.352 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -109.58 15.32 22.98 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.862 0.465 . . . . 0.0 111.566 -174.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -57.82 -49.3 77.12 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.287 0.635 . . . . 0.0 111.448 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -76.41 -15.56 59.91 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.675 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.5 m -93.08 141.17 28.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.632 0.773 . . . . 0.0 111.421 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.56 124.84 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 171.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.411 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.2 mp -118.5 134.28 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 C-N-CA 123.155 0.582 . . . . 0.0 111.74 -170.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 33.3 t80 -113.0 149.49 33.24 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.414 1.486 . . . . 0.0 108.089 169.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 65.7 mt -114.54 110.01 30.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -103.83 122.44 45.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.277 1.431 . . . . 0.0 109.447 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.76 175.58 50.98 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.88 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -82.08 111.49 18.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.602 HG21 HG12 ' A' ' 52' ' ' VAL . 69.6 p -112.14 151.92 28.92 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.887 0.875 . . . . 0.0 110.037 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -102.99 122.91 43.88 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 163.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -81.66 172.08 54.41 Favored 'Cis proline' 0 C--N 1.37 1.698 0 C-N-CA 124.031 -1.237 . . . . 0.0 112.033 1.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.61 164.6 15.79 Favored Glycine 0 C--N 1.344 0.995 0 O-C-N 123.735 0.647 . . . . 0.0 114.357 -172.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -56.11 -36.53 68.3 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.362 0.665 . . . . 0.0 111.411 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.9 pp -61.66 -43.12 99.46 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.454 0.701 . . . . 0.0 111.57 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.537 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.2 tp-100 -71.29 -51.76 22.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.345 0.658 . . . . 0.0 110.22 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.68 -51.09 70.13 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.028 0.83 . . . . 0.0 111.402 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.45 ' O ' HG23 ' A' ' 32' ' ' VAL . 15.6 m170 -54.85 -47.55 74.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.727 0.642 . . . . 0.0 111.109 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.5 -38.94 91.19 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.27 0.356 . . . . 0.0 111.571 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.602 ' HB3' HG21 ' A' ' 79' ' ' VAL . 21.2 mmt -61.22 -40.0 92.39 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.991 0.516 . . . . 0.0 111.132 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.411 HD13 ' HB ' ' A' ' 14' ' ' ILE . 70.8 mt -65.19 -49.12 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.008 0.923 . . . . 0.0 111.348 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 28' ' ' HIS . 57.9 t -65.84 -41.55 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.979 0.512 . . . . 0.0 111.573 -176.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.39 -13.04 60.1 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.321 0.648 . . . . 0.0 111.844 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.601 ' HE1' HG13 ' A' ' 79' ' ' VAL . 38.6 m80 -108.92 26.85 10.11 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.699 0.799 . . . . 0.0 111.758 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.95 7.03 75.03 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.944 172.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.89 158.1 30.28 Favored Glycine 0 C--O 1.242 0.596 0 C-N-CA 123.026 0.346 . . . . 0.0 113.94 -173.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -102.83 158.67 16.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.502 0.721 . . . . 0.0 109.653 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.37 161.71 37.63 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.389 0.676 . . . . 0.0 110.473 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.1 149.42 42.23 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.789 0.836 . . . . 0.0 110.531 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -68.9 -47.87 64.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.612 1.165 . . . . 0.0 111.566 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 77.5 t80 . . . . . 0 N--CA 1.476 0.858 0 C-N-CA 124.674 1.19 . . . . 0.0 108.96 -170.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HA ' ' HE1' ' A' ' 67' ' ' TYR . 54.1 mtpt . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -82.04 -24.32 35.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.748 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.84 151.53 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.12 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.6 p -114.57 -17.74 11.62 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -137.71 136.77 37.67 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.26 1.024 . . . . 0.0 109.096 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.619 ' HB ' HG12 ' A' ' 69' ' ' VAL . 67.4 mt -125.21 137.25 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.602 HG12 HG21 ' A' ' 20' ' ' THR . 54.5 t -105.84 133.72 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.41 1.084 . . . . 0.0 110.74 -173.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.45 146.01 20.79 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -77.14 -39.76 48.05 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -138.33 107.9 6.21 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.63 ' HB2' HD13 ' A' ' 92' ' ' LEU . 16.5 tp -100.53 119.61 58.29 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -64.32 159.55 43.19 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.623 2.882 . . . . 0.0 112.589 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.7 mt -58.99 -46.05 89.09 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.982 0.913 . . . . 0.0 112.38 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -57.56 -46.11 84.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.453 0.701 . . . . 0.0 110.713 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -66.26 -30.07 70.43 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.158 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -66.65 -38.24 86.47 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.159 0.584 . . . . 0.0 110.724 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.8 mt -70.39 -46.18 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 123.82 0.7 . . . . 0.0 110.384 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.71 -32.36 73.87 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.689 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.431 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 22.0 m-30 -103.08 15.05 30.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.451 0.701 . . . . 0.0 111.89 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.86 -18.81 62.69 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.323 0.583 . . . . 0.0 110.896 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -71.77 -19.91 61.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.268 1.027 . . . . 0.0 110.602 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.499 ' HE1' ' HA ' ' A' ' 46' ' ' LYS . 17.2 m-85 -113.47 169.83 8.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.382 1.073 . . . . 0.0 109.008 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -96.15 91.07 5.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.427 0.691 . . . . 0.0 109.413 175.566 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.619 HG12 ' HB ' ' A' ' 51' ' ' ILE . 20.3 m -82.88 129.95 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.288 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.477 HG11 ' HB2' ' A' ' 87' ' ' TRP . 31.6 m -139.79 167.56 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.754 1.221 . . . . 0.0 110.514 -175.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.6 m -75.76 155.91 84.89 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.847 172.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.06 -25.46 79.82 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.469 2.113 . . . . 0.0 111.495 172.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.5 -29.89 59.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.48 1.512 . . . . 0.0 112.651 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.433 ' CE3' HG21 ' A' ' 70' ' ' VAL . 27.6 t90 -62.18 -48.74 78.69 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.354 0.408 . . . . 0.0 110.197 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.77 -54.98 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.241 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.8 t -51.84 -52.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.841 1.257 . . . . 0.0 112.346 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -71.58 -42.1 68.17 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.732 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.435 ' HA ' HD13 ' A' ' 85' ' ' LEU . 72.5 m -61.63 -36.93 82.17 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.736 0.415 . . . . 0.0 111.448 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.602 HG21 ' HB3' ' A' ' 30' ' ' MET . 21.8 t -63.57 -46.94 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.265 1.026 . . . . 0.0 111.057 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -65.97 -43.47 87.77 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.042 0.537 . . . . 0.0 111.102 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -76.5 -15.59 59.85 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.708 0.803 . . . . 0.0 112.04 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 8' ' ' ILE . . . 58.41 40.92 23.69 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.091 0.956 . . . . 0.0 110.843 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -159.51 156.54 28.37 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.868 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -85.81 109.3 18.58 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 78' ' ' SER . 8.6 mp -79.64 155.28 76.04 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.126 0.57 . . . . 0.0 111.242 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.469 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 35.8 Cg_endo -61.12 114.83 2.36 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.426 2.084 . . . . 0.0 111.325 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.477 ' HB2' HG11 ' A' ' 70' ' ' VAL . 48.1 p90 -64.9 -20.09 66.26 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.649 0.78 . . . . 0.0 112.395 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.469 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.0 pt20 -58.19 -28.04 64.41 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.275 1.03 . . . . 0.0 112.023 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -70.6 -27.68 64.28 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.605 0.762 . . . . 0.0 110.814 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.78 5.95 14.27 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.047 0.939 . . . . 0.0 111.689 -175.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.437 ' HB2' HG22 ' A' ' 93' ' ' THR . 59.9 p -69.85 120.48 15.66 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.202 0.601 . . . . 0.0 112.287 -174.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.63 HD13 ' HB2' ' A' ' 56' ' ' LEU . 48.5 mt -73.62 -21.48 60.29 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.947 0.899 . . . . 0.0 111.666 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 91' ' ' SER . 10.3 t -65.5 -17.53 64.63 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.694 0.798 . . . . 0.0 112.112 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.4 m . . . . . 0 C--O 1.26 1.613 0 C-N-CA 123.294 0.637 . . . . 0.0 109.993 175.568 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.556 HG21 ' OG ' ' A' ' 78' ' ' SER . 57.7 mt -64.73 -51.42 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.681 -167.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.655 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 61.7 m-85 -103.17 18.04 22.67 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.886 -175.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -51.16 -59.09 4.56 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.281 1.032 . . . . 0.0 112.877 -171.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -95.81 17.39 15.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.867 0.867 . . . . 0.0 111.01 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.447 ' SG ' ' HH2' ' A' ' 74' ' ' TRP . 41.1 t -116.9 123.26 46.58 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 124.484 1.114 . . . . 0.0 109.756 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.475 HG11 HD23 ' A' ' 39' ' ' LEU . 40.6 t -101.68 128.2 54.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.533 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.2 mp -122.36 123.28 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 122.833 0.453 . . . . 0.0 111.041 -175.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 28.4 t80 -104.35 150.74 24.22 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.341 1.456 . . . . 0.0 108.134 174.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.21 130.31 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -135.81 123.78 22.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.414 1.085 . . . . 0.0 109.771 -170.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.7 -161.57 42.45 Favored Glycine 0 C--N 1.343 0.958 0 O-C-N 123.496 0.498 . . . . 0.0 112.822 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -88.03 110.73 20.84 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.237 0.615 . . . . 0.0 109.558 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.537 HG21 HG12 ' A' ' 52' ' ' VAL . 61.5 p -133.94 134.4 42.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.044 0.937 . . . . 0.0 109.271 -177.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -117.47 139.17 25.83 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -69.94 170.69 58.03 Favored 'Cis proline' 0 C--N 1.389 2.707 0 C-N-CA 124.705 -0.956 . . . . 0.0 112.567 3.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.67 149.11 5.55 Favored Glycine 0 N--CA 1.475 1.257 0 O-C-N 124.01 0.819 . . . . 0.0 114.196 -169.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -52.23 -36.08 51.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.777 0.831 . . . . 0.0 112.197 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 26' ' ' GLN . 3.6 pp -62.46 -41.44 98.76 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.27 0.628 . . . . 0.0 111.63 174.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.512 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.5 tp-100 -72.19 -50.79 24.83 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.813 0.845 . . . . 0.0 110.945 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.1 mt -54.73 -44.96 74.01 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.215 0.606 . . . . 0.0 111.008 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.515 ' HA ' HD12 ' A' ' 31' ' ' ILE . 9.5 m170 -58.75 -43.5 90.31 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 123.572 0.545 . . . . 0.0 111.417 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -66.5 -38.89 88.23 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 123.168 0.292 . . . . 0.0 111.23 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.0 mmt -58.42 -39.36 79.57 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.338 0.655 . . . . 0.0 110.947 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.533 HD13 ' HB ' ' A' ' 14' ' ' ILE . 70.9 mt -62.69 -47.8 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.07 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 28' ' ' HIS . 39.1 t -64.19 -47.6 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.653 0.596 . . . . 0.0 111.117 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.01 -33.55 73.44 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.829 0.852 . . . . 0.0 111.47 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.467 ' HE1' HG13 ' A' ' 79' ' ' VAL . 54.9 m80 -86.44 27.47 0.94 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.255 0.622 . . . . 0.0 112.274 175.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.32 28.99 73.02 Favored Glycine 0 C--N 1.357 1.73 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.29 169.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.655 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -112.44 172.43 14.66 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 115.551 0.98 . . . . 0.0 115.551 -168.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -111.16 146.22 37.25 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.702 0.801 . . . . 0.0 109.444 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -128.83 166.25 19.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.562 0.745 . . . . 0.0 109.585 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.475 HD23 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -130.3 136.22 48.91 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.051 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -82.44 -36.79 26.27 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 123.867 0.729 . . . . 0.0 112.144 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 61.3 t80 . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 122.974 0.509 . . . . 0.0 110.539 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.548 0.896 0 CA-C-O 121.542 0.687 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.6 m -79.68 -27.86 40.74 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.435 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.4 p -86.64 151.71 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.984 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.453 HG23 ' ND1' ' A' ' 50' ' ' HIS . 5.1 t -114.79 -25.4 8.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.742 0.817 . . . . 0.0 110.683 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.453 ' ND1' HG23 ' A' ' 49' ' ' THR . 53.5 m80 -133.38 127.42 33.42 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.924 0.49 . . . . 0.0 110.419 -174.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.631 ' HB ' HG12 ' A' ' 69' ' ' VAL . 61.7 mt -119.04 129.41 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.537 HG12 HG21 ' A' ' 20' ' ' THR . 70.8 t -90.76 123.27 42.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 123.63 0.772 . . . . 0.0 109.187 -173.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.93 140.69 31.23 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.834 0.853 . . . . 0.0 108.951 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -84.05 -49.95 8.43 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -116.61 132.99 56.54 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.518 -1.219 . . . . 0.0 107.719 170.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.98 101.55 10.41 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.09 160.16 48.68 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.092 2.528 . . . . 0.0 112.706 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.8 -31.97 67.1 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.052 0.941 . . . . 0.0 112.001 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 47.9 tptt -60.77 -53.42 57.61 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.269 0.628 . . . . 0.0 109.911 175.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -70.69 -19.25 62.79 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.821 0.448 . . . . 0.0 111.841 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -72.88 -27.69 62.05 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.735 0.814 . . . . 0.0 109.779 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.3 mt -79.11 -45.3 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.321 0.648 . . . . 0.0 110.043 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 24.4 mm-40 -63.52 -29.18 70.49 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.598 0.759 . . . . 0.0 112.215 -175.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -121.97 28.63 7.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.058 0.943 . . . . 0.0 110.293 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -30.68 69.26 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.447 0.699 . . . . 0.0 112.566 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -75.08 -23.63 58.03 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.119 0.568 . . . . 0.0 111.572 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -107.64 123.69 48.87 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.94 93.23 0.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.369 0.604 . . . . 0.0 109.755 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.631 HG12 ' HB ' ' A' ' 51' ' ' ILE . 27.4 m -73.89 128.83 36.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 87' ' ' TRP . 30.2 m -128.13 172.13 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.253 1.021 . . . . 0.0 109.862 -174.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -80.46 152.51 73.08 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.27 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -56.78 -25.09 59.15 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.693 2.262 . . . . 0.0 112.17 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.41 -26.5 53.55 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.884 1.273 . . . . 0.0 112.286 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.447 ' HH2' ' SG ' ' A' ' 12' ' ' CYS . 28.3 t90 -59.6 -48.45 81.62 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.825 0.284 . . . . 0.0 110.454 174.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 79' ' ' VAL . 3.3 mp -69.33 -42.71 81.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 O-C-N 124.042 0.839 . . . . 0.0 108.85 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.48 HG12 ' HE2' ' A' ' 80' ' ' LYS . 85.0 t -62.14 -50.52 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.006 0.922 . . . . 0.0 111.408 -177.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.23 -33.72 76.66 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.24 0.616 . . . . 0.0 110.849 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.556 ' OG ' HG21 ' A' ' 8' ' ' ILE . 38.5 t -62.54 -37.65 86.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.235 0.614 . . . . 0.0 111.449 177.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 75' ' ' ILE . 94.0 t -70.96 -47.13 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.502 0.721 . . . . 0.0 110.669 177.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.48 ' HE2' HG12 ' A' ' 76' ' ' VAL . 53.2 mtmt -64.74 -45.16 87.63 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.486 0.714 . . . . 0.0 111.744 -175.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -86.76 -15.51 39.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.342 0.657 . . . . 0.0 111.473 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.85 38.56 14.58 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.572 1.149 . . . . 0.0 111.869 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -149.75 164.49 35.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.395 0.678 . . . . 0.0 110.285 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.5 tp -84.05 95.26 8.52 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.8 142.94 96.15 Favored Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.449 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 16.8 Cg_endo -56.24 108.01 0.3 Allowed 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.302 2.001 . . . . 0.0 110.79 172.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.411 ' HB2' HG11 ' A' ' 70' ' ' VAL . 29.8 p90 -56.95 -22.69 39.9 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.547 1.139 . . . . 0.0 112.695 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.449 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 20.6 pt20 -57.47 -26.77 61.75 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.749 1.22 . . . . 0.0 112.105 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -67.09 -38.46 85.75 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.196 0.598 . . . . 0.0 110.72 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -99.72 -5.62 28.46 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.07 0.948 . . . . 0.0 111.521 -172.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.0 m -66.23 121.74 15.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.111 0.564 . . . . 0.0 112.304 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.8 mt -81.86 -0.65 44.54 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.557 1.143 . . . . 0.0 111.062 172.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.8 p -66.96 -20.59 65.92 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.512 1.125 . . . . 0.0 111.665 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.558 1.254 0 C-N-CA 124.587 1.155 . . . . 0.0 111.876 -178.93 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 10' ' ' LYS . 15.3 ptpt . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.53 HG23 ' HA ' ' A' ' 84' ' ' LEU . 66.9 mt -49.49 -46.23 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.024 1.33 . . . . 0.0 112.167 -177.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.495 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 78.1 m-85 -104.8 15.86 27.06 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.976 -173.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 7' ' ' LYS . 28.5 ttpp -51.53 -48.26 63.07 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.902 0.881 . . . . 0.0 113.312 -173.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -98.78 2.04 46.53 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.036 0.534 . . . . 0.0 111.436 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.4 m -97.89 110.8 23.31 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.873 0.869 . . . . 0.0 110.919 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.0 t -93.31 127.84 45.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.468 ' HB ' HD13 ' A' ' 31' ' ' ILE . 2.6 mp -114.74 136.06 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.58 0.752 . . . . 0.0 110.941 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -118.05 110.84 18.14 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 170.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.7 mt -77.22 134.28 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -138.68 122.02 17.11 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -173.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.63 -173.91 52.95 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.681 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -79.97 110.76 15.66 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.213 0.605 . . . . 0.0 109.904 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.558 HG21 HG12 ' A' ' 52' ' ' VAL . 61.8 p -121.16 136.68 54.93 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 11.0 mmpt? -104.06 135.43 19.35 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 117.85 0.295 . . . . 0.0 110.685 176.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' HD21 ' A' ' 27' ' ' LEU . 94.1 Cg_endo -74.24 173.79 54.96 Favored 'Cis proline' 0 C--N 1.378 2.099 0 C-N-CA 124.613 -0.995 . . . . 0.0 112.107 -1.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.64 156.0 3.73 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 123.885 0.741 . . . . 0.0 114.745 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -54.46 -38.4 66.31 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.572 0.749 . . . . 0.0 111.519 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.3 pp -60.62 -44.94 95.76 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 123.779 0.674 . . . . 0.0 111.338 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.528 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.7 tp-100 -69.45 -50.31 46.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.344 0.658 . . . . 0.0 110.672 -175.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.417 HD21 ' HD2' ' A' ' 22' ' ' PRO . 81.6 mt -56.1 -50.45 71.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.975 0.51 . . . . 0.0 111.447 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.438 ' HA ' HD12 ' A' ' 31' ' ' ILE . 23.5 m170 -54.82 -41.92 71.25 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.698 0.799 . . . . 0.0 111.094 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -67.81 -44.49 77.18 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.156 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 34.2 mmt -63.16 -34.1 76.9 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.158 0.583 . . . . 0.0 111.629 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.468 HD13 ' HB ' ' A' ' 14' ' ' ILE . 66.1 mt -60.54 -50.73 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.386 173.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.3 t -66.64 -39.78 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.549 0.74 . . . . 0.0 112.367 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.3 -23.55 67.47 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.698 0.799 . . . . 0.0 111.388 178.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -104.88 27.57 7.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.973 0.909 . . . . 0.0 111.044 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.49 14.16 80.52 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 114.893 -1.049 . . . . 0.0 114.114 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.86 174.88 22.85 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 114.524 0.57 . . . . 0.0 114.524 -170.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.415 ' HB2' ' NZ ' ' A' ' 37' ' ' LYS . 2.7 ttmp? -128.54 151.19 49.73 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.157 0.583 . . . . 0.0 109.787 -177.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -121.18 161.4 21.93 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.532 0.733 . . . . 0.0 109.337 170.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.24 131.94 56.33 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -64.54 -40.01 94.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.094 0.958 . . . . 0.0 112.196 -165.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.1 t80 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -175.753 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 CA--C 1.543 0.711 0 CA-C-O 121.114 0.483 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.7 m -108.31 -28.06 9.64 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.304 0.642 . . . . 0.0 110.624 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.6 150.03 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.55 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.3 p -102.89 -26.86 12.96 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.299 0.639 . . . . 0.0 111.302 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -137.35 128.48 27.72 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.814 0.846 . . . . 0.0 109.653 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.486 ' HB ' HG22 ' A' ' 69' ' ' VAL . 43.7 mt -110.65 114.68 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 175.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.558 HG12 HG21 ' A' ' 20' ' ' THR . 78.2 t -89.15 135.93 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.815 0.846 . . . . 0.0 109.919 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.37 170.59 19.71 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.598 0.759 . . . . 0.0 110.306 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.6 t -86.81 -52.23 5.62 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -145.07 103.17 3.84 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.521 ' HG ' HG11 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -89.1 114.71 61.28 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.85 143.49 91.03 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.362 2.708 . . . . 0.0 113.017 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.8 mt -55.93 -41.0 73.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.294 1.038 . . . . 0.0 112.428 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -56.61 -50.16 72.8 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.661 0.784 . . . . 0.0 110.524 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -76.1 -17.85 59.43 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.487 -175.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -68.99 -32.05 71.32 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.983 0.356 . . . . 0.0 110.162 170.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.5 mt -65.58 -42.92 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.03 -40.18 94.44 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 120.931 0.396 . . . . 0.0 111.122 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.42 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 21.0 m-85 -95.58 25.14 4.7 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.939 0.496 . . . . 0.0 111.124 -176.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.02 -16.77 62.06 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.269 0.627 . . . . 0.0 111.406 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -79.05 -14.94 58.86 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.729 0.412 . . . . 0.0 110.853 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.42 ' HD2' ' HA ' ' A' ' 64' ' ' PHE . 32.4 m-85 -115.71 152.77 32.58 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 109.408 -175.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -90.28 88.81 7.36 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.527 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 73.2 t -74.88 124.68 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 87' ' ' TRP . 32.7 m -133.03 176.64 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.941 0.896 . . . . 0.0 110.966 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.3 m -87.63 158.93 50.53 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 124.278 1.031 . . . . 0.0 109.957 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.62 -21.24 70.24 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.418 2.079 . . . . 0.0 111.794 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.23 -26.14 66.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.129 1.372 . . . . 0.0 111.637 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -62.3 -44.88 95.48 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.759 0.314 . . . . 0.0 110.381 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.495 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.6 mp -71.43 -50.98 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.985 -176.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.9 t -57.89 -52.5 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.557 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.81 -37.75 73.25 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.071 -172.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 98.2 p -65.73 -39.25 90.94 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.29 0.236 . . . . 0.0 111.139 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.06 -41.55 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.67 0.788 . . . . 0.0 110.793 176.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.57 -38.06 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.559 0.744 . . . . 0.0 111.252 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -82.28 -18.51 42.13 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.649 0.78 . . . . 0.0 111.39 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.59 32.94 22.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.716 1.206 . . . . 0.0 111.539 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -139.12 162.03 35.94 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.801 0.84 . . . . 0.0 109.922 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.53 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.0 tm? -79.21 125.37 29.37 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.97 148.64 35.1 Favored Pre-proline 0 C--O 1.243 0.713 0 C-N-CA 123.66 0.784 . . . . 0.0 109.975 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.05 115.11 2.75 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.131 1.887 . . . . 0.0 110.335 166.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.516 ' HB2' HG11 ' A' ' 70' ' ' VAL . 12.7 p90 -62.96 -25.2 68.25 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.65 0.78 . . . . 0.0 111.862 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -60.03 -22.91 63.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.388 1.075 . . . . 0.0 112.13 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -63.45 -45.45 90.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.884 0.874 . . . . 0.0 110.105 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -102.42 6.43 40.18 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.57 0.748 . . . . 0.0 111.604 -173.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 36.7 m -65.84 114.54 5.15 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.038 0.535 . . . . 0.0 112.362 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.7 -26.33 63.37 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.79 0.836 . . . . 0.0 110.201 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.527 ' HB ' ' HB ' ' A' ' 69' ' ' VAL . 8.8 t -69.95 -11.05 60.59 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.934 0.894 . . . . 0.0 112.261 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.258 1.53 0 C-N-CA 123.213 0.605 . . . . 0.0 110.091 174.563 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.3 mttm . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.4 mt -53.37 -45.67 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.845 0.858 . . . . 0.0 112.253 -172.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.47 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 70.4 m-85 -111.63 15.54 21.02 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 119.275 -0.393 . . . . 0.0 111.127 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -56.37 -41.51 76.32 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.539 0.736 . . . . 0.0 112.811 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -96.92 -3.6 41.52 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.099 0.559 . . . . 0.0 111.391 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.444 ' SG ' ' ND1' ' A' ' 50' ' ' HIS . 51.8 t -99.0 127.05 44.84 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 123.974 0.91 . . . . 0.0 110.676 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.466 HG12 HG23 ' A' ' 48' ' ' VAL . 32.4 t -106.41 134.42 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.469 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.9 mp -125.64 128.47 72.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 123.391 0.677 . . . . 0.0 111.359 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -114.69 120.32 39.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.97 1.308 . . . . 0.0 108.174 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.6 mt -93.29 109.55 21.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -98.33 123.73 42.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.672 1.189 . . . . 0.0 109.599 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.88 -159.77 52.31 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 123.416 0.447 . . . . 0.0 113.892 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.74 122.48 32.19 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.782 0.833 . . . . 0.0 110.54 -177.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.611 HG21 HG12 ' A' ' 52' ' ' VAL . 72.3 p -132.88 146.24 51.64 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.015 1.326 . . . . 0.0 108.944 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -112.49 130.51 23.32 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.02 171.75 65.21 Favored 'Cis proline' 0 C--N 1.382 2.291 0 C-N-CA 124.146 -1.189 . . . . 0.0 111.381 -0.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.28 147.71 5.91 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.833 0.708 . . . . 0.0 114.493 -173.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -52.78 -36.48 58.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.713 0.805 . . . . 0.0 112.41 -175.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 pp -59.23 -43.01 92.38 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.319 0.648 . . . . 0.0 111.615 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -67.39 -50.15 60.86 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.858 0.863 . . . . 0.0 110.327 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.406 ' O ' HG13 ' A' ' 31' ' ' ILE . 92.9 mt -55.81 -41.24 73.89 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.474 0.709 . . . . 0.0 111.732 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.619 ' HA ' HD12 ' A' ' 31' ' ' ILE . 13.0 m80 -62.46 -37.52 86.25 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.68 0.792 . . . . 0.0 110.877 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -68.36 -40.92 81.31 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.225 0.61 . . . . 0.0 110.569 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.591 ' HB3' HG21 ' A' ' 79' ' ' VAL . 64.5 mtt -59.69 -33.49 71.65 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.436 0.695 . . . . 0.0 111.142 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.619 HD12 ' HA ' ' A' ' 28' ' ' HIS . 74.4 mt -70.3 -54.1 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.321 0.648 . . . . 0.0 110.982 177.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 28' ' ' HIS . 93.8 t -65.58 -45.52 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.428 0.691 . . . . 0.0 112.185 -170.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.82 -21.03 66.71 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.479 0.712 . . . . 0.0 112.241 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -104.27 26.91 8.28 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.564 0.746 . . . . 0.0 110.726 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.36 -1.35 87.63 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.882 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . -75.51 160.37 52.0 Favored Glycine 0 CA--C 1.5 -0.859 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -170.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.436 ' HB3' HG22 ' A' ' 13' ' ' VAL . 2.9 tppp? -112.98 145.82 40.15 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -127.75 149.77 50.09 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.459 0.703 . . . . 0.0 109.329 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.462 HD23 HG11 ' A' ' 13' ' ' VAL . 1.3 mm? -116.65 128.74 55.65 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -64.54 -42.19 95.88 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.603 1.161 . . . . 0.0 111.594 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.6 p90 . . . . . 0 N--CA 1.476 0.847 0 C-N-CA 123.609 0.763 . . . . 0.0 109.515 171.663 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 122.619 1.199 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 m -87.12 -8.84 56.59 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.968 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.466 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -112.7 155.84 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.8 0.84 . . . . 0.0 110.001 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 74.1 p -111.79 -30.74 7.2 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.14 0.576 . . . . 0.0 111.231 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.444 ' ND1' ' SG ' ' A' ' 12' ' ' CYS . 80.7 m80 -128.42 134.02 48.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.872 0.869 . . . . 0.0 110.016 -175.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 36.6 mt -121.75 114.19 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 121.443 0.639 . . . . 0.0 109.798 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.611 HG12 HG21 ' A' ' 20' ' ' THR . 74.7 t -90.53 119.19 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.145 0.978 . . . . 0.0 110.413 -175.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.0 137.9 18.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.744 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.1 t -86.05 -35.23 20.43 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 171.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -127.6 99.42 5.58 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 124.213 1.005 . . . . 0.0 108.519 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -107.28 107.89 61.06 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.406 ' HG2' ' HD3' ' A' ' 60' ' ' LYS . 34.1 Cg_endo -61.41 152.63 71.56 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.155 2.57 . . . . 0.0 113.173 -173.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.33 -35.95 74.77 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.32 1.048 . . . . 0.0 112.566 -171.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -62.82 -45.26 93.46 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.567 0.699 . . . . 0.0 109.966 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HD3' ' HG2' ' A' ' 57' ' ' PRO . 1.1 mptm? -77.89 -18.34 56.27 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.001 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.417 ' NH1' ' HA ' ' A' ' 93' ' ' THR . 1.2 mmp_? -65.59 -35.23 80.21 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.18 0.592 . . . . 0.0 111.038 171.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.7 mt -69.17 -47.06 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 123.572 0.545 . . . . 0.0 109.806 172.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -58.02 -40.39 80.71 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.779 0.832 . . . . 0.0 111.655 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.41 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 18.3 m-85 -110.17 27.12 9.93 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.215 1.006 . . . . 0.0 110.741 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.42 -44.69 93.9 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.165 0.586 . . . . 0.0 111.301 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -77.62 -26.0 50.21 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.457 0.703 . . . . 0.0 110.722 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 64' ' ' PHE . 16.3 m-85 -75.52 135.69 40.62 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' A' ' 93' ' ' THR . 43.7 mmtm -80.71 86.1 5.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.355 0.598 . . . . 0.0 109.784 -177.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 93.3 t -73.76 125.25 32.59 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 91' ' ' SER . 24.0 m -131.08 173.59 14.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 C-N-CA 123.392 0.677 . . . . 0.0 110.161 -175.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.4 m -79.64 149.4 71.26 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.044 173.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.83 -28.45 87.15 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.395 2.064 . . . . 0.0 111.338 168.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.44 -23.89 64.78 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.321 1.449 . . . . 0.0 111.695 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -63.42 -48.6 77.11 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.957 0.503 . . . . 0.0 110.43 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.449 HD12 ' N ' ' A' ' 75' ' ' ILE . 2.4 mp -69.06 -45.14 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.325 -173.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -58.04 -49.73 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.24 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.85 -36.73 70.24 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.812 0.695 . . . . 0.0 110.993 -172.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.1 m -65.79 -41.25 92.18 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.611 0.365 . . . . 0.0 110.81 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.591 HG21 ' HB3' ' A' ' 30' ' ' MET . 54.7 t -71.03 -33.03 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.748 0.819 . . . . 0.0 110.841 175.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -65.39 -42.9 92.14 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.441 1.096 . . . . 0.0 110.522 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -92.91 -6.15 49.24 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.048 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.07 36.59 24.27 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.431 1.092 . . . . 0.0 111.812 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -156.45 151.91 26.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.007 0.923 . . . . 0.0 109.768 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.83 121.62 19.3 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -105.95 160.82 24.8 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 124.054 0.942 . . . . 0.0 110.342 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -54.3 108.7 0.31 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.991 2.461 . . . . 0.0 112.756 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -62.03 -34.08 75.57 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.736 174.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -58.15 -26.88 63.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.833 1.253 . . . . 0.0 112.087 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -74.54 -37.76 62.94 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.446 0.699 . . . . 0.0 110.362 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.49 -0.7 29.52 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.398 0.679 . . . . 0.0 112.33 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 27.0 p -75.42 110.7 10.0 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.055 0.455 . . . . 0.0 111.039 -177.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.6 mt -73.26 -17.38 61.34 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.332 1.053 . . . . 0.0 111.041 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.613 HG21 ' HA ' ' A' ' 68' ' ' LYS . 13.7 t -74.67 -26.48 59.88 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.608 0.763 . . . . 0.0 111.837 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.343 -0.837 . . . . 0.0 109.694 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt . . . . . 0 CA--C 1.545 0.752 0 CA-C-O 120.675 0.274 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.417 HG23 ' HA ' ' A' ' 84' ' ' LEU . 64.6 mt -67.71 -50.3 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.209 0.604 . . . . 0.0 110.223 -177.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.85 16.2 17.32 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.01 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -62.44 -36.56 82.78 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 120.913 0.387 . . . . 0.0 111.569 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -98.77 8.36 45.04 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.688 0.795 . . . . 0.0 111.161 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 71.9 m -117.24 114.1 23.15 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.605 0.762 . . . . 0.0 111.134 -174.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.35 126.77 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.41 HG23 HG23 ' A' ' 52' ' ' VAL . 3.3 mp -114.89 131.47 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.142 0.577 . . . . 0.0 111.425 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 16.7 t80 -114.34 114.27 25.68 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.639 1.175 . . . . 0.0 108.635 169.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.7 mt -88.48 137.83 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -142.74 143.05 32.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.887 0.875 . . . . 0.0 109.646 -166.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.96 -137.84 32.37 Favored Glycine 0 C--N 1.346 1.117 0 O-C-N 123.519 0.512 . . . . 0.0 111.975 -174.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.1 145.38 37.24 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 171.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.514 HG21 HG12 ' A' ' 52' ' ' VAL . 37.1 p -142.21 140.67 32.39 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.741 1.216 . . . . 0.0 108.619 178.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -109.76 126.34 29.31 Favored Pre-proline 0 N--CA 1.485 1.277 0 CA-C-N 118.288 0.495 . . . . 0.0 110.264 171.582 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HD2' HD21 ' A' ' 27' ' ' LEU . 43.9 Cg_endo -76.15 174.3 53.63 Favored 'Cis proline' 0 C--N 1.374 1.905 0 C-N-CA 124.362 -1.099 . . . . 0.0 112.076 2.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.04 144.23 4.96 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.938 0.774 . . . . 0.0 114.094 -174.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 10.0 ptp180 -55.4 -36.3 66.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.191 0.596 . . . . 0.0 112.151 -172.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.93 -32.13 72.37 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.992 0.517 . . . . 0.0 111.857 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 30' ' ' MET . 8.5 tt0 -68.45 -51.84 39.16 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.454 HD21 ' HD2' ' A' ' 22' ' ' PRO . 91.9 mt -55.29 -39.58 70.05 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.606 0.763 . . . . 0.0 111.006 176.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -59.67 -47.61 84.93 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.628 1.171 . . . . 0.0 109.514 -178.105 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -65.96 -39.65 90.59 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.029 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.557 ' HB3' HG21 ' A' ' 79' ' ' VAL . 26.4 mmt -60.79 -33.27 72.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.876 0.47 . . . . 0.0 110.986 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -72.29 -51.92 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.398 0.679 . . . . 0.0 111.004 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.0 -47.42 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.573 0.749 . . . . 0.0 111.817 -174.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.82 -16.61 58.98 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.031 0.932 . . . . 0.0 111.713 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -109.76 28.33 8.68 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.903 0.881 . . . . 0.0 111.235 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.24 5.9 88.46 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.4 -0.818 . . . . 0.0 114.227 170.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.69 160.57 32.81 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 115.105 0.802 . . . . 0.0 115.105 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -105.38 162.0 13.83 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.557 -0.821 . . . . 0.0 109.44 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -136.09 164.88 27.0 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.502 174.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.77 130.38 31.86 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -66.34 -46.69 75.95 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 124.131 0.894 . . . . 0.0 113.263 -164.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.46 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 74.7 t80 . . . . . 0 N--CA 1.479 1.014 0 C-N-CA 123.641 0.776 . . . . 0.0 109.471 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.0 m -126.96 -10.43 6.0 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.039 0.536 . . . . 0.0 110.615 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.8 p -113.54 143.28 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.066 0.546 . . . . 0.0 110.734 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 t -108.41 -13.82 14.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.923 0.489 . . . . 0.0 111.55 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -138.94 128.23 24.17 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.383 0.673 . . . . 0.0 109.953 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.645 ' HB ' HG22 ' A' ' 69' ' ' VAL . 66.4 mt -114.18 136.43 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG12 HG21 ' A' ' 20' ' ' THR . 86.8 t -113.19 119.33 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.86 173.3 11.85 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.595 0.758 . . . . 0.0 109.613 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -89.77 -44.17 10.17 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 174.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -130.34 145.84 51.84 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.041 -1.436 . . . . 0.0 108.473 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.525 ' HG ' HG11 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -136.13 117.34 11.57 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.181 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' O ' ' HG3' ' A' ' 61' ' ' ARG . 95.2 Cg_endo -77.31 155.38 32.64 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.861 2.374 . . . . 0.0 113.201 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.0 mt -51.32 -49.72 60.79 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.062 1.345 . . . . 0.0 114.266 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.56 -31.38 69.54 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.467 -177.367 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -72.11 -27.77 62.85 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 118.183 0.447 . . . . 0.0 111.131 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 85.3 mtt180 -60.1 -38.58 83.39 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 172.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.7 mt -64.88 -43.59 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.61 0.764 . . . . 0.0 110.782 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 6.2 mm-40 -72.99 -21.76 60.79 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.374 0.67 . . . . 0.0 111.396 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -113.19 27.11 9.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.275 1.03 . . . . 0.0 110.119 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.36 -28.17 69.58 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.186 0.595 . . . . 0.0 112.303 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -88.67 -29.38 19.94 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.936 0.495 . . . . 0.0 111.017 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -88.87 117.36 27.82 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -71.11 87.17 0.76 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.963 0.505 . . . . 0.0 109.677 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.645 HG22 ' HB ' ' A' ' 51' ' ' ILE . 22.9 t -81.09 128.41 38.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.34 172.31 16.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 124.874 1.27 . . . . 0.0 110.034 -175.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 60.9 p -85.28 159.47 56.33 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.81 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.32 -24.32 67.37 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.714 2.276 . . . . 0.0 112.718 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.82 -26.52 68.17 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.498 1.119 . . . . 0.0 112.084 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 37.1 t90 -61.63 -40.56 95.29 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.173 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 75' ' ' ILE . 2.8 mp -76.69 -49.65 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.025 0.93 . . . . 0.0 108.961 -177.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.98 -51.36 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.079 0.952 . . . . 0.0 111.343 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.43 -39.4 71.06 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.622 -173.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.5 p -64.49 -44.97 89.31 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 120.949 0.404 . . . . 0.0 111.309 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 30' ' ' MET . 41.7 t -65.5 -33.74 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.356 1.062 . . . . 0.0 111.298 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -72.83 -38.66 67.06 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 120.8 0.334 . . . . 0.0 110.889 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -89.0 -7.66 55.56 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.816 0.846 . . . . 0.0 112.048 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.89 27.85 16.97 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.669 1.188 . . . . 0.0 112.474 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -138.23 165.36 26.89 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.804 0.841 . . . . 0.0 110.365 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.417 ' HA ' HG23 ' A' ' 8' ' ' ILE . 51.2 tp -82.53 142.91 31.45 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 169.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.5 mt -110.61 155.06 42.8 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 123.777 0.831 . . . . 0.0 110.407 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.05 111.55 1.79 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.145 1.897 . . . . 0.0 110.309 166.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -59.64 -27.54 66.45 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.627 0.771 . . . . 0.0 111.961 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -58.37 -28.35 65.05 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.219 1.008 . . . . 0.0 111.974 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -71.9 -35.79 69.82 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.26 0.624 . . . . 0.0 110.674 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -105.91 7.48 32.17 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.649 0.78 . . . . 0.0 111.561 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.2 t -65.28 116.5 6.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.961 0.904 . . . . 0.0 112.456 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.5 -24.77 56.88 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.431 0.692 . . . . 0.0 111.443 175.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.545 HG23 ' HB ' ' A' ' 69' ' ' VAL . 22.7 p -69.56 -21.67 63.6 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.174 0.59 . . . . 0.0 112.315 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 C--O 1.249 1.069 0 CA-C-O 119.045 -0.502 . . . . 0.0 109.655 177.277 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.569 1.701 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.24 -46.84 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 124.029 0.932 . . . . 0.0 111.694 176.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -107.13 10.22 30.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.196 0.599 . . . . 0.0 111.55 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -57.46 -43.84 84.32 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.378 0.671 . . . . 0.0 111.301 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -78.69 -18.8 53.78 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.262 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.85 127.19 44.71 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.728 0.811 . . . . 0.0 112.306 -172.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 49' ' ' THR . 40.8 t -96.81 130.66 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 162.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.4 mp -121.56 122.86 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 36.8 t80 -105.1 125.52 51.07 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 167.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.434 HG12 ' HB ' ' A' ' 52' ' ' VAL . 47.4 mt -98.85 139.8 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -136.07 141.52 44.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.334 1.053 . . . . 0.0 109.893 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.47 -149.13 49.45 Favored Glycine 0 C--N 1.348 1.206 0 O-C-N 123.804 0.69 . . . . 0.0 113.439 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -95.54 116.3 28.63 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.64 0.776 . . . . 0.0 109.893 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.436 HG21 HG12 ' A' ' 52' ' ' VAL . 72.9 p -129.15 134.85 48.22 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.17 0.988 . . . . 0.0 108.673 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -111.16 131.37 22.23 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-N 117.993 0.36 . . . . 0.0 110.727 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.84 173.87 53.98 Favored 'Cis proline' 0 C--N 1.38 2.188 0 C-N-CA 124.416 -1.077 . . . . 0.0 111.992 0.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.81 146.86 9.03 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.053 0.846 . . . . 0.0 114.248 -173.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -52.39 -34.82 49.7 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.667 1.187 . . . . 0.0 112.763 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.455 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.4 pp -63.26 -43.63 97.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.452 0.301 . . . . 0.0 110.959 177.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -72.18 -41.71 66.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.083 0.553 . . . . 0.0 110.486 -176.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.6 mt -56.02 -43.96 78.24 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.344 0.658 . . . . 0.0 111.18 170.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.541 ' HA ' HD12 ' A' ' 31' ' ' ILE . 10.8 m170 -65.41 -34.94 79.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.097 0.559 . . . . 0.0 111.042 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 22.7 mm-40 -65.39 -41.17 93.99 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.584 0.354 . . . . 0.0 110.268 174.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.656 ' HB3' HG21 ' A' ' 79' ' ' VAL . 68.5 mtt -58.52 -35.72 72.73 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.364 0.665 . . . . 0.0 111.243 176.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 28' ' ' HIS . 64.6 mt -72.76 -51.8 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.757 0.823 . . . . 0.0 111.609 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.5 t -70.38 -41.83 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.286 0.634 . . . . 0.0 111.648 -172.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -65.92 -12.72 56.81 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.652 0.781 . . . . 0.0 111.983 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -107.84 24.99 12.09 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.349 1.06 . . . . 0.0 111.227 174.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.71 15.5 68.86 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.878 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.03 161.15 25.4 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 122.918 0.294 . . . . 0.0 113.335 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -106.53 148.63 27.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.673 0.789 . . . . 0.0 109.854 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -131.5 151.12 51.84 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.069 0.547 . . . . 0.0 110.746 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.6 tp -115.27 137.44 52.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.639 1.176 . . . . 0.0 108.975 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.57 -35.75 33.89 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.155 0.982 . . . . 0.0 112.997 -173.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.3 t80 . . . . . 0 N--CA 1.475 0.807 0 C-N-CA 124.568 1.147 . . . . 0.0 108.4 -169.268 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 121.925 0.869 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.7 m -84.84 -37.57 20.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.572 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.07 150.54 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.654 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 13' ' ' VAL . 10.0 t -115.17 -22.7 9.33 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.524 0.729 . . . . 0.0 111.081 175.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.416 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 27.8 m170 -133.77 126.19 30.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.491 0.717 . . . . 0.0 109.824 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.648 ' HB ' HG22 ' A' ' 69' ' ' VAL . 68.5 mt -109.39 139.84 30.66 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.436 HG12 HG21 ' A' ' 20' ' ' THR . 61.2 t -110.74 122.0 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.156 0.582 . . . . 0.0 109.704 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.69 170.65 18.2 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.454 0.701 . . . . 0.0 109.568 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.2 t -108.87 -48.24 3.32 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 168.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -106.83 91.41 3.66 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.06 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.482 ' HG ' HG11 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -112.18 106.99 55.99 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.34 147.78 44.76 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.77 2.98 . . . . 0.0 113.84 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.41 -38.34 71.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.758 0.823 . . . . 0.0 110.667 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.402 ' HB3' ' NZ ' ' A' ' 59' ' ' LYS . 3.2 mmmp? -51.56 -55.23 20.31 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.241 1.016 . . . . 0.0 110.899 172.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 63' ' ' GLU . 43.0 mtmt -80.79 -10.18 59.75 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.98 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -72.4 -30.97 65.14 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.474 0.579 . . . . 0.0 109.885 170.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.8 mt -80.54 -40.84 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 123.448 0.467 . . . . 0.0 109.922 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 42.3 mt-10 -67.34 -37.24 82.96 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.333 0.653 . . . . 0.0 111.147 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -104.68 26.59 8.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.865 0.866 . . . . 0.0 110.44 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.24 -23.79 64.84 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.828 0.451 . . . . 0.0 111.249 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.438 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.8 OUTLIER -70.52 -28.33 64.86 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.253 0.621 . . . . 0.0 110.031 175.556 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -95.45 174.77 6.85 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 170.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 34.6 mmtm -126.55 97.02 4.86 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.648 HG22 ' HB ' ' A' ' 51' ' ' ILE . 17.6 t -76.32 129.78 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.634 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.95 176.95 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.059 1.344 . . . . 0.0 109.298 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.9 m -85.95 156.51 57.92 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.464 0.706 . . . . 0.0 110.255 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' O ' HG23 ' A' ' 76' ' ' VAL . 19.8 Cg_endo -56.6 -27.57 70.35 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 123.116 2.544 . . . . 0.0 112.401 174.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -61.51 -24.11 66.38 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.884 1.274 . . . . 0.0 111.959 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -62.21 -48.09 81.53 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 172.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.6 mp -69.66 -47.08 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.0 -174.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 72' ' ' PRO . 95.9 t -59.83 -54.75 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.068 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 16.7 t70 -72.38 -36.41 68.71 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.741 -171.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.2 m -60.9 -40.32 92.68 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 120.694 0.283 . . . . 0.0 111.087 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.656 HG21 ' HB3' ' A' ' 30' ' ' MET . 45.2 t -70.0 -40.27 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.293 0.637 . . . . 0.0 111.476 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -63.57 -46.14 87.27 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.837 0.455 . . . . 0.0 110.794 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 17.5 mm-40 -80.16 -15.44 57.07 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.484 0.714 . . . . 0.0 111.066 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.86 28.8 14.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.015 1.326 . . . . 0.0 112.114 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -141.99 158.57 43.61 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.962 0.905 . . . . 0.0 109.755 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.4 tp -79.14 121.63 25.25 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.9 mt -101.68 158.57 31.53 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 124.104 0.962 . . . . 0.0 110.055 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.88 108.76 0.96 Allowed 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.153 1.902 . . . . 0.0 111.64 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -57.87 -33.15 68.39 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.726 0.81 . . . . 0.0 110.948 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -59.65 -31.16 69.28 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.533 1.133 . . . . 0.0 111.729 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -70.73 -39.44 73.35 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.548 0.739 . . . . 0.0 110.844 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -93.56 0.27 56.56 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.427 0.691 . . . . 0.0 111.661 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.6 t -72.2 124.91 26.02 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.612 0.365 . . . . 0.0 111.702 -171.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.5 mt -73.07 -43.89 61.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.99 168.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p -75.63 84.12 2.65 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.292 0.568 . . . . 0.0 109.805 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.248 1.026 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -178.642 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.3 pttp . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.479 0.181 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.4 -49.5 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.062 0.545 . . . . 0.0 111.623 -172.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.576 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 57.2 m-85 -108.4 17.48 22.07 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.778 -176.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -62.34 -43.88 97.79 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.508 0.723 . . . . 0.0 111.112 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -84.82 6.17 25.68 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.499 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.9 m -120.94 131.66 54.48 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.958 0.903 . . . . 0.0 111.261 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.457 HG22 ' HD3' ' A' ' 37' ' ' LYS . 15.1 t -103.18 127.27 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 166.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.499 ' H ' ' HA ' ' A' ' 38' ' ' PHE . 4.1 mp -118.1 120.17 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.14 0.576 . . . . 0.0 112.196 -176.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 13.0 t80 -106.54 126.26 52.04 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 166.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -97.95 110.85 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -104.25 128.13 51.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.943 0.897 . . . . 0.0 109.598 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.17 -171.45 50.32 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.383 0.427 . . . . 0.0 113.224 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.07 135.91 33.11 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.638 0.775 . . . . 0.0 110.09 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.505 HG21 HG12 ' A' ' 52' ' ' VAL . 41.5 p -138.06 148.4 45.02 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.417 1.087 . . . . 0.0 109.214 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 21' ' ' LYS . 11.9 mmpt? -105.54 120.63 48.78 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 165.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HD2' HD21 ' A' ' 27' ' ' LEU . 31.3 Cg_endo -84.2 174.62 37.64 Favored 'Cis proline' 0 CA--C 1.553 1.474 0 C-N-CA 123.896 -1.293 . . . . 0.0 111.295 -1.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.98 155.38 8.84 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -171.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -48.35 -37.1 15.81 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.022 1.329 . . . . 0.0 112.743 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.4 pp -63.05 -44.68 95.17 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.943 0.897 . . . . 0.0 111.439 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.5 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.5 tp-100 -71.83 -45.85 60.07 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.648 0.779 . . . . 0.0 110.542 -176.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.459 HD21 ' HD2' ' A' ' 22' ' ' PRO . 93.1 mt -57.86 -46.43 84.83 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.058 176.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.436 ' HA ' HD12 ' A' ' 31' ' ' ILE . 15.5 m170 -60.6 -36.46 78.62 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.019 0.528 . . . . 0.0 111.573 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -63.97 -46.41 84.77 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.74 0.416 . . . . 0.0 110.347 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.63 ' HB3' HG21 ' A' ' 79' ' ' VAL . 26.2 mmt -60.15 -34.0 72.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.71 0.804 . . . . 0.0 111.926 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 28' ' ' HIS . 78.6 mt -68.63 -51.26 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.526 0.73 . . . . 0.0 111.551 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.7 t -73.05 -40.4 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.034 0.534 . . . . 0.0 111.775 -172.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.04 -15.95 64.05 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.387 0.675 . . . . 0.0 111.754 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -109.57 26.59 10.47 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.768 0.827 . . . . 0.0 110.398 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.51 39.24 79.65 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-N 114.582 -1.19 . . . . 0.0 114.013 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.576 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -115.74 161.41 12.89 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 -173.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.457 ' HD3' HG22 ' A' ' 13' ' ' VAL . 88.3 tttt -105.86 150.13 25.9 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 122.925 0.49 . . . . 0.0 110.22 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.499 ' HA ' ' H ' ' A' ' 14' ' ' ILE . 27.0 p90 -141.85 164.73 29.39 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.374 0.67 . . . . 0.0 110.637 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.553 HD12 ' HB ' ' A' ' 48' ' ' VAL . 55.8 mt -124.8 146.88 49.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.723 0.809 . . . . 0.0 109.647 168.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -35.3 64.72 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.661 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.9 p90 . . . . . 0 N--CA 1.48 1.048 0 C-N-CA 125.517 1.527 . . . . 0.0 109.02 179.495 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.2 p -125.06 -37.96 2.38 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.3 0.64 . . . . 0.0 112.477 -171.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.553 ' HB ' HD12 ' A' ' 39' ' ' LEU . 6.6 p -82.52 152.76 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 122.262 -0.274 . . . . 0.0 110.345 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 t -114.55 -24.0 9.01 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.804 0.441 . . . . 0.0 111.508 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -129.0 130.28 46.45 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.763 0.425 . . . . 0.0 110.399 -177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 23.1 mt -116.93 134.97 58.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.505 HG12 HG21 ' A' ' 20' ' ' THR . 91.0 t -108.67 120.99 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.176 0.59 . . . . 0.0 110.954 -176.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.81 150.88 48.59 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.485 1.114 . . . . 0.0 108.625 172.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 20' ' ' THR . 41.1 t -76.71 -33.12 58.21 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 172.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -161.17 111.41 1.69 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.341 1.056 . . . . 0.0 108.348 170.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.652 HD22 HG11 ' A' ' 69' ' ' VAL . 16.4 tp -85.37 135.11 39.2 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 118.65 -0.69 . . . . 0.0 109.596 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.62 153.65 47.7 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.147 2.565 . . . . 0.0 112.56 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.59 -45.61 93.33 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.23 0.612 . . . . 0.0 112.125 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.0 mmmm -65.99 -36.81 84.32 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.642 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -66.96 -28.27 68.14 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.486 0.314 . . . . 0.0 111.649 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.17 -31.94 72.7 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.453 0.301 . . . . 0.0 110.319 173.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.9 mt -74.43 -37.76 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.07 0.548 . . . . 0.0 110.56 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 27.4 mm-40 -66.34 -42.01 88.73 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.424 0.631 . . . . 0.0 110.637 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -104.65 27.58 7.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.256 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.68 -22.83 64.35 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.495 0.718 . . . . 0.0 112.222 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.29 -6.94 59.46 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.849 0.46 . . . . 0.0 111.312 174.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -110.68 141.75 43.51 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.585 0.754 . . . . 0.0 109.411 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -79.33 86.03 5.1 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.652 HG11 HD22 ' A' ' 56' ' ' LEU . 55.7 t -75.47 130.04 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.474 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.601 HG11 ' HB2' ' A' ' 87' ' ' TRP . 35.2 m -134.65 177.18 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.003 1.321 . . . . 0.0 109.831 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -89.32 160.48 42.41 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.136 0.975 . . . . 0.0 110.541 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.459 ' HB3' HD11 ' A' ' 27' ' ' LEU . 23.3 Cg_endo -59.56 -23.38 70.79 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.802 2.335 . . . . 0.0 111.995 172.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.65 -27.31 66.25 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 124.708 1.203 . . . . 0.0 111.863 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -61.43 -43.68 98.45 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.108 0.413 . . . . 0.0 110.45 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.9 mp -72.05 -46.16 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -176.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.93 -47.8 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.371 1.068 . . . . 0.0 111.625 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.26 -42.27 75.8 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.761 0.824 . . . . 0.0 111.574 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.6 m -65.85 -36.85 84.59 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 120.72 0.295 . . . . 0.0 111.191 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 30' ' ' MET . 24.9 t -70.41 -33.86 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.771 0.828 . . . . 0.0 110.655 173.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -67.24 -34.51 77.61 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.549 0.74 . . . . 0.0 110.977 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -96.38 -13.6 23.1 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.189 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.64 39.06 24.99 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.284 1.033 . . . . 0.0 111.245 -175.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -156.18 156.53 34.35 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.884 0.874 . . . . 0.0 109.886 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.6 tp -75.51 107.77 7.87 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.245 0.618 . . . . 0.0 110.432 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.7 mt -88.72 156.09 50.22 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.556 0.742 . . . . 0.0 111.081 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.34 108.66 1.22 Allowed 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.524 2.149 . . . . 0.0 111.809 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.601 ' HB2' HG11 ' A' ' 70' ' ' VAL . 24.0 p90 -62.8 -20.91 65.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.112 0.965 . . . . 0.0 112.538 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -57.14 -35.45 69.52 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.176 0.99 . . . . 0.0 111.545 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.39 -27.23 68.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.798 0.839 . . . . 0.0 110.986 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.1 -6.15 18.87 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.696 0.798 . . . . 0.0 111.067 -175.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 75.5 m -64.19 130.17 42.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -172.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.3 mt -106.94 22.05 16.59 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.475 1.11 . . . . 0.0 110.498 173.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.7 p -64.22 -50.78 66.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.615 0.766 . . . . 0.0 110.717 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 C--O 1.251 1.163 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.659 176.49 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.5 mttp . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.403 HG23 ' HA ' ' A' ' 84' ' ' LEU . 55.9 mt -57.52 -45.72 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 123.568 0.747 . . . . 0.0 111.462 -176.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.758 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 50.8 m-85 -112.03 18.98 18.28 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.988 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -60.22 -40.21 89.36 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 118.312 0.505 . . . . 0.0 111.933 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -87.16 -7.64 57.76 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.687 0.795 . . . . 0.0 111.031 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 74.1 m -112.45 108.51 17.68 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 122.189 0.995 . . . . 0.0 111.818 -171.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.469 HG12 HG23 ' A' ' 48' ' ' VAL . 38.7 t -89.14 125.76 42.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 164.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.45 ' HB ' HD13 ' A' ' 31' ' ' ILE . 2.7 mp -110.54 128.63 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.774 0.83 . . . . 0.0 110.624 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -111.6 116.53 30.96 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 166.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.0 mt -84.62 137.13 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.421 0.688 . . . . 0.0 109.388 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -146.55 134.91 21.87 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.311 1.044 . . . . 0.0 109.696 -168.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.02 -160.2 54.02 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.638 0.586 . . . . 0.0 112.915 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.22 131.36 41.88 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -148.64 136.91 21.11 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.775 1.23 . . . . 0.0 108.843 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -116.65 134.07 22.95 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 122.974 0.51 . . . . 0.0 110.72 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.75 174.98 44.24 Favored 'Cis proline' 0 C--N 1.371 1.739 0 C-N-CA 124.408 -1.08 . . . . 0.0 110.996 -7.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.16 157.88 9.34 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -171.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -53.53 -35.44 60.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.546 1.138 . . . . 0.0 113.004 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 pp -60.62 -44.65 96.08 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.327 0.392 . . . . 0.0 110.559 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 30' ' ' MET . 6.9 tp-100 -70.48 -51.89 25.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.811 0.845 . . . . 0.0 110.045 -176.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -54.79 -41.33 70.43 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.525 0.73 . . . . 0.0 111.505 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' HG23 ' A' ' 32' ' ' VAL . 23.3 m170 -55.13 -48.2 74.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.314 0.645 . . . . 0.0 110.47 176.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.05 -38.95 92.5 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.731 0.645 . . . . 0.0 111.25 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.605 ' HB3' HG21 ' A' ' 79' ' ' VAL . 55.8 mmm -58.22 -36.54 73.3 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.505 0.722 . . . . 0.0 110.407 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.45 HD13 ' HB ' ' A' ' 14' ' ' ILE . 46.1 mt -72.23 -50.46 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.897 0.879 . . . . 0.0 111.654 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 28' ' ' HIS . 57.9 t -67.44 -42.26 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.233 -172.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.06 -12.6 61.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.967 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.457 ' NE2' HG13 ' A' ' 79' ' ' VAL . 34.1 m-70 -110.09 26.38 10.73 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.391 0.676 . . . . 0.0 111.163 173.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.83 37.93 75.67 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 114.867 -1.061 . . . . 0.0 113.615 171.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.758 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -118.61 -179.68 16.94 Favored Glycine 0 CA--C 1.503 -0.691 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 -175.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -123.74 144.52 49.63 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 121.201 0.524 . . . . 0.0 110.459 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -122.03 159.81 26.25 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.292 1.037 . . . . 0.0 108.484 173.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.421 HD22 ' HB ' ' A' ' 48' ' ' VAL . 32.7 tp -120.08 138.43 53.55 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -46.76 74.73 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 124.049 0.843 . . . . 0.0 111.98 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.8 t80 . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 123.788 0.835 . . . . 0.0 109.525 -170.0 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt . . . . . 0 CA--C 1.546 0.798 0 CA-C-O 121.138 0.494 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.4 m -108.75 12.3 25.78 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.42 1.088 . . . . 0.0 109.936 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.469 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -149.14 152.02 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.268 0.627 . . . . 0.0 109.655 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 t -107.33 -27.99 10.15 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.086 0.555 . . . . 0.0 111.595 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -124.62 135.8 53.4 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.308 0.643 . . . . 0.0 109.952 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.662 ' HB ' HG12 ' A' ' 69' ' ' VAL . 67.9 mt -121.85 116.09 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.7 t -91.5 120.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 123.951 0.901 . . . . 0.0 110.245 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.08 167.73 20.96 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.318 1.047 . . . . 0.0 108.786 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.1 t -115.45 -49.39 2.75 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -119.62 124.05 45.36 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.427 HD23 ' HG2' ' A' ' 61' ' ' ARG . 14.8 tp -150.02 128.35 5.93 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.07 155.91 17.58 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.594 2.863 . . . . 0.0 113.812 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.525 HD23 ' NH2' ' A' ' 61' ' ' ARG . 85.7 mt -55.48 -60.82 2.89 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.916 0.886 . . . . 0.0 111.022 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -59.8 -29.64 68.36 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.329 1.052 . . . . 0.0 111.851 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.484 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -68.69 -46.25 69.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.008 178.17 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.525 ' NH2' HD23 ' A' ' 58' ' ' LEU . 53.4 mtm180 -69.18 -27.49 65.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.917 0.887 . . . . 0.0 112.234 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 98.0 mt -72.37 -35.71 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.194 0.598 . . . . 0.0 109.843 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.4 -36.96 68.78 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.458 0.647 . . . . 0.0 109.504 172.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -87.98 17.49 4.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.03 0.932 . . . . 0.0 111.141 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.69 -23.81 65.34 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.035 0.534 . . . . 0.0 109.687 166.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -73.61 -6.89 49.48 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.084 0.954 . . . . 0.0 111.03 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -122.91 157.99 31.35 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.352 1.061 . . . . 0.0 109.46 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.67 85.06 5.56 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.662 HG12 ' HB ' ' A' ' 51' ' ' ILE . 22.1 m -83.06 131.38 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.187 -177.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.501 HG11 ' HB2' ' A' ' 87' ' ' TRP . 24.6 m -134.67 171.17 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.612 0.765 . . . . 0.0 109.859 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.43 ' HB3' HD21 ' A' ' 92' ' ' LEU . 47.5 p -86.85 156.95 55.21 Favored Pre-proline 0 C--O 1.245 0.828 0 C-N-CA 123.85 0.86 . . . . 0.0 109.469 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.403 ' O ' HG23 ' A' ' 76' ' ' VAL . 29.6 Cg_endo -60.4 -21.58 68.15 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 122.55 2.167 . . . . 0.0 112.707 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.23 -29.71 67.72 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.652 1.181 . . . . 0.0 111.818 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -59.58 -47.26 86.28 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.564 0.54 . . . . 0.0 110.084 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.7 mp -70.8 -51.95 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.754 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 72' ' ' PRO . 75.7 t -53.95 -52.66 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.224 1.01 . . . . 0.0 111.447 -176.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.66 -43.59 65.78 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.855 0.722 . . . . 0.0 111.158 -173.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.3 p -60.33 -36.96 79.16 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.018 0.437 . . . . 0.0 111.302 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.605 HG21 ' HB3' ' A' ' 30' ' ' MET . 46.9 t -67.89 -41.34 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.087 0.955 . . . . 0.0 111.512 176.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -67.38 -37.39 83.07 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.084 0.554 . . . . 0.0 111.285 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.19 -14.7 40.42 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.25 1.02 . . . . 0.0 111.479 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.27 26.71 15.58 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.146 1.378 . . . . 0.0 112.408 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -137.47 164.38 28.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.126 0.57 . . . . 0.0 110.32 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.403 ' HA ' HG23 ' A' ' 8' ' ' ILE . 60.7 tp -78.31 131.48 37.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.363 0.665 . . . . 0.0 110.606 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -108.33 150.66 40.84 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.744 1.218 . . . . 0.0 109.458 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.49 113.87 3.84 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.363 2.042 . . . . 0.0 110.47 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.501 ' HB2' HG11 ' A' ' 70' ' ' VAL . 64.6 p-90 -61.76 -27.8 68.99 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.629 0.771 . . . . 0.0 111.922 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -62.46 -27.82 69.39 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.134 0.974 . . . . 0.0 112.097 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -71.59 -21.07 61.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.799 0.84 . . . . 0.0 111.071 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -114.7 1.11 14.09 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.335 1.054 . . . . 0.0 110.731 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 27.0 t -69.27 131.36 44.75 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.196 0.598 . . . . 0.0 111.783 -171.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' A' ' 71' ' ' SER . 38.6 mt -96.72 8.66 43.75 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.29 0.636 . . . . 0.0 112.111 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.414 HG22 ' OG ' ' A' ' 91' ' ' SER . 13.5 t -72.43 -14.56 61.72 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.526 0.603 . . . . 0.0 111.075 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.5 t . . . . . 0 C--O 1.251 1.167 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 169.854 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 67.1 mt -55.0 -48.1 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.763 1.225 . . . . 0.0 111.867 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.583 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 73.1 m-85 -105.05 7.34 33.9 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.463 -175.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 47.3 tptt -57.1 -49.31 76.29 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.053 0.541 . . . . 0.0 110.721 -174.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -84.11 -4.95 59.13 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.937 -1.028 . . . . 0.0 111.927 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.1 m -106.37 128.21 53.86 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.28 0.632 . . . . 0.0 111.488 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.463 ' H ' HG22 ' A' ' 49' ' ' THR . 21.9 t -95.12 126.94 47.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 168.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.38 122.73 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-O 121.241 0.543 . . . . 0.0 111.491 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -104.63 143.36 33.18 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.132 1.373 . . . . 0.0 107.693 167.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.8 mt -114.36 113.46 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -102.73 123.57 46.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.29 1.036 . . . . 0.0 110.417 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.66 -169.3 50.58 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.826 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -85.54 110.32 19.13 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.554 0.742 . . . . 0.0 109.487 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.659 HG21 HG12 ' A' ' 52' ' ' VAL . 74.0 p -122.55 148.54 45.08 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.556 1.143 . . . . 0.0 108.963 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -99.9 131.66 24.12 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-N 118.155 0.434 . . . . 0.0 111.962 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HD2' HD21 ' A' ' 27' ' ' LEU . 80.9 Cg_endo -76.57 175.92 46.14 Favored 'Cis proline' 0 C--N 1.374 1.883 0 C-N-CA 124.65 -0.979 . . . . 0.0 110.933 -7.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.5 148.43 7.22 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 114.631 0.612 . . . . 0.0 114.631 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -52.26 -35.79 50.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.082 0.953 . . . . 0.0 112.927 -174.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 26' ' ' GLN . 4.1 pp -63.51 -41.24 98.53 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.502 0.321 . . . . 0.0 111.08 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.44 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.4 tp-100 -69.88 -48.43 58.75 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.675 0.79 . . . . 0.0 110.509 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.46 HD21 ' HD2' ' A' ' 22' ' ' PRO . 69.4 mt -56.48 -46.26 80.55 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.259 0.623 . . . . 0.0 111.242 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.461 ' O ' HG23 ' A' ' 32' ' ' VAL . 9.9 m80 -56.57 -43.82 80.37 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.455 0.702 . . . . 0.0 110.677 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.57 -36.74 83.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.81 0.444 . . . . 0.0 111.3 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.587 ' HB3' HG21 ' A' ' 79' ' ' VAL . 23.8 mmt -63.79 -35.2 79.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.188 0.595 . . . . 0.0 110.895 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.8 mt -70.61 -51.17 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.724 0.81 . . . . 0.0 111.244 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 28' ' ' HIS . 64.1 t -66.89 -40.33 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.111 0.564 . . . . 0.0 111.731 -173.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.09 -11.67 61.0 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.098 0.559 . . . . 0.0 111.845 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -100.33 20.49 14.67 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.208 1.003 . . . . 0.0 111.107 170.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' O ' ' HD2' ' A' ' 10' ' ' LYS . . . 72.11 9.44 71.79 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.815 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.86 159.66 46.0 Favored Glycine 0 C--O 1.24 0.518 0 N-CA-C 114.124 0.41 . . . . 0.0 114.124 -170.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -101.89 153.63 19.67 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -144.01 145.81 32.46 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.938 0.495 . . . . 0.0 110.967 -174.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HG ' HG22 ' A' ' 47' ' ' THR . 1.5 mm? -130.43 145.88 51.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.039 0.936 . . . . 0.0 109.961 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -109.45 -34.08 6.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.749 0.82 . . . . 0.0 109.069 170.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.9 p90 . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -169.838 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.622 HG22 ' HG ' ' A' ' 39' ' ' LEU . 3.0 m -84.61 -28.18 26.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.486 -176.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.448 HG23 HG12 ' A' ' 13' ' ' VAL . 11.5 p -150.09 162.95 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.956 0.903 . . . . 0.0 109.193 -172.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 13' ' ' VAL . 10.3 t -115.86 -18.19 10.82 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.504 0.593 . . . . 0.0 112.237 174.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -134.04 131.71 39.18 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.418 0.687 . . . . 0.0 110.662 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.634 ' HB ' HG12 ' A' ' 69' ' ' VAL . 54.0 mt -114.73 129.58 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.659 HG12 HG21 ' A' ' 20' ' ' THR . 62.7 t -92.03 129.01 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.89 0.876 . . . . 0.0 109.461 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.99 147.0 30.26 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.114 0.566 . . . . 0.0 110.492 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.0 t -90.07 -34.49 15.9 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -145.65 142.36 28.97 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.191 173.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.425 HD12 ' HG2' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -146.73 107.57 4.03 Favored Pre-proline 0 CA--C 1.561 1.37 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.394 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.31 159.32 53.78 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.216 2.61 . . . . 0.0 113.061 -175.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.428 ' O ' HG13 ' A' ' 62' ' ' ILE . 65.7 mt -50.99 -49.7 59.87 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.375 1.07 . . . . 0.0 112.432 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -59.56 -45.71 91.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.039 0.536 . . . . 0.0 111.209 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -69.29 -26.03 64.53 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.634 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HG2' HD12 ' A' ' 56' ' ' LEU . 58.2 mtm180 -73.88 -26.68 60.68 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.721 0.409 . . . . 0.0 111.015 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 58' ' ' LEU . 60.8 mt -76.44 -39.27 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.85 -42.01 97.68 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.864 0.866 . . . . 0.0 110.955 174.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -104.01 26.81 8.27 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.081 0.952 . . . . 0.0 110.411 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.12 -19.48 64.04 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 122.842 0.457 . . . . 0.0 111.274 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -75.49 -26.12 57.88 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.839 0.856 . . . . 0.0 110.647 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -111.7 145.42 39.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.999 0.92 . . . . 0.0 109.418 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -85.74 90.6 8.07 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -177.294 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.634 HG12 ' HB ' ' A' ' 51' ' ' ILE . 27.1 m -74.0 127.13 35.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.83 172.59 15.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.827 1.251 . . . . 0.0 109.112 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.7 m -79.44 151.5 74.86 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.99 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.43 ' O ' HG23 ' A' ' 76' ' ' VAL . 26.5 Cg_endo -60.11 -25.35 79.61 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.78 2.32 . . . . 0.0 111.643 170.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -59.12 -23.16 61.89 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.173 1.389 . . . . 0.0 112.149 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -61.3 -46.62 89.56 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.021 0.439 . . . . 0.0 109.921 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.583 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.7 mp -71.86 -47.24 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.113 -177.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 72' ' ' PRO . 61.0 t -54.92 -50.72 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.999 0.92 . . . . 0.0 111.01 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -70.58 -47.52 59.85 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.205 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.441 ' HA ' HD23 ' A' ' 85' ' ' LEU . 79.5 p -63.09 -44.31 96.08 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.281 0.363 . . . . 0.0 111.445 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.587 HG21 ' HB3' ' A' ' 30' ' ' MET . 55.5 t -59.3 -42.8 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.054 0.942 . . . . 0.0 110.738 174.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -68.97 -33.06 73.08 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.033 0.933 . . . . 0.0 111.897 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.38 -11.35 38.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.583 0.753 . . . . 0.0 111.625 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.78 22.43 12.43 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.572 1.149 . . . . 0.0 112.323 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -142.49 156.5 45.16 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.512 0.725 . . . . 0.0 109.552 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.09 117.97 18.35 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 78' ' ' SER . 4.0 mm? -92.6 144.83 29.33 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 167.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.626 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 38.2 Cg_endo -62.49 124.04 13.5 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.081 1.854 . . . . 0.0 111.587 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -64.15 -19.85 65.58 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.079 0.952 . . . . 0.0 112.469 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.626 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.8 pt20 -59.3 -25.84 64.46 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.928 0.891 . . . . 0.0 111.629 174.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -71.22 -27.07 63.22 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.779 0.832 . . . . 0.0 110.115 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -116.26 2.02 13.2 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.911 0.884 . . . . 0.0 111.975 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.4 p -66.57 110.87 3.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.473 0.709 . . . . 0.0 111.537 -173.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.416 ' HB2' HG23 ' A' ' 69' ' ' VAL . 78.3 mt -74.87 -16.34 60.68 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.834 173.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 p -47.81 -51.97 20.65 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.724 1.209 . . . . 0.0 111.601 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 CA--C 1.553 1.094 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.129 176.829 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.558 1.252 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.567 HG23 ' HA ' ' A' ' 84' ' ' LEU . 43.1 mt -54.83 -48.13 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.609 1.164 . . . . 0.0 111.109 176.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -113.87 10.11 17.66 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.882 -173.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -50.56 -65.75 0.51 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.848 0.859 . . . . 0.0 112.813 -167.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -85.8 -8.56 58.04 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.075 0.464 . . . . 0.0 110.338 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.3 m -79.9 118.02 21.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.698 0.799 . . . . 0.0 110.036 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -90.09 124.78 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 170.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.0 126.32 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.023 0.529 . . . . 0.0 111.727 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -104.96 148.82 26.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.977 1.311 . . . . 0.0 108.421 172.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -120.47 137.78 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -135.24 128.01 31.1 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.512 1.125 . . . . 0.0 108.876 -167.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.46 -159.75 48.7 Favored Glycine 0 C--N 1.343 0.924 0 O-C-N 123.404 0.44 . . . . 0.0 112.073 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -103.21 111.37 23.73 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.283 0.633 . . . . 0.0 109.624 176.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.0 p -119.49 134.64 55.12 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.743 1.217 . . . . 0.0 108.657 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -102.62 133.34 20.53 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 117.896 0.316 . . . . 0.0 110.629 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.02 164.86 85.74 Favored 'Cis proline' 0 C--N 1.384 2.405 0 C-N-CA 124.469 -1.055 . . . . 0.0 112.272 1.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.71 157.99 3.89 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 124.169 0.918 . . . . 0.0 114.556 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -54.65 -37.17 65.37 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.931 0.892 . . . . 0.0 112.478 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 26' ' ' GLN . 3.3 pp -62.96 -43.99 97.29 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.162 0.585 . . . . 0.0 110.804 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.528 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.3 tp-100 -67.79 -49.8 60.39 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.878 0.871 . . . . 0.0 110.618 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.1 mt -55.15 -51.47 66.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.877 0.871 . . . . 0.0 111.649 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.46 ' HA ' HD12 ' A' ' 31' ' ' ILE . 23.0 m170 -61.35 -35.26 76.93 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.873 0.469 . . . . 0.0 111.649 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.476 ' O ' HD13 ' A' ' 33' ' ' LEU . 43.3 mt-10 -64.23 -46.48 83.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 0.0 110.191 173.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.768 ' HB3' HG21 ' A' ' 79' ' ' VAL . 67.3 mtt -56.68 -37.3 70.66 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.465 0.65 . . . . 0.0 110.499 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 28' ' ' HIS . 77.2 mt -66.17 -50.65 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.556 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 28' ' ' HIS . 59.3 t -71.06 -29.35 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.144 0.578 . . . . 0.0 111.173 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 29' ' ' GLU . 6.8 mp -64.34 -22.73 67.05 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.515 1.126 . . . . 0.0 110.744 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.418 ' HE1' HG13 ' A' ' 79' ' ' VAL . 60.6 m80 -105.5 26.93 8.88 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.398 1.079 . . . . 0.0 110.678 173.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.35 18.14 76.62 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.471 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.2 164.41 29.62 Favored Glycine 0 C--O 1.241 0.556 0 N-CA-C 114.179 0.431 . . . . 0.0 114.179 -171.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -113.42 161.79 16.88 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.824 0.849 . . . . 0.0 109.635 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -145.78 154.29 41.86 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 122.715 0.406 . . . . 0.0 111.406 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -121.16 137.64 54.58 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -82.23 -49.92 9.57 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.619 0.768 . . . . 0.0 112.724 -173.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 N--CA 1.493 1.72 0 C-N-CA 125.6 1.56 . . . . 0.0 108.691 -176.297 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.542 0.687 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.6 m -91.51 -22.95 20.11 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 121.792 -0.567 . . . . 0.0 111.439 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 p -92.86 152.23 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 122.23 -0.294 . . . . 0.0 111.665 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.1 t -114.18 -25.34 8.53 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.348 0.659 . . . . 0.0 111.297 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -128.56 125.72 38.86 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.314 0.646 . . . . 0.0 109.742 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.478 ' HB ' HG22 ' A' ' 69' ' ' VAL . 40.4 mt -106.1 138.38 31.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.9 t -117.57 120.21 64.07 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 C-N-CA 123.905 0.882 . . . . 0.0 108.811 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -139.44 159.66 41.65 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.348 0.659 . . . . 0.0 109.612 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.0 t -84.64 -46.42 11.52 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 168.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -140.01 124.34 17.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.809 1.243 . . . . 0.0 108.933 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.447 HD22 HG11 ' A' ' 69' ' ' VAL . 38.7 tp -107.49 128.39 26.02 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.13 153.6 38.27 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.347 2.698 . . . . 0.0 112.832 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.4 mt -59.26 -44.88 92.38 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.707 0.803 . . . . 0.0 111.234 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -61.5 -46.65 89.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.24 1.016 . . . . 0.0 110.191 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -70.91 -24.66 62.5 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.993 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -73.71 -30.81 63.08 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.07 0.548 . . . . 0.0 110.132 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -70.99 -43.38 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.783 0.833 . . . . 0.0 109.957 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.32 -38.34 87.46 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.812 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.426 ' HA ' ' HD1' ' A' ' 67' ' ' TYR . 23.2 m-85 -100.22 26.26 6.7 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.976 0.911 . . . . 0.0 110.744 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 -24.95 66.59 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.291 0.637 . . . . 0.0 112.103 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -80.33 -27.45 38.34 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.072 0.549 . . . . 0.0 110.761 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.426 ' HD1' ' HA ' ' A' ' 64' ' ' PHE . 62.4 m-85 -88.72 141.63 28.35 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.78 0.832 . . . . 0.0 109.641 -177.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -82.97 85.86 7.08 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.478 HG22 ' HB ' ' A' ' 51' ' ' ILE . 41.4 t -77.9 128.68 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.266 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 87' ' ' TRP . 27.7 m -139.96 174.53 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.093 1.357 . . . . 0.0 109.466 -175.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.0 m -87.83 159.88 48.05 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.306 0.642 . . . . 0.0 110.382 171.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -58.66 -23.16 64.38 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.935 2.423 . . . . 0.0 112.485 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.21 -24.34 64.74 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.004 1.322 . . . . 0.0 112.151 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -62.15 -50.78 70.5 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 75' ' ' ILE . 2.6 mp -64.94 -52.15 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.87 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.19 -54.34 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.245 1.018 . . . . 0.0 111.537 -175.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -72.71 -37.31 67.85 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 123.335 0.397 . . . . 0.0 111.289 -172.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.5 m -63.95 -37.61 88.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.64 0.376 . . . . 0.0 111.234 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.768 HG21 ' HB3' ' A' ' 30' ' ' MET . 40.2 t -72.32 -36.8 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.896 0.878 . . . . 0.0 111.575 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -65.85 -41.09 92.12 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.763 0.425 . . . . 0.0 110.618 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -89.6 -10.33 46.42 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.78 0.832 . . . . 0.0 111.901 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 55.32 37.71 29.29 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.828 1.251 . . . . 0.0 112.226 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -146.76 155.5 42.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.815 0.846 . . . . 0.0 110.048 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.567 ' HA ' HG23 ' A' ' 8' ' ' ILE . 60.9 tp -78.11 94.76 4.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.403 0.681 . . . . 0.0 109.571 -178.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.22 151.74 66.78 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.771 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.66 110.55 0.84 Allowed 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.77 2.313 . . . . 0.0 112.685 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.514 ' HB2' HG11 ' A' ' 70' ' ' VAL . 61.7 p-90 -63.82 -22.23 66.82 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.917 0.887 . . . . 0.0 111.246 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -63.44 -24.16 67.71 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.284 1.034 . . . . 0.0 111.433 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.28 -5.99 58.4 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.232 0.613 . . . . 0.0 111.527 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -126.93 1.42 6.61 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.536 0.734 . . . . 0.0 110.895 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.9 p -68.49 113.46 6.05 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.456 0.702 . . . . 0.0 112.368 -170.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.9 mt -89.78 20.4 4.13 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.008 0.923 . . . . 0.0 111.283 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.5 p -68.4 -27.74 66.48 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.179 0.991 . . . . 0.0 111.553 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.937 176.861 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 10' ' ' LYS . 9.5 mtmp? . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.8 mt -50.49 -45.65 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 125.503 1.521 . . . . 0.0 112.243 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 75' ' ' ILE . 63.8 m-85 -108.98 16.49 22.59 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.412 0.685 . . . . 0.0 111.371 -174.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 7' ' ' LYS . 13.6 tptp -50.23 -51.91 40.36 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.035 0.934 . . . . 0.0 113.288 -168.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -99.5 -2.79 35.03 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.407 0.683 . . . . 0.0 111.069 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.6 m -82.2 128.47 34.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.141 0.577 . . . . 0.0 109.904 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.62 HG12 HG23 ' A' ' 48' ' ' VAL . 38.8 t -104.27 119.58 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 mp -119.62 131.95 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.294 0.638 . . . . 0.0 111.174 -173.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -113.67 150.95 32.49 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.935 1.694 . . . . 0.0 108.165 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.28 132.2 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -139.65 135.6 33.43 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.163 1.385 . . . . 0.0 108.562 -170.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.25 -172.76 54.35 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -92.65 110.41 21.84 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.516 HG21 HG12 ' A' ' 52' ' ' VAL . 65.4 p -113.74 141.57 47.1 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.05 0.94 . . . . 0.0 109.871 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.521 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -104.97 127.25 29.12 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 167.172 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.38 173.84 54.5 Favored 'Cis proline' 0 C--N 1.372 1.769 0 C-N-CA 124.184 -1.173 . . . . 0.0 112.276 -0.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.05 157.2 9.72 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.679 0.612 . . . . 0.0 113.939 -174.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -51.47 -35.45 39.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.127 0.971 . . . . 0.0 111.901 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.1 pp -56.76 -48.95 76.69 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.049 0.939 . . . . 0.0 112.001 177.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.528 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.8 tp-100 -72.37 -43.55 63.83 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.749 0.819 . . . . 0.0 110.334 -174.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.54 -44.79 96.4 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.854 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.58 ' HA ' HD12 ' A' ' 31' ' ' ILE . 24.1 m-70 -61.26 -36.8 81.01 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.102 0.561 . . . . 0.0 111.0 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.19 -45.05 86.38 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.745 0.418 . . . . 0.0 110.632 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.543 ' SD ' HG11 ' A' ' 79' ' ' VAL . 23.9 mmt -59.29 -31.99 69.63 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.349 0.66 . . . . 0.0 111.475 176.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 28' ' ' HIS . 84.0 mt -69.39 -52.33 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.05 175.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 28' ' ' HIS . 59.9 t -72.29 -38.84 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 122.986 0.514 . . . . 0.0 112.164 -169.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.34 -19.14 64.37 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.199 0.6 . . . . 0.0 111.661 176.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -104.43 25.89 9.63 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.624 0.77 . . . . 0.0 111.4 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.65 14.75 70.24 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.654 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.82 161.17 36.23 Favored Glycine 0 C--O 1.242 0.618 0 N-CA-C 113.954 0.342 . . . . 0.0 113.954 -171.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -103.17 144.61 31.09 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.278 1.031 . . . . 0.0 108.614 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -134.29 145.37 49.01 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 122.961 0.505 . . . . 0.0 110.627 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.41 142.86 50.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.293 1.037 . . . . 0.0 109.277 173.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -109.05 -43.71 4.13 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.919 170.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 p90 . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.559 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 122.575 1.179 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -89.01 -1.07 57.93 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.713 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.62 HG23 HG12 ' A' ' 13' ' ' VAL . 9.1 p -162.97 160.11 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.921 0.888 . . . . 0.0 109.436 -172.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.3 t -114.29 -21.27 10.51 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -126.5 139.17 53.43 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.04 0.536 . . . . 0.0 110.225 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.747 ' HB ' HG12 ' A' ' 69' ' ' VAL . 58.1 mt -124.42 129.72 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.516 HG12 HG21 ' A' ' 20' ' ' THR . 51.6 t -104.93 119.05 53.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 C-N-CA 123.741 0.816 . . . . 0.0 110.355 -172.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.07 146.44 35.45 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.6 p -85.38 -10.29 56.47 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.792 0.437 . . . . 0.0 110.613 173.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -156.76 89.05 1.07 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.48 1.112 . . . . 0.0 108.009 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.67 110.18 47.77 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.424 ' O ' ' HG3' ' A' ' 61' ' ' ARG . 54.3 Cg_exo -55.41 151.15 38.51 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.84 3.027 . . . . 0.0 114.001 -176.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.4 mt -57.2 -46.01 83.25 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 0.0 111.528 -177.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -63.88 -39.81 95.06 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.7 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.57 -34.95 77.99 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 119.431 -0.319 . . . . 0.0 111.657 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 80.0 mtt180 -60.36 -36.04 77.09 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 122.94 0.496 . . . . 0.0 110.69 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.9 mt -71.5 -42.13 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.009 0.923 . . . . 0.0 110.761 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.58 -26.94 61.05 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.204 0.602 . . . . 0.0 111.045 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.407 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 20.7 m-85 -110.28 28.72 8.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.488 1.115 . . . . 0.0 109.76 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.54 -22.84 65.51 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -91.99 -26.93 18.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.16 0.584 . . . . 0.0 110.393 176.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.407 ' HD2' ' HA ' ' A' ' 64' ' ' PHE . 65.0 m-85 -85.86 135.13 33.82 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -83.96 86.48 7.18 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.747 HG12 ' HB ' ' A' ' 51' ' ' ILE . 21.4 m -77.18 127.69 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.117 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' ' 87' ' ' TRP . 35.9 m -136.8 172.3 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.339 1.056 . . . . 0.0 109.735 -175.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.1 m -80.69 154.91 73.62 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.301 172.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.25 -22.04 63.07 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.512 2.141 . . . . 0.0 111.869 171.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.9 -29.61 60.29 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.368 1.467 . . . . 0.0 112.292 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -63.57 -49.06 74.89 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 120.8 0.333 . . . . 0.0 110.34 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.437 ' O ' HG23 ' A' ' 79' ' ' VAL . 2.8 mp -68.38 -49.43 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.979 -175.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.1 t -58.48 -53.79 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.791 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 21.1 t0 -72.65 -31.73 65.33 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.081 0.238 . . . . 0.0 111.488 -172.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.591 ' HA ' HD13 ' A' ' 85' ' ' LEU . 58.0 m -63.68 -37.86 88.95 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 120.643 0.258 . . . . 0.0 110.932 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.543 HG11 ' SD ' ' A' ' 30' ' ' MET . 86.3 t -70.87 -36.45 64.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 122.97 0.508 . . . . 0.0 110.787 175.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -62.49 -45.59 92.3 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.769 0.428 . . . . 0.0 111.06 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 10.7 mm-40 -85.37 -11.88 53.5 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.252 0.621 . . . . 0.0 111.159 -176.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.26 34.98 10.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.758 1.223 . . . . 0.0 111.691 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -153.67 168.97 24.45 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.448 0.699 . . . . 0.0 110.647 -177.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -86.37 108.39 18.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.293 0.637 . . . . 0.0 109.879 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 78' ' ' SER . 10.8 mp -83.89 152.56 62.8 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.553 0.741 . . . . 0.0 110.654 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.566 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 49.0 Cg_endo -67.1 120.85 7.95 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.459 2.106 . . . . 0.0 111.295 171.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.531 ' HB2' HG11 ' A' ' 70' ' ' VAL . 69.0 p-90 -63.66 -21.67 66.5 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.695 0.798 . . . . 0.0 111.922 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.566 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 21.0 pt20 -59.08 -29.16 67.13 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.061 0.944 . . . . 0.0 111.945 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.62 -21.33 63.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.586 0.754 . . . . 0.0 111.504 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -121.49 9.64 10.31 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.823 0.849 . . . . 0.0 110.852 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.503 ' OG ' HG22 ' A' ' 93' ' ' THR . 41.2 t -72.91 114.33 10.93 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.614 0.766 . . . . 0.0 111.446 -172.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.7 mt -91.46 2.21 56.59 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.723 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.503 HG22 ' OG ' ' A' ' 91' ' ' SER . 6.7 t -74.23 -18.28 60.77 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.602 0.637 . . . . 0.0 111.179 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.7 t . . . . . 0 C--O 1.255 1.355 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.661 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 43.1 mm . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 p -133.15 120.46 21.23 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.415 0.686 . . . . 0.0 109.592 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 m -62.11 -55.39 29.34 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.858 0.863 . . . . 0.0 111.201 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 57.29 29.43 16.79 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.308 1.043 . . . . 0.0 111.051 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.4 m -106.52 145.29 32.02 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.054 0.942 . . . . 0.0 110.146 -174.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.9 m 58.48 38.66 25.53 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.044 0.937 . . . . 0.0 110.629 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 10' ' ' LYS . 62.8 pttt -83.51 38.05 0.6 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.441 1.496 . . . . 0.0 112.227 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.467 HG23 ' HA ' ' A' ' 84' ' ' LEU . 44.7 mt -52.13 -34.7 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 125.714 1.605 . . . . 0.0 113.209 -174.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.419 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 67.8 m-85 -114.34 16.74 17.81 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.482 0.713 . . . . 0.0 110.914 -174.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 7' ' ' LYS . 25.5 tptp -54.67 -43.82 72.77 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.275 1.03 . . . . 0.0 112.899 -169.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -102.98 7.2 39.16 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.362 0.665 . . . . 0.0 111.376 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.1 m -108.37 118.87 37.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.569 0.748 . . . . 0.0 111.24 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.537 HG12 HG23 ' A' ' 48' ' ' VAL . 69.9 t -89.78 125.36 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 164.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.558 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.1 mp -117.55 127.22 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.268 0.556 . . . . 0.0 111.125 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.437 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 19.3 t80 -103.48 150.87 23.47 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.739 1.216 . . . . 0.0 107.869 169.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.552 HG12 ' HB ' ' A' ' 52' ' ' VAL . 65.1 mt -123.03 130.91 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -128.46 141.7 51.31 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.612 1.165 . . . . 0.0 109.476 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.09 -168.37 48.7 Favored Glycine 0 N--CA 1.477 1.401 0 N-CA-C 112.263 -0.335 . . . . 0.0 112.263 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -101.22 108.49 20.15 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.438 HG21 HG12 ' A' ' 52' ' ' VAL . 69.4 p -110.08 139.73 44.9 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.06 0.944 . . . . 0.0 109.433 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -105.96 126.86 29.6 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 170.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -78.81 175.23 47.42 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 124.449 -1.063 . . . . 0.0 111.977 -0.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.22 153.99 5.6 Favored Glycine 0 C--N 1.349 1.263 0 O-C-N 123.948 0.78 . . . . 0.0 114.671 -170.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -57.97 -34.76 70.29 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.665 0.786 . . . . 0.0 111.65 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.7 pp -59.97 -45.9 91.18 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 123.589 0.556 . . . . 0.0 111.14 172.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.532 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.0 tp-100 -67.11 -50.94 59.8 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.801 0.841 . . . . 0.0 111.012 -175.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.0 mt -55.93 -44.55 78.45 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.167 0.587 . . . . 0.0 111.208 177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.558 ' HA ' HD12 ' A' ' 31' ' ' ILE . 30.2 m170 -62.61 -36.66 83.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.889 0.476 . . . . 0.0 111.299 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 46.2 mt-10 -66.16 -41.59 90.15 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.801 0.44 . . . . 0.0 110.713 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.552 ' HB3' HG21 ' A' ' 79' ' ' VAL . 5.6 mmt -60.52 -33.5 72.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.803 0.841 . . . . 0.0 110.721 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.558 HD13 ' HB ' ' A' ' 14' ' ' ILE . 60.0 mt -70.07 -49.77 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.977 0.911 . . . . 0.0 111.007 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 28' ' ' HIS . 80.0 t -61.45 -48.09 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.482 0.713 . . . . 0.0 112.113 -176.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.18 -23.39 66.58 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.222 0.609 . . . . 0.0 111.629 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.5 ' NE2' HG13 ' A' ' 79' ' ' VAL . 40.3 m-70 -95.87 27.03 3.73 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.892 0.877 . . . . 0.0 111.397 175.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.67 78.04 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.724 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.42 175.76 33.4 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 114.203 0.441 . . . . 0.0 114.203 -171.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -128.74 155.45 45.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.167 0.987 . . . . 0.0 108.75 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -138.51 168.72 19.17 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.177 0.513 . . . . 0.0 112.22 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.75 140.89 50.35 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -74.51 -46.36 39.83 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.762 0.825 . . . . 0.0 111.306 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.437 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 71.9 t80 -174.18 138.65 0.59 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.578 1.151 . . . . 0.0 109.688 -171.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -106.86 150.27 26.56 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.487 0.715 . . . . 0.0 110.513 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.5 t -128.67 70.46 1.39 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.318 1.047 . . . . 0.0 108.585 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.8 t 75.4 -40.83 0.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.861 1.665 . . . . 0.0 113.671 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -70.39 148.37 48.47 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.46 0.704 . . . . 0.0 112.097 -173.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HA ' ' HE1' ' A' ' 67' ' ' TYR . 95.4 mttt -80.73 82.56 6.7 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.331 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.6 m -120.07 24.25 10.57 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.497 0.719 . . . . 0.0 109.351 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.537 HG23 HG12 ' A' ' 13' ' ' VAL . 6.1 p -154.2 155.82 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.327 0.651 . . . . 0.0 109.608 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.8 t -114.63 -25.81 8.14 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.59 0.756 . . . . 0.0 111.466 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -133.03 138.78 46.91 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.616 0.766 . . . . 0.0 110.236 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.613 ' HB ' HG22 ' A' ' 69' ' ' VAL . 58.1 mt -123.64 143.33 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.562 1.145 . . . . 0.0 108.358 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.552 ' HB ' HG12 ' A' ' 16' ' ' ILE . 97.6 t -115.74 119.79 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.419 0.688 . . . . 0.0 110.287 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.26 157.85 38.73 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.37 0.668 . . . . 0.0 110.032 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.3 t -70.78 -49.36 47.45 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -147.02 147.43 30.67 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 168.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.558 ' HG ' HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -123.46 116.23 28.23 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -173.795 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.532 ' HG2' ' HB2' ' A' ' 60' ' ' LYS . 36.9 Cg_endo -64.68 156.35 61.85 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.132 2.555 . . . . 0.0 113.429 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.07 -47.34 86.78 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.569 1.148 . . . . 0.0 113.58 -167.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -67.16 -26.99 66.92 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 120.953 0.406 . . . . 0.0 110.429 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.532 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 4.6 mptp? -81.47 -23.15 37.61 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.34 -34.24 77.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.2 mt -72.83 -39.57 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.849 0.86 . . . . 0.0 110.228 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 3.1 tp10 -63.06 -34.52 77.76 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.131 0.972 . . . . 0.0 110.435 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -117.6 27.43 9.06 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.499 -175.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.02 67.56 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.294 0.568 . . . . 0.0 111.473 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -76.41 -23.03 53.99 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.404 1.082 . . . . 0.0 111.306 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.401 ' HE1' ' HA ' ' A' ' 46' ' ' LYS . 15.9 m-85 -113.73 126.73 55.56 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.921 0.889 . . . . 0.0 109.272 -174.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.2 87.59 1.11 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.007 0.432 . . . . 0.0 110.315 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.613 HG22 ' HB ' ' A' ' 51' ' ' ILE . 16.5 t -76.08 134.45 29.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.211 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 87' ' ' TRP . 31.8 m -135.74 174.15 12.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.606 1.162 . . . . 0.0 109.531 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.5 t -86.09 152.37 55.79 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 171.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.26 -23.54 46.26 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 122.962 2.442 . . . . 0.0 113.15 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.12 -26.56 64.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.02 0.928 . . . . 0.0 112.26 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -61.02 -44.04 97.99 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.7 mp -75.6 -52.46 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.726 0.81 . . . . 0.0 108.841 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.3 t -54.91 -53.73 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.491 1.116 . . . . 0.0 111.148 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.07 -39.08 66.16 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.546 -173.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 95.5 p -60.58 -41.56 94.92 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 120.905 0.383 . . . . 0.0 110.529 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 30' ' ' MET . 70.8 t -64.51 -42.21 94.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 123.911 0.885 . . . . 0.0 111.066 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -67.61 -29.64 69.03 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.611 0.365 . . . . 0.0 111.441 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -89.78 -14.38 34.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.48 0.712 . . . . 0.0 110.925 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.97 27.38 16.23 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.168 1.387 . . . . 0.0 111.948 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -138.41 165.46 26.75 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.529 0.732 . . . . 0.0 111.02 -173.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.467 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.3 tm? -77.35 133.85 38.63 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 mt -114.18 154.92 46.18 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 123.586 0.754 . . . . 0.0 110.672 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.1 105.7 0.88 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.262 1.975 . . . . 0.0 110.81 171.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.488 ' HB2' HG11 ' A' ' 70' ' ' VAL . 36.3 p90 -66.52 -22.1 66.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.138 0.575 . . . . 0.0 111.588 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -62.44 -29.12 70.28 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.754 0.821 . . . . 0.0 111.476 174.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -67.91 -41.29 82.86 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.1 0.56 . . . . 0.0 109.904 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -93.43 4.8 53.38 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.056 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.9 t -62.14 121.27 12.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.919 0.888 . . . . 0.0 113.222 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -106.3 -0.07 24.67 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.83 0.852 . . . . 0.0 110.752 170.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.425 ' HB ' ' H ' ' A' ' 69' ' ' VAL . 11.9 t -83.3 -15.66 49.24 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.889 0.476 . . . . 0.0 110.49 172.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.252 1.229 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.838 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 32.3 mt . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.2 m -68.33 89.0 0.33 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.844 0.858 . . . . 0.0 111.38 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.5 t -99.0 142.97 29.81 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.646 1.179 . . . . 0.0 110.531 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -84.97 69.49 10.81 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.651 0.739 . . . . 0.0 109.209 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 64.0 p -139.44 174.38 10.57 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.655 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.402 ' HB3' HG13 ' A' ' 8' ' ' ILE . 14.1 m -77.54 176.44 8.92 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-O 120.761 0.315 . . . . 0.0 110.229 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -129.81 29.87 4.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.75 0.82 . . . . 0.0 109.929 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.419 HD12 ' ND1' ' A' ' 34' ' ' HIS . 66.8 mt -59.32 -42.33 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.637 0.775 . . . . 0.0 111.409 -177.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.423 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 63.7 m-85 -113.85 17.05 18.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.552 0.741 . . . . 0.0 110.868 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -54.55 -55.21 31.66 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 123.75 0.82 . . . . 0.0 112.171 -167.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -91.9 15.14 13.7 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.36 0.664 . . . . 0.0 111.271 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 54.0 t -117.11 120.38 38.16 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 123.986 0.914 . . . . 0.0 109.924 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.424 HG11 HD23 ' A' ' 39' ' ' LEU . 36.5 t -90.84 134.07 30.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 168.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.438 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.7 mp -123.45 123.29 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.046 0.538 . . . . 0.0 110.631 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -102.76 144.18 31.45 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.445 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 41.1 mt -121.68 137.68 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -147.19 136.13 22.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.688 0.795 . . . . 0.0 109.603 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.71 175.3 47.73 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 123.253 0.345 . . . . 0.0 113.156 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -73.93 111.93 9.56 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.107 0.479 . . . . 0.0 110.017 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.573 HG21 HG12 ' A' ' 52' ' ' VAL . 40.4 p -128.14 138.41 52.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.947 1.299 . . . . 0.0 108.226 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -105.33 130.22 23.45 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 118.257 0.48 . . . . 0.0 110.664 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.99 172.22 64.27 Favored 'Cis proline' 0 C--N 1.375 1.95 0 C-N-CA 124.232 -1.154 . . . . 0.0 111.485 -2.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.23 155.67 5.79 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.541 -0.589 . . . . 0.0 113.768 -174.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -55.36 -36.55 66.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.262 0.625 . . . . 0.0 111.809 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 26' ' ' GLN . 3.0 pp -59.3 -40.51 86.39 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.338 0.655 . . . . 0.0 111.738 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.454 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.1 tp-100 -74.27 -43.86 55.16 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.87 0.868 . . . . 0.0 110.509 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.1 -39.75 83.22 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.87 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.439 ' HA ' HD12 ' A' ' 31' ' ' ILE . 15.9 m170 -60.8 -39.21 88.06 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.043 0.937 . . . . 0.0 110.304 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -67.88 -41.18 83.21 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.582 0.552 . . . . 0.0 110.932 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.535 ' SD ' HG11 ' A' ' 79' ' ' VAL . 25.0 mmt -60.17 -32.53 71.14 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.315 0.646 . . . . 0.0 111.748 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 28' ' ' HIS . 70.1 mt -71.07 -52.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.065 175.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.7 t -71.45 -44.84 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.362 0.665 . . . . 0.0 112.045 -170.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.2 -15.76 57.99 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.709 0.804 . . . . 0.0 111.705 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.45 ' NE2' HG13 ' A' ' 79' ' ' VAL . 68.5 m-70 -108.98 27.82 9.1 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.726 0.81 . . . . 0.0 111.154 175.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.85 9.97 86.3 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 114.798 -1.092 . . . . 0.0 114.656 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.423 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -96.13 177.74 34.03 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 114.453 0.541 . . . . 0.0 114.453 -170.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -123.85 150.08 45.0 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.471 0.708 . . . . 0.0 110.038 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -125.0 166.6 16.06 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.49 0.716 . . . . 0.0 110.417 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.424 HD23 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -131.35 141.65 49.93 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.04 -35.05 26.07 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.474 0.71 . . . . 0.0 112.862 -176.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.9 t80 179.62 141.14 0.13 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.992 0.917 . . . . 0.0 109.51 -174.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -93.88 116.46 28.91 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.277 0.631 . . . . 0.0 109.892 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.3 m -92.71 61.77 3.68 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.368 1.067 . . . . 0.0 109.68 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.8 m 61.39 26.28 16.09 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.402 1.081 . . . . 0.0 111.967 -175.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -132.17 140.62 48.8 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.099 0.56 . . . . 0.0 110.748 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.69 78.31 6.27 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.2 m -103.39 -8.94 19.83 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.847 0.859 . . . . 0.0 110.657 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.403 ' HA ' ' HB ' ' A' ' 13' ' ' VAL . 9.5 p -123.98 159.82 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.797 0.839 . . . . 0.0 109.867 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -114.15 -27.72 7.56 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.044 0.538 . . . . 0.0 111.202 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -130.6 129.74 43.11 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.07 0.548 . . . . 0.0 110.591 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 22.5 mt -114.66 138.89 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.645 0.778 . . . . 0.0 109.045 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.573 HG12 HG21 ' A' ' 20' ' ' THR . 63.2 t -104.63 135.36 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 123.985 0.914 . . . . 0.0 109.526 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.03 163.33 39.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.019 0.928 . . . . 0.0 108.908 173.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.3 t -115.56 -49.12 2.75 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -120.06 111.59 18.07 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 tp -129.99 123.01 20.63 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.97 151.9 74.77 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.13 2.554 . . . . 0.0 112.406 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.428 HD23 ' HD2' ' A' ' 61' ' ' ARG . 94.8 mt -59.05 -32.58 69.89 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.531 0.733 . . . . 0.0 111.878 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -60.0 -43.44 95.2 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.335 0.654 . . . . 0.0 110.723 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -75.93 -28.78 58.11 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.724 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.428 ' HD2' HD23 ' A' ' 58' ' ' LEU . 61.6 mtt180 -70.87 -29.32 65.4 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.865 0.466 . . . . 0.0 110.817 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.6 mt -80.13 -37.33 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.537 0.735 . . . . 0.0 110.638 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -61.66 -45.7 92.88 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.683 0.754 . . . . 0.0 110.03 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -99.75 19.47 15.91 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.703 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.67 -18.89 62.15 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.256 0.622 . . . . 0.0 110.415 169.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -70.64 -17.47 62.87 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.897 0.879 . . . . 0.0 110.407 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.17 171.4 7.57 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.602 1.161 . . . . 0.0 109.261 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -99.28 88.13 3.83 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.425 ' H ' HG22 ' A' ' 93' ' ' THR . 39.6 t -74.49 138.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.664 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.04 177.71 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.009 1.324 . . . . 0.0 109.723 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.3 m -87.45 160.07 48.79 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.101 0.96 . . . . 0.0 109.612 172.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.422 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.7 Cg_endo -59.75 -28.0 86.26 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 122.684 2.256 . . . . 0.0 112.223 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -65.88 -16.84 64.21 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.544 1.138 . . . . 0.0 111.969 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.3 t90 -62.69 -45.8 91.08 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 75' ' ' ILE . 3.2 mp -71.16 -50.41 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.706 -177.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.53 HG12 ' HE2' ' A' ' 80' ' ' LYS . 58.8 t -62.3 -50.74 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.878 -173.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -71.57 -33.63 69.25 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.808 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.7 m -61.19 -37.19 82.05 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 117.954 0.343 . . . . 0.0 110.718 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.535 HG11 ' SD ' ' A' ' 30' ' ' MET . 44.4 t -64.6 -47.41 89.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 C-N-CA 123.866 0.866 . . . . 0.0 111.03 173.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.53 ' HE2' HG12 ' A' ' 76' ' ' VAL . 54.3 mtmt -70.17 -26.46 63.92 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.266 0.627 . . . . 0.0 112.118 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -94.99 -15.98 23.1 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.834 0.453 . . . . 0.0 111.248 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.15 28.66 18.28 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.734 1.214 . . . . 0.0 111.84 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -144.96 149.15 34.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.418 1.087 . . . . 0.0 108.603 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.0 tp -72.73 112.07 8.45 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.9 mt -83.88 153.95 64.19 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 123.514 0.725 . . . . 0.0 110.82 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -57.59 122.15 11.26 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.992 2.461 . . . . 0.0 112.454 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -64.2 -32.34 73.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.992 0.517 . . . . 0.0 110.274 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -60.52 -31.62 70.68 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.065 0.946 . . . . 0.0 111.276 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -69.33 -25.08 64.03 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.651 0.781 . . . . 0.0 110.743 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -115.99 4.71 13.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.845 0.858 . . . . 0.0 111.423 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.9 t -66.46 126.7 29.67 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -167.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.425 ' HB2' HG12 ' A' ' 69' ' ' VAL . 49.9 mt -114.68 28.34 8.8 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.057 0.943 . . . . 0.0 110.292 173.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 69' ' ' VAL . 39.7 p -65.78 -38.17 88.3 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.635 0.774 . . . . 0.0 111.027 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.254 1.294 0 C-N-CA 124.302 1.041 . . . . 0.0 109.001 -179.306 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 t -115.76 143.58 45.19 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.255 1.022 . . . . 0.0 108.867 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.2 t -164.93 169.06 16.94 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.32 0.648 . . . . 0.0 109.979 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -126.71 94.0 3.93 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.3 p -57.77 -40.36 79.61 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.916 0.865 . . . . 0.0 109.211 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 m -142.52 145.51 33.73 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.059 164.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 10' ' ' LYS . 20.9 pttp -111.02 21.22 16.66 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.237 0.615 . . . . 0.0 110.35 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 52.5 mt -66.08 -50.07 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.816 0.846 . . . . 0.0 110.584 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.41 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 50.4 m-85 -112.26 14.48 20.52 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.143 -176.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.588 ' HB2' ' HA ' ' A' ' 7' ' ' LYS . 52.2 tptt -53.54 -55.63 23.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.064 0.946 . . . . 0.0 113.476 -165.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -100.15 17.52 21.0 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.371 0.605 . . . . 0.0 109.889 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.1 t -113.06 128.39 56.48 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.048 1.339 . . . . 0.0 110.901 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.86 130.34 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.242 1.017 . . . . 0.0 109.295 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.525 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.7 mp -124.42 129.37 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 CA-C-O 121.407 0.622 . . . . 0.0 111.852 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.496 ' HB2' ' HB3' ' A' ' 39' ' ' LEU . 55.2 t80 -104.02 152.39 22.09 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.43 1.892 . . . . 0.0 108.39 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -122.78 137.89 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.066 0.546 . . . . 0.0 109.987 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 15' ' ' TYR . 58.5 t30 -143.74 141.63 30.55 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.39 1.076 . . . . 0.0 109.346 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.27 -178.92 46.49 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 116.467 -0.333 . . . . 0.0 112.699 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -92.9 110.59 22.05 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.98 0.419 . . . . 0.0 109.955 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.612 HG21 HG12 ' A' ' 52' ' ' VAL . 65.0 p -122.59 142.59 50.47 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.715 1.206 . . . . 0.0 109.717 -174.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -96.82 130.76 29.4 Favored Pre-proline 0 N--CA 1.479 0.976 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 167.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.49 176.28 42.31 Favored 'Cis proline' 0 C--N 1.373 1.831 0 C-N-CA 124.758 -0.934 . . . . 0.0 111.666 -4.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.59 152.0 7.66 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.746 0.654 . . . . 0.0 114.07 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -54.01 -34.97 61.36 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.251 1.02 . . . . 0.0 112.263 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 pp -58.09 -48.28 80.63 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.898 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -73.5 -41.77 62.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.355 0.662 . . . . 0.0 111.614 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.493 HD13 HG11 ' A' ' 52' ' ' VAL . 29.1 mt -58.34 -44.58 88.78 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.033 0.533 . . . . 0.0 110.641 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.436 ' O ' HG23 ' A' ' 32' ' ' VAL . 16.8 m170 -65.79 -34.97 79.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.567 0.347 . . . . 0.0 111.498 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -62.85 -42.2 99.66 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 117.847 0.294 . . . . 0.0 110.443 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.638 ' HB3' HG21 ' A' ' 79' ' ' VAL . 22.9 mmt -62.26 -39.06 91.64 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.881 0.872 . . . . 0.0 110.677 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.525 HD13 ' HB ' ' A' ' 14' ' ' ILE . 71.1 mt -65.87 -51.55 59.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.044 0.938 . . . . 0.0 111.463 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 28' ' ' HIS . 99.9 t -68.56 -43.67 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 122.901 0.48 . . . . 0.0 111.599 -173.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.67 -17.8 63.32 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.271 0.629 . . . . 0.0 111.795 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.424 ' NE2' HG13 ' A' ' 79' ' ' VAL . 55.5 m-70 -108.91 26.51 10.51 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.675 0.79 . . . . 0.0 111.581 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.9 -0.33 72.87 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.615 -0.721 . . . . 0.0 114.821 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . -92.52 173.97 36.0 Favored Glycine 0 C--O 1.237 0.342 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 -166.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -117.4 159.33 22.94 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.605 1.162 . . . . 0.0 109.63 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -125.27 156.63 38.28 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.764 0.826 . . . . 0.0 110.987 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.617 ' HG ' ' HB ' ' A' ' 48' ' ' VAL . 2.4 tm? -134.65 129.38 34.76 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.74 -43.36 22.74 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -175.33 146.21 0.8 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.172 0.989 . . . . 0.0 109.727 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.406 HD11 HG12 ' A' ' 48' ' ' VAL . 3.2 mm? -88.46 97.67 11.2 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.364 0.666 . . . . 0.0 110.244 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.2 t -91.53 -24.13 19.72 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 164.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.7 m -141.4 163.74 32.13 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.916 0.886 . . . . 0.0 110.819 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -84.51 166.51 17.18 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.331 0.652 . . . . 0.0 111.416 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? 68.22 3.9 3.9 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.858 1.263 . . . . 0.0 112.847 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.8 p -83.44 -18.74 37.61 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.072 0.549 . . . . 0.0 111.111 -174.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.617 ' HB ' ' HG ' ' A' ' 39' ' ' LEU . 9.8 p -136.93 156.62 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.481 0.712 . . . . 0.0 109.858 176.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.6 t -114.51 -25.31 8.41 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.436 0.695 . . . . 0.0 111.127 175.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.408 ' HB2' HG13 ' A' ' 14' ' ' ILE . 76.5 m80 -132.55 130.47 40.39 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.939 0.495 . . . . 0.0 110.616 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.64 ' HB ' HG12 ' A' ' 69' ' ' VAL . 66.7 mt -114.98 135.21 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.612 HG12 HG21 ' A' ' 20' ' ' THR . 87.5 t -91.79 129.1 42.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.26 145.93 29.59 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.5 t -88.46 -39.15 14.44 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -143.96 139.73 29.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.476 1.11 . . . . 0.0 108.264 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.3 tp -128.07 128.38 23.76 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.97 150.29 73.56 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.066 2.51 . . . . 0.0 112.317 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.2 mt -57.22 -39.83 76.26 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.946 0.898 . . . . 0.0 111.339 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.28 -43.36 99.01 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.404 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -76.64 -20.79 56.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.603 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -66.43 -41.22 89.53 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 171.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.1 mt -65.41 -43.54 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 123.717 0.636 . . . . 0.0 110.797 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.63 -42.26 82.59 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.365 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -100.36 23.33 10.31 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.549 0.74 . . . . 0.0 110.674 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.63 -27.44 67.69 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.409 0.683 . . . . 0.0 111.386 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -71.3 -19.37 62.33 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.938 0.895 . . . . 0.0 111.239 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -108.9 143.89 37.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.882 0.873 . . . . 0.0 109.204 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.04 86.17 4.23 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.64 HG12 ' HB ' ' A' ' 51' ' ' ILE . 7.6 m -78.3 127.82 38.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.22 171.41 18.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.284 1.034 . . . . 0.0 109.667 -172.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.1 m -77.92 150.25 78.01 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.399 170.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.83 -25.86 78.17 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.332 2.021 . . . . 0.0 111.39 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.7 -29.38 52.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.387 1.475 . . . . 0.0 112.271 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -60.29 -54.37 46.5 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.487 ' H ' HD12 ' A' ' 75' ' ' ILE . 3.4 mp -64.15 -48.04 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 124.227 0.955 . . . . 0.0 109.165 -175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.68 -52.24 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.835 1.254 . . . . 0.0 111.462 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.78 -33.29 66.2 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.74 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.467 ' HA ' HD13 ' A' ' 85' ' ' LEU . 61.9 m -62.34 -35.38 78.9 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.925 0.49 . . . . 0.0 111.361 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 30' ' ' MET . 71.4 t -69.5 -44.34 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.37 0.668 . . . . 0.0 110.863 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.5 -43.25 89.0 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.525 0.679 . . . . 0.0 110.843 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.626 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 64.7 mm-40 -82.65 -21.49 34.99 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.856 -176.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.66 24.93 12.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.241 1.017 . . . . 0.0 111.173 -173.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.626 ' HE ' ' HB3' ' A' ' 81' ' ' GLU . 9.2 ptp180 -134.81 166.02 23.95 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.457 0.703 . . . . 0.0 109.656 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -86.25 116.14 24.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.317 0.647 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 78' ' ' SER . 11.3 mp -90.17 155.19 47.07 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.745 0.818 . . . . 0.0 110.198 172.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.54 109.43 2.62 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.066 1.844 . . . . 0.0 110.755 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -62.38 -25.55 67.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.48 0.712 . . . . 0.0 111.725 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -57.92 -29.54 65.21 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.212 1.005 . . . . 0.0 111.64 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -75.6 -34.48 60.63 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.873 0.869 . . . . 0.0 111.046 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -96.34 -1.05 48.59 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.58 0.752 . . . . 0.0 111.253 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.2 t -72.67 115.59 12.12 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.45 0.7 . . . . 0.0 112.068 -170.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.6 mt -79.31 4.91 13.78 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.934 0.893 . . . . 0.0 111.898 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.2 p -62.4 -21.95 65.78 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.75 0.82 . . . . 0.0 111.463 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.255 1.377 0 C-N-CA 125.832 1.653 . . . . 0.0 111.189 176.253 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 10.0 pt . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.713 0.292 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 m -63.5 113.34 3.23 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 169.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.4 m -74.05 78.85 1.71 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.626 0.726 . . . . 0.0 111.171 -171.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -87.47 -18.64 29.42 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.592 1.157 . . . . 0.0 109.043 171.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 50.7 m -74.14 107.99 6.67 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.632 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.7 m -62.89 128.75 37.35 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 167.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -79.47 32.09 0.24 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -165.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.2 mt -57.78 -46.87 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.033 1.333 . . . . 0.0 111.669 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 50.9 m-85 -112.53 17.01 19.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.607 0.763 . . . . 0.0 110.828 -174.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -57.16 -44.05 83.09 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.693 0.797 . . . . 0.0 112.47 -171.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -92.05 -5.81 52.2 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.475 0.31 . . . . 0.0 111.365 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.6 m -97.55 125.84 42.49 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.525 0.678 . . . . 0.0 111.242 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.531 HG12 HG23 ' A' ' 48' ' ' VAL . 36.9 t -103.52 130.6 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 169.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 3.2 mp -118.31 136.01 56.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 123.81 0.844 . . . . 0.0 111.147 -174.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -115.45 119.7 37.07 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 124.422 1.089 . . . . 0.0 108.465 169.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.9 mt -92.36 138.28 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.164 0.586 . . . . 0.0 109.508 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -147.16 136.94 23.05 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.049 0.94 . . . . 0.0 110.098 -166.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.36 -154.17 50.18 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.266 0.354 . . . . 0.0 113.465 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -78.1 128.63 34.11 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 172.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.2 p -146.68 126.86 13.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.672 1.189 . . . . 0.0 108.512 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -114.28 135.76 22.22 Favored Pre-proline 0 N--CA 1.481 1.102 0 CA-C-N 118.212 0.46 . . . . 0.0 111.141 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.11 175.12 38.98 Favored 'Cis proline' 0 C--N 1.379 2.161 0 C-N-CA 124.827 -0.905 . . . . 0.0 112.264 -1.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.58 141.09 9.87 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 124.126 0.891 . . . . 0.0 113.392 -175.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -50.29 -34.66 24.25 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.347 1.059 . . . . 0.0 112.904 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 pp -54.55 -45.7 73.51 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.803 0.441 . . . . 0.0 111.581 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -73.12 -45.41 57.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.976 0.91 . . . . 0.0 110.719 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.3 -44.84 76.1 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.724 0.64 . . . . 0.0 111.306 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -58.96 -40.54 85.04 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.768 0.827 . . . . 0.0 110.638 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.89 -39.87 87.58 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.336 0.397 . . . . 0.0 111.195 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.547 ' HB3' HG21 ' A' ' 79' ' ' VAL . 24.4 mmt -63.37 -33.1 74.79 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.981 0.513 . . . . 0.0 111.355 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.4 mt -72.48 -51.56 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.559 0.744 . . . . 0.0 111.003 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.03 -44.95 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.218 0.607 . . . . 0.0 111.681 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 5' ' ' SER . 4.6 mm? -66.8 -11.82 56.6 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.531 0.732 . . . . 0.0 111.805 177.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -113.3 27.23 9.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.71 0.804 . . . . 0.0 111.594 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.57 -6.16 83.86 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.283 -0.872 . . . . 0.0 114.764 167.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.13 156.88 42.34 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 113.944 0.338 . . . . 0.0 113.944 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -108.99 169.71 8.51 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 43.6 p90 -144.27 151.01 38.82 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.79 127.48 53.74 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.656 169.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -33.95 76.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.079 172.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -172.81 151.32 2.24 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.608 1.163 . . . . 0.0 109.01 173.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.3 -47.43 5.18 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.7 t 56.15 56.79 5.54 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 124.615 1.197 . . . . 0.0 109.081 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.7 m 61.76 82.47 0.17 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.521 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -164.37 127.78 2.5 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -89.26 75.11 7.82 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.459 0.572 . . . . 0.0 110.394 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.3 m -108.1 -36.27 6.36 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.73 0.812 . . . . 0.0 110.496 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.531 HG23 HG12 ' A' ' 13' ' ' VAL . 6.9 p -93.29 157.77 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.086 0.554 . . . . 0.0 110.224 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 t -111.27 -32.63 6.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.969 0.508 . . . . 0.0 111.639 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -119.93 138.51 53.4 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.77 0.828 . . . . 0.0 109.088 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.685 ' HB ' HG12 ' A' ' 69' ' ' VAL . 52.7 mt -124.37 138.14 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.55 122.07 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.945 0.898 . . . . 0.0 110.378 -175.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.11 156.97 45.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.665 1.186 . . . . 0.0 108.075 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.1 t -76.23 -38.88 55.77 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -147.84 138.17 22.95 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.075 173.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.1 tp -116.49 124.57 29.31 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.61 156.59 36.25 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.564 2.842 . . . . 0.0 112.666 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.406 HD23 ' HD2' ' A' ' 61' ' ' ARG . 97.0 mt -60.01 -41.96 93.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.832 0.853 . . . . 0.0 112.039 -174.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -57.57 -41.76 81.72 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.671 0.789 . . . . 0.0 110.462 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.39 -23.45 46.78 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.823 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HD2' HD23 ' A' ' 58' ' ' LEU . 99.6 mtt180 -70.73 -33.85 71.28 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.405 0.548 . . . . 0.0 110.656 173.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.7 -45.52 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.485 0.714 . . . . 0.0 109.997 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.68 -50.82 65.5 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.054 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.436 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 18.7 m-85 -92.67 26.35 2.73 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.442 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.63 -29.89 70.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.429 0.692 . . . . 0.0 111.38 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -77.52 -25.82 50.6 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.22 0.608 . . . . 0.0 111.062 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.436 ' CD1' ' HA ' ' A' ' 64' ' ' PHE . 10.3 m-85 -89.47 145.92 24.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.744 0.818 . . . . 0.0 109.638 -177.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 68' ' ' LYS . 11.3 mptt -87.03 86.67 7.33 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.685 HG12 ' HB ' ' A' ' 51' ' ' ILE . 21.6 m -81.63 131.18 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.422 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.97 174.43 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.622 1.169 . . . . 0.0 110.112 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -82.78 157.21 67.12 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.795 0.838 . . . . 0.0 110.549 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.72 -23.28 75.84 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.672 2.248 . . . . 0.0 111.864 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.35 -27.42 65.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.331 1.452 . . . . 0.0 111.774 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -61.68 -48.71 79.55 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.506 0.504 . . . . 0.0 110.223 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.4 mp -67.47 -49.3 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.057 -175.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.2 -52.42 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.342 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.78 -36.19 70.26 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.113 -172.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.1 m -66.07 -40.34 90.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.014 0.525 . . . . 0.0 111.312 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.547 HG21 ' HB3' ' A' ' 30' ' ' MET . 23.8 t -64.88 -44.0 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.533 0.733 . . . . 0.0 110.799 178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -65.16 -36.67 84.94 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.676 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.534 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 48.0 mm-40 -86.24 -8.74 57.54 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.11 19.03 8.29 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.7 1.2 . . . . 0.0 112.763 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.534 ' HE ' ' HB3' ' A' ' 81' ' ' GLU . 13.5 ptp180 -134.21 161.85 33.77 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.509 0.724 . . . . 0.0 109.932 -172.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.8 tp -84.03 113.19 20.84 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 172.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.02 154.42 55.05 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 123.456 0.702 . . . . 0.0 109.968 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.1 117.12 3.96 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.232 1.954 . . . . 0.0 110.931 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -59.76 -27.88 66.91 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.561 0.744 . . . . 0.0 111.672 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -62.21 -25.78 67.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.481 1.113 . . . . 0.0 112.352 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -68.55 -26.99 65.69 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.588 0.755 . . . . 0.0 110.938 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -117.19 5.03 12.66 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.773 0.829 . . . . 0.0 111.114 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.6 t -72.7 125.26 27.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.136 0.574 . . . . 0.0 111.918 -171.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.4 mt -93.39 13.07 22.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.015 0.926 . . . . 0.0 111.862 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.5 p -61.7 -28.33 69.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.273 0.629 . . . . 0.0 110.654 174.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 125.075 1.35 . . . . 0.0 111.481 171.098 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 12.8 tt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.9 m -138.65 147.96 43.49 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.98 0.912 . . . . 0.0 108.958 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.4 p -156.53 145.03 19.89 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.841 0.857 . . . . 0.0 110.04 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -71.22 107.8 4.4 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.249 0.62 . . . . 0.0 110.826 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -164.31 154.69 14.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.018 0.927 . . . . 0.0 109.186 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.576 ' HB3' HG13 ' A' ' 8' ' ' ILE . 15.9 m -85.71 158.47 20.03 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.23 0.612 . . . . 0.0 111.534 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -112.06 15.12 20.73 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.947 0.899 . . . . 0.0 110.185 176.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.576 HG13 ' HB3' ' A' ' 6' ' ' SER . 76.3 mt -57.1 -46.98 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 124.154 0.982 . . . . 0.0 112.32 -168.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.439 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 55.5 m-85 -114.8 15.86 17.41 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.705 0.402 . . . . 0.0 111.292 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -64.85 -32.65 74.46 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 122.724 0.41 . . . . 0.0 111.928 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -96.96 6.75 48.07 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.839 0.456 . . . . 0.0 111.685 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 76.3 m -120.82 130.46 53.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.371 0.669 . . . . 0.0 111.477 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.494 HG12 HG23 ' A' ' 48' ' ' VAL . 39.1 t -96.95 131.8 42.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 167.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.411 HG23 HG23 ' A' ' 52' ' ' VAL . 3.6 mp -119.31 124.05 72.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.512 0.725 . . . . 0.0 110.648 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -105.97 109.74 21.79 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 166.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.5 mt -78.04 135.17 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -137.16 122.81 19.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.102 0.961 . . . . 0.0 109.257 -169.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.39 -179.13 29.8 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.406 0.441 . . . . 0.0 113.248 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -71.63 108.47 5.0 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.416 HG21 HG12 ' A' ' 52' ' ' VAL . 71.0 p -111.25 148.65 32.4 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 124.963 1.305 . . . . 0.0 108.897 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 11.2 mmpt? -107.35 122.05 42.52 Favored Pre-proline 0 N--CA 1.482 1.164 0 CA-C-N 118.229 0.468 . . . . 0.0 110.77 172.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -82.55 176.03 37.37 Favored 'Cis proline' 0 C--N 1.368 1.571 0 C-N-CA 123.939 -1.276 . . . . 0.0 111.78 0.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.17 154.04 6.89 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.704 0.628 . . . . 0.0 114.19 -173.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -55.38 -36.58 66.52 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.547 0.739 . . . . 0.0 111.858 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.9 pp -61.12 -40.69 94.74 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 123.859 0.724 . . . . 0.0 111.826 176.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.456 ' N ' HD12 ' A' ' 25' ' ' LEU . 61.1 tp60 -73.33 -46.52 48.88 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.324 0.649 . . . . 0.0 110.145 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 72' ' ' PRO . 66.3 mt -58.09 -39.24 78.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.68 0.792 . . . . 0.0 111.029 174.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -57.38 -42.72 82.71 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.752 0.821 . . . . 0.0 110.385 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -64.84 -43.39 93.23 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 79.1 mmm -62.81 -34.48 77.39 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.249 0.62 . . . . 0.0 111.212 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.6 mt -75.24 -54.94 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.486 0.714 . . . . 0.0 111.617 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.0 t -72.09 -40.18 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.224 0.61 . . . . 0.0 112.122 -166.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.48 -21.6 64.33 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.528 0.731 . . . . 0.0 111.677 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.475 ' NE2' HG13 ' A' ' 79' ' ' VAL . 60.2 m80 -105.12 26.97 8.66 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.305 1.042 . . . . 0.0 110.635 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.84 -3.74 83.11 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.853 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.49 151.79 47.03 Favored Glycine 0 C--O 1.239 0.421 0 N-CA-C 115.771 1.069 . . . . 0.0 115.771 -167.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -106.77 143.96 34.11 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -127.1 149.34 49.98 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.131 0.572 . . . . 0.0 109.724 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.25 123.47 49.32 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 175.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.55 -39.29 88.46 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.245 0.618 . . . . 0.0 112.109 -172.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -175.53 132.34 0.28 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.432 1.093 . . . . 0.0 108.716 -175.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.71 171.91 9.64 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.805 0.812 . . . . 0.0 112.482 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.7 p -135.04 -156.58 0.73 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.807 -177.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.7 t -67.06 -17.93 65.12 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.219 0.608 . . . . 0.0 111.271 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -91.29 128.96 37.32 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.893 0.877 . . . . 0.0 110.715 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.04 98.34 2.52 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.1 m -119.97 18.34 12.47 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-O 121.182 0.515 . . . . 0.0 110.71 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.494 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -144.31 147.98 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 122.016 -0.428 . . . . 0.0 110.451 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.5 t -103.79 -32.37 9.37 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.574 0.75 . . . . 0.0 111.725 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -126.06 128.76 47.9 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.5 0.72 . . . . 0.0 109.845 -175.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 41.4 mt -114.39 121.9 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.57 0.748 . . . . 0.0 109.275 175.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.416 HG12 HG21 ' A' ' 20' ' ' THR . 64.0 t -92.32 121.6 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.113 0.565 . . . . 0.0 110.022 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.0 154.07 49.36 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.207 0.603 . . . . 0.0 110.167 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.7 t -95.26 -34.61 12.14 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -140.87 120.85 13.64 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.589 ' HG ' HG11 ' A' ' 69' ' ' VAL . 2.2 tm? -127.43 108.96 21.07 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.04 155.11 70.07 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.846 2.364 . . . . 0.0 112.394 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 61' ' ' ARG . 70.6 mt -64.16 -29.74 70.84 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -172.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -59.36 -48.96 79.66 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.512 0.672 . . . . 0.0 110.298 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -76.01 -19.71 58.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.45 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 10.6 tpp85 -67.64 -40.39 84.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.41 0.684 . . . . 0.0 109.767 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.0 mt -77.06 -35.8 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.063 0.945 . . . . 0.0 110.488 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -69.16 -30.53 68.78 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.465 0.706 . . . . 0.0 111.032 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -115.55 28.64 8.53 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.205 1.002 . . . . 0.0 110.042 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.93 -33.47 75.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.509 0.724 . . . . 0.0 111.626 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -77.36 -26.72 52.24 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.004 0.522 . . . . 0.0 110.82 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -78.64 141.48 37.96 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -83.89 85.8 7.26 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.36 0.664 . . . . 0.0 109.353 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' A' ' 56' ' ' LEU . 57.3 t -78.21 127.59 38.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 174.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.05 173.78 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.139 0.975 . . . . 0.0 110.19 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.3 m -81.46 152.92 70.79 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.818 0.847 . . . . 0.0 110.402 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HB3' HD11 ' A' ' 27' ' ' LEU . 21.6 Cg_endo -59.62 -25.49 79.1 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.964 2.443 . . . . 0.0 112.698 173.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.67 -19.75 66.03 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.051 0.941 . . . . 0.0 112.047 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -59.37 -43.05 92.91 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.923 0.489 . . . . 0.0 109.83 173.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 75' ' ' ILE . 3.2 mp -75.55 -49.55 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.128 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.1 t -59.76 -51.73 69.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.321 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -71.22 -39.57 71.63 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.267 -175.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.8 p -63.62 -37.75 88.51 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 120.822 0.344 . . . . 0.0 111.699 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.475 HG13 ' NE2' ' A' ' 34' ' ' HIS . 33.4 t -62.38 -46.1 97.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 123.719 0.807 . . . . 0.0 110.696 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.1 -37.24 86.41 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.203 0.601 . . . . 0.0 111.542 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -83.96 -12.56 55.15 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.499 0.72 . . . . 0.0 111.594 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.52 26.06 15.86 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.136 1.374 . . . . 0.0 112.582 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -140.86 161.9 36.73 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.327 1.051 . . . . 0.0 109.32 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.6 tp -87.72 128.58 35.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 172.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 mp -93.56 153.39 41.28 Favored Pre-proline 0 C--O 1.241 0.646 0 C-N-CA 123.865 0.866 . . . . 0.0 108.953 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.616 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 30.0 Cg_endo -65.23 140.96 66.94 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.768 1.645 . . . . 0.0 111.865 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -57.76 -33.24 68.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.696 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.616 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 30.0 pt20 -57.7 -34.2 69.2 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.666 1.186 . . . . 0.0 113.046 -170.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.51 ' OD1' ' HG2' ' A' ' 86' ' ' PRO . 14.2 m120 -67.32 -36.02 80.61 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.576 0.35 . . . . 0.0 111.706 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -107.81 3.34 24.33 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.521 0.728 . . . . 0.0 111.31 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.9 t -67.82 118.7 11.4 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.627 0.771 . . . . 0.0 112.639 -170.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.5 mt -86.49 -35.36 19.65 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.055 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.8 t -57.41 -33.87 68.33 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 123.422 0.689 . . . . 0.0 111.614 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 p . . . . . 0 C--O 1.253 1.247 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.127 176.09 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.375 0.131 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -81.39 104.37 11.78 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.233 0.613 . . . . 0.0 110.387 -177.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.1 m -152.79 111.81 3.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.169 0.987 . . . . 0.0 108.971 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -89.51 139.43 30.54 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.137 0.575 . . . . 0.0 110.132 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 p -63.16 -39.16 93.86 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.402 0.681 . . . . 0.0 111.748 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.485 ' HB2' ' HA ' ' A' ' 34' ' ' HIS . 43.3 m -83.19 130.4 35.09 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -120.48 31.61 6.38 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.92 0.888 . . . . 0.0 108.961 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.523 HD12 ' HD2' ' A' ' 34' ' ' HIS . 40.5 mt -66.94 -39.08 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.632 1.173 . . . . 0.0 112.734 -166.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.505 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 68.6 m-85 -113.21 16.9 19.0 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.195 0.598 . . . . 0.0 110.961 -176.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -60.14 -39.6 86.88 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -169.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -94.87 11.0 33.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.961 -0.462 . . . . 0.0 111.471 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 83.2 m -122.9 135.58 54.56 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.611 0.764 . . . . 0.0 112.095 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 37' ' ' LYS . 50.0 t -104.21 134.25 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 167.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.497 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.6 mp -126.07 122.73 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 121.255 0.55 . . . . 0.0 111.107 -174.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -102.99 152.31 21.47 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.59 1.556 . . . . 0.0 107.98 174.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.1 mt -121.96 127.08 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -128.35 139.85 52.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.163 0.985 . . . . 0.0 109.565 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.65 -161.22 46.08 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.593 0.558 . . . . 0.0 112.443 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -102.19 113.12 26.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.633 0.773 . . . . 0.0 109.479 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.492 HG21 HG12 ' A' ' 52' ' ' VAL . 79.5 p -117.93 137.65 52.69 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.851 0.86 . . . . 0.0 109.829 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -106.02 125.83 32.14 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 165.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -76.72 165.16 85.81 Favored 'Cis proline' 0 C--N 1.374 1.903 0 C-N-CA 124.027 -1.239 . . . . 0.0 111.837 2.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.0 161.57 6.41 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 123.906 0.754 . . . . 0.0 114.656 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -55.8 -36.07 67.02 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.525 0.73 . . . . 0.0 111.179 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.535 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.6 pp -61.95 -42.0 98.62 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 123.753 0.658 . . . . 0.0 111.678 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.535 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.3 tp-100 -69.56 -52.24 28.06 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.328 0.651 . . . . 0.0 110.342 -175.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.528 HD13 HG11 ' A' ' 52' ' ' VAL . 71.2 mt -57.8 -44.28 86.22 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.53 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.483 ' HA ' HD12 ' A' ' 31' ' ' ILE . 13.7 m170 -61.79 -37.59 84.9 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.063 0.545 . . . . 0.0 111.321 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 52.0 mm-40 -63.28 -45.84 89.59 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.021 0.439 . . . . 0.0 110.014 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.424 ' HB3' HG21 ' A' ' 79' ' ' VAL . 25.6 mmt -60.77 -37.77 83.0 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.63 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.497 HD13 ' HB ' ' A' ' 14' ' ' ILE . 75.5 mt -62.8 -50.81 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.043 0.537 . . . . 0.0 110.981 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.65 -45.62 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.064 0.546 . . . . 0.0 111.62 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.69 -18.89 65.61 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.275 0.63 . . . . 0.0 111.848 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.523 ' HD2' HD12 ' A' ' 8' ' ' ILE . 21.0 m80 -103.76 27.1 7.82 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.423 0.689 . . . . 0.0 111.108 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.76 -3.25 87.39 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.836 166.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -91.82 171.24 34.27 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 -170.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HB2' HG22 ' A' ' 13' ' ' VAL . 42.0 mmtm -110.24 158.07 18.78 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.457 0.703 . . . . 0.0 109.736 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -133.31 153.23 51.76 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.766 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.483 HD23 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -112.2 136.52 51.51 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.25 -35.03 21.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.507 0.723 . . . . 0.0 112.056 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -176.99 139.69 0.29 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.413 1.085 . . . . 0.0 108.983 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.33 141.2 29.19 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.139 0.576 . . . . 0.0 110.369 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.7 m -85.27 45.88 1.23 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.309 1.044 . . . . 0.0 109.09 170.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.8 m 63.39 12.25 6.14 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.355 1.462 . . . . 0.0 112.315 -171.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -101.83 166.5 10.62 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.364 0.666 . . . . 0.0 111.542 -173.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -96.58 52.63 1.23 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.996 0.918 . . . . 0.0 109.816 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.8 m -84.66 5.15 29.24 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.349 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.404 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -137.04 150.72 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.856 0.862 . . . . 0.0 109.776 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.8 t -101.9 -38.18 7.92 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.058 0.543 . . . . 0.0 110.946 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.49 ' HB2' HG13 ' A' ' 14' ' ' ILE . 6.7 m-70 -118.5 133.59 55.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.285 0.634 . . . . 0.0 109.442 -172.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.659 ' HB ' HG12 ' A' ' 69' ' ' VAL . 65.5 mt -123.63 134.14 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.528 HG11 HD13 ' A' ' 27' ' ' LEU . 52.1 t -92.69 128.96 43.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.03 143.86 28.7 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.4 t -92.78 -41.44 10.11 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 166.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -145.42 120.43 10.04 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.616 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.8 mt -92.21 148.82 37.43 Favored Pre-proline 0 C--O 1.24 0.583 0 C-N-CA 123.219 0.607 . . . . 0.0 109.678 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.72 157.42 37.67 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.808 2.339 . . . . 0.0 110.849 166.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.8 mt -53.3 -53.71 46.97 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.426 0.69 . . . . 0.0 112.105 -171.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.98 -46.19 90.35 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.38 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -72.67 -19.39 61.43 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.241 0.616 . . . . 0.0 112.251 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -72.84 -40.53 65.66 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 81.4 mt -66.88 -45.6 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.457 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.44 -40.3 73.85 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.074 0.55 . . . . 0.0 111.678 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.86 17.98 4.46 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.194 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.08 -26.51 61.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.697 0.399 . . . . 0.0 110.296 167.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -70.81 -27.27 63.76 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.301 0.641 . . . . 0.0 110.407 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -90.44 153.88 20.07 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.424 ' HE2' ' H ' ' A' ' 68' ' ' LYS . 0.5 OUTLIER -84.86 85.31 7.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.109 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.659 HG12 ' HB ' ' A' ' 51' ' ' ILE . 31.6 m -85.08 129.85 37.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.835 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 m -134.98 171.56 17.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.502 1.121 . . . . 0.0 109.653 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.6 m -78.8 153.6 78.06 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.049 172.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.08 -24.95 52.02 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.743 2.296 . . . . 0.0 112.401 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.68 -27.1 48.32 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.878 1.271 . . . . 0.0 112.769 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -65.07 -45.16 86.45 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.227 0.537 . . . . 0.0 110.395 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 79' ' ' VAL . 3.2 mp -73.96 -45.5 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.74 -176.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 68.8 t -57.7 -49.8 79.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.908 0.883 . . . . 0.0 110.968 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.488 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 25.9 t70 -70.66 -35.18 72.73 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.85 0.46 . . . . 0.0 111.459 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB2' HG21 ' A' ' 8' ' ' ILE . 78.4 p -66.26 -37.33 85.23 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 120.428 0.156 . . . . 0.0 110.71 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 75' ' ' ILE . 72.6 t -64.08 -42.5 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.487 0.715 . . . . 0.0 110.771 173.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' A' ' 77' ' ' ASP . 8.2 mtpm? -63.41 -45.64 90.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.661 0.784 . . . . 0.0 111.485 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -93.79 -9.54 37.17 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.972 0.509 . . . . 0.0 112.197 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.61 36.42 22.65 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.203 1.001 . . . . 0.0 111.729 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -150.74 167.21 28.09 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.764 0.826 . . . . 0.0 110.159 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.28 106.14 18.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.21 146.77 67.72 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.466 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 17.9 Cg_endo -58.88 113.86 1.75 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.33 2.02 . . . . 0.0 111.838 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -57.56 -24.53 56.7 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.498 1.119 . . . . 0.0 111.665 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.466 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.6 pt20 -58.37 -27.9 64.64 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 124.545 1.138 . . . . 0.0 112.507 -176.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -79.33 -18.83 51.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.178 0.591 . . . . 0.0 112.091 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -110.14 1.94 19.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.813 0.845 . . . . 0.0 111.232 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m -65.82 122.5 17.46 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.622 0.769 . . . . 0.0 112.377 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.0 mt -98.83 15.2 26.22 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.631 0.772 . . . . 0.0 110.286 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -64.4 -23.53 67.32 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.573 1.149 . . . . 0.0 111.661 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 C--O 1.25 1.1 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.09 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.6 tt . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 t 62.56 73.47 0.46 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.976 1.311 . . . . 0.0 111.293 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.3 t -136.1 147.13 47.66 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.275 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -139.47 9.74 2.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.394 1.077 . . . . 0.0 109.63 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.8 m -59.9 -28.31 67.47 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.575 1.15 . . . . 0.0 112.135 -172.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.4 m -136.78 120.71 17.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.299 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -98.29 20.49 12.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.841 0.857 . . . . 0.0 110.565 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.9 mt -67.85 -49.65 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.35 1.06 . . . . 0.0 111.31 -172.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -110.28 12.02 23.34 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.432 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -58.72 -35.93 73.46 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.184 0.593 . . . . 0.0 111.651 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -108.1 16.94 22.88 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.662 0.785 . . . . 0.0 110.894 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 77.4 m -121.03 114.65 21.8 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 123.847 0.859 . . . . 0.0 110.485 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.442 HG12 HG23 ' A' ' 48' ' ' VAL . 48.6 t -97.81 125.12 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 168.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.439 HG23 HG23 ' A' ' 52' ' ' VAL . 3.2 mp -115.7 129.67 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.23 1.012 . . . . 0.0 111.356 -175.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -111.74 118.58 35.99 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 167.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.1 mt -83.28 133.74 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -137.2 125.54 23.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.63 1.172 . . . . 0.0 108.374 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.19 -176.22 51.88 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 -174.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' O ' ' HB3' ' A' ' 54' ' ' SER . 72.8 m-85 -88.01 112.34 22.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 122.813 0.445 . . . . 0.0 109.808 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.422 HG21 HG12 ' A' ' 52' ' ' VAL . 41.3 p -107.83 146.27 32.5 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.749 1.22 . . . . 0.0 109.652 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -110.87 124.54 32.72 Favored Pre-proline 0 N--CA 1.485 1.305 0 CA-C-N 117.665 0.211 . . . . 0.0 111.004 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.12 173.64 57.01 Favored 'Cis proline' 0 C--N 1.375 1.955 0 C-N-CA 124.196 -1.168 . . . . 0.0 112.043 3.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.69 149.66 10.32 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 123.749 0.656 . . . . 0.0 114.535 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -50.13 -38.49 39.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.61 1.164 . . . . 0.0 112.638 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 26' ' ' GLN . 1.4 pp -63.66 -39.45 94.36 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 122.968 0.507 . . . . 0.0 111.98 175.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.499 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.8 tp-100 -73.27 -48.61 33.32 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.093 0.957 . . . . 0.0 110.645 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 72' ' ' PRO . 88.7 mt -56.08 -45.61 79.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.522 0.729 . . . . 0.0 111.311 174.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -54.98 -39.01 68.55 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.678 0.611 . . . . 0.0 111.151 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -64.07 -46.92 82.18 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.778 0.323 . . . . 0.0 110.593 173.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.667 ' HB3' HG21 ' A' ' 79' ' ' VAL . 36.9 mmt -62.56 -35.01 78.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.534 0.734 . . . . 0.0 112.147 -175.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.9 mt -72.35 -53.68 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.566 0.746 . . . . 0.0 111.074 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.5 t -75.0 -37.22 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.878 -167.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.19 -13.84 62.64 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.751 0.82 . . . . 0.0 111.58 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.423 ' NE2' HG13 ' A' ' 79' ' ' VAL . 21.2 m-70 -106.63 26.12 10.35 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.967 0.907 . . . . 0.0 110.619 173.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.69 22.44 72.31 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.761 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.32 156.84 20.85 Favored Glycine 0 CA--C 1.503 -0.706 0 N-CA-C 113.443 0.137 . . . . 0.0 113.443 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.557 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -105.45 144.16 32.61 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.27 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -116.35 157.3 25.24 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.99 123.21 44.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 175.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -72.91 -32.93 65.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.078 0.951 . . . . 0.0 111.789 -174.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -176.13 126.07 0.2 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.428 1.091 . . . . 0.0 108.377 -172.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.69 139.15 31.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.056 0.543 . . . . 0.0 110.393 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.8 t -84.44 -157.42 0.28 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.077 0.951 . . . . 0.0 108.465 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 m -83.76 47.17 1.25 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.192 0.597 . . . . 0.0 111.85 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -159.56 172.12 18.41 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.169 0.509 . . . . 0.0 111.482 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.62 91.49 7.57 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.294 1.038 . . . . 0.0 111.427 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.9 m -117.86 17.46 14.22 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.543 0.687 . . . . 0.0 110.754 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -137.95 150.31 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.9 -0.5 . . . . 0.0 109.998 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.6 p -106.74 -31.89 8.22 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.429 0.692 . . . . 0.0 111.083 -176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 80.4 m80 -135.28 129.67 33.91 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.353 1.061 . . . . 0.0 108.369 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.559 ' HB ' HG12 ' A' ' 69' ' ' VAL . 48.8 mt -113.72 118.98 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 174.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.439 HG23 HG23 ' A' ' 14' ' ' ILE . 73.4 t -90.91 118.83 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 122.988 0.515 . . . . 0.0 109.725 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.53 144.21 34.18 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.291 0.636 . . . . 0.0 110.191 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 19' ' ' TYR . 29.8 t -115.43 -37.37 4.04 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 166.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -98.79 98.26 9.39 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.2 tp -139.91 109.96 7.18 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 122.575 0.35 . . . . 0.0 110.145 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 60' ' ' LYS . 18.6 Cg_exo -68.1 158.79 55.9 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.473 2.782 . . . . 0.0 112.012 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.77 -40.77 93.79 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.66 0.784 . . . . 0.0 111.539 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -67.04 -28.64 68.38 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.602 0.761 . . . . 0.0 111.429 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.543 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -86.98 -14.4 41.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.211 0.604 . . . . 0.0 111.178 177.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 92' ' ' LEU . 32.2 mtm180 -73.87 -28.71 61.71 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 166.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.6 mt -77.98 -43.33 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.394 0.677 . . . . 0.0 110.298 173.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.543 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 38.8 tt0 -68.21 -32.63 72.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.653 0.781 . . . . 0.0 111.241 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -110.28 27.61 9.45 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.667 0.787 . . . . 0.0 110.649 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.21 98.4 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.616 0.766 . . . . 0.0 112.6 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -72.81 -25.31 61.1 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.07 0.548 . . . . 0.0 111.289 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -86.26 138.36 31.91 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.96 88.02 3.51 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.559 HG12 ' HB ' ' A' ' 51' ' ' ILE . 35.7 m -75.9 126.3 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 91' ' ' SER . 30.4 m -135.76 178.64 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.508 1.123 . . . . 0.0 109.601 -174.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.8 m -92.2 155.19 42.96 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.686 0.794 . . . . 0.0 110.523 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.561 ' HB3' HD11 ' A' ' 27' ' ' LEU . 17.9 Cg_endo -57.46 -24.52 61.62 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.383 2.722 . . . . 0.0 113.021 174.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.45 -23.24 62.54 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.056 1.342 . . . . 0.0 112.415 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -61.06 -47.8 84.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.632 0.773 . . . . 0.0 110.507 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 75' ' ' ILE . 3.2 mp -75.05 -40.03 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.588 -172.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.2 t -53.82 -52.35 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.873 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -71.83 -44.42 63.91 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.336 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.498 ' HA ' HD23 ' A' ' 85' ' ' LEU . 61.2 m -60.34 -40.06 89.34 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.458 0.703 . . . . 0.0 112.695 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.667 HG21 ' HB3' ' A' ' 30' ' ' MET . 15.1 t -69.2 -47.95 71.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 123.454 0.702 . . . . 0.0 110.893 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -64.53 -42.8 95.52 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.074 0.549 . . . . 0.0 112.065 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -85.9 -9.42 56.97 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.086 0.555 . . . . 0.0 111.624 -177.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.15 23.16 13.77 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.871 1.268 . . . . 0.0 112.3 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.444 ' HG3' HD22 ' A' ' 85' ' ' LEU . 16.5 ptm180 -129.25 171.39 12.51 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.37 1.068 . . . . 0.0 110.029 -177.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.36 111.93 23.72 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 78' ' ' SER . 4.5 mm? -82.22 154.84 69.66 Favored Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 123.225 0.61 . . . . 0.0 110.366 174.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.21 106.8 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.463 2.108 . . . . 0.0 111.502 172.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.405 ' HB2' HG11 ' A' ' 70' ' ' VAL . 2.9 p90 -56.8 -31.91 65.15 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.632 0.773 . . . . 0.0 111.081 173.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -63.43 -23.08 67.25 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.781 1.233 . . . . 0.0 112.561 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -68.37 -37.25 80.26 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.334 0.588 . . . . 0.0 110.2 174.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -99.77 -2.43 35.17 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.654 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 75.4 m -64.55 128.21 34.81 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -173.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.422 ' O ' ' HD2' ' A' ' 61' ' ' ARG . 46.4 mt -85.83 -0.09 54.4 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.686 173.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.7 p -57.5 -43.02 83.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.312 1.045 . . . . 0.0 110.609 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 CA--C 1.558 1.266 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.349 179.85 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 47.2 mm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -90.55 58.4 3.94 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.714 0.768 . . . . 0.0 109.05 173.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.8 p -126.96 86.34 2.49 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.529 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -105.3 154.09 20.73 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.902 0.881 . . . . 0.0 109.769 178.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.6 t -168.61 178.15 4.86 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.041 0.936 . . . . 0.0 109.21 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -68.11 105.37 2.04 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -81.54 33.74 0.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.607 1.163 . . . . 0.0 113.033 -168.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.495 HG23 ' HA ' ' A' ' 84' ' ' LEU . 45.5 mt -54.03 -48.35 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.191 1.396 . . . . 0.0 112.49 -173.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.49 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 54.9 m-85 -111.02 13.02 22.04 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.017 -172.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.19 -53.48 57.64 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.345 0.658 . . . . 0.0 111.103 -169.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -87.31 -21.3 25.82 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.604 0.762 . . . . 0.0 110.509 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.8 m -72.26 131.8 43.2 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.354 0.597 . . . . 0.0 110.613 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.532 HG12 HG23 ' A' ' 48' ' ' VAL . 21.1 t -105.86 124.75 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.44 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.5 mp -121.52 123.55 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 118.227 0.467 . . . . 0.0 111.554 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 34.8 t80 -105.86 132.11 52.36 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.568 1.147 . . . . 0.0 108.011 170.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.8 mt -100.56 130.33 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -131.34 129.26 41.18 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.102 0.961 . . . . 0.0 109.21 -173.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.62 174.49 46.44 Favored Glycine 0 C--N 1.343 0.926 0 O-C-N 123.275 0.359 . . . . 0.0 112.918 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -82.06 112.28 18.98 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.959 0.504 . . . . 0.0 109.876 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.609 HG21 HG12 ' A' ' 52' ' ' VAL . 80.7 p -120.78 145.41 47.58 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.611 1.164 . . . . 0.0 110.053 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -99.75 129.09 29.48 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 122.7 0.4 . . . . 0.0 111.112 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.472 ' HD2' HD21 ' A' ' 27' ' ' LEU . 36.4 Cg_endo -81.42 177.13 36.16 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.855 -0.894 . . . . 0.0 111.662 -1.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.6 138.65 6.37 Favored Glycine 0 C--N 1.349 1.296 0 O-C-N 124.078 0.861 . . . . 0.0 113.997 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -54.25 -33.0 57.53 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.716 0.806 . . . . 0.0 112.497 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 26' ' ' GLN . 4.6 pp -55.26 -44.23 75.41 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 123.604 0.565 . . . . 0.0 111.045 175.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.455 ' N ' HD12 ' A' ' 25' ' ' LEU . 61.1 tt0 -73.75 -44.78 55.24 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.347 0.659 . . . . 0.0 110.856 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.472 HD21 ' HD2' ' A' ' 22' ' ' PRO . 81.3 mt -56.72 -39.24 73.55 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.907 0.483 . . . . 0.0 111.053 175.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 32' ' ' VAL . 15.9 m170 -63.22 -42.64 99.29 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.451 0.7 . . . . 0.0 110.036 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.18 -36.12 82.56 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.984 0.514 . . . . 0.0 110.928 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.532 ' HB3' HG21 ' A' ' 79' ' ' VAL . 32.9 mmt -66.01 -31.59 72.58 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.676 0.79 . . . . 0.0 110.932 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 28' ' ' HIS . 62.6 mt -70.82 -52.95 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.853 174.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 28' ' ' HIS . 20.9 t -68.04 -43.69 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 122.991 0.516 . . . . 0.0 111.941 -168.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.17 -19.61 61.76 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.383 0.673 . . . . 0.0 112.201 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -100.9 24.34 9.39 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.192 0.997 . . . . 0.0 110.84 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.8 18.28 70.22 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.106 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.08 160.3 30.77 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -166.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HG3' HG13 ' A' ' 13' ' ' VAL . 17.9 tppt? -106.32 142.51 35.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.402 0.681 . . . . 0.0 109.792 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -141.35 147.71 38.52 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.426 1.091 . . . . 0.0 108.635 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.4 mt -125.55 139.03 53.95 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.785 0.434 . . . . 0.0 111.09 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.41 -33.85 73.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.964 1.306 . . . . 0.0 112.374 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -171.69 143.06 1.65 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.921 0.889 . . . . 0.0 109.564 -172.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -116.49 109.64 17.55 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -82.57 74.66 9.52 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.2 m 66.94 -6.25 0.58 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.431 1.492 . . . . 0.0 114.015 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -93.85 153.17 18.41 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.157 0.583 . . . . 0.0 111.504 -168.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -100.27 59.25 1.0 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.449 1.119 . . . . 0.0 110.632 -176.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.7 m -92.66 -11.22 34.72 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.923 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.532 HG23 HG12 ' A' ' 13' ' ' VAL . 3.9 p -108.37 151.57 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.258 0.623 . . . . 0.0 109.994 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -101.78 -40.18 7.07 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 121.193 0.52 . . . . 0.0 110.705 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -128.97 142.85 50.79 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.269 1.027 . . . . 0.0 109.188 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.638 ' HB ' HG12 ' A' ' 69' ' ' VAL . 61.1 mt -123.97 138.0 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.609 HG12 HG21 ' A' ' 20' ' ' THR . 60.4 t -91.91 138.44 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.518 0.727 . . . . 0.0 110.246 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.67 151.91 29.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.589 1.155 . . . . 0.0 107.953 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.6 m -79.76 -48.66 13.24 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -137.34 142.18 41.82 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.57 117.74 11.29 Favored Pre-proline 0 CA--C 1.558 1.25 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.92 160.66 36.91 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.599 2.866 . . . . 0.0 113.556 -174.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -51.98 -45.45 64.47 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.549 1.14 . . . . 0.0 112.684 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -57.53 -43.97 84.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.587 0.755 . . . . 0.0 110.995 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -79.24 -20.77 47.39 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 119.412 -0.328 . . . . 0.0 111.306 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -66.33 -29.76 70.03 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 117.931 0.332 . . . . 0.0 110.243 168.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.7 mt -75.11 -40.73 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 110.337 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -76.1 -25.11 55.14 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.971 0.508 . . . . 0.0 111.386 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.475 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 41.4 m-85 -114.07 30.5 7.23 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.61 1.164 . . . . 0.0 109.662 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.46 -37.93 58.14 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.128 0.971 . . . . 0.0 112.773 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -87.81 -26.87 22.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.602 0.761 . . . . 0.0 111.279 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.491 ' HE1' ' HA ' ' A' ' 46' ' ' LYS . 46.0 m-85 -91.92 120.92 33.03 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.448 0.699 . . . . 0.0 109.574 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -75.06 86.35 2.35 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.638 HG12 ' HB ' ' A' ' 51' ' ' ILE . 20.1 m -76.2 128.18 37.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.84 171.68 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.954 1.302 . . . . 0.0 109.368 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 53.7 m -78.08 153.88 79.96 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.244 0.618 . . . . 0.0 111.027 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.86 -24.98 77.81 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.661 2.241 . . . . 0.0 111.888 175.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.44 -23.62 65.97 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.899 1.28 . . . . 0.0 111.504 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -62.79 -48.09 80.65 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-O 120.933 0.397 . . . . 0.0 110.033 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.49 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.8 mp -67.46 -44.35 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.055 -175.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.2 t -63.32 -51.46 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.259 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.91 -35.56 69.72 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.666 -172.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB3' HG21 ' A' ' 8' ' ' ILE . 61.1 m -63.57 -44.53 93.83 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.117 0.261 . . . . 0.0 110.422 176.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.532 HG21 ' HB3' ' A' ' 30' ' ' MET . 55.9 t -64.49 -34.26 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.454 0.702 . . . . 0.0 110.883 175.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -66.89 -32.68 74.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.303 0.641 . . . . 0.0 110.748 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -94.61 -10.98 30.3 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.61 0.764 . . . . 0.0 112.147 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.06 30.04 19.27 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.412 1.085 . . . . 0.0 112.055 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.8 ptt-85 -151.3 164.11 37.39 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.38 0.672 . . . . 0.0 110.498 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.495 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.2 tm? -79.49 106.74 11.74 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.2 mt -85.97 157.51 57.06 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.488 0.715 . . . . 0.0 109.94 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -65.49 120.8 8.06 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.079 1.853 . . . . 0.0 111.683 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -57.87 -31.52 66.79 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.542 1.137 . . . . 0.0 111.372 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -63.89 -21.69 66.58 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.702 1.201 . . . . 0.0 112.379 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -66.75 -30.8 71.11 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.139 0.576 . . . . 0.0 110.648 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.15 8.43 11.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.941 0.896 . . . . 0.0 111.946 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 p -67.74 111.52 4.31 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.997 0.519 . . . . 0.0 112.138 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.27 -11.85 58.39 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.452 0.701 . . . . 0.0 111.511 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.442 ' HB ' HG22 ' A' ' 69' ' ' VAL . 9.3 t -69.08 -27.05 65.26 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.493 0.717 . . . . 0.0 111.144 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.7 p . . . . . 0 C--O 1.251 1.16 0 C-N-CA 123.273 0.629 . . . . 0.0 109.867 175.693 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -90.04 75.69 7.08 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.619 0.768 . . . . 0.0 109.379 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.5 p -71.81 -57.15 4.59 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.471 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 54.02 30.33 11.64 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.653 1.181 . . . . 0.0 111.138 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.6 t -74.81 -18.93 60.38 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.054 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.532 ' HB2' HG13 ' A' ' 8' ' ' ILE . 25.6 p -155.56 140.14 16.94 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.89 32.2 6.02 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.035 0.934 . . . . 0.0 109.458 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.532 HG13 ' HB2' ' A' ' 6' ' ' SER . 67.6 mt -55.3 -48.59 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.193 0.997 . . . . 0.0 111.956 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -109.67 11.88 24.43 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.536 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -61.99 -41.65 98.28 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.948 0.499 . . . . 0.0 112.267 -170.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -76.62 -27.22 55.64 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.041 0.448 . . . . 0.0 110.214 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.2 m -88.1 144.18 26.64 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.284 1.04 . . . . 0.0 112.462 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.538 HG12 HG23 ' A' ' 48' ' ' VAL . 21.4 t -115.54 127.82 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.543 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.6 mp -123.19 128.19 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 122.764 0.426 . . . . 0.0 111.532 -171.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 24.6 t80 -108.36 151.37 26.1 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.377 1.471 . . . . 0.0 108.675 175.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.458 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 74.0 mt -118.32 123.18 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.373 0.669 . . . . 0.0 109.336 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -117.07 135.68 53.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.259 1.024 . . . . 0.0 109.388 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.89 -139.92 28.03 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.45 0.469 . . . . 0.0 112.767 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -112.6 120.25 40.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.304 0.642 . . . . 0.0 109.667 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.737 HG21 HG12 ' A' ' 52' ' ' VAL . 68.1 p -133.17 147.11 52.05 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.463 0.705 . . . . 0.0 109.559 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -108.91 135.61 20.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.366 0.667 . . . . 0.0 109.793 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.482 ' HD2' HD21 ' A' ' 27' ' ' LEU . 70.3 Cg_endo -74.81 177.24 39.72 Favored 'Cis proline' 0 C--N 1.369 1.631 0 C-N-CA 124.643 -0.982 . . . . 0.0 111.634 -5.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.18 146.98 3.68 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 124.019 0.824 . . . . 0.0 114.776 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -58.21 -36.38 73.05 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.077 0.951 . . . . 0.0 112.599 -172.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.01 -32.92 72.81 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.234 0.214 . . . . 0.0 110.65 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -69.19 -53.24 21.02 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.451 0.7 . . . . 0.0 110.425 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.482 HD21 ' HD2' ' A' ' 22' ' ' PRO . 87.8 mt -57.27 -40.55 77.96 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.458 0.703 . . . . 0.0 111.786 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.584 ' HA ' HD12 ' A' ' 31' ' ' ILE . 17.2 m170 -61.49 -38.96 89.23 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.9 0.48 . . . . 0.0 111.363 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.51 -35.05 68.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.628 0.371 . . . . 0.0 111.257 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.534 ' HB3' HG21 ' A' ' 79' ' ' VAL . 54.8 mtt -61.08 -31.97 71.63 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.971 0.509 . . . . 0.0 110.799 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.584 HD12 ' HA ' ' A' ' 28' ' ' HIS . 66.1 mt -68.09 -51.03 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.299 0.64 . . . . 0.0 110.986 173.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 28' ' ' HIS . 92.0 t -60.99 -50.27 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.569 0.748 . . . . 0.0 112.747 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.1 -12.58 60.36 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.441 0.696 . . . . 0.0 112.326 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -108.77 26.29 10.73 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.092 0.957 . . . . 0.0 110.13 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.0 60.48 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-N 114.58 -1.191 . . . . 0.0 114.051 171.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.33 159.63 48.84 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 -164.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.405 ' HB3' HG22 ' A' ' 13' ' ' VAL . 21.7 ttmm -103.49 152.55 21.54 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -137.23 159.04 43.07 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.043 0.449 . . . . 0.0 111.323 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.52 128.51 56.04 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 165.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -33.39 70.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.405 172.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.413 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 35.1 t80 -171.33 149.77 2.81 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 124.414 1.086 . . . . 0.0 108.7 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.11 139.67 38.33 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.538 0.735 . . . . 0.0 110.069 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.0 m -83.73 45.82 1.11 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.819 0.848 . . . . 0.0 109.391 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.9 m 58.87 23.18 11.07 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 125.384 1.473 . . . . 0.0 112.111 -172.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -107.88 145.72 33.32 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.823 0.849 . . . . 0.0 110.183 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.37 64.51 8.26 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.897 0.879 . . . . 0.0 109.777 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 m -90.45 -32.15 16.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.924 0.89 . . . . 0.0 110.223 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.538 HG23 HG12 ' A' ' 13' ' ' VAL . 6.5 p -92.98 155.26 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.196 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -109.18 -27.67 9.45 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 118.064 0.393 . . . . 0.0 111.42 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -118.77 140.47 49.9 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.224 0.61 . . . . 0.0 109.959 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.693 ' HB ' HG12 ' A' ' 69' ' ' VAL . 33.5 mt -125.08 140.07 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.737 HG12 HG21 ' A' ' 20' ' ' THR . 95.2 t -104.51 135.85 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.768 0.827 . . . . 0.0 109.666 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.02 150.18 27.99 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.41 0.684 . . . . 0.0 109.364 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -75.95 -42.68 47.87 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -139.73 133.52 30.6 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.132 -1.395 . . . . 0.0 108.034 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.579 ' HG ' HG21 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -116.14 110.37 43.58 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.88 156.42 66.0 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.964 2.442 . . . . 0.0 112.861 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.1 -47.88 81.88 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.333 1.053 . . . . 0.0 112.995 -169.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 1.1 mptm? -64.15 -31.19 72.29 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.913 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -83.55 -18.87 36.89 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.073 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -66.06 -32.5 74.01 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 168.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 64.9 mt -71.01 -49.62 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.498 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 38.6 mm-40 -66.34 -31.88 72.94 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.723 0.409 . . . . 0.0 111.76 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -106.47 25.91 10.55 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.559 0.744 . . . . 0.0 110.882 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.94 -32.88 74.57 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.054 0.454 . . . . 0.0 110.579 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -69.87 -26.47 64.21 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.101 0.961 . . . . 0.0 111.318 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -99.05 162.51 13.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.334 0.654 . . . . 0.0 110.582 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -101.58 88.21 3.37 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.693 HG12 ' HB ' ' A' ' 51' ' ' ILE . 26.8 m -75.89 134.6 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.731 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 87' ' ' TRP . 34.6 m -137.62 175.45 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.808 1.243 . . . . 0.0 109.873 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.2 m -81.85 154.5 70.48 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.762 0.825 . . . . 0.0 110.113 172.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.42 -24.22 71.11 Favored 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.51 2.14 . . . . 0.0 111.426 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.98 -21.47 63.55 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.955 1.302 . . . . 0.0 111.27 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.73 -51.45 62.31 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 123.144 0.277 . . . . 0.0 110.266 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 75' ' ' ILE . 3.1 mp -66.33 -43.94 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.79 -51.97 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.24 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -73.09 -33.15 65.43 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.197 0.599 . . . . 0.0 111.787 -171.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 71.9 m -66.97 -40.52 87.49 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.58 0.352 . . . . 0.0 110.281 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 30' ' ' MET . 55.0 t -70.68 -33.87 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.451 0.7 . . . . 0.0 110.786 173.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -64.58 -41.37 96.32 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.157 0.983 . . . . 0.0 110.523 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -95.41 -6.46 40.85 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.855 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.22 27.14 15.47 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.573 1.149 . . . . 0.0 112.33 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -142.49 159.33 42.44 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.774 0.83 . . . . 0.0 110.546 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.467 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.2 tm? -75.1 127.55 33.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.8 mt -114.7 152.12 46.0 Favored Pre-proline 0 C--O 1.24 0.596 0 C-N-CA 124.214 1.006 . . . . 0.0 109.714 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.414 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 35.3 Cg_endo -61.73 109.34 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.551 2.167 . . . . 0.0 111.877 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.549 ' HB2' HG11 ' A' ' 70' ' ' VAL . 29.9 p90 -62.14 -21.91 65.42 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.388 1.075 . . . . 0.0 112.206 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.414 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 12.7 pt20 -59.78 -25.11 64.65 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.127 0.971 . . . . 0.0 111.818 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -70.92 -31.66 68.35 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.788 0.835 . . . . 0.0 111.131 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.29 -0.79 25.97 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.905 0.882 . . . . 0.0 111.318 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -66.24 131.42 46.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.329 0.652 . . . . 0.0 112.0 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.8 mt -108.31 14.54 24.79 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.101 0.96 . . . . 0.0 110.951 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.0 p -65.56 -52.73 50.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.823 0.849 . . . . 0.0 111.321 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 C--O 1.252 1.185 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.166 -173.858 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 21.8 pt . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 p -73.51 85.19 1.54 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.034 0.534 . . . . 0.0 110.103 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.5 m -76.26 82.69 3.04 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.315 0.646 . . . . 0.0 109.602 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -123.59 69.54 1.04 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.261 -176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.3 m -147.68 132.84 18.34 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.935 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.585 ' HB2' ' HD2' ' A' ' 34' ' ' HIS . 24.8 m -67.17 106.44 2.01 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -81.01 36.0 0.39 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.739 1.216 . . . . 0.0 113.73 -165.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 82' ' ' ALA . 64.3 mt -49.08 -47.87 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.507 1.523 . . . . 0.0 112.352 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -109.58 15.32 22.98 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.862 0.465 . . . . 0.0 111.566 -174.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -57.82 -49.3 77.12 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.287 0.635 . . . . 0.0 111.448 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -76.41 -15.56 59.91 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.675 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.5 m -93.08 141.17 28.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.632 0.773 . . . . 0.0 111.421 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.56 124.84 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 171.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.411 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.2 mp -118.5 134.28 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 C-N-CA 123.155 0.582 . . . . 0.0 111.74 -170.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 33.3 t80 -113.0 149.49 33.24 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.414 1.486 . . . . 0.0 108.089 169.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 65.7 mt -114.54 110.01 30.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -103.83 122.44 45.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.277 1.431 . . . . 0.0 109.447 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.76 175.58 50.98 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.88 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -82.08 111.49 18.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.602 HG21 HG12 ' A' ' 52' ' ' VAL . 69.6 p -112.14 151.92 28.92 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.887 0.875 . . . . 0.0 110.037 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -102.99 122.91 43.88 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 163.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -81.66 172.08 54.41 Favored 'Cis proline' 0 C--N 1.37 1.698 0 C-N-CA 124.031 -1.237 . . . . 0.0 112.033 1.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.61 164.6 15.79 Favored Glycine 0 C--N 1.344 0.995 0 O-C-N 123.735 0.647 . . . . 0.0 114.357 -172.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -56.11 -36.53 68.3 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.362 0.665 . . . . 0.0 111.411 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.9 pp -61.66 -43.12 99.46 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.454 0.701 . . . . 0.0 111.57 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.537 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.2 tp-100 -71.29 -51.76 22.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.345 0.658 . . . . 0.0 110.22 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.68 -51.09 70.13 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.028 0.83 . . . . 0.0 111.402 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.45 ' O ' HG23 ' A' ' 32' ' ' VAL . 15.6 m170 -54.85 -47.55 74.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.727 0.642 . . . . 0.0 111.109 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.5 -38.94 91.19 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.27 0.356 . . . . 0.0 111.571 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.602 ' HB3' HG21 ' A' ' 79' ' ' VAL . 21.2 mmt -61.22 -40.0 92.39 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.991 0.516 . . . . 0.0 111.132 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.411 HD13 ' HB ' ' A' ' 14' ' ' ILE . 70.8 mt -65.19 -49.12 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.008 0.923 . . . . 0.0 111.348 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 28' ' ' HIS . 57.9 t -65.84 -41.55 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.979 0.512 . . . . 0.0 111.573 -176.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.39 -13.04 60.1 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.321 0.648 . . . . 0.0 111.844 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.601 ' HE1' HG13 ' A' ' 79' ' ' VAL . 38.6 m80 -108.92 26.85 10.11 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.699 0.799 . . . . 0.0 111.758 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.95 7.03 75.03 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.944 172.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.89 158.1 30.28 Favored Glycine 0 C--O 1.242 0.596 0 C-N-CA 123.026 0.346 . . . . 0.0 113.94 -173.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -102.83 158.67 16.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.502 0.721 . . . . 0.0 109.653 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.37 161.71 37.63 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.389 0.676 . . . . 0.0 110.473 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.1 149.42 42.23 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.789 0.836 . . . . 0.0 110.531 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -68.9 -47.87 64.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.612 1.165 . . . . 0.0 111.566 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 77.5 t80 -178.73 139.16 0.17 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.674 1.19 . . . . 0.0 108.96 -170.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mp -141.15 162.6 35.11 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.412 0.685 . . . . 0.0 109.441 171.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.0 m -142.96 -39.77 0.33 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.378 1.071 . . . . 0.0 109.226 172.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 t -146.59 79.96 1.54 Allowed 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.205 0.602 . . . . 0.0 109.428 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.16 136.62 1.84 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.163 175.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HA ' ' HE1' ' A' ' 67' ' ' TYR . 54.1 mtpt -105.3 47.24 0.88 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.376 0.67 . . . . 0.0 110.631 -175.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -82.04 -24.32 35.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.748 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.84 151.53 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.12 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.6 p -114.57 -17.74 11.62 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -137.71 136.77 37.67 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.26 1.024 . . . . 0.0 109.096 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.619 ' HB ' HG12 ' A' ' 69' ' ' VAL . 67.4 mt -125.21 137.25 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.602 HG12 HG21 ' A' ' 20' ' ' THR . 54.5 t -105.84 133.72 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.41 1.084 . . . . 0.0 110.74 -173.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.45 146.01 20.79 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -77.14 -39.76 48.05 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -138.33 107.9 6.21 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.63 ' HB2' HD13 ' A' ' 92' ' ' LEU . 16.5 tp -100.53 119.61 58.29 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -64.32 159.55 43.19 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.623 2.882 . . . . 0.0 112.589 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.7 mt -58.99 -46.05 89.09 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.982 0.913 . . . . 0.0 112.38 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -57.56 -46.11 84.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.453 0.701 . . . . 0.0 110.713 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -66.26 -30.07 70.43 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.158 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -66.65 -38.24 86.47 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.159 0.584 . . . . 0.0 110.724 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.8 mt -70.39 -46.18 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 123.82 0.7 . . . . 0.0 110.384 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.71 -32.36 73.87 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.689 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.431 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 22.0 m-30 -103.08 15.05 30.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.451 0.701 . . . . 0.0 111.89 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.86 -18.81 62.69 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.323 0.583 . . . . 0.0 110.896 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -71.77 -19.91 61.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.268 1.027 . . . . 0.0 110.602 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.499 ' HE1' ' HA ' ' A' ' 46' ' ' LYS . 17.2 m-85 -113.47 169.83 8.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.382 1.073 . . . . 0.0 109.008 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -96.15 91.07 5.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.427 0.691 . . . . 0.0 109.413 175.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.619 HG12 ' HB ' ' A' ' 51' ' ' ILE . 20.3 m -82.88 129.95 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.288 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.477 HG11 ' HB2' ' A' ' 87' ' ' TRP . 31.6 m -139.79 167.56 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.754 1.221 . . . . 0.0 110.514 -175.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.6 m -75.76 155.91 84.89 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.847 172.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.06 -25.46 79.82 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.469 2.113 . . . . 0.0 111.495 172.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.5 -29.89 59.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.48 1.512 . . . . 0.0 112.651 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.433 ' CE3' HG21 ' A' ' 70' ' ' VAL . 27.6 t90 -62.18 -48.74 78.69 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.354 0.408 . . . . 0.0 110.197 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.77 -54.98 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.241 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.8 t -51.84 -52.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.841 1.257 . . . . 0.0 112.346 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -71.58 -42.1 68.17 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.732 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.435 ' HA ' HD13 ' A' ' 85' ' ' LEU . 72.5 m -61.63 -36.93 82.17 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.736 0.415 . . . . 0.0 111.448 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.602 HG21 ' HB3' ' A' ' 30' ' ' MET . 21.8 t -63.57 -46.94 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.265 1.026 . . . . 0.0 111.057 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -65.97 -43.47 87.77 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.042 0.537 . . . . 0.0 111.102 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -76.5 -15.59 59.85 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.708 0.803 . . . . 0.0 112.04 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 8' ' ' ILE . . . 58.41 40.92 23.69 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.091 0.956 . . . . 0.0 110.843 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -159.51 156.54 28.37 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.868 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -85.81 109.3 18.58 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 78' ' ' SER . 8.6 mp -79.64 155.28 76.04 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.126 0.57 . . . . 0.0 111.242 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.469 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 35.8 Cg_endo -61.12 114.83 2.36 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.426 2.084 . . . . 0.0 111.325 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.477 ' HB2' HG11 ' A' ' 70' ' ' VAL . 48.1 p90 -64.9 -20.09 66.26 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.649 0.78 . . . . 0.0 112.395 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.469 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.0 pt20 -58.19 -28.04 64.41 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.275 1.03 . . . . 0.0 112.023 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -70.6 -27.68 64.28 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.605 0.762 . . . . 0.0 110.814 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.78 5.95 14.27 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.047 0.939 . . . . 0.0 111.689 -175.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.437 ' HB2' HG22 ' A' ' 93' ' ' THR . 59.9 p -69.85 120.48 15.66 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.202 0.601 . . . . 0.0 112.287 -174.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.63 HD13 ' HB2' ' A' ' 56' ' ' LEU . 48.5 mt -73.62 -21.48 60.29 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.947 0.899 . . . . 0.0 111.666 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 91' ' ' SER . 10.3 t -65.5 -17.53 64.63 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.694 0.798 . . . . 0.0 112.112 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.4 m . . . . . 0 C--O 1.26 1.613 0 C-N-CA 123.294 0.637 . . . . 0.0 109.993 175.568 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 19.8 pt . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -72.33 86.43 1.11 Allowed 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.69 0.796 . . . . 0.0 111.054 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.1 m -72.71 91.78 1.49 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.382 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -98.7 134.03 42.2 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.444 1.098 . . . . 0.0 109.482 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.2 t -69.84 -25.86 63.94 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.9 0.48 . . . . 0.0 109.894 172.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.747 ' HB2' ' HA ' ' A' ' 34' ' ' HIS . 61.2 p -74.47 88.4 2.11 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.062 177.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -120.92 28.1 8.11 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.25 1.42 . . . . 0.0 108.59 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.556 HG21 ' OG ' ' A' ' 78' ' ' SER . 57.7 mt -64.73 -51.42 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.681 -167.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.655 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 61.7 m-85 -103.17 18.04 22.67 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.886 -175.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -51.16 -59.09 4.56 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.281 1.032 . . . . 0.0 112.877 -171.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -95.81 17.39 15.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.867 0.867 . . . . 0.0 111.01 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.447 ' SG ' ' HH2' ' A' ' 74' ' ' TRP . 41.1 t -116.9 123.26 46.58 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 124.484 1.114 . . . . 0.0 109.756 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.475 HG11 HD23 ' A' ' 39' ' ' LEU . 40.6 t -101.68 128.2 54.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.533 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.2 mp -122.36 123.28 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 122.833 0.453 . . . . 0.0 111.041 -175.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 28.4 t80 -104.35 150.74 24.22 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.341 1.456 . . . . 0.0 108.134 174.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.21 130.31 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -135.81 123.78 22.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.414 1.085 . . . . 0.0 109.771 -170.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.7 -161.57 42.45 Favored Glycine 0 C--N 1.343 0.958 0 O-C-N 123.496 0.498 . . . . 0.0 112.822 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -88.03 110.73 20.84 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.237 0.615 . . . . 0.0 109.558 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.537 HG21 HG12 ' A' ' 52' ' ' VAL . 61.5 p -133.94 134.4 42.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.044 0.937 . . . . 0.0 109.271 -177.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -117.47 139.17 25.83 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -69.94 170.69 58.03 Favored 'Cis proline' 0 C--N 1.389 2.707 0 C-N-CA 124.705 -0.956 . . . . 0.0 112.567 3.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.67 149.11 5.55 Favored Glycine 0 N--CA 1.475 1.257 0 O-C-N 124.01 0.819 . . . . 0.0 114.196 -169.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -52.23 -36.08 51.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.777 0.831 . . . . 0.0 112.197 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 26' ' ' GLN . 3.6 pp -62.46 -41.44 98.76 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.27 0.628 . . . . 0.0 111.63 174.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.512 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.5 tp-100 -72.19 -50.79 24.83 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.813 0.845 . . . . 0.0 110.945 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.1 mt -54.73 -44.96 74.01 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.215 0.606 . . . . 0.0 111.008 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.515 ' HA ' HD12 ' A' ' 31' ' ' ILE . 9.5 m170 -58.75 -43.5 90.31 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 123.572 0.545 . . . . 0.0 111.417 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -66.5 -38.89 88.23 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 123.168 0.292 . . . . 0.0 111.23 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.0 mmt -58.42 -39.36 79.57 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.338 0.655 . . . . 0.0 110.947 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.533 HD13 ' HB ' ' A' ' 14' ' ' ILE . 70.9 mt -62.69 -47.8 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.07 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 28' ' ' HIS . 39.1 t -64.19 -47.6 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.653 0.596 . . . . 0.0 111.117 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.01 -33.55 73.44 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.829 0.852 . . . . 0.0 111.47 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.747 ' HA ' ' HB2' ' A' ' 6' ' ' SER . 54.9 m80 -86.44 27.47 0.94 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.255 0.622 . . . . 0.0 112.274 175.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.32 28.99 73.02 Favored Glycine 0 C--N 1.357 1.73 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.29 169.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.655 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -112.44 172.43 14.66 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 115.551 0.98 . . . . 0.0 115.551 -168.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -111.16 146.22 37.25 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.702 0.801 . . . . 0.0 109.444 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -128.83 166.25 19.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.562 0.745 . . . . 0.0 109.585 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.475 HD23 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -130.3 136.22 48.91 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.051 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -82.44 -36.79 26.27 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 123.867 0.729 . . . . 0.0 112.144 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 61.3 t80 -171.83 135.24 0.83 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.974 0.509 . . . . 0.0 110.539 -175.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.42 142.05 44.19 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.0 t -139.33 -51.36 0.53 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.323 1.049 . . . . 0.0 108.419 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -147.94 59.7 1.12 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.254 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -160.38 156.99 27.06 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.625 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.46 46.53 2.36 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.394 1.078 . . . . 0.0 110.907 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.6 m -79.68 -27.86 40.74 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.435 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.4 p -86.64 151.71 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.984 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.453 HG23 ' ND1' ' A' ' 50' ' ' HIS . 5.1 t -114.79 -25.4 8.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.742 0.817 . . . . 0.0 110.683 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.453 ' ND1' HG23 ' A' ' 49' ' ' THR . 53.5 m80 -133.38 127.42 33.42 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.924 0.49 . . . . 0.0 110.419 -174.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.631 ' HB ' HG12 ' A' ' 69' ' ' VAL . 61.7 mt -119.04 129.41 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.537 HG12 HG21 ' A' ' 20' ' ' THR . 70.8 t -90.76 123.27 42.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 123.63 0.772 . . . . 0.0 109.187 -173.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.93 140.69 31.23 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.834 0.853 . . . . 0.0 108.951 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -84.05 -49.95 8.43 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -116.61 132.99 56.54 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.518 -1.219 . . . . 0.0 107.719 170.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.98 101.55 10.41 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.09 160.16 48.68 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.092 2.528 . . . . 0.0 112.706 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.8 -31.97 67.1 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.052 0.941 . . . . 0.0 112.001 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 47.9 tptt -60.77 -53.42 57.61 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.269 0.628 . . . . 0.0 109.911 175.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -70.69 -19.25 62.79 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.821 0.448 . . . . 0.0 111.841 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -72.88 -27.69 62.05 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.735 0.814 . . . . 0.0 109.779 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.3 mt -79.11 -45.3 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.321 0.648 . . . . 0.0 110.043 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 24.4 mm-40 -63.52 -29.18 70.49 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.598 0.759 . . . . 0.0 112.215 -175.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -121.97 28.63 7.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.058 0.943 . . . . 0.0 110.293 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -30.68 69.26 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.447 0.699 . . . . 0.0 112.566 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -75.08 -23.63 58.03 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.119 0.568 . . . . 0.0 111.572 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -107.64 123.69 48.87 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.94 93.23 0.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.369 0.604 . . . . 0.0 109.755 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.631 HG12 ' HB ' ' A' ' 51' ' ' ILE . 27.4 m -73.89 128.83 36.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 87' ' ' TRP . 30.2 m -128.13 172.13 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.253 1.021 . . . . 0.0 109.862 -174.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -80.46 152.51 73.08 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.27 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -56.78 -25.09 59.15 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.693 2.262 . . . . 0.0 112.17 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.41 -26.5 53.55 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.884 1.273 . . . . 0.0 112.286 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.447 ' HH2' ' SG ' ' A' ' 12' ' ' CYS . 28.3 t90 -59.6 -48.45 81.62 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.825 0.284 . . . . 0.0 110.454 174.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 79' ' ' VAL . 3.3 mp -69.33 -42.71 81.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 O-C-N 124.042 0.839 . . . . 0.0 108.85 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.48 HG12 ' HE2' ' A' ' 80' ' ' LYS . 85.0 t -62.14 -50.52 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.006 0.922 . . . . 0.0 111.408 -177.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.23 -33.72 76.66 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.24 0.616 . . . . 0.0 110.849 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.556 ' OG ' HG21 ' A' ' 8' ' ' ILE . 38.5 t -62.54 -37.65 86.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.235 0.614 . . . . 0.0 111.449 177.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 75' ' ' ILE . 94.0 t -70.96 -47.13 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.502 0.721 . . . . 0.0 110.669 177.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.48 ' HE2' HG12 ' A' ' 76' ' ' VAL . 53.2 mtmt -64.74 -45.16 87.63 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.486 0.714 . . . . 0.0 111.744 -175.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -86.76 -15.51 39.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.342 0.657 . . . . 0.0 111.473 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.85 38.56 14.58 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.572 1.149 . . . . 0.0 111.869 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -149.75 164.49 35.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.395 0.678 . . . . 0.0 110.285 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.5 tp -84.05 95.26 8.52 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.8 142.94 96.15 Favored Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.449 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 16.8 Cg_endo -56.24 108.01 0.3 Allowed 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.302 2.001 . . . . 0.0 110.79 172.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.411 ' HB2' HG11 ' A' ' 70' ' ' VAL . 29.8 p90 -56.95 -22.69 39.9 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.547 1.139 . . . . 0.0 112.695 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.449 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 20.6 pt20 -57.47 -26.77 61.75 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.749 1.22 . . . . 0.0 112.105 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -67.09 -38.46 85.75 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.196 0.598 . . . . 0.0 110.72 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -99.72 -5.62 28.46 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.07 0.948 . . . . 0.0 111.521 -172.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.0 m -66.23 121.74 15.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.111 0.564 . . . . 0.0 112.304 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.8 mt -81.86 -0.65 44.54 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.557 1.143 . . . . 0.0 111.062 172.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.8 p -66.96 -20.59 65.92 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.512 1.125 . . . . 0.0 111.665 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.558 1.254 0 C-N-CA 124.587 1.155 . . . . 0.0 111.876 -178.93 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 49.6 mm . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.1 t -153.38 89.02 1.32 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.203 1.001 . . . . 0.0 108.498 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.3 t -78.3 116.9 19.06 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.372 0.669 . . . . 0.0 110.458 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -80.97 87.02 6.01 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.3 m -147.5 164.81 32.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.901 0.881 . . . . 0.0 110.627 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.2 m -72.67 81.9 1.13 Allowed 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 170.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 10' ' ' LYS . 15.3 ptpt -83.81 36.33 0.55 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.675 1.59 . . . . 0.0 112.999 -167.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.53 HG23 ' HA ' ' A' ' 84' ' ' LEU . 66.9 mt -49.49 -46.23 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.024 1.33 . . . . 0.0 112.167 -177.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.495 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 78.1 m-85 -104.8 15.86 27.06 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.976 -173.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 7' ' ' LYS . 28.5 ttpp -51.53 -48.26 63.07 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.902 0.881 . . . . 0.0 113.312 -173.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -98.78 2.04 46.53 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.036 0.534 . . . . 0.0 111.436 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.4 m -97.89 110.8 23.31 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.873 0.869 . . . . 0.0 110.919 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.0 t -93.31 127.84 45.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.468 ' HB ' HD13 ' A' ' 31' ' ' ILE . 2.6 mp -114.74 136.06 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.58 0.752 . . . . 0.0 110.941 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -118.05 110.84 18.14 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 170.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.7 mt -77.22 134.28 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -138.68 122.02 17.11 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -173.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.63 -173.91 52.95 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.681 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -79.97 110.76 15.66 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.213 0.605 . . . . 0.0 109.904 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.558 HG21 HG12 ' A' ' 52' ' ' VAL . 61.8 p -121.16 136.68 54.93 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 11.0 mmpt? -104.06 135.43 19.35 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 117.85 0.295 . . . . 0.0 110.685 176.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' HD21 ' A' ' 27' ' ' LEU . 94.1 Cg_endo -74.24 173.79 54.96 Favored 'Cis proline' 0 C--N 1.378 2.099 0 C-N-CA 124.613 -0.995 . . . . 0.0 112.107 -1.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.64 156.0 3.73 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 123.885 0.741 . . . . 0.0 114.745 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -54.46 -38.4 66.31 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.572 0.749 . . . . 0.0 111.519 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.3 pp -60.62 -44.94 95.76 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 123.779 0.674 . . . . 0.0 111.338 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.528 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.7 tp-100 -69.45 -50.31 46.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.344 0.658 . . . . 0.0 110.672 -175.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.417 HD21 ' HD2' ' A' ' 22' ' ' PRO . 81.6 mt -56.1 -50.45 71.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.975 0.51 . . . . 0.0 111.447 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.438 ' HA ' HD12 ' A' ' 31' ' ' ILE . 23.5 m170 -54.82 -41.92 71.25 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.698 0.799 . . . . 0.0 111.094 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -67.81 -44.49 77.18 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.156 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 34.2 mmt -63.16 -34.1 76.9 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.158 0.583 . . . . 0.0 111.629 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.468 HD13 ' HB ' ' A' ' 14' ' ' ILE . 66.1 mt -60.54 -50.73 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.386 173.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.3 t -66.64 -39.78 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.549 0.74 . . . . 0.0 112.367 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.3 -23.55 67.47 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.698 0.799 . . . . 0.0 111.388 178.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -104.88 27.57 7.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.973 0.909 . . . . 0.0 111.044 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.49 14.16 80.52 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 114.893 -1.049 . . . . 0.0 114.114 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.86 174.88 22.85 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 114.524 0.57 . . . . 0.0 114.524 -170.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.415 ' HB2' ' NZ ' ' A' ' 37' ' ' LYS . 2.7 ttmp? -128.54 151.19 49.73 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.157 0.583 . . . . 0.0 109.787 -177.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -121.18 161.4 21.93 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.532 0.733 . . . . 0.0 109.337 170.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.607 ' HB3' HD11 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -118.24 131.94 56.33 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -64.54 -40.01 94.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.094 0.958 . . . . 0.0 112.196 -165.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -177.53 139.72 0.25 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.607 HD11 ' HB3' ' A' ' 39' ' ' LEU . 2.7 mp -137.66 170.59 15.8 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.886 0.475 . . . . 0.0 110.347 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.7 t -160.04 -60.94 0.06 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.155 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.1 m -123.03 10.94 9.49 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.194 0.598 . . . . 0.0 112.526 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -120.1 131.58 55.12 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -97.09 82.92 3.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.441 0.696 . . . . 0.0 109.757 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.7 m -108.31 -28.06 9.64 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.304 0.642 . . . . 0.0 110.624 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.6 150.03 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.55 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.3 p -102.89 -26.86 12.96 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.299 0.639 . . . . 0.0 111.302 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -137.35 128.48 27.72 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.814 0.846 . . . . 0.0 109.653 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.486 ' HB ' HG22 ' A' ' 69' ' ' VAL . 43.7 mt -110.65 114.68 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 175.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.558 HG12 HG21 ' A' ' 20' ' ' THR . 78.2 t -89.15 135.93 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.815 0.846 . . . . 0.0 109.919 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.37 170.59 19.71 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.598 0.759 . . . . 0.0 110.306 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.6 t -86.81 -52.23 5.62 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -145.07 103.17 3.84 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.521 ' HG ' HG11 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -89.1 114.71 61.28 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.85 143.49 91.03 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.362 2.708 . . . . 0.0 113.017 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.8 mt -55.93 -41.0 73.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.294 1.038 . . . . 0.0 112.428 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -56.61 -50.16 72.8 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.661 0.784 . . . . 0.0 110.524 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -76.1 -17.85 59.43 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.487 -175.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -68.99 -32.05 71.32 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.983 0.356 . . . . 0.0 110.162 170.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.5 mt -65.58 -42.92 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.03 -40.18 94.44 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 120.931 0.396 . . . . 0.0 111.122 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.42 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 21.0 m-85 -95.58 25.14 4.7 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.939 0.496 . . . . 0.0 111.124 -176.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.02 -16.77 62.06 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.269 0.627 . . . . 0.0 111.406 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -79.05 -14.94 58.86 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.729 0.412 . . . . 0.0 110.853 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.42 ' HD2' ' HA ' ' A' ' 64' ' ' PHE . 32.4 m-85 -115.71 152.77 32.58 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 109.408 -175.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -90.28 88.81 7.36 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.527 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 73.2 t -74.88 124.68 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 87' ' ' TRP . 32.7 m -133.03 176.64 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.941 0.896 . . . . 0.0 110.966 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.3 m -87.63 158.93 50.53 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 124.278 1.031 . . . . 0.0 109.957 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.62 -21.24 70.24 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.418 2.079 . . . . 0.0 111.794 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.23 -26.14 66.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.129 1.372 . . . . 0.0 111.637 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -62.3 -44.88 95.48 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.759 0.314 . . . . 0.0 110.381 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.495 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.6 mp -71.43 -50.98 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.985 -176.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.9 t -57.89 -52.5 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.557 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.81 -37.75 73.25 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.071 -172.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 98.2 p -65.73 -39.25 90.94 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.29 0.236 . . . . 0.0 111.139 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.06 -41.55 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.67 0.788 . . . . 0.0 110.793 176.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.57 -38.06 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.559 0.744 . . . . 0.0 111.252 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -82.28 -18.51 42.13 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.649 0.78 . . . . 0.0 111.39 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.59 32.94 22.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.716 1.206 . . . . 0.0 111.539 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -139.12 162.03 35.94 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.801 0.84 . . . . 0.0 109.922 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.53 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.0 tm? -79.21 125.37 29.37 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.97 148.64 35.1 Favored Pre-proline 0 C--O 1.243 0.713 0 C-N-CA 123.66 0.784 . . . . 0.0 109.975 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.05 115.11 2.75 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.131 1.887 . . . . 0.0 110.335 166.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.516 ' HB2' HG11 ' A' ' 70' ' ' VAL . 12.7 p90 -62.96 -25.2 68.25 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.65 0.78 . . . . 0.0 111.862 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -60.03 -22.91 63.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.388 1.075 . . . . 0.0 112.13 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -63.45 -45.45 90.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.884 0.874 . . . . 0.0 110.105 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -102.42 6.43 40.18 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.57 0.748 . . . . 0.0 111.604 -173.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 36.7 m -65.84 114.54 5.15 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.038 0.535 . . . . 0.0 112.362 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.7 -26.33 63.37 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.79 0.836 . . . . 0.0 110.201 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.527 ' HB ' ' HB ' ' A' ' 69' ' ' VAL . 8.8 t -69.95 -11.05 60.59 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.934 0.894 . . . . 0.0 112.261 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.258 1.53 0 C-N-CA 123.213 0.605 . . . . 0.0 110.091 174.563 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m -76.27 82.48 3.05 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.1 m -109.88 72.41 0.8 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.97 -174.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -89.78 134.35 34.22 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.161 172.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -67.34 -47.36 70.72 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.322 0.649 . . . . 0.0 109.814 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.5 m -76.42 112.98 13.51 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 168.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -109.31 29.58 7.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.218 0.607 . . . . 0.0 110.373 -175.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.4 mt -53.37 -45.67 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.845 0.858 . . . . 0.0 112.253 -172.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.47 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 70.4 m-85 -111.63 15.54 21.02 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 119.275 -0.393 . . . . 0.0 111.127 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -56.37 -41.51 76.32 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.539 0.736 . . . . 0.0 112.811 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -96.92 -3.6 41.52 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.099 0.559 . . . . 0.0 111.391 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.444 ' SG ' ' ND1' ' A' ' 50' ' ' HIS . 51.8 t -99.0 127.05 44.84 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 123.974 0.91 . . . . 0.0 110.676 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.466 HG12 HG23 ' A' ' 48' ' ' VAL . 32.4 t -106.41 134.42 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.469 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.9 mp -125.64 128.47 72.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 123.391 0.677 . . . . 0.0 111.359 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -114.69 120.32 39.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.97 1.308 . . . . 0.0 108.174 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.6 mt -93.29 109.55 21.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -98.33 123.73 42.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.672 1.189 . . . . 0.0 109.599 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.88 -159.77 52.31 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 123.416 0.447 . . . . 0.0 113.892 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.74 122.48 32.19 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.782 0.833 . . . . 0.0 110.54 -177.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.611 HG21 HG12 ' A' ' 52' ' ' VAL . 72.3 p -132.88 146.24 51.64 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.015 1.326 . . . . 0.0 108.944 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -112.49 130.51 23.32 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.02 171.75 65.21 Favored 'Cis proline' 0 C--N 1.382 2.291 0 C-N-CA 124.146 -1.189 . . . . 0.0 111.381 -0.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.28 147.71 5.91 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.833 0.708 . . . . 0.0 114.493 -173.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -52.78 -36.48 58.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.713 0.805 . . . . 0.0 112.41 -175.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 pp -59.23 -43.01 92.38 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.319 0.648 . . . . 0.0 111.615 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -67.39 -50.15 60.86 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.858 0.863 . . . . 0.0 110.327 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.406 ' O ' HG13 ' A' ' 31' ' ' ILE . 92.9 mt -55.81 -41.24 73.89 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.474 0.709 . . . . 0.0 111.732 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.619 ' HA ' HD12 ' A' ' 31' ' ' ILE . 13.0 m80 -62.46 -37.52 86.25 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.68 0.792 . . . . 0.0 110.877 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -68.36 -40.92 81.31 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.225 0.61 . . . . 0.0 110.569 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.591 ' HB3' HG21 ' A' ' 79' ' ' VAL . 64.5 mtt -59.69 -33.49 71.65 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.436 0.695 . . . . 0.0 111.142 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.619 HD12 ' HA ' ' A' ' 28' ' ' HIS . 74.4 mt -70.3 -54.1 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.321 0.648 . . . . 0.0 110.982 177.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 28' ' ' HIS . 93.8 t -65.58 -45.52 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.428 0.691 . . . . 0.0 112.185 -170.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.82 -21.03 66.71 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.479 0.712 . . . . 0.0 112.241 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -104.27 26.91 8.28 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.564 0.746 . . . . 0.0 110.726 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.36 -1.35 87.63 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.882 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . -75.51 160.37 52.0 Favored Glycine 0 CA--C 1.5 -0.859 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -170.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.436 ' HB3' HG22 ' A' ' 13' ' ' VAL . 2.9 tppp? -112.98 145.82 40.15 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -127.75 149.77 50.09 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.459 0.703 . . . . 0.0 109.329 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.462 HD23 HG11 ' A' ' 13' ' ' VAL . 1.3 mm? -116.65 128.74 55.65 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -64.54 -42.19 95.88 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.603 1.161 . . . . 0.0 111.594 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -165.29 160.81 18.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.609 0.763 . . . . 0.0 109.515 171.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -124.34 119.76 30.18 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.615 0.766 . . . . 0.0 109.884 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 t -90.18 68.09 7.0 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.7 m 71.87 -22.8 0.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.835 1.654 . . . . 0.0 114.021 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -63.52 130.96 46.57 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.846 0.858 . . . . 0.0 110.876 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.644 ' H ' ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -92.71 62.63 3.82 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 122.619 1.199 . . . . 0.0 109.635 -178.459 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 m -87.12 -8.84 56.59 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.968 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.466 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -112.7 155.84 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.8 0.84 . . . . 0.0 110.001 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 74.1 p -111.79 -30.74 7.2 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.14 0.576 . . . . 0.0 111.231 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.444 ' ND1' ' SG ' ' A' ' 12' ' ' CYS . 80.7 m80 -128.42 134.02 48.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.872 0.869 . . . . 0.0 110.016 -175.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 36.6 mt -121.75 114.19 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 121.443 0.639 . . . . 0.0 109.798 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.611 HG12 HG21 ' A' ' 20' ' ' THR . 74.7 t -90.53 119.19 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.145 0.978 . . . . 0.0 110.413 -175.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.0 137.9 18.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.744 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.1 t -86.05 -35.23 20.43 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 171.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -127.6 99.42 5.58 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 124.213 1.005 . . . . 0.0 108.519 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -107.28 107.89 61.06 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.406 ' HG2' ' HD3' ' A' ' 60' ' ' LYS . 34.1 Cg_endo -61.41 152.63 71.56 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.155 2.57 . . . . 0.0 113.173 -173.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.33 -35.95 74.77 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.32 1.048 . . . . 0.0 112.566 -171.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -62.82 -45.26 93.46 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.567 0.699 . . . . 0.0 109.966 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HD3' ' HG2' ' A' ' 57' ' ' PRO . 1.1 mptm? -77.89 -18.34 56.27 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.001 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.417 ' NH1' ' HA ' ' A' ' 93' ' ' THR . 1.2 mmp_? -65.59 -35.23 80.21 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.18 0.592 . . . . 0.0 111.038 171.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.7 mt -69.17 -47.06 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 123.572 0.545 . . . . 0.0 109.806 172.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -58.02 -40.39 80.71 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.779 0.832 . . . . 0.0 111.655 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.41 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 18.3 m-85 -110.17 27.12 9.93 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.215 1.006 . . . . 0.0 110.741 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.42 -44.69 93.9 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.165 0.586 . . . . 0.0 111.301 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -77.62 -26.0 50.21 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.457 0.703 . . . . 0.0 110.722 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 64' ' ' PHE . 16.3 m-85 -75.52 135.69 40.62 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' A' ' 93' ' ' THR . 43.7 mmtm -80.71 86.1 5.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.355 0.598 . . . . 0.0 109.784 -177.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 93.3 t -73.76 125.25 32.59 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 91' ' ' SER . 24.0 m -131.08 173.59 14.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 C-N-CA 123.392 0.677 . . . . 0.0 110.161 -175.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.4 m -79.64 149.4 71.26 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.044 173.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.83 -28.45 87.15 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.395 2.064 . . . . 0.0 111.338 168.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.44 -23.89 64.78 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.321 1.449 . . . . 0.0 111.695 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -63.42 -48.6 77.11 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.957 0.503 . . . . 0.0 110.43 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.449 HD12 ' N ' ' A' ' 75' ' ' ILE . 2.4 mp -69.06 -45.14 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.325 -173.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -58.04 -49.73 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.24 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.85 -36.73 70.24 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.812 0.695 . . . . 0.0 110.993 -172.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.1 m -65.79 -41.25 92.18 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.611 0.365 . . . . 0.0 110.81 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.591 HG21 ' HB3' ' A' ' 30' ' ' MET . 54.7 t -71.03 -33.03 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.748 0.819 . . . . 0.0 110.841 175.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -65.39 -42.9 92.14 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.441 1.096 . . . . 0.0 110.522 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -92.91 -6.15 49.24 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.048 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.07 36.59 24.27 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.431 1.092 . . . . 0.0 111.812 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -156.45 151.91 26.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.007 0.923 . . . . 0.0 109.768 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.83 121.62 19.3 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -105.95 160.82 24.8 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 124.054 0.942 . . . . 0.0 110.342 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -54.3 108.7 0.31 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.991 2.461 . . . . 0.0 112.756 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -62.03 -34.08 75.57 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.736 174.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -58.15 -26.88 63.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.833 1.253 . . . . 0.0 112.087 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -74.54 -37.76 62.94 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.446 0.699 . . . . 0.0 110.362 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.49 -0.7 29.52 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.398 0.679 . . . . 0.0 112.33 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 27.0 p -75.42 110.7 10.0 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.055 0.455 . . . . 0.0 111.039 -177.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.6 mt -73.26 -17.38 61.34 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.332 1.053 . . . . 0.0 111.041 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.613 HG21 ' HA ' ' A' ' 68' ' ' LYS . 13.7 t -74.67 -26.48 59.88 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.608 0.763 . . . . 0.0 111.837 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.343 -0.837 . . . . 0.0 109.694 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 48.5 mm . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -85.0 81.68 8.79 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.796 0.839 . . . . 0.0 109.571 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.3 p -121.48 106.92 11.86 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.086 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -88.56 137.1 32.62 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.579 0.751 . . . . 0.0 109.489 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.4 t -144.02 156.51 44.41 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.258 0.623 . . . . 0.0 110.156 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.4 m -65.96 149.25 50.52 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 123.537 0.523 . . . . 0.0 110.538 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -107.76 21.94 16.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.883 0.873 . . . . 0.0 110.267 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.417 HG23 ' HA ' ' A' ' 84' ' ' LEU . 64.6 mt -67.71 -50.3 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.209 0.604 . . . . 0.0 110.223 -177.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.85 16.2 17.32 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.01 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -62.44 -36.56 82.78 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 120.913 0.387 . . . . 0.0 111.569 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -98.77 8.36 45.04 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.688 0.795 . . . . 0.0 111.161 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 71.9 m -117.24 114.1 23.15 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.605 0.762 . . . . 0.0 111.134 -174.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.35 126.77 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.41 HG23 HG23 ' A' ' 52' ' ' VAL . 3.3 mp -114.89 131.47 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.142 0.577 . . . . 0.0 111.425 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 16.7 t80 -114.34 114.27 25.68 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.639 1.175 . . . . 0.0 108.635 169.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.7 mt -88.48 137.83 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -142.74 143.05 32.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.887 0.875 . . . . 0.0 109.646 -166.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.96 -137.84 32.37 Favored Glycine 0 C--N 1.346 1.117 0 O-C-N 123.519 0.512 . . . . 0.0 111.975 -174.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.1 145.38 37.24 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 171.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.514 HG21 HG12 ' A' ' 52' ' ' VAL . 37.1 p -142.21 140.67 32.39 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.741 1.216 . . . . 0.0 108.619 178.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -109.76 126.34 29.31 Favored Pre-proline 0 N--CA 1.485 1.277 0 CA-C-N 118.288 0.495 . . . . 0.0 110.264 171.582 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HD2' HD21 ' A' ' 27' ' ' LEU . 43.9 Cg_endo -76.15 174.3 53.63 Favored 'Cis proline' 0 C--N 1.374 1.905 0 C-N-CA 124.362 -1.099 . . . . 0.0 112.076 2.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.04 144.23 4.96 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.938 0.774 . . . . 0.0 114.094 -174.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 10.0 ptp180 -55.4 -36.3 66.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.191 0.596 . . . . 0.0 112.151 -172.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.93 -32.13 72.37 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.992 0.517 . . . . 0.0 111.857 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 30' ' ' MET . 8.5 tt0 -68.45 -51.84 39.16 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.454 HD21 ' HD2' ' A' ' 22' ' ' PRO . 91.9 mt -55.29 -39.58 70.05 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.606 0.763 . . . . 0.0 111.006 176.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -59.67 -47.61 84.93 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.628 1.171 . . . . 0.0 109.514 -178.105 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -65.96 -39.65 90.59 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.029 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.557 ' HB3' HG21 ' A' ' 79' ' ' VAL . 26.4 mmt -60.79 -33.27 72.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.876 0.47 . . . . 0.0 110.986 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -72.29 -51.92 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.398 0.679 . . . . 0.0 111.004 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.0 -47.42 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.573 0.749 . . . . 0.0 111.817 -174.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.82 -16.61 58.98 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.031 0.932 . . . . 0.0 111.713 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -109.76 28.33 8.68 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.903 0.881 . . . . 0.0 111.235 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.24 5.9 88.46 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.4 -0.818 . . . . 0.0 114.227 170.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.69 160.57 32.81 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 115.105 0.802 . . . . 0.0 115.105 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -105.38 162.0 13.83 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.557 -0.821 . . . . 0.0 109.44 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -136.09 164.88 27.0 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.502 174.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.8 ' HB3' HD11 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -136.77 130.38 31.86 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -66.34 -46.69 75.95 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 124.131 0.894 . . . . 0.0 113.263 -164.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.46 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 74.7 t80 -164.49 132.74 3.43 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.641 0.776 . . . . 0.0 109.471 -175.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 39' ' ' LEU . 4.5 mp -137.2 112.26 9.04 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.956 0.502 . . . . 0.0 110.856 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.3 t -90.77 84.5 5.85 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.4 m 66.79 9.54 6.83 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.717 1.207 . . . . 0.0 112.742 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 57.9 tptt -73.62 137.39 44.19 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.356 1.063 . . . . 0.0 110.247 -176.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -98.63 72.08 2.0 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.839 0.456 . . . . 0.0 109.771 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.0 m -126.96 -10.43 6.0 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.039 0.536 . . . . 0.0 110.615 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.415 HG12 HD22 ' A' ' 42' ' ' LEU . 8.8 p -113.54 143.28 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.066 0.546 . . . . 0.0 110.734 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 t -108.41 -13.82 14.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.923 0.489 . . . . 0.0 111.55 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -138.94 128.23 24.17 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.383 0.673 . . . . 0.0 109.953 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.645 ' HB ' HG22 ' A' ' 69' ' ' VAL . 66.4 mt -114.18 136.43 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG12 HG21 ' A' ' 20' ' ' THR . 86.8 t -113.19 119.33 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.86 173.3 11.85 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.595 0.758 . . . . 0.0 109.613 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -89.77 -44.17 10.17 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 174.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -130.34 145.84 51.84 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.041 -1.436 . . . . 0.0 108.473 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.525 ' HG ' HG11 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -136.13 117.34 11.57 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.181 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' O ' ' HG3' ' A' ' 61' ' ' ARG . 95.2 Cg_endo -77.31 155.38 32.64 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.861 2.374 . . . . 0.0 113.201 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.0 mt -51.32 -49.72 60.79 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.062 1.345 . . . . 0.0 114.266 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.56 -31.38 69.54 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.467 -177.367 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -72.11 -27.77 62.85 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 118.183 0.447 . . . . 0.0 111.131 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 85.3 mtt180 -60.1 -38.58 83.39 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 172.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.7 mt -64.88 -43.59 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.61 0.764 . . . . 0.0 110.782 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 6.2 mm-40 -72.99 -21.76 60.79 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.374 0.67 . . . . 0.0 111.396 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -113.19 27.11 9.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.275 1.03 . . . . 0.0 110.119 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.36 -28.17 69.58 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.186 0.595 . . . . 0.0 112.303 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -88.67 -29.38 19.94 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.936 0.495 . . . . 0.0 111.017 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -88.87 117.36 27.82 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -71.11 87.17 0.76 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.963 0.505 . . . . 0.0 109.677 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.645 HG22 ' HB ' ' A' ' 51' ' ' ILE . 22.9 t -81.09 128.41 38.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.34 172.31 16.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 124.874 1.27 . . . . 0.0 110.034 -175.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 60.9 p -85.28 159.47 56.33 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.81 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.32 -24.32 67.37 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.714 2.276 . . . . 0.0 112.718 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.82 -26.52 68.17 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.498 1.119 . . . . 0.0 112.084 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 37.1 t90 -61.63 -40.56 95.29 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.173 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 75' ' ' ILE . 2.8 mp -76.69 -49.65 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.025 0.93 . . . . 0.0 108.961 -177.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.98 -51.36 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.079 0.952 . . . . 0.0 111.343 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.43 -39.4 71.06 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.622 -173.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.5 p -64.49 -44.97 89.31 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 120.949 0.404 . . . . 0.0 111.309 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 30' ' ' MET . 41.7 t -65.5 -33.74 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.356 1.062 . . . . 0.0 111.298 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -72.83 -38.66 67.06 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 120.8 0.334 . . . . 0.0 110.889 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -89.0 -7.66 55.56 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.816 0.846 . . . . 0.0 112.048 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.89 27.85 16.97 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.669 1.188 . . . . 0.0 112.474 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -138.23 165.36 26.89 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.804 0.841 . . . . 0.0 110.365 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.417 ' HA ' HG23 ' A' ' 8' ' ' ILE . 51.2 tp -82.53 142.91 31.45 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 169.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.5 mt -110.61 155.06 42.8 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 123.777 0.831 . . . . 0.0 110.407 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.05 111.55 1.79 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.145 1.897 . . . . 0.0 110.309 166.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -59.64 -27.54 66.45 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.627 0.771 . . . . 0.0 111.961 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -58.37 -28.35 65.05 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.219 1.008 . . . . 0.0 111.974 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -71.9 -35.79 69.82 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.26 0.624 . . . . 0.0 110.674 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -105.91 7.48 32.17 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.649 0.78 . . . . 0.0 111.561 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.2 t -65.28 116.5 6.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.961 0.904 . . . . 0.0 112.456 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.5 -24.77 56.88 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.431 0.692 . . . . 0.0 111.443 175.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.545 HG23 ' HB ' ' A' ' 69' ' ' VAL . 22.7 p -69.56 -21.67 63.6 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.174 0.59 . . . . 0.0 112.315 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 C--O 1.249 1.069 0 CA-C-O 119.045 -0.502 . . . . 0.0 109.655 177.277 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 11.8 tt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.8 t -148.6 117.57 6.74 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.4 t -155.01 163.24 40.58 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.316 0.646 . . . . 0.0 110.397 -176.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -78.91 76.69 5.4 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 166.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 p -103.85 101.24 11.04 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.848 -166.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.4 m -69.22 122.27 18.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.737 0.815 . . . . 0.0 109.484 173.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.446 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -73.92 30.12 0.08 Allowed 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -166.476 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.24 -46.84 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 124.029 0.932 . . . . 0.0 111.694 176.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -107.13 10.22 30.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.196 0.599 . . . . 0.0 111.55 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -57.46 -43.84 84.32 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.378 0.671 . . . . 0.0 111.301 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -78.69 -18.8 53.78 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.262 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.85 127.19 44.71 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.728 0.811 . . . . 0.0 112.306 -172.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 49' ' ' THR . 40.8 t -96.81 130.66 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 162.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.4 mp -121.56 122.86 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 36.8 t80 -105.1 125.52 51.07 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 167.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.434 HG12 ' HB ' ' A' ' 52' ' ' VAL . 47.4 mt -98.85 139.8 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -136.07 141.52 44.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.334 1.053 . . . . 0.0 109.893 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.47 -149.13 49.45 Favored Glycine 0 C--N 1.348 1.206 0 O-C-N 123.804 0.69 . . . . 0.0 113.439 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -95.54 116.3 28.63 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.64 0.776 . . . . 0.0 109.893 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.436 HG21 HG12 ' A' ' 52' ' ' VAL . 72.9 p -129.15 134.85 48.22 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.17 0.988 . . . . 0.0 108.673 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -111.16 131.37 22.23 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-N 117.993 0.36 . . . . 0.0 110.727 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.84 173.87 53.98 Favored 'Cis proline' 0 C--N 1.38 2.188 0 C-N-CA 124.416 -1.077 . . . . 0.0 111.992 0.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.81 146.86 9.03 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.053 0.846 . . . . 0.0 114.248 -173.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -52.39 -34.82 49.7 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.667 1.187 . . . . 0.0 112.763 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.455 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.4 pp -63.26 -43.63 97.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.452 0.301 . . . . 0.0 110.959 177.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -72.18 -41.71 66.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.083 0.553 . . . . 0.0 110.486 -176.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.6 mt -56.02 -43.96 78.24 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.344 0.658 . . . . 0.0 111.18 170.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.541 ' HA ' HD12 ' A' ' 31' ' ' ILE . 10.8 m170 -65.41 -34.94 79.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.097 0.559 . . . . 0.0 111.042 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 22.7 mm-40 -65.39 -41.17 93.99 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.584 0.354 . . . . 0.0 110.268 174.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.656 ' HB3' HG21 ' A' ' 79' ' ' VAL . 68.5 mtt -58.52 -35.72 72.73 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.364 0.665 . . . . 0.0 111.243 176.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 28' ' ' HIS . 64.6 mt -72.76 -51.8 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.757 0.823 . . . . 0.0 111.609 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.5 t -70.38 -41.83 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.286 0.634 . . . . 0.0 111.648 -172.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -65.92 -12.72 56.81 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.652 0.781 . . . . 0.0 111.983 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -107.84 24.99 12.09 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.349 1.06 . . . . 0.0 111.227 174.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.71 15.5 68.86 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.878 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.03 161.15 25.4 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 122.918 0.294 . . . . 0.0 113.335 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -106.53 148.63 27.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.673 0.789 . . . . 0.0 109.854 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -131.5 151.12 51.84 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.069 0.547 . . . . 0.0 110.746 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.6 tp -115.27 137.44 52.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.639 1.176 . . . . 0.0 108.975 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.57 -35.75 33.89 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.155 0.982 . . . . 0.0 112.997 -173.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -171.17 163.68 7.23 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.568 1.147 . . . . 0.0 108.4 -169.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 42' ' ' LEU . 4.1 mm? -100.6 76.14 1.8 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.775 0.798 . . . . 0.0 110.472 176.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.8 t -107.26 -13.22 15.19 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.873 165.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.7 m -90.06 -170.82 2.91 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.57 1.148 . . . . 0.0 110.715 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -83.16 -153.82 0.13 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.721 0.808 . . . . 0.0 108.845 173.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -77.33 73.3 3.91 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.925 0.869 . . . . 0.0 109.644 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.7 m -84.84 -37.57 20.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.572 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.07 150.54 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.654 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 13' ' ' VAL . 10.0 t -115.17 -22.7 9.33 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.524 0.729 . . . . 0.0 111.081 175.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.416 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 27.8 m170 -133.77 126.19 30.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.491 0.717 . . . . 0.0 109.824 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.648 ' HB ' HG22 ' A' ' 69' ' ' VAL . 68.5 mt -109.39 139.84 30.66 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.436 HG12 HG21 ' A' ' 20' ' ' THR . 61.2 t -110.74 122.0 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.156 0.582 . . . . 0.0 109.704 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.69 170.65 18.2 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.454 0.701 . . . . 0.0 109.568 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.2 t -108.87 -48.24 3.32 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 168.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -106.83 91.41 3.66 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.06 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.482 ' HG ' HG11 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -112.18 106.99 55.99 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.34 147.78 44.76 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.77 2.98 . . . . 0.0 113.84 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.41 -38.34 71.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.758 0.823 . . . . 0.0 110.667 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.402 ' HB3' ' NZ ' ' A' ' 59' ' ' LYS . 3.2 mmmp? -51.56 -55.23 20.31 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.241 1.016 . . . . 0.0 110.899 172.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 63' ' ' GLU . 43.0 mtmt -80.79 -10.18 59.75 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.98 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -72.4 -30.97 65.14 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.474 0.579 . . . . 0.0 109.885 170.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.8 mt -80.54 -40.84 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 123.448 0.467 . . . . 0.0 109.922 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 42.3 mt-10 -67.34 -37.24 82.96 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.333 0.653 . . . . 0.0 111.147 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -104.68 26.59 8.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.865 0.866 . . . . 0.0 110.44 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.24 -23.79 64.84 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.828 0.451 . . . . 0.0 111.249 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.438 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.8 OUTLIER -70.52 -28.33 64.86 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.253 0.621 . . . . 0.0 110.031 175.556 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -95.45 174.77 6.85 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 170.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 34.6 mmtm -126.55 97.02 4.86 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.648 HG22 ' HB ' ' A' ' 51' ' ' ILE . 17.6 t -76.32 129.78 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.634 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.95 176.95 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.059 1.344 . . . . 0.0 109.298 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.9 m -85.95 156.51 57.92 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.464 0.706 . . . . 0.0 110.255 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' O ' HG23 ' A' ' 76' ' ' VAL . 19.8 Cg_endo -56.6 -27.57 70.35 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 123.116 2.544 . . . . 0.0 112.401 174.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -61.51 -24.11 66.38 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.884 1.274 . . . . 0.0 111.959 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -62.21 -48.09 81.53 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 172.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.6 mp -69.66 -47.08 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.0 -174.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 72' ' ' PRO . 95.9 t -59.83 -54.75 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.068 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 16.7 t70 -72.38 -36.41 68.71 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.741 -171.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.2 m -60.9 -40.32 92.68 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 120.694 0.283 . . . . 0.0 111.087 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.656 HG21 ' HB3' ' A' ' 30' ' ' MET . 45.2 t -70.0 -40.27 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.293 0.637 . . . . 0.0 111.476 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -63.57 -46.14 87.27 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.837 0.455 . . . . 0.0 110.794 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 17.5 mm-40 -80.16 -15.44 57.07 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.484 0.714 . . . . 0.0 111.066 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.86 28.8 14.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.015 1.326 . . . . 0.0 112.114 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -141.99 158.57 43.61 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.962 0.905 . . . . 0.0 109.755 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.4 tp -79.14 121.63 25.25 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.9 mt -101.68 158.57 31.53 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 124.104 0.962 . . . . 0.0 110.055 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.88 108.76 0.96 Allowed 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.153 1.902 . . . . 0.0 111.64 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -57.87 -33.15 68.39 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.726 0.81 . . . . 0.0 110.948 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -59.65 -31.16 69.28 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.533 1.133 . . . . 0.0 111.729 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -70.73 -39.44 73.35 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.548 0.739 . . . . 0.0 110.844 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -93.56 0.27 56.56 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.427 0.691 . . . . 0.0 111.661 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.6 t -72.2 124.91 26.02 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.612 0.365 . . . . 0.0 111.702 -171.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.5 mt -73.07 -43.89 61.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.99 168.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p -75.63 84.12 2.65 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.292 0.568 . . . . 0.0 109.805 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.248 1.026 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -178.642 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 38.7 pt . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.9 m -145.42 -48.79 0.23 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.419 0.687 . . . . 0.0 110.152 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.2 t -135.1 132.62 38.35 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.171 0.589 . . . . 0.0 110.505 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.504 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 51.1 mt-30 -113.77 30.15 7.47 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.477 1.111 . . . . 0.0 109.925 177.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.5 p -77.25 -58.09 3.47 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -90.11 82.16 6.11 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.811 0.844 . . . . 0.0 108.868 174.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.504 ' HD3' ' HB3' ' A' ' 4' ' ' GLN . 20.3 pttp -131.1 30.09 4.6 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.338 0.655 . . . . 0.0 110.662 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.4 -49.5 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.062 0.545 . . . . 0.0 111.623 -172.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.576 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 57.2 m-85 -108.4 17.48 22.07 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.778 -176.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -62.34 -43.88 97.79 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.508 0.723 . . . . 0.0 111.112 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -84.82 6.17 25.68 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.499 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.9 m -120.94 131.66 54.48 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.958 0.903 . . . . 0.0 111.261 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.457 HG22 ' HD3' ' A' ' 37' ' ' LYS . 15.1 t -103.18 127.27 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 166.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.499 ' H ' ' HA ' ' A' ' 38' ' ' PHE . 4.1 mp -118.1 120.17 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.14 0.576 . . . . 0.0 112.196 -176.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 13.0 t80 -106.54 126.26 52.04 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 166.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -97.95 110.85 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -104.25 128.13 51.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.943 0.897 . . . . 0.0 109.598 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.17 -171.45 50.32 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.383 0.427 . . . . 0.0 113.224 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.07 135.91 33.11 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.638 0.775 . . . . 0.0 110.09 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.505 HG21 HG12 ' A' ' 52' ' ' VAL . 41.5 p -138.06 148.4 45.02 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.417 1.087 . . . . 0.0 109.214 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 21' ' ' LYS . 11.9 mmpt? -105.54 120.63 48.78 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 165.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HD2' HD21 ' A' ' 27' ' ' LEU . 31.3 Cg_endo -84.2 174.62 37.64 Favored 'Cis proline' 0 CA--C 1.553 1.474 0 C-N-CA 123.896 -1.293 . . . . 0.0 111.295 -1.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.98 155.38 8.84 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -171.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -48.35 -37.1 15.81 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.022 1.329 . . . . 0.0 112.743 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.4 pp -63.05 -44.68 95.17 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.943 0.897 . . . . 0.0 111.439 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.5 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.5 tp-100 -71.83 -45.85 60.07 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.648 0.779 . . . . 0.0 110.542 -176.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.459 HD21 ' HD2' ' A' ' 22' ' ' PRO . 93.1 mt -57.86 -46.43 84.83 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.058 176.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.436 ' HA ' HD12 ' A' ' 31' ' ' ILE . 15.5 m170 -60.6 -36.46 78.62 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.019 0.528 . . . . 0.0 111.573 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -63.97 -46.41 84.77 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.74 0.416 . . . . 0.0 110.347 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.63 ' HB3' HG21 ' A' ' 79' ' ' VAL . 26.2 mmt -60.15 -34.0 72.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.71 0.804 . . . . 0.0 111.926 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 28' ' ' HIS . 78.6 mt -68.63 -51.26 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.526 0.73 . . . . 0.0 111.551 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.7 t -73.05 -40.4 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.034 0.534 . . . . 0.0 111.775 -172.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.04 -15.95 64.05 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.387 0.675 . . . . 0.0 111.754 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -109.57 26.59 10.47 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.768 0.827 . . . . 0.0 110.398 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.51 39.24 79.65 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-N 114.582 -1.19 . . . . 0.0 114.013 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.576 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -115.74 161.41 12.89 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 -173.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.457 ' HD3' HG22 ' A' ' 13' ' ' VAL . 88.3 tttt -105.86 150.13 25.9 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 122.925 0.49 . . . . 0.0 110.22 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.499 ' HA ' ' H ' ' A' ' 14' ' ' ILE . 27.0 p90 -141.85 164.73 29.39 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.374 0.67 . . . . 0.0 110.637 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.553 HD12 ' HB ' ' A' ' 48' ' ' VAL . 55.8 mt -124.8 146.88 49.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.723 0.809 . . . . 0.0 109.647 168.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -35.3 64.72 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.661 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -175.59 175.32 2.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.517 1.527 . . . . 0.0 109.02 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -105.74 117.51 34.2 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.9 t -71.91 -42.39 66.77 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.778 0.831 . . . . 0.0 110.527 178.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.3 t -171.98 -49.7 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.681 0.792 . . . . 0.0 110.513 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -77.94 144.4 36.86 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.727 0.811 . . . . 0.0 111.919 -169.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -73.09 97.65 2.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.156 0.982 . . . . 0.0 109.147 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.2 p -125.06 -37.96 2.38 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.3 0.64 . . . . 0.0 112.477 -171.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.553 ' HB ' HD12 ' A' ' 39' ' ' LEU . 6.6 p -82.52 152.76 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 122.262 -0.274 . . . . 0.0 110.345 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 t -114.55 -24.0 9.01 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.804 0.441 . . . . 0.0 111.508 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -129.0 130.28 46.45 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.763 0.425 . . . . 0.0 110.399 -177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 23.1 mt -116.93 134.97 58.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.505 HG12 HG21 ' A' ' 20' ' ' THR . 91.0 t -108.67 120.99 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.176 0.59 . . . . 0.0 110.954 -176.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.81 150.88 48.59 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.485 1.114 . . . . 0.0 108.625 172.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 20' ' ' THR . 41.1 t -76.71 -33.12 58.21 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 172.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -161.17 111.41 1.69 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.341 1.056 . . . . 0.0 108.348 170.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.652 HD22 HG11 ' A' ' 69' ' ' VAL . 16.4 tp -85.37 135.11 39.2 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 118.65 -0.69 . . . . 0.0 109.596 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.62 153.65 47.7 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.147 2.565 . . . . 0.0 112.56 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.59 -45.61 93.33 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.23 0.612 . . . . 0.0 112.125 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.0 mmmm -65.99 -36.81 84.32 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.642 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -66.96 -28.27 68.14 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.486 0.314 . . . . 0.0 111.649 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.17 -31.94 72.7 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.453 0.301 . . . . 0.0 110.319 173.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.9 mt -74.43 -37.76 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.07 0.548 . . . . 0.0 110.56 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 27.4 mm-40 -66.34 -42.01 88.73 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.424 0.631 . . . . 0.0 110.637 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -104.65 27.58 7.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.256 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.68 -22.83 64.35 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.495 0.718 . . . . 0.0 112.222 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.29 -6.94 59.46 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.849 0.46 . . . . 0.0 111.312 174.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -110.68 141.75 43.51 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.585 0.754 . . . . 0.0 109.411 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -79.33 86.03 5.1 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.652 HG11 HD22 ' A' ' 56' ' ' LEU . 55.7 t -75.47 130.04 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.474 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.601 HG11 ' HB2' ' A' ' 87' ' ' TRP . 35.2 m -134.65 177.18 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.003 1.321 . . . . 0.0 109.831 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -89.32 160.48 42.41 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.136 0.975 . . . . 0.0 110.541 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.459 ' HB3' HD11 ' A' ' 27' ' ' LEU . 23.3 Cg_endo -59.56 -23.38 70.79 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.802 2.335 . . . . 0.0 111.995 172.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.65 -27.31 66.25 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 124.708 1.203 . . . . 0.0 111.863 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -61.43 -43.68 98.45 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.108 0.413 . . . . 0.0 110.45 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.9 mp -72.05 -46.16 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -176.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.93 -47.8 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.371 1.068 . . . . 0.0 111.625 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.26 -42.27 75.8 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.761 0.824 . . . . 0.0 111.574 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.6 m -65.85 -36.85 84.59 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 120.72 0.295 . . . . 0.0 111.191 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 30' ' ' MET . 24.9 t -70.41 -33.86 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.771 0.828 . . . . 0.0 110.655 173.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -67.24 -34.51 77.61 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.549 0.74 . . . . 0.0 110.977 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -96.38 -13.6 23.1 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.189 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.64 39.06 24.99 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.284 1.033 . . . . 0.0 111.245 -175.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -156.18 156.53 34.35 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.884 0.874 . . . . 0.0 109.886 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.6 tp -75.51 107.77 7.87 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.245 0.618 . . . . 0.0 110.432 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.7 mt -88.72 156.09 50.22 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.556 0.742 . . . . 0.0 111.081 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.34 108.66 1.22 Allowed 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.524 2.149 . . . . 0.0 111.809 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.601 ' HB2' HG11 ' A' ' 70' ' ' VAL . 24.0 p90 -62.8 -20.91 65.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.112 0.965 . . . . 0.0 112.538 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -57.14 -35.45 69.52 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.176 0.99 . . . . 0.0 111.545 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.39 -27.23 68.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.798 0.839 . . . . 0.0 110.986 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.1 -6.15 18.87 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.696 0.798 . . . . 0.0 111.067 -175.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 75.5 m -64.19 130.17 42.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -172.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.3 mt -106.94 22.05 16.59 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.475 1.11 . . . . 0.0 110.498 173.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.7 p -64.22 -50.78 66.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.615 0.766 . . . . 0.0 110.717 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 C--O 1.251 1.163 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.659 176.49 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 119.895 -0.097 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.4 p -71.46 85.2 0.83 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.536 0.734 . . . . 0.0 110.984 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.597 ' HB2' ' HB2' ' A' ' 6' ' ' SER . 22.8 p -173.9 122.61 0.33 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.48 1.112 . . . . 0.0 109.03 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -106.41 -49.76 3.28 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.071 0.548 . . . . 0.0 110.12 177.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -84.35 -26.3 28.55 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.421 0.689 . . . . 0.0 111.114 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.597 ' HB2' ' HB2' ' A' ' 3' ' ' SER . 20.3 m -84.11 27.82 0.65 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.772 0.829 . . . . 0.0 112.795 -171.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -125.26 32.01 5.46 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.183 0.993 . . . . 0.0 110.337 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.403 HG23 ' HA ' ' A' ' 84' ' ' LEU . 55.9 mt -57.52 -45.72 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 123.568 0.747 . . . . 0.0 111.462 -176.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.758 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 50.8 m-85 -112.03 18.98 18.28 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.988 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -60.22 -40.21 89.36 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 118.312 0.505 . . . . 0.0 111.933 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -87.16 -7.64 57.76 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.687 0.795 . . . . 0.0 111.031 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 74.1 m -112.45 108.51 17.68 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 122.189 0.995 . . . . 0.0 111.818 -171.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.469 HG12 HG23 ' A' ' 48' ' ' VAL . 38.7 t -89.14 125.76 42.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 164.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.45 ' HB ' HD13 ' A' ' 31' ' ' ILE . 2.7 mp -110.54 128.63 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.774 0.83 . . . . 0.0 110.624 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -111.6 116.53 30.96 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 166.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.0 mt -84.62 137.13 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.421 0.688 . . . . 0.0 109.388 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -146.55 134.91 21.87 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.311 1.044 . . . . 0.0 109.696 -168.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.02 -160.2 54.02 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.638 0.586 . . . . 0.0 112.915 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.22 131.36 41.88 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -148.64 136.91 21.11 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.775 1.23 . . . . 0.0 108.843 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -116.65 134.07 22.95 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 122.974 0.51 . . . . 0.0 110.72 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.75 174.98 44.24 Favored 'Cis proline' 0 C--N 1.371 1.739 0 C-N-CA 124.408 -1.08 . . . . 0.0 110.996 -7.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.16 157.88 9.34 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -171.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -53.53 -35.44 60.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.546 1.138 . . . . 0.0 113.004 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 pp -60.62 -44.65 96.08 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.327 0.392 . . . . 0.0 110.559 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 30' ' ' MET . 6.9 tp-100 -70.48 -51.89 25.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.811 0.845 . . . . 0.0 110.045 -176.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -54.79 -41.33 70.43 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.525 0.73 . . . . 0.0 111.505 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' HG23 ' A' ' 32' ' ' VAL . 23.3 m170 -55.13 -48.2 74.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.314 0.645 . . . . 0.0 110.47 176.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.05 -38.95 92.5 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.731 0.645 . . . . 0.0 111.25 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.605 ' HB3' HG21 ' A' ' 79' ' ' VAL . 55.8 mmm -58.22 -36.54 73.3 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.505 0.722 . . . . 0.0 110.407 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.45 HD13 ' HB ' ' A' ' 14' ' ' ILE . 46.1 mt -72.23 -50.46 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.897 0.879 . . . . 0.0 111.654 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 28' ' ' HIS . 57.9 t -67.44 -42.26 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.233 -172.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.06 -12.6 61.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.967 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.457 ' NE2' HG13 ' A' ' 79' ' ' VAL . 34.1 m-70 -110.09 26.38 10.73 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.391 0.676 . . . . 0.0 111.163 173.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.83 37.93 75.67 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 114.867 -1.061 . . . . 0.0 113.615 171.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.758 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -118.61 -179.68 16.94 Favored Glycine 0 CA--C 1.503 -0.691 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 -175.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -123.74 144.52 49.63 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 121.201 0.524 . . . . 0.0 110.459 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -122.03 159.81 26.25 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.292 1.037 . . . . 0.0 108.484 173.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.421 HD22 ' HB ' ' A' ' 48' ' ' VAL . 32.7 tp -120.08 138.43 53.55 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -46.76 74.73 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 124.049 0.843 . . . . 0.0 111.98 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -179.74 146.28 0.25 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.788 0.835 . . . . 0.0 109.525 -170.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.56 130.74 35.01 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.152 0.581 . . . . 0.0 109.943 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.7 t -81.24 -62.89 1.53 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.4 m -155.9 -58.2 0.1 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.58 0.752 . . . . 0.0 110.156 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -66.27 153.53 42.31 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.946 0.898 . . . . 0.0 111.175 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -59.55 96.37 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.661 0.784 . . . . 0.0 110.071 171.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.4 m -108.75 12.3 25.78 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.42 1.088 . . . . 0.0 109.936 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.469 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -149.14 152.02 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.268 0.627 . . . . 0.0 109.655 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 t -107.33 -27.99 10.15 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.086 0.555 . . . . 0.0 111.595 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -124.62 135.8 53.4 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.308 0.643 . . . . 0.0 109.952 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.662 ' HB ' HG12 ' A' ' 69' ' ' VAL . 67.9 mt -121.85 116.09 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.7 t -91.5 120.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 123.951 0.901 . . . . 0.0 110.245 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.08 167.73 20.96 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.318 1.047 . . . . 0.0 108.786 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.1 t -115.45 -49.39 2.75 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -119.62 124.05 45.36 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.427 HD23 ' HG2' ' A' ' 61' ' ' ARG . 14.8 tp -150.02 128.35 5.93 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.07 155.91 17.58 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.594 2.863 . . . . 0.0 113.812 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.525 HD23 ' NH2' ' A' ' 61' ' ' ARG . 85.7 mt -55.48 -60.82 2.89 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.916 0.886 . . . . 0.0 111.022 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -59.8 -29.64 68.36 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.329 1.052 . . . . 0.0 111.851 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.484 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -68.69 -46.25 69.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.008 178.17 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.525 ' NH2' HD23 ' A' ' 58' ' ' LEU . 53.4 mtm180 -69.18 -27.49 65.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.917 0.887 . . . . 0.0 112.234 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 98.0 mt -72.37 -35.71 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.194 0.598 . . . . 0.0 109.843 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.4 -36.96 68.78 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.458 0.647 . . . . 0.0 109.504 172.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -87.98 17.49 4.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.03 0.932 . . . . 0.0 111.141 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.69 -23.81 65.34 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.035 0.534 . . . . 0.0 109.687 166.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -73.61 -6.89 49.48 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.084 0.954 . . . . 0.0 111.03 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -122.91 157.99 31.35 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.352 1.061 . . . . 0.0 109.46 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.67 85.06 5.56 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.662 HG12 ' HB ' ' A' ' 51' ' ' ILE . 22.1 m -83.06 131.38 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.187 -177.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.501 HG11 ' HB2' ' A' ' 87' ' ' TRP . 24.6 m -134.67 171.17 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.612 0.765 . . . . 0.0 109.859 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.43 ' HB3' HD21 ' A' ' 92' ' ' LEU . 47.5 p -86.85 156.95 55.21 Favored Pre-proline 0 C--O 1.245 0.828 0 C-N-CA 123.85 0.86 . . . . 0.0 109.469 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.403 ' O ' HG23 ' A' ' 76' ' ' VAL . 29.6 Cg_endo -60.4 -21.58 68.15 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 122.55 2.167 . . . . 0.0 112.707 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.23 -29.71 67.72 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.652 1.181 . . . . 0.0 111.818 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -59.58 -47.26 86.28 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.564 0.54 . . . . 0.0 110.084 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.7 mp -70.8 -51.95 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.754 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 72' ' ' PRO . 75.7 t -53.95 -52.66 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.224 1.01 . . . . 0.0 111.447 -176.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.66 -43.59 65.78 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.855 0.722 . . . . 0.0 111.158 -173.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.3 p -60.33 -36.96 79.16 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.018 0.437 . . . . 0.0 111.302 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.605 HG21 ' HB3' ' A' ' 30' ' ' MET . 46.9 t -67.89 -41.34 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.087 0.955 . . . . 0.0 111.512 176.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -67.38 -37.39 83.07 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.084 0.554 . . . . 0.0 111.285 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.19 -14.7 40.42 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.25 1.02 . . . . 0.0 111.479 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.27 26.71 15.58 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.146 1.378 . . . . 0.0 112.408 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -137.47 164.38 28.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.126 0.57 . . . . 0.0 110.32 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.403 ' HA ' HG23 ' A' ' 8' ' ' ILE . 60.7 tp -78.31 131.48 37.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.363 0.665 . . . . 0.0 110.606 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -108.33 150.66 40.84 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.744 1.218 . . . . 0.0 109.458 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.49 113.87 3.84 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.363 2.042 . . . . 0.0 110.47 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.501 ' HB2' HG11 ' A' ' 70' ' ' VAL . 64.6 p-90 -61.76 -27.8 68.99 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.629 0.771 . . . . 0.0 111.922 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -62.46 -27.82 69.39 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.134 0.974 . . . . 0.0 112.097 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -71.59 -21.07 61.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.799 0.84 . . . . 0.0 111.071 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -114.7 1.11 14.09 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.335 1.054 . . . . 0.0 110.731 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 27.0 t -69.27 131.36 44.75 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.196 0.598 . . . . 0.0 111.783 -171.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' A' ' 71' ' ' SER . 38.6 mt -96.72 8.66 43.75 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.29 0.636 . . . . 0.0 112.111 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.414 HG22 ' OG ' ' A' ' 91' ' ' SER . 13.5 t -72.43 -14.56 61.72 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.526 0.603 . . . . 0.0 111.075 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.5 t . . . . . 0 C--O 1.251 1.167 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 169.854 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.3 p -92.94 51.85 1.75 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -72.47 -50.12 28.41 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.833 -170.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 56.94 29.18 15.86 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.265 1.031 . . . . 0.0 110.575 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.2 m -75.88 101.39 5.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.494 1.118 . . . . 0.0 111.846 -172.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.9 p -63.6 125.08 23.09 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 167.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -82.87 33.57 0.44 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.367 1.067 . . . . 0.0 113.445 -161.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 67.1 mt -55.0 -48.1 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.763 1.225 . . . . 0.0 111.867 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.583 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 73.1 m-85 -105.05 7.34 33.9 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.463 -175.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 47.3 tptt -57.1 -49.31 76.29 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.053 0.541 . . . . 0.0 110.721 -174.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -84.11 -4.95 59.13 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.937 -1.028 . . . . 0.0 111.927 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.1 m -106.37 128.21 53.86 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.28 0.632 . . . . 0.0 111.488 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.463 ' H ' HG22 ' A' ' 49' ' ' THR . 21.9 t -95.12 126.94 47.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 168.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.38 122.73 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-O 121.241 0.543 . . . . 0.0 111.491 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -104.63 143.36 33.18 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.132 1.373 . . . . 0.0 107.693 167.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.8 mt -114.36 113.46 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -102.73 123.57 46.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.29 1.036 . . . . 0.0 110.417 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.66 -169.3 50.58 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.826 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -85.54 110.32 19.13 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.554 0.742 . . . . 0.0 109.487 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.659 HG21 HG12 ' A' ' 52' ' ' VAL . 74.0 p -122.55 148.54 45.08 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.556 1.143 . . . . 0.0 108.963 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -99.9 131.66 24.12 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-N 118.155 0.434 . . . . 0.0 111.962 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HD2' HD21 ' A' ' 27' ' ' LEU . 80.9 Cg_endo -76.57 175.92 46.14 Favored 'Cis proline' 0 C--N 1.374 1.883 0 C-N-CA 124.65 -0.979 . . . . 0.0 110.933 -7.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.5 148.43 7.22 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 114.631 0.612 . . . . 0.0 114.631 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -52.26 -35.79 50.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.082 0.953 . . . . 0.0 112.927 -174.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 26' ' ' GLN . 4.1 pp -63.51 -41.24 98.53 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.502 0.321 . . . . 0.0 111.08 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.44 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.4 tp-100 -69.88 -48.43 58.75 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.675 0.79 . . . . 0.0 110.509 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.46 HD21 ' HD2' ' A' ' 22' ' ' PRO . 69.4 mt -56.48 -46.26 80.55 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.259 0.623 . . . . 0.0 111.242 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.461 ' O ' HG23 ' A' ' 32' ' ' VAL . 9.9 m80 -56.57 -43.82 80.37 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.455 0.702 . . . . 0.0 110.677 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.57 -36.74 83.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.81 0.444 . . . . 0.0 111.3 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.587 ' HB3' HG21 ' A' ' 79' ' ' VAL . 23.8 mmt -63.79 -35.2 79.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.188 0.595 . . . . 0.0 110.895 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.8 mt -70.61 -51.17 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.724 0.81 . . . . 0.0 111.244 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 28' ' ' HIS . 64.1 t -66.89 -40.33 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.111 0.564 . . . . 0.0 111.731 -173.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.09 -11.67 61.0 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.098 0.559 . . . . 0.0 111.845 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -100.33 20.49 14.67 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.208 1.003 . . . . 0.0 111.107 170.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' O ' ' HD2' ' A' ' 10' ' ' LYS . . . 72.11 9.44 71.79 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.815 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.86 159.66 46.0 Favored Glycine 0 C--O 1.24 0.518 0 N-CA-C 114.124 0.41 . . . . 0.0 114.124 -170.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -101.89 153.63 19.67 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -144.01 145.81 32.46 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.938 0.495 . . . . 0.0 110.967 -174.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HG ' HG22 ' A' ' 47' ' ' THR . 1.5 mm? -130.43 145.88 51.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.039 0.936 . . . . 0.0 109.961 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -109.45 -34.08 6.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.749 0.82 . . . . 0.0 109.069 170.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -117.64 138.47 51.95 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -169.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.489 ' HA ' HG21 ' A' ' 47' ' ' THR . 0.8 OUTLIER -106.32 168.34 9.22 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.346 0.593 . . . . 0.0 110.838 -170.222 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.8 t -135.49 174.35 10.71 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.866 1.266 . . . . 0.0 108.337 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -69.81 -24.63 63.51 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.277 0.56 . . . . 0.0 110.211 172.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -82.13 177.71 8.66 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.353 1.061 . . . . 0.0 111.332 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.29 88.27 0.45 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.622 HG22 ' HG ' ' A' ' 39' ' ' LEU . 3.0 m -84.61 -28.18 26.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.486 -176.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.448 HG23 HG12 ' A' ' 13' ' ' VAL . 11.5 p -150.09 162.95 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.956 0.903 . . . . 0.0 109.193 -172.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 13' ' ' VAL . 10.3 t -115.86 -18.19 10.82 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.504 0.593 . . . . 0.0 112.237 174.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -134.04 131.71 39.18 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.418 0.687 . . . . 0.0 110.662 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.634 ' HB ' HG12 ' A' ' 69' ' ' VAL . 54.0 mt -114.73 129.58 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.659 HG12 HG21 ' A' ' 20' ' ' THR . 62.7 t -92.03 129.01 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.89 0.876 . . . . 0.0 109.461 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.99 147.0 30.26 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.114 0.566 . . . . 0.0 110.492 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.0 t -90.07 -34.49 15.9 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -145.65 142.36 28.97 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.191 173.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.425 HD12 ' HG2' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -146.73 107.57 4.03 Favored Pre-proline 0 CA--C 1.561 1.37 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.394 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.31 159.32 53.78 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.216 2.61 . . . . 0.0 113.061 -175.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.428 ' O ' HG13 ' A' ' 62' ' ' ILE . 65.7 mt -50.99 -49.7 59.87 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.375 1.07 . . . . 0.0 112.432 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -59.56 -45.71 91.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.039 0.536 . . . . 0.0 111.209 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -69.29 -26.03 64.53 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.634 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HG2' HD12 ' A' ' 56' ' ' LEU . 58.2 mtm180 -73.88 -26.68 60.68 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.721 0.409 . . . . 0.0 111.015 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 58' ' ' LEU . 60.8 mt -76.44 -39.27 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.85 -42.01 97.68 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.864 0.866 . . . . 0.0 110.955 174.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -104.01 26.81 8.27 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.081 0.952 . . . . 0.0 110.411 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.12 -19.48 64.04 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 122.842 0.457 . . . . 0.0 111.274 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -75.49 -26.12 57.88 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.839 0.856 . . . . 0.0 110.647 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -111.7 145.42 39.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.999 0.92 . . . . 0.0 109.418 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -85.74 90.6 8.07 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -177.294 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.634 HG12 ' HB ' ' A' ' 51' ' ' ILE . 27.1 m -74.0 127.13 35.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.83 172.59 15.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.827 1.251 . . . . 0.0 109.112 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.7 m -79.44 151.5 74.86 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.99 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.43 ' O ' HG23 ' A' ' 76' ' ' VAL . 26.5 Cg_endo -60.11 -25.35 79.61 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.78 2.32 . . . . 0.0 111.643 170.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -59.12 -23.16 61.89 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.173 1.389 . . . . 0.0 112.149 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -61.3 -46.62 89.56 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.021 0.439 . . . . 0.0 109.921 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.583 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.7 mp -71.86 -47.24 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.113 -177.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 72' ' ' PRO . 61.0 t -54.92 -50.72 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.999 0.92 . . . . 0.0 111.01 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -70.58 -47.52 59.85 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.205 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.441 ' HA ' HD23 ' A' ' 85' ' ' LEU . 79.5 p -63.09 -44.31 96.08 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.281 0.363 . . . . 0.0 111.445 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.587 HG21 ' HB3' ' A' ' 30' ' ' MET . 55.5 t -59.3 -42.8 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.054 0.942 . . . . 0.0 110.738 174.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -68.97 -33.06 73.08 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.033 0.933 . . . . 0.0 111.897 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.38 -11.35 38.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.583 0.753 . . . . 0.0 111.625 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.78 22.43 12.43 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.572 1.149 . . . . 0.0 112.323 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -142.49 156.5 45.16 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.512 0.725 . . . . 0.0 109.552 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.09 117.97 18.35 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 78' ' ' SER . 4.0 mm? -92.6 144.83 29.33 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 167.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.626 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 38.2 Cg_endo -62.49 124.04 13.5 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.081 1.854 . . . . 0.0 111.587 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -64.15 -19.85 65.58 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.079 0.952 . . . . 0.0 112.469 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.626 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.8 pt20 -59.3 -25.84 64.46 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.928 0.891 . . . . 0.0 111.629 174.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -71.22 -27.07 63.22 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.779 0.832 . . . . 0.0 110.115 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -116.26 2.02 13.2 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.911 0.884 . . . . 0.0 111.975 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.4 p -66.57 110.87 3.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.473 0.709 . . . . 0.0 111.537 -173.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.416 ' HB2' HG23 ' A' ' 69' ' ' VAL . 78.3 mt -74.87 -16.34 60.68 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.834 173.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 p -47.81 -51.97 20.65 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.724 1.209 . . . . 0.0 111.601 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 CA--C 1.553 1.094 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.129 176.829 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.9 t -83.67 66.7 9.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.396 0.679 . . . . 0.0 109.661 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.7 p -72.41 100.28 2.65 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.028 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -113.92 93.8 4.54 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.879 0.871 . . . . 0.0 108.841 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 m -137.83 131.97 31.9 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.426 1.09 . . . . 0.0 109.581 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.504 ' HB2' ' HD2' ' A' ' 34' ' ' HIS . 17.7 m -62.22 126.04 25.98 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.098 0.559 . . . . 0.0 109.939 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.35 32.32 0.19 Allowed 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -170.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.567 HG23 ' HA ' ' A' ' 84' ' ' LEU . 43.1 mt -54.83 -48.13 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.609 1.164 . . . . 0.0 111.109 176.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -113.87 10.11 17.66 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.882 -173.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -50.56 -65.75 0.51 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.848 0.859 . . . . 0.0 112.813 -167.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -85.8 -8.56 58.04 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.075 0.464 . . . . 0.0 110.338 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.3 m -79.9 118.02 21.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.698 0.799 . . . . 0.0 110.036 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -90.09 124.78 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 170.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.0 126.32 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.023 0.529 . . . . 0.0 111.727 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -104.96 148.82 26.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.977 1.311 . . . . 0.0 108.421 172.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -120.47 137.78 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -135.24 128.01 31.1 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.512 1.125 . . . . 0.0 108.876 -167.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.46 -159.75 48.7 Favored Glycine 0 C--N 1.343 0.924 0 O-C-N 123.404 0.44 . . . . 0.0 112.073 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -103.21 111.37 23.73 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.283 0.633 . . . . 0.0 109.624 176.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.0 p -119.49 134.64 55.12 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.743 1.217 . . . . 0.0 108.657 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -102.62 133.34 20.53 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 117.896 0.316 . . . . 0.0 110.629 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.02 164.86 85.74 Favored 'Cis proline' 0 C--N 1.384 2.405 0 C-N-CA 124.469 -1.055 . . . . 0.0 112.272 1.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.71 157.99 3.89 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 124.169 0.918 . . . . 0.0 114.556 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -54.65 -37.17 65.37 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.931 0.892 . . . . 0.0 112.478 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 26' ' ' GLN . 3.3 pp -62.96 -43.99 97.29 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.162 0.585 . . . . 0.0 110.804 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.528 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.3 tp-100 -67.79 -49.8 60.39 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.878 0.871 . . . . 0.0 110.618 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.1 mt -55.15 -51.47 66.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.877 0.871 . . . . 0.0 111.649 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.46 ' HA ' HD12 ' A' ' 31' ' ' ILE . 23.0 m170 -61.35 -35.26 76.93 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.873 0.469 . . . . 0.0 111.649 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.476 ' O ' HD13 ' A' ' 33' ' ' LEU . 43.3 mt-10 -64.23 -46.48 83.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 0.0 110.191 173.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.768 ' HB3' HG21 ' A' ' 79' ' ' VAL . 67.3 mtt -56.68 -37.3 70.66 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.465 0.65 . . . . 0.0 110.499 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 28' ' ' HIS . 77.2 mt -66.17 -50.65 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.556 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 28' ' ' HIS . 59.3 t -71.06 -29.35 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.144 0.578 . . . . 0.0 111.173 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 29' ' ' GLU . 6.8 mp -64.34 -22.73 67.05 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.515 1.126 . . . . 0.0 110.744 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.504 ' HD2' ' HB2' ' A' ' 6' ' ' SER . 60.6 m80 -105.5 26.93 8.88 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.398 1.079 . . . . 0.0 110.678 173.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.35 18.14 76.62 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.471 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.2 164.41 29.62 Favored Glycine 0 C--O 1.241 0.556 0 N-CA-C 114.179 0.431 . . . . 0.0 114.179 -171.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -113.42 161.79 16.88 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.824 0.849 . . . . 0.0 109.635 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -145.78 154.29 41.86 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 122.715 0.406 . . . . 0.0 111.406 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -121.16 137.64 54.58 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -82.23 -49.92 9.57 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.619 0.768 . . . . 0.0 112.724 -173.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -166.97 134.48 2.5 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.6 1.56 . . . . 0.0 108.691 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.438 HD11 HG12 ' A' ' 48' ' ' VAL . 3.4 mm? -82.51 100.76 10.28 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.465 0.706 . . . . 0.0 110.272 -175.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.2 p -92.64 65.49 4.33 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.322 0.649 . . . . 0.0 109.809 175.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.8 t 64.4 12.94 7.71 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.845 1.258 . . . . 0.0 112.527 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -123.62 119.62 30.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.373 0.669 . . . . 0.0 110.624 -174.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 69.3 7.99 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.367 1.067 . . . . 0.0 112.514 -173.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.6 m -91.51 -22.95 20.11 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 121.792 -0.567 . . . . 0.0 111.439 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.438 HG12 HD11 ' A' ' 42' ' ' LEU . 6.1 p -92.86 152.23 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 122.23 -0.294 . . . . 0.0 111.665 -175.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.1 t -114.18 -25.34 8.53 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.348 0.659 . . . . 0.0 111.297 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -128.56 125.72 38.86 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.314 0.646 . . . . 0.0 109.742 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.478 ' HB ' HG22 ' A' ' 69' ' ' VAL . 40.4 mt -106.1 138.38 31.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.9 t -117.57 120.21 64.07 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 C-N-CA 123.905 0.882 . . . . 0.0 108.811 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -139.44 159.66 41.65 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.348 0.659 . . . . 0.0 109.612 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.0 t -84.64 -46.42 11.52 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 168.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -140.01 124.34 17.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.809 1.243 . . . . 0.0 108.933 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.447 HD22 HG11 ' A' ' 69' ' ' VAL . 38.7 tp -107.49 128.39 26.02 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.13 153.6 38.27 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.347 2.698 . . . . 0.0 112.832 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.4 mt -59.26 -44.88 92.38 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.707 0.803 . . . . 0.0 111.234 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -61.5 -46.65 89.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.24 1.016 . . . . 0.0 110.191 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -70.91 -24.66 62.5 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.993 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -73.71 -30.81 63.08 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.07 0.548 . . . . 0.0 110.132 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -70.99 -43.38 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.783 0.833 . . . . 0.0 109.957 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.32 -38.34 87.46 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.812 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.426 ' HA ' ' HD1' ' A' ' 67' ' ' TYR . 23.2 m-85 -100.22 26.26 6.7 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.976 0.911 . . . . 0.0 110.744 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 -24.95 66.59 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.291 0.637 . . . . 0.0 112.103 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -80.33 -27.45 38.34 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.072 0.549 . . . . 0.0 110.761 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.426 ' HD1' ' HA ' ' A' ' 64' ' ' PHE . 62.4 m-85 -88.72 141.63 28.35 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.78 0.832 . . . . 0.0 109.641 -177.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -82.97 85.86 7.08 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.478 HG22 ' HB ' ' A' ' 51' ' ' ILE . 41.4 t -77.9 128.68 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.266 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 87' ' ' TRP . 27.7 m -139.96 174.53 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.093 1.357 . . . . 0.0 109.466 -175.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.0 m -87.83 159.88 48.05 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.306 0.642 . . . . 0.0 110.382 171.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -58.66 -23.16 64.38 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.935 2.423 . . . . 0.0 112.485 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.21 -24.34 64.74 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.004 1.322 . . . . 0.0 112.151 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -62.15 -50.78 70.5 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 75' ' ' ILE . 2.6 mp -64.94 -52.15 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.87 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.19 -54.34 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.245 1.018 . . . . 0.0 111.537 -175.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -72.71 -37.31 67.85 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 123.335 0.397 . . . . 0.0 111.289 -172.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.5 m -63.95 -37.61 88.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.64 0.376 . . . . 0.0 111.234 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.768 HG21 ' HB3' ' A' ' 30' ' ' MET . 40.2 t -72.32 -36.8 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.896 0.878 . . . . 0.0 111.575 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -65.85 -41.09 92.12 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.763 0.425 . . . . 0.0 110.618 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -89.6 -10.33 46.42 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.78 0.832 . . . . 0.0 111.901 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 55.32 37.71 29.29 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.828 1.251 . . . . 0.0 112.226 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -146.76 155.5 42.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.815 0.846 . . . . 0.0 110.048 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.567 ' HA ' HG23 ' A' ' 8' ' ' ILE . 60.9 tp -78.11 94.76 4.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.403 0.681 . . . . 0.0 109.571 -178.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.22 151.74 66.78 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.771 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.66 110.55 0.84 Allowed 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.77 2.313 . . . . 0.0 112.685 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.514 ' HB2' HG11 ' A' ' 70' ' ' VAL . 61.7 p-90 -63.82 -22.23 66.82 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.917 0.887 . . . . 0.0 111.246 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -63.44 -24.16 67.71 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.284 1.034 . . . . 0.0 111.433 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.28 -5.99 58.4 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.232 0.613 . . . . 0.0 111.527 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -126.93 1.42 6.61 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.536 0.734 . . . . 0.0 110.895 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.9 p -68.49 113.46 6.05 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.456 0.702 . . . . 0.0 112.368 -170.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.9 mt -89.78 20.4 4.13 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.008 0.923 . . . . 0.0 111.283 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.5 p -68.4 -27.74 66.48 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.179 0.991 . . . . 0.0 111.553 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.937 176.861 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 58.3 mt . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -87.03 53.6 2.88 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.866 0.866 . . . . 0.0 110.526 -175.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.1 t -146.11 110.7 5.14 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.47 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -73.24 141.14 47.27 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.808 0.843 . . . . 0.0 110.131 178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.1 m 57.97 32.71 22.32 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.549 1.14 . . . . 0.0 112.37 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.5 p -86.68 15.77 5.36 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.008 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 10' ' ' LYS . 9.5 mtmp? -82.08 35.26 0.43 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.648 1.179 . . . . 0.0 112.103 -174.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.8 mt -50.49 -45.65 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 125.503 1.521 . . . . 0.0 112.243 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 75' ' ' ILE . 63.8 m-85 -108.98 16.49 22.59 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.412 0.685 . . . . 0.0 111.371 -174.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 7' ' ' LYS . 13.6 tptp -50.23 -51.91 40.36 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.035 0.934 . . . . 0.0 113.288 -168.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -99.5 -2.79 35.03 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.407 0.683 . . . . 0.0 111.069 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.6 m -82.2 128.47 34.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.141 0.577 . . . . 0.0 109.904 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.62 HG12 HG23 ' A' ' 48' ' ' VAL . 38.8 t -104.27 119.58 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 mp -119.62 131.95 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.294 0.638 . . . . 0.0 111.174 -173.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -113.67 150.95 32.49 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.935 1.694 . . . . 0.0 108.165 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.28 132.2 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -139.65 135.6 33.43 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.163 1.385 . . . . 0.0 108.562 -170.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.25 -172.76 54.35 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -92.65 110.41 21.84 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.516 HG21 HG12 ' A' ' 52' ' ' VAL . 65.4 p -113.74 141.57 47.1 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.05 0.94 . . . . 0.0 109.871 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.521 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -104.97 127.25 29.12 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 167.172 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.38 173.84 54.5 Favored 'Cis proline' 0 C--N 1.372 1.769 0 C-N-CA 124.184 -1.173 . . . . 0.0 112.276 -0.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.05 157.2 9.72 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.679 0.612 . . . . 0.0 113.939 -174.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -51.47 -35.45 39.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.127 0.971 . . . . 0.0 111.901 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.1 pp -56.76 -48.95 76.69 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.049 0.939 . . . . 0.0 112.001 177.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.528 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.8 tp-100 -72.37 -43.55 63.83 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.749 0.819 . . . . 0.0 110.334 -174.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.54 -44.79 96.4 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.854 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.58 ' HA ' HD12 ' A' ' 31' ' ' ILE . 24.1 m-70 -61.26 -36.8 81.01 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.102 0.561 . . . . 0.0 111.0 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.19 -45.05 86.38 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.745 0.418 . . . . 0.0 110.632 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.543 ' SD ' HG11 ' A' ' 79' ' ' VAL . 23.9 mmt -59.29 -31.99 69.63 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.349 0.66 . . . . 0.0 111.475 176.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 28' ' ' HIS . 84.0 mt -69.39 -52.33 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.05 175.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 28' ' ' HIS . 59.9 t -72.29 -38.84 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 122.986 0.514 . . . . 0.0 112.164 -169.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.34 -19.14 64.37 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.199 0.6 . . . . 0.0 111.661 176.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -104.43 25.89 9.63 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.624 0.77 . . . . 0.0 111.4 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.65 14.75 70.24 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.654 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.82 161.17 36.23 Favored Glycine 0 C--O 1.242 0.618 0 N-CA-C 113.954 0.342 . . . . 0.0 113.954 -171.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -103.17 144.61 31.09 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.278 1.031 . . . . 0.0 108.614 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -134.29 145.37 49.01 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 122.961 0.505 . . . . 0.0 110.627 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.41 142.86 50.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.293 1.037 . . . . 0.0 109.277 173.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -109.05 -43.71 4.13 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.919 170.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -120.78 135.67 55.09 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.97 157.65 16.19 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.239 -171.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.4 t -92.77 12.73 22.49 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.532 0.733 . . . . 0.0 110.759 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.4 t 64.25 16.18 9.9 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.763 1.225 . . . . 0.0 110.906 -171.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -122.59 -170.73 2.14 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.069 1.347 . . . . 0.0 108.576 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -75.86 67.76 2.3 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.575 1.179 . . . . 0.0 110.186 174.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -89.01 -1.07 57.93 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.713 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.62 HG23 HG12 ' A' ' 13' ' ' VAL . 9.1 p -162.97 160.11 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.921 0.888 . . . . 0.0 109.436 -172.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.3 t -114.29 -21.27 10.51 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -126.5 139.17 53.43 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.04 0.536 . . . . 0.0 110.225 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.747 ' HB ' HG12 ' A' ' 69' ' ' VAL . 58.1 mt -124.42 129.72 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.516 HG12 HG21 ' A' ' 20' ' ' THR . 51.6 t -104.93 119.05 53.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 C-N-CA 123.741 0.816 . . . . 0.0 110.355 -172.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.07 146.44 35.45 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.6 p -85.38 -10.29 56.47 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.792 0.437 . . . . 0.0 110.613 173.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -156.76 89.05 1.07 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.48 1.112 . . . . 0.0 108.009 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.67 110.18 47.77 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.424 ' O ' ' HG3' ' A' ' 61' ' ' ARG . 54.3 Cg_exo -55.41 151.15 38.51 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.84 3.027 . . . . 0.0 114.001 -176.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.4 mt -57.2 -46.01 83.25 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 0.0 111.528 -177.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -63.88 -39.81 95.06 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.7 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.57 -34.95 77.99 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 119.431 -0.319 . . . . 0.0 111.657 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 80.0 mtt180 -60.36 -36.04 77.09 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 122.94 0.496 . . . . 0.0 110.69 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.9 mt -71.5 -42.13 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.009 0.923 . . . . 0.0 110.761 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.58 -26.94 61.05 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.204 0.602 . . . . 0.0 111.045 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.407 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 20.7 m-85 -110.28 28.72 8.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.488 1.115 . . . . 0.0 109.76 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.54 -22.84 65.51 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -91.99 -26.93 18.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.16 0.584 . . . . 0.0 110.393 176.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.407 ' HD2' ' HA ' ' A' ' 64' ' ' PHE . 65.0 m-85 -85.86 135.13 33.82 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -83.96 86.48 7.18 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.747 HG12 ' HB ' ' A' ' 51' ' ' ILE . 21.4 m -77.18 127.69 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.117 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' ' 87' ' ' TRP . 35.9 m -136.8 172.3 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.339 1.056 . . . . 0.0 109.735 -175.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.1 m -80.69 154.91 73.62 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.301 172.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.25 -22.04 63.07 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.512 2.141 . . . . 0.0 111.869 171.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.9 -29.61 60.29 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.368 1.467 . . . . 0.0 112.292 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -63.57 -49.06 74.89 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 120.8 0.333 . . . . 0.0 110.34 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.437 ' O ' HG23 ' A' ' 79' ' ' VAL . 2.8 mp -68.38 -49.43 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.979 -175.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.1 t -58.48 -53.79 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.791 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 21.1 t0 -72.65 -31.73 65.33 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.081 0.238 . . . . 0.0 111.488 -172.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.591 ' HA ' HD13 ' A' ' 85' ' ' LEU . 58.0 m -63.68 -37.86 88.95 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 120.643 0.258 . . . . 0.0 110.932 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.543 HG11 ' SD ' ' A' ' 30' ' ' MET . 86.3 t -70.87 -36.45 64.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 122.97 0.508 . . . . 0.0 110.787 175.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -62.49 -45.59 92.3 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.769 0.428 . . . . 0.0 111.06 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 10.7 mm-40 -85.37 -11.88 53.5 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.252 0.621 . . . . 0.0 111.159 -176.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.26 34.98 10.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.758 1.223 . . . . 0.0 111.691 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -153.67 168.97 24.45 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.448 0.699 . . . . 0.0 110.647 -177.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -86.37 108.39 18.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.293 0.637 . . . . 0.0 109.879 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 78' ' ' SER . 10.8 mp -83.89 152.56 62.8 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.553 0.741 . . . . 0.0 110.654 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.566 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 49.0 Cg_endo -67.1 120.85 7.95 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.459 2.106 . . . . 0.0 111.295 171.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.531 ' HB2' HG11 ' A' ' 70' ' ' VAL . 69.0 p-90 -63.66 -21.67 66.5 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.695 0.798 . . . . 0.0 111.922 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.566 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 21.0 pt20 -59.08 -29.16 67.13 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.061 0.944 . . . . 0.0 111.945 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.62 -21.33 63.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.586 0.754 . . . . 0.0 111.504 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -121.49 9.64 10.31 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.823 0.849 . . . . 0.0 110.852 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.503 ' OG ' HG22 ' A' ' 93' ' ' THR . 41.2 t -72.91 114.33 10.93 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.614 0.766 . . . . 0.0 111.446 -172.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.7 mt -91.46 2.21 56.59 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.723 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.503 HG22 ' OG ' ' A' ' 91' ' ' SER . 6.7 t -74.23 -18.28 60.77 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.602 0.637 . . . . 0.0 111.179 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.7 t . . . . . 0 C--O 1.255 1.355 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.661 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 10' ' ' LYS . 62.8 pttt . . . . . 0 CA--C 1.558 1.253 0 CA-C-O 121.387 0.613 . . . . 0.0 112.227 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.467 HG23 ' HA ' ' A' ' 84' ' ' LEU . 44.7 mt -52.13 -34.7 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 125.714 1.605 . . . . 0.0 113.209 -174.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.419 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 67.8 m-85 -114.34 16.74 17.81 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.482 0.713 . . . . 0.0 110.914 -174.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 7' ' ' LYS . 25.5 tptp -54.67 -43.82 72.77 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.275 1.03 . . . . 0.0 112.899 -169.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -102.98 7.2 39.16 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.362 0.665 . . . . 0.0 111.376 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.1 m -108.37 118.87 37.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.569 0.748 . . . . 0.0 111.24 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.537 HG12 HG23 ' A' ' 48' ' ' VAL . 69.9 t -89.78 125.36 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 164.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.558 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.1 mp -117.55 127.22 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.268 0.556 . . . . 0.0 111.125 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.437 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 19.3 t80 -103.48 150.87 23.47 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.739 1.216 . . . . 0.0 107.869 169.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.552 HG12 ' HB ' ' A' ' 52' ' ' VAL . 65.1 mt -123.03 130.91 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -128.46 141.7 51.31 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.612 1.165 . . . . 0.0 109.476 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.09 -168.37 48.7 Favored Glycine 0 N--CA 1.477 1.401 0 N-CA-C 112.263 -0.335 . . . . 0.0 112.263 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -101.22 108.49 20.15 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.438 HG21 HG12 ' A' ' 52' ' ' VAL . 69.4 p -110.08 139.73 44.9 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.06 0.944 . . . . 0.0 109.433 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -105.96 126.86 29.6 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 170.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -78.81 175.23 47.42 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 124.449 -1.063 . . . . 0.0 111.977 -0.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.22 153.99 5.6 Favored Glycine 0 C--N 1.349 1.263 0 O-C-N 123.948 0.78 . . . . 0.0 114.671 -170.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -57.97 -34.76 70.29 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.665 0.786 . . . . 0.0 111.65 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.7 pp -59.97 -45.9 91.18 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 123.589 0.556 . . . . 0.0 111.14 172.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.532 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.0 tp-100 -67.11 -50.94 59.8 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.801 0.841 . . . . 0.0 111.012 -175.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.0 mt -55.93 -44.55 78.45 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.167 0.587 . . . . 0.0 111.208 177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.558 ' HA ' HD12 ' A' ' 31' ' ' ILE . 30.2 m170 -62.61 -36.66 83.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.889 0.476 . . . . 0.0 111.299 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 46.2 mt-10 -66.16 -41.59 90.15 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.801 0.44 . . . . 0.0 110.713 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.552 ' HB3' HG21 ' A' ' 79' ' ' VAL . 5.6 mmt -60.52 -33.5 72.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.803 0.841 . . . . 0.0 110.721 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.558 HD13 ' HB ' ' A' ' 14' ' ' ILE . 60.0 mt -70.07 -49.77 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.977 0.911 . . . . 0.0 111.007 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 28' ' ' HIS . 80.0 t -61.45 -48.09 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.482 0.713 . . . . 0.0 112.113 -176.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.18 -23.39 66.58 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.222 0.609 . . . . 0.0 111.629 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.5 ' NE2' HG13 ' A' ' 79' ' ' VAL . 40.3 m-70 -95.87 27.03 3.73 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.892 0.877 . . . . 0.0 111.397 175.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.67 78.04 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.724 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.42 175.76 33.4 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 114.203 0.441 . . . . 0.0 114.203 -171.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -128.74 155.45 45.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.167 0.987 . . . . 0.0 108.75 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -138.51 168.72 19.17 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.177 0.513 . . . . 0.0 112.22 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.75 140.89 50.35 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -74.51 -46.36 39.83 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.762 0.825 . . . . 0.0 111.306 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.437 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 71.9 t80 . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 124.578 1.151 . . . . 0.0 109.688 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HA ' ' HE1' ' A' ' 67' ' ' TYR . 95.4 mttt . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 120.894 0.378 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.6 m -120.07 24.25 10.57 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.497 0.719 . . . . 0.0 109.351 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.537 HG23 HG12 ' A' ' 13' ' ' VAL . 6.1 p -154.2 155.82 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.327 0.651 . . . . 0.0 109.608 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.8 t -114.63 -25.81 8.14 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.59 0.756 . . . . 0.0 111.466 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -133.03 138.78 46.91 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.616 0.766 . . . . 0.0 110.236 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.613 ' HB ' HG22 ' A' ' 69' ' ' VAL . 58.1 mt -123.64 143.33 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.562 1.145 . . . . 0.0 108.358 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.552 ' HB ' HG12 ' A' ' 16' ' ' ILE . 97.6 t -115.74 119.79 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.419 0.688 . . . . 0.0 110.287 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.26 157.85 38.73 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.37 0.668 . . . . 0.0 110.032 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.3 t -70.78 -49.36 47.45 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -147.02 147.43 30.67 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 168.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.558 ' HG ' HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -123.46 116.23 28.23 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -173.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.532 ' HG2' ' HB2' ' A' ' 60' ' ' LYS . 36.9 Cg_endo -64.68 156.35 61.85 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.132 2.555 . . . . 0.0 113.429 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.07 -47.34 86.78 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.569 1.148 . . . . 0.0 113.58 -167.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -67.16 -26.99 66.92 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 120.953 0.406 . . . . 0.0 110.429 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.532 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 4.6 mptp? -81.47 -23.15 37.61 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.34 -34.24 77.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.2 mt -72.83 -39.57 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.849 0.86 . . . . 0.0 110.228 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 3.1 tp10 -63.06 -34.52 77.76 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.131 0.972 . . . . 0.0 110.435 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -117.6 27.43 9.06 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.499 -175.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.02 67.56 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.294 0.568 . . . . 0.0 111.473 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -76.41 -23.03 53.99 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.404 1.082 . . . . 0.0 111.306 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.401 ' HE1' ' HA ' ' A' ' 46' ' ' LYS . 15.9 m-85 -113.73 126.73 55.56 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.921 0.889 . . . . 0.0 109.272 -174.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.2 87.59 1.11 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.007 0.432 . . . . 0.0 110.315 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.613 HG22 ' HB ' ' A' ' 51' ' ' ILE . 16.5 t -76.08 134.45 29.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.211 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 87' ' ' TRP . 31.8 m -135.74 174.15 12.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.606 1.162 . . . . 0.0 109.531 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.5 t -86.09 152.37 55.79 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 171.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.26 -23.54 46.26 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 122.962 2.442 . . . . 0.0 113.15 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.12 -26.56 64.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.02 0.928 . . . . 0.0 112.26 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -61.02 -44.04 97.99 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.7 mp -75.6 -52.46 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.726 0.81 . . . . 0.0 108.841 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.3 t -54.91 -53.73 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.491 1.116 . . . . 0.0 111.148 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.07 -39.08 66.16 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.546 -173.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 95.5 p -60.58 -41.56 94.92 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 120.905 0.383 . . . . 0.0 110.529 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 30' ' ' MET . 70.8 t -64.51 -42.21 94.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 123.911 0.885 . . . . 0.0 111.066 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -67.61 -29.64 69.03 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.611 0.365 . . . . 0.0 111.441 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -89.78 -14.38 34.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.48 0.712 . . . . 0.0 110.925 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.97 27.38 16.23 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.168 1.387 . . . . 0.0 111.948 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -138.41 165.46 26.75 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.529 0.732 . . . . 0.0 111.02 -173.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.467 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.3 tm? -77.35 133.85 38.63 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 mt -114.18 154.92 46.18 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 123.586 0.754 . . . . 0.0 110.672 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.1 105.7 0.88 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.262 1.975 . . . . 0.0 110.81 171.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.488 ' HB2' HG11 ' A' ' 70' ' ' VAL . 36.3 p90 -66.52 -22.1 66.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.138 0.575 . . . . 0.0 111.588 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -62.44 -29.12 70.28 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.754 0.821 . . . . 0.0 111.476 174.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -67.91 -41.29 82.86 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.1 0.56 . . . . 0.0 109.904 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -93.43 4.8 53.38 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.056 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.9 t -62.14 121.27 12.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.919 0.888 . . . . 0.0 113.222 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -106.3 -0.07 24.67 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.83 0.852 . . . . 0.0 110.752 170.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.425 ' HB ' ' H ' ' A' ' 69' ' ' VAL . 11.9 t -83.3 -15.66 49.24 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.889 0.476 . . . . 0.0 110.49 172.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.252 1.229 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.838 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.419 HD12 ' ND1' ' A' ' 34' ' ' HIS . 66.8 mt -59.32 -42.33 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.637 0.775 . . . . 0.0 111.409 -177.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.423 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 63.7 m-85 -113.85 17.05 18.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.552 0.741 . . . . 0.0 110.868 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -54.55 -55.21 31.66 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 123.75 0.82 . . . . 0.0 112.171 -167.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -91.9 15.14 13.7 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.36 0.664 . . . . 0.0 111.271 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 54.0 t -117.11 120.38 38.16 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 123.986 0.914 . . . . 0.0 109.924 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.424 HG11 HD23 ' A' ' 39' ' ' LEU . 36.5 t -90.84 134.07 30.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 168.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.438 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.7 mp -123.45 123.29 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.046 0.538 . . . . 0.0 110.631 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -102.76 144.18 31.45 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.445 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 41.1 mt -121.68 137.68 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -147.19 136.13 22.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.688 0.795 . . . . 0.0 109.603 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.71 175.3 47.73 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 123.253 0.345 . . . . 0.0 113.156 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -73.93 111.93 9.56 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.107 0.479 . . . . 0.0 110.017 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.573 HG21 HG12 ' A' ' 52' ' ' VAL . 40.4 p -128.14 138.41 52.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.947 1.299 . . . . 0.0 108.226 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -105.33 130.22 23.45 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 118.257 0.48 . . . . 0.0 110.664 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.99 172.22 64.27 Favored 'Cis proline' 0 C--N 1.375 1.95 0 C-N-CA 124.232 -1.154 . . . . 0.0 111.485 -2.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.23 155.67 5.79 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.541 -0.589 . . . . 0.0 113.768 -174.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -55.36 -36.55 66.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.262 0.625 . . . . 0.0 111.809 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 26' ' ' GLN . 3.0 pp -59.3 -40.51 86.39 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.338 0.655 . . . . 0.0 111.738 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.454 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.1 tp-100 -74.27 -43.86 55.16 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.87 0.868 . . . . 0.0 110.509 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.1 -39.75 83.22 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.87 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.439 ' HA ' HD12 ' A' ' 31' ' ' ILE . 15.9 m170 -60.8 -39.21 88.06 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.043 0.937 . . . . 0.0 110.304 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -67.88 -41.18 83.21 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.582 0.552 . . . . 0.0 110.932 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.535 ' SD ' HG11 ' A' ' 79' ' ' VAL . 25.0 mmt -60.17 -32.53 71.14 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.315 0.646 . . . . 0.0 111.748 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 28' ' ' HIS . 70.1 mt -71.07 -52.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.065 175.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.7 t -71.45 -44.84 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.362 0.665 . . . . 0.0 112.045 -170.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.2 -15.76 57.99 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.709 0.804 . . . . 0.0 111.705 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.45 ' NE2' HG13 ' A' ' 79' ' ' VAL . 68.5 m-70 -108.98 27.82 9.1 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.726 0.81 . . . . 0.0 111.154 175.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.85 9.97 86.3 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 114.798 -1.092 . . . . 0.0 114.656 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.423 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -96.13 177.74 34.03 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 114.453 0.541 . . . . 0.0 114.453 -170.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -123.85 150.08 45.0 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.471 0.708 . . . . 0.0 110.038 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -125.0 166.6 16.06 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.49 0.716 . . . . 0.0 110.417 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.424 HD23 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -131.35 141.65 49.93 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.04 -35.05 26.07 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.474 0.71 . . . . 0.0 112.862 -176.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.9 t80 . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 123.992 0.917 . . . . 0.0 109.51 -174.496 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.55 0.949 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.2 m -103.39 -8.94 19.83 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.847 0.859 . . . . 0.0 110.657 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.403 ' HA ' ' HB ' ' A' ' 13' ' ' VAL . 9.5 p -123.98 159.82 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.797 0.839 . . . . 0.0 109.867 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -114.15 -27.72 7.56 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.044 0.538 . . . . 0.0 111.202 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -130.6 129.74 43.11 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.07 0.548 . . . . 0.0 110.591 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 22.5 mt -114.66 138.89 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.645 0.778 . . . . 0.0 109.045 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.573 HG12 HG21 ' A' ' 20' ' ' THR . 63.2 t -104.63 135.36 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 123.985 0.914 . . . . 0.0 109.526 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.03 163.33 39.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.019 0.928 . . . . 0.0 108.908 173.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.3 t -115.56 -49.12 2.75 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -120.06 111.59 18.07 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 tp -129.99 123.01 20.63 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.97 151.9 74.77 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.13 2.554 . . . . 0.0 112.406 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.428 HD23 ' HD2' ' A' ' 61' ' ' ARG . 94.8 mt -59.05 -32.58 69.89 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.531 0.733 . . . . 0.0 111.878 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -60.0 -43.44 95.2 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.335 0.654 . . . . 0.0 110.723 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -75.93 -28.78 58.11 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.724 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.428 ' HD2' HD23 ' A' ' 58' ' ' LEU . 61.6 mtt180 -70.87 -29.32 65.4 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.865 0.466 . . . . 0.0 110.817 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.6 mt -80.13 -37.33 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.537 0.735 . . . . 0.0 110.638 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -61.66 -45.7 92.88 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.683 0.754 . . . . 0.0 110.03 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -99.75 19.47 15.91 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.703 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.67 -18.89 62.15 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.256 0.622 . . . . 0.0 110.415 169.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -70.64 -17.47 62.87 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.897 0.879 . . . . 0.0 110.407 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.17 171.4 7.57 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.602 1.161 . . . . 0.0 109.261 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -99.28 88.13 3.83 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' A' ' 92' ' ' LEU . 39.6 t -74.49 138.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.664 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.04 177.71 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.009 1.324 . . . . 0.0 109.723 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.3 m -87.45 160.07 48.79 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.101 0.96 . . . . 0.0 109.612 172.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.422 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.7 Cg_endo -59.75 -28.0 86.26 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 122.684 2.256 . . . . 0.0 112.223 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -65.88 -16.84 64.21 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.544 1.138 . . . . 0.0 111.969 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.3 t90 -62.69 -45.8 91.08 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 75' ' ' ILE . 3.2 mp -71.16 -50.41 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.706 -177.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.53 HG12 ' HE2' ' A' ' 80' ' ' LYS . 58.8 t -62.3 -50.74 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.878 -173.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -71.57 -33.63 69.25 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.808 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.7 m -61.19 -37.19 82.05 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 117.954 0.343 . . . . 0.0 110.718 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.535 HG11 ' SD ' ' A' ' 30' ' ' MET . 44.4 t -64.6 -47.41 89.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 C-N-CA 123.866 0.866 . . . . 0.0 111.03 173.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.53 ' HE2' HG12 ' A' ' 76' ' ' VAL . 54.3 mtmt -70.17 -26.46 63.92 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.266 0.627 . . . . 0.0 112.118 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -94.99 -15.98 23.1 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.834 0.453 . . . . 0.0 111.248 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.15 28.66 18.28 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.734 1.214 . . . . 0.0 111.84 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -144.96 149.15 34.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.418 1.087 . . . . 0.0 108.603 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.0 tp -72.73 112.07 8.45 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.9 mt -83.88 153.95 64.19 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 123.514 0.725 . . . . 0.0 110.82 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -57.59 122.15 11.26 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.992 2.461 . . . . 0.0 112.454 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -64.2 -32.34 73.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.992 0.517 . . . . 0.0 110.274 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -60.52 -31.62 70.68 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.065 0.946 . . . . 0.0 111.276 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -69.33 -25.08 64.03 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.651 0.781 . . . . 0.0 110.743 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -115.99 4.71 13.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.845 0.858 . . . . 0.0 111.423 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.9 t -66.46 126.7 29.67 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -167.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.425 ' HB2' HG12 ' A' ' 69' ' ' VAL . 49.9 mt -114.68 28.34 8.8 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.057 0.943 . . . . 0.0 110.292 173.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 69' ' ' VAL . 39.7 p -65.78 -38.17 88.3 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.635 0.774 . . . . 0.0 111.027 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.254 1.294 0 C-N-CA 124.302 1.041 . . . . 0.0 109.001 -179.306 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 10' ' ' LYS . 20.9 pttp . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 120.673 0.273 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 52.5 mt -66.08 -50.07 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.816 0.846 . . . . 0.0 110.584 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.41 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 50.4 m-85 -112.26 14.48 20.52 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.143 -176.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.588 ' HB2' ' HA ' ' A' ' 7' ' ' LYS . 52.2 tptt -53.54 -55.63 23.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.064 0.946 . . . . 0.0 113.476 -165.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -100.15 17.52 21.0 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.371 0.605 . . . . 0.0 109.889 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.49 ' SG ' ' CD2' ' A' ' 50' ' ' HIS . 29.1 t -113.06 128.39 56.48 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.048 1.339 . . . . 0.0 110.901 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.86 130.34 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.242 1.017 . . . . 0.0 109.295 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.525 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.7 mp -124.42 129.37 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 CA-C-O 121.407 0.622 . . . . 0.0 111.852 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.496 ' HB2' ' HB3' ' A' ' 39' ' ' LEU . 55.2 t80 -104.02 152.39 22.09 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.43 1.892 . . . . 0.0 108.39 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -122.78 137.89 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.066 0.546 . . . . 0.0 109.987 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 15' ' ' TYR . 58.5 t30 -143.74 141.63 30.55 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.39 1.076 . . . . 0.0 109.346 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.27 -178.92 46.49 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 116.467 -0.333 . . . . 0.0 112.699 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -92.9 110.59 22.05 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.98 0.419 . . . . 0.0 109.955 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.612 HG21 HG12 ' A' ' 52' ' ' VAL . 65.0 p -122.59 142.59 50.47 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.715 1.206 . . . . 0.0 109.717 -174.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -96.82 130.76 29.4 Favored Pre-proline 0 N--CA 1.479 0.976 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 167.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.49 176.28 42.31 Favored 'Cis proline' 0 C--N 1.373 1.831 0 C-N-CA 124.758 -0.934 . . . . 0.0 111.666 -4.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.59 152.0 7.66 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.746 0.654 . . . . 0.0 114.07 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -54.01 -34.97 61.36 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.251 1.02 . . . . 0.0 112.263 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 pp -58.09 -48.28 80.63 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.898 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.514 HE21 ' HA ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -73.5 -41.77 62.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.355 0.662 . . . . 0.0 111.614 -175.235 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.493 HD13 HG11 ' A' ' 52' ' ' VAL . 29.1 mt -58.34 -44.58 88.78 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.033 0.533 . . . . 0.0 110.641 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.436 ' O ' HG23 ' A' ' 32' ' ' VAL . 16.8 m170 -65.79 -34.97 79.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.567 0.347 . . . . 0.0 111.498 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -62.85 -42.2 99.66 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 117.847 0.294 . . . . 0.0 110.443 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.638 ' HB3' HG21 ' A' ' 79' ' ' VAL . 22.9 mmt -62.26 -39.06 91.64 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.881 0.872 . . . . 0.0 110.677 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.525 HD13 ' HB ' ' A' ' 14' ' ' ILE . 71.1 mt -65.87 -51.55 59.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.044 0.938 . . . . 0.0 111.463 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 28' ' ' HIS . 99.9 t -68.56 -43.67 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 122.901 0.48 . . . . 0.0 111.599 -173.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.67 -17.8 63.32 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.271 0.629 . . . . 0.0 111.795 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.424 ' NE2' HG13 ' A' ' 79' ' ' VAL . 55.5 m-70 -108.91 26.51 10.51 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.675 0.79 . . . . 0.0 111.581 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.9 -0.33 72.87 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.615 -0.721 . . . . 0.0 114.821 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . -92.52 173.97 36.0 Favored Glycine 0 C--O 1.237 0.342 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 -166.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -117.4 159.33 22.94 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.605 1.162 . . . . 0.0 109.63 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -125.27 156.63 38.28 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.764 0.826 . . . . 0.0 110.987 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.617 ' HG ' ' HB ' ' A' ' 48' ' ' VAL . 2.4 tm? -134.65 129.38 34.76 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.44 ' HD2' ' H ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -79.74 -43.36 22.74 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.44 ' H ' ' HD2' ' A' ' 40' ' ' HIS . 71.9 t80 . . . . . 0 N--CA 1.474 0.76 0 C-N-CA 124.172 0.989 . . . . 0.0 109.727 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.8 p -83.44 -18.74 37.61 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.072 0.549 . . . . 0.0 111.111 -174.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.617 ' HB ' ' HG ' ' A' ' 39' ' ' LEU . 9.8 p -136.93 156.62 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.481 0.712 . . . . 0.0 109.858 176.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.522 HG23 ' HD2' ' A' ' 50' ' ' HIS . 4.6 t -114.51 -25.31 8.41 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.436 0.695 . . . . 0.0 111.127 175.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.522 ' HD2' HG23 ' A' ' 49' ' ' THR . 80.5 m-70 -132.55 130.47 40.39 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.939 0.495 . . . . 0.0 110.616 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.64 ' HB ' HG12 ' A' ' 69' ' ' VAL . 66.7 mt -114.98 135.21 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.612 HG12 HG21 ' A' ' 20' ' ' THR . 87.5 t -91.79 129.1 42.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.26 145.93 29.59 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.5 t -88.46 -39.15 14.44 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -143.96 139.73 29.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.476 1.11 . . . . 0.0 108.264 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.3 tp -128.07 128.38 23.76 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.97 150.29 73.56 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.066 2.51 . . . . 0.0 112.317 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.2 mt -57.22 -39.83 76.26 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.946 0.898 . . . . 0.0 111.339 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.28 -43.36 99.01 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.404 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -76.64 -20.79 56.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.603 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -66.43 -41.22 89.53 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 171.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.1 mt -65.41 -43.54 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 123.717 0.636 . . . . 0.0 110.797 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.63 -42.26 82.59 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.365 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -100.36 23.33 10.31 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.549 0.74 . . . . 0.0 110.674 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.63 -27.44 67.69 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.409 0.683 . . . . 0.0 111.386 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -71.3 -19.37 62.33 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.938 0.895 . . . . 0.0 111.239 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -108.9 143.89 37.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.882 0.873 . . . . 0.0 109.204 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.04 86.17 4.23 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.64 HG12 ' HB ' ' A' ' 51' ' ' ILE . 7.6 m -78.3 127.82 38.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.22 171.41 18.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.284 1.034 . . . . 0.0 109.667 -172.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.1 m -77.92 150.25 78.01 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.399 170.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.83 -25.86 78.17 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.332 2.021 . . . . 0.0 111.39 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.7 -29.38 52.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.387 1.475 . . . . 0.0 112.271 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -60.29 -54.37 46.5 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.487 ' H ' HD12 ' A' ' 75' ' ' ILE . 3.4 mp -64.15 -48.04 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 124.227 0.955 . . . . 0.0 109.165 -175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.68 -52.24 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.835 1.254 . . . . 0.0 111.462 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.78 -33.29 66.2 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.74 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.467 ' HA ' HD13 ' A' ' 85' ' ' LEU . 61.9 m -62.34 -35.38 78.9 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.925 0.49 . . . . 0.0 111.361 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 30' ' ' MET . 71.4 t -69.5 -44.34 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.37 0.668 . . . . 0.0 110.863 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.5 -43.25 89.0 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.525 0.679 . . . . 0.0 110.843 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.626 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 64.7 mm-40 -82.65 -21.49 34.99 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.856 -176.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.66 24.93 12.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.241 1.017 . . . . 0.0 111.173 -173.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.626 ' HE ' ' HB3' ' A' ' 81' ' ' GLU . 9.2 ptp180 -134.81 166.02 23.95 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.457 0.703 . . . . 0.0 109.656 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -86.25 116.14 24.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.317 0.647 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 78' ' ' SER . 11.3 mp -90.17 155.19 47.07 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.745 0.818 . . . . 0.0 110.198 172.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.54 109.43 2.62 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.066 1.844 . . . . 0.0 110.755 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -62.38 -25.55 67.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.48 0.712 . . . . 0.0 111.725 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -57.92 -29.54 65.21 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.212 1.005 . . . . 0.0 111.64 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -75.6 -34.48 60.63 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.873 0.869 . . . . 0.0 111.046 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -96.34 -1.05 48.59 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.58 0.752 . . . . 0.0 111.253 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.2 t -72.67 115.59 12.12 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.45 0.7 . . . . 0.0 112.068 -170.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.6 mt -79.31 4.91 13.78 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.934 0.893 . . . . 0.0 111.898 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.2 p -62.4 -21.95 65.78 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.75 0.82 . . . . 0.0 111.463 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.255 1.377 0 C-N-CA 125.832 1.653 . . . . 0.0 111.189 176.253 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.2 mt -57.78 -46.87 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.033 1.333 . . . . 0.0 111.669 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 50.9 m-85 -112.53 17.01 19.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.607 0.763 . . . . 0.0 110.828 -174.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -57.16 -44.05 83.09 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.693 0.797 . . . . 0.0 112.47 -171.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -92.05 -5.81 52.2 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.475 0.31 . . . . 0.0 111.365 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.6 m -97.55 125.84 42.49 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.525 0.678 . . . . 0.0 111.242 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.531 HG12 HG23 ' A' ' 48' ' ' VAL . 36.9 t -103.52 130.6 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 169.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 3.2 mp -118.31 136.01 56.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 123.81 0.844 . . . . 0.0 111.147 -174.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -115.45 119.7 37.07 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 124.422 1.089 . . . . 0.0 108.465 169.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.9 mt -92.36 138.28 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.164 0.586 . . . . 0.0 109.508 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -147.16 136.94 23.05 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.049 0.94 . . . . 0.0 110.098 -166.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.36 -154.17 50.18 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.266 0.354 . . . . 0.0 113.465 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -78.1 128.63 34.11 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 172.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.2 p -146.68 126.86 13.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.672 1.189 . . . . 0.0 108.512 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -114.28 135.76 22.22 Favored Pre-proline 0 N--CA 1.481 1.102 0 CA-C-N 118.212 0.46 . . . . 0.0 111.141 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.11 175.12 38.98 Favored 'Cis proline' 0 C--N 1.379 2.161 0 C-N-CA 124.827 -0.905 . . . . 0.0 112.264 -1.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.58 141.09 9.87 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 124.126 0.891 . . . . 0.0 113.392 -175.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -50.29 -34.66 24.25 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.347 1.059 . . . . 0.0 112.904 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 pp -54.55 -45.7 73.51 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.803 0.441 . . . . 0.0 111.581 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -73.12 -45.41 57.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.976 0.91 . . . . 0.0 110.719 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.3 -44.84 76.1 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.724 0.64 . . . . 0.0 111.306 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -58.96 -40.54 85.04 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.768 0.827 . . . . 0.0 110.638 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.89 -39.87 87.58 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.336 0.397 . . . . 0.0 111.195 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.547 ' HB3' HG21 ' A' ' 79' ' ' VAL . 24.4 mmt -63.37 -33.1 74.79 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.981 0.513 . . . . 0.0 111.355 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.4 mt -72.48 -51.56 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.559 0.744 . . . . 0.0 111.003 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.03 -44.95 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.218 0.607 . . . . 0.0 111.681 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.8 -11.82 56.6 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.531 0.732 . . . . 0.0 111.805 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -113.3 27.23 9.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.71 0.804 . . . . 0.0 111.594 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.57 -6.16 83.86 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.283 -0.872 . . . . 0.0 114.764 167.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.13 156.88 42.34 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 113.944 0.338 . . . . 0.0 113.944 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -108.99 169.71 8.51 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 43.6 p90 -144.27 151.01 38.82 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.79 127.48 53.74 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.656 169.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -33.95 76.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.079 172.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.1 p90 . . . . . 0 C--O 1.241 0.643 0 C-N-CA 124.608 1.163 . . . . 0.0 109.01 173.539 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.19 0.519 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.3 m -108.1 -36.27 6.36 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.73 0.812 . . . . 0.0 110.496 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.531 HG23 HG12 ' A' ' 13' ' ' VAL . 6.9 p -93.29 157.77 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.086 0.554 . . . . 0.0 110.224 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 t -111.27 -32.63 6.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.969 0.508 . . . . 0.0 111.639 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -119.93 138.51 53.4 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.77 0.828 . . . . 0.0 109.088 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.685 ' HB ' HG12 ' A' ' 69' ' ' VAL . 52.7 mt -124.37 138.14 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.55 122.07 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.945 0.898 . . . . 0.0 110.378 -175.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.11 156.97 45.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.665 1.186 . . . . 0.0 108.075 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.1 t -76.23 -38.88 55.77 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -147.84 138.17 22.95 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.075 173.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.1 tp -116.49 124.57 29.31 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.61 156.59 36.25 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.564 2.842 . . . . 0.0 112.666 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.406 HD23 ' HD2' ' A' ' 61' ' ' ARG . 97.0 mt -60.01 -41.96 93.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.832 0.853 . . . . 0.0 112.039 -174.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -57.57 -41.76 81.72 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.671 0.789 . . . . 0.0 110.462 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.39 -23.45 46.78 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.823 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HD2' HD23 ' A' ' 58' ' ' LEU . 99.6 mtt180 -70.73 -33.85 71.28 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.405 0.548 . . . . 0.0 110.656 173.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.7 -45.52 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.485 0.714 . . . . 0.0 109.997 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.68 -50.82 65.5 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.054 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.436 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 18.7 m-85 -92.67 26.35 2.73 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.442 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.63 -29.89 70.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.429 0.692 . . . . 0.0 111.38 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -77.52 -25.82 50.6 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.22 0.608 . . . . 0.0 111.062 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.436 ' CD1' ' HA ' ' A' ' 64' ' ' PHE . 10.3 m-85 -89.47 145.92 24.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.744 0.818 . . . . 0.0 109.638 -177.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 68' ' ' LYS . 11.3 mptt -87.03 86.67 7.33 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.685 HG12 ' HB ' ' A' ' 51' ' ' ILE . 21.6 m -81.63 131.18 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.422 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.97 174.43 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.622 1.169 . . . . 0.0 110.112 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -82.78 157.21 67.12 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.795 0.838 . . . . 0.0 110.549 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.72 -23.28 75.84 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.672 2.248 . . . . 0.0 111.864 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.35 -27.42 65.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.331 1.452 . . . . 0.0 111.774 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -61.68 -48.71 79.55 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.506 0.504 . . . . 0.0 110.223 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.4 mp -67.47 -49.3 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.057 -175.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.2 -52.42 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.342 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.78 -36.19 70.26 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.113 -172.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.1 m -66.07 -40.34 90.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.014 0.525 . . . . 0.0 111.312 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.547 HG21 ' HB3' ' A' ' 30' ' ' MET . 23.8 t -64.88 -44.0 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.533 0.733 . . . . 0.0 110.799 178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -65.16 -36.67 84.94 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.676 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.534 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 48.0 mm-40 -86.24 -8.74 57.54 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.11 19.03 8.29 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.7 1.2 . . . . 0.0 112.763 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.534 ' HE ' ' HB3' ' A' ' 81' ' ' GLU . 13.5 ptp180 -134.21 161.85 33.77 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.509 0.724 . . . . 0.0 109.932 -172.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.8 tp -84.03 113.19 20.84 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 172.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.02 154.42 55.05 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 123.456 0.702 . . . . 0.0 109.968 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.1 117.12 3.96 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.232 1.954 . . . . 0.0 110.931 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -59.76 -27.88 66.91 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.561 0.744 . . . . 0.0 111.672 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -62.21 -25.78 67.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.481 1.113 . . . . 0.0 112.352 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -68.55 -26.99 65.69 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.588 0.755 . . . . 0.0 110.938 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -117.19 5.03 12.66 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.773 0.829 . . . . 0.0 111.114 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.6 t -72.7 125.26 27.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.136 0.574 . . . . 0.0 111.918 -171.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.4 mt -93.39 13.07 22.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.015 0.926 . . . . 0.0 111.862 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.5 p -61.7 -28.33 69.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.273 0.629 . . . . 0.0 110.654 174.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 125.075 1.35 . . . . 0.0 111.481 171.098 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.8 mttm . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.1 -46.98 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 124.154 0.982 . . . . 0.0 112.32 -168.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.439 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 55.5 m-85 -114.8 15.86 17.41 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.705 0.402 . . . . 0.0 111.292 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -64.85 -32.65 74.46 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 122.724 0.41 . . . . 0.0 111.928 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -96.96 6.75 48.07 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.839 0.456 . . . . 0.0 111.685 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 76.3 m -120.82 130.46 53.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.371 0.669 . . . . 0.0 111.477 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.494 HG12 HG23 ' A' ' 48' ' ' VAL . 39.1 t -96.95 131.8 42.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 167.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.411 HG23 HG23 ' A' ' 52' ' ' VAL . 3.6 mp -119.31 124.05 72.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.512 0.725 . . . . 0.0 110.648 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -105.97 109.74 21.79 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 166.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.5 mt -78.04 135.17 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -137.16 122.81 19.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.102 0.961 . . . . 0.0 109.257 -169.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.39 -179.13 29.8 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.406 0.441 . . . . 0.0 113.248 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -71.63 108.47 5.0 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.416 HG21 HG12 ' A' ' 52' ' ' VAL . 71.0 p -111.25 148.65 32.4 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 124.963 1.305 . . . . 0.0 108.897 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 11.2 mmpt? -107.35 122.05 42.52 Favored Pre-proline 0 N--CA 1.482 1.164 0 CA-C-N 118.229 0.468 . . . . 0.0 110.77 172.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -82.55 176.03 37.37 Favored 'Cis proline' 0 C--N 1.368 1.571 0 C-N-CA 123.939 -1.276 . . . . 0.0 111.78 0.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.17 154.04 6.89 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.704 0.628 . . . . 0.0 114.19 -173.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -55.38 -36.58 66.52 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.547 0.739 . . . . 0.0 111.858 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.9 pp -61.12 -40.69 94.74 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 123.859 0.724 . . . . 0.0 111.826 176.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.456 ' N ' HD12 ' A' ' 25' ' ' LEU . 61.1 tp60 -73.33 -46.52 48.88 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.324 0.649 . . . . 0.0 110.145 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 72' ' ' PRO . 66.3 mt -58.09 -39.24 78.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.68 0.792 . . . . 0.0 111.029 174.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -57.38 -42.72 82.71 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.752 0.821 . . . . 0.0 110.385 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -64.84 -43.39 93.23 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 79.1 mmm -62.81 -34.48 77.39 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.249 0.62 . . . . 0.0 111.212 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.6 mt -75.24 -54.94 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.486 0.714 . . . . 0.0 111.617 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.0 t -72.09 -40.18 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.224 0.61 . . . . 0.0 112.122 -166.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.48 -21.6 64.33 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.528 0.731 . . . . 0.0 111.677 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.475 ' NE2' HG13 ' A' ' 79' ' ' VAL . 60.2 m80 -105.12 26.97 8.66 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.305 1.042 . . . . 0.0 110.635 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.84 -3.74 83.11 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.853 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.49 151.79 47.03 Favored Glycine 0 C--O 1.239 0.421 0 N-CA-C 115.771 1.069 . . . . 0.0 115.771 -167.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -106.77 143.96 34.11 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -127.1 149.34 49.98 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.131 0.572 . . . . 0.0 109.724 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.25 123.47 49.32 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 175.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.55 -39.29 88.46 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.245 0.618 . . . . 0.0 112.109 -172.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.3 t80 . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 124.432 1.093 . . . . 0.0 108.716 -175.25 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.1 m -119.97 18.34 12.47 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-O 121.182 0.515 . . . . 0.0 110.71 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.494 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -144.31 147.98 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 122.016 -0.428 . . . . 0.0 110.451 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.5 t -103.79 -32.37 9.37 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.574 0.75 . . . . 0.0 111.725 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -126.06 128.76 47.9 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.5 0.72 . . . . 0.0 109.845 -175.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 41.4 mt -114.39 121.9 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.57 0.748 . . . . 0.0 109.275 175.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.416 HG12 HG21 ' A' ' 20' ' ' THR . 64.0 t -92.32 121.6 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.113 0.565 . . . . 0.0 110.022 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.0 154.07 49.36 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.207 0.603 . . . . 0.0 110.167 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.7 t -95.26 -34.61 12.14 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -140.87 120.85 13.64 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.589 ' HG ' HG11 ' A' ' 69' ' ' VAL . 2.2 tm? -127.43 108.96 21.07 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.04 155.11 70.07 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.846 2.364 . . . . 0.0 112.394 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 61' ' ' ARG . 70.6 mt -64.16 -29.74 70.84 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -172.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -59.36 -48.96 79.66 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.512 0.672 . . . . 0.0 110.298 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -76.01 -19.71 58.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.45 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 10.6 tpp85 -67.64 -40.39 84.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.41 0.684 . . . . 0.0 109.767 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.0 mt -77.06 -35.8 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.063 0.945 . . . . 0.0 110.488 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -69.16 -30.53 68.78 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.465 0.706 . . . . 0.0 111.032 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -115.55 28.64 8.53 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.205 1.002 . . . . 0.0 110.042 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.93 -33.47 75.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.509 0.724 . . . . 0.0 111.626 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -77.36 -26.72 52.24 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.004 0.522 . . . . 0.0 110.82 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -78.64 141.48 37.96 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -83.89 85.8 7.26 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.36 0.664 . . . . 0.0 109.353 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' A' ' 56' ' ' LEU . 57.3 t -78.21 127.59 38.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 174.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.05 173.78 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.139 0.975 . . . . 0.0 110.19 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.3 m -81.46 152.92 70.79 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.818 0.847 . . . . 0.0 110.402 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HB3' HD11 ' A' ' 27' ' ' LEU . 21.6 Cg_endo -59.62 -25.49 79.1 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.964 2.443 . . . . 0.0 112.698 173.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.67 -19.75 66.03 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.051 0.941 . . . . 0.0 112.047 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -59.37 -43.05 92.91 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.923 0.489 . . . . 0.0 109.83 173.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 75' ' ' ILE . 3.2 mp -75.55 -49.55 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.128 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.1 t -59.76 -51.73 69.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.321 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -71.22 -39.57 71.63 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.267 -175.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.8 p -63.62 -37.75 88.51 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 120.822 0.344 . . . . 0.0 111.699 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.475 HG13 ' NE2' ' A' ' 34' ' ' HIS . 33.4 t -62.38 -46.1 97.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 123.719 0.807 . . . . 0.0 110.696 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.1 -37.24 86.41 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.203 0.601 . . . . 0.0 111.542 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -83.96 -12.56 55.15 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.499 0.72 . . . . 0.0 111.594 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.52 26.06 15.86 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.136 1.374 . . . . 0.0 112.582 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -140.86 161.9 36.73 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.327 1.051 . . . . 0.0 109.32 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.6 tp -87.72 128.58 35.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 172.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 mp -93.56 153.39 41.28 Favored Pre-proline 0 C--O 1.241 0.646 0 C-N-CA 123.865 0.866 . . . . 0.0 108.953 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.616 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 30.0 Cg_endo -65.23 140.96 66.94 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.768 1.645 . . . . 0.0 111.865 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -57.76 -33.24 68.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.696 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.616 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 30.0 pt20 -57.7 -34.2 69.2 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.666 1.186 . . . . 0.0 113.046 -170.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.51 ' OD1' ' HG2' ' A' ' 86' ' ' PRO . 14.2 m120 -67.32 -36.02 80.61 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.576 0.35 . . . . 0.0 111.706 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -107.81 3.34 24.33 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.521 0.728 . . . . 0.0 111.31 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.9 t -67.82 118.7 11.4 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.627 0.771 . . . . 0.0 112.639 -170.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.5 mt -86.49 -35.36 19.65 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.055 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.8 t -57.41 -33.87 68.33 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 123.422 0.689 . . . . 0.0 111.614 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 p . . . . . 0 C--O 1.253 1.247 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.127 176.09 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.523 HD12 ' HD2' ' A' ' 34' ' ' HIS . 40.5 mt -66.94 -39.08 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.632 1.173 . . . . 0.0 112.734 -166.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.505 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 68.6 m-85 -113.21 16.9 19.0 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.195 0.598 . . . . 0.0 110.961 -176.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -60.14 -39.6 86.88 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -169.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -94.87 11.0 33.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.961 -0.462 . . . . 0.0 111.471 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 83.2 m -122.9 135.58 54.56 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.611 0.764 . . . . 0.0 112.095 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 37' ' ' LYS . 50.0 t -104.21 134.25 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 167.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.497 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.6 mp -126.07 122.73 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 121.255 0.55 . . . . 0.0 111.107 -174.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -102.99 152.31 21.47 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.59 1.556 . . . . 0.0 107.98 174.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.1 mt -121.96 127.08 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -128.35 139.85 52.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.163 0.985 . . . . 0.0 109.565 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.65 -161.22 46.08 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.593 0.558 . . . . 0.0 112.443 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -102.19 113.12 26.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.633 0.773 . . . . 0.0 109.479 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.492 HG21 HG12 ' A' ' 52' ' ' VAL . 79.5 p -117.93 137.65 52.69 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.851 0.86 . . . . 0.0 109.829 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -106.02 125.83 32.14 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 165.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -76.72 165.16 85.81 Favored 'Cis proline' 0 C--N 1.374 1.903 0 C-N-CA 124.027 -1.239 . . . . 0.0 111.837 2.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.0 161.57 6.41 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 123.906 0.754 . . . . 0.0 114.656 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -55.8 -36.07 67.02 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.525 0.73 . . . . 0.0 111.179 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.535 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.6 pp -61.95 -42.0 98.62 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 123.753 0.658 . . . . 0.0 111.678 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.535 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.3 tp-100 -69.56 -52.24 28.06 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.328 0.651 . . . . 0.0 110.342 -175.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.528 HD13 HG11 ' A' ' 52' ' ' VAL . 71.2 mt -57.8 -44.28 86.22 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.53 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.483 ' HA ' HD12 ' A' ' 31' ' ' ILE . 13.7 m170 -61.79 -37.59 84.9 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.063 0.545 . . . . 0.0 111.321 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 52.0 mm-40 -63.28 -45.84 89.59 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.021 0.439 . . . . 0.0 110.014 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.424 ' HB3' HG21 ' A' ' 79' ' ' VAL . 25.6 mmt -60.77 -37.77 83.0 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.63 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.497 HD13 ' HB ' ' A' ' 14' ' ' ILE . 75.5 mt -62.8 -50.81 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.043 0.537 . . . . 0.0 110.981 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.65 -45.62 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.064 0.546 . . . . 0.0 111.62 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.69 -18.89 65.61 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.275 0.63 . . . . 0.0 111.848 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.523 ' HD2' HD12 ' A' ' 8' ' ' ILE . 21.0 m80 -103.76 27.1 7.82 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.423 0.689 . . . . 0.0 111.108 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.76 -3.25 87.39 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.836 166.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -91.82 171.24 34.27 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 -170.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HB2' HG22 ' A' ' 13' ' ' VAL . 42.0 mmtm -110.24 158.07 18.78 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.457 0.703 . . . . 0.0 109.736 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -133.31 153.23 51.76 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.766 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.483 HD23 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -112.2 136.52 51.51 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -85.25 -35.03 21.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.507 0.723 . . . . 0.0 112.056 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.0 t80 . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 124.413 1.085 . . . . 0.0 108.983 -175.967 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.2 mttt . . . . . 0 CA--C 1.544 0.718 0 CA-C-O 121.612 0.72 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.8 m -84.66 5.15 29.24 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.349 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.404 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -137.04 150.72 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.856 0.862 . . . . 0.0 109.776 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.8 t -101.9 -38.18 7.92 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.058 0.543 . . . . 0.0 110.946 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.579 ' HD2' ' HB2' ' A' ' 68' ' ' LYS . 56.2 m170 -118.5 133.59 55.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.285 0.634 . . . . 0.0 109.442 -172.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.659 ' HB ' HG12 ' A' ' 69' ' ' VAL . 65.5 mt -123.63 134.14 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.528 HG11 HD13 ' A' ' 27' ' ' LEU . 52.1 t -92.69 128.96 43.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.03 143.86 28.7 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.4 t -92.78 -41.44 10.11 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 166.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -145.42 120.43 10.04 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.616 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.8 mt -92.21 148.82 37.43 Favored Pre-proline 0 C--O 1.24 0.583 0 C-N-CA 123.219 0.607 . . . . 0.0 109.678 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.72 157.42 37.67 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.808 2.339 . . . . 0.0 110.849 166.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.8 mt -53.3 -53.71 46.97 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.426 0.69 . . . . 0.0 112.105 -171.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.98 -46.19 90.35 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.38 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -72.67 -19.39 61.43 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.241 0.616 . . . . 0.0 112.251 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -72.84 -40.53 65.66 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 81.4 mt -66.88 -45.6 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.457 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.44 -40.3 73.85 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.074 0.55 . . . . 0.0 111.678 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.86 17.98 4.46 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.194 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.08 -26.51 61.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.697 0.399 . . . . 0.0 110.296 167.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -70.81 -27.27 63.76 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.301 0.641 . . . . 0.0 110.407 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -90.44 153.88 20.07 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.579 ' HB2' ' HD2' ' A' ' 50' ' ' HIS . 0.5 OUTLIER -84.86 85.31 7.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.659 HG12 ' HB ' ' A' ' 51' ' ' ILE . 31.6 m -85.08 129.85 37.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.835 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 m -134.98 171.56 17.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.502 1.121 . . . . 0.0 109.653 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.6 m -78.8 153.6 78.06 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.049 172.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.08 -24.95 52.02 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.743 2.296 . . . . 0.0 112.401 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.68 -27.1 48.32 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.878 1.271 . . . . 0.0 112.769 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -65.07 -45.16 86.45 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.227 0.537 . . . . 0.0 110.395 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 79' ' ' VAL . 3.2 mp -73.96 -45.5 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.74 -176.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 68.8 t -57.7 -49.8 79.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.908 0.883 . . . . 0.0 110.968 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.488 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 25.9 t70 -70.66 -35.18 72.73 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.85 0.46 . . . . 0.0 111.459 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB2' HG21 ' A' ' 8' ' ' ILE . 78.4 p -66.26 -37.33 85.23 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 120.428 0.156 . . . . 0.0 110.71 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 75' ' ' ILE . 72.6 t -64.08 -42.5 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.487 0.715 . . . . 0.0 110.771 173.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' A' ' 77' ' ' ASP . 8.2 mtpm? -63.41 -45.64 90.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.661 0.784 . . . . 0.0 111.485 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -93.79 -9.54 37.17 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.972 0.509 . . . . 0.0 112.197 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.61 36.42 22.65 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.203 1.001 . . . . 0.0 111.729 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -150.74 167.21 28.09 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.764 0.826 . . . . 0.0 110.159 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.28 106.14 18.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.21 146.77 67.72 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.466 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 17.9 Cg_endo -58.88 113.86 1.75 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.33 2.02 . . . . 0.0 111.838 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -57.56 -24.53 56.7 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.498 1.119 . . . . 0.0 111.665 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.466 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.6 pt20 -58.37 -27.9 64.64 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 124.545 1.138 . . . . 0.0 112.507 -176.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -79.33 -18.83 51.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.178 0.591 . . . . 0.0 112.091 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -110.14 1.94 19.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.813 0.845 . . . . 0.0 111.232 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m -65.82 122.5 17.46 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.622 0.769 . . . . 0.0 112.377 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.0 mt -98.83 15.2 26.22 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.631 0.772 . . . . 0.0 110.286 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -64.4 -23.53 67.32 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.573 1.149 . . . . 0.0 111.661 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 C--O 1.25 1.1 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.09 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 121.101 0.477 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.9 mt -67.85 -49.65 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.35 1.06 . . . . 0.0 111.31 -172.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -110.28 12.02 23.34 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.432 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -58.72 -35.93 73.46 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.184 0.593 . . . . 0.0 111.651 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -108.1 16.94 22.88 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.662 0.785 . . . . 0.0 110.894 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 77.4 m -121.03 114.65 21.8 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 123.847 0.859 . . . . 0.0 110.485 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.442 HG12 HG23 ' A' ' 48' ' ' VAL . 48.6 t -97.81 125.12 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 168.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.439 HG23 HG23 ' A' ' 52' ' ' VAL . 3.2 mp -115.7 129.67 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.23 1.012 . . . . 0.0 111.356 -175.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -111.74 118.58 35.99 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 167.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.1 mt -83.28 133.74 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -137.2 125.54 23.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.63 1.172 . . . . 0.0 108.374 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.19 -176.22 51.88 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 -174.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' O ' ' HB3' ' A' ' 54' ' ' SER . 72.8 m-85 -88.01 112.34 22.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 122.813 0.445 . . . . 0.0 109.808 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.422 HG21 HG12 ' A' ' 52' ' ' VAL . 41.3 p -107.83 146.27 32.5 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.749 1.22 . . . . 0.0 109.652 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -110.87 124.54 32.72 Favored Pre-proline 0 N--CA 1.485 1.305 0 CA-C-N 117.665 0.211 . . . . 0.0 111.004 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.12 173.64 57.01 Favored 'Cis proline' 0 C--N 1.375 1.955 0 C-N-CA 124.196 -1.168 . . . . 0.0 112.043 3.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.69 149.66 10.32 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 123.749 0.656 . . . . 0.0 114.535 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -50.13 -38.49 39.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.61 1.164 . . . . 0.0 112.638 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 26' ' ' GLN . 1.4 pp -63.66 -39.45 94.36 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 122.968 0.507 . . . . 0.0 111.98 175.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.499 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.8 tp-100 -73.27 -48.61 33.32 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.093 0.957 . . . . 0.0 110.645 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 72' ' ' PRO . 88.7 mt -56.08 -45.61 79.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.522 0.729 . . . . 0.0 111.311 174.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -54.98 -39.01 68.55 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.678 0.611 . . . . 0.0 111.151 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -64.07 -46.92 82.18 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.778 0.323 . . . . 0.0 110.593 173.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.667 ' HB3' HG21 ' A' ' 79' ' ' VAL . 36.9 mmt -62.56 -35.01 78.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.534 0.734 . . . . 0.0 112.147 -175.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.9 mt -72.35 -53.68 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.566 0.746 . . . . 0.0 111.074 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.5 t -75.0 -37.22 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.878 -167.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.19 -13.84 62.64 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.751 0.82 . . . . 0.0 111.58 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.423 ' NE2' HG13 ' A' ' 79' ' ' VAL . 21.2 m-70 -106.63 26.12 10.35 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.967 0.907 . . . . 0.0 110.619 173.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.69 22.44 72.31 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.761 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.32 156.84 20.85 Favored Glycine 0 CA--C 1.503 -0.706 0 N-CA-C 113.443 0.137 . . . . 0.0 113.443 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.557 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -105.45 144.16 32.61 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -116.35 157.3 25.24 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.99 123.21 44.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 175.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -72.91 -32.93 65.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.078 0.951 . . . . 0.0 111.789 -174.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.9 t80 . . . . . 0 C--O 1.238 0.466 0 C-N-CA 124.428 1.091 . . . . 0.0 108.377 -172.57 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 121.082 0.467 . . . . 0.0 111.427 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.9 m -117.86 17.46 14.22 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.543 0.687 . . . . 0.0 110.754 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -137.95 150.31 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.9 -0.5 . . . . 0.0 109.998 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.6 p -106.74 -31.89 8.22 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.429 0.692 . . . . 0.0 111.083 -176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 80.4 m80 -135.28 129.67 33.91 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.353 1.061 . . . . 0.0 108.369 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.559 ' HB ' HG12 ' A' ' 69' ' ' VAL . 48.8 mt -113.72 118.98 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 174.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.439 HG23 HG23 ' A' ' 14' ' ' ILE . 73.4 t -90.91 118.83 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 122.988 0.515 . . . . 0.0 109.725 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.53 144.21 34.18 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.291 0.636 . . . . 0.0 110.191 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 19' ' ' TYR . 29.8 t -115.43 -37.37 4.04 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 166.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -98.79 98.26 9.39 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.2 tp -139.91 109.96 7.18 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 122.575 0.35 . . . . 0.0 110.145 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 60' ' ' LYS . 18.6 Cg_exo -68.1 158.79 55.9 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.473 2.782 . . . . 0.0 112.012 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.77 -40.77 93.79 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.66 0.784 . . . . 0.0 111.539 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -67.04 -28.64 68.38 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.602 0.761 . . . . 0.0 111.429 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.543 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -86.98 -14.4 41.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.211 0.604 . . . . 0.0 111.178 177.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 92' ' ' LEU . 32.2 mtm180 -73.87 -28.71 61.71 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 166.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.6 mt -77.98 -43.33 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.394 0.677 . . . . 0.0 110.298 173.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.543 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 38.8 tt0 -68.21 -32.63 72.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.653 0.781 . . . . 0.0 111.241 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -110.28 27.61 9.45 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.667 0.787 . . . . 0.0 110.649 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.21 98.4 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.616 0.766 . . . . 0.0 112.6 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -72.81 -25.31 61.1 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.07 0.548 . . . . 0.0 111.289 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -86.26 138.36 31.91 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.96 88.02 3.51 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.559 HG12 ' HB ' ' A' ' 51' ' ' ILE . 35.7 m -75.9 126.3 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 91' ' ' SER . 30.4 m -135.76 178.64 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.508 1.123 . . . . 0.0 109.601 -174.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.8 m -92.2 155.19 42.96 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.686 0.794 . . . . 0.0 110.523 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.561 ' HB3' HD11 ' A' ' 27' ' ' LEU . 17.9 Cg_endo -57.46 -24.52 61.62 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.383 2.722 . . . . 0.0 113.021 174.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.45 -23.24 62.54 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.056 1.342 . . . . 0.0 112.415 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -61.06 -47.8 84.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.632 0.773 . . . . 0.0 110.507 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 75' ' ' ILE . 3.2 mp -75.05 -40.03 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.588 -172.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.2 t -53.82 -52.35 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.873 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -71.83 -44.42 63.91 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.336 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.498 ' HA ' HD23 ' A' ' 85' ' ' LEU . 61.2 m -60.34 -40.06 89.34 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.458 0.703 . . . . 0.0 112.695 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.667 HG21 ' HB3' ' A' ' 30' ' ' MET . 15.1 t -69.2 -47.95 71.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 123.454 0.702 . . . . 0.0 110.893 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -64.53 -42.8 95.52 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.074 0.549 . . . . 0.0 112.065 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -85.9 -9.42 56.97 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.086 0.555 . . . . 0.0 111.624 -177.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.15 23.16 13.77 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.871 1.268 . . . . 0.0 112.3 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.444 ' HG3' HD22 ' A' ' 85' ' ' LEU . 16.5 ptm180 -129.25 171.39 12.51 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.37 1.068 . . . . 0.0 110.029 -177.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.36 111.93 23.72 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 78' ' ' SER . 4.5 mm? -82.22 154.84 69.66 Favored Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 123.225 0.61 . . . . 0.0 110.366 174.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.21 106.8 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.463 2.108 . . . . 0.0 111.502 172.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.405 ' HB2' HG11 ' A' ' 70' ' ' VAL . 2.9 p90 -56.8 -31.91 65.15 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.632 0.773 . . . . 0.0 111.081 173.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -63.43 -23.08 67.25 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.781 1.233 . . . . 0.0 112.561 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -68.37 -37.25 80.26 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.334 0.588 . . . . 0.0 110.2 174.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -99.77 -2.43 35.17 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.654 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 75.4 m -64.55 128.21 34.81 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -173.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.422 ' O ' ' HD2' ' A' ' 61' ' ' ARG . 46.4 mt -85.83 -0.09 54.4 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.686 173.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.7 p -57.5 -43.02 83.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.312 1.045 . . . . 0.0 110.609 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 CA--C 1.558 1.266 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.349 179.85 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.495 HG23 ' HA ' ' A' ' 84' ' ' LEU . 45.5 mt -54.03 -48.35 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.191 1.396 . . . . 0.0 112.49 -173.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.49 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 54.9 m-85 -111.02 13.02 22.04 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.017 -172.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.19 -53.48 57.64 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.345 0.658 . . . . 0.0 111.103 -169.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -87.31 -21.3 25.82 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.604 0.762 . . . . 0.0 110.509 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.8 m -72.26 131.8 43.2 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.354 0.597 . . . . 0.0 110.613 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.532 HG12 HG23 ' A' ' 48' ' ' VAL . 21.1 t -105.86 124.75 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.44 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.5 mp -121.52 123.55 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 118.227 0.467 . . . . 0.0 111.554 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 34.8 t80 -105.86 132.11 52.36 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.568 1.147 . . . . 0.0 108.011 170.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.8 mt -100.56 130.33 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -131.34 129.26 41.18 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.102 0.961 . . . . 0.0 109.21 -173.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.62 174.49 46.44 Favored Glycine 0 C--N 1.343 0.926 0 O-C-N 123.275 0.359 . . . . 0.0 112.918 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -82.06 112.28 18.98 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.959 0.504 . . . . 0.0 109.876 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.609 HG21 HG12 ' A' ' 52' ' ' VAL . 80.7 p -120.78 145.41 47.58 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.611 1.164 . . . . 0.0 110.053 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -99.75 129.09 29.48 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 122.7 0.4 . . . . 0.0 111.112 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.472 ' HD2' HD21 ' A' ' 27' ' ' LEU . 36.4 Cg_endo -81.42 177.13 36.16 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.855 -0.894 . . . . 0.0 111.662 -1.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.6 138.65 6.37 Favored Glycine 0 C--N 1.349 1.296 0 O-C-N 124.078 0.861 . . . . 0.0 113.997 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -54.25 -33.0 57.53 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.716 0.806 . . . . 0.0 112.497 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 26' ' ' GLN . 4.6 pp -55.26 -44.23 75.41 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 123.604 0.565 . . . . 0.0 111.045 175.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.455 ' N ' HD12 ' A' ' 25' ' ' LEU . 61.1 tt0 -73.75 -44.78 55.24 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.347 0.659 . . . . 0.0 110.856 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.472 HD21 ' HD2' ' A' ' 22' ' ' PRO . 81.3 mt -56.72 -39.24 73.55 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.907 0.483 . . . . 0.0 111.053 175.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 32' ' ' VAL . 15.9 m170 -63.22 -42.64 99.29 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.451 0.7 . . . . 0.0 110.036 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.18 -36.12 82.56 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.984 0.514 . . . . 0.0 110.928 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.532 ' HB3' HG21 ' A' ' 79' ' ' VAL . 32.9 mmt -66.01 -31.59 72.58 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.676 0.79 . . . . 0.0 110.932 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 28' ' ' HIS . 62.6 mt -70.82 -52.95 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.853 174.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 28' ' ' HIS . 20.9 t -68.04 -43.69 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 122.991 0.516 . . . . 0.0 111.941 -168.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.17 -19.61 61.76 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.383 0.673 . . . . 0.0 112.201 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -100.9 24.34 9.39 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.192 0.997 . . . . 0.0 110.84 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.8 18.28 70.22 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.106 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.08 160.3 30.77 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -166.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HG3' HG13 ' A' ' 13' ' ' VAL . 17.9 tppt? -106.32 142.51 35.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.402 0.681 . . . . 0.0 109.792 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -141.35 147.71 38.52 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.426 1.091 . . . . 0.0 108.635 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.4 mt -125.55 139.03 53.95 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.785 0.434 . . . . 0.0 111.09 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.41 -33.85 73.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.964 1.306 . . . . 0.0 112.374 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.8 t80 . . . . . 0 N--CA 1.469 0.51 0 C-N-CA 123.921 0.889 . . . . 0.0 109.564 -172.218 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HA ' ' HE1' ' A' ' 67' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 122.449 1.119 . . . . 0.0 110.632 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.7 m -92.66 -11.22 34.72 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.923 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.532 HG23 HG12 ' A' ' 13' ' ' VAL . 3.9 p -108.37 151.57 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.258 0.623 . . . . 0.0 109.994 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -101.78 -40.18 7.07 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 121.193 0.52 . . . . 0.0 110.705 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -128.97 142.85 50.79 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.269 1.027 . . . . 0.0 109.188 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.638 ' HB ' HG12 ' A' ' 69' ' ' VAL . 61.1 mt -123.97 138.0 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.609 HG12 HG21 ' A' ' 20' ' ' THR . 60.4 t -91.91 138.44 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.518 0.727 . . . . 0.0 110.246 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.67 151.91 29.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.589 1.155 . . . . 0.0 107.953 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.6 m -79.76 -48.66 13.24 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -137.34 142.18 41.82 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.57 117.74 11.29 Favored Pre-proline 0 CA--C 1.558 1.25 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.92 160.66 36.91 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.599 2.866 . . . . 0.0 113.556 -174.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -51.98 -45.45 64.47 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.549 1.14 . . . . 0.0 112.684 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -57.53 -43.97 84.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.587 0.755 . . . . 0.0 110.995 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -79.24 -20.77 47.39 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 119.412 -0.328 . . . . 0.0 111.306 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -66.33 -29.76 70.03 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 117.931 0.332 . . . . 0.0 110.243 168.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.7 mt -75.11 -40.73 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 110.337 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -76.1 -25.11 55.14 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.971 0.508 . . . . 0.0 111.386 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.475 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 41.4 m-85 -114.07 30.5 7.23 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.61 1.164 . . . . 0.0 109.662 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.46 -37.93 58.14 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.128 0.971 . . . . 0.0 112.773 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -87.81 -26.87 22.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.602 0.761 . . . . 0.0 111.279 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.491 ' HE1' ' HA ' ' A' ' 46' ' ' LYS . 46.0 m-85 -91.92 120.92 33.03 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.448 0.699 . . . . 0.0 109.574 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -75.06 86.35 2.35 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.638 HG12 ' HB ' ' A' ' 51' ' ' ILE . 20.1 m -76.2 128.18 37.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.84 171.68 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.954 1.302 . . . . 0.0 109.368 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 53.7 m -78.08 153.88 79.96 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.244 0.618 . . . . 0.0 111.027 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.86 -24.98 77.81 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.661 2.241 . . . . 0.0 111.888 175.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.44 -23.62 65.97 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.899 1.28 . . . . 0.0 111.504 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -62.79 -48.09 80.65 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-O 120.933 0.397 . . . . 0.0 110.033 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.49 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.8 mp -67.46 -44.35 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.055 -175.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.2 t -63.32 -51.46 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.259 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.91 -35.56 69.72 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.666 -172.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB3' HG21 ' A' ' 8' ' ' ILE . 61.1 m -63.57 -44.53 93.83 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.117 0.261 . . . . 0.0 110.422 176.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.532 HG21 ' HB3' ' A' ' 30' ' ' MET . 55.9 t -64.49 -34.26 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.454 0.702 . . . . 0.0 110.883 175.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -66.89 -32.68 74.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.303 0.641 . . . . 0.0 110.748 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -94.61 -10.98 30.3 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.61 0.764 . . . . 0.0 112.147 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.06 30.04 19.27 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.412 1.085 . . . . 0.0 112.055 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.8 ptt-85 -151.3 164.11 37.39 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.38 0.672 . . . . 0.0 110.498 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.495 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.2 tm? -79.49 106.74 11.74 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.2 mt -85.97 157.51 57.06 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.488 0.715 . . . . 0.0 109.94 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -65.49 120.8 8.06 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.079 1.853 . . . . 0.0 111.683 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -57.87 -31.52 66.79 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.542 1.137 . . . . 0.0 111.372 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -63.89 -21.69 66.58 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.702 1.201 . . . . 0.0 112.379 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -66.75 -30.8 71.11 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.139 0.576 . . . . 0.0 110.648 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.15 8.43 11.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.941 0.896 . . . . 0.0 111.946 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 p -67.74 111.52 4.31 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.997 0.519 . . . . 0.0 112.138 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.27 -11.85 58.39 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.452 0.701 . . . . 0.0 111.511 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.442 ' HB ' HG22 ' A' ' 69' ' ' VAL . 9.3 t -69.08 -27.05 65.26 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.493 0.717 . . . . 0.0 111.144 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.7 p . . . . . 0 C--O 1.251 1.16 0 C-N-CA 123.273 0.629 . . . . 0.0 109.867 175.693 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.467 HG23 ' HA ' ' A' ' 84' ' ' LEU . 67.6 mt -55.3 -48.59 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.193 0.997 . . . . 0.0 111.956 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -109.67 11.88 24.43 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.536 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -61.99 -41.65 98.28 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.948 0.499 . . . . 0.0 112.267 -170.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -76.62 -27.22 55.64 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.041 0.448 . . . . 0.0 110.214 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.2 m -88.1 144.18 26.64 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.284 1.04 . . . . 0.0 112.462 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.538 HG12 HG23 ' A' ' 48' ' ' VAL . 21.4 t -115.54 127.82 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.543 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.6 mp -123.19 128.19 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 122.764 0.426 . . . . 0.0 111.532 -171.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 24.6 t80 -108.36 151.37 26.1 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.377 1.471 . . . . 0.0 108.675 175.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.458 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 74.0 mt -118.32 123.18 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.373 0.669 . . . . 0.0 109.336 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -117.07 135.68 53.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.259 1.024 . . . . 0.0 109.388 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.89 -139.92 28.03 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.45 0.469 . . . . 0.0 112.767 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -112.6 120.25 40.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.304 0.642 . . . . 0.0 109.667 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.737 HG21 HG12 ' A' ' 52' ' ' VAL . 68.1 p -133.17 147.11 52.05 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.463 0.705 . . . . 0.0 109.559 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -108.91 135.61 20.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.366 0.667 . . . . 0.0 109.793 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.482 ' HD2' HD21 ' A' ' 27' ' ' LEU . 70.3 Cg_endo -74.81 177.24 39.72 Favored 'Cis proline' 0 C--N 1.369 1.631 0 C-N-CA 124.643 -0.982 . . . . 0.0 111.634 -5.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.18 146.98 3.68 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 124.019 0.824 . . . . 0.0 114.776 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -58.21 -36.38 73.05 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.077 0.951 . . . . 0.0 112.599 -172.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.01 -32.92 72.81 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.234 0.214 . . . . 0.0 110.65 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -69.19 -53.24 21.02 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.451 0.7 . . . . 0.0 110.425 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.482 HD21 ' HD2' ' A' ' 22' ' ' PRO . 87.8 mt -57.27 -40.55 77.96 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.458 0.703 . . . . 0.0 111.786 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.584 ' HA ' HD12 ' A' ' 31' ' ' ILE . 17.2 m170 -61.49 -38.96 89.23 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.9 0.48 . . . . 0.0 111.363 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.51 -35.05 68.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.628 0.371 . . . . 0.0 111.257 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.534 ' HB3' HG21 ' A' ' 79' ' ' VAL . 54.8 mtt -61.08 -31.97 71.63 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.971 0.509 . . . . 0.0 110.799 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.584 HD12 ' HA ' ' A' ' 28' ' ' HIS . 66.1 mt -68.09 -51.03 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.299 0.64 . . . . 0.0 110.986 173.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 28' ' ' HIS . 92.0 t -60.99 -50.27 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.569 0.748 . . . . 0.0 112.747 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.1 -12.58 60.36 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.441 0.696 . . . . 0.0 112.326 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -108.77 26.29 10.73 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.092 0.957 . . . . 0.0 110.13 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.0 60.48 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-N 114.58 -1.191 . . . . 0.0 114.051 171.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.33 159.63 48.84 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 -164.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.405 ' HB3' HG22 ' A' ' 13' ' ' VAL . 21.7 ttmm -103.49 152.55 21.54 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -137.23 159.04 43.07 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.043 0.449 . . . . 0.0 111.323 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.52 128.51 56.04 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 165.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.1 -33.39 70.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.405 172.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.413 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 35.1 t80 . . . . . 0 C--N 1.351 0.639 0 C-N-CA 124.414 1.086 . . . . 0.0 108.7 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.775 0 CA-C-O 121.357 0.598 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 m -90.45 -32.15 16.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.924 0.89 . . . . 0.0 110.223 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.538 HG23 HG12 ' A' ' 13' ' ' VAL . 6.5 p -92.98 155.26 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.196 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -109.18 -27.67 9.45 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 118.064 0.393 . . . . 0.0 111.42 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -118.77 140.47 49.9 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.224 0.61 . . . . 0.0 109.959 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.693 ' HB ' HG12 ' A' ' 69' ' ' VAL . 33.5 mt -125.08 140.07 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.737 HG12 HG21 ' A' ' 20' ' ' THR . 95.2 t -104.51 135.85 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.768 0.827 . . . . 0.0 109.666 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.02 150.18 27.99 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.41 0.684 . . . . 0.0 109.364 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -75.95 -42.68 47.87 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -139.73 133.52 30.6 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.132 -1.395 . . . . 0.0 108.034 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.579 ' HG ' HG21 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -116.14 110.37 43.58 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.88 156.42 66.0 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.964 2.442 . . . . 0.0 112.861 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.1 -47.88 81.88 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.333 1.053 . . . . 0.0 112.995 -169.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 1.1 mptm? -64.15 -31.19 72.29 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.913 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -83.55 -18.87 36.89 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.073 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -66.06 -32.5 74.01 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 168.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 64.9 mt -71.01 -49.62 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.498 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 38.6 mm-40 -66.34 -31.88 72.94 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.723 0.409 . . . . 0.0 111.76 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -106.47 25.91 10.55 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.559 0.744 . . . . 0.0 110.882 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.94 -32.88 74.57 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.054 0.454 . . . . 0.0 110.579 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -69.87 -26.47 64.21 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.101 0.961 . . . . 0.0 111.318 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -99.05 162.51 13.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.334 0.654 . . . . 0.0 110.582 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -101.58 88.21 3.37 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.693 HG12 ' HB ' ' A' ' 51' ' ' ILE . 26.8 m -75.89 134.6 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.731 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 87' ' ' TRP . 34.6 m -137.62 175.45 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.808 1.243 . . . . 0.0 109.873 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.2 m -81.85 154.5 70.48 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.762 0.825 . . . . 0.0 110.113 172.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.42 -24.22 71.11 Favored 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.51 2.14 . . . . 0.0 111.426 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.98 -21.47 63.55 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.955 1.302 . . . . 0.0 111.27 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.73 -51.45 62.31 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 123.144 0.277 . . . . 0.0 110.266 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 75' ' ' ILE . 3.1 mp -66.33 -43.94 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.79 -51.97 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.24 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -73.09 -33.15 65.43 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.197 0.599 . . . . 0.0 111.787 -171.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 71.9 m -66.97 -40.52 87.49 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.58 0.352 . . . . 0.0 110.281 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 30' ' ' MET . 55.0 t -70.68 -33.87 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.451 0.7 . . . . 0.0 110.786 173.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -64.58 -41.37 96.32 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.157 0.983 . . . . 0.0 110.523 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -95.41 -6.46 40.85 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.855 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.22 27.14 15.47 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.573 1.149 . . . . 0.0 112.33 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -142.49 159.33 42.44 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.774 0.83 . . . . 0.0 110.546 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.467 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.2 tm? -75.1 127.55 33.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.8 mt -114.7 152.12 46.0 Favored Pre-proline 0 C--O 1.24 0.596 0 C-N-CA 124.214 1.006 . . . . 0.0 109.714 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.414 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 35.3 Cg_endo -61.73 109.34 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.551 2.167 . . . . 0.0 111.877 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.549 ' HB2' HG11 ' A' ' 70' ' ' VAL . 29.9 p90 -62.14 -21.91 65.42 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.388 1.075 . . . . 0.0 112.206 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.414 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 12.7 pt20 -59.78 -25.11 64.65 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.127 0.971 . . . . 0.0 111.818 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -70.92 -31.66 68.35 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.788 0.835 . . . . 0.0 111.131 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.29 -0.79 25.97 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.905 0.882 . . . . 0.0 111.318 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -66.24 131.42 46.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.329 0.652 . . . . 0.0 112.0 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.8 mt -108.31 14.54 24.79 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.101 0.96 . . . . 0.0 110.951 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.0 p -65.56 -52.73 50.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.823 0.849 . . . . 0.0 111.321 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 C--O 1.252 1.185 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.166 -173.858 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 82' ' ' ALA . 64.3 mt -49.08 -47.87 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.507 1.523 . . . . 0.0 112.352 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -109.58 15.32 22.98 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.862 0.465 . . . . 0.0 111.566 -174.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -57.82 -49.3 77.12 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.287 0.635 . . . . 0.0 111.448 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -76.41 -15.56 59.91 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.675 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.5 m -93.08 141.17 28.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.632 0.773 . . . . 0.0 111.421 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.56 124.84 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 171.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.411 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.2 mp -118.5 134.28 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 C-N-CA 123.155 0.582 . . . . 0.0 111.74 -170.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 33.3 t80 -113.0 149.49 33.24 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.414 1.486 . . . . 0.0 108.089 169.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 65.7 mt -114.54 110.01 30.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -103.83 122.44 45.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.277 1.431 . . . . 0.0 109.447 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.76 175.58 50.98 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.88 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -82.08 111.49 18.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.602 HG21 HG12 ' A' ' 52' ' ' VAL . 69.6 p -112.14 151.92 28.92 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.887 0.875 . . . . 0.0 110.037 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -102.99 122.91 43.88 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 163.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -81.66 172.08 54.41 Favored 'Cis proline' 0 C--N 1.37 1.698 0 C-N-CA 124.031 -1.237 . . . . 0.0 112.033 1.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.61 164.6 15.79 Favored Glycine 0 C--N 1.344 0.995 0 O-C-N 123.735 0.647 . . . . 0.0 114.357 -172.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -56.11 -36.53 68.3 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.362 0.665 . . . . 0.0 111.411 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.9 pp -61.66 -43.12 99.46 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.454 0.701 . . . . 0.0 111.57 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.537 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.2 tp-100 -71.29 -51.76 22.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.345 0.658 . . . . 0.0 110.22 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.68 -51.09 70.13 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.028 0.83 . . . . 0.0 111.402 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.45 ' O ' HG23 ' A' ' 32' ' ' VAL . 15.6 m170 -54.85 -47.55 74.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.727 0.642 . . . . 0.0 111.109 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.5 -38.94 91.19 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.27 0.356 . . . . 0.0 111.571 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.602 ' HB3' HG21 ' A' ' 79' ' ' VAL . 21.2 mmt -61.22 -40.0 92.39 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.991 0.516 . . . . 0.0 111.132 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.411 HD13 ' HB ' ' A' ' 14' ' ' ILE . 70.8 mt -65.19 -49.12 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.008 0.923 . . . . 0.0 111.348 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 28' ' ' HIS . 57.9 t -65.84 -41.55 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.979 0.512 . . . . 0.0 111.573 -176.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.39 -13.04 60.1 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.321 0.648 . . . . 0.0 111.844 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.601 ' HE1' HG13 ' A' ' 79' ' ' VAL . 38.6 m80 -108.92 26.85 10.11 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.699 0.799 . . . . 0.0 111.758 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.95 7.03 75.03 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.944 172.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.89 158.1 30.28 Favored Glycine 0 C--O 1.242 0.596 0 C-N-CA 123.026 0.346 . . . . 0.0 113.94 -173.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -102.83 158.67 16.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.502 0.721 . . . . 0.0 109.653 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.37 161.71 37.63 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.389 0.676 . . . . 0.0 110.473 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.1 149.42 42.23 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.789 0.836 . . . . 0.0 110.531 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -68.9 -47.87 64.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.612 1.165 . . . . 0.0 111.566 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 77.5 t80 . . . . . 0 N--CA 1.476 0.858 0 C-N-CA 124.674 1.19 . . . . 0.0 108.96 -170.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HA ' ' HE1' ' A' ' 67' ' ' TYR . 54.1 mtpt . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -82.04 -24.32 35.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.748 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.84 151.53 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.12 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.6 p -114.57 -17.74 11.62 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -137.71 136.77 37.67 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.26 1.024 . . . . 0.0 109.096 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.619 ' HB ' HG12 ' A' ' 69' ' ' VAL . 67.4 mt -125.21 137.25 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.602 HG12 HG21 ' A' ' 20' ' ' THR . 54.5 t -105.84 133.72 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.41 1.084 . . . . 0.0 110.74 -173.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.45 146.01 20.79 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -77.14 -39.76 48.05 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -138.33 107.9 6.21 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.63 ' HB2' HD13 ' A' ' 92' ' ' LEU . 16.5 tp -100.53 119.61 58.29 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -64.32 159.55 43.19 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.623 2.882 . . . . 0.0 112.589 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.7 mt -58.99 -46.05 89.09 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.982 0.913 . . . . 0.0 112.38 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -57.56 -46.11 84.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.453 0.701 . . . . 0.0 110.713 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -66.26 -30.07 70.43 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.158 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -66.65 -38.24 86.47 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.159 0.584 . . . . 0.0 110.724 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.8 mt -70.39 -46.18 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 123.82 0.7 . . . . 0.0 110.384 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.71 -32.36 73.87 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.689 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.431 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 22.0 m-30 -103.08 15.05 30.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.451 0.701 . . . . 0.0 111.89 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.86 -18.81 62.69 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.323 0.583 . . . . 0.0 110.896 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -71.77 -19.91 61.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.268 1.027 . . . . 0.0 110.602 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.499 ' HE1' ' HA ' ' A' ' 46' ' ' LYS . 17.2 m-85 -113.47 169.83 8.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.382 1.073 . . . . 0.0 109.008 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -96.15 91.07 5.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.427 0.691 . . . . 0.0 109.413 175.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.619 HG12 ' HB ' ' A' ' 51' ' ' ILE . 20.3 m -82.88 129.95 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.288 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.477 HG11 ' HB2' ' A' ' 87' ' ' TRP . 31.6 m -139.79 167.56 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.754 1.221 . . . . 0.0 110.514 -175.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.6 m -75.76 155.91 84.89 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.847 172.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.06 -25.46 79.82 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.469 2.113 . . . . 0.0 111.495 172.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.5 -29.89 59.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.48 1.512 . . . . 0.0 112.651 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.433 ' CE3' HG21 ' A' ' 70' ' ' VAL . 27.6 t90 -62.18 -48.74 78.69 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.354 0.408 . . . . 0.0 110.197 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.77 -54.98 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.241 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.8 t -51.84 -52.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.841 1.257 . . . . 0.0 112.346 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -71.58 -42.1 68.17 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.732 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.435 ' HA ' HD13 ' A' ' 85' ' ' LEU . 72.5 m -61.63 -36.93 82.17 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.736 0.415 . . . . 0.0 111.448 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.602 HG21 ' HB3' ' A' ' 30' ' ' MET . 21.8 t -63.57 -46.94 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.265 1.026 . . . . 0.0 111.057 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -65.97 -43.47 87.77 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.042 0.537 . . . . 0.0 111.102 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -76.5 -15.59 59.85 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.708 0.803 . . . . 0.0 112.04 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 8' ' ' ILE . . . 58.41 40.92 23.69 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.091 0.956 . . . . 0.0 110.843 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -159.51 156.54 28.37 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.868 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -85.81 109.3 18.58 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 78' ' ' SER . 8.6 mp -79.64 155.28 76.04 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.126 0.57 . . . . 0.0 111.242 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.469 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 35.8 Cg_endo -61.12 114.83 2.36 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.426 2.084 . . . . 0.0 111.325 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.477 ' HB2' HG11 ' A' ' 70' ' ' VAL . 48.1 p90 -64.9 -20.09 66.26 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.649 0.78 . . . . 0.0 112.395 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.469 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.0 pt20 -58.19 -28.04 64.41 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.275 1.03 . . . . 0.0 112.023 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -70.6 -27.68 64.28 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.605 0.762 . . . . 0.0 110.814 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.78 5.95 14.27 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.047 0.939 . . . . 0.0 111.689 -175.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.437 ' HB2' HG22 ' A' ' 93' ' ' THR . 59.9 p -69.85 120.48 15.66 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.202 0.601 . . . . 0.0 112.287 -174.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.63 HD13 ' HB2' ' A' ' 56' ' ' LEU . 48.5 mt -73.62 -21.48 60.29 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.947 0.899 . . . . 0.0 111.666 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 91' ' ' SER . 10.3 t -65.5 -17.53 64.63 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.694 0.798 . . . . 0.0 112.112 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.4 m . . . . . 0 C--O 1.26 1.613 0 C-N-CA 123.294 0.637 . . . . 0.0 109.993 175.568 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.556 HG21 ' OG ' ' A' ' 78' ' ' SER . 57.7 mt -64.73 -51.42 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.681 -167.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.655 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 61.7 m-85 -103.17 18.04 22.67 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.886 -175.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -51.16 -59.09 4.56 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.281 1.032 . . . . 0.0 112.877 -171.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -95.81 17.39 15.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.867 0.867 . . . . 0.0 111.01 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.447 ' SG ' ' HH2' ' A' ' 74' ' ' TRP . 41.1 t -116.9 123.26 46.58 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 124.484 1.114 . . . . 0.0 109.756 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.475 HG11 HD23 ' A' ' 39' ' ' LEU . 40.6 t -101.68 128.2 54.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.533 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.2 mp -122.36 123.28 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 122.833 0.453 . . . . 0.0 111.041 -175.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 28.4 t80 -104.35 150.74 24.22 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.341 1.456 . . . . 0.0 108.134 174.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.21 130.31 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -135.81 123.78 22.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.414 1.085 . . . . 0.0 109.771 -170.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.7 -161.57 42.45 Favored Glycine 0 C--N 1.343 0.958 0 O-C-N 123.496 0.498 . . . . 0.0 112.822 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -88.03 110.73 20.84 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.237 0.615 . . . . 0.0 109.558 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.537 HG21 HG12 ' A' ' 52' ' ' VAL . 61.5 p -133.94 134.4 42.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.044 0.937 . . . . 0.0 109.271 -177.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -117.47 139.17 25.83 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -69.94 170.69 58.03 Favored 'Cis proline' 0 C--N 1.389 2.707 0 C-N-CA 124.705 -0.956 . . . . 0.0 112.567 3.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.67 149.11 5.55 Favored Glycine 0 N--CA 1.475 1.257 0 O-C-N 124.01 0.819 . . . . 0.0 114.196 -169.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -52.23 -36.08 51.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.777 0.831 . . . . 0.0 112.197 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 26' ' ' GLN . 3.6 pp -62.46 -41.44 98.76 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.27 0.628 . . . . 0.0 111.63 174.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.512 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.5 tp-100 -72.19 -50.79 24.83 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.813 0.845 . . . . 0.0 110.945 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.1 mt -54.73 -44.96 74.01 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.215 0.606 . . . . 0.0 111.008 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.515 ' HA ' HD12 ' A' ' 31' ' ' ILE . 9.5 m170 -58.75 -43.5 90.31 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 123.572 0.545 . . . . 0.0 111.417 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -66.5 -38.89 88.23 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 123.168 0.292 . . . . 0.0 111.23 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.0 mmt -58.42 -39.36 79.57 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.338 0.655 . . . . 0.0 110.947 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.533 HD13 ' HB ' ' A' ' 14' ' ' ILE . 70.9 mt -62.69 -47.8 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.07 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 28' ' ' HIS . 39.1 t -64.19 -47.6 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.653 0.596 . . . . 0.0 111.117 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.01 -33.55 73.44 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.829 0.852 . . . . 0.0 111.47 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.467 ' HE1' HG13 ' A' ' 79' ' ' VAL . 54.9 m80 -86.44 27.47 0.94 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.255 0.622 . . . . 0.0 112.274 175.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.32 28.99 73.02 Favored Glycine 0 C--N 1.357 1.73 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.29 169.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.655 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -112.44 172.43 14.66 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 115.551 0.98 . . . . 0.0 115.551 -168.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -111.16 146.22 37.25 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.702 0.801 . . . . 0.0 109.444 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -128.83 166.25 19.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.562 0.745 . . . . 0.0 109.585 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.475 HD23 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -130.3 136.22 48.91 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.051 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -82.44 -36.79 26.27 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 123.867 0.729 . . . . 0.0 112.144 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 61.3 t80 . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 122.974 0.509 . . . . 0.0 110.539 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.548 0.896 0 CA-C-O 121.542 0.687 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.6 m -79.68 -27.86 40.74 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.435 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.4 p -86.64 151.71 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.984 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.453 HG23 ' ND1' ' A' ' 50' ' ' HIS . 5.1 t -114.79 -25.4 8.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.742 0.817 . . . . 0.0 110.683 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.453 ' ND1' HG23 ' A' ' 49' ' ' THR . 53.5 m80 -133.38 127.42 33.42 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.924 0.49 . . . . 0.0 110.419 -174.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.631 ' HB ' HG12 ' A' ' 69' ' ' VAL . 61.7 mt -119.04 129.41 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.537 HG12 HG21 ' A' ' 20' ' ' THR . 70.8 t -90.76 123.27 42.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 123.63 0.772 . . . . 0.0 109.187 -173.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.93 140.69 31.23 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.834 0.853 . . . . 0.0 108.951 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -84.05 -49.95 8.43 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.61 132.99 56.54 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.518 -1.219 . . . . 0.0 107.719 170.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.98 101.55 10.41 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.09 160.16 48.68 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.092 2.528 . . . . 0.0 112.706 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.8 -31.97 67.1 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.052 0.941 . . . . 0.0 112.001 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 47.9 tptt -60.77 -53.42 57.61 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.269 0.628 . . . . 0.0 109.911 175.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -70.69 -19.25 62.79 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.821 0.448 . . . . 0.0 111.841 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -72.88 -27.69 62.05 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.735 0.814 . . . . 0.0 109.779 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.3 mt -79.11 -45.3 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.321 0.648 . . . . 0.0 110.043 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 24.4 mm-40 -63.52 -29.18 70.49 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.598 0.759 . . . . 0.0 112.215 -175.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -121.97 28.63 7.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.058 0.943 . . . . 0.0 110.293 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -30.68 69.26 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.447 0.699 . . . . 0.0 112.566 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -75.08 -23.63 58.03 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.119 0.568 . . . . 0.0 111.572 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -107.64 123.69 48.87 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.94 93.23 0.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.369 0.604 . . . . 0.0 109.755 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.631 HG12 ' HB ' ' A' ' 51' ' ' ILE . 27.4 m -73.89 128.83 36.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 87' ' ' TRP . 30.2 m -128.13 172.13 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.253 1.021 . . . . 0.0 109.862 -174.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -80.46 152.51 73.08 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.27 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -56.78 -25.09 59.15 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.693 2.262 . . . . 0.0 112.17 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.41 -26.5 53.55 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.884 1.273 . . . . 0.0 112.286 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.447 ' HH2' ' SG ' ' A' ' 12' ' ' CYS . 28.3 t90 -59.6 -48.45 81.62 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.825 0.284 . . . . 0.0 110.454 174.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 79' ' ' VAL . 3.3 mp -69.33 -42.71 81.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 O-C-N 124.042 0.839 . . . . 0.0 108.85 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.48 HG12 ' HE2' ' A' ' 80' ' ' LYS . 85.0 t -62.14 -50.52 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.006 0.922 . . . . 0.0 111.408 -177.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.23 -33.72 76.66 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.24 0.616 . . . . 0.0 110.849 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.556 ' OG ' HG21 ' A' ' 8' ' ' ILE . 38.5 t -62.54 -37.65 86.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.235 0.614 . . . . 0.0 111.449 177.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 75' ' ' ILE . 94.0 t -70.96 -47.13 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.502 0.721 . . . . 0.0 110.669 177.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.48 ' HE2' HG12 ' A' ' 76' ' ' VAL . 53.2 mtmt -64.74 -45.16 87.63 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.486 0.714 . . . . 0.0 111.744 -175.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -86.76 -15.51 39.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.342 0.657 . . . . 0.0 111.473 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.85 38.56 14.58 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.572 1.149 . . . . 0.0 111.869 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -149.75 164.49 35.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.395 0.678 . . . . 0.0 110.285 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.5 tp -84.05 95.26 8.52 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.8 142.94 96.15 Favored Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.449 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 16.8 Cg_endo -56.24 108.01 0.3 Allowed 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.302 2.001 . . . . 0.0 110.79 172.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.411 ' HB2' HG11 ' A' ' 70' ' ' VAL . 29.8 p90 -56.95 -22.69 39.9 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.547 1.139 . . . . 0.0 112.695 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.449 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 20.6 pt20 -57.47 -26.77 61.75 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.749 1.22 . . . . 0.0 112.105 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.445 HD21 ' HG2' ' A' ' 86' ' ' PRO . 61.4 m-20 -67.09 -38.46 85.75 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.196 0.598 . . . . 0.0 110.72 175.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -99.72 -5.62 28.46 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.07 0.948 . . . . 0.0 111.521 -172.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.0 m -66.23 121.74 15.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.111 0.564 . . . . 0.0 112.304 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.8 mt -81.86 -0.65 44.54 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.557 1.143 . . . . 0.0 111.062 172.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.8 p -66.96 -20.59 65.92 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.512 1.125 . . . . 0.0 111.665 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.558 1.254 0 C-N-CA 124.587 1.155 . . . . 0.0 111.876 -178.93 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 10' ' ' LYS . 15.3 ptpt . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.53 HG23 ' HA ' ' A' ' 84' ' ' LEU . 66.9 mt -49.49 -46.23 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.024 1.33 . . . . 0.0 112.167 -177.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.495 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 78.1 m-85 -104.8 15.86 27.06 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.976 -173.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 7' ' ' LYS . 28.5 ttpp -51.53 -48.26 63.07 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.902 0.881 . . . . 0.0 113.312 -173.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -98.78 2.04 46.53 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.036 0.534 . . . . 0.0 111.436 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.4 m -97.89 110.8 23.31 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.873 0.869 . . . . 0.0 110.919 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.0 t -93.31 127.84 45.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.468 ' HB ' HD13 ' A' ' 31' ' ' ILE . 2.6 mp -114.74 136.06 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.58 0.752 . . . . 0.0 110.941 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -118.05 110.84 18.14 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 170.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.7 mt -77.22 134.28 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -138.68 122.02 17.11 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -173.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.63 -173.91 52.95 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.681 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -79.97 110.76 15.66 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.213 0.605 . . . . 0.0 109.904 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.558 HG21 HG12 ' A' ' 52' ' ' VAL . 61.8 p -121.16 136.68 54.93 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 11.0 mmpt? -104.06 135.43 19.35 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 117.85 0.295 . . . . 0.0 110.685 176.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' HD21 ' A' ' 27' ' ' LEU . 94.1 Cg_endo -74.24 173.79 54.96 Favored 'Cis proline' 0 C--N 1.378 2.099 0 C-N-CA 124.613 -0.995 . . . . 0.0 112.107 -1.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.64 156.0 3.73 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 123.885 0.741 . . . . 0.0 114.745 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -54.46 -38.4 66.31 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.572 0.749 . . . . 0.0 111.519 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.3 pp -60.62 -44.94 95.76 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 123.779 0.674 . . . . 0.0 111.338 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.528 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.7 tp-100 -69.45 -50.31 46.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.344 0.658 . . . . 0.0 110.672 -175.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.417 HD21 ' HD2' ' A' ' 22' ' ' PRO . 81.6 mt -56.1 -50.45 71.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.975 0.51 . . . . 0.0 111.447 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.438 ' HA ' HD12 ' A' ' 31' ' ' ILE . 23.5 m170 -54.82 -41.92 71.25 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.698 0.799 . . . . 0.0 111.094 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -67.81 -44.49 77.18 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.156 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 34.2 mmt -63.16 -34.1 76.9 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.158 0.583 . . . . 0.0 111.629 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.468 HD13 ' HB ' ' A' ' 14' ' ' ILE . 66.1 mt -60.54 -50.73 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.386 173.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.3 t -66.64 -39.78 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.549 0.74 . . . . 0.0 112.367 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.3 -23.55 67.47 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.698 0.799 . . . . 0.0 111.388 178.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -104.88 27.57 7.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.973 0.909 . . . . 0.0 111.044 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.49 14.16 80.52 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 114.893 -1.049 . . . . 0.0 114.114 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.86 174.88 22.85 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 114.524 0.57 . . . . 0.0 114.524 -170.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.415 ' HB2' ' NZ ' ' A' ' 37' ' ' LYS . 2.7 ttmp? -128.54 151.19 49.73 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.157 0.583 . . . . 0.0 109.787 -177.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -121.18 161.4 21.93 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.532 0.733 . . . . 0.0 109.337 170.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.24 131.94 56.33 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -64.54 -40.01 94.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.094 0.958 . . . . 0.0 112.196 -165.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.1 t80 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -175.753 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 CA--C 1.543 0.711 0 CA-C-O 121.114 0.483 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.7 m -108.31 -28.06 9.64 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.304 0.642 . . . . 0.0 110.624 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.6 150.03 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.55 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.3 p -102.89 -26.86 12.96 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.299 0.639 . . . . 0.0 111.302 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -137.35 128.48 27.72 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.814 0.846 . . . . 0.0 109.653 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.486 ' HB ' HG22 ' A' ' 69' ' ' VAL . 43.7 mt -110.65 114.68 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 175.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.558 HG12 HG21 ' A' ' 20' ' ' THR . 78.2 t -89.15 135.93 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.815 0.846 . . . . 0.0 109.919 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.37 170.59 19.71 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.598 0.759 . . . . 0.0 110.306 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.6 t -86.81 -52.23 5.62 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -145.07 103.17 3.84 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.521 ' HG ' HG11 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -89.1 114.71 61.28 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.85 143.49 91.03 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.362 2.708 . . . . 0.0 113.017 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.8 mt -55.93 -41.0 73.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.294 1.038 . . . . 0.0 112.428 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -56.61 -50.16 72.8 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.661 0.784 . . . . 0.0 110.524 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -76.1 -17.85 59.43 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.487 -175.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -68.99 -32.05 71.32 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.983 0.356 . . . . 0.0 110.162 170.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.5 mt -65.58 -42.92 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.03 -40.18 94.44 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 120.931 0.396 . . . . 0.0 111.122 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.42 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 21.0 m-85 -95.58 25.14 4.7 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.939 0.496 . . . . 0.0 111.124 -176.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.02 -16.77 62.06 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.269 0.627 . . . . 0.0 111.406 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -79.05 -14.94 58.86 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.729 0.412 . . . . 0.0 110.853 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.42 ' HD2' ' HA ' ' A' ' 64' ' ' PHE . 32.4 m-85 -115.71 152.77 32.58 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 109.408 -175.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -90.28 88.81 7.36 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.527 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 73.2 t -74.88 124.68 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 87' ' ' TRP . 32.7 m -133.03 176.64 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.941 0.896 . . . . 0.0 110.966 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.3 m -87.63 158.93 50.53 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 124.278 1.031 . . . . 0.0 109.957 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.62 -21.24 70.24 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.418 2.079 . . . . 0.0 111.794 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.23 -26.14 66.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.129 1.372 . . . . 0.0 111.637 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -62.3 -44.88 95.48 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.759 0.314 . . . . 0.0 110.381 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.495 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.6 mp -71.43 -50.98 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.985 -176.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.9 t -57.89 -52.5 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.557 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.81 -37.75 73.25 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.071 -172.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 98.2 p -65.73 -39.25 90.94 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.29 0.236 . . . . 0.0 111.139 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.06 -41.55 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.67 0.788 . . . . 0.0 110.793 176.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.57 -38.06 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.559 0.744 . . . . 0.0 111.252 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -82.28 -18.51 42.13 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.649 0.78 . . . . 0.0 111.39 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.59 32.94 22.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.716 1.206 . . . . 0.0 111.539 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -139.12 162.03 35.94 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.801 0.84 . . . . 0.0 109.922 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.53 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.0 tm? -79.21 125.37 29.37 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.97 148.64 35.1 Favored Pre-proline 0 C--O 1.243 0.713 0 C-N-CA 123.66 0.784 . . . . 0.0 109.975 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.05 115.11 2.75 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.131 1.887 . . . . 0.0 110.335 166.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.516 ' HB2' HG11 ' A' ' 70' ' ' VAL . 12.7 p90 -62.96 -25.2 68.25 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.65 0.78 . . . . 0.0 111.862 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -60.03 -22.91 63.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.388 1.075 . . . . 0.0 112.13 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -63.45 -45.45 90.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.884 0.874 . . . . 0.0 110.105 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -102.42 6.43 40.18 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.57 0.748 . . . . 0.0 111.604 -173.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 36.7 m -65.84 114.54 5.15 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.038 0.535 . . . . 0.0 112.362 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.7 -26.33 63.37 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.79 0.836 . . . . 0.0 110.201 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.527 ' HB ' ' HB ' ' A' ' 69' ' ' VAL . 8.8 t -69.95 -11.05 60.59 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.934 0.894 . . . . 0.0 112.261 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.258 1.53 0 C-N-CA 123.213 0.605 . . . . 0.0 110.091 174.563 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.3 mttm . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.4 mt -53.37 -45.67 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.845 0.858 . . . . 0.0 112.253 -172.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.47 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 70.4 m-85 -111.63 15.54 21.02 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 119.275 -0.393 . . . . 0.0 111.127 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -56.37 -41.51 76.32 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.539 0.736 . . . . 0.0 112.811 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -96.92 -3.6 41.52 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.099 0.559 . . . . 0.0 111.391 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.444 ' SG ' ' ND1' ' A' ' 50' ' ' HIS . 51.8 t -99.0 127.05 44.84 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 123.974 0.91 . . . . 0.0 110.676 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.466 HG12 HG23 ' A' ' 48' ' ' VAL . 32.4 t -106.41 134.42 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.469 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.9 mp -125.64 128.47 72.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 123.391 0.677 . . . . 0.0 111.359 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -114.69 120.32 39.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.97 1.308 . . . . 0.0 108.174 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.6 mt -93.29 109.55 21.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -98.33 123.73 42.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.672 1.189 . . . . 0.0 109.599 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.88 -159.77 52.31 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 123.416 0.447 . . . . 0.0 113.892 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.74 122.48 32.19 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.782 0.833 . . . . 0.0 110.54 -177.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.611 HG21 HG12 ' A' ' 52' ' ' VAL . 72.3 p -132.88 146.24 51.64 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.015 1.326 . . . . 0.0 108.944 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -112.49 130.51 23.32 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.02 171.75 65.21 Favored 'Cis proline' 0 C--N 1.382 2.291 0 C-N-CA 124.146 -1.189 . . . . 0.0 111.381 -0.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.28 147.71 5.91 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.833 0.708 . . . . 0.0 114.493 -173.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -52.78 -36.48 58.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.713 0.805 . . . . 0.0 112.41 -175.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 pp -59.23 -43.01 92.38 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.319 0.648 . . . . 0.0 111.615 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -67.39 -50.15 60.86 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.858 0.863 . . . . 0.0 110.327 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.406 ' O ' HG13 ' A' ' 31' ' ' ILE . 92.9 mt -55.81 -41.24 73.89 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.474 0.709 . . . . 0.0 111.732 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.619 ' HA ' HD12 ' A' ' 31' ' ' ILE . 13.0 m80 -62.46 -37.52 86.25 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.68 0.792 . . . . 0.0 110.877 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -68.36 -40.92 81.31 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.225 0.61 . . . . 0.0 110.569 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.591 ' HB3' HG21 ' A' ' 79' ' ' VAL . 64.5 mtt -59.69 -33.49 71.65 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.436 0.695 . . . . 0.0 111.142 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.619 HD12 ' HA ' ' A' ' 28' ' ' HIS . 74.4 mt -70.3 -54.1 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.321 0.648 . . . . 0.0 110.982 177.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 28' ' ' HIS . 93.8 t -65.58 -45.52 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.428 0.691 . . . . 0.0 112.185 -170.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.82 -21.03 66.71 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.479 0.712 . . . . 0.0 112.241 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -104.27 26.91 8.28 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.564 0.746 . . . . 0.0 110.726 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.36 -1.35 87.63 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.882 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . -75.51 160.37 52.0 Favored Glycine 0 CA--C 1.5 -0.859 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -170.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.436 ' HB3' HG22 ' A' ' 13' ' ' VAL . 2.9 tppp? -112.98 145.82 40.15 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -127.75 149.77 50.09 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.459 0.703 . . . . 0.0 109.329 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.462 HD23 HG11 ' A' ' 13' ' ' VAL . 1.3 mm? -116.65 128.74 55.65 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.42 ' H ' ' CD2' ' A' ' 40' ' ' HIS . 0.3 OUTLIER -64.54 -42.19 95.88 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.603 1.161 . . . . 0.0 111.594 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.6 p90 . . . . . 0 N--CA 1.476 0.847 0 C-N-CA 123.609 0.763 . . . . 0.0 109.515 171.663 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 122.619 1.199 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 m -87.12 -8.84 56.59 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.968 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.466 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -112.7 155.84 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.8 0.84 . . . . 0.0 110.001 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 74.1 p -111.79 -30.74 7.2 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.14 0.576 . . . . 0.0 111.231 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.444 ' ND1' ' SG ' ' A' ' 12' ' ' CYS . 80.7 m80 -128.42 134.02 48.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.872 0.869 . . . . 0.0 110.016 -175.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 36.6 mt -121.75 114.19 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 121.443 0.639 . . . . 0.0 109.798 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.611 HG12 HG21 ' A' ' 20' ' ' THR . 74.7 t -90.53 119.19 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.145 0.978 . . . . 0.0 110.413 -175.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.0 137.9 18.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.744 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.1 t -86.05 -35.23 20.43 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 171.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -127.6 99.42 5.58 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 124.213 1.005 . . . . 0.0 108.519 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -107.28 107.89 61.06 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.406 ' HG2' ' HD3' ' A' ' 60' ' ' LYS . 34.1 Cg_endo -61.41 152.63 71.56 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.155 2.57 . . . . 0.0 113.173 -173.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.33 -35.95 74.77 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.32 1.048 . . . . 0.0 112.566 -171.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -62.82 -45.26 93.46 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.567 0.699 . . . . 0.0 109.966 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HD3' ' HG2' ' A' ' 57' ' ' PRO . 1.1 mptm? -77.89 -18.34 56.27 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.001 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.417 ' NH1' ' HA ' ' A' ' 93' ' ' THR . 1.2 mmp_? -65.59 -35.23 80.21 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.18 0.592 . . . . 0.0 111.038 171.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.7 mt -69.17 -47.06 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 123.572 0.545 . . . . 0.0 109.806 172.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -58.02 -40.39 80.71 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.779 0.832 . . . . 0.0 111.655 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.41 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 18.3 m-85 -110.17 27.12 9.93 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.215 1.006 . . . . 0.0 110.741 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.42 -44.69 93.9 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.165 0.586 . . . . 0.0 111.301 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.42 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.8 OUTLIER -77.62 -26.0 50.21 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.457 0.703 . . . . 0.0 110.722 179.195 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 64' ' ' PHE . 16.3 m-85 -75.52 135.69 40.62 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' A' ' 93' ' ' THR . 43.7 mmtm -80.71 86.1 5.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.355 0.598 . . . . 0.0 109.784 -177.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 93.3 t -73.76 125.25 32.59 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 91' ' ' SER . 24.0 m -131.08 173.59 14.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 C-N-CA 123.392 0.677 . . . . 0.0 110.161 -175.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.4 m -79.64 149.4 71.26 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.044 173.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.83 -28.45 87.15 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.395 2.064 . . . . 0.0 111.338 168.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.44 -23.89 64.78 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.321 1.449 . . . . 0.0 111.695 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -63.42 -48.6 77.11 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.957 0.503 . . . . 0.0 110.43 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.4 mp -69.06 -45.14 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.325 -173.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -58.04 -49.73 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.24 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.85 -36.73 70.24 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.812 0.695 . . . . 0.0 110.993 -172.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.1 m -65.79 -41.25 92.18 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.611 0.365 . . . . 0.0 110.81 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.591 HG21 ' HB3' ' A' ' 30' ' ' MET . 54.7 t -71.03 -33.03 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.748 0.819 . . . . 0.0 110.841 175.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -65.39 -42.9 92.14 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.441 1.096 . . . . 0.0 110.522 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -92.91 -6.15 49.24 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.048 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.07 36.59 24.27 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.431 1.092 . . . . 0.0 111.812 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -156.45 151.91 26.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.007 0.923 . . . . 0.0 109.768 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.83 121.62 19.3 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -105.95 160.82 24.8 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 124.054 0.942 . . . . 0.0 110.342 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -54.3 108.7 0.31 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.991 2.461 . . . . 0.0 112.756 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -62.03 -34.08 75.57 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.736 174.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -58.15 -26.88 63.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.833 1.253 . . . . 0.0 112.087 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -74.54 -37.76 62.94 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.446 0.699 . . . . 0.0 110.362 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.49 -0.7 29.52 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.398 0.679 . . . . 0.0 112.33 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 27.0 p -75.42 110.7 10.0 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.055 0.455 . . . . 0.0 111.039 -177.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.6 mt -73.26 -17.38 61.34 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.332 1.053 . . . . 0.0 111.041 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.613 HG21 ' HA ' ' A' ' 68' ' ' LYS . 13.7 t -74.67 -26.48 59.88 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.608 0.763 . . . . 0.0 111.837 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.343 -0.837 . . . . 0.0 109.694 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt . . . . . 0 CA--C 1.545 0.752 0 CA-C-O 120.675 0.274 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.417 HG23 ' HA ' ' A' ' 84' ' ' LEU . 64.6 mt -67.71 -50.3 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.209 0.604 . . . . 0.0 110.223 -177.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.85 16.2 17.32 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.01 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -62.44 -36.56 82.78 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 120.913 0.387 . . . . 0.0 111.569 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -98.77 8.36 45.04 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.688 0.795 . . . . 0.0 111.161 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 71.9 m -117.24 114.1 23.15 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.605 0.762 . . . . 0.0 111.134 -174.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.35 126.77 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.41 HG23 HG23 ' A' ' 52' ' ' VAL . 3.3 mp -114.89 131.47 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.142 0.577 . . . . 0.0 111.425 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 16.7 t80 -114.34 114.27 25.68 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.639 1.175 . . . . 0.0 108.635 169.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.7 mt -88.48 137.83 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -142.74 143.05 32.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.887 0.875 . . . . 0.0 109.646 -166.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.96 -137.84 32.37 Favored Glycine 0 C--N 1.346 1.117 0 O-C-N 123.519 0.512 . . . . 0.0 111.975 -174.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.1 145.38 37.24 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 171.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.514 HG21 HG12 ' A' ' 52' ' ' VAL . 37.1 p -142.21 140.67 32.39 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.741 1.216 . . . . 0.0 108.619 178.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -109.76 126.34 29.31 Favored Pre-proline 0 N--CA 1.485 1.277 0 CA-C-N 118.288 0.495 . . . . 0.0 110.264 171.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HD2' HD21 ' A' ' 27' ' ' LEU . 43.9 Cg_endo -76.15 174.3 53.63 Favored 'Cis proline' 0 C--N 1.374 1.905 0 C-N-CA 124.362 -1.099 . . . . 0.0 112.076 2.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.04 144.23 4.96 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.938 0.774 . . . . 0.0 114.094 -174.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 10.0 ptp180 -55.4 -36.3 66.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.191 0.596 . . . . 0.0 112.151 -172.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.93 -32.13 72.37 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.992 0.517 . . . . 0.0 111.857 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 30' ' ' MET . 8.5 tt0 -68.45 -51.84 39.16 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.454 HD21 ' HD2' ' A' ' 22' ' ' PRO . 91.9 mt -55.29 -39.58 70.05 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.606 0.763 . . . . 0.0 111.006 176.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -59.67 -47.61 84.93 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.628 1.171 . . . . 0.0 109.514 -178.105 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -65.96 -39.65 90.59 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.029 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.557 ' HB3' HG21 ' A' ' 79' ' ' VAL . 26.4 mmt -60.79 -33.27 72.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.876 0.47 . . . . 0.0 110.986 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -72.29 -51.92 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.398 0.679 . . . . 0.0 111.004 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.0 -47.42 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.573 0.749 . . . . 0.0 111.817 -174.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.82 -16.61 58.98 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.031 0.932 . . . . 0.0 111.713 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -109.76 28.33 8.68 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.903 0.881 . . . . 0.0 111.235 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.24 5.9 88.46 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.4 -0.818 . . . . 0.0 114.227 170.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.69 160.57 32.81 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 115.105 0.802 . . . . 0.0 115.105 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -105.38 162.0 13.83 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.557 -0.821 . . . . 0.0 109.44 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -136.09 164.88 27.0 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.502 174.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.77 130.38 31.86 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -66.34 -46.69 75.95 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 124.131 0.894 . . . . 0.0 113.263 -164.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.46 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 74.7 t80 . . . . . 0 N--CA 1.479 1.014 0 C-N-CA 123.641 0.776 . . . . 0.0 109.471 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.0 m -126.96 -10.43 6.0 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.039 0.536 . . . . 0.0 110.615 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.8 p -113.54 143.28 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.066 0.546 . . . . 0.0 110.734 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 t -108.41 -13.82 14.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.923 0.489 . . . . 0.0 111.55 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -138.94 128.23 24.17 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.383 0.673 . . . . 0.0 109.953 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.645 ' HB ' HG22 ' A' ' 69' ' ' VAL . 66.4 mt -114.18 136.43 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG12 HG21 ' A' ' 20' ' ' THR . 86.8 t -113.19 119.33 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.86 173.3 11.85 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.595 0.758 . . . . 0.0 109.613 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -89.77 -44.17 10.17 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 174.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -130.34 145.84 51.84 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.041 -1.436 . . . . 0.0 108.473 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.525 ' HG ' HG11 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -136.13 117.34 11.57 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.181 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' O ' ' HG3' ' A' ' 61' ' ' ARG . 95.2 Cg_endo -77.31 155.38 32.64 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.861 2.374 . . . . 0.0 113.201 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.0 mt -51.32 -49.72 60.79 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.062 1.345 . . . . 0.0 114.266 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.56 -31.38 69.54 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.467 -177.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -72.11 -27.77 62.85 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 118.183 0.447 . . . . 0.0 111.131 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 85.3 mtt180 -60.1 -38.58 83.39 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 172.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.7 mt -64.88 -43.59 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.61 0.764 . . . . 0.0 110.782 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 6.2 mm-40 -72.99 -21.76 60.79 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.374 0.67 . . . . 0.0 111.396 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -113.19 27.11 9.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.275 1.03 . . . . 0.0 110.119 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.36 -28.17 69.58 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.186 0.595 . . . . 0.0 112.303 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -88.67 -29.38 19.94 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.936 0.495 . . . . 0.0 111.017 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -88.87 117.36 27.82 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -71.11 87.17 0.76 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.963 0.505 . . . . 0.0 109.677 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.645 HG22 ' HB ' ' A' ' 51' ' ' ILE . 22.9 t -81.09 128.41 38.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.34 172.31 16.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 124.874 1.27 . . . . 0.0 110.034 -175.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 60.9 p -85.28 159.47 56.33 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.81 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.32 -24.32 67.37 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.714 2.276 . . . . 0.0 112.718 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.82 -26.52 68.17 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.498 1.119 . . . . 0.0 112.084 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 37.1 t90 -61.63 -40.56 95.29 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.173 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 75' ' ' ILE . 2.8 mp -76.69 -49.65 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.025 0.93 . . . . 0.0 108.961 -177.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.98 -51.36 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.079 0.952 . . . . 0.0 111.343 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.43 -39.4 71.06 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.622 -173.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.5 p -64.49 -44.97 89.31 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 120.949 0.404 . . . . 0.0 111.309 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 30' ' ' MET . 41.7 t -65.5 -33.74 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.356 1.062 . . . . 0.0 111.298 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -72.83 -38.66 67.06 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 120.8 0.334 . . . . 0.0 110.889 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -89.0 -7.66 55.56 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.816 0.846 . . . . 0.0 112.048 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.89 27.85 16.97 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.669 1.188 . . . . 0.0 112.474 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -138.23 165.36 26.89 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.804 0.841 . . . . 0.0 110.365 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.417 ' HA ' HG23 ' A' ' 8' ' ' ILE . 51.2 tp -82.53 142.91 31.45 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 169.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.5 mt -110.61 155.06 42.8 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 123.777 0.831 . . . . 0.0 110.407 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.05 111.55 1.79 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.145 1.897 . . . . 0.0 110.309 166.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -59.64 -27.54 66.45 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.627 0.771 . . . . 0.0 111.961 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -58.37 -28.35 65.05 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.219 1.008 . . . . 0.0 111.974 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -71.9 -35.79 69.82 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.26 0.624 . . . . 0.0 110.674 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -105.91 7.48 32.17 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.649 0.78 . . . . 0.0 111.561 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.2 t -65.28 116.5 6.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.961 0.904 . . . . 0.0 112.456 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.5 -24.77 56.88 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.431 0.692 . . . . 0.0 111.443 175.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.545 HG23 ' HB ' ' A' ' 69' ' ' VAL . 22.7 p -69.56 -21.67 63.6 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.174 0.59 . . . . 0.0 112.315 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 C--O 1.249 1.069 0 CA-C-O 119.045 -0.502 . . . . 0.0 109.655 177.277 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.569 1.701 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.24 -46.84 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 124.029 0.932 . . . . 0.0 111.694 176.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -107.13 10.22 30.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.196 0.599 . . . . 0.0 111.55 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -57.46 -43.84 84.32 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.378 0.671 . . . . 0.0 111.301 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -78.69 -18.8 53.78 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.262 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.85 127.19 44.71 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.728 0.811 . . . . 0.0 112.306 -172.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 49' ' ' THR . 40.8 t -96.81 130.66 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 162.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.4 mp -121.56 122.86 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 36.8 t80 -105.1 125.52 51.07 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 167.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.434 HG12 ' HB ' ' A' ' 52' ' ' VAL . 47.4 mt -98.85 139.8 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -136.07 141.52 44.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.334 1.053 . . . . 0.0 109.893 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.47 -149.13 49.45 Favored Glycine 0 C--N 1.348 1.206 0 O-C-N 123.804 0.69 . . . . 0.0 113.439 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -95.54 116.3 28.63 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.64 0.776 . . . . 0.0 109.893 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.436 HG21 HG12 ' A' ' 52' ' ' VAL . 72.9 p -129.15 134.85 48.22 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.17 0.988 . . . . 0.0 108.673 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -111.16 131.37 22.23 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-N 117.993 0.36 . . . . 0.0 110.727 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.84 173.87 53.98 Favored 'Cis proline' 0 C--N 1.38 2.188 0 C-N-CA 124.416 -1.077 . . . . 0.0 111.992 0.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.81 146.86 9.03 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.053 0.846 . . . . 0.0 114.248 -173.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -52.39 -34.82 49.7 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.667 1.187 . . . . 0.0 112.763 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.455 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.4 pp -63.26 -43.63 97.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.452 0.301 . . . . 0.0 110.959 177.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -72.18 -41.71 66.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.083 0.553 . . . . 0.0 110.486 -176.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.6 mt -56.02 -43.96 78.24 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.344 0.658 . . . . 0.0 111.18 170.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.541 ' HA ' HD12 ' A' ' 31' ' ' ILE . 10.8 m170 -65.41 -34.94 79.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.097 0.559 . . . . 0.0 111.042 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 22.7 mm-40 -65.39 -41.17 93.99 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.584 0.354 . . . . 0.0 110.268 174.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.656 ' HB3' HG21 ' A' ' 79' ' ' VAL . 68.5 mtt -58.52 -35.72 72.73 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.364 0.665 . . . . 0.0 111.243 176.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 28' ' ' HIS . 64.6 mt -72.76 -51.8 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.757 0.823 . . . . 0.0 111.609 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.5 t -70.38 -41.83 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.286 0.634 . . . . 0.0 111.648 -172.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -65.92 -12.72 56.81 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.652 0.781 . . . . 0.0 111.983 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -107.84 24.99 12.09 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.349 1.06 . . . . 0.0 111.227 174.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.71 15.5 68.86 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.878 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.03 161.15 25.4 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 122.918 0.294 . . . . 0.0 113.335 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -106.53 148.63 27.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.673 0.789 . . . . 0.0 109.854 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -131.5 151.12 51.84 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.069 0.547 . . . . 0.0 110.746 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.6 tp -115.27 137.44 52.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.639 1.176 . . . . 0.0 108.975 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.57 -35.75 33.89 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.155 0.982 . . . . 0.0 112.997 -173.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.3 t80 . . . . . 0 N--CA 1.475 0.807 0 C-N-CA 124.568 1.147 . . . . 0.0 108.4 -169.268 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 121.925 0.869 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.7 m -84.84 -37.57 20.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.572 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.07 150.54 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.654 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 13' ' ' VAL . 10.0 t -115.17 -22.7 9.33 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.524 0.729 . . . . 0.0 111.081 175.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.416 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 27.8 m170 -133.77 126.19 30.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.491 0.717 . . . . 0.0 109.824 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.648 ' HB ' HG22 ' A' ' 69' ' ' VAL . 68.5 mt -109.39 139.84 30.66 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.436 HG12 HG21 ' A' ' 20' ' ' THR . 61.2 t -110.74 122.0 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.156 0.582 . . . . 0.0 109.704 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.69 170.65 18.2 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.454 0.701 . . . . 0.0 109.568 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.2 t -108.87 -48.24 3.32 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 168.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -106.83 91.41 3.66 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.06 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.482 ' HG ' HG11 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -112.18 106.99 55.99 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.34 147.78 44.76 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.77 2.98 . . . . 0.0 113.84 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.41 -38.34 71.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.758 0.823 . . . . 0.0 110.667 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.402 ' HB3' ' NZ ' ' A' ' 59' ' ' LYS . 3.2 mmmp? -51.56 -55.23 20.31 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.241 1.016 . . . . 0.0 110.899 172.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 63' ' ' GLU . 43.0 mtmt -80.79 -10.18 59.75 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.98 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -72.4 -30.97 65.14 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.474 0.579 . . . . 0.0 109.885 170.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.8 mt -80.54 -40.84 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 123.448 0.467 . . . . 0.0 109.922 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 42.3 mt-10 -67.34 -37.24 82.96 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.333 0.653 . . . . 0.0 111.147 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -104.68 26.59 8.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.865 0.866 . . . . 0.0 110.44 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.24 -23.79 64.84 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.828 0.451 . . . . 0.0 111.249 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.438 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.8 OUTLIER -70.52 -28.33 64.86 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.253 0.621 . . . . 0.0 110.031 175.556 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -95.45 174.77 6.85 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 170.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 34.6 mmtm -126.55 97.02 4.86 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.648 HG22 ' HB ' ' A' ' 51' ' ' ILE . 17.6 t -76.32 129.78 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.634 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.95 176.95 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.059 1.344 . . . . 0.0 109.298 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.9 m -85.95 156.51 57.92 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.464 0.706 . . . . 0.0 110.255 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' O ' HG23 ' A' ' 76' ' ' VAL . 19.8 Cg_endo -56.6 -27.57 70.35 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 123.116 2.544 . . . . 0.0 112.401 174.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -61.51 -24.11 66.38 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.884 1.274 . . . . 0.0 111.959 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -62.21 -48.09 81.53 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 172.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.6 mp -69.66 -47.08 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.0 -174.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 72' ' ' PRO . 95.9 t -59.83 -54.75 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.068 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 16.7 t70 -72.38 -36.41 68.71 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.741 -171.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.2 m -60.9 -40.32 92.68 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 120.694 0.283 . . . . 0.0 111.087 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.656 HG21 ' HB3' ' A' ' 30' ' ' MET . 45.2 t -70.0 -40.27 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.293 0.637 . . . . 0.0 111.476 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -63.57 -46.14 87.27 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.837 0.455 . . . . 0.0 110.794 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 17.5 mm-40 -80.16 -15.44 57.07 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.484 0.714 . . . . 0.0 111.066 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.86 28.8 14.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.015 1.326 . . . . 0.0 112.114 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -141.99 158.57 43.61 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.962 0.905 . . . . 0.0 109.755 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.4 tp -79.14 121.63 25.25 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.9 mt -101.68 158.57 31.53 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 124.104 0.962 . . . . 0.0 110.055 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.88 108.76 0.96 Allowed 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.153 1.902 . . . . 0.0 111.64 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -57.87 -33.15 68.39 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.726 0.81 . . . . 0.0 110.948 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -59.65 -31.16 69.28 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.533 1.133 . . . . 0.0 111.729 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -70.73 -39.44 73.35 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.548 0.739 . . . . 0.0 110.844 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -93.56 0.27 56.56 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.427 0.691 . . . . 0.0 111.661 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.6 t -72.2 124.91 26.02 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.612 0.365 . . . . 0.0 111.702 -171.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.5 mt -73.07 -43.89 61.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.99 168.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p -75.63 84.12 2.65 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.292 0.568 . . . . 0.0 109.805 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.248 1.026 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -178.642 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.3 pttp . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.479 0.181 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.4 -49.5 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.062 0.545 . . . . 0.0 111.623 -172.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.576 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 57.2 m-85 -108.4 17.48 22.07 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.778 -176.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -62.34 -43.88 97.79 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.508 0.723 . . . . 0.0 111.112 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -84.82 6.17 25.68 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.499 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.9 m -120.94 131.66 54.48 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.958 0.903 . . . . 0.0 111.261 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.457 HG22 ' HD3' ' A' ' 37' ' ' LYS . 15.1 t -103.18 127.27 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 166.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.499 ' H ' ' HA ' ' A' ' 38' ' ' PHE . 4.1 mp -118.1 120.17 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.14 0.576 . . . . 0.0 112.196 -176.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 13.0 t80 -106.54 126.26 52.04 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 166.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -97.95 110.85 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -104.25 128.13 51.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.943 0.897 . . . . 0.0 109.598 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.17 -171.45 50.32 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.383 0.427 . . . . 0.0 113.224 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.07 135.91 33.11 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.638 0.775 . . . . 0.0 110.09 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.505 HG21 HG12 ' A' ' 52' ' ' VAL . 41.5 p -138.06 148.4 45.02 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.417 1.087 . . . . 0.0 109.214 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 21' ' ' LYS . 11.9 mmpt? -105.54 120.63 48.78 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 165.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HD2' HD21 ' A' ' 27' ' ' LEU . 31.3 Cg_endo -84.2 174.62 37.64 Favored 'Cis proline' 0 CA--C 1.553 1.474 0 C-N-CA 123.896 -1.293 . . . . 0.0 111.295 -1.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.98 155.38 8.84 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -171.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -48.35 -37.1 15.81 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.022 1.329 . . . . 0.0 112.743 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.4 pp -63.05 -44.68 95.17 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.943 0.897 . . . . 0.0 111.439 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.5 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.5 tp-100 -71.83 -45.85 60.07 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.648 0.779 . . . . 0.0 110.542 -176.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.459 HD21 ' HD2' ' A' ' 22' ' ' PRO . 93.1 mt -57.86 -46.43 84.83 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.058 176.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.436 ' HA ' HD12 ' A' ' 31' ' ' ILE . 15.5 m170 -60.6 -36.46 78.62 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.019 0.528 . . . . 0.0 111.573 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -63.97 -46.41 84.77 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.74 0.416 . . . . 0.0 110.347 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.63 ' HB3' HG21 ' A' ' 79' ' ' VAL . 26.2 mmt -60.15 -34.0 72.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.71 0.804 . . . . 0.0 111.926 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 28' ' ' HIS . 78.6 mt -68.63 -51.26 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.526 0.73 . . . . 0.0 111.551 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.7 t -73.05 -40.4 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.034 0.534 . . . . 0.0 111.775 -172.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.04 -15.95 64.05 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.387 0.675 . . . . 0.0 111.754 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -109.57 26.59 10.47 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.768 0.827 . . . . 0.0 110.398 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.51 39.24 79.65 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-N 114.582 -1.19 . . . . 0.0 114.013 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.576 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -115.74 161.41 12.89 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 -173.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.457 ' HD3' HG22 ' A' ' 13' ' ' VAL . 88.3 tttt -105.86 150.13 25.9 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 122.925 0.49 . . . . 0.0 110.22 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.499 ' HA ' ' H ' ' A' ' 14' ' ' ILE . 27.0 p90 -141.85 164.73 29.39 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.374 0.67 . . . . 0.0 110.637 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.553 HD12 ' HB ' ' A' ' 48' ' ' VAL . 55.8 mt -124.8 146.88 49.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.723 0.809 . . . . 0.0 109.647 168.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.484 ' HD2' ' H ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -73.87 -35.3 64.72 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.661 175.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.484 ' H ' ' HD2' ' A' ' 40' ' ' HIS . 53.9 p90 . . . . . 0 N--CA 1.48 1.048 0 C-N-CA 125.517 1.527 . . . . 0.0 109.02 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.2 p -125.06 -37.96 2.38 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.3 0.64 . . . . 0.0 112.477 -171.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.553 ' HB ' HD12 ' A' ' 39' ' ' LEU . 6.6 p -82.52 152.76 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 122.262 -0.274 . . . . 0.0 110.345 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 t -114.55 -24.0 9.01 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.804 0.441 . . . . 0.0 111.508 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -129.0 130.28 46.45 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.763 0.425 . . . . 0.0 110.399 -177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 23.1 mt -116.93 134.97 58.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.505 HG12 HG21 ' A' ' 20' ' ' THR . 91.0 t -108.67 120.99 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.176 0.59 . . . . 0.0 110.954 -176.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.81 150.88 48.59 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.485 1.114 . . . . 0.0 108.625 172.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 20' ' ' THR . 41.1 t -76.71 -33.12 58.21 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 172.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -161.17 111.41 1.69 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.341 1.056 . . . . 0.0 108.348 170.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.652 HD22 HG11 ' A' ' 69' ' ' VAL . 16.4 tp -85.37 135.11 39.2 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 118.65 -0.69 . . . . 0.0 109.596 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.62 153.65 47.7 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.147 2.565 . . . . 0.0 112.56 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.59 -45.61 93.33 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.23 0.612 . . . . 0.0 112.125 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.0 mmmm -65.99 -36.81 84.32 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.642 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -66.96 -28.27 68.14 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.486 0.314 . . . . 0.0 111.649 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.17 -31.94 72.7 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.453 0.301 . . . . 0.0 110.319 173.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.9 mt -74.43 -37.76 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.07 0.548 . . . . 0.0 110.56 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 27.4 mm-40 -66.34 -42.01 88.73 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.424 0.631 . . . . 0.0 110.637 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -104.65 27.58 7.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.256 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.68 -22.83 64.35 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.495 0.718 . . . . 0.0 112.222 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.29 -6.94 59.46 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.849 0.46 . . . . 0.0 111.312 174.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -110.68 141.75 43.51 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.585 0.754 . . . . 0.0 109.411 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -79.33 86.03 5.1 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.652 HG11 HD22 ' A' ' 56' ' ' LEU . 55.7 t -75.47 130.04 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.474 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.601 HG11 ' HB2' ' A' ' 87' ' ' TRP . 35.2 m -134.65 177.18 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.003 1.321 . . . . 0.0 109.831 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -89.32 160.48 42.41 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.136 0.975 . . . . 0.0 110.541 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.459 ' HB3' HD11 ' A' ' 27' ' ' LEU . 23.3 Cg_endo -59.56 -23.38 70.79 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.802 2.335 . . . . 0.0 111.995 172.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.65 -27.31 66.25 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 124.708 1.203 . . . . 0.0 111.863 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -61.43 -43.68 98.45 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.108 0.413 . . . . 0.0 110.45 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.9 mp -72.05 -46.16 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -176.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.93 -47.8 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.371 1.068 . . . . 0.0 111.625 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.26 -42.27 75.8 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.761 0.824 . . . . 0.0 111.574 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.6 m -65.85 -36.85 84.59 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 120.72 0.295 . . . . 0.0 111.191 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 30' ' ' MET . 24.9 t -70.41 -33.86 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.771 0.828 . . . . 0.0 110.655 173.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -67.24 -34.51 77.61 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.549 0.74 . . . . 0.0 110.977 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -96.38 -13.6 23.1 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.189 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.64 39.06 24.99 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.284 1.033 . . . . 0.0 111.245 -175.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -156.18 156.53 34.35 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.884 0.874 . . . . 0.0 109.886 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.6 tp -75.51 107.77 7.87 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.245 0.618 . . . . 0.0 110.432 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.7 mt -88.72 156.09 50.22 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.556 0.742 . . . . 0.0 111.081 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.34 108.66 1.22 Allowed 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.524 2.149 . . . . 0.0 111.809 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.601 ' HB2' HG11 ' A' ' 70' ' ' VAL . 24.0 p90 -62.8 -20.91 65.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.112 0.965 . . . . 0.0 112.538 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -57.14 -35.45 69.52 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.176 0.99 . . . . 0.0 111.545 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.39 -27.23 68.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.798 0.839 . . . . 0.0 110.986 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.1 -6.15 18.87 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.696 0.798 . . . . 0.0 111.067 -175.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 75.5 m -64.19 130.17 42.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -172.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.3 mt -106.94 22.05 16.59 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.475 1.11 . . . . 0.0 110.498 173.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.7 p -64.22 -50.78 66.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.615 0.766 . . . . 0.0 110.717 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 C--O 1.251 1.163 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.659 176.49 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.5 mttp . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.403 HG23 ' HA ' ' A' ' 84' ' ' LEU . 55.9 mt -57.52 -45.72 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 123.568 0.747 . . . . 0.0 111.462 -176.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.758 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 50.8 m-85 -112.03 18.98 18.28 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.988 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -60.22 -40.21 89.36 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 118.312 0.505 . . . . 0.0 111.933 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -87.16 -7.64 57.76 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.687 0.795 . . . . 0.0 111.031 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 74.1 m -112.45 108.51 17.68 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 122.189 0.995 . . . . 0.0 111.818 -171.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.469 HG12 HG23 ' A' ' 48' ' ' VAL . 38.7 t -89.14 125.76 42.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 164.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.45 ' HB ' HD13 ' A' ' 31' ' ' ILE . 2.7 mp -110.54 128.63 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.774 0.83 . . . . 0.0 110.624 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -111.6 116.53 30.96 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 166.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.0 mt -84.62 137.13 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.421 0.688 . . . . 0.0 109.388 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -146.55 134.91 21.87 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.311 1.044 . . . . 0.0 109.696 -168.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.02 -160.2 54.02 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.638 0.586 . . . . 0.0 112.915 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.22 131.36 41.88 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -148.64 136.91 21.11 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.775 1.23 . . . . 0.0 108.843 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -116.65 134.07 22.95 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 122.974 0.51 . . . . 0.0 110.72 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.75 174.98 44.24 Favored 'Cis proline' 0 C--N 1.371 1.739 0 C-N-CA 124.408 -1.08 . . . . 0.0 110.996 -7.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.16 157.88 9.34 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -171.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -53.53 -35.44 60.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.546 1.138 . . . . 0.0 113.004 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 pp -60.62 -44.65 96.08 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.327 0.392 . . . . 0.0 110.559 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 30' ' ' MET . 6.9 tp-100 -70.48 -51.89 25.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.811 0.845 . . . . 0.0 110.045 -176.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -54.79 -41.33 70.43 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.525 0.73 . . . . 0.0 111.505 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' HG23 ' A' ' 32' ' ' VAL . 23.3 m170 -55.13 -48.2 74.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.314 0.645 . . . . 0.0 110.47 176.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.05 -38.95 92.5 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.731 0.645 . . . . 0.0 111.25 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.605 ' HB3' HG21 ' A' ' 79' ' ' VAL . 55.8 mmm -58.22 -36.54 73.3 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.505 0.722 . . . . 0.0 110.407 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.45 HD13 ' HB ' ' A' ' 14' ' ' ILE . 46.1 mt -72.23 -50.46 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.897 0.879 . . . . 0.0 111.654 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 28' ' ' HIS . 57.9 t -67.44 -42.26 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.233 -172.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.06 -12.6 61.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.967 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.457 ' NE2' HG13 ' A' ' 79' ' ' VAL . 34.1 m-70 -110.09 26.38 10.73 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.391 0.676 . . . . 0.0 111.163 173.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.83 37.93 75.67 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 114.867 -1.061 . . . . 0.0 113.615 171.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.758 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -118.61 -179.68 16.94 Favored Glycine 0 CA--C 1.503 -0.691 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 -175.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -123.74 144.52 49.63 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 121.201 0.524 . . . . 0.0 110.459 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -122.03 159.81 26.25 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.292 1.037 . . . . 0.0 108.484 173.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.421 HD22 ' HB ' ' A' ' 48' ' ' VAL . 32.7 tp -120.08 138.43 53.55 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.64 -46.76 74.73 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 124.049 0.843 . . . . 0.0 111.98 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.8 t80 . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 123.788 0.835 . . . . 0.0 109.525 -170.0 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt . . . . . 0 CA--C 1.546 0.798 0 CA-C-O 121.138 0.494 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.4 m -108.75 12.3 25.78 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.42 1.088 . . . . 0.0 109.936 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.469 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -149.14 152.02 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.268 0.627 . . . . 0.0 109.655 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 t -107.33 -27.99 10.15 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.086 0.555 . . . . 0.0 111.595 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -124.62 135.8 53.4 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.308 0.643 . . . . 0.0 109.952 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.662 ' HB ' HG12 ' A' ' 69' ' ' VAL . 67.9 mt -121.85 116.09 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.7 t -91.5 120.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 123.951 0.901 . . . . 0.0 110.245 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.08 167.73 20.96 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.318 1.047 . . . . 0.0 108.786 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.1 t -115.45 -49.39 2.75 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -119.62 124.05 45.36 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.427 HD23 ' HG2' ' A' ' 61' ' ' ARG . 14.8 tp -150.02 128.35 5.93 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.07 155.91 17.58 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.594 2.863 . . . . 0.0 113.812 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.525 HD23 ' NH2' ' A' ' 61' ' ' ARG . 85.7 mt -55.48 -60.82 2.89 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.916 0.886 . . . . 0.0 111.022 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -59.8 -29.64 68.36 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.329 1.052 . . . . 0.0 111.851 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.484 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -68.69 -46.25 69.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.008 178.17 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.525 ' NH2' HD23 ' A' ' 58' ' ' LEU . 53.4 mtm180 -69.18 -27.49 65.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.917 0.887 . . . . 0.0 112.234 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 98.0 mt -72.37 -35.71 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.194 0.598 . . . . 0.0 109.843 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.4 -36.96 68.78 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.458 0.647 . . . . 0.0 109.504 172.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -87.98 17.49 4.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.03 0.932 . . . . 0.0 111.141 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.69 -23.81 65.34 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.035 0.534 . . . . 0.0 109.687 166.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -73.61 -6.89 49.48 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.084 0.954 . . . . 0.0 111.03 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -122.91 157.99 31.35 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.352 1.061 . . . . 0.0 109.46 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.67 85.06 5.56 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.662 HG12 ' HB ' ' A' ' 51' ' ' ILE . 22.1 m -83.06 131.38 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.187 -177.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.501 HG11 ' HB2' ' A' ' 87' ' ' TRP . 24.6 m -134.67 171.17 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.612 0.765 . . . . 0.0 109.859 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.43 ' HB3' HD21 ' A' ' 92' ' ' LEU . 47.5 p -86.85 156.95 55.21 Favored Pre-proline 0 C--O 1.245 0.828 0 C-N-CA 123.85 0.86 . . . . 0.0 109.469 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.403 ' O ' HG23 ' A' ' 76' ' ' VAL . 29.6 Cg_endo -60.4 -21.58 68.15 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 122.55 2.167 . . . . 0.0 112.707 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.23 -29.71 67.72 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.652 1.181 . . . . 0.0 111.818 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -59.58 -47.26 86.28 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.564 0.54 . . . . 0.0 110.084 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.7 mp -70.8 -51.95 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.754 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 72' ' ' PRO . 75.7 t -53.95 -52.66 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.224 1.01 . . . . 0.0 111.447 -176.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.66 -43.59 65.78 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.855 0.722 . . . . 0.0 111.158 -173.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.3 p -60.33 -36.96 79.16 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.018 0.437 . . . . 0.0 111.302 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.605 HG21 ' HB3' ' A' ' 30' ' ' MET . 46.9 t -67.89 -41.34 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.087 0.955 . . . . 0.0 111.512 176.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -67.38 -37.39 83.07 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.084 0.554 . . . . 0.0 111.285 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.19 -14.7 40.42 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.25 1.02 . . . . 0.0 111.479 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.27 26.71 15.58 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.146 1.378 . . . . 0.0 112.408 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -137.47 164.38 28.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.126 0.57 . . . . 0.0 110.32 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.403 ' HA ' HG23 ' A' ' 8' ' ' ILE . 60.7 tp -78.31 131.48 37.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.363 0.665 . . . . 0.0 110.606 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -108.33 150.66 40.84 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.744 1.218 . . . . 0.0 109.458 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.49 113.87 3.84 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.363 2.042 . . . . 0.0 110.47 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.501 ' HB2' HG11 ' A' ' 70' ' ' VAL . 64.6 p-90 -61.76 -27.8 68.99 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.629 0.771 . . . . 0.0 111.922 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -62.46 -27.82 69.39 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.134 0.974 . . . . 0.0 112.097 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -71.59 -21.07 61.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.799 0.84 . . . . 0.0 111.071 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -114.7 1.11 14.09 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.335 1.054 . . . . 0.0 110.731 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 27.0 t -69.27 131.36 44.75 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.196 0.598 . . . . 0.0 111.783 -171.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' A' ' 71' ' ' SER . 38.6 mt -96.72 8.66 43.75 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.29 0.636 . . . . 0.0 112.111 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.414 HG22 ' OG ' ' A' ' 91' ' ' SER . 13.5 t -72.43 -14.56 61.72 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.526 0.603 . . . . 0.0 111.075 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.5 t . . . . . 0 C--O 1.251 1.167 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 169.854 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.469 HD12 ' CD2' ' A' ' 34' ' ' HIS . 67.1 mt -55.0 -48.1 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.763 1.225 . . . . 0.0 111.867 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.583 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 73.1 m-85 -105.05 7.34 33.9 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.463 -175.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 47.3 tptt -57.1 -49.31 76.29 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.053 0.541 . . . . 0.0 110.721 -174.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -84.11 -4.95 59.13 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.937 -1.028 . . . . 0.0 111.927 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.1 m -106.37 128.21 53.86 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.28 0.632 . . . . 0.0 111.488 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.463 ' H ' HG22 ' A' ' 49' ' ' THR . 21.9 t -95.12 126.94 47.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 168.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.38 122.73 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-O 121.241 0.543 . . . . 0.0 111.491 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -104.63 143.36 33.18 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.132 1.373 . . . . 0.0 107.693 167.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.8 mt -114.36 113.46 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -102.73 123.57 46.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.29 1.036 . . . . 0.0 110.417 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.66 -169.3 50.58 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.826 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -85.54 110.32 19.13 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.554 0.742 . . . . 0.0 109.487 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.659 HG21 HG12 ' A' ' 52' ' ' VAL . 74.0 p -122.55 148.54 45.08 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.556 1.143 . . . . 0.0 108.963 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -99.9 131.66 24.12 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-N 118.155 0.434 . . . . 0.0 111.962 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HD2' HD21 ' A' ' 27' ' ' LEU . 80.9 Cg_endo -76.57 175.92 46.14 Favored 'Cis proline' 0 C--N 1.374 1.883 0 C-N-CA 124.65 -0.979 . . . . 0.0 110.933 -7.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.5 148.43 7.22 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 114.631 0.612 . . . . 0.0 114.631 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -52.26 -35.79 50.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.082 0.953 . . . . 0.0 112.927 -174.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 26' ' ' GLN . 4.1 pp -63.51 -41.24 98.53 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.502 0.321 . . . . 0.0 111.08 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.44 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.4 tp-100 -69.88 -48.43 58.75 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.675 0.79 . . . . 0.0 110.509 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.46 HD21 ' HD2' ' A' ' 22' ' ' PRO . 69.4 mt -56.48 -46.26 80.55 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.259 0.623 . . . . 0.0 111.242 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.461 ' O ' HG23 ' A' ' 32' ' ' VAL . 9.9 m80 -56.57 -43.82 80.37 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.455 0.702 . . . . 0.0 110.677 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.57 -36.74 83.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.81 0.444 . . . . 0.0 111.3 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.587 ' HB3' HG21 ' A' ' 79' ' ' VAL . 23.8 mmt -63.79 -35.2 79.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.188 0.595 . . . . 0.0 110.895 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.8 mt -70.61 -51.17 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.724 0.81 . . . . 0.0 111.244 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 28' ' ' HIS . 64.1 t -66.89 -40.33 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.111 0.564 . . . . 0.0 111.731 -173.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.09 -11.67 61.0 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.098 0.559 . . . . 0.0 111.845 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.469 ' CD2' HD12 ' A' ' 8' ' ' ILE . 22.9 m80 -100.33 20.49 14.67 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.208 1.003 . . . . 0.0 111.107 170.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' O ' ' HD2' ' A' ' 10' ' ' LYS . . . 72.11 9.44 71.79 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.815 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.86 159.66 46.0 Favored Glycine 0 C--O 1.24 0.518 0 N-CA-C 114.124 0.41 . . . . 0.0 114.124 -170.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -101.89 153.63 19.67 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -144.01 145.81 32.46 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.938 0.495 . . . . 0.0 110.967 -174.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HG ' HG22 ' A' ' 47' ' ' THR . 1.5 mm? -130.43 145.88 51.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.039 0.936 . . . . 0.0 109.961 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -109.45 -34.08 6.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.749 0.82 . . . . 0.0 109.069 170.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.9 p90 . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -169.838 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.622 HG22 ' HG ' ' A' ' 39' ' ' LEU . 3.0 m -84.61 -28.18 26.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.486 -176.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.448 HG23 HG12 ' A' ' 13' ' ' VAL . 11.5 p -150.09 162.95 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.956 0.903 . . . . 0.0 109.193 -172.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 13' ' ' VAL . 10.3 t -115.86 -18.19 10.82 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.504 0.593 . . . . 0.0 112.237 174.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -134.04 131.71 39.18 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.418 0.687 . . . . 0.0 110.662 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.634 ' HB ' HG12 ' A' ' 69' ' ' VAL . 54.0 mt -114.73 129.58 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.659 HG12 HG21 ' A' ' 20' ' ' THR . 62.7 t -92.03 129.01 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.89 0.876 . . . . 0.0 109.461 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.99 147.0 30.26 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.114 0.566 . . . . 0.0 110.492 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.0 t -90.07 -34.49 15.9 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -145.65 142.36 28.97 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.191 173.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.425 HD12 ' HG2' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -146.73 107.57 4.03 Favored Pre-proline 0 CA--C 1.561 1.37 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.394 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.31 159.32 53.78 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.216 2.61 . . . . 0.0 113.061 -175.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.428 ' O ' HG13 ' A' ' 62' ' ' ILE . 65.7 mt -50.99 -49.7 59.87 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.375 1.07 . . . . 0.0 112.432 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -59.56 -45.71 91.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.039 0.536 . . . . 0.0 111.209 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -69.29 -26.03 64.53 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.634 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HG2' HD12 ' A' ' 56' ' ' LEU . 58.2 mtm180 -73.88 -26.68 60.68 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.721 0.409 . . . . 0.0 111.015 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 58' ' ' LEU . 60.8 mt -76.44 -39.27 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.85 -42.01 97.68 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.864 0.866 . . . . 0.0 110.955 174.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -104.01 26.81 8.27 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.081 0.952 . . . . 0.0 110.411 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.12 -19.48 64.04 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 122.842 0.457 . . . . 0.0 111.274 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -75.49 -26.12 57.88 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.839 0.856 . . . . 0.0 110.647 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -111.7 145.42 39.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.999 0.92 . . . . 0.0 109.418 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -85.74 90.6 8.07 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -177.294 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.634 HG12 ' HB ' ' A' ' 51' ' ' ILE . 27.1 m -74.0 127.13 35.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.83 172.59 15.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.827 1.251 . . . . 0.0 109.112 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.7 m -79.44 151.5 74.86 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.99 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.43 ' O ' HG23 ' A' ' 76' ' ' VAL . 26.5 Cg_endo -60.11 -25.35 79.61 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.78 2.32 . . . . 0.0 111.643 170.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -59.12 -23.16 61.89 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.173 1.389 . . . . 0.0 112.149 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -61.3 -46.62 89.56 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.021 0.439 . . . . 0.0 109.921 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.583 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.7 mp -71.86 -47.24 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.113 -177.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 72' ' ' PRO . 61.0 t -54.92 -50.72 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.999 0.92 . . . . 0.0 111.01 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -70.58 -47.52 59.85 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.205 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.441 ' HA ' HD23 ' A' ' 85' ' ' LEU . 79.5 p -63.09 -44.31 96.08 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.281 0.363 . . . . 0.0 111.445 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.587 HG21 ' HB3' ' A' ' 30' ' ' MET . 55.5 t -59.3 -42.8 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.054 0.942 . . . . 0.0 110.738 174.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -68.97 -33.06 73.08 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.033 0.933 . . . . 0.0 111.897 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.38 -11.35 38.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.583 0.753 . . . . 0.0 111.625 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.78 22.43 12.43 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.572 1.149 . . . . 0.0 112.323 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -142.49 156.5 45.16 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.512 0.725 . . . . 0.0 109.552 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.09 117.97 18.35 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 78' ' ' SER . 4.0 mm? -92.6 144.83 29.33 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 167.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.626 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 38.2 Cg_endo -62.49 124.04 13.5 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.081 1.854 . . . . 0.0 111.587 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -64.15 -19.85 65.58 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.079 0.952 . . . . 0.0 112.469 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.626 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.8 pt20 -59.3 -25.84 64.46 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.928 0.891 . . . . 0.0 111.629 174.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -71.22 -27.07 63.22 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.779 0.832 . . . . 0.0 110.115 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -116.26 2.02 13.2 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.911 0.884 . . . . 0.0 111.975 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.4 p -66.57 110.87 3.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.473 0.709 . . . . 0.0 111.537 -173.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.416 ' HB2' HG23 ' A' ' 69' ' ' VAL . 78.3 mt -74.87 -16.34 60.68 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.834 173.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 p -47.81 -51.97 20.65 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.724 1.209 . . . . 0.0 111.601 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 CA--C 1.553 1.094 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.129 176.829 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.558 1.252 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.567 HG23 ' HA ' ' A' ' 84' ' ' LEU . 43.1 mt -54.83 -48.13 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.609 1.164 . . . . 0.0 111.109 176.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -113.87 10.11 17.66 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.882 -173.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -50.56 -65.75 0.51 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.848 0.859 . . . . 0.0 112.813 -167.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -85.8 -8.56 58.04 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.075 0.464 . . . . 0.0 110.338 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.3 m -79.9 118.02 21.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.698 0.799 . . . . 0.0 110.036 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -90.09 124.78 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 170.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.0 126.32 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.023 0.529 . . . . 0.0 111.727 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -104.96 148.82 26.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.977 1.311 . . . . 0.0 108.421 172.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -120.47 137.78 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -135.24 128.01 31.1 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.512 1.125 . . . . 0.0 108.876 -167.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.46 -159.75 48.7 Favored Glycine 0 C--N 1.343 0.924 0 O-C-N 123.404 0.44 . . . . 0.0 112.073 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -103.21 111.37 23.73 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.283 0.633 . . . . 0.0 109.624 176.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.0 p -119.49 134.64 55.12 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.743 1.217 . . . . 0.0 108.657 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -102.62 133.34 20.53 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 117.896 0.316 . . . . 0.0 110.629 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.02 164.86 85.74 Favored 'Cis proline' 0 C--N 1.384 2.405 0 C-N-CA 124.469 -1.055 . . . . 0.0 112.272 1.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.71 157.99 3.89 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 124.169 0.918 . . . . 0.0 114.556 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -54.65 -37.17 65.37 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.931 0.892 . . . . 0.0 112.478 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 26' ' ' GLN . 3.3 pp -62.96 -43.99 97.29 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.162 0.585 . . . . 0.0 110.804 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.528 ' N ' HD12 ' A' ' 25' ' ' LEU . 56.2 tp60 -67.79 -49.8 60.39 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.878 0.871 . . . . 0.0 110.618 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.1 mt -55.15 -51.47 66.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.877 0.871 . . . . 0.0 111.649 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.46 ' HA ' HD12 ' A' ' 31' ' ' ILE . 23.0 m170 -61.35 -35.26 76.93 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.873 0.469 . . . . 0.0 111.649 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.476 ' O ' HD13 ' A' ' 33' ' ' LEU . 43.3 mt-10 -64.23 -46.48 83.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 0.0 110.191 173.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.768 ' HB3' HG21 ' A' ' 79' ' ' VAL . 67.3 mtt -56.68 -37.3 70.66 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.465 0.65 . . . . 0.0 110.499 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 28' ' ' HIS . 77.2 mt -66.17 -50.65 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.556 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 28' ' ' HIS . 59.3 t -71.06 -29.35 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.144 0.578 . . . . 0.0 111.173 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 29' ' ' GLU . 6.8 mp -64.34 -22.73 67.05 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.515 1.126 . . . . 0.0 110.744 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.418 ' HE1' HG13 ' A' ' 79' ' ' VAL . 60.6 m80 -105.5 26.93 8.88 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.398 1.079 . . . . 0.0 110.678 173.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.35 18.14 76.62 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.471 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.2 164.41 29.62 Favored Glycine 0 C--O 1.241 0.556 0 N-CA-C 114.179 0.431 . . . . 0.0 114.179 -171.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -113.42 161.79 16.88 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.824 0.849 . . . . 0.0 109.635 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -145.78 154.29 41.86 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 122.715 0.406 . . . . 0.0 111.406 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -121.16 137.64 54.58 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.23 -49.92 9.57 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.619 0.768 . . . . 0.0 112.724 -173.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 N--CA 1.493 1.72 0 C-N-CA 125.6 1.56 . . . . 0.0 108.691 -176.297 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.542 0.687 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.6 m -91.51 -22.95 20.11 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 121.792 -0.567 . . . . 0.0 111.439 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 p -92.86 152.23 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 122.23 -0.294 . . . . 0.0 111.665 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.461 HG23 ' HD2' ' A' ' 50' ' ' HIS . 10.1 t -114.18 -25.34 8.53 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.348 0.659 . . . . 0.0 111.297 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.461 ' HD2' HG23 ' A' ' 49' ' ' THR . 58.5 m-70 -128.56 125.72 38.86 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.314 0.646 . . . . 0.0 109.742 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.478 ' HB ' HG22 ' A' ' 69' ' ' VAL . 40.4 mt -106.1 138.38 31.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.9 t -117.57 120.21 64.07 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 C-N-CA 123.905 0.882 . . . . 0.0 108.811 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -139.44 159.66 41.65 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.348 0.659 . . . . 0.0 109.612 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.0 t -84.64 -46.42 11.52 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 168.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -140.01 124.34 17.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.809 1.243 . . . . 0.0 108.933 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.447 HD22 HG11 ' A' ' 69' ' ' VAL . 38.7 tp -107.49 128.39 26.02 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.13 153.6 38.27 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.347 2.698 . . . . 0.0 112.832 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.4 mt -59.26 -44.88 92.38 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.707 0.803 . . . . 0.0 111.234 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -61.5 -46.65 89.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.24 1.016 . . . . 0.0 110.191 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -70.91 -24.66 62.5 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.993 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -73.71 -30.81 63.08 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.07 0.548 . . . . 0.0 110.132 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -70.99 -43.38 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.783 0.833 . . . . 0.0 109.957 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.32 -38.34 87.46 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.812 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.426 ' HA ' ' HD1' ' A' ' 67' ' ' TYR . 23.2 m-85 -100.22 26.26 6.7 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.976 0.911 . . . . 0.0 110.744 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 -24.95 66.59 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.291 0.637 . . . . 0.0 112.103 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -80.33 -27.45 38.34 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.072 0.549 . . . . 0.0 110.761 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.426 ' HD1' ' HA ' ' A' ' 64' ' ' PHE . 62.4 m-85 -88.72 141.63 28.35 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.78 0.832 . . . . 0.0 109.641 -177.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -82.97 85.86 7.08 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.478 HG22 ' HB ' ' A' ' 51' ' ' ILE . 41.4 t -77.9 128.68 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.266 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 87' ' ' TRP . 27.7 m -139.96 174.53 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.093 1.357 . . . . 0.0 109.466 -175.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.0 m -87.83 159.88 48.05 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.306 0.642 . . . . 0.0 110.382 171.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -58.66 -23.16 64.38 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.935 2.423 . . . . 0.0 112.485 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.21 -24.34 64.74 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.004 1.322 . . . . 0.0 112.151 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -62.15 -50.78 70.5 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 75' ' ' ILE . 2.6 mp -64.94 -52.15 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.87 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.19 -54.34 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.245 1.018 . . . . 0.0 111.537 -175.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -72.71 -37.31 67.85 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 123.335 0.397 . . . . 0.0 111.289 -172.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.5 m -63.95 -37.61 88.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.64 0.376 . . . . 0.0 111.234 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.768 HG21 ' HB3' ' A' ' 30' ' ' MET . 40.2 t -72.32 -36.8 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.896 0.878 . . . . 0.0 111.575 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -65.85 -41.09 92.12 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.763 0.425 . . . . 0.0 110.618 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -89.6 -10.33 46.42 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.78 0.832 . . . . 0.0 111.901 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 55.32 37.71 29.29 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.828 1.251 . . . . 0.0 112.226 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -146.76 155.5 42.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.815 0.846 . . . . 0.0 110.048 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.567 ' HA ' HG23 ' A' ' 8' ' ' ILE . 60.9 tp -78.11 94.76 4.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.403 0.681 . . . . 0.0 109.571 -178.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.22 151.74 66.78 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.771 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.66 110.55 0.84 Allowed 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.77 2.313 . . . . 0.0 112.685 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.514 ' HB2' HG11 ' A' ' 70' ' ' VAL . 61.7 p-90 -63.82 -22.23 66.82 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.917 0.887 . . . . 0.0 111.246 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -63.44 -24.16 67.71 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.284 1.034 . . . . 0.0 111.433 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.28 -5.99 58.4 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.232 0.613 . . . . 0.0 111.527 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -126.93 1.42 6.61 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.536 0.734 . . . . 0.0 110.895 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.9 p -68.49 113.46 6.05 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.456 0.702 . . . . 0.0 112.368 -170.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.9 mt -89.78 20.4 4.13 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.008 0.923 . . . . 0.0 111.283 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.5 p -68.4 -27.74 66.48 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.179 0.991 . . . . 0.0 111.553 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.937 176.861 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 10' ' ' LYS . 9.5 mtmp? . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.8 mt -50.49 -45.65 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 125.503 1.521 . . . . 0.0 112.243 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 75' ' ' ILE . 63.8 m-85 -108.98 16.49 22.59 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.412 0.685 . . . . 0.0 111.371 -174.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 7' ' ' LYS . 13.6 tptp -50.23 -51.91 40.36 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.035 0.934 . . . . 0.0 113.288 -168.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -99.5 -2.79 35.03 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.407 0.683 . . . . 0.0 111.069 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.6 m -82.2 128.47 34.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.141 0.577 . . . . 0.0 109.904 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.62 HG12 HG23 ' A' ' 48' ' ' VAL . 38.8 t -104.27 119.58 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 mp -119.62 131.95 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.294 0.638 . . . . 0.0 111.174 -173.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -113.67 150.95 32.49 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.935 1.694 . . . . 0.0 108.165 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.28 132.2 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -139.65 135.6 33.43 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.163 1.385 . . . . 0.0 108.562 -170.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.25 -172.76 54.35 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -92.65 110.41 21.84 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.516 HG21 HG12 ' A' ' 52' ' ' VAL . 65.4 p -113.74 141.57 47.1 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.05 0.94 . . . . 0.0 109.871 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.521 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -104.97 127.25 29.12 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 167.172 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.38 173.84 54.5 Favored 'Cis proline' 0 C--N 1.372 1.769 0 C-N-CA 124.184 -1.173 . . . . 0.0 112.276 -0.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.05 157.2 9.72 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.679 0.612 . . . . 0.0 113.939 -174.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -51.47 -35.45 39.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.127 0.971 . . . . 0.0 111.901 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.1 pp -56.76 -48.95 76.69 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.049 0.939 . . . . 0.0 112.001 177.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.528 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.8 tp-100 -72.37 -43.55 63.83 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.749 0.819 . . . . 0.0 110.334 -174.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.54 -44.79 96.4 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.854 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.58 ' HA ' HD12 ' A' ' 31' ' ' ILE . 16.5 m170 -61.26 -36.8 81.01 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.102 0.561 . . . . 0.0 111.0 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.19 -45.05 86.38 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.745 0.418 . . . . 0.0 110.632 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.543 ' SD ' HG11 ' A' ' 79' ' ' VAL . 23.9 mmt -59.29 -31.99 69.63 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.349 0.66 . . . . 0.0 111.475 176.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 28' ' ' HIS . 84.0 mt -69.39 -52.33 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.05 175.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 28' ' ' HIS . 59.9 t -72.29 -38.84 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 122.986 0.514 . . . . 0.0 112.164 -169.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.34 -19.14 64.37 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.199 0.6 . . . . 0.0 111.661 176.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -104.43 25.89 9.63 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.624 0.77 . . . . 0.0 111.4 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.65 14.75 70.24 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.654 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.82 161.17 36.23 Favored Glycine 0 C--O 1.242 0.618 0 N-CA-C 113.954 0.342 . . . . 0.0 113.954 -171.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -103.17 144.61 31.09 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.278 1.031 . . . . 0.0 108.614 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -134.29 145.37 49.01 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 122.961 0.505 . . . . 0.0 110.627 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.41 142.86 50.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.293 1.037 . . . . 0.0 109.277 173.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -109.05 -43.71 4.13 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.919 170.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 p90 . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.559 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 122.575 1.179 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -89.01 -1.07 57.93 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.713 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.62 HG23 HG12 ' A' ' 13' ' ' VAL . 9.1 p -162.97 160.11 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.921 0.888 . . . . 0.0 109.436 -172.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.3 t -114.29 -21.27 10.51 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -126.5 139.17 53.43 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.04 0.536 . . . . 0.0 110.225 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.747 ' HB ' HG12 ' A' ' 69' ' ' VAL . 58.1 mt -124.42 129.72 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.516 HG12 HG21 ' A' ' 20' ' ' THR . 51.6 t -104.93 119.05 53.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 C-N-CA 123.741 0.816 . . . . 0.0 110.355 -172.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.07 146.44 35.45 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.6 p -85.38 -10.29 56.47 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.792 0.437 . . . . 0.0 110.613 173.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -156.76 89.05 1.07 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.48 1.112 . . . . 0.0 108.009 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.67 110.18 47.77 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.424 ' O ' ' HG3' ' A' ' 61' ' ' ARG . 54.3 Cg_exo -55.41 151.15 38.51 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.84 3.027 . . . . 0.0 114.001 -176.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.4 mt -57.2 -46.01 83.25 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 0.0 111.528 -177.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -63.88 -39.81 95.06 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.7 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.57 -34.95 77.99 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 119.431 -0.319 . . . . 0.0 111.657 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 80.0 mtt180 -60.36 -36.04 77.09 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 122.94 0.496 . . . . 0.0 110.69 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.9 mt -71.5 -42.13 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.009 0.923 . . . . 0.0 110.761 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.58 -26.94 61.05 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.204 0.602 . . . . 0.0 111.045 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.407 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 20.7 m-85 -110.28 28.72 8.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.488 1.115 . . . . 0.0 109.76 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.54 -22.84 65.51 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -91.99 -26.93 18.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.16 0.584 . . . . 0.0 110.393 176.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.407 ' HD2' ' HA ' ' A' ' 64' ' ' PHE . 65.0 m-85 -85.86 135.13 33.82 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -83.96 86.48 7.18 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.747 HG12 ' HB ' ' A' ' 51' ' ' ILE . 21.4 m -77.18 127.69 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.117 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' ' 87' ' ' TRP . 35.9 m -136.8 172.3 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.339 1.056 . . . . 0.0 109.735 -175.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.1 m -80.69 154.91 73.62 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.301 172.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.25 -22.04 63.07 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.512 2.141 . . . . 0.0 111.869 171.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.9 -29.61 60.29 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.368 1.467 . . . . 0.0 112.292 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -63.57 -49.06 74.89 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 120.8 0.333 . . . . 0.0 110.34 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.437 ' O ' HG23 ' A' ' 79' ' ' VAL . 2.8 mp -68.38 -49.43 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.979 -175.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.1 t -58.48 -53.79 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.791 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 21.1 t0 -72.65 -31.73 65.33 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.081 0.238 . . . . 0.0 111.488 -172.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.591 ' HA ' HD13 ' A' ' 85' ' ' LEU . 58.0 m -63.68 -37.86 88.95 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 120.643 0.258 . . . . 0.0 110.932 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.543 HG11 ' SD ' ' A' ' 30' ' ' MET . 86.3 t -70.87 -36.45 64.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 122.97 0.508 . . . . 0.0 110.787 175.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -62.49 -45.59 92.3 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.769 0.428 . . . . 0.0 111.06 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 10.7 mm-40 -85.37 -11.88 53.5 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.252 0.621 . . . . 0.0 111.159 -176.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.26 34.98 10.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.758 1.223 . . . . 0.0 111.691 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -153.67 168.97 24.45 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.448 0.699 . . . . 0.0 110.647 -177.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -86.37 108.39 18.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.293 0.637 . . . . 0.0 109.879 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 78' ' ' SER . 10.8 mp -83.89 152.56 62.8 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.553 0.741 . . . . 0.0 110.654 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.566 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 49.0 Cg_endo -67.1 120.85 7.95 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.459 2.106 . . . . 0.0 111.295 171.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.531 ' HB2' HG11 ' A' ' 70' ' ' VAL . 69.0 p-90 -63.66 -21.67 66.5 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.695 0.798 . . . . 0.0 111.922 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.566 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 21.0 pt20 -59.08 -29.16 67.13 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.061 0.944 . . . . 0.0 111.945 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.62 -21.33 63.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.586 0.754 . . . . 0.0 111.504 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -121.49 9.64 10.31 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.823 0.849 . . . . 0.0 110.852 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.503 ' OG ' HG22 ' A' ' 93' ' ' THR . 41.2 t -72.91 114.33 10.93 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.614 0.766 . . . . 0.0 111.446 -172.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.7 mt -91.46 2.21 56.59 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.723 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.503 HG22 ' OG ' ' A' ' 91' ' ' SER . 6.7 t -74.23 -18.28 60.77 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.602 0.637 . . . . 0.0 111.179 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.7 t . . . . . 0 C--O 1.255 1.355 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.661 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 43.1 mm . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 p -133.15 120.46 21.23 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.415 0.686 . . . . 0.0 109.592 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 m -62.11 -55.39 29.34 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.858 0.863 . . . . 0.0 111.201 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 57.29 29.43 16.79 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.308 1.043 . . . . 0.0 111.051 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.4 m -106.52 145.29 32.02 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.054 0.942 . . . . 0.0 110.146 -174.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.9 m 58.48 38.66 25.53 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.044 0.937 . . . . 0.0 110.629 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 10' ' ' LYS . 62.8 pttt -83.51 38.05 0.6 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.441 1.496 . . . . 0.0 112.227 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.467 HG23 ' HA ' ' A' ' 84' ' ' LEU . 44.7 mt -52.13 -34.7 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 125.714 1.605 . . . . 0.0 113.209 -174.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.419 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 67.8 m-85 -114.34 16.74 17.81 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.482 0.713 . . . . 0.0 110.914 -174.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 7' ' ' LYS . 25.5 tptp -54.67 -43.82 72.77 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.275 1.03 . . . . 0.0 112.899 -169.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -102.98 7.2 39.16 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.362 0.665 . . . . 0.0 111.376 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.1 m -108.37 118.87 37.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.569 0.748 . . . . 0.0 111.24 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.537 HG12 HG23 ' A' ' 48' ' ' VAL . 69.9 t -89.78 125.36 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 164.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.558 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.1 mp -117.55 127.22 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.268 0.556 . . . . 0.0 111.125 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.437 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 19.3 t80 -103.48 150.87 23.47 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.739 1.216 . . . . 0.0 107.869 169.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.552 HG12 ' HB ' ' A' ' 52' ' ' VAL . 65.1 mt -123.03 130.91 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -128.46 141.7 51.31 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.612 1.165 . . . . 0.0 109.476 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.09 -168.37 48.7 Favored Glycine 0 N--CA 1.477 1.401 0 N-CA-C 112.263 -0.335 . . . . 0.0 112.263 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -101.22 108.49 20.15 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.438 HG21 HG12 ' A' ' 52' ' ' VAL . 69.4 p -110.08 139.73 44.9 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.06 0.944 . . . . 0.0 109.433 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -105.96 126.86 29.6 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 170.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -78.81 175.23 47.42 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 124.449 -1.063 . . . . 0.0 111.977 -0.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.22 153.99 5.6 Favored Glycine 0 C--N 1.349 1.263 0 O-C-N 123.948 0.78 . . . . 0.0 114.671 -170.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -57.97 -34.76 70.29 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.665 0.786 . . . . 0.0 111.65 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.7 pp -59.97 -45.9 91.18 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 123.589 0.556 . . . . 0.0 111.14 172.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.532 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.0 tp-100 -67.11 -50.94 59.8 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.801 0.841 . . . . 0.0 111.012 -175.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.0 mt -55.93 -44.55 78.45 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.167 0.587 . . . . 0.0 111.208 177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.558 ' HA ' HD12 ' A' ' 31' ' ' ILE . 30.2 m170 -62.61 -36.66 83.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.889 0.476 . . . . 0.0 111.299 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 46.2 mt-10 -66.16 -41.59 90.15 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.801 0.44 . . . . 0.0 110.713 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.552 ' HB3' HG21 ' A' ' 79' ' ' VAL . 5.6 mmt -60.52 -33.5 72.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.803 0.841 . . . . 0.0 110.721 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.558 HD13 ' HB ' ' A' ' 14' ' ' ILE . 60.0 mt -70.07 -49.77 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.977 0.911 . . . . 0.0 111.007 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 28' ' ' HIS . 80.0 t -61.45 -48.09 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.482 0.713 . . . . 0.0 112.113 -176.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.18 -23.39 66.58 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.222 0.609 . . . . 0.0 111.629 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.5 ' NE2' HG13 ' A' ' 79' ' ' VAL . 40.3 m-70 -95.87 27.03 3.73 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.892 0.877 . . . . 0.0 111.397 175.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.67 78.04 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.724 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.42 175.76 33.4 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 114.203 0.441 . . . . 0.0 114.203 -171.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -128.74 155.45 45.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.167 0.987 . . . . 0.0 108.75 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -138.51 168.72 19.17 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.177 0.513 . . . . 0.0 112.22 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.75 140.89 50.35 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -74.51 -46.36 39.83 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.762 0.825 . . . . 0.0 111.306 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.437 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 71.9 t80 -174.18 138.65 0.59 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.578 1.151 . . . . 0.0 109.688 -171.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -106.86 150.27 26.56 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.487 0.715 . . . . 0.0 110.513 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.5 t -128.67 70.46 1.39 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.318 1.047 . . . . 0.0 108.585 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.8 t 75.4 -40.83 0.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.861 1.665 . . . . 0.0 113.671 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -70.39 148.37 48.47 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.46 0.704 . . . . 0.0 112.097 -173.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HA ' ' HE1' ' A' ' 67' ' ' TYR . 95.4 mttt -80.73 82.56 6.7 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.331 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.6 m -120.07 24.25 10.57 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.497 0.719 . . . . 0.0 109.351 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.537 HG23 HG12 ' A' ' 13' ' ' VAL . 6.1 p -154.2 155.82 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.327 0.651 . . . . 0.0 109.608 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.8 t -114.63 -25.81 8.14 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.59 0.756 . . . . 0.0 111.466 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -133.03 138.78 46.91 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.616 0.766 . . . . 0.0 110.236 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.613 ' HB ' HG22 ' A' ' 69' ' ' VAL . 58.1 mt -123.64 143.33 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.562 1.145 . . . . 0.0 108.358 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.552 ' HB ' HG12 ' A' ' 16' ' ' ILE . 97.6 t -115.74 119.79 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.419 0.688 . . . . 0.0 110.287 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.26 157.85 38.73 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.37 0.668 . . . . 0.0 110.032 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.3 t -70.78 -49.36 47.45 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -147.02 147.43 30.67 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 168.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.558 ' HG ' HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -123.46 116.23 28.23 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -173.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.532 ' HG2' ' HB2' ' A' ' 60' ' ' LYS . 36.9 Cg_endo -64.68 156.35 61.85 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.132 2.555 . . . . 0.0 113.429 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.07 -47.34 86.78 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.569 1.148 . . . . 0.0 113.58 -167.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -67.16 -26.99 66.92 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 120.953 0.406 . . . . 0.0 110.429 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.532 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 4.6 mptp? -81.47 -23.15 37.61 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.34 -34.24 77.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.2 mt -72.83 -39.57 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.849 0.86 . . . . 0.0 110.228 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 3.1 tp10 -63.06 -34.52 77.76 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.131 0.972 . . . . 0.0 110.435 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -117.6 27.43 9.06 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.499 -175.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.02 67.56 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.294 0.568 . . . . 0.0 111.473 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -76.41 -23.03 53.99 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.404 1.082 . . . . 0.0 111.306 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.401 ' HE1' ' HA ' ' A' ' 46' ' ' LYS . 15.9 m-85 -113.73 126.73 55.56 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.921 0.889 . . . . 0.0 109.272 -174.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.2 87.59 1.11 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.007 0.432 . . . . 0.0 110.315 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.613 HG22 ' HB ' ' A' ' 51' ' ' ILE . 16.5 t -76.08 134.45 29.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.211 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 87' ' ' TRP . 31.8 m -135.74 174.15 12.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.606 1.162 . . . . 0.0 109.531 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.5 t -86.09 152.37 55.79 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 171.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.26 -23.54 46.26 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 122.962 2.442 . . . . 0.0 113.15 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.12 -26.56 64.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.02 0.928 . . . . 0.0 112.26 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -61.02 -44.04 97.99 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.7 mp -75.6 -52.46 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.726 0.81 . . . . 0.0 108.841 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.3 t -54.91 -53.73 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.491 1.116 . . . . 0.0 111.148 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.07 -39.08 66.16 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.546 -173.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 95.5 p -60.58 -41.56 94.92 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 120.905 0.383 . . . . 0.0 110.529 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 30' ' ' MET . 70.8 t -64.51 -42.21 94.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 123.911 0.885 . . . . 0.0 111.066 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -67.61 -29.64 69.03 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.611 0.365 . . . . 0.0 111.441 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -89.78 -14.38 34.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.48 0.712 . . . . 0.0 110.925 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.97 27.38 16.23 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.168 1.387 . . . . 0.0 111.948 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -138.41 165.46 26.75 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.529 0.732 . . . . 0.0 111.02 -173.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.467 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.3 tm? -77.35 133.85 38.63 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 mt -114.18 154.92 46.18 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 123.586 0.754 . . . . 0.0 110.672 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.1 105.7 0.88 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.262 1.975 . . . . 0.0 110.81 171.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.488 ' HB2' HG11 ' A' ' 70' ' ' VAL . 36.3 p90 -66.52 -22.1 66.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.138 0.575 . . . . 0.0 111.588 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -62.44 -29.12 70.28 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.754 0.821 . . . . 0.0 111.476 174.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -67.91 -41.29 82.86 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.1 0.56 . . . . 0.0 109.904 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -93.43 4.8 53.38 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.056 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.9 t -62.14 121.27 12.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.919 0.888 . . . . 0.0 113.222 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -106.3 -0.07 24.67 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.83 0.852 . . . . 0.0 110.752 170.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.425 ' HB ' ' H ' ' A' ' 69' ' ' VAL . 11.9 t -83.3 -15.66 49.24 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.889 0.476 . . . . 0.0 110.49 172.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.252 1.229 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.838 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 32.3 mt . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.2 m -68.33 89.0 0.33 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.844 0.858 . . . . 0.0 111.38 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.5 t -99.0 142.97 29.81 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.646 1.179 . . . . 0.0 110.531 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -84.97 69.49 10.81 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.651 0.739 . . . . 0.0 109.209 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 64.0 p -139.44 174.38 10.57 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.655 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.402 ' HB3' HG13 ' A' ' 8' ' ' ILE . 14.1 m -77.54 176.44 8.92 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-O 120.761 0.315 . . . . 0.0 110.229 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -129.81 29.87 4.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.75 0.82 . . . . 0.0 109.929 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.419 HD12 ' ND1' ' A' ' 34' ' ' HIS . 66.8 mt -59.32 -42.33 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.637 0.775 . . . . 0.0 111.409 -177.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.423 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 63.7 m-85 -113.85 17.05 18.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.552 0.741 . . . . 0.0 110.868 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -54.55 -55.21 31.66 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 123.75 0.82 . . . . 0.0 112.171 -167.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -91.9 15.14 13.7 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.36 0.664 . . . . 0.0 111.271 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 54.0 t -117.11 120.38 38.16 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 123.986 0.914 . . . . 0.0 109.924 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.424 HG11 HD23 ' A' ' 39' ' ' LEU . 36.5 t -90.84 134.07 30.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 168.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.438 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.7 mp -123.45 123.29 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.046 0.538 . . . . 0.0 110.631 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -102.76 144.18 31.45 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.445 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 41.1 mt -121.68 137.68 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -147.19 136.13 22.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.688 0.795 . . . . 0.0 109.603 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.71 175.3 47.73 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 123.253 0.345 . . . . 0.0 113.156 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -73.93 111.93 9.56 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.107 0.479 . . . . 0.0 110.017 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.573 HG21 HG12 ' A' ' 52' ' ' VAL . 40.4 p -128.14 138.41 52.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.947 1.299 . . . . 0.0 108.226 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -105.33 130.22 23.45 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 118.257 0.48 . . . . 0.0 110.664 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.99 172.22 64.27 Favored 'Cis proline' 0 C--N 1.375 1.95 0 C-N-CA 124.232 -1.154 . . . . 0.0 111.485 -2.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.23 155.67 5.79 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.541 -0.589 . . . . 0.0 113.768 -174.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -55.36 -36.55 66.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.262 0.625 . . . . 0.0 111.809 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 26' ' ' GLN . 3.0 pp -59.3 -40.51 86.39 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.338 0.655 . . . . 0.0 111.738 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.454 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.1 tp-100 -74.27 -43.86 55.16 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.87 0.868 . . . . 0.0 110.509 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.1 -39.75 83.22 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.87 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.439 ' HA ' HD12 ' A' ' 31' ' ' ILE . 15.9 m170 -60.8 -39.21 88.06 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.043 0.937 . . . . 0.0 110.304 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -67.88 -41.18 83.21 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.582 0.552 . . . . 0.0 110.932 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.535 ' SD ' HG11 ' A' ' 79' ' ' VAL . 25.0 mmt -60.17 -32.53 71.14 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.315 0.646 . . . . 0.0 111.748 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 28' ' ' HIS . 70.1 mt -71.07 -52.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.065 175.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.7 t -71.45 -44.84 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.362 0.665 . . . . 0.0 112.045 -170.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.2 -15.76 57.99 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.709 0.804 . . . . 0.0 111.705 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.45 ' NE2' HG13 ' A' ' 79' ' ' VAL . 68.5 m-70 -108.98 27.82 9.1 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.726 0.81 . . . . 0.0 111.154 175.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.85 9.97 86.3 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 114.798 -1.092 . . . . 0.0 114.656 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.423 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -96.13 177.74 34.03 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 114.453 0.541 . . . . 0.0 114.453 -170.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -123.85 150.08 45.0 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.471 0.708 . . . . 0.0 110.038 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -125.0 166.6 16.06 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.49 0.716 . . . . 0.0 110.417 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.424 HD23 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -131.35 141.65 49.93 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.04 -35.05 26.07 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.474 0.71 . . . . 0.0 112.862 -176.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.9 t80 179.62 141.14 0.13 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.992 0.917 . . . . 0.0 109.51 -174.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -93.88 116.46 28.91 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.277 0.631 . . . . 0.0 109.892 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.3 m -92.71 61.77 3.68 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.368 1.067 . . . . 0.0 109.68 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.8 m 61.39 26.28 16.09 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.402 1.081 . . . . 0.0 111.967 -175.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -132.17 140.62 48.8 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.099 0.56 . . . . 0.0 110.748 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.69 78.31 6.27 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.2 m -103.39 -8.94 19.83 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.847 0.859 . . . . 0.0 110.657 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.403 ' HA ' ' HB ' ' A' ' 13' ' ' VAL . 9.5 p -123.98 159.82 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.797 0.839 . . . . 0.0 109.867 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -114.15 -27.72 7.56 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.044 0.538 . . . . 0.0 111.202 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -130.6 129.74 43.11 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.07 0.548 . . . . 0.0 110.591 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 22.5 mt -114.66 138.89 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.645 0.778 . . . . 0.0 109.045 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.573 HG12 HG21 ' A' ' 20' ' ' THR . 63.2 t -104.63 135.36 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 123.985 0.914 . . . . 0.0 109.526 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.03 163.33 39.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.019 0.928 . . . . 0.0 108.908 173.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.3 t -115.56 -49.12 2.75 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -120.06 111.59 18.07 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 tp -129.99 123.01 20.63 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.97 151.9 74.77 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.13 2.554 . . . . 0.0 112.406 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.428 HD23 ' HD2' ' A' ' 61' ' ' ARG . 94.8 mt -59.05 -32.58 69.89 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.531 0.733 . . . . 0.0 111.878 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -60.0 -43.44 95.2 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.335 0.654 . . . . 0.0 110.723 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -75.93 -28.78 58.11 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.724 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.428 ' HD2' HD23 ' A' ' 58' ' ' LEU . 61.6 mtt180 -70.87 -29.32 65.4 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.865 0.466 . . . . 0.0 110.817 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.6 mt -80.13 -37.33 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.537 0.735 . . . . 0.0 110.638 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -61.66 -45.7 92.88 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.683 0.754 . . . . 0.0 110.03 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -99.75 19.47 15.91 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.703 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.67 -18.89 62.15 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.256 0.622 . . . . 0.0 110.415 169.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -70.64 -17.47 62.87 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.897 0.879 . . . . 0.0 110.407 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.17 171.4 7.57 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.602 1.161 . . . . 0.0 109.261 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -99.28 88.13 3.83 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.425 ' H ' HG22 ' A' ' 93' ' ' THR . 39.6 t -74.49 138.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.664 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.04 177.71 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.009 1.324 . . . . 0.0 109.723 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.3 m -87.45 160.07 48.79 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.101 0.96 . . . . 0.0 109.612 172.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.422 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.7 Cg_endo -59.75 -28.0 86.26 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 122.684 2.256 . . . . 0.0 112.223 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -65.88 -16.84 64.21 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.544 1.138 . . . . 0.0 111.969 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.3 t90 -62.69 -45.8 91.08 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 75' ' ' ILE . 3.2 mp -71.16 -50.41 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.706 -177.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.53 HG12 ' HE2' ' A' ' 80' ' ' LYS . 58.8 t -62.3 -50.74 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.878 -173.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -71.57 -33.63 69.25 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.808 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.7 m -61.19 -37.19 82.05 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 117.954 0.343 . . . . 0.0 110.718 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.535 HG11 ' SD ' ' A' ' 30' ' ' MET . 44.4 t -64.6 -47.41 89.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 C-N-CA 123.866 0.866 . . . . 0.0 111.03 173.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.53 ' HE2' HG12 ' A' ' 76' ' ' VAL . 54.3 mtmt -70.17 -26.46 63.92 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.266 0.627 . . . . 0.0 112.118 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -94.99 -15.98 23.1 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.834 0.453 . . . . 0.0 111.248 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.15 28.66 18.28 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.734 1.214 . . . . 0.0 111.84 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -144.96 149.15 34.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.418 1.087 . . . . 0.0 108.603 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.0 tp -72.73 112.07 8.45 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.9 mt -83.88 153.95 64.19 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 123.514 0.725 . . . . 0.0 110.82 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -57.59 122.15 11.26 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.992 2.461 . . . . 0.0 112.454 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -64.2 -32.34 73.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.992 0.517 . . . . 0.0 110.274 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -60.52 -31.62 70.68 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.065 0.946 . . . . 0.0 111.276 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -69.33 -25.08 64.03 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.651 0.781 . . . . 0.0 110.743 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -115.99 4.71 13.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.845 0.858 . . . . 0.0 111.423 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.9 t -66.46 126.7 29.67 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -167.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.425 ' HB2' HG12 ' A' ' 69' ' ' VAL . 49.9 mt -114.68 28.34 8.8 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.057 0.943 . . . . 0.0 110.292 173.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 69' ' ' VAL . 39.7 p -65.78 -38.17 88.3 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.635 0.774 . . . . 0.0 111.027 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.254 1.294 0 C-N-CA 124.302 1.041 . . . . 0.0 109.001 -179.306 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 t -115.76 143.58 45.19 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.255 1.022 . . . . 0.0 108.867 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.2 t -164.93 169.06 16.94 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.32 0.648 . . . . 0.0 109.979 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -126.71 94.0 3.93 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.3 p -57.77 -40.36 79.61 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.916 0.865 . . . . 0.0 109.211 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 m -142.52 145.51 33.73 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.059 164.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 10' ' ' LYS . 20.9 pttp -111.02 21.22 16.66 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.237 0.615 . . . . 0.0 110.35 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 52.5 mt -66.08 -50.07 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.816 0.846 . . . . 0.0 110.584 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.41 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 50.4 m-85 -112.26 14.48 20.52 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.143 -176.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.588 ' HB2' ' HA ' ' A' ' 7' ' ' LYS . 52.2 tptt -53.54 -55.63 23.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.064 0.946 . . . . 0.0 113.476 -165.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -100.15 17.52 21.0 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.371 0.605 . . . . 0.0 109.889 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.49 ' SG ' ' CD2' ' A' ' 50' ' ' HIS . 29.1 t -113.06 128.39 56.48 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.048 1.339 . . . . 0.0 110.901 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.86 130.34 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.242 1.017 . . . . 0.0 109.295 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.525 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.7 mp -124.42 129.37 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 CA-C-O 121.407 0.622 . . . . 0.0 111.852 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.496 ' HB2' ' HB3' ' A' ' 39' ' ' LEU . 55.2 t80 -104.02 152.39 22.09 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.43 1.892 . . . . 0.0 108.39 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -122.78 137.89 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.066 0.546 . . . . 0.0 109.987 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 15' ' ' TYR . 58.5 t30 -143.74 141.63 30.55 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.39 1.076 . . . . 0.0 109.346 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.27 -178.92 46.49 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 116.467 -0.333 . . . . 0.0 112.699 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -92.9 110.59 22.05 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.98 0.419 . . . . 0.0 109.955 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.612 HG21 HG12 ' A' ' 52' ' ' VAL . 65.0 p -122.59 142.59 50.47 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.715 1.206 . . . . 0.0 109.717 -174.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -96.82 130.76 29.4 Favored Pre-proline 0 N--CA 1.479 0.976 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 167.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.49 176.28 42.31 Favored 'Cis proline' 0 C--N 1.373 1.831 0 C-N-CA 124.758 -0.934 . . . . 0.0 111.666 -4.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.59 152.0 7.66 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.746 0.654 . . . . 0.0 114.07 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -54.01 -34.97 61.36 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.251 1.02 . . . . 0.0 112.263 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 pp -58.09 -48.28 80.63 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.898 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.514 HE21 ' HA ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -73.5 -41.77 62.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.355 0.662 . . . . 0.0 111.614 -175.235 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.493 HD13 HG11 ' A' ' 52' ' ' VAL . 29.1 mt -58.34 -44.58 88.78 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.033 0.533 . . . . 0.0 110.641 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.436 ' O ' HG23 ' A' ' 32' ' ' VAL . 16.8 m170 -65.79 -34.97 79.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.567 0.347 . . . . 0.0 111.498 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -62.85 -42.2 99.66 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 117.847 0.294 . . . . 0.0 110.443 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.638 ' HB3' HG21 ' A' ' 79' ' ' VAL . 22.9 mmt -62.26 -39.06 91.64 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.881 0.872 . . . . 0.0 110.677 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.525 HD13 ' HB ' ' A' ' 14' ' ' ILE . 71.1 mt -65.87 -51.55 59.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.044 0.938 . . . . 0.0 111.463 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 28' ' ' HIS . 99.9 t -68.56 -43.67 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 122.901 0.48 . . . . 0.0 111.599 -173.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.67 -17.8 63.32 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.271 0.629 . . . . 0.0 111.795 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.424 ' NE2' HG13 ' A' ' 79' ' ' VAL . 55.5 m-70 -108.91 26.51 10.51 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.675 0.79 . . . . 0.0 111.581 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.9 -0.33 72.87 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.615 -0.721 . . . . 0.0 114.821 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . -92.52 173.97 36.0 Favored Glycine 0 C--O 1.237 0.342 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 -166.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -117.4 159.33 22.94 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.605 1.162 . . . . 0.0 109.63 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -125.27 156.63 38.28 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.764 0.826 . . . . 0.0 110.987 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.617 ' HG ' ' HB ' ' A' ' 48' ' ' VAL . 2.4 tm? -134.65 129.38 34.76 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.44 ' HD2' ' H ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -79.74 -43.36 22.74 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.44 ' H ' ' HD2' ' A' ' 40' ' ' HIS . 71.9 t80 -175.33 146.21 0.8 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.172 0.989 . . . . 0.0 109.727 -170.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.406 HD11 HG12 ' A' ' 48' ' ' VAL . 3.2 mm? -88.46 97.67 11.2 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.364 0.666 . . . . 0.0 110.244 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.2 t -91.53 -24.13 19.72 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 164.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.7 m -141.4 163.74 32.13 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.916 0.886 . . . . 0.0 110.819 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -84.51 166.51 17.18 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.331 0.652 . . . . 0.0 111.416 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? 68.22 3.9 3.9 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.858 1.263 . . . . 0.0 112.847 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.8 p -83.44 -18.74 37.61 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.072 0.549 . . . . 0.0 111.111 -174.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.617 ' HB ' ' HG ' ' A' ' 39' ' ' LEU . 9.8 p -136.93 156.62 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.481 0.712 . . . . 0.0 109.858 176.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.522 HG23 ' HD2' ' A' ' 50' ' ' HIS . 4.6 t -114.51 -25.31 8.41 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.436 0.695 . . . . 0.0 111.127 175.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.522 ' HD2' HG23 ' A' ' 49' ' ' THR . 80.5 m-70 -132.55 130.47 40.39 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.939 0.495 . . . . 0.0 110.616 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.64 ' HB ' HG12 ' A' ' 69' ' ' VAL . 66.7 mt -114.98 135.21 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.612 HG12 HG21 ' A' ' 20' ' ' THR . 87.5 t -91.79 129.1 42.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.26 145.93 29.59 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.5 t -88.46 -39.15 14.44 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -143.96 139.73 29.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.476 1.11 . . . . 0.0 108.264 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.3 tp -128.07 128.38 23.76 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.97 150.29 73.56 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.066 2.51 . . . . 0.0 112.317 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.2 mt -57.22 -39.83 76.26 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.946 0.898 . . . . 0.0 111.339 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.28 -43.36 99.01 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.404 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -76.64 -20.79 56.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.603 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -66.43 -41.22 89.53 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 171.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.1 mt -65.41 -43.54 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 123.717 0.636 . . . . 0.0 110.797 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.63 -42.26 82.59 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.365 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -100.36 23.33 10.31 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.549 0.74 . . . . 0.0 110.674 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.63 -27.44 67.69 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.409 0.683 . . . . 0.0 111.386 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -71.3 -19.37 62.33 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.938 0.895 . . . . 0.0 111.239 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -108.9 143.89 37.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.882 0.873 . . . . 0.0 109.204 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.04 86.17 4.23 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.64 HG12 ' HB ' ' A' ' 51' ' ' ILE . 7.6 m -78.3 127.82 38.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.22 171.41 18.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.284 1.034 . . . . 0.0 109.667 -172.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.1 m -77.92 150.25 78.01 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.399 170.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.83 -25.86 78.17 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.332 2.021 . . . . 0.0 111.39 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.7 -29.38 52.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.387 1.475 . . . . 0.0 112.271 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -60.29 -54.37 46.5 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.487 ' H ' HD12 ' A' ' 75' ' ' ILE . 3.4 mp -64.15 -48.04 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 124.227 0.955 . . . . 0.0 109.165 -175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.68 -52.24 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.835 1.254 . . . . 0.0 111.462 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.78 -33.29 66.2 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.74 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.467 ' HA ' HD13 ' A' ' 85' ' ' LEU . 61.9 m -62.34 -35.38 78.9 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.925 0.49 . . . . 0.0 111.361 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 30' ' ' MET . 71.4 t -69.5 -44.34 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.37 0.668 . . . . 0.0 110.863 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.5 -43.25 89.0 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.525 0.679 . . . . 0.0 110.843 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.626 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 64.7 mm-40 -82.65 -21.49 34.99 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.856 -176.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.66 24.93 12.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.241 1.017 . . . . 0.0 111.173 -173.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.626 ' HE ' ' HB3' ' A' ' 81' ' ' GLU . 9.2 ptp180 -134.81 166.02 23.95 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.457 0.703 . . . . 0.0 109.656 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -86.25 116.14 24.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.317 0.647 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 78' ' ' SER . 11.3 mp -90.17 155.19 47.07 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.745 0.818 . . . . 0.0 110.198 172.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.54 109.43 2.62 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.066 1.844 . . . . 0.0 110.755 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -62.38 -25.55 67.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.48 0.712 . . . . 0.0 111.725 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -57.92 -29.54 65.21 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.212 1.005 . . . . 0.0 111.64 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -75.6 -34.48 60.63 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.873 0.869 . . . . 0.0 111.046 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -96.34 -1.05 48.59 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.58 0.752 . . . . 0.0 111.253 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.2 t -72.67 115.59 12.12 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.45 0.7 . . . . 0.0 112.068 -170.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.6 mt -79.31 4.91 13.78 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.934 0.893 . . . . 0.0 111.898 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.2 p -62.4 -21.95 65.78 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.75 0.82 . . . . 0.0 111.463 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.255 1.377 0 C-N-CA 125.832 1.653 . . . . 0.0 111.189 176.253 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 10.0 pt . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.713 0.292 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 m -63.5 113.34 3.23 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 169.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.4 m -74.05 78.85 1.71 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.626 0.726 . . . . 0.0 111.171 -171.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -87.47 -18.64 29.42 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.592 1.157 . . . . 0.0 109.043 171.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 50.7 m -74.14 107.99 6.67 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.632 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.7 m -62.89 128.75 37.35 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 167.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -79.47 32.09 0.24 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -165.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.2 mt -57.78 -46.87 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.033 1.333 . . . . 0.0 111.669 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 50.9 m-85 -112.53 17.01 19.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.607 0.763 . . . . 0.0 110.828 -174.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -57.16 -44.05 83.09 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.693 0.797 . . . . 0.0 112.47 -171.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -92.05 -5.81 52.2 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.475 0.31 . . . . 0.0 111.365 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.6 m -97.55 125.84 42.49 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.525 0.678 . . . . 0.0 111.242 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.531 HG12 HG23 ' A' ' 48' ' ' VAL . 36.9 t -103.52 130.6 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 169.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 3.2 mp -118.31 136.01 56.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 123.81 0.844 . . . . 0.0 111.147 -174.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -115.45 119.7 37.07 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 124.422 1.089 . . . . 0.0 108.465 169.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.9 mt -92.36 138.28 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.164 0.586 . . . . 0.0 109.508 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -147.16 136.94 23.05 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.049 0.94 . . . . 0.0 110.098 -166.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.36 -154.17 50.18 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.266 0.354 . . . . 0.0 113.465 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -78.1 128.63 34.11 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 172.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.2 p -146.68 126.86 13.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.672 1.189 . . . . 0.0 108.512 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -114.28 135.76 22.22 Favored Pre-proline 0 N--CA 1.481 1.102 0 CA-C-N 118.212 0.46 . . . . 0.0 111.141 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.11 175.12 38.98 Favored 'Cis proline' 0 C--N 1.379 2.161 0 C-N-CA 124.827 -0.905 . . . . 0.0 112.264 -1.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.58 141.09 9.87 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 124.126 0.891 . . . . 0.0 113.392 -175.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -50.29 -34.66 24.25 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.347 1.059 . . . . 0.0 112.904 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 pp -54.55 -45.7 73.51 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.803 0.441 . . . . 0.0 111.581 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -73.12 -45.41 57.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.976 0.91 . . . . 0.0 110.719 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.3 -44.84 76.1 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.724 0.64 . . . . 0.0 111.306 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -58.96 -40.54 85.04 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.768 0.827 . . . . 0.0 110.638 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.89 -39.87 87.58 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.336 0.397 . . . . 0.0 111.195 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.547 ' HB3' HG21 ' A' ' 79' ' ' VAL . 24.4 mmt -63.37 -33.1 74.79 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.981 0.513 . . . . 0.0 111.355 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.4 mt -72.48 -51.56 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.559 0.744 . . . . 0.0 111.003 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.03 -44.95 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.218 0.607 . . . . 0.0 111.681 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 5' ' ' SER . 4.6 mm? -66.8 -11.82 56.6 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.531 0.732 . . . . 0.0 111.805 177.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -113.3 27.23 9.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.71 0.804 . . . . 0.0 111.594 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.57 -6.16 83.86 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.283 -0.872 . . . . 0.0 114.764 167.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.13 156.88 42.34 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 113.944 0.338 . . . . 0.0 113.944 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -108.99 169.71 8.51 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 43.6 p90 -144.27 151.01 38.82 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.79 127.48 53.74 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.656 169.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -33.95 76.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.079 172.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -172.81 151.32 2.24 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.608 1.163 . . . . 0.0 109.01 173.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.3 -47.43 5.18 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.7 t 56.15 56.79 5.54 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 124.615 1.197 . . . . 0.0 109.081 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.7 m 61.76 82.47 0.17 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.521 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -164.37 127.78 2.5 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -89.26 75.11 7.82 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.459 0.572 . . . . 0.0 110.394 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.3 m -108.1 -36.27 6.36 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.73 0.812 . . . . 0.0 110.496 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.531 HG23 HG12 ' A' ' 13' ' ' VAL . 6.9 p -93.29 157.77 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.086 0.554 . . . . 0.0 110.224 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 t -111.27 -32.63 6.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.969 0.508 . . . . 0.0 111.639 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -119.93 138.51 53.4 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.77 0.828 . . . . 0.0 109.088 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.685 ' HB ' HG12 ' A' ' 69' ' ' VAL . 52.7 mt -124.37 138.14 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.55 122.07 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.945 0.898 . . . . 0.0 110.378 -175.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.11 156.97 45.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.665 1.186 . . . . 0.0 108.075 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.1 t -76.23 -38.88 55.77 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -147.84 138.17 22.95 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.075 173.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.1 tp -116.49 124.57 29.31 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.61 156.59 36.25 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.564 2.842 . . . . 0.0 112.666 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.406 HD23 ' HD2' ' A' ' 61' ' ' ARG . 97.0 mt -60.01 -41.96 93.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.832 0.853 . . . . 0.0 112.039 -174.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -57.57 -41.76 81.72 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.671 0.789 . . . . 0.0 110.462 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.39 -23.45 46.78 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.823 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HD2' HD23 ' A' ' 58' ' ' LEU . 99.6 mtt180 -70.73 -33.85 71.28 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.405 0.548 . . . . 0.0 110.656 173.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.7 -45.52 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.485 0.714 . . . . 0.0 109.997 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.68 -50.82 65.5 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.054 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.436 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 18.7 m-85 -92.67 26.35 2.73 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.442 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.63 -29.89 70.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.429 0.692 . . . . 0.0 111.38 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -77.52 -25.82 50.6 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.22 0.608 . . . . 0.0 111.062 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.436 ' CD1' ' HA ' ' A' ' 64' ' ' PHE . 10.3 m-85 -89.47 145.92 24.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.744 0.818 . . . . 0.0 109.638 -177.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 68' ' ' LYS . 11.3 mptt -87.03 86.67 7.33 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.685 HG12 ' HB ' ' A' ' 51' ' ' ILE . 21.6 m -81.63 131.18 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.422 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.97 174.43 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.622 1.169 . . . . 0.0 110.112 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -82.78 157.21 67.12 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.795 0.838 . . . . 0.0 110.549 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.72 -23.28 75.84 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.672 2.248 . . . . 0.0 111.864 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.35 -27.42 65.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.331 1.452 . . . . 0.0 111.774 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -61.68 -48.71 79.55 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.506 0.504 . . . . 0.0 110.223 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.4 mp -67.47 -49.3 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.057 -175.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.2 -52.42 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.342 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.78 -36.19 70.26 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.113 -172.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.1 m -66.07 -40.34 90.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.014 0.525 . . . . 0.0 111.312 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.547 HG21 ' HB3' ' A' ' 30' ' ' MET . 23.8 t -64.88 -44.0 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.533 0.733 . . . . 0.0 110.799 178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -65.16 -36.67 84.94 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.676 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.534 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 48.0 mm-40 -86.24 -8.74 57.54 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.11 19.03 8.29 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.7 1.2 . . . . 0.0 112.763 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.534 ' HE ' ' HB3' ' A' ' 81' ' ' GLU . 13.5 ptp180 -134.21 161.85 33.77 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.509 0.724 . . . . 0.0 109.932 -172.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.8 tp -84.03 113.19 20.84 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 172.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.02 154.42 55.05 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 123.456 0.702 . . . . 0.0 109.968 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.1 117.12 3.96 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.232 1.954 . . . . 0.0 110.931 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -59.76 -27.88 66.91 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.561 0.744 . . . . 0.0 111.672 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -62.21 -25.78 67.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.481 1.113 . . . . 0.0 112.352 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -68.55 -26.99 65.69 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.588 0.755 . . . . 0.0 110.938 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -117.19 5.03 12.66 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.773 0.829 . . . . 0.0 111.114 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.6 t -72.7 125.26 27.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.136 0.574 . . . . 0.0 111.918 -171.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.4 mt -93.39 13.07 22.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.015 0.926 . . . . 0.0 111.862 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.5 p -61.7 -28.33 69.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.273 0.629 . . . . 0.0 110.654 174.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 125.075 1.35 . . . . 0.0 111.481 171.098 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 12.8 tt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.9 m -138.65 147.96 43.49 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.98 0.912 . . . . 0.0 108.958 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.4 p -156.53 145.03 19.89 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.841 0.857 . . . . 0.0 110.04 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -71.22 107.8 4.4 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.249 0.62 . . . . 0.0 110.826 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -164.31 154.69 14.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.018 0.927 . . . . 0.0 109.186 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.576 ' HB3' HG13 ' A' ' 8' ' ' ILE . 15.9 m -85.71 158.47 20.03 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.23 0.612 . . . . 0.0 111.534 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -112.06 15.12 20.73 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.947 0.899 . . . . 0.0 110.185 176.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.576 HG13 ' HB3' ' A' ' 6' ' ' SER . 76.3 mt -57.1 -46.98 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 124.154 0.982 . . . . 0.0 112.32 -168.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.439 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 55.5 m-85 -114.8 15.86 17.41 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.705 0.402 . . . . 0.0 111.292 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -64.85 -32.65 74.46 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 122.724 0.41 . . . . 0.0 111.928 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -96.96 6.75 48.07 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.839 0.456 . . . . 0.0 111.685 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 76.3 m -120.82 130.46 53.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.371 0.669 . . . . 0.0 111.477 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.494 HG12 HG23 ' A' ' 48' ' ' VAL . 39.1 t -96.95 131.8 42.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 167.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.411 HG23 HG23 ' A' ' 52' ' ' VAL . 3.6 mp -119.31 124.05 72.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.512 0.725 . . . . 0.0 110.648 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -105.97 109.74 21.79 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 166.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.5 mt -78.04 135.17 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -137.16 122.81 19.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.102 0.961 . . . . 0.0 109.257 -169.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.39 -179.13 29.8 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.406 0.441 . . . . 0.0 113.248 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -71.63 108.47 5.0 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.416 HG21 HG12 ' A' ' 52' ' ' VAL . 71.0 p -111.25 148.65 32.4 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 124.963 1.305 . . . . 0.0 108.897 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 11.2 mmpt? -107.35 122.05 42.52 Favored Pre-proline 0 N--CA 1.482 1.164 0 CA-C-N 118.229 0.468 . . . . 0.0 110.77 172.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -82.55 176.03 37.37 Favored 'Cis proline' 0 C--N 1.368 1.571 0 C-N-CA 123.939 -1.276 . . . . 0.0 111.78 0.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.17 154.04 6.89 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.704 0.628 . . . . 0.0 114.19 -173.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -55.38 -36.58 66.52 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.547 0.739 . . . . 0.0 111.858 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.9 pp -61.12 -40.69 94.74 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 123.859 0.724 . . . . 0.0 111.826 176.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.456 ' N ' HD12 ' A' ' 25' ' ' LEU . 61.1 tp60 -73.33 -46.52 48.88 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.324 0.649 . . . . 0.0 110.145 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 72' ' ' PRO . 66.3 mt -58.09 -39.24 78.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.68 0.792 . . . . 0.0 111.029 174.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -57.38 -42.72 82.71 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.752 0.821 . . . . 0.0 110.385 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -64.84 -43.39 93.23 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 79.1 mmm -62.81 -34.48 77.39 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.249 0.62 . . . . 0.0 111.212 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.6 mt -75.24 -54.94 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.486 0.714 . . . . 0.0 111.617 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.0 t -72.09 -40.18 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.224 0.61 . . . . 0.0 112.122 -166.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.48 -21.6 64.33 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.528 0.731 . . . . 0.0 111.677 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.475 ' NE2' HG13 ' A' ' 79' ' ' VAL . 60.2 m80 -105.12 26.97 8.66 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.305 1.042 . . . . 0.0 110.635 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.84 -3.74 83.11 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.853 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.49 151.79 47.03 Favored Glycine 0 C--O 1.239 0.421 0 N-CA-C 115.771 1.069 . . . . 0.0 115.771 -167.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -106.77 143.96 34.11 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -127.1 149.34 49.98 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.131 0.572 . . . . 0.0 109.724 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.25 123.47 49.32 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 175.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.55 -39.29 88.46 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.245 0.618 . . . . 0.0 112.109 -172.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -175.53 132.34 0.28 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.432 1.093 . . . . 0.0 108.716 -175.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.71 171.91 9.64 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.805 0.812 . . . . 0.0 112.482 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.7 p -135.04 -156.58 0.73 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.807 -177.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.7 t -67.06 -17.93 65.12 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.219 0.608 . . . . 0.0 111.271 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -91.29 128.96 37.32 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.893 0.877 . . . . 0.0 110.715 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.04 98.34 2.52 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.1 m -119.97 18.34 12.47 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-O 121.182 0.515 . . . . 0.0 110.71 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.494 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -144.31 147.98 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 122.016 -0.428 . . . . 0.0 110.451 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.5 t -103.79 -32.37 9.37 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.574 0.75 . . . . 0.0 111.725 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -126.06 128.76 47.9 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.5 0.72 . . . . 0.0 109.845 -175.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 41.4 mt -114.39 121.9 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.57 0.748 . . . . 0.0 109.275 175.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.416 HG12 HG21 ' A' ' 20' ' ' THR . 64.0 t -92.32 121.6 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.113 0.565 . . . . 0.0 110.022 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.0 154.07 49.36 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.207 0.603 . . . . 0.0 110.167 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.7 t -95.26 -34.61 12.14 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -140.87 120.85 13.64 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.589 ' HG ' HG11 ' A' ' 69' ' ' VAL . 2.2 tm? -127.43 108.96 21.07 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.04 155.11 70.07 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.846 2.364 . . . . 0.0 112.394 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 61' ' ' ARG . 70.6 mt -64.16 -29.74 70.84 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -172.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -59.36 -48.96 79.66 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.512 0.672 . . . . 0.0 110.298 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -76.01 -19.71 58.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.45 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 10.6 tpp85 -67.64 -40.39 84.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.41 0.684 . . . . 0.0 109.767 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.0 mt -77.06 -35.8 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.063 0.945 . . . . 0.0 110.488 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -69.16 -30.53 68.78 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.465 0.706 . . . . 0.0 111.032 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -115.55 28.64 8.53 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.205 1.002 . . . . 0.0 110.042 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.93 -33.47 75.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.509 0.724 . . . . 0.0 111.626 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -77.36 -26.72 52.24 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.004 0.522 . . . . 0.0 110.82 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -78.64 141.48 37.96 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -83.89 85.8 7.26 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.36 0.664 . . . . 0.0 109.353 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' A' ' 56' ' ' LEU . 57.3 t -78.21 127.59 38.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 174.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.05 173.78 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.139 0.975 . . . . 0.0 110.19 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.3 m -81.46 152.92 70.79 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.818 0.847 . . . . 0.0 110.402 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HB3' HD11 ' A' ' 27' ' ' LEU . 21.6 Cg_endo -59.62 -25.49 79.1 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.964 2.443 . . . . 0.0 112.698 173.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.67 -19.75 66.03 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.051 0.941 . . . . 0.0 112.047 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -59.37 -43.05 92.91 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.923 0.489 . . . . 0.0 109.83 173.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 75' ' ' ILE . 3.2 mp -75.55 -49.55 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.128 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.1 t -59.76 -51.73 69.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.321 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -71.22 -39.57 71.63 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.267 -175.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.8 p -63.62 -37.75 88.51 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 120.822 0.344 . . . . 0.0 111.699 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.475 HG13 ' NE2' ' A' ' 34' ' ' HIS . 33.4 t -62.38 -46.1 97.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 123.719 0.807 . . . . 0.0 110.696 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.1 -37.24 86.41 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.203 0.601 . . . . 0.0 111.542 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -83.96 -12.56 55.15 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.499 0.72 . . . . 0.0 111.594 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.52 26.06 15.86 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.136 1.374 . . . . 0.0 112.582 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -140.86 161.9 36.73 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.327 1.051 . . . . 0.0 109.32 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.6 tp -87.72 128.58 35.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 172.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 mp -93.56 153.39 41.28 Favored Pre-proline 0 C--O 1.241 0.646 0 C-N-CA 123.865 0.866 . . . . 0.0 108.953 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.616 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 30.0 Cg_endo -65.23 140.96 66.94 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.768 1.645 . . . . 0.0 111.865 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -57.76 -33.24 68.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.696 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.616 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 30.0 pt20 -57.7 -34.2 69.2 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.666 1.186 . . . . 0.0 113.046 -170.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.51 ' OD1' ' HG2' ' A' ' 86' ' ' PRO . 14.2 m120 -67.32 -36.02 80.61 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.576 0.35 . . . . 0.0 111.706 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -107.81 3.34 24.33 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.521 0.728 . . . . 0.0 111.31 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.9 t -67.82 118.7 11.4 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.627 0.771 . . . . 0.0 112.639 -170.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.5 mt -86.49 -35.36 19.65 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.055 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.8 t -57.41 -33.87 68.33 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 123.422 0.689 . . . . 0.0 111.614 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 p . . . . . 0 C--O 1.253 1.247 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.127 176.09 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.375 0.131 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -81.39 104.37 11.78 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.233 0.613 . . . . 0.0 110.387 -177.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.1 m -152.79 111.81 3.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.169 0.987 . . . . 0.0 108.971 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -89.51 139.43 30.54 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.137 0.575 . . . . 0.0 110.132 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 p -63.16 -39.16 93.86 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.402 0.681 . . . . 0.0 111.748 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.485 ' HB2' ' HA ' ' A' ' 34' ' ' HIS . 43.3 m -83.19 130.4 35.09 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -120.48 31.61 6.38 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.92 0.888 . . . . 0.0 108.961 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.523 HD12 ' HD2' ' A' ' 34' ' ' HIS . 40.5 mt -66.94 -39.08 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.632 1.173 . . . . 0.0 112.734 -166.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.505 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 68.6 m-85 -113.21 16.9 19.0 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.195 0.598 . . . . 0.0 110.961 -176.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -60.14 -39.6 86.88 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -169.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -94.87 11.0 33.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.961 -0.462 . . . . 0.0 111.471 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 83.2 m -122.9 135.58 54.56 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.611 0.764 . . . . 0.0 112.095 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 37' ' ' LYS . 50.0 t -104.21 134.25 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 167.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.497 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.6 mp -126.07 122.73 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 121.255 0.55 . . . . 0.0 111.107 -174.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -102.99 152.31 21.47 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.59 1.556 . . . . 0.0 107.98 174.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.1 mt -121.96 127.08 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -128.35 139.85 52.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.163 0.985 . . . . 0.0 109.565 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.65 -161.22 46.08 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.593 0.558 . . . . 0.0 112.443 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -102.19 113.12 26.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.633 0.773 . . . . 0.0 109.479 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.492 HG21 HG12 ' A' ' 52' ' ' VAL . 79.5 p -117.93 137.65 52.69 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.851 0.86 . . . . 0.0 109.829 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -106.02 125.83 32.14 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 165.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -76.72 165.16 85.81 Favored 'Cis proline' 0 C--N 1.374 1.903 0 C-N-CA 124.027 -1.239 . . . . 0.0 111.837 2.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.0 161.57 6.41 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 123.906 0.754 . . . . 0.0 114.656 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -55.8 -36.07 67.02 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.525 0.73 . . . . 0.0 111.179 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.535 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.6 pp -61.95 -42.0 98.62 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 123.753 0.658 . . . . 0.0 111.678 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.535 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.3 tp-100 -69.56 -52.24 28.06 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.328 0.651 . . . . 0.0 110.342 -175.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.528 HD13 HG11 ' A' ' 52' ' ' VAL . 71.2 mt -57.8 -44.28 86.22 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.53 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.483 ' HA ' HD12 ' A' ' 31' ' ' ILE . 13.7 m170 -61.79 -37.59 84.9 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.063 0.545 . . . . 0.0 111.321 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 52.0 mm-40 -63.28 -45.84 89.59 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.021 0.439 . . . . 0.0 110.014 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.424 ' HB3' HG21 ' A' ' 79' ' ' VAL . 25.6 mmt -60.77 -37.77 83.0 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.63 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.497 HD13 ' HB ' ' A' ' 14' ' ' ILE . 75.5 mt -62.8 -50.81 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.043 0.537 . . . . 0.0 110.981 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.65 -45.62 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.064 0.546 . . . . 0.0 111.62 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.69 -18.89 65.61 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.275 0.63 . . . . 0.0 111.848 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.523 ' HD2' HD12 ' A' ' 8' ' ' ILE . 21.0 m80 -103.76 27.1 7.82 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.423 0.689 . . . . 0.0 111.108 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.76 -3.25 87.39 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.836 166.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -91.82 171.24 34.27 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 -170.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HB2' HG22 ' A' ' 13' ' ' VAL . 42.0 mmtm -110.24 158.07 18.78 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.457 0.703 . . . . 0.0 109.736 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -133.31 153.23 51.76 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.766 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.483 HD23 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -112.2 136.52 51.51 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -85.25 -35.03 21.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.507 0.723 . . . . 0.0 112.056 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -176.99 139.69 0.29 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.413 1.085 . . . . 0.0 108.983 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.33 141.2 29.19 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.139 0.576 . . . . 0.0 110.369 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.7 m -85.27 45.88 1.23 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.309 1.044 . . . . 0.0 109.09 170.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.8 m 63.39 12.25 6.14 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.355 1.462 . . . . 0.0 112.315 -171.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -101.83 166.5 10.62 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.364 0.666 . . . . 0.0 111.542 -173.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -96.58 52.63 1.23 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.996 0.918 . . . . 0.0 109.816 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.8 m -84.66 5.15 29.24 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.349 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.404 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -137.04 150.72 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.856 0.862 . . . . 0.0 109.776 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.8 t -101.9 -38.18 7.92 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.058 0.543 . . . . 0.0 110.946 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.579 ' HD2' ' HB2' ' A' ' 68' ' ' LYS . 56.2 m170 -118.5 133.59 55.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.285 0.634 . . . . 0.0 109.442 -172.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.659 ' HB ' HG12 ' A' ' 69' ' ' VAL . 65.5 mt -123.63 134.14 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.528 HG11 HD13 ' A' ' 27' ' ' LEU . 52.1 t -92.69 128.96 43.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.03 143.86 28.7 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.4 t -92.78 -41.44 10.11 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 166.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -145.42 120.43 10.04 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.616 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.8 mt -92.21 148.82 37.43 Favored Pre-proline 0 C--O 1.24 0.583 0 C-N-CA 123.219 0.607 . . . . 0.0 109.678 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.72 157.42 37.67 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.808 2.339 . . . . 0.0 110.849 166.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.8 mt -53.3 -53.71 46.97 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.426 0.69 . . . . 0.0 112.105 -171.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.98 -46.19 90.35 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.38 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -72.67 -19.39 61.43 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.241 0.616 . . . . 0.0 112.251 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -72.84 -40.53 65.66 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 81.4 mt -66.88 -45.6 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.457 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.44 -40.3 73.85 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.074 0.55 . . . . 0.0 111.678 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.86 17.98 4.46 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.194 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.08 -26.51 61.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.697 0.399 . . . . 0.0 110.296 167.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -70.81 -27.27 63.76 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.301 0.641 . . . . 0.0 110.407 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -90.44 153.88 20.07 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.579 ' HB2' ' HD2' ' A' ' 50' ' ' HIS . 0.5 OUTLIER -84.86 85.31 7.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.659 HG12 ' HB ' ' A' ' 51' ' ' ILE . 31.6 m -85.08 129.85 37.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.835 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 m -134.98 171.56 17.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.502 1.121 . . . . 0.0 109.653 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.6 m -78.8 153.6 78.06 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.049 172.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.08 -24.95 52.02 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.743 2.296 . . . . 0.0 112.401 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.68 -27.1 48.32 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.878 1.271 . . . . 0.0 112.769 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -65.07 -45.16 86.45 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.227 0.537 . . . . 0.0 110.395 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 79' ' ' VAL . 3.2 mp -73.96 -45.5 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.74 -176.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 68.8 t -57.7 -49.8 79.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.908 0.883 . . . . 0.0 110.968 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.488 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 25.9 t70 -70.66 -35.18 72.73 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.85 0.46 . . . . 0.0 111.459 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB2' HG21 ' A' ' 8' ' ' ILE . 78.4 p -66.26 -37.33 85.23 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 120.428 0.156 . . . . 0.0 110.71 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 75' ' ' ILE . 72.6 t -64.08 -42.5 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.487 0.715 . . . . 0.0 110.771 173.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' A' ' 77' ' ' ASP . 8.2 mtpm? -63.41 -45.64 90.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.661 0.784 . . . . 0.0 111.485 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -93.79 -9.54 37.17 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.972 0.509 . . . . 0.0 112.197 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.61 36.42 22.65 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.203 1.001 . . . . 0.0 111.729 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -150.74 167.21 28.09 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.764 0.826 . . . . 0.0 110.159 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.28 106.14 18.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.21 146.77 67.72 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.466 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 17.9 Cg_endo -58.88 113.86 1.75 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.33 2.02 . . . . 0.0 111.838 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -57.56 -24.53 56.7 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.498 1.119 . . . . 0.0 111.665 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.466 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.6 pt20 -58.37 -27.9 64.64 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 124.545 1.138 . . . . 0.0 112.507 -176.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -79.33 -18.83 51.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.178 0.591 . . . . 0.0 112.091 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -110.14 1.94 19.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.813 0.845 . . . . 0.0 111.232 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m -65.82 122.5 17.46 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.622 0.769 . . . . 0.0 112.377 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.0 mt -98.83 15.2 26.22 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.631 0.772 . . . . 0.0 110.286 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -64.4 -23.53 67.32 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.573 1.149 . . . . 0.0 111.661 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 C--O 1.25 1.1 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.09 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.6 tt . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 t 62.56 73.47 0.46 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.976 1.311 . . . . 0.0 111.293 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.3 t -136.1 147.13 47.66 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.275 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -139.47 9.74 2.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.394 1.077 . . . . 0.0 109.63 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.8 m -59.9 -28.31 67.47 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.575 1.15 . . . . 0.0 112.135 -172.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.4 m -136.78 120.71 17.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.299 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -98.29 20.49 12.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.841 0.857 . . . . 0.0 110.565 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.9 mt -67.85 -49.65 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.35 1.06 . . . . 0.0 111.31 -172.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -110.28 12.02 23.34 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.432 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -58.72 -35.93 73.46 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.184 0.593 . . . . 0.0 111.651 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -108.1 16.94 22.88 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.662 0.785 . . . . 0.0 110.894 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 77.4 m -121.03 114.65 21.8 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 123.847 0.859 . . . . 0.0 110.485 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.442 HG12 HG23 ' A' ' 48' ' ' VAL . 48.6 t -97.81 125.12 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 168.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.439 HG23 HG23 ' A' ' 52' ' ' VAL . 3.2 mp -115.7 129.67 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.23 1.012 . . . . 0.0 111.356 -175.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -111.74 118.58 35.99 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 167.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.1 mt -83.28 133.74 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -137.2 125.54 23.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.63 1.172 . . . . 0.0 108.374 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.19 -176.22 51.88 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 -174.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' O ' ' HB3' ' A' ' 54' ' ' SER . 72.8 m-85 -88.01 112.34 22.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 122.813 0.445 . . . . 0.0 109.808 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.422 HG21 HG12 ' A' ' 52' ' ' VAL . 41.3 p -107.83 146.27 32.5 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.749 1.22 . . . . 0.0 109.652 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -110.87 124.54 32.72 Favored Pre-proline 0 N--CA 1.485 1.305 0 CA-C-N 117.665 0.211 . . . . 0.0 111.004 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.12 173.64 57.01 Favored 'Cis proline' 0 C--N 1.375 1.955 0 C-N-CA 124.196 -1.168 . . . . 0.0 112.043 3.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.69 149.66 10.32 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 123.749 0.656 . . . . 0.0 114.535 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -50.13 -38.49 39.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.61 1.164 . . . . 0.0 112.638 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 26' ' ' GLN . 1.4 pp -63.66 -39.45 94.36 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 122.968 0.507 . . . . 0.0 111.98 175.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.499 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.8 tp-100 -73.27 -48.61 33.32 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.093 0.957 . . . . 0.0 110.645 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 72' ' ' PRO . 88.7 mt -56.08 -45.61 79.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.522 0.729 . . . . 0.0 111.311 174.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -54.98 -39.01 68.55 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.678 0.611 . . . . 0.0 111.151 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -64.07 -46.92 82.18 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.778 0.323 . . . . 0.0 110.593 173.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.667 ' HB3' HG21 ' A' ' 79' ' ' VAL . 36.9 mmt -62.56 -35.01 78.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.534 0.734 . . . . 0.0 112.147 -175.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.9 mt -72.35 -53.68 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.566 0.746 . . . . 0.0 111.074 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.5 t -75.0 -37.22 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.878 -167.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.19 -13.84 62.64 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.751 0.82 . . . . 0.0 111.58 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.423 ' NE2' HG13 ' A' ' 79' ' ' VAL . 21.2 m-70 -106.63 26.12 10.35 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.967 0.907 . . . . 0.0 110.619 173.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.69 22.44 72.31 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.761 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.32 156.84 20.85 Favored Glycine 0 CA--C 1.503 -0.706 0 N-CA-C 113.443 0.137 . . . . 0.0 113.443 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.557 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -105.45 144.16 32.61 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -116.35 157.3 25.24 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.99 123.21 44.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 175.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -72.91 -32.93 65.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.078 0.951 . . . . 0.0 111.789 -174.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -176.13 126.07 0.2 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.428 1.091 . . . . 0.0 108.377 -172.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.69 139.15 31.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.056 0.543 . . . . 0.0 110.393 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.8 t -84.44 -157.42 0.28 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.077 0.951 . . . . 0.0 108.465 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 m -83.76 47.17 1.25 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.192 0.597 . . . . 0.0 111.85 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -159.56 172.12 18.41 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.169 0.509 . . . . 0.0 111.482 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.62 91.49 7.57 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.294 1.038 . . . . 0.0 111.427 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.9 m -117.86 17.46 14.22 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.543 0.687 . . . . 0.0 110.754 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -137.95 150.31 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.9 -0.5 . . . . 0.0 109.998 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.6 p -106.74 -31.89 8.22 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.429 0.692 . . . . 0.0 111.083 -176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 80.4 m80 -135.28 129.67 33.91 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.353 1.061 . . . . 0.0 108.369 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.559 ' HB ' HG12 ' A' ' 69' ' ' VAL . 48.8 mt -113.72 118.98 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 174.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.439 HG23 HG23 ' A' ' 14' ' ' ILE . 73.4 t -90.91 118.83 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 122.988 0.515 . . . . 0.0 109.725 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.53 144.21 34.18 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.291 0.636 . . . . 0.0 110.191 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 19' ' ' TYR . 29.8 t -115.43 -37.37 4.04 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 166.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -98.79 98.26 9.39 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.2 tp -139.91 109.96 7.18 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 122.575 0.35 . . . . 0.0 110.145 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 60' ' ' LYS . 18.6 Cg_exo -68.1 158.79 55.9 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.473 2.782 . . . . 0.0 112.012 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.77 -40.77 93.79 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.66 0.784 . . . . 0.0 111.539 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -67.04 -28.64 68.38 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.602 0.761 . . . . 0.0 111.429 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.543 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -86.98 -14.4 41.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.211 0.604 . . . . 0.0 111.178 177.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 92' ' ' LEU . 32.2 mtm180 -73.87 -28.71 61.71 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 166.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.6 mt -77.98 -43.33 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.394 0.677 . . . . 0.0 110.298 173.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.543 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 38.8 tt0 -68.21 -32.63 72.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.653 0.781 . . . . 0.0 111.241 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -110.28 27.61 9.45 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.667 0.787 . . . . 0.0 110.649 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.21 98.4 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.616 0.766 . . . . 0.0 112.6 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -72.81 -25.31 61.1 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.07 0.548 . . . . 0.0 111.289 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -86.26 138.36 31.91 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.96 88.02 3.51 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.559 HG12 ' HB ' ' A' ' 51' ' ' ILE . 35.7 m -75.9 126.3 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 91' ' ' SER . 30.4 m -135.76 178.64 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.508 1.123 . . . . 0.0 109.601 -174.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.8 m -92.2 155.19 42.96 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.686 0.794 . . . . 0.0 110.523 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.561 ' HB3' HD11 ' A' ' 27' ' ' LEU . 17.9 Cg_endo -57.46 -24.52 61.62 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.383 2.722 . . . . 0.0 113.021 174.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.45 -23.24 62.54 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.056 1.342 . . . . 0.0 112.415 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -61.06 -47.8 84.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.632 0.773 . . . . 0.0 110.507 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 75' ' ' ILE . 3.2 mp -75.05 -40.03 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.588 -172.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.2 t -53.82 -52.35 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.873 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -71.83 -44.42 63.91 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.336 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.498 ' HA ' HD23 ' A' ' 85' ' ' LEU . 61.2 m -60.34 -40.06 89.34 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.458 0.703 . . . . 0.0 112.695 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.667 HG21 ' HB3' ' A' ' 30' ' ' MET . 15.1 t -69.2 -47.95 71.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 123.454 0.702 . . . . 0.0 110.893 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -64.53 -42.8 95.52 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.074 0.549 . . . . 0.0 112.065 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -85.9 -9.42 56.97 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.086 0.555 . . . . 0.0 111.624 -177.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.15 23.16 13.77 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.871 1.268 . . . . 0.0 112.3 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.444 ' HG3' HD22 ' A' ' 85' ' ' LEU . 16.5 ptm180 -129.25 171.39 12.51 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.37 1.068 . . . . 0.0 110.029 -177.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.36 111.93 23.72 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 78' ' ' SER . 4.5 mm? -82.22 154.84 69.66 Favored Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 123.225 0.61 . . . . 0.0 110.366 174.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.21 106.8 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.463 2.108 . . . . 0.0 111.502 172.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.405 ' HB2' HG11 ' A' ' 70' ' ' VAL . 2.9 p90 -56.8 -31.91 65.15 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.632 0.773 . . . . 0.0 111.081 173.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -63.43 -23.08 67.25 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.781 1.233 . . . . 0.0 112.561 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -68.37 -37.25 80.26 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.334 0.588 . . . . 0.0 110.2 174.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -99.77 -2.43 35.17 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.654 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 75.4 m -64.55 128.21 34.81 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -173.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.422 ' O ' ' HD2' ' A' ' 61' ' ' ARG . 46.4 mt -85.83 -0.09 54.4 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.686 173.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.7 p -57.5 -43.02 83.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.312 1.045 . . . . 0.0 110.609 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 CA--C 1.558 1.266 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.349 179.85 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 47.2 mm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -90.55 58.4 3.94 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.714 0.768 . . . . 0.0 109.05 173.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.8 p -126.96 86.34 2.49 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.529 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -105.3 154.09 20.73 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.902 0.881 . . . . 0.0 109.769 178.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.6 t -168.61 178.15 4.86 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.041 0.936 . . . . 0.0 109.21 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -68.11 105.37 2.04 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -81.54 33.74 0.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.607 1.163 . . . . 0.0 113.033 -168.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.495 HG23 ' HA ' ' A' ' 84' ' ' LEU . 45.5 mt -54.03 -48.35 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.191 1.396 . . . . 0.0 112.49 -173.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.49 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 54.9 m-85 -111.02 13.02 22.04 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.017 -172.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.19 -53.48 57.64 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.345 0.658 . . . . 0.0 111.103 -169.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -87.31 -21.3 25.82 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.604 0.762 . . . . 0.0 110.509 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.8 m -72.26 131.8 43.2 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.354 0.597 . . . . 0.0 110.613 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.532 HG12 HG23 ' A' ' 48' ' ' VAL . 21.1 t -105.86 124.75 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.44 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.5 mp -121.52 123.55 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 118.227 0.467 . . . . 0.0 111.554 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 34.8 t80 -105.86 132.11 52.36 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.568 1.147 . . . . 0.0 108.011 170.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.8 mt -100.56 130.33 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -131.34 129.26 41.18 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.102 0.961 . . . . 0.0 109.21 -173.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.62 174.49 46.44 Favored Glycine 0 C--N 1.343 0.926 0 O-C-N 123.275 0.359 . . . . 0.0 112.918 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -82.06 112.28 18.98 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.959 0.504 . . . . 0.0 109.876 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.609 HG21 HG12 ' A' ' 52' ' ' VAL . 80.7 p -120.78 145.41 47.58 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.611 1.164 . . . . 0.0 110.053 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -99.75 129.09 29.48 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 122.7 0.4 . . . . 0.0 111.112 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.472 ' HD2' HD21 ' A' ' 27' ' ' LEU . 36.4 Cg_endo -81.42 177.13 36.16 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.855 -0.894 . . . . 0.0 111.662 -1.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.6 138.65 6.37 Favored Glycine 0 C--N 1.349 1.296 0 O-C-N 124.078 0.861 . . . . 0.0 113.997 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -54.25 -33.0 57.53 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.716 0.806 . . . . 0.0 112.497 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 26' ' ' GLN . 4.6 pp -55.26 -44.23 75.41 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 123.604 0.565 . . . . 0.0 111.045 175.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.455 ' N ' HD12 ' A' ' 25' ' ' LEU . 61.1 tt0 -73.75 -44.78 55.24 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.347 0.659 . . . . 0.0 110.856 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.472 HD21 ' HD2' ' A' ' 22' ' ' PRO . 81.3 mt -56.72 -39.24 73.55 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.907 0.483 . . . . 0.0 111.053 175.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 32' ' ' VAL . 15.9 m170 -63.22 -42.64 99.29 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.451 0.7 . . . . 0.0 110.036 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.18 -36.12 82.56 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.984 0.514 . . . . 0.0 110.928 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.532 ' HB3' HG21 ' A' ' 79' ' ' VAL . 32.9 mmt -66.01 -31.59 72.58 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.676 0.79 . . . . 0.0 110.932 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 28' ' ' HIS . 62.6 mt -70.82 -52.95 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.853 174.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 28' ' ' HIS . 20.9 t -68.04 -43.69 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 122.991 0.516 . . . . 0.0 111.941 -168.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.17 -19.61 61.76 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.383 0.673 . . . . 0.0 112.201 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -100.9 24.34 9.39 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.192 0.997 . . . . 0.0 110.84 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.8 18.28 70.22 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.106 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.08 160.3 30.77 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -166.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HG3' HG13 ' A' ' 13' ' ' VAL . 17.9 tppt? -106.32 142.51 35.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.402 0.681 . . . . 0.0 109.792 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -141.35 147.71 38.52 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.426 1.091 . . . . 0.0 108.635 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.4 mt -125.55 139.03 53.95 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.785 0.434 . . . . 0.0 111.09 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.41 -33.85 73.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.964 1.306 . . . . 0.0 112.374 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -171.69 143.06 1.65 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.921 0.889 . . . . 0.0 109.564 -172.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -116.49 109.64 17.55 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -82.57 74.66 9.52 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.2 m 66.94 -6.25 0.58 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.431 1.492 . . . . 0.0 114.015 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -93.85 153.17 18.41 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.157 0.583 . . . . 0.0 111.504 -168.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -100.27 59.25 1.0 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.449 1.119 . . . . 0.0 110.632 -176.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.7 m -92.66 -11.22 34.72 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.923 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.532 HG23 HG12 ' A' ' 13' ' ' VAL . 3.9 p -108.37 151.57 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.258 0.623 . . . . 0.0 109.994 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -101.78 -40.18 7.07 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 121.193 0.52 . . . . 0.0 110.705 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -128.97 142.85 50.79 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.269 1.027 . . . . 0.0 109.188 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.638 ' HB ' HG12 ' A' ' 69' ' ' VAL . 61.1 mt -123.97 138.0 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.609 HG12 HG21 ' A' ' 20' ' ' THR . 60.4 t -91.91 138.44 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.518 0.727 . . . . 0.0 110.246 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.67 151.91 29.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.589 1.155 . . . . 0.0 107.953 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.6 m -79.76 -48.66 13.24 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -137.34 142.18 41.82 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.57 117.74 11.29 Favored Pre-proline 0 CA--C 1.558 1.25 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.92 160.66 36.91 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.599 2.866 . . . . 0.0 113.556 -174.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -51.98 -45.45 64.47 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.549 1.14 . . . . 0.0 112.684 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -57.53 -43.97 84.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.587 0.755 . . . . 0.0 110.995 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -79.24 -20.77 47.39 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 119.412 -0.328 . . . . 0.0 111.306 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -66.33 -29.76 70.03 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 117.931 0.332 . . . . 0.0 110.243 168.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.7 mt -75.11 -40.73 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 110.337 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -76.1 -25.11 55.14 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.971 0.508 . . . . 0.0 111.386 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.475 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 41.4 m-85 -114.07 30.5 7.23 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.61 1.164 . . . . 0.0 109.662 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.46 -37.93 58.14 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.128 0.971 . . . . 0.0 112.773 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -87.81 -26.87 22.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.602 0.761 . . . . 0.0 111.279 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.491 ' HE1' ' HA ' ' A' ' 46' ' ' LYS . 46.0 m-85 -91.92 120.92 33.03 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.448 0.699 . . . . 0.0 109.574 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -75.06 86.35 2.35 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.638 HG12 ' HB ' ' A' ' 51' ' ' ILE . 20.1 m -76.2 128.18 37.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.84 171.68 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.954 1.302 . . . . 0.0 109.368 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 53.7 m -78.08 153.88 79.96 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.244 0.618 . . . . 0.0 111.027 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.86 -24.98 77.81 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.661 2.241 . . . . 0.0 111.888 175.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.44 -23.62 65.97 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.899 1.28 . . . . 0.0 111.504 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -62.79 -48.09 80.65 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-O 120.933 0.397 . . . . 0.0 110.033 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.49 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.8 mp -67.46 -44.35 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.055 -175.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.2 t -63.32 -51.46 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.259 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.91 -35.56 69.72 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.666 -172.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB3' HG21 ' A' ' 8' ' ' ILE . 61.1 m -63.57 -44.53 93.83 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.117 0.261 . . . . 0.0 110.422 176.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.532 HG21 ' HB3' ' A' ' 30' ' ' MET . 55.9 t -64.49 -34.26 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.454 0.702 . . . . 0.0 110.883 175.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -66.89 -32.68 74.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.303 0.641 . . . . 0.0 110.748 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -94.61 -10.98 30.3 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.61 0.764 . . . . 0.0 112.147 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.06 30.04 19.27 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.412 1.085 . . . . 0.0 112.055 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.8 ptt-85 -151.3 164.11 37.39 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.38 0.672 . . . . 0.0 110.498 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.495 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.2 tm? -79.49 106.74 11.74 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.2 mt -85.97 157.51 57.06 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.488 0.715 . . . . 0.0 109.94 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -65.49 120.8 8.06 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.079 1.853 . . . . 0.0 111.683 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -57.87 -31.52 66.79 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.542 1.137 . . . . 0.0 111.372 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -63.89 -21.69 66.58 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.702 1.201 . . . . 0.0 112.379 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -66.75 -30.8 71.11 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.139 0.576 . . . . 0.0 110.648 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.15 8.43 11.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.941 0.896 . . . . 0.0 111.946 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 p -67.74 111.52 4.31 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.997 0.519 . . . . 0.0 112.138 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.27 -11.85 58.39 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.452 0.701 . . . . 0.0 111.511 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.442 ' HB ' HG22 ' A' ' 69' ' ' VAL . 9.3 t -69.08 -27.05 65.26 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.493 0.717 . . . . 0.0 111.144 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.7 p . . . . . 0 C--O 1.251 1.16 0 C-N-CA 123.273 0.629 . . . . 0.0 109.867 175.693 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -90.04 75.69 7.08 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.619 0.768 . . . . 0.0 109.379 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.5 p -71.81 -57.15 4.59 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.471 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 54.02 30.33 11.64 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.653 1.181 . . . . 0.0 111.138 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.6 t -74.81 -18.93 60.38 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.054 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.532 ' HB2' HG13 ' A' ' 8' ' ' ILE . 25.6 p -155.56 140.14 16.94 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.89 32.2 6.02 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.035 0.934 . . . . 0.0 109.458 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.532 HG13 ' HB2' ' A' ' 6' ' ' SER . 67.6 mt -55.3 -48.59 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.193 0.997 . . . . 0.0 111.956 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -109.67 11.88 24.43 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.536 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -61.99 -41.65 98.28 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.948 0.499 . . . . 0.0 112.267 -170.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -76.62 -27.22 55.64 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.041 0.448 . . . . 0.0 110.214 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.2 m -88.1 144.18 26.64 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.284 1.04 . . . . 0.0 112.462 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.538 HG12 HG23 ' A' ' 48' ' ' VAL . 21.4 t -115.54 127.82 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.543 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.6 mp -123.19 128.19 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 122.764 0.426 . . . . 0.0 111.532 -171.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 24.6 t80 -108.36 151.37 26.1 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.377 1.471 . . . . 0.0 108.675 175.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.458 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 74.0 mt -118.32 123.18 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.373 0.669 . . . . 0.0 109.336 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -117.07 135.68 53.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.259 1.024 . . . . 0.0 109.388 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.89 -139.92 28.03 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.45 0.469 . . . . 0.0 112.767 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -112.6 120.25 40.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.304 0.642 . . . . 0.0 109.667 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.737 HG21 HG12 ' A' ' 52' ' ' VAL . 68.1 p -133.17 147.11 52.05 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.463 0.705 . . . . 0.0 109.559 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -108.91 135.61 20.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.366 0.667 . . . . 0.0 109.793 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.482 ' HD2' HD21 ' A' ' 27' ' ' LEU . 70.3 Cg_endo -74.81 177.24 39.72 Favored 'Cis proline' 0 C--N 1.369 1.631 0 C-N-CA 124.643 -0.982 . . . . 0.0 111.634 -5.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.18 146.98 3.68 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 124.019 0.824 . . . . 0.0 114.776 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -58.21 -36.38 73.05 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.077 0.951 . . . . 0.0 112.599 -172.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.01 -32.92 72.81 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.234 0.214 . . . . 0.0 110.65 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -69.19 -53.24 21.02 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.451 0.7 . . . . 0.0 110.425 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.482 HD21 ' HD2' ' A' ' 22' ' ' PRO . 87.8 mt -57.27 -40.55 77.96 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.458 0.703 . . . . 0.0 111.786 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.584 ' HA ' HD12 ' A' ' 31' ' ' ILE . 17.2 m170 -61.49 -38.96 89.23 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.9 0.48 . . . . 0.0 111.363 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.51 -35.05 68.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.628 0.371 . . . . 0.0 111.257 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.534 ' HB3' HG21 ' A' ' 79' ' ' VAL . 54.8 mtt -61.08 -31.97 71.63 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.971 0.509 . . . . 0.0 110.799 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.584 HD12 ' HA ' ' A' ' 28' ' ' HIS . 66.1 mt -68.09 -51.03 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.299 0.64 . . . . 0.0 110.986 173.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 28' ' ' HIS . 92.0 t -60.99 -50.27 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.569 0.748 . . . . 0.0 112.747 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.1 -12.58 60.36 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.441 0.696 . . . . 0.0 112.326 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -108.77 26.29 10.73 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.092 0.957 . . . . 0.0 110.13 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.0 60.48 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-N 114.58 -1.191 . . . . 0.0 114.051 171.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.33 159.63 48.84 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 -164.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.405 ' HB3' HG22 ' A' ' 13' ' ' VAL . 21.7 ttmm -103.49 152.55 21.54 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -137.23 159.04 43.07 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.043 0.449 . . . . 0.0 111.323 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.52 128.51 56.04 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 165.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.1 -33.39 70.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.405 172.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.413 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 35.1 t80 -171.33 149.77 2.81 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 124.414 1.086 . . . . 0.0 108.7 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.11 139.67 38.33 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.538 0.735 . . . . 0.0 110.069 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.0 m -83.73 45.82 1.11 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.819 0.848 . . . . 0.0 109.391 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.9 m 58.87 23.18 11.07 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 125.384 1.473 . . . . 0.0 112.111 -172.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -107.88 145.72 33.32 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.823 0.849 . . . . 0.0 110.183 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.37 64.51 8.26 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.897 0.879 . . . . 0.0 109.777 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 m -90.45 -32.15 16.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.924 0.89 . . . . 0.0 110.223 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.538 HG23 HG12 ' A' ' 13' ' ' VAL . 6.5 p -92.98 155.26 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.196 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -109.18 -27.67 9.45 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 118.064 0.393 . . . . 0.0 111.42 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -118.77 140.47 49.9 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.224 0.61 . . . . 0.0 109.959 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.693 ' HB ' HG12 ' A' ' 69' ' ' VAL . 33.5 mt -125.08 140.07 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.737 HG12 HG21 ' A' ' 20' ' ' THR . 95.2 t -104.51 135.85 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.768 0.827 . . . . 0.0 109.666 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.02 150.18 27.99 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.41 0.684 . . . . 0.0 109.364 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -75.95 -42.68 47.87 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -139.73 133.52 30.6 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.132 -1.395 . . . . 0.0 108.034 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.579 ' HG ' HG21 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -116.14 110.37 43.58 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.88 156.42 66.0 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.964 2.442 . . . . 0.0 112.861 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.1 -47.88 81.88 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.333 1.053 . . . . 0.0 112.995 -169.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 1.1 mptm? -64.15 -31.19 72.29 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.913 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -83.55 -18.87 36.89 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.073 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -66.06 -32.5 74.01 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 168.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 64.9 mt -71.01 -49.62 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.498 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 38.6 mm-40 -66.34 -31.88 72.94 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.723 0.409 . . . . 0.0 111.76 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -106.47 25.91 10.55 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.559 0.744 . . . . 0.0 110.882 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.94 -32.88 74.57 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.054 0.454 . . . . 0.0 110.579 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -69.87 -26.47 64.21 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.101 0.961 . . . . 0.0 111.318 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -99.05 162.51 13.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.334 0.654 . . . . 0.0 110.582 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -101.58 88.21 3.37 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.693 HG12 ' HB ' ' A' ' 51' ' ' ILE . 26.8 m -75.89 134.6 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.731 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 87' ' ' TRP . 34.6 m -137.62 175.45 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.808 1.243 . . . . 0.0 109.873 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.2 m -81.85 154.5 70.48 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.762 0.825 . . . . 0.0 110.113 172.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.42 -24.22 71.11 Favored 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.51 2.14 . . . . 0.0 111.426 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.98 -21.47 63.55 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.955 1.302 . . . . 0.0 111.27 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.73 -51.45 62.31 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 123.144 0.277 . . . . 0.0 110.266 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 75' ' ' ILE . 3.1 mp -66.33 -43.94 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.79 -51.97 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.24 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -73.09 -33.15 65.43 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.197 0.599 . . . . 0.0 111.787 -171.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 71.9 m -66.97 -40.52 87.49 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.58 0.352 . . . . 0.0 110.281 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 30' ' ' MET . 55.0 t -70.68 -33.87 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.451 0.7 . . . . 0.0 110.786 173.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -64.58 -41.37 96.32 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.157 0.983 . . . . 0.0 110.523 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -95.41 -6.46 40.85 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.855 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.22 27.14 15.47 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.573 1.149 . . . . 0.0 112.33 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -142.49 159.33 42.44 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.774 0.83 . . . . 0.0 110.546 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.467 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.2 tm? -75.1 127.55 33.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.8 mt -114.7 152.12 46.0 Favored Pre-proline 0 C--O 1.24 0.596 0 C-N-CA 124.214 1.006 . . . . 0.0 109.714 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.414 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 35.3 Cg_endo -61.73 109.34 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.551 2.167 . . . . 0.0 111.877 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.549 ' HB2' HG11 ' A' ' 70' ' ' VAL . 29.9 p90 -62.14 -21.91 65.42 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.388 1.075 . . . . 0.0 112.206 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.414 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 12.7 pt20 -59.78 -25.11 64.65 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.127 0.971 . . . . 0.0 111.818 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -70.92 -31.66 68.35 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.788 0.835 . . . . 0.0 111.131 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.29 -0.79 25.97 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.905 0.882 . . . . 0.0 111.318 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -66.24 131.42 46.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.329 0.652 . . . . 0.0 112.0 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.8 mt -108.31 14.54 24.79 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.101 0.96 . . . . 0.0 110.951 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.0 p -65.56 -52.73 50.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.823 0.849 . . . . 0.0 111.321 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 C--O 1.252 1.185 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.166 -173.858 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 21.8 pt . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 p -73.51 85.19 1.54 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.034 0.534 . . . . 0.0 110.103 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.5 m -76.26 82.69 3.04 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.315 0.646 . . . . 0.0 109.602 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -123.59 69.54 1.04 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.261 -176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.3 m -147.68 132.84 18.34 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.935 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.585 ' HB2' ' HD2' ' A' ' 34' ' ' HIS . 24.8 m -67.17 106.44 2.01 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -81.01 36.0 0.39 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.739 1.216 . . . . 0.0 113.73 -165.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 82' ' ' ALA . 64.3 mt -49.08 -47.87 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.507 1.523 . . . . 0.0 112.352 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -109.58 15.32 22.98 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.862 0.465 . . . . 0.0 111.566 -174.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -57.82 -49.3 77.12 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.287 0.635 . . . . 0.0 111.448 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -76.41 -15.56 59.91 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.675 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.5 m -93.08 141.17 28.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.632 0.773 . . . . 0.0 111.421 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.56 124.84 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 171.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.411 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.2 mp -118.5 134.28 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 C-N-CA 123.155 0.582 . . . . 0.0 111.74 -170.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 33.3 t80 -113.0 149.49 33.24 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.414 1.486 . . . . 0.0 108.089 169.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 65.7 mt -114.54 110.01 30.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -103.83 122.44 45.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.277 1.431 . . . . 0.0 109.447 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.76 175.58 50.98 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.88 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -82.08 111.49 18.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.602 HG21 HG12 ' A' ' 52' ' ' VAL . 69.6 p -112.14 151.92 28.92 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.887 0.875 . . . . 0.0 110.037 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -102.99 122.91 43.88 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 163.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -81.66 172.08 54.41 Favored 'Cis proline' 0 C--N 1.37 1.698 0 C-N-CA 124.031 -1.237 . . . . 0.0 112.033 1.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.61 164.6 15.79 Favored Glycine 0 C--N 1.344 0.995 0 O-C-N 123.735 0.647 . . . . 0.0 114.357 -172.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -56.11 -36.53 68.3 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.362 0.665 . . . . 0.0 111.411 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.9 pp -61.66 -43.12 99.46 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.454 0.701 . . . . 0.0 111.57 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.537 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.2 tp-100 -71.29 -51.76 22.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.345 0.658 . . . . 0.0 110.22 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.68 -51.09 70.13 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.028 0.83 . . . . 0.0 111.402 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.45 ' O ' HG23 ' A' ' 32' ' ' VAL . 15.6 m170 -54.85 -47.55 74.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.727 0.642 . . . . 0.0 111.109 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.5 -38.94 91.19 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.27 0.356 . . . . 0.0 111.571 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.602 ' HB3' HG21 ' A' ' 79' ' ' VAL . 21.2 mmt -61.22 -40.0 92.39 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.991 0.516 . . . . 0.0 111.132 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.411 HD13 ' HB ' ' A' ' 14' ' ' ILE . 70.8 mt -65.19 -49.12 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.008 0.923 . . . . 0.0 111.348 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 28' ' ' HIS . 57.9 t -65.84 -41.55 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.979 0.512 . . . . 0.0 111.573 -176.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.39 -13.04 60.1 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.321 0.648 . . . . 0.0 111.844 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.601 ' HE1' HG13 ' A' ' 79' ' ' VAL . 38.6 m80 -108.92 26.85 10.11 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.699 0.799 . . . . 0.0 111.758 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.95 7.03 75.03 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.944 172.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.89 158.1 30.28 Favored Glycine 0 C--O 1.242 0.596 0 C-N-CA 123.026 0.346 . . . . 0.0 113.94 -173.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -102.83 158.67 16.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.502 0.721 . . . . 0.0 109.653 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.37 161.71 37.63 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.389 0.676 . . . . 0.0 110.473 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.1 149.42 42.23 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.789 0.836 . . . . 0.0 110.531 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -68.9 -47.87 64.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.612 1.165 . . . . 0.0 111.566 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 77.5 t80 -178.73 139.16 0.17 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.674 1.19 . . . . 0.0 108.96 -170.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mp -141.15 162.6 35.11 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.412 0.685 . . . . 0.0 109.441 171.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.0 m -142.96 -39.77 0.33 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.378 1.071 . . . . 0.0 109.226 172.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 t -146.59 79.96 1.54 Allowed 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.205 0.602 . . . . 0.0 109.428 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.16 136.62 1.84 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.163 175.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HA ' ' HE1' ' A' ' 67' ' ' TYR . 54.1 mtpt -105.3 47.24 0.88 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.376 0.67 . . . . 0.0 110.631 -175.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -82.04 -24.32 35.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.748 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.84 151.53 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.12 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.6 p -114.57 -17.74 11.62 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -137.71 136.77 37.67 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.26 1.024 . . . . 0.0 109.096 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.619 ' HB ' HG12 ' A' ' 69' ' ' VAL . 67.4 mt -125.21 137.25 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.602 HG12 HG21 ' A' ' 20' ' ' THR . 54.5 t -105.84 133.72 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.41 1.084 . . . . 0.0 110.74 -173.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.45 146.01 20.79 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -77.14 -39.76 48.05 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -138.33 107.9 6.21 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.63 ' HB2' HD13 ' A' ' 92' ' ' LEU . 16.5 tp -100.53 119.61 58.29 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -64.32 159.55 43.19 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.623 2.882 . . . . 0.0 112.589 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.7 mt -58.99 -46.05 89.09 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.982 0.913 . . . . 0.0 112.38 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -57.56 -46.11 84.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.453 0.701 . . . . 0.0 110.713 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -66.26 -30.07 70.43 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.158 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -66.65 -38.24 86.47 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.159 0.584 . . . . 0.0 110.724 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.8 mt -70.39 -46.18 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 123.82 0.7 . . . . 0.0 110.384 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.71 -32.36 73.87 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.689 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.431 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 22.0 m-30 -103.08 15.05 30.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.451 0.701 . . . . 0.0 111.89 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.86 -18.81 62.69 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.323 0.583 . . . . 0.0 110.896 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -71.77 -19.91 61.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.268 1.027 . . . . 0.0 110.602 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.499 ' HE1' ' HA ' ' A' ' 46' ' ' LYS . 17.2 m-85 -113.47 169.83 8.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.382 1.073 . . . . 0.0 109.008 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -96.15 91.07 5.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.427 0.691 . . . . 0.0 109.413 175.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.619 HG12 ' HB ' ' A' ' 51' ' ' ILE . 20.3 m -82.88 129.95 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.288 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.477 HG11 ' HB2' ' A' ' 87' ' ' TRP . 31.6 m -139.79 167.56 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.754 1.221 . . . . 0.0 110.514 -175.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.6 m -75.76 155.91 84.89 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.847 172.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.06 -25.46 79.82 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.469 2.113 . . . . 0.0 111.495 172.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.5 -29.89 59.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.48 1.512 . . . . 0.0 112.651 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.433 ' CE3' HG21 ' A' ' 70' ' ' VAL . 27.6 t90 -62.18 -48.74 78.69 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.354 0.408 . . . . 0.0 110.197 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.77 -54.98 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.241 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.8 t -51.84 -52.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.841 1.257 . . . . 0.0 112.346 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -71.58 -42.1 68.17 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.732 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.435 ' HA ' HD13 ' A' ' 85' ' ' LEU . 72.5 m -61.63 -36.93 82.17 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.736 0.415 . . . . 0.0 111.448 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.602 HG21 ' HB3' ' A' ' 30' ' ' MET . 21.8 t -63.57 -46.94 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.265 1.026 . . . . 0.0 111.057 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -65.97 -43.47 87.77 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.042 0.537 . . . . 0.0 111.102 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -76.5 -15.59 59.85 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.708 0.803 . . . . 0.0 112.04 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 8' ' ' ILE . . . 58.41 40.92 23.69 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.091 0.956 . . . . 0.0 110.843 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -159.51 156.54 28.37 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.868 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -85.81 109.3 18.58 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 78' ' ' SER . 8.6 mp -79.64 155.28 76.04 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.126 0.57 . . . . 0.0 111.242 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.469 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 35.8 Cg_endo -61.12 114.83 2.36 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.426 2.084 . . . . 0.0 111.325 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.477 ' HB2' HG11 ' A' ' 70' ' ' VAL . 48.1 p90 -64.9 -20.09 66.26 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.649 0.78 . . . . 0.0 112.395 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.469 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.0 pt20 -58.19 -28.04 64.41 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.275 1.03 . . . . 0.0 112.023 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -70.6 -27.68 64.28 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.605 0.762 . . . . 0.0 110.814 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.78 5.95 14.27 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.047 0.939 . . . . 0.0 111.689 -175.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.437 ' HB2' HG22 ' A' ' 93' ' ' THR . 59.9 p -69.85 120.48 15.66 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.202 0.601 . . . . 0.0 112.287 -174.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.63 HD13 ' HB2' ' A' ' 56' ' ' LEU . 48.5 mt -73.62 -21.48 60.29 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.947 0.899 . . . . 0.0 111.666 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 91' ' ' SER . 10.3 t -65.5 -17.53 64.63 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.694 0.798 . . . . 0.0 112.112 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.4 m . . . . . 0 C--O 1.26 1.613 0 C-N-CA 123.294 0.637 . . . . 0.0 109.993 175.568 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 19.8 pt . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -72.33 86.43 1.11 Allowed 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.69 0.796 . . . . 0.0 111.054 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.1 m -72.71 91.78 1.49 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.382 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -98.7 134.03 42.2 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.444 1.098 . . . . 0.0 109.482 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.2 t -69.84 -25.86 63.94 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.9 0.48 . . . . 0.0 109.894 172.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.747 ' HB2' ' HA ' ' A' ' 34' ' ' HIS . 61.2 p -74.47 88.4 2.11 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.062 177.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -120.92 28.1 8.11 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.25 1.42 . . . . 0.0 108.59 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.556 HG21 ' OG ' ' A' ' 78' ' ' SER . 57.7 mt -64.73 -51.42 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.681 -167.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.655 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 61.7 m-85 -103.17 18.04 22.67 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.886 -175.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -51.16 -59.09 4.56 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.281 1.032 . . . . 0.0 112.877 -171.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -95.81 17.39 15.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.867 0.867 . . . . 0.0 111.01 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.447 ' SG ' ' HH2' ' A' ' 74' ' ' TRP . 41.1 t -116.9 123.26 46.58 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 124.484 1.114 . . . . 0.0 109.756 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.475 HG11 HD23 ' A' ' 39' ' ' LEU . 40.6 t -101.68 128.2 54.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.533 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.2 mp -122.36 123.28 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 122.833 0.453 . . . . 0.0 111.041 -175.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 28.4 t80 -104.35 150.74 24.22 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.341 1.456 . . . . 0.0 108.134 174.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.21 130.31 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -135.81 123.78 22.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.414 1.085 . . . . 0.0 109.771 -170.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.7 -161.57 42.45 Favored Glycine 0 C--N 1.343 0.958 0 O-C-N 123.496 0.498 . . . . 0.0 112.822 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -88.03 110.73 20.84 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.237 0.615 . . . . 0.0 109.558 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.537 HG21 HG12 ' A' ' 52' ' ' VAL . 61.5 p -133.94 134.4 42.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.044 0.937 . . . . 0.0 109.271 -177.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -117.47 139.17 25.83 Favored Pre-proline 0 N--CA 1.481 1.121 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -69.94 170.69 58.03 Favored 'Cis proline' 0 C--N 1.389 2.707 0 C-N-CA 124.705 -0.956 . . . . 0.0 112.567 3.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.67 149.11 5.55 Favored Glycine 0 N--CA 1.475 1.257 0 O-C-N 124.01 0.819 . . . . 0.0 114.196 -169.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -52.23 -36.08 51.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.777 0.831 . . . . 0.0 112.197 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 26' ' ' GLN . 3.6 pp -62.46 -41.44 98.76 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.27 0.628 . . . . 0.0 111.63 174.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.512 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.5 tp-100 -72.19 -50.79 24.83 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.813 0.845 . . . . 0.0 110.945 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.1 mt -54.73 -44.96 74.01 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.215 0.606 . . . . 0.0 111.008 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.515 ' HA ' HD12 ' A' ' 31' ' ' ILE . 9.5 m170 -58.75 -43.5 90.31 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 123.572 0.545 . . . . 0.0 111.417 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -66.5 -38.89 88.23 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 123.168 0.292 . . . . 0.0 111.23 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.0 mmt -58.42 -39.36 79.57 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.338 0.655 . . . . 0.0 110.947 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.533 HD13 ' HB ' ' A' ' 14' ' ' ILE . 70.9 mt -62.69 -47.8 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.07 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 28' ' ' HIS . 39.1 t -64.19 -47.6 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.653 0.596 . . . . 0.0 111.117 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.01 -33.55 73.44 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.829 0.852 . . . . 0.0 111.47 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.747 ' HA ' ' HB2' ' A' ' 6' ' ' SER . 54.9 m80 -86.44 27.47 0.94 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.255 0.622 . . . . 0.0 112.274 175.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.32 28.99 73.02 Favored Glycine 0 C--N 1.357 1.73 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.29 169.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.655 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -112.44 172.43 14.66 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 115.551 0.98 . . . . 0.0 115.551 -168.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -111.16 146.22 37.25 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.702 0.801 . . . . 0.0 109.444 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -128.83 166.25 19.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.562 0.745 . . . . 0.0 109.585 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.475 HD23 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -130.3 136.22 48.91 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.051 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -82.44 -36.79 26.27 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 123.867 0.729 . . . . 0.0 112.144 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 61.3 t80 -171.83 135.24 0.83 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.974 0.509 . . . . 0.0 110.539 -175.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.42 142.05 44.19 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.0 t -139.33 -51.36 0.53 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.323 1.049 . . . . 0.0 108.419 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -147.94 59.7 1.12 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.254 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -160.38 156.99 27.06 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.625 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.46 46.53 2.36 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.394 1.078 . . . . 0.0 110.907 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.6 m -79.68 -27.86 40.74 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.435 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.4 p -86.64 151.71 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.984 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.453 HG23 ' ND1' ' A' ' 50' ' ' HIS . 5.1 t -114.79 -25.4 8.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.742 0.817 . . . . 0.0 110.683 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.453 ' ND1' HG23 ' A' ' 49' ' ' THR . 53.5 m80 -133.38 127.42 33.42 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.924 0.49 . . . . 0.0 110.419 -174.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.631 ' HB ' HG12 ' A' ' 69' ' ' VAL . 61.7 mt -119.04 129.41 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.537 HG12 HG21 ' A' ' 20' ' ' THR . 70.8 t -90.76 123.27 42.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 123.63 0.772 . . . . 0.0 109.187 -173.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.93 140.69 31.23 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.834 0.853 . . . . 0.0 108.951 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -84.05 -49.95 8.43 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.61 132.99 56.54 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.518 -1.219 . . . . 0.0 107.719 170.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.98 101.55 10.41 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.09 160.16 48.68 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.092 2.528 . . . . 0.0 112.706 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.8 -31.97 67.1 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.052 0.941 . . . . 0.0 112.001 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 47.9 tptt -60.77 -53.42 57.61 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.269 0.628 . . . . 0.0 109.911 175.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -70.69 -19.25 62.79 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.821 0.448 . . . . 0.0 111.841 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -72.88 -27.69 62.05 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.735 0.814 . . . . 0.0 109.779 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.3 mt -79.11 -45.3 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.321 0.648 . . . . 0.0 110.043 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 24.4 mm-40 -63.52 -29.18 70.49 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.598 0.759 . . . . 0.0 112.215 -175.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -121.97 28.63 7.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.058 0.943 . . . . 0.0 110.293 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -30.68 69.26 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.447 0.699 . . . . 0.0 112.566 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -75.08 -23.63 58.03 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.119 0.568 . . . . 0.0 111.572 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -107.64 123.69 48.87 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.94 93.23 0.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.369 0.604 . . . . 0.0 109.755 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.631 HG12 ' HB ' ' A' ' 51' ' ' ILE . 27.4 m -73.89 128.83 36.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 87' ' ' TRP . 30.2 m -128.13 172.13 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.253 1.021 . . . . 0.0 109.862 -174.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -80.46 152.51 73.08 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.27 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -56.78 -25.09 59.15 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.693 2.262 . . . . 0.0 112.17 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.41 -26.5 53.55 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.884 1.273 . . . . 0.0 112.286 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.447 ' HH2' ' SG ' ' A' ' 12' ' ' CYS . 28.3 t90 -59.6 -48.45 81.62 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.825 0.284 . . . . 0.0 110.454 174.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 79' ' ' VAL . 3.3 mp -69.33 -42.71 81.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 O-C-N 124.042 0.839 . . . . 0.0 108.85 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.48 HG12 ' HE2' ' A' ' 80' ' ' LYS . 85.0 t -62.14 -50.52 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.006 0.922 . . . . 0.0 111.408 -177.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.23 -33.72 76.66 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.24 0.616 . . . . 0.0 110.849 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.556 ' OG ' HG21 ' A' ' 8' ' ' ILE . 38.5 t -62.54 -37.65 86.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.235 0.614 . . . . 0.0 111.449 177.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 75' ' ' ILE . 94.0 t -70.96 -47.13 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.502 0.721 . . . . 0.0 110.669 177.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.48 ' HE2' HG12 ' A' ' 76' ' ' VAL . 53.2 mtmt -64.74 -45.16 87.63 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.486 0.714 . . . . 0.0 111.744 -175.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -86.76 -15.51 39.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.342 0.657 . . . . 0.0 111.473 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.85 38.56 14.58 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.572 1.149 . . . . 0.0 111.869 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -149.75 164.49 35.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.395 0.678 . . . . 0.0 110.285 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.5 tp -84.05 95.26 8.52 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.8 142.94 96.15 Favored Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.449 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 16.8 Cg_endo -56.24 108.01 0.3 Allowed 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.302 2.001 . . . . 0.0 110.79 172.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.411 ' HB2' HG11 ' A' ' 70' ' ' VAL . 29.8 p90 -56.95 -22.69 39.9 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.547 1.139 . . . . 0.0 112.695 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.449 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 20.6 pt20 -57.47 -26.77 61.75 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.749 1.22 . . . . 0.0 112.105 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.445 HD21 ' HG2' ' A' ' 86' ' ' PRO . 61.4 m-20 -67.09 -38.46 85.75 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.196 0.598 . . . . 0.0 110.72 175.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -99.72 -5.62 28.46 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.07 0.948 . . . . 0.0 111.521 -172.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.0 m -66.23 121.74 15.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.111 0.564 . . . . 0.0 112.304 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.8 mt -81.86 -0.65 44.54 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.557 1.143 . . . . 0.0 111.062 172.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.8 p -66.96 -20.59 65.92 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.512 1.125 . . . . 0.0 111.665 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.558 1.254 0 C-N-CA 124.587 1.155 . . . . 0.0 111.876 -178.93 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 49.6 mm . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.1 t -153.38 89.02 1.32 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.203 1.001 . . . . 0.0 108.498 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.3 t -78.3 116.9 19.06 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.372 0.669 . . . . 0.0 110.458 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -80.97 87.02 6.01 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.3 m -147.5 164.81 32.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.901 0.881 . . . . 0.0 110.627 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.2 m -72.67 81.9 1.13 Allowed 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 170.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 10' ' ' LYS . 15.3 ptpt -83.81 36.33 0.55 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.675 1.59 . . . . 0.0 112.999 -167.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.53 HG23 ' HA ' ' A' ' 84' ' ' LEU . 66.9 mt -49.49 -46.23 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.024 1.33 . . . . 0.0 112.167 -177.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.495 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 78.1 m-85 -104.8 15.86 27.06 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.976 -173.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 7' ' ' LYS . 28.5 ttpp -51.53 -48.26 63.07 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.902 0.881 . . . . 0.0 113.312 -173.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -98.78 2.04 46.53 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.036 0.534 . . . . 0.0 111.436 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.4 m -97.89 110.8 23.31 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.873 0.869 . . . . 0.0 110.919 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.0 t -93.31 127.84 45.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.468 ' HB ' HD13 ' A' ' 31' ' ' ILE . 2.6 mp -114.74 136.06 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.58 0.752 . . . . 0.0 110.941 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -118.05 110.84 18.14 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 170.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.7 mt -77.22 134.28 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -138.68 122.02 17.11 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -173.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.63 -173.91 52.95 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.681 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -79.97 110.76 15.66 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.213 0.605 . . . . 0.0 109.904 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.558 HG21 HG12 ' A' ' 52' ' ' VAL . 61.8 p -121.16 136.68 54.93 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 11.0 mmpt? -104.06 135.43 19.35 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 117.85 0.295 . . . . 0.0 110.685 176.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' HD21 ' A' ' 27' ' ' LEU . 94.1 Cg_endo -74.24 173.79 54.96 Favored 'Cis proline' 0 C--N 1.378 2.099 0 C-N-CA 124.613 -0.995 . . . . 0.0 112.107 -1.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.64 156.0 3.73 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 123.885 0.741 . . . . 0.0 114.745 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -54.46 -38.4 66.31 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.572 0.749 . . . . 0.0 111.519 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.3 pp -60.62 -44.94 95.76 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 123.779 0.674 . . . . 0.0 111.338 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.528 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.7 tp-100 -69.45 -50.31 46.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.344 0.658 . . . . 0.0 110.672 -175.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.417 HD21 ' HD2' ' A' ' 22' ' ' PRO . 81.6 mt -56.1 -50.45 71.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.975 0.51 . . . . 0.0 111.447 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.438 ' HA ' HD12 ' A' ' 31' ' ' ILE . 23.5 m170 -54.82 -41.92 71.25 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.698 0.799 . . . . 0.0 111.094 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -67.81 -44.49 77.18 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.156 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 34.2 mmt -63.16 -34.1 76.9 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.158 0.583 . . . . 0.0 111.629 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.468 HD13 ' HB ' ' A' ' 14' ' ' ILE . 66.1 mt -60.54 -50.73 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.386 173.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.3 t -66.64 -39.78 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.549 0.74 . . . . 0.0 112.367 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.3 -23.55 67.47 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.698 0.799 . . . . 0.0 111.388 178.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -104.88 27.57 7.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.973 0.909 . . . . 0.0 111.044 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.49 14.16 80.52 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 114.893 -1.049 . . . . 0.0 114.114 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.86 174.88 22.85 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 114.524 0.57 . . . . 0.0 114.524 -170.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.415 ' HB2' ' NZ ' ' A' ' 37' ' ' LYS . 2.7 ttmp? -128.54 151.19 49.73 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.157 0.583 . . . . 0.0 109.787 -177.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -121.18 161.4 21.93 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.532 0.733 . . . . 0.0 109.337 170.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.607 ' HB3' HD11 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -118.24 131.94 56.33 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -64.54 -40.01 94.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.094 0.958 . . . . 0.0 112.196 -165.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -177.53 139.72 0.25 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.607 HD11 ' HB3' ' A' ' 39' ' ' LEU . 2.7 mp -137.66 170.59 15.8 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.886 0.475 . . . . 0.0 110.347 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.7 t -160.04 -60.94 0.06 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.155 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.1 m -123.03 10.94 9.49 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.194 0.598 . . . . 0.0 112.526 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -120.1 131.58 55.12 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -97.09 82.92 3.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.441 0.696 . . . . 0.0 109.757 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.7 m -108.31 -28.06 9.64 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.304 0.642 . . . . 0.0 110.624 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.6 150.03 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.55 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.3 p -102.89 -26.86 12.96 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.299 0.639 . . . . 0.0 111.302 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -137.35 128.48 27.72 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.814 0.846 . . . . 0.0 109.653 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.486 ' HB ' HG22 ' A' ' 69' ' ' VAL . 43.7 mt -110.65 114.68 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 175.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.558 HG12 HG21 ' A' ' 20' ' ' THR . 78.2 t -89.15 135.93 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.815 0.846 . . . . 0.0 109.919 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.37 170.59 19.71 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.598 0.759 . . . . 0.0 110.306 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.6 t -86.81 -52.23 5.62 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -145.07 103.17 3.84 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.521 ' HG ' HG11 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -89.1 114.71 61.28 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.85 143.49 91.03 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.362 2.708 . . . . 0.0 113.017 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.8 mt -55.93 -41.0 73.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.294 1.038 . . . . 0.0 112.428 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -56.61 -50.16 72.8 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.661 0.784 . . . . 0.0 110.524 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -76.1 -17.85 59.43 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.487 -175.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -68.99 -32.05 71.32 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.983 0.356 . . . . 0.0 110.162 170.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.5 mt -65.58 -42.92 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.03 -40.18 94.44 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 120.931 0.396 . . . . 0.0 111.122 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.42 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 21.0 m-85 -95.58 25.14 4.7 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.939 0.496 . . . . 0.0 111.124 -176.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.02 -16.77 62.06 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.269 0.627 . . . . 0.0 111.406 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -79.05 -14.94 58.86 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.729 0.412 . . . . 0.0 110.853 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.42 ' HD2' ' HA ' ' A' ' 64' ' ' PHE . 32.4 m-85 -115.71 152.77 32.58 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 109.408 -175.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -90.28 88.81 7.36 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.527 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 73.2 t -74.88 124.68 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 87' ' ' TRP . 32.7 m -133.03 176.64 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.941 0.896 . . . . 0.0 110.966 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.3 m -87.63 158.93 50.53 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 124.278 1.031 . . . . 0.0 109.957 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.62 -21.24 70.24 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.418 2.079 . . . . 0.0 111.794 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.23 -26.14 66.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.129 1.372 . . . . 0.0 111.637 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -62.3 -44.88 95.48 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.759 0.314 . . . . 0.0 110.381 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.495 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.6 mp -71.43 -50.98 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.985 -176.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.9 t -57.89 -52.5 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.557 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.81 -37.75 73.25 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.071 -172.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 98.2 p -65.73 -39.25 90.94 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.29 0.236 . . . . 0.0 111.139 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.06 -41.55 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.67 0.788 . . . . 0.0 110.793 176.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.57 -38.06 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.559 0.744 . . . . 0.0 111.252 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -82.28 -18.51 42.13 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.649 0.78 . . . . 0.0 111.39 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.59 32.94 22.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.716 1.206 . . . . 0.0 111.539 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -139.12 162.03 35.94 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.801 0.84 . . . . 0.0 109.922 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.53 ' HA ' HG23 ' A' ' 8' ' ' ILE . 3.0 tm? -79.21 125.37 29.37 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.97 148.64 35.1 Favored Pre-proline 0 C--O 1.243 0.713 0 C-N-CA 123.66 0.784 . . . . 0.0 109.975 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.05 115.11 2.75 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.131 1.887 . . . . 0.0 110.335 166.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.516 ' HB2' HG11 ' A' ' 70' ' ' VAL . 12.7 p90 -62.96 -25.2 68.25 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.65 0.78 . . . . 0.0 111.862 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -60.03 -22.91 63.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.388 1.075 . . . . 0.0 112.13 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -63.45 -45.45 90.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.884 0.874 . . . . 0.0 110.105 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -102.42 6.43 40.18 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.57 0.748 . . . . 0.0 111.604 -173.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 36.7 m -65.84 114.54 5.15 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.038 0.535 . . . . 0.0 112.362 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.7 -26.33 63.37 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.79 0.836 . . . . 0.0 110.201 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.527 ' HB ' ' HB ' ' A' ' 69' ' ' VAL . 8.8 t -69.95 -11.05 60.59 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.934 0.894 . . . . 0.0 112.261 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.258 1.53 0 C-N-CA 123.213 0.605 . . . . 0.0 110.091 174.563 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m -76.27 82.48 3.05 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.1 m -109.88 72.41 0.8 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.97 -174.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -89.78 134.35 34.22 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.161 172.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -67.34 -47.36 70.72 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.322 0.649 . . . . 0.0 109.814 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.5 m -76.42 112.98 13.51 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 168.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -109.31 29.58 7.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.218 0.607 . . . . 0.0 110.373 -175.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.4 mt -53.37 -45.67 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.845 0.858 . . . . 0.0 112.253 -172.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.47 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 70.4 m-85 -111.63 15.54 21.02 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 119.275 -0.393 . . . . 0.0 111.127 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -56.37 -41.51 76.32 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.539 0.736 . . . . 0.0 112.811 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -96.92 -3.6 41.52 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.099 0.559 . . . . 0.0 111.391 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.444 ' SG ' ' ND1' ' A' ' 50' ' ' HIS . 51.8 t -99.0 127.05 44.84 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 123.974 0.91 . . . . 0.0 110.676 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.466 HG12 HG23 ' A' ' 48' ' ' VAL . 32.4 t -106.41 134.42 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.469 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.9 mp -125.64 128.47 72.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 123.391 0.677 . . . . 0.0 111.359 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -114.69 120.32 39.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.97 1.308 . . . . 0.0 108.174 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.6 mt -93.29 109.55 21.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -98.33 123.73 42.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.672 1.189 . . . . 0.0 109.599 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.88 -159.77 52.31 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 123.416 0.447 . . . . 0.0 113.892 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.74 122.48 32.19 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.782 0.833 . . . . 0.0 110.54 -177.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.611 HG21 HG12 ' A' ' 52' ' ' VAL . 72.3 p -132.88 146.24 51.64 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.015 1.326 . . . . 0.0 108.944 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -112.49 130.51 23.32 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.02 171.75 65.21 Favored 'Cis proline' 0 C--N 1.382 2.291 0 C-N-CA 124.146 -1.189 . . . . 0.0 111.381 -0.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.28 147.71 5.91 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.833 0.708 . . . . 0.0 114.493 -173.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -52.78 -36.48 58.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.713 0.805 . . . . 0.0 112.41 -175.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 pp -59.23 -43.01 92.38 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.319 0.648 . . . . 0.0 111.615 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -67.39 -50.15 60.86 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.858 0.863 . . . . 0.0 110.327 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.406 ' O ' HG13 ' A' ' 31' ' ' ILE . 92.9 mt -55.81 -41.24 73.89 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.474 0.709 . . . . 0.0 111.732 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.619 ' HA ' HD12 ' A' ' 31' ' ' ILE . 13.0 m80 -62.46 -37.52 86.25 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.68 0.792 . . . . 0.0 110.877 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -68.36 -40.92 81.31 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.225 0.61 . . . . 0.0 110.569 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.591 ' HB3' HG21 ' A' ' 79' ' ' VAL . 64.5 mtt -59.69 -33.49 71.65 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.436 0.695 . . . . 0.0 111.142 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.619 HD12 ' HA ' ' A' ' 28' ' ' HIS . 74.4 mt -70.3 -54.1 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.321 0.648 . . . . 0.0 110.982 177.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 28' ' ' HIS . 93.8 t -65.58 -45.52 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.428 0.691 . . . . 0.0 112.185 -170.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.82 -21.03 66.71 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.479 0.712 . . . . 0.0 112.241 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -104.27 26.91 8.28 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.564 0.746 . . . . 0.0 110.726 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.36 -1.35 87.63 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.882 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . -75.51 160.37 52.0 Favored Glycine 0 CA--C 1.5 -0.859 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -170.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.436 ' HB3' HG22 ' A' ' 13' ' ' VAL . 2.9 tppp? -112.98 145.82 40.15 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -127.75 149.77 50.09 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.459 0.703 . . . . 0.0 109.329 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.462 HD23 HG11 ' A' ' 13' ' ' VAL . 1.3 mm? -116.65 128.74 55.65 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.42 ' H ' ' CD2' ' A' ' 40' ' ' HIS . 0.3 OUTLIER -64.54 -42.19 95.88 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.603 1.161 . . . . 0.0 111.594 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -165.29 160.81 18.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.609 0.763 . . . . 0.0 109.515 171.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -124.34 119.76 30.18 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.615 0.766 . . . . 0.0 109.884 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 t -90.18 68.09 7.0 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.7 m 71.87 -22.8 0.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.835 1.654 . . . . 0.0 114.021 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -63.52 130.96 46.57 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.846 0.858 . . . . 0.0 110.876 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.644 ' HD2' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -92.71 62.63 3.82 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 122.619 1.199 . . . . 0.0 109.635 -178.459 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 m -87.12 -8.84 56.59 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.968 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.466 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -112.7 155.84 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.8 0.84 . . . . 0.0 110.001 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 74.1 p -111.79 -30.74 7.2 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.14 0.576 . . . . 0.0 111.231 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.444 ' ND1' ' SG ' ' A' ' 12' ' ' CYS . 80.7 m80 -128.42 134.02 48.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.872 0.869 . . . . 0.0 110.016 -175.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 36.6 mt -121.75 114.19 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 121.443 0.639 . . . . 0.0 109.798 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.611 HG12 HG21 ' A' ' 20' ' ' THR . 74.7 t -90.53 119.19 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.145 0.978 . . . . 0.0 110.413 -175.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.0 137.9 18.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.744 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.1 t -86.05 -35.23 20.43 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 171.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -127.6 99.42 5.58 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 124.213 1.005 . . . . 0.0 108.519 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -107.28 107.89 61.06 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.406 ' HG2' ' HD3' ' A' ' 60' ' ' LYS . 34.1 Cg_endo -61.41 152.63 71.56 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.155 2.57 . . . . 0.0 113.173 -173.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.33 -35.95 74.77 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.32 1.048 . . . . 0.0 112.566 -171.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -62.82 -45.26 93.46 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.567 0.699 . . . . 0.0 109.966 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HD3' ' HG2' ' A' ' 57' ' ' PRO . 1.1 mptm? -77.89 -18.34 56.27 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.001 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.417 ' NH1' ' HA ' ' A' ' 93' ' ' THR . 1.2 mmp_? -65.59 -35.23 80.21 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.18 0.592 . . . . 0.0 111.038 171.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.7 mt -69.17 -47.06 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 123.572 0.545 . . . . 0.0 109.806 172.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -58.02 -40.39 80.71 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.779 0.832 . . . . 0.0 111.655 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.41 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 18.3 m-85 -110.17 27.12 9.93 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.215 1.006 . . . . 0.0 110.741 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.42 -44.69 93.9 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.165 0.586 . . . . 0.0 111.301 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.42 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.8 OUTLIER -77.62 -26.0 50.21 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.457 0.703 . . . . 0.0 110.722 179.195 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 64' ' ' PHE . 16.3 m-85 -75.52 135.69 40.62 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' A' ' 93' ' ' THR . 43.7 mmtm -80.71 86.1 5.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.355 0.598 . . . . 0.0 109.784 -177.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 93.3 t -73.76 125.25 32.59 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 91' ' ' SER . 24.0 m -131.08 173.59 14.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 C-N-CA 123.392 0.677 . . . . 0.0 110.161 -175.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.4 m -79.64 149.4 71.26 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.044 173.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.83 -28.45 87.15 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.395 2.064 . . . . 0.0 111.338 168.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.44 -23.89 64.78 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.321 1.449 . . . . 0.0 111.695 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -63.42 -48.6 77.11 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.957 0.503 . . . . 0.0 110.43 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.4 mp -69.06 -45.14 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.325 -173.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -58.04 -49.73 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.24 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.85 -36.73 70.24 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.812 0.695 . . . . 0.0 110.993 -172.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.1 m -65.79 -41.25 92.18 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.611 0.365 . . . . 0.0 110.81 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.591 HG21 ' HB3' ' A' ' 30' ' ' MET . 54.7 t -71.03 -33.03 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.748 0.819 . . . . 0.0 110.841 175.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -65.39 -42.9 92.14 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.441 1.096 . . . . 0.0 110.522 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -92.91 -6.15 49.24 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.048 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.07 36.59 24.27 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.431 1.092 . . . . 0.0 111.812 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -156.45 151.91 26.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.007 0.923 . . . . 0.0 109.768 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.83 121.62 19.3 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -105.95 160.82 24.8 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 124.054 0.942 . . . . 0.0 110.342 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -54.3 108.7 0.31 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.991 2.461 . . . . 0.0 112.756 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -62.03 -34.08 75.57 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.736 174.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -58.15 -26.88 63.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.833 1.253 . . . . 0.0 112.087 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -74.54 -37.76 62.94 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.446 0.699 . . . . 0.0 110.362 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.49 -0.7 29.52 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.398 0.679 . . . . 0.0 112.33 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 27.0 p -75.42 110.7 10.0 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.055 0.455 . . . . 0.0 111.039 -177.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.6 mt -73.26 -17.38 61.34 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.332 1.053 . . . . 0.0 111.041 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.613 HG21 ' HA ' ' A' ' 68' ' ' LYS . 13.7 t -74.67 -26.48 59.88 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.608 0.763 . . . . 0.0 111.837 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.343 -0.837 . . . . 0.0 109.694 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 48.5 mm . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -85.0 81.68 8.79 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.796 0.839 . . . . 0.0 109.571 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.3 p -121.48 106.92 11.86 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.086 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -88.56 137.1 32.62 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.579 0.751 . . . . 0.0 109.489 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.4 t -144.02 156.51 44.41 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.258 0.623 . . . . 0.0 110.156 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.4 m -65.96 149.25 50.52 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 123.537 0.523 . . . . 0.0 110.538 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -107.76 21.94 16.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.883 0.873 . . . . 0.0 110.267 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.417 HG23 ' HA ' ' A' ' 84' ' ' LEU . 64.6 mt -67.71 -50.3 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.209 0.604 . . . . 0.0 110.223 -177.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.85 16.2 17.32 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.01 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -62.44 -36.56 82.78 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 120.913 0.387 . . . . 0.0 111.569 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -98.77 8.36 45.04 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.688 0.795 . . . . 0.0 111.161 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 71.9 m -117.24 114.1 23.15 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.605 0.762 . . . . 0.0 111.134 -174.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.35 126.77 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.41 HG23 HG23 ' A' ' 52' ' ' VAL . 3.3 mp -114.89 131.47 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.142 0.577 . . . . 0.0 111.425 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 41' ' ' TYR . 16.7 t80 -114.34 114.27 25.68 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.639 1.175 . . . . 0.0 108.635 169.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.7 mt -88.48 137.83 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -142.74 143.05 32.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.887 0.875 . . . . 0.0 109.646 -166.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.96 -137.84 32.37 Favored Glycine 0 C--N 1.346 1.117 0 O-C-N 123.519 0.512 . . . . 0.0 111.975 -174.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.1 145.38 37.24 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 171.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.514 HG21 HG12 ' A' ' 52' ' ' VAL . 37.1 p -142.21 140.67 32.39 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.741 1.216 . . . . 0.0 108.619 178.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -109.76 126.34 29.31 Favored Pre-proline 0 N--CA 1.485 1.277 0 CA-C-N 118.288 0.495 . . . . 0.0 110.264 171.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HD2' HD21 ' A' ' 27' ' ' LEU . 43.9 Cg_endo -76.15 174.3 53.63 Favored 'Cis proline' 0 C--N 1.374 1.905 0 C-N-CA 124.362 -1.099 . . . . 0.0 112.076 2.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.04 144.23 4.96 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.938 0.774 . . . . 0.0 114.094 -174.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 10.0 ptp180 -55.4 -36.3 66.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.191 0.596 . . . . 0.0 112.151 -172.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.93 -32.13 72.37 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.992 0.517 . . . . 0.0 111.857 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 30' ' ' MET . 8.5 tt0 -68.45 -51.84 39.16 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.454 HD21 ' HD2' ' A' ' 22' ' ' PRO . 91.9 mt -55.29 -39.58 70.05 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.606 0.763 . . . . 0.0 111.006 176.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -59.67 -47.61 84.93 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.628 1.171 . . . . 0.0 109.514 -178.105 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -65.96 -39.65 90.59 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.029 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.557 ' HB3' HG21 ' A' ' 79' ' ' VAL . 26.4 mmt -60.79 -33.27 72.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.876 0.47 . . . . 0.0 110.986 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -72.29 -51.92 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.398 0.679 . . . . 0.0 111.004 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.0 -47.42 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.573 0.749 . . . . 0.0 111.817 -174.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.82 -16.61 58.98 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.031 0.932 . . . . 0.0 111.713 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -109.76 28.33 8.68 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.903 0.881 . . . . 0.0 111.235 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.24 5.9 88.46 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.4 -0.818 . . . . 0.0 114.227 170.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.69 160.57 32.81 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 115.105 0.802 . . . . 0.0 115.105 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -105.38 162.0 13.83 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.557 -0.821 . . . . 0.0 109.44 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -136.09 164.88 27.0 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.502 174.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.8 ' HB3' HD11 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -136.77 130.38 31.86 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -66.34 -46.69 75.95 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 124.131 0.894 . . . . 0.0 113.263 -164.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.46 ' HA ' ' CE1' ' A' ' 15' ' ' TYR . 74.7 t80 -164.49 132.74 3.43 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.641 0.776 . . . . 0.0 109.471 -175.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 39' ' ' LEU . 4.5 mp -137.2 112.26 9.04 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.956 0.502 . . . . 0.0 110.856 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.3 t -90.77 84.5 5.85 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.4 m 66.79 9.54 6.83 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.717 1.207 . . . . 0.0 112.742 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 57.9 tptt -73.62 137.39 44.19 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.356 1.063 . . . . 0.0 110.247 -176.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -98.63 72.08 2.0 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.839 0.456 . . . . 0.0 109.771 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.0 m -126.96 -10.43 6.0 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.039 0.536 . . . . 0.0 110.615 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.415 HG12 HD22 ' A' ' 42' ' ' LEU . 8.8 p -113.54 143.28 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.066 0.546 . . . . 0.0 110.734 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 t -108.41 -13.82 14.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.923 0.489 . . . . 0.0 111.55 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -138.94 128.23 24.17 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.383 0.673 . . . . 0.0 109.953 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.645 ' HB ' HG22 ' A' ' 69' ' ' VAL . 66.4 mt -114.18 136.43 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG12 HG21 ' A' ' 20' ' ' THR . 86.8 t -113.19 119.33 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.86 173.3 11.85 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.595 0.758 . . . . 0.0 109.613 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -89.77 -44.17 10.17 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 174.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -130.34 145.84 51.84 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.041 -1.436 . . . . 0.0 108.473 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.525 ' HG ' HG11 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -136.13 117.34 11.57 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.181 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' O ' ' HG3' ' A' ' 61' ' ' ARG . 95.2 Cg_endo -77.31 155.38 32.64 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.861 2.374 . . . . 0.0 113.201 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.0 mt -51.32 -49.72 60.79 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.062 1.345 . . . . 0.0 114.266 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.56 -31.38 69.54 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.467 -177.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -72.11 -27.77 62.85 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 118.183 0.447 . . . . 0.0 111.131 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 85.3 mtt180 -60.1 -38.58 83.39 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 172.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.7 mt -64.88 -43.59 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.61 0.764 . . . . 0.0 110.782 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 6.2 mm-40 -72.99 -21.76 60.79 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.374 0.67 . . . . 0.0 111.396 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -113.19 27.11 9.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.275 1.03 . . . . 0.0 110.119 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.36 -28.17 69.58 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.186 0.595 . . . . 0.0 112.303 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -88.67 -29.38 19.94 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.936 0.495 . . . . 0.0 111.017 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -88.87 117.36 27.82 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -71.11 87.17 0.76 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.963 0.505 . . . . 0.0 109.677 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.645 HG22 ' HB ' ' A' ' 51' ' ' ILE . 22.9 t -81.09 128.41 38.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.34 172.31 16.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 124.874 1.27 . . . . 0.0 110.034 -175.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 60.9 p -85.28 159.47 56.33 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.81 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.32 -24.32 67.37 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.714 2.276 . . . . 0.0 112.718 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.82 -26.52 68.17 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.498 1.119 . . . . 0.0 112.084 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 37.1 t90 -61.63 -40.56 95.29 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.173 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 75' ' ' ILE . 2.8 mp -76.69 -49.65 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.025 0.93 . . . . 0.0 108.961 -177.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.98 -51.36 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.079 0.952 . . . . 0.0 111.343 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.43 -39.4 71.06 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.622 -173.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.5 p -64.49 -44.97 89.31 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 120.949 0.404 . . . . 0.0 111.309 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 30' ' ' MET . 41.7 t -65.5 -33.74 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.356 1.062 . . . . 0.0 111.298 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -72.83 -38.66 67.06 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 120.8 0.334 . . . . 0.0 110.889 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -89.0 -7.66 55.56 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.816 0.846 . . . . 0.0 112.048 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.89 27.85 16.97 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.669 1.188 . . . . 0.0 112.474 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -138.23 165.36 26.89 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.804 0.841 . . . . 0.0 110.365 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.417 ' HA ' HG23 ' A' ' 8' ' ' ILE . 51.2 tp -82.53 142.91 31.45 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 169.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.5 mt -110.61 155.06 42.8 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 123.777 0.831 . . . . 0.0 110.407 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.05 111.55 1.79 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.145 1.897 . . . . 0.0 110.309 166.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -59.64 -27.54 66.45 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.627 0.771 . . . . 0.0 111.961 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -58.37 -28.35 65.05 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.219 1.008 . . . . 0.0 111.974 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -71.9 -35.79 69.82 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.26 0.624 . . . . 0.0 110.674 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -105.91 7.48 32.17 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.649 0.78 . . . . 0.0 111.561 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.2 t -65.28 116.5 6.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.961 0.904 . . . . 0.0 112.456 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.5 -24.77 56.88 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.431 0.692 . . . . 0.0 111.443 175.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.545 HG23 ' HB ' ' A' ' 69' ' ' VAL . 22.7 p -69.56 -21.67 63.6 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.174 0.59 . . . . 0.0 112.315 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 C--O 1.249 1.069 0 CA-C-O 119.045 -0.502 . . . . 0.0 109.655 177.277 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 11.8 tt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.8 t -148.6 117.57 6.74 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.4 t -155.01 163.24 40.58 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.316 0.646 . . . . 0.0 110.397 -176.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -78.91 76.69 5.4 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 166.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 p -103.85 101.24 11.04 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.848 -166.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.4 m -69.22 122.27 18.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.737 0.815 . . . . 0.0 109.484 173.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.446 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -73.92 30.12 0.08 Allowed 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -166.476 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.24 -46.84 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 124.029 0.932 . . . . 0.0 111.694 176.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -107.13 10.22 30.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.196 0.599 . . . . 0.0 111.55 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -57.46 -43.84 84.32 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.378 0.671 . . . . 0.0 111.301 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -78.69 -18.8 53.78 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.262 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.85 127.19 44.71 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.728 0.811 . . . . 0.0 112.306 -172.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 49' ' ' THR . 40.8 t -96.81 130.66 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 162.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 31' ' ' ILE . 4.4 mp -121.56 122.86 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 36.8 t80 -105.1 125.52 51.07 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 167.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.434 HG12 ' HB ' ' A' ' 52' ' ' VAL . 47.4 mt -98.85 139.8 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -136.07 141.52 44.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.334 1.053 . . . . 0.0 109.893 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.47 -149.13 49.45 Favored Glycine 0 C--N 1.348 1.206 0 O-C-N 123.804 0.69 . . . . 0.0 113.439 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -95.54 116.3 28.63 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.64 0.776 . . . . 0.0 109.893 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.436 HG21 HG12 ' A' ' 52' ' ' VAL . 72.9 p -129.15 134.85 48.22 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.17 0.988 . . . . 0.0 108.673 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -111.16 131.37 22.23 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-N 117.993 0.36 . . . . 0.0 110.727 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.84 173.87 53.98 Favored 'Cis proline' 0 C--N 1.38 2.188 0 C-N-CA 124.416 -1.077 . . . . 0.0 111.992 0.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.81 146.86 9.03 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.053 0.846 . . . . 0.0 114.248 -173.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -52.39 -34.82 49.7 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.667 1.187 . . . . 0.0 112.763 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.455 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.4 pp -63.26 -43.63 97.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.452 0.301 . . . . 0.0 110.959 177.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -72.18 -41.71 66.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.083 0.553 . . . . 0.0 110.486 -176.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.6 mt -56.02 -43.96 78.24 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.344 0.658 . . . . 0.0 111.18 170.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.541 ' HA ' HD12 ' A' ' 31' ' ' ILE . 10.8 m170 -65.41 -34.94 79.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.097 0.559 . . . . 0.0 111.042 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 22.7 mm-40 -65.39 -41.17 93.99 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.584 0.354 . . . . 0.0 110.268 174.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.656 ' HB3' HG21 ' A' ' 79' ' ' VAL . 68.5 mtt -58.52 -35.72 72.73 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.364 0.665 . . . . 0.0 111.243 176.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 28' ' ' HIS . 64.6 mt -72.76 -51.8 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.757 0.823 . . . . 0.0 111.609 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.5 t -70.38 -41.83 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.286 0.634 . . . . 0.0 111.648 -172.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -65.92 -12.72 56.81 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.652 0.781 . . . . 0.0 111.983 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -107.84 24.99 12.09 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.349 1.06 . . . . 0.0 111.227 174.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.71 15.5 68.86 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.878 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.03 161.15 25.4 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 122.918 0.294 . . . . 0.0 113.335 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -106.53 148.63 27.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.673 0.789 . . . . 0.0 109.854 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -131.5 151.12 51.84 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.069 0.547 . . . . 0.0 110.746 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.6 tp -115.27 137.44 52.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.639 1.176 . . . . 0.0 108.975 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.57 -35.75 33.89 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.155 0.982 . . . . 0.0 112.997 -173.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -171.17 163.68 7.23 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.568 1.147 . . . . 0.0 108.4 -169.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 42' ' ' LEU . 4.1 mm? -100.6 76.14 1.8 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.775 0.798 . . . . 0.0 110.472 176.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.8 t -107.26 -13.22 15.19 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.873 165.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.7 m -90.06 -170.82 2.91 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.57 1.148 . . . . 0.0 110.715 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -83.16 -153.82 0.13 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.721 0.808 . . . . 0.0 108.845 173.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -77.33 73.3 3.91 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.925 0.869 . . . . 0.0 109.644 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.7 m -84.84 -37.57 20.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.572 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.07 150.54 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.654 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 13' ' ' VAL . 10.0 t -115.17 -22.7 9.33 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.524 0.729 . . . . 0.0 111.081 175.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.416 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 27.8 m170 -133.77 126.19 30.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.491 0.717 . . . . 0.0 109.824 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.648 ' HB ' HG22 ' A' ' 69' ' ' VAL . 68.5 mt -109.39 139.84 30.66 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.436 HG12 HG21 ' A' ' 20' ' ' THR . 61.2 t -110.74 122.0 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.156 0.582 . . . . 0.0 109.704 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.69 170.65 18.2 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.454 0.701 . . . . 0.0 109.568 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.2 t -108.87 -48.24 3.32 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 168.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -106.83 91.41 3.66 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.06 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.482 ' HG ' HG11 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -112.18 106.99 55.99 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.34 147.78 44.76 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.77 2.98 . . . . 0.0 113.84 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.41 -38.34 71.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.758 0.823 . . . . 0.0 110.667 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.402 ' HB3' ' NZ ' ' A' ' 59' ' ' LYS . 3.2 mmmp? -51.56 -55.23 20.31 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.241 1.016 . . . . 0.0 110.899 172.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 63' ' ' GLU . 43.0 mtmt -80.79 -10.18 59.75 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.98 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -72.4 -30.97 65.14 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.474 0.579 . . . . 0.0 109.885 170.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.8 mt -80.54 -40.84 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 123.448 0.467 . . . . 0.0 109.922 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 42.3 mt-10 -67.34 -37.24 82.96 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.333 0.653 . . . . 0.0 111.147 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -104.68 26.59 8.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.865 0.866 . . . . 0.0 110.44 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.24 -23.79 64.84 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.828 0.451 . . . . 0.0 111.249 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.438 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.8 OUTLIER -70.52 -28.33 64.86 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.253 0.621 . . . . 0.0 110.031 175.556 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -95.45 174.77 6.85 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 170.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 34.6 mmtm -126.55 97.02 4.86 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.648 HG22 ' HB ' ' A' ' 51' ' ' ILE . 17.6 t -76.32 129.78 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.634 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.95 176.95 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.059 1.344 . . . . 0.0 109.298 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.9 m -85.95 156.51 57.92 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.464 0.706 . . . . 0.0 110.255 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' O ' HG23 ' A' ' 76' ' ' VAL . 19.8 Cg_endo -56.6 -27.57 70.35 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 123.116 2.544 . . . . 0.0 112.401 174.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -61.51 -24.11 66.38 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.884 1.274 . . . . 0.0 111.959 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -62.21 -48.09 81.53 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 172.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.6 mp -69.66 -47.08 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.0 -174.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 72' ' ' PRO . 95.9 t -59.83 -54.75 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.068 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 16.7 t70 -72.38 -36.41 68.71 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.741 -171.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.2 m -60.9 -40.32 92.68 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 120.694 0.283 . . . . 0.0 111.087 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.656 HG21 ' HB3' ' A' ' 30' ' ' MET . 45.2 t -70.0 -40.27 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.293 0.637 . . . . 0.0 111.476 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -63.57 -46.14 87.27 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.837 0.455 . . . . 0.0 110.794 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 17.5 mm-40 -80.16 -15.44 57.07 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.484 0.714 . . . . 0.0 111.066 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.86 28.8 14.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.015 1.326 . . . . 0.0 112.114 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -141.99 158.57 43.61 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.962 0.905 . . . . 0.0 109.755 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.4 tp -79.14 121.63 25.25 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.9 mt -101.68 158.57 31.53 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 124.104 0.962 . . . . 0.0 110.055 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.88 108.76 0.96 Allowed 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.153 1.902 . . . . 0.0 111.64 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -57.87 -33.15 68.39 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.726 0.81 . . . . 0.0 110.948 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -59.65 -31.16 69.28 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.533 1.133 . . . . 0.0 111.729 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -70.73 -39.44 73.35 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.548 0.739 . . . . 0.0 110.844 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -93.56 0.27 56.56 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.427 0.691 . . . . 0.0 111.661 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.6 t -72.2 124.91 26.02 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.612 0.365 . . . . 0.0 111.702 -171.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.5 mt -73.07 -43.89 61.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.99 168.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p -75.63 84.12 2.65 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.292 0.568 . . . . 0.0 109.805 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.248 1.026 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -178.642 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 38.7 pt . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.9 m -145.42 -48.79 0.23 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.419 0.687 . . . . 0.0 110.152 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.2 t -135.1 132.62 38.35 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.171 0.589 . . . . 0.0 110.505 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.504 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 51.1 mt-30 -113.77 30.15 7.47 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.477 1.111 . . . . 0.0 109.925 177.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.5 p -77.25 -58.09 3.47 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -90.11 82.16 6.11 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.811 0.844 . . . . 0.0 108.868 174.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.504 ' HD3' ' HB3' ' A' ' 4' ' ' GLN . 20.3 pttp -131.1 30.09 4.6 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.338 0.655 . . . . 0.0 110.662 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.4 -49.5 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.062 0.545 . . . . 0.0 111.623 -172.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.576 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 57.2 m-85 -108.4 17.48 22.07 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.778 -176.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -62.34 -43.88 97.79 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.508 0.723 . . . . 0.0 111.112 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -84.82 6.17 25.68 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.499 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.9 m -120.94 131.66 54.48 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.958 0.903 . . . . 0.0 111.261 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.457 HG22 ' HD3' ' A' ' 37' ' ' LYS . 15.1 t -103.18 127.27 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 166.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.499 ' H ' ' HA ' ' A' ' 38' ' ' PHE . 4.1 mp -118.1 120.17 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.14 0.576 . . . . 0.0 112.196 -176.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 13.0 t80 -106.54 126.26 52.04 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 166.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -97.95 110.85 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -104.25 128.13 51.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.943 0.897 . . . . 0.0 109.598 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.17 -171.45 50.32 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.383 0.427 . . . . 0.0 113.224 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.07 135.91 33.11 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.638 0.775 . . . . 0.0 110.09 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.505 HG21 HG12 ' A' ' 52' ' ' VAL . 41.5 p -138.06 148.4 45.02 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.417 1.087 . . . . 0.0 109.214 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 21' ' ' LYS . 11.9 mmpt? -105.54 120.63 48.78 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 165.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HD2' HD21 ' A' ' 27' ' ' LEU . 31.3 Cg_endo -84.2 174.62 37.64 Favored 'Cis proline' 0 CA--C 1.553 1.474 0 C-N-CA 123.896 -1.293 . . . . 0.0 111.295 -1.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.98 155.38 8.84 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -171.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -48.35 -37.1 15.81 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.022 1.329 . . . . 0.0 112.743 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.4 pp -63.05 -44.68 95.17 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.943 0.897 . . . . 0.0 111.439 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.5 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.5 tp-100 -71.83 -45.85 60.07 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.648 0.779 . . . . 0.0 110.542 -176.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.459 HD21 ' HD2' ' A' ' 22' ' ' PRO . 93.1 mt -57.86 -46.43 84.83 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.058 176.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.436 ' HA ' HD12 ' A' ' 31' ' ' ILE . 15.5 m170 -60.6 -36.46 78.62 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.019 0.528 . . . . 0.0 111.573 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -63.97 -46.41 84.77 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.74 0.416 . . . . 0.0 110.347 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.63 ' HB3' HG21 ' A' ' 79' ' ' VAL . 26.2 mmt -60.15 -34.0 72.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.71 0.804 . . . . 0.0 111.926 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 28' ' ' HIS . 78.6 mt -68.63 -51.26 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.526 0.73 . . . . 0.0 111.551 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.7 t -73.05 -40.4 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.034 0.534 . . . . 0.0 111.775 -172.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.04 -15.95 64.05 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.387 0.675 . . . . 0.0 111.754 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -109.57 26.59 10.47 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.768 0.827 . . . . 0.0 110.398 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.51 39.24 79.65 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-N 114.582 -1.19 . . . . 0.0 114.013 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.576 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -115.74 161.41 12.89 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 -173.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.457 ' HD3' HG22 ' A' ' 13' ' ' VAL . 88.3 tttt -105.86 150.13 25.9 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 122.925 0.49 . . . . 0.0 110.22 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.499 ' HA ' ' H ' ' A' ' 14' ' ' ILE . 27.0 p90 -141.85 164.73 29.39 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.374 0.67 . . . . 0.0 110.637 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.553 HD12 ' HB ' ' A' ' 48' ' ' VAL . 55.8 mt -124.8 146.88 49.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.723 0.809 . . . . 0.0 109.647 168.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.484 ' HD2' ' H ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -73.87 -35.3 64.72 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.661 175.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.484 ' H ' ' HD2' ' A' ' 40' ' ' HIS . 53.9 p90 -175.59 175.32 2.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.517 1.527 . . . . 0.0 109.02 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -105.74 117.51 34.2 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.9 t -71.91 -42.39 66.77 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.778 0.831 . . . . 0.0 110.527 178.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.3 t -171.98 -49.7 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.681 0.792 . . . . 0.0 110.513 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -77.94 144.4 36.86 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.727 0.811 . . . . 0.0 111.919 -169.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -73.09 97.65 2.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.156 0.982 . . . . 0.0 109.147 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.2 p -125.06 -37.96 2.38 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.3 0.64 . . . . 0.0 112.477 -171.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.553 ' HB ' HD12 ' A' ' 39' ' ' LEU . 6.6 p -82.52 152.76 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 122.262 -0.274 . . . . 0.0 110.345 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 t -114.55 -24.0 9.01 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.804 0.441 . . . . 0.0 111.508 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -129.0 130.28 46.45 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.763 0.425 . . . . 0.0 110.399 -177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 23.1 mt -116.93 134.97 58.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.505 HG12 HG21 ' A' ' 20' ' ' THR . 91.0 t -108.67 120.99 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.176 0.59 . . . . 0.0 110.954 -176.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.81 150.88 48.59 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.485 1.114 . . . . 0.0 108.625 172.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 20' ' ' THR . 41.1 t -76.71 -33.12 58.21 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 172.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -161.17 111.41 1.69 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.341 1.056 . . . . 0.0 108.348 170.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.652 HD22 HG11 ' A' ' 69' ' ' VAL . 16.4 tp -85.37 135.11 39.2 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 118.65 -0.69 . . . . 0.0 109.596 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.62 153.65 47.7 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.147 2.565 . . . . 0.0 112.56 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.59 -45.61 93.33 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.23 0.612 . . . . 0.0 112.125 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.0 mmmm -65.99 -36.81 84.32 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.642 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -66.96 -28.27 68.14 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.486 0.314 . . . . 0.0 111.649 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.17 -31.94 72.7 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.453 0.301 . . . . 0.0 110.319 173.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.9 mt -74.43 -37.76 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.07 0.548 . . . . 0.0 110.56 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 27.4 mm-40 -66.34 -42.01 88.73 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.424 0.631 . . . . 0.0 110.637 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -104.65 27.58 7.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.256 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.68 -22.83 64.35 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.495 0.718 . . . . 0.0 112.222 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.29 -6.94 59.46 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.849 0.46 . . . . 0.0 111.312 174.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -110.68 141.75 43.51 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.585 0.754 . . . . 0.0 109.411 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -79.33 86.03 5.1 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.652 HG11 HD22 ' A' ' 56' ' ' LEU . 55.7 t -75.47 130.04 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.474 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.601 HG11 ' HB2' ' A' ' 87' ' ' TRP . 35.2 m -134.65 177.18 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.003 1.321 . . . . 0.0 109.831 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -89.32 160.48 42.41 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.136 0.975 . . . . 0.0 110.541 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.459 ' HB3' HD11 ' A' ' 27' ' ' LEU . 23.3 Cg_endo -59.56 -23.38 70.79 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.802 2.335 . . . . 0.0 111.995 172.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.65 -27.31 66.25 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 124.708 1.203 . . . . 0.0 111.863 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -61.43 -43.68 98.45 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.108 0.413 . . . . 0.0 110.45 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.9 mp -72.05 -46.16 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -176.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.93 -47.8 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.371 1.068 . . . . 0.0 111.625 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.26 -42.27 75.8 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.761 0.824 . . . . 0.0 111.574 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.6 m -65.85 -36.85 84.59 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 120.72 0.295 . . . . 0.0 111.191 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 30' ' ' MET . 24.9 t -70.41 -33.86 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.771 0.828 . . . . 0.0 110.655 173.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -67.24 -34.51 77.61 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.549 0.74 . . . . 0.0 110.977 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -96.38 -13.6 23.1 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.189 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.64 39.06 24.99 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.284 1.033 . . . . 0.0 111.245 -175.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -156.18 156.53 34.35 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.884 0.874 . . . . 0.0 109.886 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.6 tp -75.51 107.77 7.87 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.245 0.618 . . . . 0.0 110.432 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.7 mt -88.72 156.09 50.22 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.556 0.742 . . . . 0.0 111.081 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.34 108.66 1.22 Allowed 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.524 2.149 . . . . 0.0 111.809 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.601 ' HB2' HG11 ' A' ' 70' ' ' VAL . 24.0 p90 -62.8 -20.91 65.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.112 0.965 . . . . 0.0 112.538 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -57.14 -35.45 69.52 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.176 0.99 . . . . 0.0 111.545 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.39 -27.23 68.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.798 0.839 . . . . 0.0 110.986 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.1 -6.15 18.87 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.696 0.798 . . . . 0.0 111.067 -175.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 75.5 m -64.19 130.17 42.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -172.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.3 mt -106.94 22.05 16.59 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.475 1.11 . . . . 0.0 110.498 173.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.7 p -64.22 -50.78 66.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.615 0.766 . . . . 0.0 110.717 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 C--O 1.251 1.163 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.659 176.49 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 119.895 -0.097 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.4 p -71.46 85.2 0.83 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.536 0.734 . . . . 0.0 110.984 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.597 ' HB2' ' HB2' ' A' ' 6' ' ' SER . 22.8 p -173.9 122.61 0.33 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.48 1.112 . . . . 0.0 109.03 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -106.41 -49.76 3.28 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.071 0.548 . . . . 0.0 110.12 177.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -84.35 -26.3 28.55 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.421 0.689 . . . . 0.0 111.114 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.597 ' HB2' ' HB2' ' A' ' 3' ' ' SER . 20.3 m -84.11 27.82 0.65 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.772 0.829 . . . . 0.0 112.795 -171.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -125.26 32.01 5.46 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.183 0.993 . . . . 0.0 110.337 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.403 HG23 ' HA ' ' A' ' 84' ' ' LEU . 55.9 mt -57.52 -45.72 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 123.568 0.747 . . . . 0.0 111.462 -176.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.758 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 50.8 m-85 -112.03 18.98 18.28 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.988 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -60.22 -40.21 89.36 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 118.312 0.505 . . . . 0.0 111.933 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -87.16 -7.64 57.76 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.687 0.795 . . . . 0.0 111.031 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 74.1 m -112.45 108.51 17.68 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 122.189 0.995 . . . . 0.0 111.818 -171.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.469 HG12 HG23 ' A' ' 48' ' ' VAL . 38.7 t -89.14 125.76 42.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 164.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.45 ' HB ' HD13 ' A' ' 31' ' ' ILE . 2.7 mp -110.54 128.63 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.774 0.83 . . . . 0.0 110.624 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -111.6 116.53 30.96 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 166.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.0 mt -84.62 137.13 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.421 0.688 . . . . 0.0 109.388 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -146.55 134.91 21.87 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.311 1.044 . . . . 0.0 109.696 -168.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.02 -160.2 54.02 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.638 0.586 . . . . 0.0 112.915 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.22 131.36 41.88 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -148.64 136.91 21.11 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.775 1.23 . . . . 0.0 108.843 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -116.65 134.07 22.95 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 122.974 0.51 . . . . 0.0 110.72 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.75 174.98 44.24 Favored 'Cis proline' 0 C--N 1.371 1.739 0 C-N-CA 124.408 -1.08 . . . . 0.0 110.996 -7.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.16 157.88 9.34 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -171.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -53.53 -35.44 60.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.546 1.138 . . . . 0.0 113.004 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 pp -60.62 -44.65 96.08 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.327 0.392 . . . . 0.0 110.559 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 30' ' ' MET . 6.9 tp-100 -70.48 -51.89 25.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.811 0.845 . . . . 0.0 110.045 -176.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -54.79 -41.33 70.43 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.525 0.73 . . . . 0.0 111.505 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' HG23 ' A' ' 32' ' ' VAL . 23.3 m170 -55.13 -48.2 74.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.314 0.645 . . . . 0.0 110.47 176.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.05 -38.95 92.5 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.731 0.645 . . . . 0.0 111.25 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.605 ' HB3' HG21 ' A' ' 79' ' ' VAL . 55.8 mmm -58.22 -36.54 73.3 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.505 0.722 . . . . 0.0 110.407 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.45 HD13 ' HB ' ' A' ' 14' ' ' ILE . 46.1 mt -72.23 -50.46 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.897 0.879 . . . . 0.0 111.654 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 28' ' ' HIS . 57.9 t -67.44 -42.26 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.233 -172.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.06 -12.6 61.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.967 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.457 ' NE2' HG13 ' A' ' 79' ' ' VAL . 34.1 m-70 -110.09 26.38 10.73 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.391 0.676 . . . . 0.0 111.163 173.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.83 37.93 75.67 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 114.867 -1.061 . . . . 0.0 113.615 171.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.758 ' HA3' ' HB2' ' A' ' 9' ' ' PHE . . . -118.61 -179.68 16.94 Favored Glycine 0 CA--C 1.503 -0.691 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 -175.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -123.74 144.52 49.63 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 121.201 0.524 . . . . 0.0 110.459 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -122.03 159.81 26.25 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.292 1.037 . . . . 0.0 108.484 173.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.421 HD22 ' HB ' ' A' ' 48' ' ' VAL . 32.7 tp -120.08 138.43 53.55 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.64 -46.76 74.73 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 124.049 0.843 . . . . 0.0 111.98 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -179.74 146.28 0.25 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.788 0.835 . . . . 0.0 109.525 -170.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.56 130.74 35.01 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.152 0.581 . . . . 0.0 109.943 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.7 t -81.24 -62.89 1.53 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.4 m -155.9 -58.2 0.1 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.58 0.752 . . . . 0.0 110.156 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -66.27 153.53 42.31 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.946 0.898 . . . . 0.0 111.175 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -59.55 96.37 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.661 0.784 . . . . 0.0 110.071 171.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.4 m -108.75 12.3 25.78 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.42 1.088 . . . . 0.0 109.936 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.469 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -149.14 152.02 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.268 0.627 . . . . 0.0 109.655 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 t -107.33 -27.99 10.15 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.086 0.555 . . . . 0.0 111.595 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -124.62 135.8 53.4 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.308 0.643 . . . . 0.0 109.952 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.662 ' HB ' HG12 ' A' ' 69' ' ' VAL . 67.9 mt -121.85 116.09 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.7 t -91.5 120.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 123.951 0.901 . . . . 0.0 110.245 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.08 167.73 20.96 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.318 1.047 . . . . 0.0 108.786 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.1 t -115.45 -49.39 2.75 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -119.62 124.05 45.36 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.427 HD23 ' HG2' ' A' ' 61' ' ' ARG . 14.8 tp -150.02 128.35 5.93 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.07 155.91 17.58 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.594 2.863 . . . . 0.0 113.812 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.525 HD23 ' NH2' ' A' ' 61' ' ' ARG . 85.7 mt -55.48 -60.82 2.89 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.916 0.886 . . . . 0.0 111.022 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -59.8 -29.64 68.36 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.329 1.052 . . . . 0.0 111.851 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.484 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -68.69 -46.25 69.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.008 178.17 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.525 ' NH2' HD23 ' A' ' 58' ' ' LEU . 53.4 mtm180 -69.18 -27.49 65.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.917 0.887 . . . . 0.0 112.234 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 98.0 mt -72.37 -35.71 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.194 0.598 . . . . 0.0 109.843 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.4 -36.96 68.78 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.458 0.647 . . . . 0.0 109.504 172.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -87.98 17.49 4.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.03 0.932 . . . . 0.0 111.141 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.69 -23.81 65.34 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.035 0.534 . . . . 0.0 109.687 166.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -73.61 -6.89 49.48 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.084 0.954 . . . . 0.0 111.03 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -122.91 157.99 31.35 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.352 1.061 . . . . 0.0 109.46 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.67 85.06 5.56 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.662 HG12 ' HB ' ' A' ' 51' ' ' ILE . 22.1 m -83.06 131.38 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.187 -177.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.501 HG11 ' HB2' ' A' ' 87' ' ' TRP . 24.6 m -134.67 171.17 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.612 0.765 . . . . 0.0 109.859 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.43 ' HB3' HD21 ' A' ' 92' ' ' LEU . 47.5 p -86.85 156.95 55.21 Favored Pre-proline 0 C--O 1.245 0.828 0 C-N-CA 123.85 0.86 . . . . 0.0 109.469 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.403 ' O ' HG23 ' A' ' 76' ' ' VAL . 29.6 Cg_endo -60.4 -21.58 68.15 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 122.55 2.167 . . . . 0.0 112.707 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.23 -29.71 67.72 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.652 1.181 . . . . 0.0 111.818 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -59.58 -47.26 86.28 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.564 0.54 . . . . 0.0 110.084 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.7 mp -70.8 -51.95 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.754 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 72' ' ' PRO . 75.7 t -53.95 -52.66 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.224 1.01 . . . . 0.0 111.447 -176.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.66 -43.59 65.78 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.855 0.722 . . . . 0.0 111.158 -173.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.3 p -60.33 -36.96 79.16 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.018 0.437 . . . . 0.0 111.302 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.605 HG21 ' HB3' ' A' ' 30' ' ' MET . 46.9 t -67.89 -41.34 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.087 0.955 . . . . 0.0 111.512 176.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -67.38 -37.39 83.07 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.084 0.554 . . . . 0.0 111.285 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.19 -14.7 40.42 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.25 1.02 . . . . 0.0 111.479 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.27 26.71 15.58 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.146 1.378 . . . . 0.0 112.408 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -137.47 164.38 28.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.126 0.57 . . . . 0.0 110.32 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.403 ' HA ' HG23 ' A' ' 8' ' ' ILE . 60.7 tp -78.31 131.48 37.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.363 0.665 . . . . 0.0 110.606 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -108.33 150.66 40.84 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.744 1.218 . . . . 0.0 109.458 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.49 113.87 3.84 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.363 2.042 . . . . 0.0 110.47 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.501 ' HB2' HG11 ' A' ' 70' ' ' VAL . 64.6 p-90 -61.76 -27.8 68.99 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.629 0.771 . . . . 0.0 111.922 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -62.46 -27.82 69.39 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.134 0.974 . . . . 0.0 112.097 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -71.59 -21.07 61.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.799 0.84 . . . . 0.0 111.071 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -114.7 1.11 14.09 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.335 1.054 . . . . 0.0 110.731 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 27.0 t -69.27 131.36 44.75 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.196 0.598 . . . . 0.0 111.783 -171.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' A' ' 71' ' ' SER . 38.6 mt -96.72 8.66 43.75 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.29 0.636 . . . . 0.0 112.111 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.414 HG22 ' OG ' ' A' ' 91' ' ' SER . 13.5 t -72.43 -14.56 61.72 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.526 0.603 . . . . 0.0 111.075 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.5 t . . . . . 0 C--O 1.251 1.167 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 169.854 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.3 p -92.94 51.85 1.75 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -72.47 -50.12 28.41 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.833 -170.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 56.94 29.18 15.86 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.265 1.031 . . . . 0.0 110.575 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.2 m -75.88 101.39 5.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.494 1.118 . . . . 0.0 111.846 -172.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.9 p -63.6 125.08 23.09 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 167.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -82.87 33.57 0.44 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.367 1.067 . . . . 0.0 113.445 -161.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.469 HD12 ' CD2' ' A' ' 34' ' ' HIS . 67.1 mt -55.0 -48.1 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.763 1.225 . . . . 0.0 111.867 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.583 ' HZ ' ' HA ' ' A' ' 75' ' ' ILE . 73.1 m-85 -105.05 7.34 33.9 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.463 -175.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 47.3 tptt -57.1 -49.31 76.29 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.053 0.541 . . . . 0.0 110.721 -174.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -84.11 -4.95 59.13 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.937 -1.028 . . . . 0.0 111.927 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.1 m -106.37 128.21 53.86 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.28 0.632 . . . . 0.0 111.488 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.463 ' H ' HG22 ' A' ' 49' ' ' THR . 21.9 t -95.12 126.94 47.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 168.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.38 122.73 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-O 121.241 0.543 . . . . 0.0 111.491 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -104.63 143.36 33.18 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.132 1.373 . . . . 0.0 107.693 167.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.8 mt -114.36 113.46 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -102.73 123.57 46.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.29 1.036 . . . . 0.0 110.417 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.66 -169.3 50.58 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.826 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -85.54 110.32 19.13 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.554 0.742 . . . . 0.0 109.487 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.659 HG21 HG12 ' A' ' 52' ' ' VAL . 74.0 p -122.55 148.54 45.08 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.556 1.143 . . . . 0.0 108.963 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -99.9 131.66 24.12 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-N 118.155 0.434 . . . . 0.0 111.962 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HD2' HD21 ' A' ' 27' ' ' LEU . 80.9 Cg_endo -76.57 175.92 46.14 Favored 'Cis proline' 0 C--N 1.374 1.883 0 C-N-CA 124.65 -0.979 . . . . 0.0 110.933 -7.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.5 148.43 7.22 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 114.631 0.612 . . . . 0.0 114.631 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -52.26 -35.79 50.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.082 0.953 . . . . 0.0 112.927 -174.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 26' ' ' GLN . 4.1 pp -63.51 -41.24 98.53 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.502 0.321 . . . . 0.0 111.08 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.44 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.4 tp-100 -69.88 -48.43 58.75 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.675 0.79 . . . . 0.0 110.509 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.46 HD21 ' HD2' ' A' ' 22' ' ' PRO . 69.4 mt -56.48 -46.26 80.55 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.259 0.623 . . . . 0.0 111.242 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.461 ' O ' HG23 ' A' ' 32' ' ' VAL . 9.9 m80 -56.57 -43.82 80.37 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.455 0.702 . . . . 0.0 110.677 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.57 -36.74 83.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.81 0.444 . . . . 0.0 111.3 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.587 ' HB3' HG21 ' A' ' 79' ' ' VAL . 23.8 mmt -63.79 -35.2 79.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.188 0.595 . . . . 0.0 110.895 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.8 mt -70.61 -51.17 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.724 0.81 . . . . 0.0 111.244 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 28' ' ' HIS . 64.1 t -66.89 -40.33 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.111 0.564 . . . . 0.0 111.731 -173.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.09 -11.67 61.0 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.098 0.559 . . . . 0.0 111.845 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.469 ' CD2' HD12 ' A' ' 8' ' ' ILE . 22.9 m80 -100.33 20.49 14.67 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.208 1.003 . . . . 0.0 111.107 170.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' O ' ' HD2' ' A' ' 10' ' ' LYS . . . 72.11 9.44 71.79 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.815 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.86 159.66 46.0 Favored Glycine 0 C--O 1.24 0.518 0 N-CA-C 114.124 0.41 . . . . 0.0 114.124 -170.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -101.89 153.63 19.67 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -144.01 145.81 32.46 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.938 0.495 . . . . 0.0 110.967 -174.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HG ' HG22 ' A' ' 47' ' ' THR . 1.5 mm? -130.43 145.88 51.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.039 0.936 . . . . 0.0 109.961 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -109.45 -34.08 6.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.749 0.82 . . . . 0.0 109.069 170.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -117.64 138.47 51.95 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -169.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.489 ' HA ' HG21 ' A' ' 47' ' ' THR . 0.8 OUTLIER -106.32 168.34 9.22 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.346 0.593 . . . . 0.0 110.838 -170.222 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.8 t -135.49 174.35 10.71 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.866 1.266 . . . . 0.0 108.337 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -69.81 -24.63 63.51 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.277 0.56 . . . . 0.0 110.211 172.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -82.13 177.71 8.66 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.353 1.061 . . . . 0.0 111.332 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.29 88.27 0.45 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.622 HG22 ' HG ' ' A' ' 39' ' ' LEU . 3.0 m -84.61 -28.18 26.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.486 -176.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.448 HG23 HG12 ' A' ' 13' ' ' VAL . 11.5 p -150.09 162.95 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.956 0.903 . . . . 0.0 109.193 -172.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 13' ' ' VAL . 10.3 t -115.86 -18.19 10.82 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.504 0.593 . . . . 0.0 112.237 174.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -134.04 131.71 39.18 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.418 0.687 . . . . 0.0 110.662 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.634 ' HB ' HG12 ' A' ' 69' ' ' VAL . 54.0 mt -114.73 129.58 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.659 HG12 HG21 ' A' ' 20' ' ' THR . 62.7 t -92.03 129.01 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.89 0.876 . . . . 0.0 109.461 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.99 147.0 30.26 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.114 0.566 . . . . 0.0 110.492 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.0 t -90.07 -34.49 15.9 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -145.65 142.36 28.97 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.191 173.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.425 HD12 ' HG2' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -146.73 107.57 4.03 Favored Pre-proline 0 CA--C 1.561 1.37 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.394 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.31 159.32 53.78 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.216 2.61 . . . . 0.0 113.061 -175.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.428 ' O ' HG13 ' A' ' 62' ' ' ILE . 65.7 mt -50.99 -49.7 59.87 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.375 1.07 . . . . 0.0 112.432 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -59.56 -45.71 91.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.039 0.536 . . . . 0.0 111.209 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -69.29 -26.03 64.53 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.634 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HG2' HD12 ' A' ' 56' ' ' LEU . 58.2 mtm180 -73.88 -26.68 60.68 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.721 0.409 . . . . 0.0 111.015 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 58' ' ' LEU . 60.8 mt -76.44 -39.27 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.85 -42.01 97.68 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.864 0.866 . . . . 0.0 110.955 174.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -104.01 26.81 8.27 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.081 0.952 . . . . 0.0 110.411 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.12 -19.48 64.04 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 122.842 0.457 . . . . 0.0 111.274 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -75.49 -26.12 57.88 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.839 0.856 . . . . 0.0 110.647 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -111.7 145.42 39.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.999 0.92 . . . . 0.0 109.418 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -85.74 90.6 8.07 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -177.294 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.634 HG12 ' HB ' ' A' ' 51' ' ' ILE . 27.1 m -74.0 127.13 35.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.83 172.59 15.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.827 1.251 . . . . 0.0 109.112 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.7 m -79.44 151.5 74.86 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.99 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.43 ' O ' HG23 ' A' ' 76' ' ' VAL . 26.5 Cg_endo -60.11 -25.35 79.61 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.78 2.32 . . . . 0.0 111.643 170.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -59.12 -23.16 61.89 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.173 1.389 . . . . 0.0 112.149 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -61.3 -46.62 89.56 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.021 0.439 . . . . 0.0 109.921 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.583 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . 2.7 mp -71.86 -47.24 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.113 -177.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 72' ' ' PRO . 61.0 t -54.92 -50.72 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.999 0.92 . . . . 0.0 111.01 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -70.58 -47.52 59.85 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.205 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.441 ' HA ' HD23 ' A' ' 85' ' ' LEU . 79.5 p -63.09 -44.31 96.08 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.281 0.363 . . . . 0.0 111.445 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.587 HG21 ' HB3' ' A' ' 30' ' ' MET . 55.5 t -59.3 -42.8 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.054 0.942 . . . . 0.0 110.738 174.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -68.97 -33.06 73.08 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.033 0.933 . . . . 0.0 111.897 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.38 -11.35 38.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.583 0.753 . . . . 0.0 111.625 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.78 22.43 12.43 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.572 1.149 . . . . 0.0 112.323 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -142.49 156.5 45.16 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.512 0.725 . . . . 0.0 109.552 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.09 117.97 18.35 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 78' ' ' SER . 4.0 mm? -92.6 144.83 29.33 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 167.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.626 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 38.2 Cg_endo -62.49 124.04 13.5 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.081 1.854 . . . . 0.0 111.587 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -64.15 -19.85 65.58 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.079 0.952 . . . . 0.0 112.469 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.626 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.8 pt20 -59.3 -25.84 64.46 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.928 0.891 . . . . 0.0 111.629 174.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -71.22 -27.07 63.22 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.779 0.832 . . . . 0.0 110.115 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -116.26 2.02 13.2 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.911 0.884 . . . . 0.0 111.975 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.4 p -66.57 110.87 3.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.473 0.709 . . . . 0.0 111.537 -173.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.416 ' HB2' HG23 ' A' ' 69' ' ' VAL . 78.3 mt -74.87 -16.34 60.68 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.834 173.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 p -47.81 -51.97 20.65 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.724 1.209 . . . . 0.0 111.601 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 CA--C 1.553 1.094 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.129 176.829 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.9 t -83.67 66.7 9.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.396 0.679 . . . . 0.0 109.661 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.7 p -72.41 100.28 2.65 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.028 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -113.92 93.8 4.54 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.879 0.871 . . . . 0.0 108.841 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 m -137.83 131.97 31.9 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.426 1.09 . . . . 0.0 109.581 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.504 ' HB2' ' HD2' ' A' ' 34' ' ' HIS . 17.7 m -62.22 126.04 25.98 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.098 0.559 . . . . 0.0 109.939 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.35 32.32 0.19 Allowed 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -170.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.567 HG23 ' HA ' ' A' ' 84' ' ' LEU . 43.1 mt -54.83 -48.13 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.609 1.164 . . . . 0.0 111.109 176.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -113.87 10.11 17.66 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.882 -173.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -50.56 -65.75 0.51 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.848 0.859 . . . . 0.0 112.813 -167.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -85.8 -8.56 58.04 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.075 0.464 . . . . 0.0 110.338 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.3 m -79.9 118.02 21.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.698 0.799 . . . . 0.0 110.036 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -90.09 124.78 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 170.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.0 126.32 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.023 0.529 . . . . 0.0 111.727 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -104.96 148.82 26.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.977 1.311 . . . . 0.0 108.421 172.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -120.47 137.78 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -135.24 128.01 31.1 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.512 1.125 . . . . 0.0 108.876 -167.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.46 -159.75 48.7 Favored Glycine 0 C--N 1.343 0.924 0 O-C-N 123.404 0.44 . . . . 0.0 112.073 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -103.21 111.37 23.73 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.283 0.633 . . . . 0.0 109.624 176.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.0 p -119.49 134.64 55.12 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.743 1.217 . . . . 0.0 108.657 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -102.62 133.34 20.53 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 117.896 0.316 . . . . 0.0 110.629 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.02 164.86 85.74 Favored 'Cis proline' 0 C--N 1.384 2.405 0 C-N-CA 124.469 -1.055 . . . . 0.0 112.272 1.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.71 157.99 3.89 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 124.169 0.918 . . . . 0.0 114.556 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -54.65 -37.17 65.37 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.931 0.892 . . . . 0.0 112.478 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 26' ' ' GLN . 3.3 pp -62.96 -43.99 97.29 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.162 0.585 . . . . 0.0 110.804 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.528 ' N ' HD12 ' A' ' 25' ' ' LEU . 56.2 tp60 -67.79 -49.8 60.39 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.878 0.871 . . . . 0.0 110.618 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.1 mt -55.15 -51.47 66.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.877 0.871 . . . . 0.0 111.649 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.46 ' HA ' HD12 ' A' ' 31' ' ' ILE . 23.0 m170 -61.35 -35.26 76.93 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.873 0.469 . . . . 0.0 111.649 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.476 ' O ' HD13 ' A' ' 33' ' ' LEU . 43.3 mt-10 -64.23 -46.48 83.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 0.0 110.191 173.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.768 ' HB3' HG21 ' A' ' 79' ' ' VAL . 67.3 mtt -56.68 -37.3 70.66 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.465 0.65 . . . . 0.0 110.499 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 28' ' ' HIS . 77.2 mt -66.17 -50.65 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.556 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 28' ' ' HIS . 59.3 t -71.06 -29.35 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.144 0.578 . . . . 0.0 111.173 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 29' ' ' GLU . 6.8 mp -64.34 -22.73 67.05 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.515 1.126 . . . . 0.0 110.744 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.504 ' HD2' ' HB2' ' A' ' 6' ' ' SER . 60.6 m80 -105.5 26.93 8.88 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.398 1.079 . . . . 0.0 110.678 173.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.35 18.14 76.62 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.471 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.2 164.41 29.62 Favored Glycine 0 C--O 1.241 0.556 0 N-CA-C 114.179 0.431 . . . . 0.0 114.179 -171.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -113.42 161.79 16.88 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.824 0.849 . . . . 0.0 109.635 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -145.78 154.29 41.86 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 122.715 0.406 . . . . 0.0 111.406 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -121.16 137.64 54.58 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.23 -49.92 9.57 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.619 0.768 . . . . 0.0 112.724 -173.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -166.97 134.48 2.5 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.6 1.56 . . . . 0.0 108.691 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.438 HD11 HG12 ' A' ' 48' ' ' VAL . 3.4 mm? -82.51 100.76 10.28 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.465 0.706 . . . . 0.0 110.272 -175.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.2 p -92.64 65.49 4.33 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.322 0.649 . . . . 0.0 109.809 175.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.8 t 64.4 12.94 7.71 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.845 1.258 . . . . 0.0 112.527 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -123.62 119.62 30.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.373 0.669 . . . . 0.0 110.624 -174.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 69.3 7.99 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.367 1.067 . . . . 0.0 112.514 -173.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.6 m -91.51 -22.95 20.11 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 121.792 -0.567 . . . . 0.0 111.439 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.438 HG12 HD11 ' A' ' 42' ' ' LEU . 6.1 p -92.86 152.23 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 122.23 -0.294 . . . . 0.0 111.665 -175.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.461 HG23 ' HD2' ' A' ' 50' ' ' HIS . 10.1 t -114.18 -25.34 8.53 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.348 0.659 . . . . 0.0 111.297 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.461 ' HD2' HG23 ' A' ' 49' ' ' THR . 58.5 m-70 -128.56 125.72 38.86 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.314 0.646 . . . . 0.0 109.742 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.478 ' HB ' HG22 ' A' ' 69' ' ' VAL . 40.4 mt -106.1 138.38 31.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.9 t -117.57 120.21 64.07 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 C-N-CA 123.905 0.882 . . . . 0.0 108.811 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -139.44 159.66 41.65 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.348 0.659 . . . . 0.0 109.612 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.0 t -84.64 -46.42 11.52 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 168.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -140.01 124.34 17.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.809 1.243 . . . . 0.0 108.933 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.447 HD22 HG11 ' A' ' 69' ' ' VAL . 38.7 tp -107.49 128.39 26.02 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.13 153.6 38.27 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.347 2.698 . . . . 0.0 112.832 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.4 mt -59.26 -44.88 92.38 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.707 0.803 . . . . 0.0 111.234 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -61.5 -46.65 89.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.24 1.016 . . . . 0.0 110.191 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -70.91 -24.66 62.5 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.993 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -73.71 -30.81 63.08 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.07 0.548 . . . . 0.0 110.132 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -70.99 -43.38 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.783 0.833 . . . . 0.0 109.957 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.32 -38.34 87.46 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.812 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.426 ' HA ' ' HD1' ' A' ' 67' ' ' TYR . 23.2 m-85 -100.22 26.26 6.7 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.976 0.911 . . . . 0.0 110.744 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 -24.95 66.59 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.291 0.637 . . . . 0.0 112.103 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -80.33 -27.45 38.34 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.072 0.549 . . . . 0.0 110.761 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.426 ' HD1' ' HA ' ' A' ' 64' ' ' PHE . 62.4 m-85 -88.72 141.63 28.35 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.78 0.832 . . . . 0.0 109.641 -177.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -82.97 85.86 7.08 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.478 HG22 ' HB ' ' A' ' 51' ' ' ILE . 41.4 t -77.9 128.68 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.266 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 87' ' ' TRP . 27.7 m -139.96 174.53 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.093 1.357 . . . . 0.0 109.466 -175.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.0 m -87.83 159.88 48.05 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.306 0.642 . . . . 0.0 110.382 171.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -58.66 -23.16 64.38 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.935 2.423 . . . . 0.0 112.485 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.21 -24.34 64.74 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.004 1.322 . . . . 0.0 112.151 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -62.15 -50.78 70.5 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 75' ' ' ILE . 2.6 mp -64.94 -52.15 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.87 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.19 -54.34 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.245 1.018 . . . . 0.0 111.537 -175.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -72.71 -37.31 67.85 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 123.335 0.397 . . . . 0.0 111.289 -172.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.5 m -63.95 -37.61 88.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.64 0.376 . . . . 0.0 111.234 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.768 HG21 ' HB3' ' A' ' 30' ' ' MET . 40.2 t -72.32 -36.8 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.896 0.878 . . . . 0.0 111.575 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -65.85 -41.09 92.12 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.763 0.425 . . . . 0.0 110.618 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -89.6 -10.33 46.42 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.78 0.832 . . . . 0.0 111.901 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 55.32 37.71 29.29 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.828 1.251 . . . . 0.0 112.226 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -146.76 155.5 42.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.815 0.846 . . . . 0.0 110.048 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.567 ' HA ' HG23 ' A' ' 8' ' ' ILE . 60.9 tp -78.11 94.76 4.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.403 0.681 . . . . 0.0 109.571 -178.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.22 151.74 66.78 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.771 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.66 110.55 0.84 Allowed 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.77 2.313 . . . . 0.0 112.685 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.514 ' HB2' HG11 ' A' ' 70' ' ' VAL . 61.7 p-90 -63.82 -22.23 66.82 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.917 0.887 . . . . 0.0 111.246 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -63.44 -24.16 67.71 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.284 1.034 . . . . 0.0 111.433 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.28 -5.99 58.4 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.232 0.613 . . . . 0.0 111.527 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -126.93 1.42 6.61 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.536 0.734 . . . . 0.0 110.895 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.9 p -68.49 113.46 6.05 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.456 0.702 . . . . 0.0 112.368 -170.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.9 mt -89.78 20.4 4.13 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.008 0.923 . . . . 0.0 111.283 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.5 p -68.4 -27.74 66.48 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.179 0.991 . . . . 0.0 111.553 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.937 176.861 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 58.3 mt . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -87.03 53.6 2.88 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.866 0.866 . . . . 0.0 110.526 -175.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.1 t -146.11 110.7 5.14 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.47 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -73.24 141.14 47.27 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.808 0.843 . . . . 0.0 110.131 178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.1 m 57.97 32.71 22.32 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.549 1.14 . . . . 0.0 112.37 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.5 p -86.68 15.77 5.36 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.008 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 10' ' ' LYS . 9.5 mtmp? -82.08 35.26 0.43 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.648 1.179 . . . . 0.0 112.103 -174.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.8 mt -50.49 -45.65 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 125.503 1.521 . . . . 0.0 112.243 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 75' ' ' ILE . 63.8 m-85 -108.98 16.49 22.59 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.412 0.685 . . . . 0.0 111.371 -174.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 7' ' ' LYS . 13.6 tptp -50.23 -51.91 40.36 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.035 0.934 . . . . 0.0 113.288 -168.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -99.5 -2.79 35.03 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.407 0.683 . . . . 0.0 111.069 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.6 m -82.2 128.47 34.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.141 0.577 . . . . 0.0 109.904 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.62 HG12 HG23 ' A' ' 48' ' ' VAL . 38.8 t -104.27 119.58 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 mp -119.62 131.95 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.294 0.638 . . . . 0.0 111.174 -173.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -113.67 150.95 32.49 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.935 1.694 . . . . 0.0 108.165 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.28 132.2 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -139.65 135.6 33.43 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.163 1.385 . . . . 0.0 108.562 -170.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.25 -172.76 54.35 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -92.65 110.41 21.84 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.516 HG21 HG12 ' A' ' 52' ' ' VAL . 65.4 p -113.74 141.57 47.1 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.05 0.94 . . . . 0.0 109.871 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.521 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -104.97 127.25 29.12 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 167.172 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.38 173.84 54.5 Favored 'Cis proline' 0 C--N 1.372 1.769 0 C-N-CA 124.184 -1.173 . . . . 0.0 112.276 -0.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.05 157.2 9.72 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.679 0.612 . . . . 0.0 113.939 -174.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -51.47 -35.45 39.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.127 0.971 . . . . 0.0 111.901 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 26' ' ' GLN . 2.1 pp -56.76 -48.95 76.69 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.049 0.939 . . . . 0.0 112.001 177.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.528 ' N ' HD12 ' A' ' 25' ' ' LEU . 6.8 tp-100 -72.37 -43.55 63.83 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.749 0.819 . . . . 0.0 110.334 -174.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.54 -44.79 96.4 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.854 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.58 ' HA ' HD12 ' A' ' 31' ' ' ILE . 16.5 m170 -61.26 -36.8 81.01 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.102 0.561 . . . . 0.0 111.0 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.19 -45.05 86.38 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.745 0.418 . . . . 0.0 110.632 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.543 ' SD ' HG11 ' A' ' 79' ' ' VAL . 23.9 mmt -59.29 -31.99 69.63 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.349 0.66 . . . . 0.0 111.475 176.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 28' ' ' HIS . 84.0 mt -69.39 -52.33 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.05 175.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 28' ' ' HIS . 59.9 t -72.29 -38.84 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 122.986 0.514 . . . . 0.0 112.164 -169.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.34 -19.14 64.37 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.199 0.6 . . . . 0.0 111.661 176.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -104.43 25.89 9.63 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.624 0.77 . . . . 0.0 111.4 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.65 14.75 70.24 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.654 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.82 161.17 36.23 Favored Glycine 0 C--O 1.242 0.618 0 N-CA-C 113.954 0.342 . . . . 0.0 113.954 -171.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -103.17 144.61 31.09 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.278 1.031 . . . . 0.0 108.614 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -134.29 145.37 49.01 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 122.961 0.505 . . . . 0.0 110.627 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.41 142.86 50.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.293 1.037 . . . . 0.0 109.277 173.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -109.05 -43.71 4.13 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.919 170.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -120.78 135.67 55.09 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.97 157.65 16.19 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.239 -171.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.4 t -92.77 12.73 22.49 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.532 0.733 . . . . 0.0 110.759 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.4 t 64.25 16.18 9.9 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.763 1.225 . . . . 0.0 110.906 -171.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -122.59 -170.73 2.14 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.069 1.347 . . . . 0.0 108.576 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -75.86 67.76 2.3 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.575 1.179 . . . . 0.0 110.186 174.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -89.01 -1.07 57.93 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.713 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.62 HG23 HG12 ' A' ' 13' ' ' VAL . 9.1 p -162.97 160.11 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.921 0.888 . . . . 0.0 109.436 -172.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.3 t -114.29 -21.27 10.51 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -126.5 139.17 53.43 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.04 0.536 . . . . 0.0 110.225 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.747 ' HB ' HG12 ' A' ' 69' ' ' VAL . 58.1 mt -124.42 129.72 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.516 HG12 HG21 ' A' ' 20' ' ' THR . 51.6 t -104.93 119.05 53.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 C-N-CA 123.741 0.816 . . . . 0.0 110.355 -172.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.07 146.44 35.45 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.6 p -85.38 -10.29 56.47 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.792 0.437 . . . . 0.0 110.613 173.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -156.76 89.05 1.07 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.48 1.112 . . . . 0.0 108.009 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.67 110.18 47.77 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.424 ' O ' ' HG3' ' A' ' 61' ' ' ARG . 54.3 Cg_exo -55.41 151.15 38.51 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.84 3.027 . . . . 0.0 114.001 -176.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.4 mt -57.2 -46.01 83.25 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 0.0 111.528 -177.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -63.88 -39.81 95.06 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.7 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.57 -34.95 77.99 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 119.431 -0.319 . . . . 0.0 111.657 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 80.0 mtt180 -60.36 -36.04 77.09 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 122.94 0.496 . . . . 0.0 110.69 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.9 mt -71.5 -42.13 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.009 0.923 . . . . 0.0 110.761 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.58 -26.94 61.05 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.204 0.602 . . . . 0.0 111.045 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.407 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . 20.7 m-85 -110.28 28.72 8.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.488 1.115 . . . . 0.0 109.76 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.54 -22.84 65.51 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -91.99 -26.93 18.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.16 0.584 . . . . 0.0 110.393 176.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.407 ' HD2' ' HA ' ' A' ' 64' ' ' PHE . 65.0 m-85 -85.86 135.13 33.82 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -83.96 86.48 7.18 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.747 HG12 ' HB ' ' A' ' 51' ' ' ILE . 21.4 m -77.18 127.69 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.117 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' ' 87' ' ' TRP . 35.9 m -136.8 172.3 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.339 1.056 . . . . 0.0 109.735 -175.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.1 m -80.69 154.91 73.62 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.301 172.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.25 -22.04 63.07 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.512 2.141 . . . . 0.0 111.869 171.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.9 -29.61 60.29 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.368 1.467 . . . . 0.0 112.292 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -63.57 -49.06 74.89 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 120.8 0.333 . . . . 0.0 110.34 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.437 ' O ' HG23 ' A' ' 79' ' ' VAL . 2.8 mp -68.38 -49.43 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.979 -175.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.1 t -58.48 -53.79 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.791 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 21.1 t0 -72.65 -31.73 65.33 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.081 0.238 . . . . 0.0 111.488 -172.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.591 ' HA ' HD13 ' A' ' 85' ' ' LEU . 58.0 m -63.68 -37.86 88.95 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 120.643 0.258 . . . . 0.0 110.932 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.543 HG11 ' SD ' ' A' ' 30' ' ' MET . 86.3 t -70.87 -36.45 64.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 122.97 0.508 . . . . 0.0 110.787 175.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -62.49 -45.59 92.3 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.769 0.428 . . . . 0.0 111.06 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 10.7 mm-40 -85.37 -11.88 53.5 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.252 0.621 . . . . 0.0 111.159 -176.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.26 34.98 10.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.758 1.223 . . . . 0.0 111.691 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -153.67 168.97 24.45 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.448 0.699 . . . . 0.0 110.647 -177.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -86.37 108.39 18.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.293 0.637 . . . . 0.0 109.879 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 78' ' ' SER . 10.8 mp -83.89 152.56 62.8 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.553 0.741 . . . . 0.0 110.654 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.566 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 49.0 Cg_endo -67.1 120.85 7.95 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.459 2.106 . . . . 0.0 111.295 171.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.531 ' HB2' HG11 ' A' ' 70' ' ' VAL . 69.0 p-90 -63.66 -21.67 66.5 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.695 0.798 . . . . 0.0 111.922 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.566 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 21.0 pt20 -59.08 -29.16 67.13 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.061 0.944 . . . . 0.0 111.945 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.62 -21.33 63.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.586 0.754 . . . . 0.0 111.504 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -121.49 9.64 10.31 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.823 0.849 . . . . 0.0 110.852 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.503 ' OG ' HG22 ' A' ' 93' ' ' THR . 41.2 t -72.91 114.33 10.93 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.614 0.766 . . . . 0.0 111.446 -172.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.7 mt -91.46 2.21 56.59 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.723 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.503 HG22 ' OG ' ' A' ' 91' ' ' SER . 6.7 t -74.23 -18.28 60.77 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.602 0.637 . . . . 0.0 111.179 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.7 t . . . . . 0 C--O 1.255 1.355 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.661 . . . . . . . . 0 0 . 1 stop_ save_